As Filed with the Securities and Exchange Commission on December 16, 2020
Registration File No. 333-248236
811-23604
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM N-6
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 o
Pre-Effective Amendment No.1 x
Post-Effective Amendment No.
and
REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 x
Amendment No.
(Check appropriate box or boxes)
Protective COLI VUL
(Exact name of registrant)
Protective Life Insurance Company
(Name of depositor)
2801 Highway 280 South
Birmingham, Alabama 35223
(Address of depositors principal executive offices)
(800) 265-1545
Depositors Telephone Number, including Area Code
ALYSON SAAD, Esq.
2801 Highway 280 South
Birmingham, Alabama 35223
(Name and address of agent for service)
Copy to:
Jo Cicchetti, Esq.
Faegre Drinker Biddle & Reath LLP
1500 K Street NW, Suite 1100
Washington, DC 20005 USA
Approximate date of proposed public offering: As soon as practicable after the effective date of this Registration Statement.
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until Registrant shall file a further amendment which specifically states that this Registration Statement shall become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
Title of Securities Being Registered: Individual Flexible Premium Variable Universal Life Insurance Policies
The information in this Prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.
PROSPECTUS
____, 2020 Protective Executive Benefits Registered VUL A Flexible Premium Variable Universal Life Insurance Policy |
Issued by
Protective COLI VUL and Protective Life Insurance Company 2801 Highway 280 South Birmingham, Alabama 35223 Telephone: (800) 265-1545 |
This Prospectus describes the Protective Executive Benefits Registered VUL individual flexible premium variable universal life insurance policy (the "Policy") issued by Protective Life Insurance Company (the "Company" or "Protective Life").
The Policy is designed for use by corporations and employers to provide life insurance coverage in connection with, among other things, deferred compensation plans and employer-financed insurance purchase arrangements. Under this Policy, the "Owner" is the corporation, employer or individual to whom the Policy is issued, and the "Insured" is the individual whose life is insured by the Policy. Under this Policy, the Owner is entitled to all rights in the Policy, including the right to designate a Beneficiary, and the Insured is the life insured under the Policy. Throughout this Prospectus, the Owner is also referred to as "you" or "your." The Policy is designed to meet the definition of a "life insurance contract" for federal income tax purposes.
This Prospectus sets forth basic information about the Policy and the Variable Account that a prospective investor should know before investing. As the Owner, you should consider the Policy in conjunction with other insurance you own. It may not be advantageous to replace existing insurance with the Policy, or to finance the purchase of the Policy through a loan or through withdrawals from another policy. Replacement of existing insurance with the Policy may reduce or otherwise change existing life insurance benefits. Additional fees and charges also may apply. Please read this Prospectus and the Statement of Additional Information carefully before you invest.
This Prospectus contains important information you should understand before purchasing a Policy, including a description of the material rights and obligations under the Policy. We use certain special terms that are defined in the Glossary. Your Policy and any riders or endorsements are the formal contractual agreement between you and the Company. It is important that you read the Policy and endorsements which reflect other variations. All material state variations can be found in Appendix B of the Prospectus. You should keep this Prospectus on file for future reference.
A prospectus for each of the Funds available through the Variable Account contains comprehensive information about each Fund. Please read these documents before investing and save them for future reference.
Beginning January 1, 2021, we will no longer send you paper copies of shareholder reports for the Funds ("Reports") unless you specifically request paper copies from us. Instead, the Reports will be available on a website. We will notify you by mail each time the Reports are posted. The notice will provide the website links to access the Reports as well as instructions for requesting paper copies. If you wish to continue receiving your Reports in paper free of charge from us, please call 1-888-353-2654. Your election to receive the Reports in paper will apply to all Funds available with your Contract. If you have already elected to receive the Reports electronically, you will not be affected by this change and need not take any action. If you wish to receive the Reports and other SEC disclosure documents from us electronically, please contact us at 1-888-353-2654.
Please note that the Policies and/or the Funds:
• are not guaranteed to provide any benefits;
• are not insured by the FDIC or any other government agency;
• are not bank deposits or other obligations of a bank and are not bank guaranteed; and
• are subject to risks, including loss of the amount invested, tax risks and Policy Lapse.
The Securities and Exchange Commission ("SEC") has not approved or disapproved the Policy or determined that this Prospectus is accurate or complete. Any representation to the contrary is a criminal offense.
PRO.COLI.1020
TABLE OF CONTENTS
SUMMARY OF THE POLICY AND ITS
BENEFITS AND RISKS |
3 |
||||||
Summary of Policy Risks |
5 |
||||||
FEE TABLES |
8 |
||||||
FUND EXPENSES |
10 |
||||||
THE COMPANY AND THE
FIXED ACCOUNT |
10 |
||||||
THE VARIABLE ACCOUNT AND
FUNDS |
11 |
||||||
AIM Variable Insurance Funds (Invesco
Variable Insurance Funds) |
14 |
||||||
Alger Portfolios |
|
||||||
American Century Variable
Portfolios, Inc. |
14 |
||||||
American Century Variable
Portfolios II, Inc. |
14 |
||||||
American Funds Insurance Series® |
14 |
||||||
Blackrock Variable Series Funds, Inc. |
15 |
||||||
BNY Mellon Stock Index Fund, Inc. |
15 |
||||||
BNY Mellon Variable Investment Fund |
|
||||||
Columbia Funds Variable Insurance
Trust |
|
||||||
Davis Variable Account Fund, Inc. |
15 |
||||||
Deutsche DWS Investments
VIT Funds |
15 |
||||||
Deutsche DWS Variable Series I |
15 |
||||||
Deutsche DWS Variable Series II |
15 |
||||||
Eaton Vance Variable Trust |
15 |
||||||
Federated Insurance Series |
15 |
||||||
Fidelity® Variable Insurance Products |
16 |
||||||
Fidelity Variable Insurance Products
Fund III |
16 |
||||||
Goldman Sachs Variable Insurance
Trust |
16 |
||||||
Great-West Funds, Inc. |
16 |
||||||
Great-West Lifetime Funds |
17 |
||||||
Great-West Profile Funds |
18 |
||||||
Janus Aspen Series |
18 |
||||||
JPMorgan Insurance Trust |
18 |
||||||
Legg Mason Partners Variable Equity
Trust |
19 |
Lord Abbett Series Fund, Inc. |
19 |
||||||
MFS® Variable Insurance Trust |
19 |
||||||
MFS® Variable Insurance Trust II |
19 |
||||||
MFS® Variable Insurance Trust III |
19 |
||||||
Neuberger Berman Advisers
Management Trust |
19 |
||||||
PIMCO Variable Insurance Trust |
20 |
||||||
Pioneer Variable Contracts Trust |
20 |
||||||
Putnam Variable Trust |
20 |
||||||
Royce Capital Fund |
|
||||||
T. Rowe Price Equity Series, Inc |
21 |
||||||
VanEck VIP Trust |
21 |
||||||
Victory Variable Insurance Funds |
21 |
||||||
THE POLICY |
23 |
||||||
PREMIUMS |
24 |
||||||
CALCULATION OF POLICY VALUE |
26 |
||||||
DEATH BENEFIT PROCEEDS |
27 |
||||||
TRANSFERS OF POLICY VALUE |
30 |
||||||
SURRENDERS AND WITHDRAWALS |
34 |
||||||
POLICY LOANS |
35 |
||||||
SUSPENSION OR DELAYS IN
PAYMENTS |
36 |
||||||
POLICY REINSTATEMENT |
37 |
||||||
CHARGES AND DEDUCTIONS |
38 |
||||||
REPORTS TO OWNERS |
41 |
||||||
TAX CONSIDERATIONS |
41 |
||||||
SUPPLEMENTAL BENEFITS |
48 |
||||||
USE OF THE POLICY |
50 |
||||||
STATE VARIATIONS |
51 |
||||||
SALE OF THE POLICIES |
52 |
||||||
PAYMENTS WE RECEIVE |
53 |
||||||
BUSINESS DISRUPTION AND
CYBERSECURITY RISKS |
54 |
||||||
LEGAL PROCEEDINGS |
54 |
||||||
FINANCIAL STATEMENTS |
55 |
||||||
GLOSSARY |
55 |
||||||
STATEMENT OF ADDITIONAL
INFORMATION |
60 |
||||||
Table of Contents |
60 |
||||||
APPENDIX A |
A-1 |
||||||
APPENDIX B |
B-1 |
2
SUMMARY OF THE POLICY AND ITS BENEFITS AND RISKS
The Policy is an individual flexible premium variable universal life insurance policy. This summary describes the Policy's important benefits and risks. The sections in the Prospectus following this summary discuss the Policy's benefits and other provisions in more detail. Capitalized terms used in this Prospectus are defined where first used and/or in the Glossary at the end of this Prospectus.
The Policy is offered for sale in all jurisdictions where we are authorized to do business and where the Policy is approved by the appropriate insurance department or regulatory authorities. Individual Policy features may not be available in all states or may vary by state. The state in which your Policy is issued governs whether or not certain features, Riders, endorsements, charges and fees are allowed in your Policy. Any significant variations from the information appearing in this Prospectus which are required due to individual state requirements are contained in your Policy (or provided by separate Rider or endorsement). Appendix B in this Prospectus describes all material state variations.
The Company is a variable life insurance policy provider. It is not a fiduciary and therefore does not give advice or make recommendations regarding insurance or investment products.
Purposes of the Policy. The Policy is designed for use by corporations and employers and certain individuals to provide life insurance coverage in connection with, among other things, deferred compensation plans and employer-financed insurance purchase agreements. We will issue Policies on the lives of prospective Insureds who meet our underwriting standards. The Owner of the Policy is the person, persons, or entity entitled to all rights in this Policy while the Insured (the person whose life is covered by the Policy) is living, including designation of a Beneficiary.
Flexibility. The Policy is designed to be flexible to meet your specific life insurance needs. You have the flexibility to choose the investment options and premiums you pay. The Sub-Accounts are separate divisions of the Variable Account (Protective COLI VUL separate account) that invest in a particular Fund (an underlying mutual fund). The Fixed Account is part of the Company's General Account, which holds all of the Company's assets other than those held in the Variable Account or other separate accounts.
Investment Options. You may invest in your choice of numerous different investment options available in the Sub-Accounts, as well as a Fixed Account, within your Policy.
Premium Payments. Premium is an amount you pay to the Company to establish and maintain life insurance coverage. The minimum initial premium will vary based on various factors, including the age of the Insured and the Death Benefit Option you select, but may not be less than $100.00. Thereafter, you have the flexibility to choose the amount and timing of premium payments, within certain limits.
Death Benefit. You may select one of two Death Benefit Options used to determine the amount payable on the death of the Insured:
Option 1: Level Death
The Death Benefit will be the greater of:
a) The Total Face Amount shown on the Policy Schedule, less any partial withdrawals; or
b) The Cash Value on the Insured's date of death multiplied by the applicable factor in the Table of Death Benefit Factors shown on the Policy Schedule for the Insured's age at date of death.
Option 2: Coverage Plus
The Death Benefit will be the greater of:
a) The Total Face Amount shown on the Policy Schedule, plus the Policy Value on the Insured's date of death; or
b) The Cash Value on the Insured's date of death multiplied by the applicable factor in the Table of Death Benefit Factors shown on the Policy Schedule for the Insured's age at date of death.
The Death Benefit may be greater if necessary to satisfy federal tax law requirements. Policy Value is the sum of the values in the Variable Account, the Fixed Account, and the value in the Loan Account (an account within the Company's General Account that holds the collateral for Policy Loans). Cash Value is Policy Value plus any applicable Return of Expense Charge Benefit (a percentage of the expense charge that is payable upon a complete surrender).
Cancellation Privilege. For a limited time after you receive your Policy, you have the right to cancel your Policy and receive a refund. The Policy will be void from the start, and the Company will refund the Policy Value plus any fees and charges, less any withdrawals or distributions made. The Owner bears the investment risk of amounts allocated to the Sub-Accounts during the Cancellation Period, except in states that require a return of premium. In those states that require us to return your premium, we will refund the greater of the Policy Value or the premium paid plus any fees and charges, less any withdrawals and distributions already made. See "THE POLICY Cancellation Privilege."
3
Policy Maturity. If the Insured is living and the Policy is in force on the Policy Anniversary at Attained Age 121 then this Policy will remain in force. The Death Benefit will be equal to Policy Value. No Premium payments will be required. Partial withdrawals and Policy loans will be permitted, subject to the provisions herein and the provisions of any riders and endorsements attached to the Policy. No further cost of insurance charges will be deducted.
Transfers. At any time after the Cancellation Period (period during which the Owner may return the Policy for a refund), you may transfer Policy Value among the Sub-Accounts and the Fixed Account, subject to the restrictions including on amount and frequency of transfers described in "TRANSFERS OF POLICY VALUE" below. The Company also may restrict or refuse to honor frequent transfers, including "market timing" transfers. See "TRANSFERS OF POLICY VALUE" for more information. In addition, a Policy Owner may elect to make automatic or scheduled transfers under the Dollar-Cost Averaging (a systematic and automatic way to allocate a pre-determined dollar amount among the Sub-Accounts) and Portfolio Rebalancing (a way to periodically transfer value among specified Sub-Accounts) features. See "TRANSFERS OF POLICY VALUE Dollar-Cost Averaging" and "TRANSFERS OF POLICY VALUE Portfolio Rebalancing."
Withdrawals. You may request a partial withdrawal of your Policy at any time while the Policy is in force. The amount of any partial withdrawal must be at least $500 and may not exceed 90% of your Policy Value less outstanding Policy Debt (sum of all outstanding policy loans plus accrued interest). We will charge an administrative fee not greater than $25 per withdrawal on partial withdrawals after the first in a Policy Year. The Total Face Amount (if Death Benefit Option 1 applies) and your Policy Value will be reduced by the amount of any withdrawals. Withdrawals may have tax consequences. See "TAX CONSIDERATIONS."
Surrender Benefit. The Owner may surrender this Policy for the surrender benefit. The surrender benefit is the Cash Surrender Value less any monthly cost of insurance charges on the date of surrender. Cash Surrender Value is the Cash Value minus Policy Debt and any liens for payments made under an accelerated death benefit endorsement plus accrued interest. All coverage will end on the effective date of surrender of the Policy. No Death Benefits will be paid after the effective date of surrender of the Policy.
Loans. While the Policy is in force, the Owner, by Request, may obtain a Policy loan on the security of the Policy. Policy loan amounts will be withdrawn first on a pro rata basis from the Sub-Accounts and/or Fixed Account unless the Company, at its discretion, allows the Owner to specify such Sub-Accounts and/or Fixed Account. Loans may be treated as taxable income if your Policy is a "modified endowment contract" ("MEC") for federal income tax purposes. In general, a Policy will be treated as a MEC if total premiums paid at any time during the first seven Policy Years exceed the sum of the net level premiums which would have been paid on or before that time if the Policy provided for paid-up future benefits after the payment of seven level annual premiums ("seven-pay test"). See also TAX CONSIDERATIONS Policies that are MECs.
Target Premium. Your target premium is actuarially determined and will depend on the Base Policy Face Amount of your Policy, your Issue Age (Insured's age as of the nearest birthday on the Policy Effective Date), your sex (except in unisex states), and rating class (if any). The target premium is used to determine your expense charge applied to the premium and the sales compensation we pay. Payment of the target premium does not guarantee that your Policy will not lapse, and you may need to pay additional premiums to keep your Policy in force. Notwithstanding payment of the target premium, a Policy will Lapse if its Policy Value less the sum of all outstanding Policy loans plus accrued interest is insufficient to cover the fees and charges deducted from Policy Value each month. See "CHARGES AND FEES Monthly Deductions." If the Cash Surrender Value on any Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. See POLICY REINSTATEMENT Lapse. Each increase to the Base Policy Face Amount is considered to be a new segment to the Policy. Each segment will have a separate target premium associated with it.
Changes in Total Face Amount. You may increase or decrease the Total Face Amount of the Policy at any time within certain limits. Each increase or decrease in the Total Face Amount must be at least $25,000. The minimum face amount is $100,000. See "DEATH BENEFIT PROCEEDS Changing the Face Amount."
Settlement Options. Payment of Death Benefit proceeds will be paid in a lump sum unless the Beneficiary chooses to receive the proceeds under a settlement option that the Company is then offering.
Return of Expense Charge Benefit. Under certain conditions and where permitted by applicable state insurance law, if the Owner fully surrenders the Policy for its Cash Surrender Value during the first seven Policy Years, the Company will include the Return of Expense Charge Benefit in the Cash Value. See "SURRENDERS AND WITHDRAWALS Return of Expense Charge Benefit".
4
Supplemental Benefits. The following riders and endorsements are available:
• Term Life Insurance;
• Change of Insured (not available to individual Owners); and
• Terminal Illness Accelerated Death Benefit (only available to individual Owners. May not be available in every state)
There is no charge for the Change of Insured Endorsement; however, there is a one-time fee assessed for administration and underwriting costs when this endorsement is exercised. There is no charge for the Terminal Illness Accelerated Death Benefit Endorsement however there is a onetime transaction charge when this Endorsement is invoked and will be deducted from the accelerated death benefit payment paid to the Owner.
The Variable Account. We have established a separate account, referred to herein as the "Variable Account," to fund the variable benefits under the Policy. The assets of the Variable Account are insulated from the claims of our general creditors. See "THE VARIABLE ACCOUNT AND THE FUNDS."
Investment Options and Funds. You may allocate net Premium among the available Sub-Accounts of the Variable Account or the Fixed Account. Each Sub-Account invests in the shares of a Fund. Each Fund has its own investments objectives, strategies and risks, which are described in the accompanying prospectuses for the Funds. You may Transfer Policy Value from one Sub-Account to another Sub-Account or the Fixed Account, subject to the terms and restrictions described herein.
The Fixed Account. The Fixed Account consists of assets owned by Protective Life with respect to the Policies, other than those in the Variable Account. Subject to applicable law, Protective Life has sole discretion over the investment of the assets of the Fixed Account. The Fixed Account is part of our General Account. Unlike premiums and Policy Value allocated to the Variable Account, we assume the risk of investment gain or loss on amounts held in the Fixed Account. Guarantees of Net Premiums (premium payments minus the applicable premium expense charges) allocated to the Fixed Account, and interest credited thereto, are backed by Protective Life. The Fixed Account Value is calculated daily.
You generally may allocate some or all of your Net Premium and may transfer some or all of your Policy Value to the Fixed Account. However, there are limitations on transfers involving the Fixed Account. Due to these limitations, if you want to transfer all of your Policy Value from the Fixed Account to the Variable Account, it may take several years to do so. You should carefully consider whether the Fixed Account meets your investment needs.
See also "THE COMPANY AND THE FIXED ACCOUNT."
Reinstatement. Subject to the terms and conditions described herein, a Policy may be reinstated within 3 years after the coverage ceased, unless it has been surrendered.
Summary of Policy Risks
Investment Risk (Policy Value not Guaranteed). If you invest your Policy Value in one or more Sub-Accounts, then you will be subject to the risk that investment performance may be unfavorable causing the Policy Value to decrease and the monthly deduction of fees and charges ("Monthly Deduction") to increase (which, in turn, further decreases future Policy Value). This is because poor investment performance diminishes Policy Value thereby increasing the Net Amount at Risk (the difference between the Death Benefit and the Policy Value) under the Policy and, correspondingly, increasing the cost of insurance which is part of the Monthly Deduction. You could lose everything you invest.
If you allocate Policy Value to the Fixed Account, then we credit your Policy Value (in the Fixed Account) with a declared rate of interest, but you assume the risk that the rate may decrease, although it will never be lower than the guaranteed minimum annual interest effective rate of 2%. See "THE VARIABLE ACCOUNT AND THE FUNDS."
Risk of Lapse. Your Policy may terminate if your Policy Value on any Monthly Anniversary Day (the same day each month as the Policy Effective Date) is less than the amount of the Monthly Deduction due on that date. If your Policy would terminate due to insufficient value, we will send you notice of the premium required to prevent termination of the Policy at the expiration of the grace period while the Insured is living ("Lapse"). You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions or the Policy will Lapse. (See "POLICY REINSTATEMENT"). You may reinstate a Lapsed Policy, subject to certain conditions. A lapse of your Policy at a time when a policy loan is outstanding may have tax consequences. See "TAX CONSIDERATIONS."
5
Surrender Risks. The Cash Surrender Value of the Policy is generally the Cash Value less any Policy Debt and any liens (including accrued interest) and less any Monthly Deduction applied on the date of surrender. No Death Benefit Proceeds will be paid after the effective date of surrender of the Policy.
You should purchase the Policy only if you have the financial ability to keep it in force for a substantial period of time. You should not purchase the Policy if you intend to surrender all or part of the account value in the near future. We designed the Policy to meet long-term financial goals. The Policy is not suitable as a short-term investment.
A surrender or withdrawal may have tax consequences. See "TAX CONSIDERATIONS."
Tax Risks. Although the federal income tax requirements applicable to the Policy are complex and there is limited guidance regarding these requirements, we anticipate that the Policy will be treated as a life insurance contract for federal income tax purposes. Assuming that a Policy qualifies as a life insurance contract for federal income tax purposes, you generally should not be considered to be in receipt of any portion of your Policy's Cash Value until there is an actual distribution from the Policy. Moreover, Death Benefits payable under the Policy should be excludable from the gross income of the Beneficiary. Although the Beneficiary generally should not have to pay federal income tax on the Death Benefit, other taxes, such as estate taxes, may apply. This Policy is intended to qualify as life insurance for tax purposes and is designed to meet the requirements of Section 7702 of the Internal Revenue Code of 1986, as amended ("Internal Revenue Code" or "Code"), as they existed on the Issue Date. The applicable factor used in determining the minimum Death Benefit shall be the factor required by Section 7702 of the Code as shown in your Policy. Under Death Benefit Option 1, your Death Benefit will generally be the Face Amount. However, in the event the minimum Death Benefit exceeds the Face Amount, the Company reserves the right to refund the portion of any premium or Cash Value such that the minimum Death Benefit no longer exceeds the Face Amount. Under Death Benefit Option 2, your Death Benefit will always vary with the Policy Value. However, in the event the minimum Death Benefit exceeds the Face Amount plus the Policy Value under Death Benefit Option 2, the Company reserves the right to refund the portion of any premium or Cash Value such that the minimum Death Benefit no longer exceeds the Face Amount plus Policy Value. See "Death Benefit Options" for detailed information about each Death Benefit Option.
Your Policy may become a modified endowment contract as a result of: (1) the payment of premiums exceeding the limits of Section 7702A of the Code, (2) certain changes to your Policy, such as a reduction in your Death Benefit or certain rider benefits, or (3) an exchange of a contract which is a modified endowment contract for this Policy.
If your Policy becomes a modified endowment contract, transactions such as surrenders, withdrawals and loans will be treated first as a distribution of the earnings in the Policy and generally will be taxable as ordinary income in the year received, to the extent there is any gain in the Policy. In addition, if the Policy Owner is under age 59-1/2 at the time of a surrender, withdrawal or loan, the amount that is included in income is generally subject to a 10% penalty tax.
If the Policy is not a modified endowment contract, distributions generally are treated first as a return of basis or investment in the Policy and then as taxable income. Moreover, loans are generally not treated as distributions. Finally, surrenders, withdrawals or loans from a Policy that is not a modified endowment contract are not subject to the 10% penalty tax.
The Policy may be used in various arrangements, including non-qualified deferred compensation or salary continuance plans, split dollar insurance plans, executive bonus plans, and others. The tax consequences of such plans vary depending on the particular facts and circumstances of each individual arrangement. For more information regarding certain arrangements, see "TAX CONSIDERATIONS" and, specifically, the sections discussing "Employer-Owned Life Insurance," "Split-Dollar Life Insurance," and "Employer-Financed Insurance Purchase Arrangements Tax and Other Legal Issues."
See "TAX CONSIDERATIONS" for a discussion of certain tax risks and considerations relating to employer owned life insurance. You should consult a qualified tax adviser for assistance in all Policy related tax matters.
Loan Risks. A policy loan, whether or not repaid, has a permanent effect on the Policy Value, and potentially the Death Benefit, because the investment results of the Sub-Accounts and current interest rates credited on the Fixed Account Value do not apply to Policy Value in the Loan Account. The larger the loan and the longer the loan is outstanding, the greater will be the effect on Policy Value held as collateral in the Loan Account. Interest credited on the portion of the Policy Value being used as collateral for a Policy loan is the loan interest rate less an amount deducted from the loan interest rate to cover the costs the Company incurs by providing the loaned cash value ("Loan Interest Credit Spread"). The interest credited will not exceed 4%.
Your Policy may Lapse if your outstanding loan amounts reduce the Cash Surrender Value to zero. If a Policy lapses with loans outstanding, some or all of the loan amounts may be subject to income tax. See "TAX CONSIDERATIONS Tax
6
Treatment of Loans." Policy loans also may increase the potential for Lapse if the investment results of the Sub-Accounts to which Cash Surrender Value is allocated is unfavorable.
If the Insured dies while a loan is outstanding, the loan balance, which includes any unpaid interest, will be deducted from the Death Benefit.
See "POLICY LOANS."
Fund Risks. We do not guarantee that a Fund will meet its investment objectives and strategies. Policy Value may increase or decrease depending on the investment performance of the Funds. You bear the risk that those Funds may not meet their investment objectives. A comprehensive discussion of the risks of each Fund may be found in each Fund's prospectus. Please refer to the Funds' prospectuses for more information.
General Account Risks. The Company's general obligations and any guaranteed benefits under the Policy are supported by our General Account (and not by the Variable Account) and are subject to the Company's claims-paying ability. The Fixed Account is part of the General Account. An Owner should look to the financial strength of Protective Life for its claims-paying ability. Assets in the General Account are not segregated for the exclusive benefit of any particular Policy or obligation. General Account assets are also available to the Company's general creditors and the conduct of our routine business activities. For more information on Protective Life's financial strength, you may review our financial statements and/or check our current rating with one or more of the independent sources that rate insurance companies for their financial strength and stability. Such ratings are subject to change and have no bearing on the performance of the Funds. See also "THE COMPANY AND THE FIXED ACCOUNT Our General Account."
Potential for Increased Charges and Fees. The Company has the right to increase (up to the maximum amount noted in the fee table) the charges and fees we deduct. See also "FEE TABLES" and "CHARGES AND DEDUCTIONS."
7
FEE TABLES
The following tables describe the fees, charges and expenses that you will pay when buying, owning, and surrendering the Policy. If the amount of a charge depends on the personal characteristics of the Insured, then the fee table lists the minimum and maximum charges we assess under the Policy, and the fees and charges of a representative Insured with the characteristics set forth in the table. These charges may not be typical of the charges you will pay.
The first table describes the fees, charges and expenses that you will pay at the time that you pay premiums, surrender the Policy, allow the Policy to Lapse, decrease the Face Amount, transfer Policy Value among the Sub-Accounts and to and from the Fixed Account, and make withdrawals.
Transaction Fees |
|||||||||||||||
Charge |
When Charge is
Deducted |
Amount Deducted
Maximum Guaranteed Charge |
Amount Deducted
Current Charge |
||||||||||||
Premium Expense Charge (consists of the Sales Load and Premium Tax): |
Upon receipt of each premium payment |
10% of each premium payment |
6.0% of each premium payment |
||||||||||||
Sales Load:(1) |
Upon receipt of each premium payment |
6.5% of each premium payment |
Current: 2.5% of each premium payment up to target and 1.0% of each premium payment in excess of target |
||||||||||||
Premium Tax:(1) |
Upon receipt of each premium payment |
3.5% of each premium payment |
3.5% of each premium payment |
||||||||||||
Surrender Charge: |
There is no surrender charge associated with your Policy. However, the surrender of your Policy may have tax consequences. |
||||||||||||||
Transfer Fee:(2) |
Upon each transfer in excess of 12 in a Policy Year |
$ |
10 |
per transfer |
$ |
10 |
per transfer |
||||||||
Withdrawal Charge: |
At the time of each partial withdrawal of Policy Value |
$25 deducted from Policy Value for all partial withdrawals after the first made in the same Policy Year. |
$25 deducted from Policy Value for all partial withdrawals made after the first made in the same Policy Year. |
||||||||||||
Change of Death Benefit Option Fee: |
Upon change of option |
$100 deducted from Policy Value for each change of death benefit option. |
$100 deducted from Policy Value for each change of death benefit option. |
(1) The Sales Load and Premium Tax are components of the Premium Expense Charge (and are not in addition to).
(2) Currently, electronic transfers do not count towards the 12 free transfers; however, we reserve the right, at any time, to charge for electronic transfers in excess of the free transfers allowed. See "CHARGES AND DEDUCTIONS."
8
The next table describes the fees and expenses that you will pay periodically during the time that you own the Policy, not including the Funds' fees and expenses.
(1) Cost of insurance charges vary based on individual characteristics such as the Insured's Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Day. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges shown in the table may not be typical of the charges you will pay. Your Policy's Schedule will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and Premium classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See "CHARGES AND DEDUCTIONS". Owners may obtain more information about their particular cost of insurance charge by contacting our Home Office at 888-353-2654.
(2) The Net Amount at Risk as of any Monthly Anniversary Day is equal to: (a) the Death Benefit discounted at one plus the monthly guaranteed interest rate minus the Policy Value (prior to deducting the Cost of Insurance), if the Death Benefit Option is Death Benefit Option 1 (Level Death Benefit); or, (b) the Death Benefit minus the Policy Value discounted at one plus the monthly guaranteed interest rate, if the Death Benefit Option is Death Benefit Option 2 (Coverage Plus).
9
(3) The mortality and expense risk charge is accrued daily and deducted on each Monthly Anniversary Day from the assets in the Sub-Accounts.
(4) As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, lapse, surrender, termination, or the Insured's death.
FUND EXPENSES
The next item shows the minimum and maximum total operating expenses charged by the Funds that you pay periodically during the time that you own the Policy. Expenses of the Funds may be higher or lower in the future. More detail concerning each Fund's fees and expenses is contained in the prospectus for each Fund.
Annual Fund Operating Expenses:
Range of Expenses for the Funds
Minimum |
Maximum |
||||||||||||||
Total Annual Fund Operating Expenses(^)
(total of all expenses that are deducted from Fund assets, including management fees, 12b-1 fees, and other expenses) |
0.27 |
% |
- |
2.61 |
%(*) |
(^) Total Annual Fund Operating Expenses are based in part on estimated amounts for the current fiscal year.
(*) The range of Total Annual Fund Operating Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds' advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund's expenses.
For information concerning compensation paid to sales representatives in connection with the sale of the Policies, see "SALE OF THE POLICIES."
THE COMPANY AND THE FIXED ACCOUNT
Protective Life Insurance Company
The Policies are issued by Protective Life. Protective Life is a Tennessee corporation and was founded in 1907. Protective Life markets individual life insurance, credit life and disability insurance, guaranteed investment contracts, guaranteed funding agreements, fixed and variable annuities and extended service contracts. Protective Life is currently licensed to transact life insurance business in 49 states and the District of Columbia. As of December 31, 2019, Protective Life had total assets of approximately $120.5 billion. Protective Life is the principal operating subsidiary of Protective Life Corporation ("PLC"), a U.S. insurance holding Dai-ichi is a top 20 global life insurance company. Dai-ichi's stock is traded on the Tokyo Stock Exchange. As of December 31, 2019, PLC had total assets of approximately $121.1 billion. To find out more information about us, go to www.protective.com.
Our General Account
The assets of our General Account support our insurance and annuity obligations and are subject to our general liabilities from business operations and to claims by our creditors. Because amounts allocated to the Fixed Account, plus any guarantees under the Policy that exceed your Policy Value (such as those that may be associated with the Death Benefit), are paid from our General Account, any amounts that we may pay under the Policy in excess of Variable Account Value are subject to our financial strength and claims-paying ability. It is important to note that there is no guarantee that we will always be able to meet our claims-paying obligations, and that there are risks to purchasing any insurance product. For this reason, you should consider our financial strength and claims-paying ability to meet our obligations under the Policy when purchasing a Policy and making investment decisions.
We encourage both existing and prospective Policy Owners to read and understand our financial statements. We prepare our financial statements on both a statutory basis, as required by state regulators, and according to Generally Accepted Accounting Principles (GAAP). Our audited GAAP financial statements are included in the Statement of Additional Information (which is available at no charge by calling us at 1-800-456-6330 or writing us at the address shown on the cover page of this Prospectus). In addition, the Statement of Additional Information is available on the SEC's website at http://www.sec.gov.
10
You also will find on our website information on ratings assigned to us by one or more independent rating organizations. These ratings are opinions of our financial capacity to meet the obligations of our insurance and annuity contracts based on our financial strength and/or claims-paying ability.
The Fixed Account
The Fixed Account consists of assets owned by Protective Life with respect to the Policies, other than those in the Variable Account. Subject to applicable law, Protective Life has sole discretion over the investment of the assets of the Fixed Account. The Fixed Account is part of our General Account. Unlike premiums and Policy Value allocated to the Variable Account, we assume the risk of investment gain or loss on amounts held in the Fixed Account. Guarantees of Net Premiums allocated to the Fixed Account, and interest credited thereto, are backed by Protective Life. The Fixed Account Value is calculated daily.
You generally may allocate some or all of your Net Premium and may transfer some or all of your Policy Value to the Fixed Account. However, there are limitations on transfers involving the Fixed Account. Due to these limitations, if you want to transfer all of your Policy Value from the Fixed Account to the Variable Account, it may take several years to do so. You should carefully consider whether the Fixed Account meets your investment needs. See "TRANSFERS OF POLICY VALUE Fixed Account Transfers."
Because of exemptive and exclusionary provisions, interests in the Fixed Account have not been registered under the Securities Act of 1933 nor has the Fixed Account been registered as an investment company under the Investment Company Act of 1940. Accordingly, neither the Fixed Account nor any interests therein are subject to the provisions of these Acts. The disclosure regarding the Fixed Account is, however, subject to certain generally applicable provisions of the federal securities laws relating to the accuracy and completeness of statements made in prospectuses.
Interest Credited on Fixed Account Value. Protective Life guarantees that the interest credited will not be less than the annual guaranteed interest rate shown in your Policy and will never be less than the minimum annual interest rate of 2.00%, for all policies sold under this Prospectus. For purposes of crediting interest, amounts deducted, transferred or withdrawn from the Fixed Account are accounted for on a "first-in-first-out" (FIFO) basis.
Payments from the Fixed Account. Payments from the Fixed Account for an exchange or surrender request may be deferred for up to six months from the date Protective Life receives the Written Notice in Good Order. If a payment from the Fixed Account is deferred for 30 days or more, it will bear interest at a rate of 2% per year (or an alternative rate if required by applicable state insurance law), compounded annually while payment is deferred. Payments of a loan or withdrawal from the Fixed Account are treated as transfers and subject to the transfer limitations out of the Fixed Account.
We may delay the payment of proceeds of any partial withdrawal, surrender, or loan after our receipt of Written Notice in Good Order of your request where the proceeds would be taken from Fixed Account Value.
THE VARIABLE ACCOUNT AND FUNDS
Protective COLI VUL separate account (referred to herein as the Variable Account)
Protective COLI VUL separate account is a separate investment account of Protective Life established under Tennessee law by the board of directors of Protective Life on February 25, 2020. The Variable Account is registered with the SEC as a unit investment trust under the Investment Company Act of 1940, as amended (the "1940 Act") and is a "separate account" within the meaning of the federal securities laws.
Protective Life owns the assets of the Variable Account. These assets are held separate from other assets of the Company and are not part of Protective Life's General Account. You assume all of the investment risk for premiums and Policy Value allocated to the Sub-Accounts. Your Policy Value in the Sub-Accounts is part of the assets of the Variable Account. Assets of the Variable Account equal to the reserves or other contract liabilities of the Variable Account will not be charged with liabilities that arise from any other business that Protective Life conducts. Protective Life may transfer to its General Account any assets of the Variable Account which exceed the reserves and other contract liabilities of the Variable Account (which are always at least equal to the aggregate Variable Account Values under the Policies). Protective Life may accumulate in the Variable Account the charge for mortality and expense risks and investment results applicable to those assets that are in excess of the reserves and other contract liabilities related to the Policies. Protective Life is obligated to pay all benefits provided under the Policies.
11
The Company has absolute ownership of the assets of the Variable Account. The portion of the assets of the Variable Account equal to the reserves and other contract liabilities with respect to the Variable Account are not chargeable with liabilities arising out of any other business the Company may conduct.
The assets of the Variable Account are divided into a series of Sub-Accounts. Each Sub-Account invests exclusively in shares of a corresponding Fund. Any amounts of income, dividends, and gains distributed from the shares of a Fund will be reinvested in additional shares of that Fund at its Net Asset Value Per Share.
When permitted by law, the Company may:
(1) Restrict premium payments or Transfers into any Sub-Account;
(2) Transfer assets of one Variable Account to another Variable Account;
(3) Add new Sub-Accounts to or remove existing Sub-Accounts from the Variable Account or combine Sub-Accounts;
(4) Make new Sub-Accounts or other Sub-Accounts available to such classes of policies as the Company may determine;
(5) Close certain Sub-Accounts to allocations of premium payments or transfers of Policy Value;
(6) Add new Funds or remove existing Funds;
(7) Substitute a different Fund for any existing Fund if shares of a Fund are no longer available for investment or if the Company determines that investment in a Fund is no longer appropriate in light of the purposes of the Variable Account;
(8) Deregister the Variable Account under the Investment Company Act of 1940 if such registration is no longer required;
(9) Operate the Variable Account as a management investment company under the Investment Company Act of 1940 or in any other form permitted by law;
(10) Make any changes to the Variable Account or its operations as may be required by the Investment Company Act of 1940 or other applicable law or regulations;
(11) Create new Variable Accounts; and
(12) Combine Variable Accounts.
The investment policy of the Variable Account will not be changed without approval pursuant to the insurance laws of the Company's state of domicile. If required, approval of or change of investment policy will be filed with the insurance department of the state where this Policy is delivered.
The values and benefits of this Policy provided by the Variable Account depend on the investment performance of the Funds in which your selected Sub-Accounts are invested. The Company does not guarantee the investment performance of the Funds. The Owner bears the full investment risk for Net Premiums allocated or Policy Value transferred to the Sub-Accounts.
The Variable Account is divided into Sub-Accounts. The income, gains or losses, whether or not realized, from the assets of each Sub-Account are credited to or charged against that Sub-Account without regard to any other income, gains or losses of Protective Life. Each Sub-Account invests exclusively in shares of a corresponding Fund. Therefore, the investment experience of your Policy depends on the experience of the Sub-Accounts you select and not the investment experience of Protective Life's other assets. In the future, the Variable Account may include other Sub-Accounts that are not available under the Policies and are not otherwise discussed in this Prospectus.
12
The Funds
Each Sub-Account invests in a corresponding Fund. Each Fund is a registered investment company or separate investment series of one of the following registered investment companies:
Fund |
Fund Manager/
Investment Adviser |
Subadvisors |
|||||||||
AIM Variable Insurance Funds (Invesco Variable Insurance Funds) |
Invesco Advisers, Inc. |
||||||||||
American Century Variable Portfolios, Inc. |
American Century Investment Management, Inc. |
||||||||||
American Funds Insurance Series |
Capital Research and Management |
||||||||||
Blackrock Variable Series Funds, Inc. |
BlackRock Advisors, LLC |
||||||||||
BNY Mellon Stock Index Fund, Inc. |
BNY Mellon Investment Adviser, Inc. |
||||||||||
Davis Variable Account Fund, Inc. |
Davis Selected Advisers, L.P. |
||||||||||
Deutsche DWS Investments VIT Funds |
DWS Investment Management Americas, Inc. |
Northern Trust Investments, Inc. |
|||||||||
Deutsche DWS Variable Series |
DWS Investment Management Americas, Inc. |
||||||||||
Deutsche DWS Variable Series II |
DWS Investment Management Americas, Inc. |
||||||||||
Eaton Vance Variable Trust |
Eaton Vance Management |
Boston Management and Research |
|||||||||
Federated Insurance Series |
Federated Investment Management Company |
||||||||||
Fidelity Variable Insurance Products |
Fidelity Management & Research Company |
FMR Co., Inc.
Strategic Advisors, Inc. Fidelity Investments Money Management, Inc. |
|||||||||
Great-West Funds, Inc. |
Great-West Capital Management, LLC |
||||||||||
Janus Aspen Series |
Janus Capital Management LLC |
||||||||||
JPMorgan Insurance Trust |
J.P. Morgan Investment Management Inc. |
||||||||||
Legg Mason Partners Variable Equity Trust |
Legg Mason Partners Fund Advisor, LLC |
ClearBridge Advisors, LLC |
|||||||||
Lord Abbett Series Fund, Inc. |
Lord, Abbett & Co. LLC |
||||||||||
MFS Variable Insurance Trust |
Massachusetts Financial Services Company |
||||||||||
MFS Variable Insurance Trust II |
Massachusetts Financial Services Company |
||||||||||
MFS Variable Insurance Trust III |
Massachusetts Financial Services Company |
||||||||||
Neuberger Berman Advisers Management Trust |
Neuberger Berman Investment Advisers LLC |
13
Fund |
Fund Manager/
Investment Adviser |
Subadvisors |
|||||||||
PIMCO Variable Insurance Trust |
Pacific Investment Management Company, LLC. |
Research Affiliates, LLC |
|||||||||
Pioneer Variable Contracts Trust |
Amundi Pioneer Asset Management, Inc |
||||||||||
Putnam Variable Trust |
Putnam Investment Management, LLC |
||||||||||
T. Rowe Price Equity Services, Inc. |
T. Rowe Price Associates, Inc. |
||||||||||
VanEck VIP Trust |
Van Eck Associates Corporation |
||||||||||
Victory Variable insurance Funds |
Victory Capital Services, Inc. |
Fund Investment Objectives. The investment objectives of the Funds are briefly described below:
AIM Variable Insurance Funds (Invesco Variable Insurance Funds)
Invesco Oppenheimer V.I. Main Street Small Cap Fund® , Series I Shares
The Fund seeks capital appreciation.
Invesco V.I. Global Real Estate Fund, Series II Shares
This Fund seeks total return through growth of capital and current income.
Invesco V.I. International Growth Fund, Series I Shares
This Fund seeks long-term growth of capital.
Invesco V.I. Mid Cap Core Equity Fund, Series I Shares
This Fund seeks long-term growth of capital.
American Century Variable Portfolios, Inc.
American Century Investments® VP Capital Appreciation Fund, Class I Shares
This Fund seeks capital growth.
American Century Investments® VP Mid Cap Value Fund, Class I Shares
This Fund seeks long-term capital growth; income is a secondary consideration.
American Century Investments® VP Ultra Fund, Class I Shares
This Fund seeks long-term capital growth.
American Century Investments® VP Value Fund, Class I Shares
This Fund seeks long-term capital growth; income is a secondary consideration.
American Century Variable Portfolios II, Inc.
American Century Investments® VP Inflation Protection Fund, Class II Shares
This Fund seeks long-term total return using a strategy that seeks to protect against U.S. inflation.
American Funds Insurance Series®
IS Global Small Capitalization Fund, Class 2
The Fund's investment objective is to provide long-term growth of capital.
IS Growth Fund, Class 2
The Fund's investment objective is to provide growth of capital.
14
IS Growth-Income Fund, Class 2
The Fund's investment objectives are to achieve long-term growth of capital and income.
IS International Fund, Class 2
The Fund's investment objective is to provide long-term growth of capital.
IS New World Fund® , Class 2
The Fund's investment objective is long-term capital appreciation.
Blackrock Variable Series Funds, Inc.
BlackRock Global Allocation V.I. Fund, Class I Shares
This Fund seeks high total investment return.
BlackRock High Yield V.I. Fund, Class I Shares
This Fund seeks to maximize total return, consistent with income generation and prudent investment management.
BlackRock 60/40 Target Allocation ETF V.I. Fund, Class I Shares
This Fund seeks to provide total return.
BNY Mellon Stock Index Fund, Inc.
BNY Mellon Stock Index Fund, Initial Shares
This Fund seeks to match the total return of the Standard & Poor's ® 500 Composite Stock Price Index (S&P 500® Index).
Davis Variable Account Fund, Inc.
Davis Financial Portfolio
This Fund seeks long-term growth of capital.
Deutsche DWS Investments VIT Funds
DWS Small Cap Index VIP, Class A Shares
This Fund seeks to replicate, as closely as possible, before the deduction of expenses, the performance of the Russell 2000® Index, which emphasizes stocks of small U.S. companies.
Deutsche DWS Variable Series I
DWS Core Equity VIP, Class A Shares
This Fund seeks long-term growth of capital, current income and growth of income.
Deutsche DWS Variable Series II
DWS High Income VIP, Class A Shares
This Fund seeks a high level of current income.
Eaton Vance Variable Trust
Eaton Vance VT Floating-Rate Income Fund, Initial Class Shares
This Fund seeks to provide a high level of current income.
Federated Hermes Insurance Series
Federated High Income Bond Fund II, Primary Class Shares
This Fund seeks high current income.
15
Fidelity® Variable Insurance Products
VIP Emerging Markets Portfolio, Service Class 2
This Fund seeks capital appreciation.
Fidelity Variable Insurance Products Fund III
Fidelity® Variable Insurance Products Mid Cap Portfolio, Service Class 2
This Fund seeks long-term growth of capital.
Great-West Funds, Inc.
Great-West Ariel Mid Cap Value Fund, Investor Class Shares
This Fund seeks long-term capital appreciation.
Great-West Bond Index Fund, Investor Class Shares
The fund seeks investment results that track the total return of the debt securities that comprise the Bloomberg Barclays U.S. Aggregate Bond Index (the "benchmark index").
Great-West Core Bond Fund, Investor Class Shares
This fund seeks to provide total return, consisting of two components: (1) changes in the market vale of its portfolio holdings (both realized and unrealized appreciation); and (2) income received from its portfolio holdings.
Great-West Emerging Markets Equity Fund, Investor Class Shares
This Fund seeks long-term capital appreciation.
Great-West Global Bond Fund, Investor Class Shares
This Fund seeks current income with capital appreciation and growth of income.
Great-West Government Money Market Fund, Investor Class Shares
This Fund seeks as high a level of current income as is consistent with the preservation of capital and liquidity.
Great-West Inflation-Protected Securities Fund, Investor Class Shares
This Fund seeks real return consistent with the preservation of capital.
Great-West International Index Fund, Investor Class Shares
This Fund seeks investment results, before fees and expenses that track the total return of the common stock that comprise the MSCI EAFE (Europe, Australasia, Far East) Index.
Great-West International Value Fund, Investor Class Shares
This Fund seeks long-term capital growth.
Great-West Large Cap Growth Fund, Investor Class Shares
This Fund seeks long-term growth of capital.
Great-West Large Cap Value Fund, Investor Class Shares
This Fund seeks capital growth and current income.
Great-West Mid Cap Value Fund, Investor Class Shares
This Fund seeks long-term growth of capital.
Great-West Multi-Sector Bond Fund, Investor Class Shares
This Fund seeks high total investment return through a combination of current income and capital appreciation.
Great-West Real Estate Index Fund, Investor Class Shares
This Fund seeks investment results, before fees and expenses, that track the total return of a benchmark index that measures the performance of publicly traded equity real estate investment trusts ("REITs").
16
Great-West S&P Mid Cap 400 Index Fund, Investor Class Shares
This Fund seeks investment results, before fees and expenses, which track the total return of the common stocks that comprise the Standard & Poor's ("S&P") MidCap 400® Index.
Great-West S&P Small Cap 600 Index Fund, Investor Class Shares
This Fund seeks investment results that track the total return of the common stocks that compise the Standard & Poor's ("S&P") SmallCap 600® Index.
Great-West Short Duration Bond Fund, Investor Class Shares
This Fund seeks maximum total return that is consistent with preservation of capital and liquidity.
Great-West Small Cap Growth Fund, Investor Class Shares
This Fund seeks long-term capital appreciation.
Great-West Small Cap Value Fund, Investor Class Shares
This Fund seeks long-term capital growth.
Great-West T. Rowe Price Mid Cap Growth Fund, Investor Class Shares
This Fund seeks long-term capital appreciation.
Great-West U.S. Government Securities Fund, Investor Class Shares
The Fund seeks the highest level of return consistent with preservation of capital and substantial credit protection.
Great-West Lifetime Funds
Great-West Lifetime 2015 Fund, Investor Class Shares
The Fund seeks income and secondarily, capital growth.
Great-West Lifetime 2020 Fund, Investor Class Shares
The Fund seeks capital appreciation and income consistent with its current asset allocation; after 2020, it seeks income and secondarily capital growth.
Great-West Lifetime 2025 Fund, Investor Class Shares
The Fund seeks capital appreciation and income consistent with its current asset allocation; after 2025, it seeks income and secondarily capital growth.
Great-West Lifetime 2030 Fund, Investor Class Shares
The Fund seeks capital appreciation and income consistent with its current asset allocation; after 2030, it seeks income and secondarily capital growth.
Great-West Lifetime 2035 Fund, Investor Class Shares
The Fund seeks capital appreciation and income consistent with its current asset allocation; after 2035, it seeks income and secondarily capital growth.
Great-West Lifetime 2040 Fund, Investor Class Shares
The Fund seeks capital appreciation and income consistent with its current asset allocation; after 2040, it seeks income and secondarily capital growth.
Great-West Lifetime 2045 Fund, Investor Class Shares
The Fund seeks capital appreciation and income consistent with its current asset allocation; after 2045, it seeks income and secondarily capital growth.
Great-West Lifetime 2050 Fund, Investor Class Shares
The Fund seeks capital appreciation and income consistent with its current asset allocation; after 2050, it seeks income and secondarily capital growth.
17
Great-West Lifetime 2055 Fund, Investor Class Shares
The Fund seeks capital appreciation and income consistent with its current asset allocation; after 2055, it seeks income and secondarily capital growth.
Great-West Lifetime 2060 Fund, Investor Class Shares
The Fund seeks capital appreciation and income consistent with its current asset allocation; after 2060, it seeks income and secondarily capital growth.
Great-West Profile Funds
Great-West Aggressive Profile Fund, Investor Class Shares
The Fund seeks long-term capital appreciation primarily through investments in underlying funds that emphasize equity investments.
Great-West Conservative Profile Fund, Investor Class Shares
The Fund seeks capital preservation primarily through investments in underlying funds that emphasize fixed income investments.
Great-West Moderate Profile Fund, Investor Class Shares
The Fund seeks long-term capital appreciation primarily through investments in underlying funds with a relatively equal emphasis on equity and fixed income investments.
Great-West Moderately Aggressive Profile Fund, Investor Class Shares
The Fund seeks long-term capital appreciation primarily through investments in underlying funds that emphasize equity investments and, to a lesser degree, in underlying funds that emphasize fixed income investments.
Great-West Moderately Conservative Profile Fund, Investor Class Shares
The Fund seeks income and capital appreciation primarily through investments in underlying funds that emphasize fixed income investments and, to a lesser degree, in underlying funds that emphasize equity investments.
Janus Aspen Series
Janus Henderson VIT Balanced Portfolio, Institutional Shares
This Fund seeks long-term capital growth, consistent with preservation of capital and balanced by current income.
Janus Henderson VIT Enterprise Portfolio, Institutional Shares
This Fund seeks long-term growth of capital.
Janus Henderson VIT Flexible Bond Portfolio, Institutional Shares
This Fund seeks to obtain maximum total return, consistent with preservation of capital.
Janus Henderson VIT Forty Portfolio, Institutional Shares
This Fund seeks long-term growth of capital.
Janus Henderson VIT Global Technology and Innovation Portfolio, Institutional Shares
This Fund seeks long-term growth of capital.
JPMorgan Insurance Trust
JPMorgan Insurance Trust Small Cap Core Portfolio, Class 1 Shares
This Fund seeks capital growth over the long term.
JPMorgan Insurance Trust U.S. Equity Portfolio, Class 1 Shares
This Fund seeks high total return.
18
Legg Mason Partners Variable Equity Trust
ClearBridge Variable Mid Cap Portfolio, Class I
This Fund seeks long-term growth of capital.
ClearBridge Variable Small Cap Growth Portfolio, Class I
This Fund seeks long-term growth of capital.
Lord Abbett Series Fund, Inc.
Total Return Portfolio, Class VC Shares
The Fund seeks income and capital appreciation to produce a high total return.
MFS® Variable Insurance Trust
MFS® Growth Series, Initial Class Shares
This Fund seeks capital appreciation.
MFS® Mid Cap Growth Series, Initial Class Shares
The Fund seeks capital appreciation.
MFS® Research Series, Initial Class Shares
This Fund seeks capital appreciation.
MFS® Total Return Bond Series, Initial Class Shares
This Fund seeks total return with an emphasis on current income, but also considering capital appreciation.
MFS® Value Series, Initial Class Shares
This Fund seeks capital appreciation.
MFS® Variable Insurance Trust II
MFS® International Growth Portfolio, Initial Class Shares
The Fund seeks capital appreciation.
MFS® Variable Insurance Trust III
MFS® Blended Research® Small Cap Equity Portfolio, Initial Class Shares
The Fund seeks capital appreciation.
MFS® Global Real Estate Portfolio, Initial Class Shares
The Fund seeks total return.
MFS® Mid Cap Value Portfolio, Initial Class Shares
The Fund seeks capital appreciation.
Neuberger Berman Advisers Management Trust
Neuberger Berman AMT Mid Cap Intrinsic Value Portfolio, Class I Shares
The Fund seeks growth of capital.
Neuberger Berman AMT Sustainable Equity Portfolio, Class I Shares
The Fund seeks long-term growth of capital by investing primarily in securities of companies that meet the Fund's environmental, social, and governance (ESG) criteria.
19
PIMCO Variable Insurance Trust
CommodityRealReturn® Strategy Portfolio, Administrative Class Shares
The Portfolio seeks maximum real return, consistent with prudent investment management.
Global Bond Opportunities Portfolio, Administrative Class Shares
The Portfolio seeks maximum total return, consistent with preservation of capital and prudent investment management.
High Yield Portfolio, Administrative Class Shares
The Portfolio seeks maximum total return, consistent with preservation of capital and prudent investment management.
Low Duration Portfolio, Administrative Class Shares
This Portfolio seeks maximum total return, consistent with preservation of capital and prudent investment management.
Real Return Portfolio, Administrative Class Shares
This Portfolio seeks maximum real return, consistent with preservation of real capital and prudent investment management.
Total Return Portfolio, Administrative Class Shares
This Portfolio seeks maximum total return, consistent with preservation of capital and prudent investment management.
Pioneer Variable Contracts Trust
Pioneer Real Estate Shares VCT Portfolio, Class I Shares
The Fund seeks long-term growth of capital; current income is a secondary objective.
Putnam Variable Trust
Putnam VT Equity Income Fund, Class IA Shares
The Fund seeks capital growth and current income.
Putnam VT Global Asset Allocation Fund, Class IA Shares
The Fund seeks long-term return consistent with preservation of capital
Putnam VT Global Equity Fund, Class IA Shares
The Fund seeks capital appreciation
Putnam VT Growth Opportunities Fund, Class IA Shares
The Fund seeks capital appreciation
Putnam VT High Yield Fund, Class IA Shares
The Fund seeks high current income.
Putnam VT Income Fund, Class IA Shares
The Fund seeks high current income consistent with what the manager believes to be prudent risk.
Putnam VT International Value Fund, Class IA Shares
The Fund seeks capital appreciation and, as a secondary objective, current income
Putnam VT Research Fund, Class IA Shares
The Fund seeks capital appreciation
Putnam VT Small Cap Value Fund, Class IA Shares
The Fund seeks capital appreciation
20
Putnam VT Sustainable Future Fund, Class IA Shares
The Fund seeks capital appreciation and, as a secondary objective, current income.
T. Rowe Price Equity Series, Inc
T. Rowe PriceBlue Chip Growth Portfolio, Portfolio-II Class Shares
The Fund seeks to provide long-term capital growth; income is a secondary objective.
VanEck VIP Trust
VanEck VIP Global Hard Assets Fund, Initial Class Shares
This Fund seeks long-term capital appreciation by investing primarily in hard asset securities. Income is a secondary consideration.
Victory Variable Insurance Funds
Victory RS Small Cap Growth Equity VIP Series, Class I Shares
The Fund seeks long-term capital growth.
You should contact your representative for further information on the availability of the Divisions.
There is no assurance that the stated objectives and policies of any of the Funds will be achieved. More detailed information concerning the investment objectives, policies and restrictions of the Funds, the expenses of the Funds, the risks attendant to investing in the Funds and other aspects of their operations can be found in the current prospectuses for the Funds and the current Statement of Additional Information for each of the Funds. You may obtain a prospectus or a Statement of Additional Information for any of the Funds by contacting Protective Life or by asking your financial professional. You should read the Funds' prospectuses carefully before making any decision concerning the allocation of Net Premiums or transfers among the Sub-Accounts.
Selection of Funds
We select the Funds offered through the Policies based on several criteria, including the following:
1. asset class coverage;
2. the strength of the investment adviser's (or sub-adviser's) reputation and tenure;
3. brand recognition;
4. performance;
5. the capability and qualification of each investment firm; and
6. whether our distributors are likely to recommend the Funds to Policy Owners.
Another factor we consider during the selection process is whether the Fund, its adviser, its sub-adviser, or an affiliate will make payments to us or our affiliates. Such payments create a conflict of interest for us because we have an incentive to offer Funds (or classes of shares of Funds) for which such payments and fees are available to us. For a more detailed discussion of these payments and the potential conflicts of interest, see "PAYMENTS WE RECEIVE." We also consider whether the Fund, its adviser, sub-adviser, or distributor (or an affiliate) can provide marketing and distribution support for sale of the Policies. For a discussion of these arrangements, see "Certain Payments We Receive with Regard to the Funds." We review each Fund periodically after it is selected. Upon review, we may remove a Fund or restrict allocation of additional Premium payments and/or transfers of Policy Value to a Fund if we determine the Fund no longer meets one or more of the criteria and/or if the Fund has not attracted significant Policy Owner assets. We do not recommend or endorse any particular Fund, and we do not provide investment advice.
21
Other Information About the Funds
Shares of these Funds are offered only to: (1) the Variable Account, (2) other separate accounts of Protective Life supporting variable annuity contracts or variable life insurance policies, (3) separate accounts of other life insurance companies supporting variable annuity contracts or variable life insurance policies, and (4) certain qualified retirement plans. Such shares are not offered directly to investors but are available only through the purchase of such contracts or policies or through such plans. See the prospectus for each Fund for details about that Fund.
Certain Funds may have investment objectives and policies similar to other mutual funds (sometimes having similar names) that are managed by the same investment adviser or manager. The investment results of the Funds, however, may be more or less favorable than the results of such other mutual funds. Protective Life does not guarantee or make any representation that the investment results of any Fund is, or will be, comparable to any other mutual fund, even one with the same investment adviser or manager.
For a discussion of the potential conflicts of interest that may arise as a result of the sale of Fund shares to separate accounts that support variable annuity contracts, variable life insurance policies and certain qualified pension and retirement plans as well as the sale of Fund shares to the separate accounts of insurance companies that are not affiliated with Protective Life, see the prospectuses for the Funds. Fund shares are not offered directly to investors but are available only through the purchase of such contracts or policies or through such plans. YOU MAY OBTAIN A PROSPECTUS AND, IF AVAILABLE, A FUND SUMMARY, CONTAINING COMPLETE INFORMATION ON EACH FUND, WITHOUT CHARGE, UPON REQUEST BY CONTACTING US AT 1-888-353-2654. If you received a summary prospectus for a Fund, please follow the directions on the first page of the summary prospectus to obtain a copy of the Fund's prospectus. See the prospectus for each Fund for details about that Fund.
There is no guarantee that any Fund will meet its investment objectives. Please refer to the prospectus for each of the Funds you are considering for more information.
Certain Payments We Receive with Regard to the Funds from Advisers and/or Distributors
We (and our affiliates) may receive payments from the Funds' advisers, sub-advisers, distributors, or affiliates thereof (collectively, "Fund Sponsors"). These payments are negotiated and thus differ by Fund (sometimes substantially), and the amounts we (or our affiliates) receive may be significant. These payments are made for various purposes, including payment for services provided and expenses incurred by us (and our affiliates) in promoting, marketing, distributing, and administering the Policies; and, for our role as intermediary to the Funds. We (and our affiliates) may profit from these payments. These payments may be derived from revenue sharing arrangements paid from the legitimate profits of Fund Sponsors or 12b-1 fees deducted from Fund assets. For a more detailed discussion of these payments and the potential conflicts of interest, see "PAYMENTS WE RECEIVE."
Addition, Deletion, or Substitution of Investments
The assets of the Variable Account are divided into a series of Sub-Accounts. Each Sub-Account invests exclusively in the shares of a corresponding Fund. Protective Life may add new Sub-Accounts to or remove existing Sub-Accounts from the Variable Account or combine Sub-Accounts. If the shares of a Fund are no longer available for investment or further investment in any Fund should become inappropriate in view of the purposes of the Variable Account, Protective Life may redeem the shares of that Fund and substitute shares of another Fund. Substituted Funds may have higher fees and expenses or may be available only to certain classes of purchasers. Protective Life will not substitute any shares without notice and any necessary approval of the SEC and state insurance authorities.
Subject to applicable law and any required SEC approval, Protective Life may establish new Sub-Accounts or eliminate one or more Sub-Accounts if marketing needs, tax considerations or investment conditions warrant. Any new Sub-Accounts may be made available to existing Owner(s) or may be closed to certain classes of purchasers. Protective Life may prohibit the allocation of Net Premium and transfer of Policy Value to a Sub-Account.
If any of these substitutions or changes are made, Protective Life may by appropriate endorsement change the Policy to reflect the substitution or other change. If Protective Life deems it to be in the best interest of Owner(s), the Variable Account may be operated as a management investment company under the 1940 Act, it may be deregistered under that Act if registration is no longer required, or it may be combined with other Protective Life separate accounts, or its assets may be transferred to other Protective Life separate accounts, subject to any required Owner and/or regulatory approval. Protective Life may make any changes to the Variable Account required by the 1940 Act or other applicable law or regulation.
22
Voting Fund Shares
Protective Life is the legal owner of Fund shares held by the Sub-Accounts and has the right to vote on all matters submitted to shareholders of the Funds. However, in accordance with applicable law, Protective Life will vote shares held in the Sub-Accounts at meetings of shareholders of the Funds in accordance with instructions received from Owners with Policy Value in the Sub-Accounts. However, if the law changes to allow the Company to vote the shares in its own right, the Company may decide to do so.
Protective Life will send or make available to Owners voting instruction forms and other voting materials (such as Fund proxy statements, reports and other proxy materials) prior to shareholders meetings. The number of votes as to which an Owner may give instructions is calculated separately for each Sub-Account and may include fractional votes.
An Owner holds a voting interest in each Sub-Account to which Policy Value is allocated under his or her Policy. Owners only have voting interests while the Insured is alive. The number of votes for which an Owner may give instructions is based on the Owner's percentage interest of a Sub-Account determined as of the date established by the Fund for determining shareholders eligible to vote at the meeting of that Fund.
It is important that each Owner provide voting instructions to Protective Life because Shares as to which no timely instructions are received and shares held directly by Protective Life are voted by Protective Life in proportion to the voting instructions that are received with respect to all Policies participating in a Sub-Account. As a result, a small number of Owners may control the outcome of a vote.
Protective Life may, if required by state insurance officials, disregard Owner voting instructions if such instructions would require shares to be voted so as to cause a change in sub-classification or investment objectives of one or more of the Funds, or to approve or disapprove the investment management agreement or an investment advisory agreement. In addition, Protective Life may under certain circumstances disregard voting instructions that would require changes in the investment management agreement, investment manager, an investment advisory agreement or an investment adviser of one or more of the Funds, provided that Protective Life reasonably disapproves of such changes in accordance with applicable regulations under the 1940 Act. If Protective Life ever disregards voting instructions, Owners will be advised of that action and of the reasons for such action in the next semiannual report.
THE POLICY
Purchasing a Policy
For insurance coverage to take effect under a Policy, you must submit a completed application and at least the minimum initial premium payment through a licensed representative of Protective Life who is also a registered representative of a broker-dealer having a distribution agreement with Investment Distributors, Inc. Protective Life requires satisfactory evidence of the insurability, which may include a medical examination of the Insured. Generally, Protective Life will issue a Policy covering an Insured up to age 75 if Evidence of Insurability satisfies Protective Life's underwriting rules. No Policy will be issued to an Insured under the age of 20 years. Minimum age requirements may apply. Acceptance of an application depends on Protective Life's underwriting rules, and Protective Life may reject an application for any reason. Applicants must be acceptable risks based on our applicable underwriting limits and standards. We will not issue a Policy until the underwriting process has been completed to our satisfaction. We reserve the right to reject an application for any lawful reason or to "rate" an Insured as a substandard risk, which will result in increased cost of insurance rates. The cost of insurance rate also may vary depending on the type of underwriting we use. A Policy is issued after Protective Life approves the application. Payment of Premium is not a requirement to issue a Policy but your insurance will not take effect until you pay your minimum initial premium. Premium may be collected at the time of Policy delivery. We generally do not accept premium payments before approval of an application; however, at our discretion, we may elect to do so. We will not credit interest or allocate your premium payment for the period while your application is in underwriting.
Insurance coverage under a Policy begins on the Policy Effective Date.
In order to obtain a more favorable Issue Age, Protective Life may permit the Owner to "backdate" a Policy by electing a Policy Effective Date up to six months prior to the date of the original application, subject to state requirements (3 months in Ohio, not allowed in Montana). Charges for the Monthly Deduction for the backdated period are deducted as of the Policy Effective Date.
The Owner of the Policy may exercise all rights provided under the Policy. By Written Notice received by Protective Life at the Home Office while the Insured is living, the Owner may name a contingent Owner or a new Owner. A change in Owner may have tax consequences. See "TAX CONSIDERATIONS Other Considerations."
23
Fees, charges and benefits available under the Policy may vary depending on the state in which the Policy is issued.
Cancellation Privilege
You may cancel your Policy for a refund during the Cancellation Period by returning it to Protective Life's Home Office, or to the sales representative who sold it along with a written cancellation request. The Cancellation Period is determined by the law of the state in which the application is signed and is shown in Appendix B. In most states it expires at the latest of
1. 10 days after you receive your Policy, or
2. 45 days after you sign your application.
Return of the Policy by mail is effective upon receipt by Protective Life. We will treat the Policy as if it had never been issued. In states that require us to return Policy Value if you cancel your Policy, Net Premium will be allocated to the Sub-Accounts you select on your application. In those states, we will refund your Policy Value (less surrenders, withdrawals and distributions) as of the date we received your cancellation request. This amount may be higher or lower than your premium payments depending on the investment performance of the Sub-Accounts you selected, which means you bear the investment risk until we receive your Policy and notice of cancellation. In those states that require us to return your premium, we will refund the greater of the Policy Value or the premium paid plus any fees and charges, less any withdrawals and distributions already made. For a list of states which require return of premium please refer to Appendix B.
Where state laws provide for the Company to refund the Premium if the Policy is cancelled during the right to cancel period, the Company reserves the right to allocate the Premiums to the Money Market Sub-Account.
Age Requirements
An Insured's Issue Age must be between 20 and 75 for Policies issued on a fully underwritten basis and between 20 and 70 for Policies issued on a guaranteed underwriting or a simplified underwriting basis.
Changes in the Policy or Benefits
At any time Protective Life may make such changes in the Policy as are necessary to assure compliance with any applicable laws or with regulations or rulings issued by a government agency. This includes, but is not limited to, changes necessary to comply at all times with the definition of life insurance prescribed by the Internal Revenue Code. Any such changes will apply uniformly to all affected Policies, and Owners will receive notification of such changes.
Specialized Uses of the Policy
Because your Policy provides for an accumulation of Policy Values as well as Death Benefit, you may wish to use it for various individual and business planning purposes. Purchasing the Policy in part for such purposes may involve certain risks. For example, if the investment performance of the Sub-Accounts is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate sufficient Policy Value to fund the purpose for which you purchased the Policy. Withdrawals and Policy Loans may significantly affect current and future Policy Value, Cash Surrender Value or Death Benefit Proceeds. The Policy is designed to provide benefits on a long-term basis. Before purchasing a Policy for a specialized purpose, you should consider whether the long-term nature of the Policy is consistent with the purpose for which it is being considered. In addition, using a Policy for a specialized purpose may have tax consequences. See "TAX CONSIDERATIONS Other Considerations."
PREMIUMS
Minimum Initial Premium. The minimum initial premium required depends on a number of factors, including the age, sex and Premium class of the proposed Insured, the Initial Face Amount requested by the applicant, any supplemental riders and endorsements requested by the applicant and the planned periodic premiums that the applicant selects. Consult your sales representative for information about the initial premium required for the coverage you desire.
Periodic Premiums. The Company may recommend a periodic Premium amount. The actual amount of Premium needed may change, depending on the number of Premium payments made, changes in coverage, investment experience, monthly risk rate, and partial withdrawals and policy loans made. While you are not required to make additional premium payments according to a fixed schedule, you may select a periodic premium schedule and corresponding billing period, subject to our limits. We will send you reminder notices for the periodic premium, unless
24
you request to have reminder notices suspended. You are not required, however, to pay the periodic premium; you may increase or decrease the periodic premium subject to our limits, and you may skip a payment or make unscheduled payments. Depending on the investment performance of the Funds you select, the periodic premium may not be sufficient to keep your Policy in force, and you may need to change your premium payment schedule or make additional payments in order to prevent termination of your Policy.
Additional, Unscheduled Premiums. You may pay additional, unscheduled premium payments to us in the amounts and at the times you choose, subject to the limitations described below. To find out whether your premium payment has been received, contact us at the Home Office address or telephone number shown on the first page of this Prospectus. We reserve the right to limit the number of premium payments we accept on an annual basis. No premium payment may be less than $100 per Policy without our consent, although we will accept a smaller premium payment if necessary to keep your Policy in force. We reserve the right to restrict or refuse any premium payments that exceed the Initial premium amount shown on your Policy.
Protective Life reserves the right to limit the amount and frequency of periodic premiums and additional premium under the Policy or the amount and frequency of Net Premiums that may be allocated to the Fixed Account at any time. Protective Life also reserves the right to refuse to accept such additional premium under the Policy or allocate additional Net Premium to the Fixed Account at any time without prior notice. In all cases, Protective Life will accept additional premium necessary to prevent the Policy from lapsing.
Premium Limitations. Premiums are accepted until Attained Age of 121. Premiums may be paid by any method acceptable to Protective Life. If by check, the check must be from an Owner (or the Owner's designee other than a sales representative), payable to Protective Life, and be dated prior to its receipt at the Home Office.
Additional limitations apply to premiums. Premium payments must be at least $100 and must be remitted to the Home Office although we will accept a smaller premium payment if necessary to keep your Policy in force.
We also reserve the right not to accept a premium payment that causes the Death Benefit to increase by an amount that exceeds the premium received. Evidence of Insurability satisfactory to us may be required before we accept any such premium. Protective Life also reserves the right to limit the amount and frequency of any premium payment. See "TAX CONSIDERATIONS" and the discussion of Cash Value Accumulation Test under "DEATH BENEFIT PROCEEDS." If the Death Benefit is based on the applicable factor in the Table of Death Benefit Factors shown in the Policy Schedule, the Company reserves the right to refund the portion of any premium or Cash Value which causes the Death Benefit to be based on such factors. Protective Life will also monitor Policies and will notify the Owner on a timely basis if his or her Policy is in jeopardy of becoming a modified endowment contract under the Code, if applicable. See "TAX CONSIDERATIONS."
Premium Payments Upon Increase in Face Amount. Depending on the Policy Value at the time of an increase in the Face Amount and the amount of the increase requested, an additional premium payment may be necessary to keep the Policy in force or a change in the amount of planned periodic premiums may be advisable. You will be notified if a premium payment is necessary or a change is appropriate.
Net Premium Allocations
You must indicate in the application how Net Premiums are to be allocated to the Sub-Accounts and/or to the Fixed Account. These allocation instructions apply to both initial and subsequent Net Premiums. You may change the allocation instructions in effect at any time until Attained Age of 121 by Written Notice to Protective Life at the Home Office or by emailing us at GWExecBenefits@protective.com
Whole percentages must be used. The sum of the allocations to the Sub-Accounts and the Fixed Account must be equal to 100% of any Net Premiums. Protective Life reserves the right to establish (i) a limitation on the number of Sub-Accounts to which Net Premiums may be allocated and/or (ii) a minimum allocation requirement for the Sub-Accounts and the Fixed Account.
Where state laws provide for the Company to refund premium if the Policy is cancelled during the right to cancel period, the Company reserves the right to allocate your premium to the Money Market Sub-Account until the expiration of the number of days in the Cancellation Period plus 6 days starting from the date that the Policy is mailed from the Home Office. Thereafter, the Policy Value in the Money Market Sub-Account and all Net Premiums will be allocated according to your allocation instructions then in effect.
If Protective Life receives a premium payment at the Home Office before 3:00 P.M. Central Time, Protective Life will process the payment as of the Valuation Date it is received. Protective Life processes premium payments received at
25
the Home Office at or after 3:00 P.M. Central Time as of the next Valuation Date. However, premium will not be accepted in connection with an increase in Face Amount until underwriting has been completed. When approved, Net Premium received will be allocated in accordance to your allocation instructions then in effect.
Unless designated by the Owner as a loan repayment, premiums received from Owners (other than planned periodic premiums) are treated as unscheduled premiums.
Protective Life reserves the right to limit the amount and frequency of planned periodic premiums and additional unscheduled premiums (each and "additional premium") under the Policy or the amount and frequency of Net Premiums that may be allocated to the Fixed Account at any time and to refuse to accept such additional premium under the Policy or allocate additional Net Premium to the Fixed Account at any time without prior notice. In all cases, Protective Life will accept additional premium necessary to prevent the Policy from lapsing. Protective Life will notify the Owner that a premium payment, whether a planned periodic premium or additional premium, may result in a Policy becoming a Modified Endowment Contract ("MEC").Protective Life reserves the right not to accept a premium that will cause the Policy to become a MEC, unless otherwise instructed by the Owner.
If mandated by law, we may reject a premium payment. We may also provide information about you and your account to a government regulator.
CALCULATION OF POLICY VALUE
Variable Account Value
Each premium less any expense charge will be credited to the Policy Value on the date received at the Home Office. On the Monthly Anniversary Day, a deduction will be made for the cost of insurance. Variable Account Value reflects the investment experience of the Sub-Accounts to which it is allocated, any premiums allocated to the Sub-Accounts, transfers in or out of the Sub-Accounts (including loans), any withdrawals of Variable Account Value and Monthly Deductions. There is no guaranteed minimum Variable Account Value. A Policy's Variable Account Value therefore depends upon a number of factors.
The Variable Account Value for a Policy at any time is the sum of the Sub-Account Values for the Policy on the Valuation Date most recently completed.
Determination of Units
For each Sub-Account, the Net Premium(s) or unloaned Policy Value transferred are converted into units. The number of units credited is determined by dividing the dollar amount directed to each Sub-Account by the value of the unit for that Sub-Account for the Valuation Date on which the Net Premium(s) or transferred amount is invested in the Sub-Account. Therefore, Net Premiums allocated to or amounts transferred to a Sub-Account under a Policy increase the number of units of that Sub-Account credited to the Policy.
Determination of Unit Value
The unit value at the end of every Valuation Date is the unit value at the end of the previous Valuation Date times the Net Investment Factor, as described below. The Sub-Account Value for a Policy is determined on any day by multiplying the number of units attributable to the Policy in that Sub-Account by the unit value for that Sub-Account on that day as further described below.
Sub-Account Value
The Sub-Account Value is the total dollar amount of all units credited to the Owner's Policy under each of the Sub-Accounts and excluding the Fixed Account, if applicable. Each Sub-Account's Value is equal to the sum of:
• The net asset value of the Fund(s) in the Sub-Account at the last Valuation Date;
• Any Premium, less expense charges deducted from Premiums received during the current Valuation Period which is allocated to the Sub-Account;
• Any policy loan repayment amount allocated to the Sub-Account;
• All values transferred to the Sub-Account;
• Any net investment return allocated to the Sub-Account.
26
Minus the following:
• All values transferred to another Sub-Account, the Fixed Account if applicable, and Policy Debt taken from the Sub-Account during the current Valuation Period;
• All partial withdrawals from the Sub-Account during the current Valuation Period;
• Monthly Deductions;
• An amount for transaction charges, if any, Transfer fees and change of death benefit option fee if these fees are deducted from the Sub-Accounts.
Net Investment Factor
The Net Investment Factor is an index applied to measure the investment performance of a Sub-Account from one Valuation Period to the next. Each Sub-Account has a Net Investment Factor for each Valuation Period which may be greater or less than one. Therefore, the value of a unit may increase or decrease. The Net Investment Factor for any Valuation Period is determined by dividing (1) by (2), where:
(1) Is the net result of:
a. The net asset value per share of the Fund(s) held in the Sub-Account, determined as of the end of the current Valuation Period; plus
b. The per share amount of any dividend (or, if applicable, capital gain distributions) made by the Fund(s) to the Sub-Account, if the "ex-dividend" date occurs during the current Valuation Period; minus or plus
c. A per share charge or credit for any taxes incurred by or reserved for the Fund(s), which is determined by the Company to have resulted from the operations of the Sub-Account.
(2) Is the net result of:
a. The net asset value per share of the Fund(s) held in the Sub-Account, determined at the end of the last Valuation Period.
The Company will deduct from the assets of the Sub-Account(s) all fees and expenses incurred in connection with the operation of the Sub-Account(s).
Fixed Account Value
The Fixed Account Value under a Policy at any time is equal to the sum of:
• the Net Premium(s) allocated to the Fixed Account; plus
• Sub-Account Value transferred to the Fixed Account; plus
• interest credited to the Fixed Account.
MINUS the following
• The portion of any accrued Policy fees and charges allocated to the Fixed Account;
• An amount for the cost of insurance (as defined in the "Cost of Insurance" provision of the Policy) deducted from the Fixed Account on the Monthly Anniversary Day;
• An amount for transaction charges, Transfer fees and change of death benefit option fee deducted from the Fixed Account;
• Partial withdrawals from the Fixed Account including any applicable partial withdrawal charges; and
• Transfers from the Fixed Account.
See "THE COMPANY AND THE FIXED ACCOUNT The Fixed Account," for a discussion of how interest is credited to the Fixed Account.
DEATH BENEFIT PROCEEDS
As long as the Policy remains in force, Protective Life will pay the Beneficiary the Death Benefit Proceeds upon receipt at the Home Office of Due Proof of Death of the Insured. Protective Life may require return of the Policy. The Death
27
Benefit Proceeds are paid to the primary Beneficiary or a contingent Beneficiary. The Owner may name one or more primary or contingent Beneficiaries. Unless designated irrevocably, the Owner may change the Beneficiary by Written Notice prior to the death of any Owner. If no Beneficiary survives the Insured, the Death Benefit Proceeds are paid to the Owner or the Owner's estate. Death Benefit Proceeds are paid in a lump sum or under a settlement option that the Company is then offering. Payment of the Death Benefit Proceeds may have tax consequences. See "TAX CONSIDERATIONS Tax Treatment of Life Insurance Death Benefit Proceeds."
Please note that any Death Benefit payment we make in excess of the Variable Account Value, including payments under any rider, is subject to our financial strength and claims-paying ability.
Limits on Policy Rights
Incontestability. Unless fraud is involved, Protective Life will not contest the Policy, or any supplemental rider or endorsement, after the Policy, rider, or endorsement has been in force during the Insured's lifetime for two years from the Policy Effective Date or the effective date of the rider or endorsement. Likewise, unless fraud is involved, Protective Life will not contest an increase in the Face Amount with respect to statements made in the Evidence of Insurability for that increase after the increase has been in force during the life of the Insured for two years after the effective date of the increase.
Suicide Exclusion. If the Insured dies by suicide, while sane or insane, within two years after the Policy Effective Date, the Death Benefit will be limited to the premium payments made before death, less any Policy Debt, liens (including accrued interest) and any withdrawals. If the Face Amount is increased and if the Insured commits suicide, while sane or insane, within 2 years from the effective date of any increase, the Company will pay the cost of insurance paid for the amount of increase. The Face Amount of the Policy will be reduced to the Face Amount that was in effect prior to the increase. The Company will not pay any portion of the increased Face Amount, other than the Death Benefit (and only if it is greater than the Face Amount prior to the increase).
The Company reserves the right to request and obtain evidence as to the manner and/or cause of the Insured's death.
Misstatement of Age or Sex. If the Insured's age or sex (in non-unisex states) has been misstated in the application for the Policy or in any application for supplemental riders or endorsements, the Death Benefit under the Policy or such supplemental riders or endorsements is the amount which would have been provided by the most recent cost of insurance charge, and the cost of such supplemental riders or endorsements, at the correct age and sex. The applicable factor used in determining the Death Benefit shall be the factor required by Section 7702 of the Code reflecting the Insured's correct age and/or sex.
If the age is misstated in such a way that the Insured was not eligible for coverage under the Policy, a mortality charge and benefit will be extrapolated.
Calculation of Death Benefit Proceeds
The Death Benefit Proceeds are equal to the Death Benefit calculated as of the date of the Insured's death, less (1) any Policy Debt on that date and any liens for payments made under an accelerated death benefit rider or endorsement (including any accrued interest), and less (2) any past due Monthly Deductions.
The calculation of the Death Benefit depends on the Death Benefit Option elected.
Federal Tax Compliance Test. Under Section 7702 of the Internal Revenue Code, a Policy will generally be treated as life insurance for federal tax purposes if, at all times, it satisfies the Cash Value Accumulation Test.
The Cash Value Accumulation Test ("CVAT") does not have a premium limit, but does require that the Death Benefit be at least a certain percentage (varying based on the Attained Age, sex and Premium class of the Insured) of the Cash Value.
The Death Benefit Option you choose will also affect the amount of your Death Benefit.
Under Death Benefit Option 1, your Death Benefit will generally be the Face Amount. Under Death Benefit Option 2, your Death Benefit will always vary with the Policy Value. However, the Death Benefit may vary based on the Cash Value if the minimum Death Benefit is greater than the Face Amount under the Death Benefit Option 1 or the Face Amount plus the Policy Value under Death Benefit Option 2. See "Death Benefit Options" for detailed information about each Death Benefit Option.
You should consult your tax advisor or registered representative for more information about which death benefit option you should choose in light of your specific goals and circumstances.
28
The Death Benefit Proceeds are payable when Protective Life receives a properly completed claim form and Due Proof of Death of the Insured while the Policy is in force. The Death Benefit Proceeds will be paid to the Beneficiary, or Beneficiaries, in a lump sum, unless a Settlement Option currently being offered by the Company is selected. If there is more than one Beneficiary, each Beneficiary must submit instructions in Good Order specifying the manner in which they wish to receive their portion of the Death Benefit Proceeds. The Death Benefit Proceeds are determined as of the date of the Insured's death and are moved to the General Account until payment is made. Protective Life will pay interest on the Death Benefit Proceeds payable to each Beneficiary determined in accordance with applicable state law to the date of payment.
Death Benefit Options
The Policy has two Death Benefit options.
Option 1. The "Level Death" Option. Under this option, the death benefit is the greater of
• the Policy's Total Face Amount shown on the Policy Schedule, less any partial withdrawals; or
• the Cash Value on the Insured's date of death multiplied by the applicable factor in the Table of Death Benefit Factors shown in the Policy Schedule for the Insured's age at date of death.
This death benefit option should be selected if you want to minimize your cost of insurance.
Option 2. The "Coverage Plus" Option. Under this option, the death benefit is the greater of
• The Total Face Amount shown on the Policy Schedule, plus the Policy Value on the Insured's date of death; or,
• the Cash Value on the Insured's date of death multiplied by the applicable factor in the Table of Death Benefit Factors shown in the Policy Schedule for the Insured's age at date of death.
This death benefit option should be selected if you want to maximize your death benefit.
Your Cash Value and Death Benefit fluctuate based on the performance of the investment options you select and the expenses and deductions charged to your account. The Cash Value includes the Return of Expense Charge Benefit, if applicable, and thus the amount of this benefit can affect the amount of the Death Benefit.
There is no minimum Death Benefit guarantee associated with this Policy.
Examples of Death Benefit calculations for both Death Benefit Options are found in Appendix A.
Changing Death Benefit Options
The Owner must indicate a Death Benefit Option in the application for the Policy. On or after the first Policy Anniversary, but not more than once each Policy Year, the Owner may change the Death Benefit Option on the Policy subject to the following rules. The request must be received in writing in Good Order at the Home Office. After any change, the Face Amount must be at least $100,000. The effective date of the change will be the Monthly Anniversary Day that coincides with or next follows the day that Protective Life approves the request. Protective Life may require satisfactory Evidence of Insurability. All changes must be approved by Protective Life at the Home Office before they will be effective. Any change will be effective on the Monthly Anniversary following the date the Company approves the Request. Protective Life reserves the right to decline to change the Death Benefit Option if after the change the Death Benefit would not be based on the applicable factor in the Table of Death Benefit Factors shown in the Policy Schedule.
When a change from Option 1 to Option 2 is made, the Face Amount after the change is effected will be equal to the Face Amount before the change less the Policy Value on the effective date of the change. When a change from Option 2 to Option 1 is made, the Face Amount after the change will be equal to the Face Amount before the change is effected plus the Policy Value on the effective date of the change.
There is a maximum fee of $100 for change of death benefits as stated in the Policy Schedule.
Changing the Face Amount
The Owner may request a change in the Face Amount of the Policy at any time within certain limits. The request must be received in writing in Good Order at the Home Office.
Increasing the Face Amount. Any increase in the Face Amount must be at least $25,000 and an application must be submitted in Good Order. Protective Life will require satisfactory Evidence of Insurability. In addition, the Insured's
29
current Attained Age must be less than the maximum Issue Age for the Policies, as determined by Protective Life from time to time. A change in periodic premiums may be advisable. See "PREMIUMS Premium Payments Upon Increase in Face Amount." The increase in Face Amount will become effective as of the Monthly Anniversary Day following the date that Protective Life approves the request for the increase, and the Policy Value will be adjusted to the extent necessary to reflect a Monthly Deduction as of the effective date based on the increase in Face Amount.
Each increase to the Face Amount is considered to be a new segment to the Policy. When an increase is approved, Net Premium is allocated against the original Policy segment up to the seven-pay Premium limit established on the Issue Date. Any excess Net Premium is then allocated toward the new segment. Each segment will have a separate target Premium associated with it. The expense charge applied to Net Premium is higher up to target and lower for Net Premium in excess of the target as described in detail in the "CHARGES AND DEDUCTIONS" section of this Prospectus. The expense charge formula will apply to each segment based on the target Net Premium for that segment. In addition, each segment will have a new incontestability period and suicide exclusion period as described in the "DEATH BENEFIT PROCEEDS Limits on Policy Rights" section of this Prospectus.
Increasing the Face Amount of the Policy may increase the Death Benefit and may have the effect of increasing monthly cost of insurance charges. Increasing the Face Amount may also have tax consequences. See "TAX CONSIDERATIONS." Please consult your tax advisor.
Decreasing the Face Amount. The minimum decrease in the Face Amount is $25,000 and a request must be submitted in Good Order. The decrease in Face Amount will become effective on the Monthly Anniversary Day following the date that Protective Life approves the request for the decrease. If the decrease would cause the Death Benefit to be based on the applicable factor in the Table of Death Benefit Factors shown in the Policy Schedule, Protective Life reserves the right to decline or limit the amount of such decrease. Although Protective Life will attempt to notify an Owner if a decrease in the Face Amount will cause a Policy to be considered a modified endowment contract under Section 7702A of the Code, we will not automatically return premium. See "TAX CONSIDERATIONS Policies That Are MECs." Decreasing the Face Amount also may have other tax consequences. See "TAX CONSIDERATIONS Certain Distributions Required by the Tax Law in the First 15 Policy Years."
The Face Amount after any decrease must be at least $100,000. If the Initial Face Amount of the Policy has been increased prior to the requested decrease, then the decrease will first be applied against any previous increases in Face Amount in the reverse order in which they occurred.
Decreasing the Face Amount of the Policy may reduce the Death Benefit and may have the effect of decreasing monthly cost of insurance charges.
Settlement Options
The Death Benefit payable on the Insured's death will be paid in a lump sum unless the Owner elects to receive all or a portion of the Death Benefit Proceeds under a settlement option that the Company is then offering. See TAX CONSIDERATIONS Tax Treatment of Life Insurance Death Benefit Proceeds.
Escheatment of Death Benefit
Every state has unclaimed property laws which generally declare life insurance policies to be abandoned after a period of inactivity of 3 to 5 years from the date the Death Benefit is due and payable. For example, if the payment of a Death Benefit has been triggered, but, if after a thorough search, Protective Life is still unable to locate the Beneficiary of the Death Benefit, or the Beneficiary does not come forward to claim the Death Benefit in a timely manner, the Death Benefit will be paid to the abandoned property division or unclaimed property office of the state in which the Beneficiary or the Owner last resided, as shown on our books and records, or to our state of domicile. This "escheatment" is revocable, however, and the state is obligated to pay the Death Benefit (without interest) if your Beneficiary steps forward to claim the Death Benefit with the proper documentation. To prevent such escheatment, it is important that you update your Beneficiary designations, including addresses, if and as they change. Such updates should be communicated in writing, by telephone, or other approved electronic means to the Home Office.
TRANSFERS OF POLICY VALUE
Upon receipt of Written Notice in Good Order to Protective Life at the Home Office you may transfer the Fixed Account Value to the Variable Account or the Variable Account Value to the Fixed Account subject to certain restrictions described below. Transfer requests received at the Home Office before 3:00 P.M. Central Time are processed as of the Valuation Date the request is received. Requests received in Good Order at or after 3:00 P.M. Central Time are processed as of the next Valuation Date.
30
Fixed Account Transfers
Transfers into the Fixed Account are limited to once every 60 days and to a maximum amount of $20 million, which can be increased with prior Home Office approval. Your transfer will be rejected if it would cause the value of the Fixed Account to exceed such maximum dollar amount. The limits on the frequency and amount of Transfers into the Fixed Account may be changed or waived by the Company.
Transfers from the Fixed Account may only be made once every 365 days. The maximum to be transferred out will be the greater of 25% of your balance in the Fixed Account or the amount of the transfer in the previous 365-day period. Due to these limitations, if you want to transfer all of your Policy Value from the Fixed Account to the Variable Account, it may take several years to do so. Loans and partial withdrawals are treated as Transfers out of the Fixed Account.
Sub-Account Transfers
Subject to our rules as they may exist from time to time, you may at any time (in some circumstances only after the Cancellation Period) transfer to another Sub-Account, all or a portion of the Variable Account Value allocated to a Sub-Account.
A fee of $10 per transfer will apply for all non-electronic transfers in excess of 12 made in a Policy Year. We may change the amount of the transfer fee; however, it is guaranteed to never exceed $10 per transfer. All transfers requested on the same Business Day will count as only one transfer toward the 12 free transfers. Likewise, any transfers under dollar cost averaging or periodic rebalancing of your Sub-Account Value under the rebalancing option do not count toward the 12 free transfers (a one-time rrebalancing, however, will be counted as one transfer). Currently, electronic transfers do not count towards the 12 free transfers; however, we reserve the right, at any time, to charge for electronic transfers in excess of the free transfers allowed.
Upon receipt of Written Notice in Good Order, or where transfers are allowed to be made electronically or in such manner as Protective Life authorizes from time to time, to Protective Life at the Home Office, you may transfer the Variable Account Value between Sub-Accounts, subject to certain restrictions described below. Transfers may be requested by indicating the transfer of either a specified dollar amount or a specified percentage of the Sub-Account Value from which the transfer will be made. Transfer requests received at the Home Office before 3:00 P.M. Central Time are processed as of the Valuation Date the request is received. Requests received in Good Order at or after 3:00 P.M. Central Time are processed as of the next Valuation Date.
Transfer privileges are subject to our consent. We reserve the right to impose limitations on transfers, including, but not limited to: (1) the minimum amount that may be transferred to a Sub-Account; and (2) the minimum Sub-Account Value that must remain following a transfer from that Sub-Account. In addition, we may enforce the restriction on transfers set forth in your Policy and in cases of identified market timing unless the Sub-Account has additional restrictions that are noted in the respective Fund's prospectus. See "Limitations on frequent transfers, including 'market timing' transfers" below.
Protective Life may, however defer transfers under the same conditions that payment of Death Benefit Proceeds, withdrawals and surrenders may be delayed. See "SUSPENSIONS OR DELAYS IN PAYMENTS." The minimum amount that may be transferred is the lesser of $100 or the entire amount in any Sub-Account from which the transfer is made. If, after the transfer, the amount remaining in a Sub-Account(s) would be less than $1000, Protective Life reserves the right to transfer the entire amount instead of the requested amount.
We will give written notice thirty (30) days before we limit the number of transfers. The transfer fee, if any, is deducted from the amount being transferred. Protective Life reserves the right to terminate, suspend or modify transfer privileges at any time.
Limitations on frequent transfers, including "market timing" transfers. Frequent transfers may involve an effort to take advantage of the possibility of a lag between a change in the value of a Fund's portfolio securities and the reflection of that change in the Fund's share price. This strategy, sometimes referred to as "market timing," involves an attempt to buy shares of a Fund at a price that does not reflect the current market value of the portfolio securities of the Fund, and then to realize a profit when the Fund shares are sold the next Valuation Date or thereafter.
When you request a transfer among the Sub-Accounts, your request triggers the purchase and redemption of Fund shares. Frequent transfers cause frequent purchases and redemptions of Fund shares. Frequent purchases and redemptions of Fund shares can cause adverse effects for a Fund, Fund shareholders, the Variable Account, other
31
Owners, beneficiaries or Owners of other variable life insurance policies we issue that invest in the Variable Account and the Funds. Frequent transfers can result in the following adverse effects:
• Increased brokerage trading and transaction costs;
• Disruption of planned investment strategies;
• Forced and unplanned liquidation and portfolio turnover;
• Lost opportunity costs; and
• Large asset swings that decrease the Fund's ability to provide maximum investment return to all Policy Owners.
In order to try to protect our Policy Owners and the Funds from the potential adverse effects of frequent transfer activity, the Company has implemented certain market timing policies and procedures (the "Market Timing Procedures"). Our Market Timing Procedures are designed to detect and prevent frequent, short-term transfer activity that may adversely affect the Funds, Fund shareholders, the Separate Account, other Policy Owners' beneficiaries and Policy Owners of other variable life policies we issue that invest in the Funds.
We monitor transfer activity in the Policies to identify frequent transfer activity in any Policy. Our current Market Timing Procedures are intended to detect transfer activity in which the transfers exceed a certain dollar amount and a certain number of transfers involving the same Sub-Accounts within a specific time period. We regularly review transaction reports in an attempt to identify transfers that exceed our established parameters. We do not include transfers made pursuant to the Dollar-Cost Averaging and Portfolio Rebalancing programs when monitoring for frequent transfer activity.
When we identify transfer activity exceeding our established parameters in a Policy or group of Policies that appear to be under common control, we suspend non-written methods of requesting transfers for that Policy or group of Policies. All transfer requests for the affected Policy or group of Policies must be made by Written Notice in Good Order to the Home Office. We notify the affected Policy Owner(s) in writing of these restrictions.
In addition to our Market Timing Procedures, the Funds may have their own market timing policies and restrictions. While we reserve the right to enforce the Funds' policies and procedures, Owners and other persons with interests under the Policies should be aware that we may not have the contractual authority or the operational capacity to apply the market timing policies and procedures of the Funds. However, under SEC rules, we are required to: (1) enter into a written agreement with each Fund or its principal underwriter that obligates us to provide to the Fund promptly upon request certain information about the trading activity of individual Owners, and (2) execute instructions from the Fund to restrict or prohibit further purchases or transfers by specific Owners who violate the market timing policies established by the Fund.
Some of the Funds have reserved the right to temporarily or permanently refuse payments or transfer requests from us if, in the judgment of the Fund's investment adviser, the Fund would be unable to invest effectively in accordance with its investment objective or policies, or would otherwise potentially be adversely affected. To the extent permitted by law, we reserve the right to delay or refuse to honor a transfer request, or to reverse a transfer at any time we are unable to purchase or redeem shares of any of the Funds because of the Fund's refusal or restriction on purchases or redemptions. We will notify the Policy Owner(s) of any refusal or restriction on a purchase or redemption by a Fund relating to that Policy Owner's transfer request. Some Funds also may impose redemption fees on short-term trading (i.e., redemptions of mutual Fund shares within a certain number of business days after purchase). We also reserve the right to implement, administer, and collect any redemption fees imposed by any of the Funds. You should read the prospectus of each of the Funds for more information about its ability to refuse or restrict purchases or redemptions of its shares, which may be more or less restrictive than our Market Timing Procedures and those of other Funds, and to impose redemption fees.
We apply our Market Timing Procedures consistently to all Policy Owners without special arrangement, waiver or exception. We reserve the right to change our Market Timing Procedures at any time without prior notice as we deem necessary or appropriate to better detect and deter potentially harmful frequent transfer activity, to comply with state or federal regulatory requirements, or both. We may change our parameters to monitor for different dollar amounts, number of transfers, time period of the transfers, or any of these.
Policy Owners seeking to engage in frequent transfer activity may employ a variety of strategies to avoid detection. Our ability to detect and deter such transfer activity is limited by operational systems and technological limitations. Furthermore, the identification of Policy Owners determined to be engaged in transfer activity that may adversely affect others involves judgments that are inherently subjective. Accordingly, despite our best efforts, we cannot guarantee that our Market Timing Procedures will detect or deter every potential market timer. In addition, because
32
other insurance companies, retirement plans, or both may invest in the Funds, we cannot guarantee that the Funds will not suffer harm from frequent transfer activity in contracts or policies issued by other insurance companies or by retirement plan participants.
Reservation of Rights
Protective Life reserves the right without prior notice to modify, restrict, suspend or eliminate the transfer privileges at any time, for any class of Policies, for any reason. In particular, we reserve the right not to honor transfer requests by a third party holding a power of attorney from an Owner where that third party requests simultaneous transfers on behalf of the Owners of two or more Policies. In the event Protective Life chooses to exercise these rights, we will notify the affected Owners in writing or through a supplement to this Prospectus.
Dollar-Cost Averaging
If you elect at the time of application or at any time thereafter by Written Notice in Good Order to Protective Life at the Home Office, you may systematically and automatically allocate a predetermined dollar amount, subject to our minimum, at regular intervals from a Sub-Account ("Source Sub-Account") to one or more other specified Sub-Accounts, subject to the following restriction: no transfers may be made into or out of the Fixed Account. This is known as the Dollar-Cost Averaging method of investment. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one particular time, you may be less susceptible to the impact of market fluctuations in Sub-Account unit values. Protective Life, however, makes no guarantee that the Dollar-Cost Averaging method will result in a profit or protect against loss.
The unit value will be determined on the dates of the transfers. You must specify the dollar amount to be transferred into each designated Sub-Account. Transfers may be set up on any one of the following frequency periods: monthly, quarterly, semiannually, or annually. The transfer will be initiated on the next frequency period following the date of your request. We will provide a list of Sub-Accounts eligible for Dollar-Cost Averaging that may be modified from time to time. Amounts transferred through Dollar-Cost Averaging are not counted against the 12 free transfers allowed in a Policy Year. You may not participate in Dollar-Cost Averaging and Portfolio Rebalancing (described below) at the same time. Participation in Dollar-Cost Averaging does not assure a greater profit, or any profit, nor will it prevent or necessarily alleviate losses in a declining market.
Automatic transfers for Dollar-Cost Averaging are subject to all transfer restrictions and limits on frequent transfer activity. Dollar-Cost Averaging transfers may commence on any day of the month that you request. If no day is selected, transfers will occur on the Monthly Anniversary Day. We have the right to restrict these transfers until 6 days after the end of the Cancellation Period.
Once elected, Protective Life will continue to process Dollar-Cost Averaging transfers until the earlier of the following: (1) the number of designated transfers has been completed, (2) the Policy Value in the appropriate source Sub-Account is depleted, (3) the Owner, by Written Notice received by Protective Life at the Home Office, instructs Protective Life to cease the automatic transfers, (4) a grace period begins under the Policy, or (5) the maximum amount of Policy Value has been transferred under the Dollar-Cost Averaging program.
Automatic transfers made to facilitate Dollar-Cost Averaging will not count toward the 12 transfers permitted each Policy Year. Protective Life reserves the right to modify, suspend, or terminate dollar cost averaging at any time.
Portfolio Rebalancing
At the time of application or at any time thereafter by Written Notice in Good Order to Protective Life, you may instruct Protective Life to automatically transfer, on a periodic basis, your Variable Account Value among specified Sub-Accounts to achieve a particular percentage allocation of Variable Account Value among such Sub-Accounts ("Portfolio Rebalancing"). Such percentage allocations must be in whole numbers and must allocate amounts only among the Sub-Accounts. Portfolio Rebalancing does not include transfers into or out of the Fixed Account. There is no charge for this service. A minimum Variable Account Value of $100 is required for Portfolio Rebalancing. Participation in portfolio rebalancing does not assure a greater profit, or any profit, nor will it prevent or necessarily alleviate losses in a declining market.
Unless you instruct otherwise when electing rebalancing, the percentage allocation of your Variable Account Value for Portfolio Rebalancing will be based on your premium allocation instructions in effect at the time of rebalancing. You can change your premium allocation instructions by submitting Written Notice in Good Order to the Home Office. Portfolio Rebalancing may commence on any day of the month that you request except the 29th, 30th or 31st. If no
33
day is selected, rebalancing will occur on each applicable Monthly Anniversary Day. We have the right to restrict Portfolio Rebalancing until six days after the end of the Cancellation Period.
You may request that rebalancing occur one time only. If Protective Life receives Written Notice at the Home Office before 3:00 P.M. Central Time, the transfer will take place that same day. If Protective Life receives Written Notice at the Home Office at or after 3:00 P.M. Central Time, Protective Life will process the transfer as of the next Business Day. This transfer will count as one transfer towards the 12 free transfers allowed in a Policy Year.
You may also choose to rebalance your Variable Account Value on a quarterly, semiannual, or annual basis, in which case the first transfer will be initiated on the next frequency period following the date of your request. On that date, your Variable Account Value will be automatically reallocated to the selected Sub-Accounts. Thereafter, your Variable Account Value will be rebalanced once each frequency period. In order to participate in the Portfolio Rebalancing option, your entire Variable Account Value must be included. Transfers made with these frequencies will not count against the 12 free transfers allowed in a Policy Year.
You may change or terminate Portfolio Rebalancing by Written Notice in Good Order received by Protective Life at the Home Office. Portfolio Rebalancing transfers will not count as one of the 12 free transfers available during any Policy Year.
Protective Life reserves the right to modify, suspend, or terminate portfolio rebalancing at any time.
Note: You may not participate in the Portfolio Rebalancing and Dollar-Cost Averaging programs at the same time.
SURRENDERS AND WITHDRAWALS
Surrender Privileges
At any time while the Policy is still in force and while the Insured is still living, you may surrender your Policy for its Cash Surrender Value. Cash Surrender Value is determined as of the end of the Valuation Period during which the Written Notice in Good Order requesting the surrender, the Policy and any other required documents are received by Protective Life at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 P.M. Central Time. Protective Life will process any surrender request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Date. The Cash Surrender Value is paid in a lump sum unless the Owner requests payment under a settlement option that the Company is then offering. Payment is generally made within 7 calendar days but may be subject to postponement, See "SUSPENSIONS OR DELAYS IN PAYMENTS." A Policy which terminates upon surrender cannot later be reinstated. Surrenders may have tax consequences. See "TAX CONSIDERATIONS."
Return of Expense Charge Benefit
If the Policy is surrendered for the surrender benefit within the first 7 years from the Policy Date the Company will return a percentage of the expense charge. The Return of Expense Charge Benefit will be a percentage of the Policy Value Account on the date the surrender Request is received at the Administrative Office. The Return of Expense Charge Benefit will equal the percentage of expense charge paid plus 1% in Policy Year 1, and will then be reduced by a proportional amount in each Policy Year thereafter with it equaling 1% in Policy Year 7. Beginning in Policy Year 8 and all subsequent Policy Years, the Return of Expense Charge Benefit will be 0%.
The Return of Expense Charge Benefit is not available if the Policy is surrendered under the terms of Section 1035 of the Code and is not calculated for a Policy loan, partial withdrawal or when coverage under the Policy lapses.
The Return of Expense Charge Benefit creates a General Account obligation of the Company. The Return of Expense Charge Benefit is payable to the Owner. The Company may reduce or eliminate any Return of Expense Charge Benefit when there is a change of Owner or an assignment of the Policy.
The following examples demonstrate the Return of Expense Charge Benefit. The Assume you have a Policy Value of $10,000, have not taken any loans, and have not elected the Term Life Insurance Rider.
34
Withdrawal Privileges
You may request, by Written Notice in Good Order received at the Home Office, a partial withdrawal of your Policy at any time while the Policy is in force. The amount of any partial withdrawal must be at least $500 and may not exceed 90% of your Policy Value less outstanding Policy Debt. We will charge an administrative fee not greater than $25 per withdrawal on partial withdrawals after the first in a Policy Year. The partial withdrawal fee will be deducted proportionally from all Sub-Accounts and Fixed Account. There are limits to taking partial withdrawals from the Fixed Account. See "THE COMPANY AND THE FIXED ACCOUNT The Fixed Account."
The Total Face Amount (if Death Benefit Option 1 applies) and your Policy Value will be reduced by the amount of any withdrawals. Withdrawals may have tax consequences. See "TAX CONSIDERATIONS." Protective Life will withdraw the amount requested, plus a withdrawal charge from unloaned Policy Value as of the end of the Valuation Period during which the Written Notice in Good Order is received at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 P.M. Central Time.
Protective Life will process any withdrawal request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Date.
The amount of a withdrawal will be withdrawn from the Sub-Accounts and the Fixed Account in proportion to the amounts in the Sub-Accounts and the Fixed Account bearing on your Policy Value. You cannot repay amounts taken as a partial withdrawal. Any subsequent payments received by us will be treated as additional premium payments and will be subject to our limitations on premiums.
POLICY LOANS
You may request a loan under your Policy. Loans allow you to access Policy Value without incurring taxes and charges associated with withdrawals. Policy loans must be requested by Written Notice in Good Order received at the Home Office. Generally the minimum loan amount is $500 and the maximum loan amount is 90% of the Policy Value. This maximum is reduced by (i) any Policy Debt or any lien outstanding (including accrued interest) on the Valuation Date your loan request is received and (ii) the current Monthly Deductions remaining for the balance of the Policy Year. Outstanding Policy Debt, any lien, and the Monthly Deductions therefore reduces the amount available for new Policy loans. Loan proceeds generally are mailed within seven calendar days of the loan being approved.
Loan Collateral
When a Policy loan is made, an amount equal to the loan is transferred out of the Sub-Accounts and/or the Fixed Account and into a Loan Account established for the Policy. Like the Fixed Account, a Policy's Loan Account is part of Protective Life's General Account and amounts therein earn interest as credited by Protective Life from time to time. Because Loan Account values are part of Policy Value, a loan will have no immediate effect on the Policy Value. In contrast, Cash Surrender Value (including, as applicable, Variable Account Value and Fixed Account Value) under a Policy is reduced immediately by the amount transferred to the Loan Account. The Owner can specify the Sub-Accounts and/or the Fixed Account from which collateral is transferred to the Loan Account. If no allocation is specified, collateral is transferred from each Sub-Account and from the Fixed Account in the same proportion that the value in each Sub-Account and the Fixed Account bears to the total unloaned Policy Value on the date that the loan is made.
On each Policy Anniversary, an amount of Policy Value equal to any due and unpaid loan interest (explained below), is also transferred to the Loan Account. Such interest is transferred from each Sub-Account and the Fixed Account in the same proportion that each Sub-Account Value and the Fixed Account Value bears to the total unloaned Policy Value.
Loan Repayment
You may repay all or part of your Policy Debt (the amount borrowed plus accrued interest) at any time while the Insured is living and the Policy is in force. Loan repayments in Good Order must be sent to the Home Office and are credited as of the Valuation Date received. The Owner may specify by Written Notice that any unscheduled premiums
35
paid while a loan is outstanding be applied as loan repayments. (Loan repayments, unlike unscheduled premium payments, are not subject to the premium expense charge.) When a loan repayment is made, Policy Value in the Loan Account in an amount equal to the repayment is transferred from the Loan Account to the Sub-Accounts and the Fixed Account. Thus, a loan repayment will have no immediate effect on the Policy Value, but the Cash Surrender Value (including, as applicable, Variable Account Value and Fixed Account Value) under a Policy is increased immediately by the amount transferred from the Loan Account. Unless specified otherwise by the Owner(s), amounts are transferred to the Sub-Accounts and the Fixed Account in the same proportion that Net Premiums are allocated. Protective Life's ability to credit interest on Policy Value in the Loan Account is subject to the Company's financial strength and claims paying ability.
Interest
The interest rate on the Policy loan will be determined annually, using a simple interest formula, at the beginning of each Policy Year. Specific loan interest rate information can be obtained by calling 888-353-2654. That interest rate will be guaranteed for that Policy Year and will apply to all Policy loans outstanding during that Policy Year. Interest is due and payable on each Policy Anniversary. Interest not paid when due will be added to the principal amount of the loan and will bear interest at the loan interest rate.
Presently, the maximum interest rate for Policy loans is the Moody's Corporate Bond Yield Average Monthly Average Corporates, which is published by Moody's Investor Service, Inc. If the Moody's Corporate Bond Yield Average ceases to be published, the maximum interest rate for Policy loans will be derived from a substantially similar average adopted by your state's Insurance Commissioner.
We must reduce our Policy loan interest rate if the maximum loan interest rate is lower than the loan interest rate for the previous Policy Year by one-half of one percent or more.
We may increase the Policy loan interest rate but such increase must be at least one-half of one percent. No increase may be made if the Policy loan interest rate would exceed the maximum loan interest rate.
We will send you advance notice of any increase in the Policy loan rate.
Non-Payment of Policy Loan
If the Insured dies while a loan is outstanding, the Policy Debt (which includes any accrued but unpaid interest) is deducted from the Death Benefit in calculating the Death Benefit Proceeds.
Effect of Policy Loans
A loan, whether or not repaid, has a permanent effect on the Death Benefit and Policy Value because the investment results of the Sub-Accounts and current interest rates credited on Fixed Account Value do not apply to Policy Value in the Loan Account. The larger the loan and longer the loan is outstanding, the greater will be the effect of Policy Value held as collateral in the Loan Account. Depending on the investment results of the Sub-Accounts or credited interest rates for the Fixed Account while the loan is outstanding, the effect could be favorable or unfavorable. Policy loans also may increase the potential for Lapse if investment results of the Sub-Accounts to which Cash Surrender Value is allocated is unfavorable. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan balance and will increase Policy Debt. If a Policy lapses with loans outstanding, certain amounts may be subject to income tax. In addition, if your Policy is a "modified endowment contract," loans may be currently taxable and subject to a 10% penalty tax. See "TAX CONSIDERATIONS," for a discussion of the tax treatment of Policy loans.
SUSPENSION OR DELAYS IN PAYMENTS
Protective Life will ordinarily pay any Death Benefit proceeds, Policy loans, withdrawals, or surrenders within seven calendar days after receipt at the Home Office of all the documents required for such a payment. Other than the Death Benefit, which is determined as of the date of death of the Insured, the amount will be determined as of the Valuation Date of receipt of all required documents in Good Order at the Home Office. However, Protective Life may delay making a payment or processing a transfer request if (1) the New York Stock Exchange is closed for other than a regular holiday or weekend, trading on the Exchange is restricted by the SEC, or the SEC declares that an emergency exists as a result of which the disposal or valuation of Variable Account assets is not reasonably practicable; (2) the SEC by order permits postponement of payment to protect Owners; or (3) your Premium check
36
has not cleared your bank. See also "Payments from the Fixed Account," under the heading "THE COMPANY AND THE FIXED ACCOUNT THE FIXED ACCOUNT."
In certain circumstances, applicable federal law may require Protective Life to "freeze" your account and refuse your request for a transfer, withdrawal, surrender, loan or death proceeds until receipt of instructions from the appropriate regulator. We also may be required to provide information about you and your account to a government regulator.
If, pursuant to SEC rules, the Money Market Sub-Account suspends payment of redemption proceeds in connection with a liquidation of the Fund, we will delay payment of any transfer, partial withdrawal, surrender, loan, or death benefit from the Money Market Sub-Account until the Fund is liquidated.
The Company may defer payment of any withdrawal, surrender or Policy loan proceeds from the Fixed Account for up to 6 months after a Request is received. If the Company delays payment of surrender benefits under this Policy, the Company will pay interest at the rate specified under applicable state law as required, if any, at the time of the Request.
POLICY REINSTATEMENT
Lapse
Failure to pay planned periodic premiums will not necessarily cause a Policy to Lapse (terminate without value). Paying all planned periodic premiums will not necessarily prevent a Policy from lapsing. A Policy will Lapse if its Policy Value less the Policy Debt is insufficient to cover the Monthly Deduction on the Monthly Anniversary Day. If the Cash Surrender Value on any Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. This could happen if investment experience has been sufficiently unfavorable that it has resulted in a decrease in Cash Surrender Value or the Cash Surrender Value has decreased because you have not paid sufficient Net Premiums to offset prior Monthly Deductions.
You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions. Protective Life will send you, at your last known address and the last known address of any assignee of record, notice of the premium required to prevent Lapse. A Policy will remain in effect during the grace period. If the Insured should die during the grace period, the Death Benefit Proceeds payable to the Beneficiary will reflect a reduction for the Monthly Deductions due on or before the date of the Insured's death as well as any unpaid Policy Debt or liens (including accrued interest). See "DEATH BENEFIT PROCEEDS." Unless the premium stated in the notice is paid before the grace period ends, the Policy will Lapse. A Policy Lapse may have tax consequences. See "TAX CONSIDERATIONS."
Policy Maturity. If the Insured is living and the Policy is in force on the Policy Anniversary at attained age 121 then this Policy will remain in force. The Death Benefit will be equal to the Policy Value. No premium payments will be required. Partial withdrawals and Policy loans will be permitted, subject to the provisions herein and the provisions of any riders and endorsements attached to the Policy. No further cost of insurance charges will be deducted.
The Policy Value will remain in the Sub-Accounts and/or Fixed Account, in accordance with your then current allocation instructions. You may change your Sub-Account allocation instructions and you may transfer your Policy Value among the Sub-Accounts. All charges under your Policy, to the extent applicable, will continue to be assessed, except we will no longer make a deduction each Policy Month for the cost of insurance. As your Policy Value changes based on the investment experience of the Sub-Accounts, the Death Benefit will increase or decrease accordingly. You may surrender the matured Policy at any time. Please see "TAX CONSIDERATIONS Treatment When Insured Reaches Attained Age 121" below.
Reinstatement
A Policy may be reinstated within 3 years after the coverage ceased, unless it has been surrendered. For a Policy to be reinstated, the Company must receive:
1. A Request from the Owner;
2. Evidence of insurability for the Insured and any other person covered by any rider or endorsement, at the Owner's expense;
3. Payment of the cost of insurance for the grace period;
4. Payment of an amount equal to 4 months' cost of insurance and other expense charges. Such payment less the expense charges will be credited to the Policy Value as of the date of reinstatement; and
37
5. Payment or reinstatement of any Policy Debt which was outstanding as of the date the coverage ceased, including interest thereon. Interest will be the maximum loan interest rate per year and will be compounded annually to the date of the Policy reinstatement.
Reinstatement will become effective on the date the application for reinstatement is approved by the Company. In some circumstances, the reinstated Policy may be a modified endowment contract under Section 7702A of the Code, even if the Policy was not a modified endowment contract prior to lapse. Please see TAX CONSIDERATIONS Policies That Are MECs-Modified Endowment Contracts below.
CHARGES AND DEDUCTIONS
This section describes the charges and deductions we make under the Policy to compensate us for the services and benefits we provide, costs and expenses we incur, and risks we assume. We may profit from the charges deducted, and we may use any such profits for any purpose, including payment of distribution expenses. Unless otherwise stated fees and charges will be deducted from the Policy Value on a pro-rata basis from the Sub-Accounts and/or Fixed Account, where applicable. You may request that fees and charges be deducted from specific Sub-Accounts and/or the Fixed Account, where applicable or designate a specific Sub-Account for this purpose.
Any such request is subject to the provisions or restrictions of any riders, endorsements, or any Sub-Accounts and the available Sub-Account Value(s) or Fixed Account Value where applicable.
If there is insufficient value in a selected Sub-Account(s) or the Fixed Account, then Protective Life may deduct any fees and charges or the remainder of such fees and charges on a pro-rata basis from the Sub-Accounts or Fixed Account where applicable. You may be required to maintain in any designated Sub-Account(s) amounts sufficient to cover estimated Policy fees and charges for specified periods. We reserve the right to transfer Sub-Account Value from any Sub-Account or Fixed Account to a Money Market Sub-Account in amounts sufficient to cover estimated Policy fees and charges for specified periods.
Premium Expense Charge
We deduct a premium expense charge from each premium you pay. The premium expense charge compensates us for certain sales and premium tax expenses associated with the Policies and the Variable Account. The maximum premium expense charge is equal to 10% of each premium payment you make. This would include any premium paid to reinstate the Policy. The Company may assess an expense charge less than the maximum expense charge.
We will deduct a maximum charge of 10% from each premium payment, which is broken down as follows. A maximum of 6.5% will be deducted as sales load to compensate us in part for sales and promotional expenses in connection with selling the Policies, such as commissions, the cost of preparing sales literature, other promotional activities and other direct and indirect expenses. A maximum of 3.5% of premium will be used to cover premium taxes and certain federal income tax obligations resulting from the receipt of premiums. All states and some cities and municipalities impose taxes on premiums paid for life insurance, which generally range from 2% to 4% of premium but may exceed 4% in some states. The amount of your state's premium tax may be higher or lower than the amount attributable to premium taxes that we deduct from your premium payments.
The current expense charge applied to premium for sales load is 2.5% of premium up to target and 1.0% of premium in excess of target for Policy Years 1 through 10. Your target premium will depend on the Base Policy Face Amount, your Issue Age, your sex (except in unisex states), and rating class (if any) and equals the maximum premium payable under the seven-pay test such that the Policy will not constitute a modified endowment contract under Section 7702A of the Code. There are other events, however, such as a decrease in Death Benefit or lapse of the Policy, which could cause the Policy to be a modified endowment contract under Section 7702A of the Code. See TAX CONSIDERATIONS Policies That Are MECs. Thereafter, there is no charge for sales load. The current expense charge applied to premium to cover our premium taxes and the federal tax obligation described above is 3.5% in all Policy Years.
For a description of the effects of entering into the Term Life Insurance Rider, see "SUPPLEMENTAL BENEFITS Term Life Insurance Rider" below.
Monthly Deduction
Each month we will deduct an amount from your Policy Value to pay for the benefits provided by your Policy. This amount is called the Monthly Deduction and equals the sum of:
• the cost of insurance charges;
38
• the monthly administration charge; and
• the mortality and expense risk charge.
If you do not select the Sub-Account(s) from which the Monthly Deduction is deducted, the Monthly Deduction will be deducted from the Sub-Accounts and the Fixed Account pro-rata on the basis of the unloaned Policy Value.
The Owner may select the Sub-Accounts from which you want us to deduct the Monthly Deduction. However, if as of the date the Monthly Deduction is to be deducted, the value in any of the selected Sub-Accounts is less than the charge to be deducted from that Sub-Account, Protective Life will instead deduct the Monthly Deduction on a pro-rata basis from each Sub-Account and the Fixed Account under the Policy based on the unloaned Policy Value attributable to each Sub-Account and the Fixed Account.
Cost of Insurance Charge. This charge compensates Protective Life for the expense of underwriting the Death Benefit.
The cost of insurance charge is calculated as follows:
An amount will be deducted on each Monthly Anniversary from the Policy Value to pay the cost of insurance for that Policy Month. The cost of insurance is calculated on the Monthly Anniversary Day and is equal to:
(a) The Death Benefit divided by the death benefit interest rate factor as shown on the Policy Schedule, less the Policy Value on each Monthly Anniversary Day, multiplied by the current monthly risk rate for the Insured's Attained Age; plus
(b) The extra premium for any rated premium class; plus
(c) The monthly administration charge, plus
(d) The cost of insurance for any riders or endorsements.
If there has been an increase or decrease in Death Benefit during the Policy Year, the cost of insurance calculation will be adjusted accordingly to reflect the change.
The Net Amount at Risk is equal to the Death Benefit divided by the death benefit interest rate as shown on the Policy Schedule minus the Policy Value (prior to deducting the Cost of Insurance).
Anything that decreases Policy Value, such as negative investment experience or withdrawals, will increase the Net Amount at Risk and result in higher cost of insurance charges. The Net Amount at Risk is affected by investment performance, loans, payments of premiums, Policy fees and charges, the Death Benefit Option chosen, withdrawals, and increases or decreases in Face Amount.
The cost of insurance charge for each increment of Face Amount is calculated separately to the extent a different cost of insurance rate applies. If there is a decrease in Face Amount after an increase, the decrease is applied first to decrease any prior increases in Face Amount, starting with the most recent increase.
Cost of Insurance Rates. The cost of insurance rate for a Policy is based on and varies with the Issue Age, sex and Premium class of the Insured and on the number of years that a Policy has been in force. Protective Life places Insureds in the following Premium classes, based on underwriting: fully underwritten (ages 20-75) and guaranteed underwriting (ages 20-70). Protective Life guarantees that the cost of insurance rates used to calculate the monthly cost of insurance charge will not exceed the maximum cost of insurance rates set forth in the Policies. The guaranteed rates for standard classes are based on the 2017 Commissioners' Standard Ordinary Mortality Tables, Male or Female, Smoker or Nonsmoker Mortality Rates ("2017 CSO Tables"). The guaranteed rates for substandard classes are based on multiples of, or additions to, the 2017 CSO Tables. Currently, the guaranteed minimum rate is $0.01 per $1000 and the guaranteed maximum rate is $83.33 per $1000.
Protective Life's current cost of insurance rates may be less than the guaranteed rates that are set forth in the Policy. Current cost of insurance rates will be determined based on Protective Life's expectations as to future mortality, investment earnings, expenses, taxes, and persistency experience. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience.
Protective Life will also determine a separate cost of insurance rate for each increment of Face Amount based on the Policy duration and the Issue Age, sex and Premium class of the Insured at the time of the request for an increase. The following rules will apply for purposes of determining the Net Amount at Risk for each Premium class.
Protective Life places the Insured in a Premium class when the Policy is issued, based on Protective Life's underwriting of the application. This original Premium class applies to the Initial Face Amount. When an increase in
39
Face Amount is requested, Protective Life conducts underwriting before approving the increase (except as noted below) to determine whether a different Premium class will apply to the increase. If the Premium class for the increase has lower cost of insurance rates than the original Premium class (or the Premium class of a previous increase), the Premium class for the increase also will be applied to the Initial Face Amount and any previous increases in Face Amount beginning as of the effective date of the current increase. If the Premium class for the increase has a higher cost of insurance rate than the original Premium class (or the Premium class of a previous increase), the Premium class for the increase will apply only to the increase in Face Amount.
Monthly Risk Rates. The maximum monthly risk rate is shown on the Policy Schedule. The Company may charge a lower monthly risk rate. The maximum risk rates shown are based on the Mortality Tables as shown on the Policy Schedule, age nearest birthday. The Company reserves the right to change the monthly risk rate based on the Company's expectations of future mortality, investment earnings, persistency, capital and reserve requirements, reinsurance cost and expenses (including taxes) subject to the maximum risk rates. Any change in the monthly risk rate will not discriminate unfairly within any class of Owners or Insureds.
Legal Considerations Relating to Sex Distinct Premium Payments and Benefits. Mortality tables for the Policies generally distinguish between males and females. Thus, premiums and benefits under Policies covering males and females of the same age will generally differ.
Protective Life does, however, also offer Policies based on unisex mortality tables on Policies issued in Montana. Employers and employee organizations considering purchase of a Policy should consult with their legal advisors to determine whether purchase of a Policy based on sex-distinct actuarial tables is consistent with Title VII of the Civil Rights Act of 1964 or other applicable law. Upon request, Protective Life may offer Policies with unisex mortality tables to such prospective purchasers.
Monthly Administration Charge. We will deduct a maximum of $10 from your Policy Value on the Monthly Anniversary Day to cover our administrative costs, such as salaries, postage, telephone, office equipment and periodic reports. This charge may be increased or decreased by us from time to time based on our expectations of future expenses, but will never exceed $10.
Supplemental Rider and Endorsement Charges. There is no cost to add the Change of Insured Endorsement to the Policy; however, we will assess a one-time fee at the time it is exercised. The fee for the Terminal Illness Accelerated Death Benefit Endorsement will be deducted from the accelerated death benefit payment paid to the Owner, if exercised. See "Supplemental Riders and Endorsements" and "Supplemental Rider and Endorsement Charges" in the Periodic Charges Other Than Fund Operating Expenses table above.
Mortality and Expense Risk Charge. We deduct a mortality and expense risk charge each month from your Policy Value. This charge compensates Protective Life for the mortality risk it assumes under the Policies. The mortality risk is that the Insureds will live for a shorter time than we project. The expense risk Protective Life assumes is that the expenses that we incur in issuing and administering the Policies and the Variable Account will exceed the amounts realized from the administration charges assessed against the Policies.
Protective Life deducts a monthly charge from assets in the Sub-Accounts attributable to the Policies. It is based on an annual rate that we accrue against each Sub-Account on a daily basis and deduct on each Monthly Anniversary Day by cancelling accumulation units on a pro-rata basis across all Sub-Accounts.
We convert the mortality and expense risk charge into a daily rate by dividing the annual rate by 365. The mortality and expense risk charge will be determined by us from time to time based on our expectations of future interest, mortality experience, persistency, expenses and taxes, but will not exceed 0.90% annually. Currently, the charge is 0.28% for Policy Years 1 through 20 and 0.10% thereafter. On surrender and payment of the death benefit, we will deduct the pro-rata portion of the mortality and expense risk charge that has accrued.
Transfer Fee
We allow you to make 12 free transfers of Policy Value each Policy Year. In order to cover administrative expenses, Protective Life will charge a maximum transfer fee of $10 on any additional transfers in a Policy Year. If the fee is imposed, it will be deducted from the amount requested to be transferred. If an amount is being transferred from more than one Sub-Account or the Fixed Account (subject to the Fixed Account transfer restrictions discussed herein), the transfer fee will be deducted proportionately from the amount being transferred from each. Currently, electronic transfers do not count towards the 12 free transfers; however, we reserve the right, at any time, to charge for electronic transfers in excess of the free transfers allowed. Transfers made under Dollar-Cost Averaging or the Portfolio Rebalancing option are not subject to the fee and do not count as transfers for this purpose (except a one-time rebalancing under the Portfolio Rebalancing option will count as one transfer).
40
Withdrawal Charges
Protective Life will deduct a maximum administrative charge of $25 for all withdrawals after the first made in the same Policy Year. This charge will be deducted from the Policy Value in addition to the amount requested to be withdrawn. The partial withdrawal fee will be deducted proportionally from all Sub-Accounts.
Fund Expenses
The value of the net assets of each Sub-Account reflects the investment management fees and other expenses incurred by the corresponding Fund in which the Sub-Account invests. For further information, consult the Funds' prospectuses.
Other Information
We sell the Policies through registered representatives of broker-dealers. These registered representatives are also appointed and licensed as insurance agents of Protective Life. We pay commissions and other compensation to the broker-dealers for selling the Policies. You do not directly pay the commissions and other compensation, we do. We intend to recover commissions and other compensation, marketing, administrative and other expenses and costs of Policy benefits through the fees and charges imposed under the Policies. See "SALE OF THE POLICIES" for more information about payments we make to the broker-dealers.
Corporate Purchasers or Eligible Groups
The Policy is available for individuals and for corporations and other institutions. For corporate or other group or sponsored arrangements, fee-only arrangements or clients of registered investment advisers purchasing one or more Policies, Protective Life may reduce the amount of the premium expense charge, monthly administration charge, or other charges where the expenses associated with the sale of the Policy or Policies or the underwriting or other administrative costs associated with the Policy or Policies are reduced. Sales, underwriting or other administrative expenses may be reduced for reasons such as expected economies resulting from a corporate purchase, a group or sponsored arrangement or arrangements, fee-only arrangements or clients of registered investment advisers.
REPORTS TO OWNERS
The Company maintains all records relating to the Variable Account, Sub-Accounts and the Fixed Account. We will send you a report at least once each Policy Year within 30 days after a Policy Anniversary. The report will show the current Policy Value, current allocation to each Sub-Account and/or the Fixed Account, death benefit, premiums paid, investment experience since your last report, deductions made since the last report, and any further information that may be required by the laws of the state in which your Policy was issued. It will also show the balance of all outstanding Policy loans and accrued interest on such loans. There is no charge for this report.
In addition, we will send you the financial statements of the Funds and other reports as specified in the 1940 Act. We also will mail you confirmation notices or other appropriate notices of Policy transactions quarterly or more frequently within the time periods specified by law. Please give us prompt written notice of any address change. Please read your statements and confirmations carefully and verify their accuracy and contact us promptly with any questions.
TAX CONSIDERATIONS
The following discussion of the federal income tax treatment of the Policy is not exhaustive, does not purport to cover all situations, and is not intended as tax advice. The federal income tax treatment of the Policy is unclear in certain circumstances, and a qualified tax adviser should always be consulted with regard to the application of law to individual circumstances. This discussion is based on the Internal Revenue Code of 1986, as amended (the "Code"), Treasury Department regulations, and interpretations existing on the date of this Prospectus. These authorities, however, are subject to change by Congress, the Treasury Department, and judicial decisions.
The Policy may be used in various arrangements, including non-qualified deferred compensation or salary continuance plans, split dollar insurance plans, executive bonus plans, retiree medical benefit plans and others. The tax consequences of such plans vary depending on the particular facts and circumstances of each individual arrangement. Therefore, if the use of the Policy in any such arrangement is contemplated, you should consult a qualified tax adviser for advice on the tax attributes and consequences of the particular arrangement. See also "Employer-Owned Life Insurance," "Split-Dollar Life Insurance," and "Employer-Financed Insurance Purchase Arrangements Tax and Other Legal Issues" for more information regarding certain arrangements.
41
This discussion does not address state or local tax consequences associated with the purchase of the Policy. The state and local tax consequences with respect to your Policy may be different than the federal tax consequences. In addition, PROTECTIVE LIFE MAKES NO GUARANTEE REGARDING ANY TAX TREATMENT FEDERAL, STATE OR LOCAL OF ANY POLICY OR OF ANY TRANSACTION INVOLVING A POLICY.
Tax Status of Protective Life
Protective Life is taxed as a life insurance company under the Code. Since the operations of the Variable Account are a part of, and are taxed with, the operations of Protective Life, the Variable Account is not separately taxed as a "regulated investment company" under the Code. Under existing federal income tax laws, Protective Life is not taxed on investment income and realized capital gains of the Variable Account, although Protective Life's federal taxes are increased in respect of the Policies because of the federal tax law's treatment of deferred acquisition costs. Currently, a charge for federal income taxes is not deducted from the Sub-Accounts or the Policy's Cash Value. However, Protective Life does deduct a premium expense charge from each premium payment in all Policy Years in part to compensate us for the federal tax treatment of deferred acquisition costs. Protective Life reserves the right in the future to make a charge against the Variable Account or the Cash Values of a Policy for any federal, state, or local income taxes that we incur and determine to be properly attributable to the Variable Account or the Policy. Protective Life will promptly notify the Owner of any such charge.
Taxation of Insurance Policies
Tax Status of the Policies. Section 7702 of the Code establishes a statutory definition of life insurance for federal tax purposes. While the requirements of this section of the Code are complex, and limited guidance has been provided from the Internal Revenue Service ("IRS") or otherwise, Protective Life believes that the Policy will meet the current statutory definition of life insurance, which places limitations on the Cash Values that can accumulate relative to the Death Benefit. As a result, the Death Benefit payable under the Policy will generally be excludable from the Beneficiary's gross income, and interest and other income credited under the Policy will not be taxable unless certain withdrawals are made (or are deemed to be made) from the Policy prior to the Insured's death, as discussed below. This tax treatment will only apply, however, if (1) the investments of the Variable Account are "adequately diversified" in accordance with Treasury Department regulations, and (2) Protective Life, rather than the Owner, is considered the owner of the assets of the Variable Account for federal income tax purposes.
Diversification Requirements. The Code and Treasury Department regulations prescribe the manner in which the investments of a segregated asset account, such as the Variable Account, are to be "adequately diversified". If the Variable Account fails to comply with these diversification standards, the Policy will not be treated as a life insurance contract for federal income tax purposes and the Owner would generally be taxed currently on the income on the contract (as defined in the tax law). Protective Life expects that the Variable Account, through the Funds, will comply with the diversification requirements prescribed by the Code and Treasury Department regulations.
Ownership Treatment. In certain circumstances, variable life insurance contract owners may be considered the owners, for federal income tax purposes, of the assets of a segregated asset account, such as the Variable Account, used to support their contracts. In those circumstances, income and gains from the segregated asset account would be includible in the contract owners' gross income. The IRS has stated in published rulings that a variable contract owner will be considered the owner of the assets of a segregated asset account if the owner possesses incidents of ownership in those assets, such as the ability to exercise investment control over the assets.
The ownership rights under the Policy are similar to, but differ in certain respects from, the ownership rights described by the IRS in certain rulings where it was determined that contract owners were not owners of the assets of a segregated asset account (and thus were not currently taxable on the income and gains). For example, the Owner of this Policy has the choice of more investment options to which to allocate premium payments and Variable Account Value than were addressed in such rulings. These differences could result in the Policy Owner being treated as the owner of a portion of the assets of the Variable Account and thus subject to current taxation on the income and gains from those assets. In addition, Protective Life does not know what standards will be set forth in any further regulations or rulings which the Treasury Department or IRS may issue. Protective Life therefore reserves the right to modify the Policy as necessary to attempt to prevent Owners from being considered the owners of the assets of the Variable Account. However, there is no assurance that such efforts would be successful.
The remainder of this discussion assumes that the Policy will be treated as a life insurance contract for federal tax purposes.
42
Tax Treatment of Life Insurance Death Benefit Proceeds and Terminal Illness Accelerated Death Benefits. In general, the amount of the Death Benefit Proceeds payable from a Policy by reason of the death of the Insured is excludable from gross income under Section 101 of the Code. Certain transfers of the Policy for valuable consideration, however, may result in a portion of the Death Benefit Proceeds being taxable.
If the Death Benefit Proceeds are not received in a lump sum and are, instead, applied under another Settlement Option that the Company is then offering, generally payments will be prorated between amounts attributable to the Death Benefit which will be excludable from the Beneficiary's income and amounts attributable to interest (accruing after the Insured's death) which will be includible in the Beneficiary's income. If the Death Benefit Proceeds are applied under an interest income Settlement Option, the interest credited will be currently includible in the Beneficiary's income.
Accelerated death benefits paid under this Policy upon the Insured's terminal illness generally will be excludable from income under Section 101 of the Code. Certain exceptions apply, however, such as where the Policy was previously transferred for valuable consideration in certain situations. Accelerated death benefits also will not be excludable from income under Section 101 of the Code where paid to a taxpayer other than the insured if such taxpayer has an insurable interest with respect to the life of the Insured by reason of the Insured being a director, officer, or employee of the taxpayer or by reason of the Insured being financially interested in any trade or business carried on by the taxpayer.
Tax Deferral During Accumulation Period. Under existing provisions of the Code, except as described below, any increase in an Owner's Cash Value is generally not taxable to the Owner unless amounts are received (or are deemed to be received) from the Policy prior to the Insured's death. If there is a surrender of the Policy, an amount equal to the excess of the amount received over the "investment in the contract" will generally be includible in the Owner's income. The "investment in the contract" generally is the aggregate premiums paid less the aggregate amount previously received under the Policy to the extent such amounts received were excludable from gross income. Whether withdrawals (or other amounts deemed to be distributed) from the Policy constitute income to the Owner depends, in part, upon whether the Policy is considered a "modified endowment contract" ("MEC") for federal income tax purposes.
Policies Not Owned by Individuals
In the case of a Policy issued to a nonnatural taxpayer, or held for the benefit of such an entity, a portion of the taxpayer's otherwise deductible interest expenses may not be deductible as a result of ownership of a Policy even if no loans are taken under the Policy. An exception to this rule is provided for certain life insurance contracts which cover the life of an individual who is a 20 percent owner, or an officer, director, or employee, of a trade or business. Entities that are considering purchasing the Policy, or entities that will be beneficiaries under a Policy, should consult a tax advisor.
Policies That Are MECs
Modified Endowment Contracts. Section 7702A of the Code treats certain life insurance contracts as MECs. In general, a Policy will be treated as a MEC if total premiums paid at any time during the first seven Policy Years exceed the sum of the net level premiums which would have been paid on or before that time if the Policy provided for paid-up future benefits after the payment of seven level annual premiums ("seven-pay test"). A Policy also may become a MEC in certain other circumstances. For example, if there is a "material change" to the Policy (including certain increases in the Death Benefit), the seven-pay test generally is applied anew and limits premiums which can be paid for a further seven years in order to avoid MEC status. A Policy may be treated as a MEC upon a "material change" to the Policy, such as where premium paid at the time of the material change exceeds the new seven-pay test limit.
We will monitor your premium payments and other Policy transactions and notify you if a payment or other transaction might cause your Policy to become a MEC. We will not invest any Premium or portion of a Premium that would cause your Policy to become a MEC without instruction to do so from you. We will promptly notify you or your agent of the excess cash received. We will not process the Premium payment unless we receive a MEC acceptance form or Policy change form within 48 hours of receipt of the excess funds. If paperwork is received that allows us to process the transaction, the effective date generally will be the date of the new paperwork.
Further, if a transaction occurs which decreases the Face Amount of your Policy during the first seven years, we will retest your Policy, as of the date of its purchase, based on the lower Face Amount to determine compliance with the seven-pay test. Also, if a decrease in Face Amount occurs within seven years of a "material change," we will retest
43
your Policy for compliance with the new seven-pay test from the date of the "material change." Failure to comply in either case would result in the Policy's classification as a MEC regardless of our efforts to provide a payment schedule that would not otherwise violate the seven-pay test. A decrease in the Face Amount due to a lapse of the Policy during a seven-pay test period also can cause the Policy to be treated as a MEC, although there is a limited exception to such treatment where the lapse resulted from nonpayment of premiums and benefits are reinstated within 90 days of the decrease.
The rules relating to whether a Policy will be treated as a MEC are complex and cannot be fully described in the limited confines of this summary. Therefore, you should consult with a competent tax adviser to determine whether a particular transaction will cause your Policy to be treated as a MEC.
Distributions
Distributions Under a Policy that is Not a MEC. If the Policy is not a MEC, the amount of any withdrawal from the Policy generally will be treated first as non-taxable recovery of premium and then as income from the Policy. Thus, a withdrawal from a Policy that is not a MEC generally will not be includible in income except to the extent it exceeds the investment in the contract immediately before the withdrawal.
Certain Distributions Required by the Tax Law in the First 15 Policy Years. As indicated above, Section 7702 of the Code places limitations on the Cash Values that can accumulate relative to the Death Benefit. Where cash distributions are required under Section 7702 of the Code in connection with a reduction in benefits during the first 15 years after the Policy is issued (or if withdrawals are made in anticipation of a reduction in benefits, within the meaning of the tax law, during this period), some or all of such amounts may be includible in income notwithstanding the general rule described in the preceding paragraph. A reduction in benefits may result upon a decrease in the Face Amount, a change from one Death Benefit Option to the other, if withdrawals are made, and in certain other instances.
Tax Treatment of Loans. If a Policy is not classified as a MEC, a loan received under the Policy generally will be treated as indebtedness of the Owner. As a result, no part of any loan under a Policy will constitute income to the Owner so long as the Policy remains in force. However, in those situations where the interest rate credited to the Loan Account is identical (or nearly identical) to the interest rate charged for the loan, it is possible that some or all of the loan proceeds may be includible in income. If a Policy lapses or is surrendered when a loan is outstanding, the Cash Value of the Policy that served as collateral for, and repays, the outstanding loan will be treated as the proceeds of a surrender for purposes of determining whether any amounts are includable in the Owner's income. This treatment applies both under Policies that are not classified as MECs and under Policies that are classified as MECs. As a result, the amount of your taxable income could increase by some or all of the outstanding loan upon a lapse or surrender.
Generally, interest paid on any loans under this Policy will not be tax deductible. The non-deductibility of interest includes interest paid or accrued on indebtedness with respect to one or more life insurance policies owned by a taxpayer covering any individual who is or has been an officer or employee of, or financially interested in, any trade or business carried on by the taxpayer. A limited exception to this rule exists for certain interest paid in connection with certain "key person" insurance. In the case of interest paid in connection with a loan with respect to a Policy covering the life of any key person, interest is deductible only to the extent that the aggregate amount of loans under one or more life insurance policies does not exceed $50,000. Further, even as to such loans up to $50,000, interest would not be deductible if the Policy were deemed for federal tax purposes to be a single premium life insurance policy or, in certain circumstances, if the loans were treated as "systematic borrowing" within the meaning of the tax law. A "key person" is an individual who is either an officer or a 20 percent owner of the taxpayer. The maximum number of individuals who can be treated as key persons may not exceed the greater of (1) 5 individuals or (2) the lesser of 5 percent of the total number of officers and employees of the taxpayer or 20 individuals. Owners should consult a tax advisor regarding the deductibility of interest incurred in connection with this Policy.
Distributions Under a Policy That Is a MEC. If treated as a MEC, your Policy will be subject to the following tax rules:
• First, partial withdrawals are treated as ordinary income subject to ordinary income tax up to the amount equal to the excess (if any) of your Cash Value immediately before the distribution over the "investment in the contract" at the time of the distribution.
• Second, Policy loans and loans secured by a Policy are treated as partial withdrawals and taxed accordingly. Any past- due loan interest that is added to the amount of the loan is treated as a loan.
44
• Third, a ten percent additional penalty tax is imposed on that portion of any distribution (including distributions upon surrender), Policy loans, or loans secured by a Policy, that is included in income, except where the distribution or loan is made to a taxpayer that is a natural person, and:
1. is made when the taxpayer is age 591/2 or older (where the taxpayer is a natural person);
2. is attributable to the taxpayer becoming disabled; or
3. is part of a series of substantially equal periodic payments (not less frequently than annually) made for the life (or life expectancy) of the taxpayer or the joint lives (or joint life expectancies) of such taxpayer and his beneficiary, as defined in the tax law.
If the Owner assigns or pledges any portion of the Policy Value (or agrees to assign or pledge any portion), such portion will be treated as a withdrawal for tax purposes. If the entire Policy Value is assigned or pledged, subsequent increases in the Policy Value are also treated as withdrawals for as long as the assignment or pledge remains in place. The Owner's investment in the contract is increased by the amount includible in income with respect to any assignment, pledge, or loan, though it is not affected by any other aspect of the assignment, pledge, or loan (including its release or repayment). Before assigning, pledging, or requesting a loan under a Policy treated as a MEC, an Owner should consult a tax advisor.
Aggregation of Policies. All life insurance contracts which are treated as MECs and which are purchased by the same policyholder from Protective Life or any of its affiliates within the same calendar year will be aggregated and treated as one contract for purposes of determining the tax on withdrawals (including deemed withdrawals). The effects of such aggregation are not always clear; however, it could affect the amount of a surrender or a withdrawal (or a deemed withdrawal) that is taxable and the amount which might be subject to the 10% penalty tax described above.
Treatment When Insured Reaches Attained Age 121. As described above, when the Insured reaches Attained Age 121, no further premiums can be paid and no cost of insurance charges will be deducted. We believe that the Policy will continue to qualify as a "life insurance contract" under the Code. However, there is uncertainty regarding the tax treatment of the Policy at such time. It is possible, for example, that you would be viewed as constructively receiving the Cash Value in the year in which the Insured attains age 121 and would realize taxable income at that time, even if no actual distribution is made at that time.
Section 1035 Exchanges
Section 1035 of the Code provides that no gain or loss will be recognized on the exchange of a life insurance policy for another life insurance policy, endowment contract, annuity contract, or qualified long-term care insurance contract, provided that certain requirements are met. If the Policy is being issued in exchange for another life insurance policy, the requirements that must be met to receive tax-free treatment under Section 1035 of the Code include but are not limited to: (1) the policies must have the same insured, and (2) the exchange must occur through an assignment of your old policy to us or by a direct transfer of the policy value of the old policy to us by the issuer of the old policy. If your old policy was a MEC, the Policy will also be a MEC. If any money or other property is received in the exchange ("boot"), gain (but not loss) will be recognized equal to the lesser of the gain realized on the exchange or the amount of the boot received. You cannot exchange an endowment, annuity, or long-term care insurance contract for a life insurance policy tax-free. Generally, the Policy will have the same investment in the contract as the exchanged policy. However, if boot is received in the exchange the investment in the contract will be adjusted. Special rules and procedures apply to Section 1035 exchanges. These rules can be complex, and if you wish to take advantage of Section 1035, you should consult a tax and/or legal adviser.
Actions to Ensure Compliance with the Tax Law
Protective Life reserves the right to increase the Death Benefit (which may result in larger charges under a Policy) or to take any other action deemed necessary to ensure the compliance of the Policy with the federal tax definition of life insurance. If the Death Benefit is based on the applicable factor in the Table of Death Benefit Factors shown on the Policy Schedule, the Company in its sole discretion may refund all or a portion of the Cash Value which causes the Death Benefit to be based on such applicable factor.
Other Considerations
Changing the Owner, designating an irrevocable beneficiary, exchanging the Policy, increasing the Face Amount, changing from one Death Benefit Option to another, and other changes under the Policy may have tax consequences (other than those discussed herein) depending on the circumstances of such change or withdrawal. For example, in
45
addition to consequences under Sections 7702 and 7702A of the Code, changes to a Policy may affect the application of Section 101(j) (relating to employer-owned life insurance) and Section 264(f) (disallowing certain interest expense deductions), with adverse tax consequences to the Owner. In addition, special tax consequences may apply if you sell your Policy.
Estate, Gift and Generation-Skipping Transfer Tax Considerations
The transfer of the Policy or designation of a beneficiary may have federal, state, and/or local transfer and inheritance tax consequences, including the imposition of gift, estate, and generation-skipping transfer taxes. For example, the transfer of the Policy to, or the designation as a beneficiary of, or the payment of proceeds to, a person who is assigned to a generation which is two or more generations below the generation assignment of the owner may have generation-skipping transfer tax consequences in addition to gift and estate tax consequences under federal tax law. The individual situation of each Owner or beneficiary will determine the extent, if any, to which federal, state, and local transfer and inheritance taxes may be imposed and how ownership or receipt of Policy proceeds will be treated for purposes of federal, state and local estate, inheritance, generation-skipping and other taxes.
If this Policy is used with estate and gift tax planning in mind, you should consult with your tax advisor as to the most up-to-date information as to federal estate, gift, and generation skipping tax rules.
Medicare Hospital Insurance Tax
A Medicare hospital insurance tax of 3.8% will apply to some types of investment income. This tax will apply to the taxable portion of (1) any proceeds distributed from the Policy as annuity payments pursuant to a settlement option prior to the death of the Insured, or (2) the proceeds of any sale or disposition of the Policy. This tax only applies to taxpayers with "modified adjusted gross income" above $250,000 in the case of married couples filing jointly or a qualifying widow(er) with dependent child, $125,000 in the case of married couples filing separately, and $200,000 for all others. For more information regarding this tax and whether it may apply to you, please consult your tax advisor.
Federal Income Tax Withholding
In General. Protective Life will withhold and remit to the federal government a part of the taxable portion of a surrender and withdrawal made under a Policy unless the Owner notifies Protective Life in writing and such notice is received at the Home Office at or before the time of the surrender or withdrawal that he or she elects not to have any amounts withheld. Regardless of whether the Owner requests that no taxes be withheld or whether Protective Life withholds a sufficient amount of taxes, the Owner will be responsible for the payment of any taxes including any penalty tax that may be due on the amounts received. The Owner may also be required to pay penalties under the estimated tax rules if the Owner's withholding and estimated tax payments are insufficient to satisfy the Owner's tax liability.
Trade or Business Entity Owns or Is Directly or Indirectly a Beneficiary of the Policy
Where a Policy is owned by other than a natural person, the Owner's ability to deduct interest on business borrowing unrelated to the Policy can be impacted as a result of its ownership of cash value life insurance. No deduction generally will be allowed for a portion of a taxpayer's otherwise deductible interest expense unless the Policy covers only one individual and such individual is, at the time first covered by the Policy, a 20 percent owner of the trade or business entity that owns the Policy, or an officer, director, or employee of such trade or business.
Although this limitation generally does not apply to Policies held by natural persons, if a trade or business (other than one carried on as a sole proprietorship) is directly or indirectly the beneficiary under a Policy (e.g., pursuant to a split-dollar agreement), the Policy will be treated as held by such trade or business. The effect will be that a portion of the trade or business entity's deduction for its interest expenses will be disallowed unless the above exception for a 20 percent owner, employee, officer or director applies.
The portion of the entity's interest deduction that is disallowed will generally be a pro rata amount which bears the same ratio to such interest expense as the taxpayer's average unborrowed cash value bears to the sum of the taxpayer's average unborrowed cash value and average adjusted bases of all other assets. Any corporate or business use of the Policy should be carefully reviewed by your tax adviser with attention to these rules as well as any other rules and possible tax law changes that could occur with respect to corporate-owned life insurance. In the case of a Policy owned by an insurance company, similar rules apply under Sections 807 and 832 of the Code.
46
Employer-Owned Life Insurance
Section 101(j) of to the Code denies the tax-free treatment of death benefits payable under an employer-owned life insurance contract unless certain notice and consent requirements are met and either (1) certain rules relating to the insured employee's status are satisfied or (2) certain rules relating to the payment of the "amount received under the contract" to, or for the benefit of, certain beneficiaries or successors of the insured employee are satisfied. These rules apply to life insurance contracts owned by corporations (including S corporations), individual sole proprietors, estates and trusts, and partnerships that are engaged in a trade or business. Any business contemplating the purchase of a Policy on the life of an employee should consult with its legal and tax advisers regarding the applicability of Section 101(j) of the Code to the proposed purchase.
Split Dollar Life Insurance
A tax adviser should also be consulted if you have purchased or are considering the purchase of a Policy for a split dollar insurance plan. Any business contemplating the purchase of a new life insurance contract or a change in an existing contract should consult a tax adviser.
Other Employee Benefit Programs
Complex rules may apply when a Policy is held by an employer or a trust, or acquired by an employee, in connection with the provision of employee benefits. These Policy owners also must consider whether the Policy was applied for by, or issued to, a person having an insurable interest under applicable state law, as the lack of insurable interest may, among other things, affect the qualification of the Policy as life insurance for federal income tax purposes and the right of the Beneficiary to death benefits. Employers and employer-created trusts may be subject to reporting, disclosure and fiduciary obligations under the Employee Retirement Income Security Act of 1974, as amended. You should consult your legal advisor.
Employer-Financed Insurance Purchase Arrangements
In addition to corporations and other employers, the Policy is also available for purchase by individuals whose employers will pay some or all of the Premiums due under the Policy pursuant to an employer-financed insurance purchase arrangement. In such cases, references in this Prospectus to the "Owner" of the Policy will refer to the individual and, depending on the context, references to the "payment of premiums" will refer to payments to Protective Life under the Policy by the employer and/or by the employee.
Employers and employees contemplating the purchase of a Policy as a part of an employer-financed insurance purchase arrangement should consult qualified legal and tax counsel with regard to the issues presented by such a transaction. For this purpose, an employer- financed insurance purchase arrangement is a plan or arrangement which contemplates that an employer will pay one or more Premiums for the purchase of a Policy that will be owned, subject to certain restrictions, by an employee or by a person or entity designated by the employee.
The tax rules that apply to employer-financed insurance purchase arrangements are complex and depend on the particular facts associated with the arrangement. Thus, your qualified legal and tax advisors will need to evaluate the tax treatment of the arrangement based on your specific facts. The following general considerations often are relevant to such arrangements:
1. Payments by the employer under typical employer-financed insurance purchase arrangements are only deductible for income tax purposes when the payments are taxable to the employee with respect to whom they are made.
2. The payment of some or all of the premiums by the employer may create an ERISA welfare benefit plan which is subject to the reporting, disclosure, fiduciary and enforcement provisions of ERISA.
3. The payment of some or all of the premiums by the employer usually will not prevent the Owner from being treated as the owner of the Policy for federal income tax purposes.
4. A number of factors, including the performance of the Policy and whether the employer pays planned premiums, may cause a lapse of the Policy or may result in a need for later additional unscheduled premiums to keep your Policy in force.
5. An employee considering whether to participate in an employer-financed insurance purchase arrangement should consider whether the financial and tax benefits of the ownership of the Policy outweigh the costs, such as sales loads and cost of insurance charges that will be incurred as a result of the purchase and ownership of the Policy.
47
6. An employee considering whether to participate in an employer-financed insurance purchase arrangement should consider whether the designation of another person or entity as the owner of the Policy will have adverse consequences under applicable gift, estate, inheritance, or income tax laws.
7. An employee considering whether to participate in an employer-financed insurance purchase arrangement should consider whether the financial performance of the Policy will support any planned withdrawals or borrowings under the Policy.
8. In an employer-financed insurance purchase arrangement, the procedures described below in "TRANSFERS OF POLICY VALUE Limitations on frequent transfers, including 'market timing' transfers," which are designed to prevent or minimize market timing and excessive trading by Owners may, in certain circumstances, require us to perform standardized trade monitoring; in other circumstances such monitoring will be performed by the Fund. Certain Funds require us to provide reports of the Owner's trading activity, if prohibited trading, as defined by the Fund, is suspected. The determination of whether there is prohibited trading based on the Funds' definition of prohibited trading may be made by us or by the Fund. The Fund determines the restrictions imposed, which could be one of the four restrictions described in this Prospectus or by restricting the Owner from making Transfers into the identified Fund for the period of time specified by the Fund.
Change of Insured Endorsement
If the Insured is changed pursuant to the Change of Insured Endorsement, the Policy will be treated for tax purposes as if it were exchanged for a new Policy. The exchange will be taxable under Section 1001 of the Code, and the transaction will not qualify for tax-free treatment under Section 1035 of the Code. The Company makes no representations concerning the tax effects of the Change of Insured Endorsement. Owners are responsible for seeking tax counsel regarding the tax effects of the endorsement. Upon a change of Insured pursuant to the Change of Insured Endorsement, the guaranteed mortality charges under the Policy after the change will be based on the new Insured, and those charges may need to be based on a different mortality table than applied prior to the change, such as to ensure compliance with Section 7702 of the Code. The Company also reserves the right to refund Cash Value at the time of such change, including for purposes of maintaining compliance with Section 7702 of the Code.
Nonresident Aliens and Foreign Corporations
The discussion above provides general information regarding U.S. federal income and withholding tax consequences to life insurance purchasers that are U.S. citizens or residents. Purchasers or beneficiaries that are not U.S. citizens or residents will generally be subject to U.S. federal withholding tax on taxable distributions (including taxable Death Benefits) from life insurance policies at a 30% rate, unless a lower treaty rate applies. Prospective purchasers that are not U.S. citizens or residents are advised to consult with a tax advisor regarding federal tax withholding with respect to distributions from a Policy.
FATCA Withholding
If the payee of a distribution (including the Death Benefit) from the Policy is a foreign financial institution ("FFI") or a non-financial foreign entity ("NFFE") within the meaning of the Code as amended by the Foreign Account Tax Compliance Act ("FATCA"), the distribution could be subject to U.S. federal withholding tax on the taxable amount of the distribution at a 30% rate irrespective of the status of any beneficial owner of the Policy or the nature of the distribution. The rules relating to FATCA are complex, and a tax advisor should be consulted if an FFI or NFFE is or may be designated as a payee with respect to the Policy.
SUPPLEMENTAL BENEFITS
The following supplemental benefits available through riders and endorsements may be available to be added to your Policy subject to state availability. Monthly charges, if applicable, for these riders and endorsements will be deducted from your Policy Value as part of the monthly deduction. See "Monthly Deduction." Not all such riders and endorsements may be available at any time, and supplemental riders and endorsements in addition to those listed below may be made available. The Term Life Insurance Rider (i) is not available to individual Owners, (ii) can only be added at the time of Policy issue, (iii) is subject to additional underwriting, (iv) the purchaser must satisfy certain criteria such as the number of Policies it expects to purchase and the expected aggregate Face Amount under all such Policies, and (v) may not be available in every state, each as further discussed below under "Term Life Insurance Rider."
48
The Change of Insured Endorsement (i) is not available to individual Owners, and (ii) can only be added at the time of Policy issue, as further discussed below under "Change of Insured Endorsement (not available to individual Owners)." The Terminal Illness Accelerated Death Benefit Endorsement (i) is only available to individual Owners, (ii) can only be added at the time of Policy issue, and (iii) may not be available in every state, as discussed below under "Terminal Illness Accelerated Death Benefit Endorsement (only available to individual Owners)." Please ask your Protective Life agent for further information, or contact the Home Office.
Term Life Insurance Rider. This rider provides term life insurance on the Insured. Coverage is renewable annually until the Insured's Attained Age 121. The amount of coverage provided under this rider varies from month to month as described below. We will pay the rider's death benefit to the Beneficiary when we receive Due Proof of death of the Insured while this rider is in force.
We offer this rider in circumstances that result in the savings of sales and distribution expenses and administrative costs. To qualify, a corporation, employer, or other purchaser must satisfy certain criteria such as, for example, the number of Policies it expects to purchase and the expected Face Amount under all such Policies. Generally, the sales contacts and effort and administrative costs per Policy depend on factors such as the number of Policies purchased by a single Owner, the purpose for which the Policies are purchased, and the characteristics of the proposed Insureds. The amount of reduction and the criteria for qualification are related to the sales effort and administrative costs resulting from sales to a qualifying Owner. Protective Life from time to time may modify on a uniform basis both the amounts of reductions and the criteria for qualification. Reductions in these charges will not be unfairly discriminatory against any person, including the affected Owners funded by the Variable Account.
If you purchase this rider, the Total Face Amount shown on your Policy's Schedule will be equal to the amount of coverage provided by this rider (i.e., the "Term Life Insurance Face Amount") plus the Base Policy Face Amount. The minimum allocation of Face Amount between your Policy and the rider is 10% and 90% at inception, respectively.
The amount of the Rider Death Benefit depends on the death benefit option that applies under your Policy. The option under the rider will at all times be the same as the option you have chosen for your Policy. The Rider Death Benefit will be determined on each Monthly Anniversary Day in accordance with one of those options. The Rider Death Benefit is payable in addition to the Death Benefit otherwise provided by the Policy. For each of the options, any outstanding Policy Debt will reduce the total Death Benefit payable. The effect of the total Death Benefit payable under the rider will depend on the Death Benefit option that applies under the Policy on the Insured's date of death.
Option 1: Level Death
The Rider Death Benefit will be:
• the greater of:
a) the Total Face Amount shown on the Policy Schedule, less any partial withdrawals; and
b) the Cash Value on the Insured's date of death multiplied by the applicable Factor shown in the Table on the Policy Schedule and based on the age of the Insured on date of death.
• less the greater of:
c) the Base Policy Face Amount shown on the Policy Schedule; and
d) the Policy Value of the Policy.
Option 2: Coverage Plus
The Rider Death Benefit will be:
• the greater of:
a) the Total Face Amount shown on the Policy Schedule, plus the Policy Value Account on the Insured's date of death; and
b) the Cash Value on the Insured's date of death multiplied by the applicable Factor shown in the Table on the Policy Schedule based on the age of the Insured at date of death.
• less
c) the Base Policy Face Amount shown on the Policy Schedule; plus
d) the Policy Value of the Policy.
49
If you purchase this rider, the sales load will be proportionately lower as a result of a reduction in commission payments. Commissions payable to sales representatives for the sale of the Policy are calculated based on the total premium payments. As a result, this rider generally is not offered in connection with any Policy with annual premium payments of less than $100,000, except for policies issued on a guaranteed issue basis. In our discretion, we may decline to offer this rider or refuse to consent to a proposed allocation of coverage between a Policy and term rider.
If this rider is offered, the commissions will vary depending on the allocation of your coverage between the Policy and the term rider. The same initial Death Benefit will result in the highest commission when there is no term rider, with the commission declining as the portion of the Death Benefit coverage allocated to the term rider increases. Thus, the lowest commission amount is payable, and the lowest amount of sales load deducted from your premiums will occur, when the maximum term rider is purchased.
You may terminate this rider by submitting Written Notice in Good Order to our Home Office. This rider also will terminate on the earliest of the following dates:
• The date the Policy is surrendered, terminated or lapses; or
• The date of death of the Insured.
Change of Insured Endorsement (not available to Individual Owners). This endorsement permits you to change the Insured under your Policy or any Insured that has been named by virtue of this endorsement. Before we change the Insured you must provide us with (1) a written request in Good Order for the change signed by you and approved by us; (2) Evidence of Insurability for the new Insured; (3) evidence that there is an insurable interest between you and the new Insured; (4) evidence that the new Insured's age, at the nearest birthday, is under 70 years; and (5) evidence that the new Insured was born prior to the Policy Effective Date. We may charge a fee for administrative and underwriting expenses when you change the Insured. The minimum charge is $100 per change and the maximum charge is $400 per change. When a change of Insured takes effect, premiums will be based on the new Insured's age, sex, mortality class and the premium rate in effect on the Policy Effective Date. See also "TAX CONSIDERATIONS Change of Insured Endorsement."
Terminal Illness Accelerated Death Benefit Endorsement (only available to individual Owners). The endorsement provides for an accelerated death benefit payment to the Owner if the Insured has a qualifying terminal illness and all of the terms and conditions of the endorsement are met. The accelerated death benefit is based on a portion of the Face Amount and is subject to a maximum accelerated death benefit. The fee for the Terminal Illness Accelerated Death Benefit Endorsement will be deducted from the accelerated death benefit payment paid to the Owner. See "FEE TABLES Periodic Charges Other Than Fund Operating Expenses." However, a lien equal to the accelerated death benefit payment is established against the Policy and reflects interest. The primary impact of the lien and any accumulated interest is a reduction in the amount of the Death Benefit by the amount of the lien plus accumulated interest. The lien also reduces the amount available for Policy loans and withdrawals. Consult your sales representative and review the endorsement for limitations, terms and conditions. See also "TAX CONSIDERATIONS Tax Treatment of Life Insurance Death Benefit Proceeds and Terminal Illness Accelerated Death Benefits."
USE OF THE POLICY
Life insurance, including variable life insurance, can be used to provide for many individual and business needs, in addition to providing a death benefit. Possible applications of a variable life insurance policy, such as this Policy include: (1) serving as vehicle for accumulating funds for a college education, (2) estate planning, (3) serving as an investment vehicle on various types of deferred compensation arrangements, (4) buy-sell arrangements, (5) split dollar arrangements, and (6) a supplement to other retirement plans. The Policy described in this Prospectus is offered to corporations and other employers to provide life insurance coverage in connection with, among other things, deferred compensation plans and employer-financed insurance purchase arrangements.
As with any investment, using this Policy under these or other applications entails certain risks. For example, if investment performance of Sub-Accounts to which Policy Value is allocated is poorer than expected or if sufficient premiums are not paid, the Policy may lapse or may not accumulate Cash Surrender Value sufficient to adequately fund the application for which the Policy was purchased. Similarly, certain transactions under a Policy entail risks in connection with the application for which the Policy is purchased. Withdrawals, Policy loans and interest paid on Policy loans may significantly affect current and future Policy Value, Cash Surrender Value or Death Benefit Proceeds. If, for example, a Policy loan is taken but not repaid prior to the death of the Insured, the Policy Debt is subtracted from the Death Benefit in computing the Death Benefit Proceeds to be paid to a Beneficiary.
50
Prior to utilizing this Policy for the above applications, you should consider whether the anticipated duration of the Policy is appropriate for the application for which you intend to purchase it.
In addition, you need to consider the tax implications of using the Policy with these applications. The tax implications of using this Policy with these applications can be complex and generally are not addressed in the discussion of "TAX CONSIDERATIONS" above. Loans and withdrawals will affect the Policy Value and Death Benefit. There may be penalties and taxes if the Policy is surrendered, lapses, matures or if a withdrawal or a loan is made. Because of these risks, you need to carefully consider how you use this Policy. This Policy may not be suitable for all persons, under any of these applications.
Replacement of Life Insurance or Annuities
The term replacement has a special meaning in the life insurance industry. Before you make a decision to buy, we want you to understand what impact a replacement may have on your existing insurance policy.
A replacement occurs when you buy a new life insurance policy or annuity contract, and a policy or contract you already own has or will be:
1. Lapsed, forfeited, surrendered or partially surrendered, assigned to the replacing insurer, or otherwise terminated;
2. converted to reduced paid-up insurance, continued as extended term insurance, or otherwise reduced in value by the use of nonforfeiture benefits or other policy values;
3. amended to effect either a reduction in benefits or in the term for which coverage would otherwise remain in force or for which benefits would be paid
4. reissued with any reduction in cash value, or
5. pledged as collateral or subject to borrowing, whether in a single loan or under a schedule of borrowing over a period of time.
There are circumstances when replacing your existing life insurance policy or annuity contract can benefit you. As a general rule, however, replacement is not in your best interest. A replacement may affect your plan of insurance in the following ways:
1. You will pay new acquisition costs;
2. You may have to submit to new medical examinations;
3. You may pay increased premiums because of the increased age or changed health of the Insured;
4. Claims made in the early policy years may be contested;
5. You may have to pay surrender charges and/or income taxes on your current policy or contract values;
6. Your new policy or contract values may be subject to surrender charges; and
7. If part of a financed purchase, your existing policy or contract values or Death Benefit may be reduced.
You should carefully compare the costs and benefits of your existing policy or contract with those of the new policy or contract to determine whether replacement is in your best interest.
STATE VARIATIONS
Policies issued in your state may provide different features and benefits from, and impose different costs than, those described in this Prospectus because of state law variations. These differences include, among other things, cancellation period rights, issue age limitations, and the general availability of riders. This Prospectus describes the material rights and obligations of an Owner, and the maximum fees and charges for all Policy features and benefits are set forth in the fee table of this Prospectus. See your Policy for specific variations because any such state variations will be included in your Policy or in riders or endorsements attached to your Policy. See your agent or contact us for specific information that is applicable to your state. Appendix B in this Prospectus describes all material state variations.
51
SALE OF THE POLICIES
We have entered into an agreement with Investment Distributors, Inc. ("IDI") under which IDI has agreed to distribute the Policies on a "best efforts" basis. Under the agreement, IDI serves as principal underwriter (as defined under Federal securities laws and regulations) for the Policies. IDI is a Tennessee corporation and was established in 1993. IDI, a wholly owned subsidiary of PLC, is an affiliate of Protective Life, and its Home Office shares the same address as Protective Life. IDI is registered with the SEC under the Securities Exchange Act of 1934 as a broker-dealer and is a member firm of the Financial Industry Regulatory Authority ("FINRA").
IDI does not sell Policies directly to purchasers. IDI, together with Protective Life, enters into distribution agreements with other broker-dealers (collectively, "Selling Broker-Dealers") for the sale of the Policies. Registered representatives of the Selling Broker-Dealers must be licensed as insurance agents by applicable state insurance authorities and appointed as agents of Protective Life in order to sell the Policies.
We pay commissions and additional asset-based compensation to Selling Broker-Dealers through IDI. IDI does not retain any commission payment or other amounts as principal underwriter for the Policies. However, we may pay some or all of IDI's operating and other expenses.
We paid the following aggregate dollar amounts to IDI in commissions and additional asset-based compensation relating to sales of our variable life policies, other than the Policies. IDI did not retain any of these amounts, and passed along this compensation directly to the Selling Broker-Dealers.
Fiscal Year Ended |
Amount Paid to IDI |
||||||
December 31, 2017 |
$ |
8,903,766 |
|||||
December 31, 2018 |
$ |
7,510,893 |
|||||
December 31, 2019 |
$ |
8,251,305 |
We offer the Policies on a continuous basis. While we anticipate continuing to offer the Policies, we reserve the right to discontinue the offering at any time.
Selling Broker-Dealers
We pay commissions and may provide some form of non-cash compensation to all Selling Broker-Dealers in connection with the promotion and sale of the Policies. A portion of any payments made to Selling Broker-Dealers may be passed on to their registered representatives in accordance with their internal compensation programs. We may use any of our corporate assets to pay commissions and other costs of distributing the Policies, including any profit from the mortality and expense risk charge. Commissions and other incentives or payments described below are not charged directly to Policy Owners or the Variable Account. We intend to recoup commissions and other sales expenses through fees and charges deducted under the Policies.
Compensation We Pay to All Selling Broker-Dealers. We pay commissions as a percentage of initial and subsequent premium payments at the time we receive them, as a percentage of Policy Value on an ongoing basis, or a combination of both. The maximum sales commission is 25% of Premium. We may also pay to selected Selling Broker-Dealers additional compensation in the form of (1) payments for participation in meetings and conferences that include presentations about our products (including the Policies), and (2) payments to help defray the costs of sales conferences and educational seminars for the Selling Broker-Dealers' registered representatives.
The registered representative who sells you the Policy typically receives a portion of the compensation we pay to his or her Selling Broker-Dealer, depending on the agreement between the Selling Broker-Dealer and your registered representative and the Selling Broker-Dealer's internal compensation program. These programs may include other types of cash and non-cash compensation and other benefits. A registered representative may be required to return all or a portion of the commissions paid if: (i) a Policy terminates prior to the third Policy Anniversary; or (ii) a Policy is surrendered for the Surrender Benefit within the first seven Policy Years and applicable state insurance law permits a return of expense charge. If you would like information about what your registered representative and the Selling Broker-Dealer for whom he or she works may receive in connection with your purchase of a Policy, please ask your registered representative.
Non-Cash Compensation. In the normal course of business, we may also provide non-cash compensation in connection with the promotion of the Policies, including conferences and seminars (including travel, lodging and meals in connection therewith), and items of relatively small value, such as promotional gifts, meals, or tickets to sporting or entertainment events, in accordance with all applicable federal and state rules, including FINRA's non-cash compensation rules.
52
Additional Compensation We Pay to Selected Selling Broker-Dealers. In addition to the cash and non-cash compensation described above, we may pay additional asset-based compensation in the form of marketing allowances and "revenue sharing" to selected Selling Broker-Dealers. These payments may be (1) additional amounts as a percentage of premium payments on our variable insurance products, and (2) additional "trail" commissions, which are periodic payments as a percentage of the contract and policy values or variable account values of our variable insurance products. Some or all of these additional asset-based compensation payments may be conditioned upon the Selling Broker-Dealer producing a specified amount of new premium payments and/or premiums and/or maintaining a specified amount of contract and policy value with us.
The Selling Broker-Dealers to whom we pay additional asset-based compensation provide preferential treatment with respect to our products in their marketing programs. Preferential treatment of our products by a Selling Broker-Dealer may include any or all of the following: (1) enhanced marketing of our products over non-preferred products; (2) increased access to the Selling Broker- Dealer's registered representatives; and (3) payment of higher compensation to registered representatives for selling our products than for selling non-preferred products.
Conflicts of Interest. The prospect of receiving, or the receipt of, additional asset-based and/or incentive compensation creates a conflict of interest because it may provide Selling Broker-Dealers and/or their registered representatives with an incentive to favor sales of our variable insurance products (including the Policies) over other variable insurance products (or other investments) with respect to which a Selling Broker-Dealer does not receive additional compensation, or receives lower levels of additional compensation. You may wish to take such payment arrangements into account when considering and evaluating any recommendation relating to the Policies. If you would like information about what your registered representative and the Selling Broker-Dealer for whom he or she works may receive in connection with your purchase of a Policy, please ask your registered representative.
Fund Payments to Broker-Dealers. The Funds and their related companies may pay a broker-dealer for services provided with regard to the sale of Fund shares to the Sub-Accounts under the Policy. The amount and/or structure of the compensation can possibly create a conflict of interest as it may influence the broker-dealer and your registered representative to present this Policy (and certain Sub-Accounts under the Policy) over other investment alternatives. The variations in compensation, however, may also reflect differences in sales effort or ongoing customer services expected of the broker-dealer or other intermediary or your salesperson. You should ask your registered representative about variations and how he or she and his or her broker-dealer are compensated for selling the Policy.
PAYMENTS WE RECEIVE
Fund Sponsors may compensate us for providing the administrative, recordkeeping and reporting services they would normally be required to provide to individual shareholders or for cost savings experienced by the Fund Sponsors. Such compensation is typically a percentage of the Variable Account assets invested in the relevant Fund and generally may range up to 0.35% of net assets. IDI, a broker-dealer and affiliate of Protective Life and the principal underwriter and distributor of the Policy, may also receive Rule 12b-1 fees (ranging up to 0.25%) directly from certain Funds for providing marketing and distribution related services related to shares of Funds (or certain classes of shares of Funds) offered in connection with a Fund's Rule 12b-1 plan. If IDI receives 12b-1 fees, combined compensation for administrative and distribution related services generally ranges up to 0.60% annually of the Variable Account assets invested in a Fund.
Other Payments. A Fund Sponsor may provide us (or our affiliates) and/ or broker-dealers that sell the Policies ("selling firms") with marketing support, may pay us (or our affiliates) and/or selling firms amounts to participate in national and regional sales conferences and meetings with the sales desks, and may occasionally provide us (or our affiliates) and/or selling firms with items of relatively small value, such as promotional gifts, meals, tickets, or other similar items in the normal course of business.
Conflicts of Interest. Such payments and fees create a conflict of interest for the Company because we have an incentive to offer Funds (or classes of shares of Funds) for which such payments and fees are available to us. We consider such payments and fees, among other things, when deciding to include a Fund (or class of shares of a Fund) as an investment option under the Policy. Other available investment portfolios (or other available classes of shares of the Funds) may have lower fees and better overall investment performance than the Funds (or classes of shares of the Funds) offered under the Policy.
For details about the compensation payments we make in connection with the sale of the Policies, see "SALE OF THE POLICIES."
53
BUSINESS DISRUPTION AND CYBERSECURITY RISKS
Business Disruption and Cyber Security Risks. We rely heavily on interconnected computer systems and digital data to conduct our variable product business. Because our variable product business is highly dependent upon the effective operation of our computer systems and those of our business partners, our business is vulnerable to disruptions from utility outages, and susceptible to operational and information security risks resulting from information systems failure (e.g., hardware and software malfunctions), and cyber-attacks. These risks include, among other things, the theft, misuse, corruption and destruction of data maintained online or digitally, interference with or denial of service, attacks on websites and other operational disruption and unauthorized use or abuse of confidential customer information. Systems failures and cyberattacks, as well as, any other catastrophic event, including natural and manmade disasters, public health emergencies, pandemic diseases, terrorist attacks, floods or severe storms affecting us, any third-party administrator, the underlying funds, intermediaries and other affiliated or third-party service providers may adversely affect us, our business operations and your account value. Systems failures and cyber-attacks may also interfere with our processing of contract transactions, including the processing of orders from our website or with the underlying funds, impact our ability to calculate account values, cause the release and possible destruction of confidential customer or business information, impede order processing, subject us and/or our service providers and intermediaries to regulatory fines and financial losses and/or cause reputational damage. In addition, the occurrence of any pandemic disease (like COVID-19), natural disaster, terrorist attack or any other event that results in our workforce, and/or employees of service providers and/or third party administrators, being compromised and unable or unwilling to fully perform their responsibilities, could likewise result in interruptions in our service, including our ability to issue contracts and process contract transactions. Even if our workforce and employees of our service providers and/or third party administrators were able to work remotely, those remote work arrangements could result in our business operations being less efficient than under normal circumstances and lead to delays in our issuing contracts and processing of other contract-related transactions. Cybersecurity risks and catastrophic events may also impact the issuers of securities in which the underlying funds invest, which may cause the funds underlying your contract to lose value. While there can be no assurance that we or the underlying funds or our service providers will avoid losses affecting your contract due to cyber-attacks, information security breaches or other catastrophic events in the future, we take reasonable steps to mitigate these risks and secure our systems and business operations from such failures, attacks and events.
COVID-19. The outbreak of the novel coronavirus known as COVID-19 was declared a pandemic by the World Health Organization in March 2020. Equity and financial markets have experienced increased volatility and negative returns, and interest rates have declined due to the COVID-19 pandemic and other market factors. Such events can adversely impact us and our operations. Management believes the Company is taking appropriate actions to mitigate the negative impact to our business and operations. However, the full impact of COVID-19 is unknown and cannot be reasonably estimated or predicted at this time as these events are still developing.
Moreover, these market conditions have impacted the performance of the Funds underlying the Sub-Accounts. If these market conditions continue, and depending on your individual circumstances (e.g., your selected investment options and the timing of any contributions, transfers, or withdrawals), you may experience (perhaps significant) negative returns under the policy. The duration of the COVID-19 pandemic, and the future impact that the pandemic may have on the financial markets and global economy, cannot be foreseen, however. You should consult with a financial professional about how the COVID-19 pandemic and the recent market conditions may impact your future investment decisions related to the policy, such as purchasing the policy or making contributions, transfers, or withdrawals, based on your individual circumstances.
LEGAL PROCEEDINGS
Protective Life and its subsidiaries, like other insurance companies, in the ordinary course of business are involved in some class action and other lawsuits, or alternatively in arbitration. In some class action and other lawsuits involving insurance companies, substantial damages have been sought and material payments have been made. Although the outcome of any litigation or arbitration cannot be predicted, Protective Life believes that at the present time there are no pending or threatened lawsuits that are reasonably likely to have a material adverse impact on Protective Life's or the Variable Account's financial position.
We are currently being audited on behalf of multiple states' treasury and controllers' offices for compliance with laws and regulations concerning the identification, reporting, and escheatment of unclaimed benefits or abandoned funds. The audits focus on insurance company processes and procedures for identifying unreported death claims, and their use of the Social Security Death Master File to identify deceased insureds and contract Owners. In addition, we are the subject of a multistate market conduct examination with a similar focus on the handling of unreported claims and abandoned property. The audits and related examination activity may result in additional payments to beneficiaries, escheatment of
54
funds deemed abandoned, administrative penalties, and changes in our procedures for the identification of unreported claims and handling of escheatable property. We do not believe that any regulatory actions or agreements that result from these examinations will have a material adverse impact on the Variable Account, on IDI's ability to perform under its principal underwriting agreement, or on our ability to meet our obligations under the Policy.
FINANCIAL STATEMENTS
There are no financial statements for Protective COLI VUL separate account because it had not commenced as of December 31, 2019.
The audited consolidated balance sheets for Protective Life as of December 31, 2019 and 2018 and the related consolidated statements of income, comprehensive income (loss), shareowner's equity and cash flows for the three years in the period ended December 31, 2019 as well as the Reports of Independent Registered Public Accounting Firms are contained in the Statements of Additional Information.
GLOSSARY
"We", "us", "our", "Protective Life", and "Company"
Refer to Protective Life Insurance Company. "You", "your" and "Owner" refer to the person(s) who have been issued a Policy.
Attained Age
The Insured's age as of the nearest birthday on the Policy Effective Date, plus the number of complete Policy Years since the Policy Effective Date.
Base Policy Face Amount
The amount of life insurance coverage identified as the Base Policy Face Amount on the Policy Schedule.
Beneficiary
The person, persons or entity whom the Owner designates to receive the proceeds of the Policy upon the death of the Insured. The Owner may designate a primary Beneficiary or Beneficiaries, as well as a contingent Beneficiary or Beneficiaries to receive the proceeds if there is no primary Beneficiary(ies) living at the time of the Insured's death. A Beneficiary may also be designated as irrevocable which may limit the Owner's ability to alter that designation or make future Policy changes.
Cancellation Period
Period shown in Appendix B during which the Owner may exercise the cancellation privilege and return the Policy for a refund.
Cash Surrender Value: Calculated on the effective date of the surrender is equal to:
(a) Cash Value; less
(b) Policy Debt; and less
(c) Any liens for payments made under an accelerated death benefit endorsement plus accrued interest.
Cash Value
Policy Value plus any applicable Return of Expense Charge Benefit.
Death Benefit
The amount of insurance provided under the Policy used to determine the Death Benefit Proceeds.
55
Death Benefit Proceeds
The amount payable to the Beneficiary if the Insured dies while the Policy is in force. It is equal to the Death Benefit plus any death benefit under any rider or endorsement to the Policy less (1) any Policy Debt (2) any liens for payments made under an accelerated death benefit endorsement plus accrued interest and (3) less any unpaid Monthly Deductions if the Insured dies during a grace period.
Death Benefit Option
One of two options that an Owner may select for the computation of Death Benefit Proceeds, Face Amount (Option 1, Level), or Face Amount Plus Policy Value (Option 2, Coverage Plus).
Due Proof of Death
Receipt at our Home Office of a certified death certificate or judicial order from a court of competent jurisdiction or similar tribunal.
Evidence of Insurability
Information about an Insured which is used to approve or reinstate this Policy or any additional benefit.
Face Amount/Total Face Amount
Total Face Amount is the sum of the Base Policy Face Amount (life insurance coverage) as shown on the Policy Schedule plus any endorsements or riders attached to the Policy that provided additional life insurance coverage on the Insured, if applicable, as shown on the Policy Schedule. The minimum Face Amount permitted under the Policy is $100,000. Face Amount is equal to the amount listed as Base Policy Face Amount on the Policy Schedule.
Fixed Account
Part of Protective Life's General Account to or from which Policy Value may be transferred and into which Net Premiums may be allocated under a Policy.
Fixed Account Value
The Policy Value in the Fixed Account.
Fund
An underlying mutual fund in which a Sub-Account invests. Each Fund is an investment company registered with the SEC or a separate investment series of a registered investment company.
General Account
All of the Company's assets other than those allocated to the Variable Account or any other separate account. The Company has complete ownership and control of the assets in the General Account.
Good Order ("good order")
A request or transaction generally is considered in "Good Order" if we receive it at our Home Office within the time limits, if any, we prescribe for a particular transaction or instruction, it includes all information necessary for us to execute the requested instruction or transaction, and is signed by the individual or individuals authorized to provide the instruction or engage in the transaction. A request or transaction may be rejected or delayed if not in Good Order. Good Order generally means the actual receipt by us of the instructions relating to the requested transaction in writing (or, when permitted, by telephone or Internet as described above) along with all forms, information and supporting legal documentation we require to affect the instruction or transaction. This information and documentation generally includes, to the extent applicable: the completed application or instruction form; evidence of insurability; your policy number; the transaction amount (in dollars or percentage terms); the names and allocations to and/or from the Funds affected by the requested transaction; the signatures of the Policy Owner (exactly as indicated on the Policy), if necessary; Social Security Number or Tax I.D.; and any other information or supporting documentation that we may require, including any consents. With respect to premium payments, Good Order also generally includes receipt by one of us of sufficient funds to affect the purchase. We may, in our sole discretion, determine whether any particular
56
transaction request is in Good Order, and we reserve the right to change or waive any Good Order requirement at any time. If you have questions, you should contact us or your financial professional before submitting the form or request.
Home Office
2801 Highway 280 South, Birmingham, Alabama 35223. The mailing address for the Home Office is P.O. Box 292 Birmingham, AL 35201-0292. The Home Office is referred to as the "Administrative Office" in the Policy.
Insured
The person whose life is covered by the Policy.
Issue Age
The Insured's age as of the nearest birthday on the Policy Effective Date.
Issue Date
The date the Policy is issued.
Lapse
Termination of the Policy at the expiration of the grace period while the Insured is still living.
Loan Account
An account within Protective Life's General Account to which Fixed Account Value and/or Variable Account Value plus interest credited on the portion of the Policy Value being used as collateral for the outstanding Policy loans is transferred as collateral for Policy loans.
Loan Account Value
The Policy Value in the Loan Account.
Loan Interest Credit Spread
An amount deducted from the loan interest rate to cover the costs the Company incurs by providing the loaned cash value. The maximum Loan Interest Credit Spread is 1.5% and is shown on the Policy Schedule and in the table of Periodic Charges Other Than Fund Operating Expenses.
Money Market Sub-Account
A Fund which seeks a high level of current income as is consistent with the preservation of capital and liquidity and investing in short term, high quality, liquid debt and monetary instruments.
Monthly Anniversary Day
The same day in each month as the Policy Effective Date.
Monthly Deduction
The fees and charges deducted monthly from the Fixed Account Value and/or Variable Account Value as described on the Policy Schedule.
Net Amount at Risk
The Net Amount at Risk as of any Monthly Anniversary Day is equal to: (a) the Death Benefit discounted at one plus the monthly guaranteed interest rate minus the Policy Value (prior to deducting the Cost of Insurance), if the Death Benefit Option is Death Benefit Option 1 (Level Death Benefit); or, (b) the Death Benefit minus the Policy Value discounted at one plus the monthly guaranteed interest rate, if the Death Benefit Option is Death Benefit Option 2 (Coverage Plus).
Net Premium
A premium payment minus the applicable premium expense charges.
57
Owner
The person, or persons, or entity entitled to all rights in this Policy while the Insured is living including designation of a Beneficiary. These rights are subject to any assignment and to the rights of any Irrevocable Beneficiary. The Owner may name a contingent Owner who will own this Policy if the Owner dies while this Policy is in force. If the Owner dies before the Insured, any contingent Owner named in the application, or subsequent endorsement, will become the new Owner. If no contingent Owner is named, the Owner's estate becomes the new Owner. The Owner may change the Owner (including a contingent Owner) by Written Notice.
Policy Anniversary
The same day and month in each Policy Year as the Policy Effective Date.
Policy Debt
The sum of all outstanding policy loans plus accrued interest.
Policy Effective Date
The date shown in the Policy as of which coverage under the Policy begins. In the Policy, Policy Effective Date is known as "Policy Date."
Policy Month
The Policy Month begins on a Monthly Anniversary Day and ends on the day prior to the next Monthly Anniversary Day.
Policy Value
The sum of the Variable Account Value, the Fixed Account Value, and the Loan Account Value. Policy Value is referred to as "Policy Value Account" in the Policy.
Policy Year
Each period of twelve months commencing with the Policy Effective Date and each Policy Anniversary thereafter.
Return of Expense Charge Benefit
Where applicable, the Company will calculate and return a percentage of the expense charge. The Return of Expense Charge Benefit calculation is based on a percentage of the Policy Value, and is only payable upon a complete surrender of the Policy. Refer to the "Return of Expense Charge Benefit" provision in the Policy for the percentage and duration of the Return of Expense Charge Benefit and any limitations and requirements.
Request
Any written, telephoned, electronic or computerized instruction in a form satisfactory to the Company and received at the Home or Administrative Office from the Owner or an assignee of record, as specified in a form acceptable to the Company and which may be required in writing, or the Beneficiary (as applicable) as required by any provision of the Policy or as required by the Company. In addition, subject to the Company's administrative requirements as they may exist from time to time and to any requirements that may be imposed by the Funds or other investments, the Company reserves the right to require advance Written Notice from the Owner.
Sub-Account
A separate division of the Variable Account established to invest in a particular Fund.
Sub-Account Value
The sum of the values of the Sub-Accounts credited to the Owner as Policy Value.
58
Valuation Date
The date on which the net asset value of each Fund is determined. A Valuation Date is each day that the NYSE is open for regular business. The value of a Sub-Account's assets is determined at the end of each Valuation Date. To determine the value of an asset on a day that is not a Valuation Date, the value of that asset as of the end of the previous Valuation Date will be used.
Valuation Period
The period commencing with the close of regular trading on the New York Stock Exchange on any Valuation Date and ending at the close of regular trading on the New York Stock Exchange on the next succeeding Valuation Date.
Variable Account
One of the accounts into which Premiums may be paid under this Policy, net of Policy fees and charges described herein. The account is a segregated investment account established by the Company and a separate account under Tennessee law named the Protective COLI VUL separate account. The Company owns the assets in the Variable Account. The investments held in the Variable Account provide variable life insurance benefits under this Policy. This account is kept separate from the General Account and other separate accounts the Company may have. The Variable Account is registered with the Securities and Exchange Commission ("SEC") under the Investment Company Act of 1940, as amended. Protective COLI VUL separate account, a separate investment account of Protective Life to and from which Policy Value may be transferred and into which Net Premiums may be allocated.
Variable Account Value
The sum of all Sub-Account Values.
Written Notice
A notice or request submitted in writing in a form satisfactory to Protective Life and received at the Home Office via U.S. postal service or nationally recognized overnight delivery service. Protective Life reserves the right to require advance Written Notice from the Owner for (i) premium allocations; (ii) Policy loans and loan repayments; and surrenders, partial withdrawals, or transfers.
59
STATEMENT OF ADDITIONAL INFORMATION
Table of Contents
Page |
|||||||
ADDITIONAL POLICY INFORMATION |
1 |
||||||
LIMITS ON POLICY RIGHTS |
1 |
||||||
MISSTATEMENT OF AGE OR SEX |
1 |
||||||
SETTLEMENT OPTIONS |
1 |
||||||
SUPPLEMENTAL RIDERS AND ENDORSEMENTS |
1 |
||||||
ILLUSTRATIONS |
1 |
||||||
ADDITIONAL INFORMATION |
1 |
||||||
CEFLI |
1 |
||||||
OTHER INVESTORS IN THE FUNDS |
1 |
||||||
ASSIGNMENT |
2 |
||||||
STATE REGULATION |
2 |
||||||
REPORTS TO OWNERS |
2 |
||||||
LEGAL MATTERS |
2 |
||||||
EXPERTS |
3 |
||||||
REINSURANCE |
3 |
||||||
ADDITIONAL INFORMATION |
3 |
||||||
FINANCIAL STATEMENTS |
3 |
||||||
INDEX TO FINANCIAL STATEMENTS |
60
APPENDIX A
OPTION 1
MEC EXAMPLE.
For purposes of this example, assume that the Insured is a male, standard nonsmoker class and the Insured's Attained Age is 40. Under Option 1, a Policy with a $100,000 Face Amount will generally pay $100,000 in Death Benefits. However, because the Death Benefit must be equal to or be greater than 491% (rounded for simplicity), which is the applicable Death Benefit Factor for the Insured based on age and underwriting class, of the Cash Value, any time that the Cash Value exceeds $20,367, the Death Benefit will exceed the $100,000 Face Amount. Each additional dollar added to Cash Value above $20,367 will increase the Death Benefit by $4.91 during Attained Age 40. A Policy with a $100,000 Face Amount and a Cash Value of $50,000 will provide Death Benefit of $245,500 ($50,000 x 491%); a Cash Value of $60,000 will provide a Death Benefit of $294,600 ($60,000 x 491%); a Cash Value of $70,000 will provide a Death Benefit of $343,700 ($70,000 x 491%).
Similarly, so long as Cash Value exceeds $20,367, each dollar taken out of Cash Value will reduce the Death Benefit by $4.91. If, for example, the Cash Value is reduced from $35,000 to $20,367 because of partial surrenders, charges, or negative investment performance, the Death Benefit will be reduced from $171,850 to $100,000. If at any time, however, the Cash Value multiplied by the Death Benefit Factor is less than the Face Amount, the Death Benefit will equal the current Face Amount of the Policy.
The Death Benefit Factor percentage becomes lower as the Insured's Attained Age increases. If the Attained Age of the Insured in the example above were, for example, 50 (rather than 40), the specified amount factor would be 350%. The Death Benefit would not exceed the $100,000 Face Amount unless the Cash Value exceeded approximately $28,571 (rather than $20,367), and each dollar then added to or taken from the Cash Value would change the life insurance proceeds by $3.50 (rather than $4.91).
Calculations:
Death Benefit is the greater of the Face Amount and the Cash Value multiplied by the applicable Death Benefit Factor
For example: Death Benefit Factor (Male NS 40) = 4.91
If the Cash Value exceeds 20,367 (100,000 / 4.91), then the Death Benefit will exceed the Face Amount. If the Cash Value is less than this amount, the Death Benefit will equal the Face Amount.
Other Cash Value & Death Benefit examples, assuming male, standard nonsmoker, Attained Age 40:
Cash Value = 50,000
Death Benefit = Max(100,000; 50,000 x 4.91 = 245,500) = 245,000
Cash Value = 60,000
Death Benefit = Max(100,000; 60,000 x 4.91 = 294,600) = 294,600
Cash Value = 15,000
Death Benefit = Max(100,000; 15,000 x 4.91 = 73,650) = 100,000
For a male, standard nonsmoker, attained age 50 (Death Benefit Factor = 3.50):
If the Cash Value exceeds 28,571 (100,000 / 3.50), then the Death Benefit will exceed the Face Amount. If the Cash Value is less than this amount, the Death Benefit will equal the Face Amount.
NON-MEC EXAMPLE.
The IRC under section 7702 defines a life insurance contact. Under section 7702A, the IRS codifies that a policy that is life insurance under 7702, but fails a 7-pay test comparing cumulative premiums paid to the policy to the sum of the "net level premiums" (defined here as "7-Pay Premiums") over the first seven years, would become a MEC. In this case, the policy would continue to legally be defined as a life insurance contract, but may incur penalties and adverse tax consequences when withdrawing funds from the policy or taking policy loans. By dividing the single premium calculated as the necessary to fund the policy under IRC 7702 by an annual annuity of $1 paid for seven years, we are able to come up with a set of "7-Pay Factors" per $1,000 of Face Amount that are multiplied by the policy's Face Amount to determine allowable 7-Pay Premiums for the policy.
For purposes of this example, assume that the Insured is a male, standard nonsmoker class and the Insured's Issue Age is 40. Under Option 1, a Policy with a $100,000 Face Amount will generally pay $100,000 in Death Benefits. The 7-Pay Premium for this policy and attained age is $3,277 (7-Pay Factor of 32.77 per 1,000 of Face Amount). If cumulative
A-1
premiums paid within the first seven years exceed the cumulative 7-Pay Premiums through that policy year, the policy will become a MEC.
As another example, assume that the Insured is a male, standard nonsmoker class and the Insured's Issue Age is 50. Under Option 1, a Policy with a $100,000 Face Amount will generally pay $100,000 in Death Benefits. The 7-Pay Premium is $4,606 (7-Pay Factor of 46.06 per 1,000 of Face Amount). If more than $4,606 is paid in the first year or if cumulative premiums paid in the first seven years exceeded the sum of the 7-Pay Premiums through that policy year, the policy would become a MEC. If instead, the policyholder wanted to put more money in, they could alternatively purchase a policy with a higher Face Amount, which would allow for more premiums allowed at the same ratio. For a male, standard nonsmoker with an Issue Age of 50 purchasing $200,000 of Face Amount, the 7-Pay Premiums would instead be $9,212 (200,000 / 1,000 x 46.06).
Other examples of 7-Pay Premiums determined from Face Amount:
Male, standard nonsmoker, Issue Age of 30
Face Amount = 100,000
7-Pay Factor = 23.00
7-Pay Premium = 23.00 x (100,000 / 1,000) = 2,300
If cumulative premiums within the first 7 years exceed the sum of the 7-Pay Premiums through that policy year, then the policy will be a MEC. For example, if $2,000 of Premium is paid in Policy Year 1 and then $3,000 of premium is paid in Policy Year 2, the cumulative premiums ($2,000 + $3,000 = $5,000) would exceed the sum of the 7-Pay Premiums ($2,300 + $2,300 = $4,600) and the policy would become a MEC.
Male, standard nonsmoker, Issue Age of 50
Face Amount = 200,000
7-Pay Factor = 46.06
7-Pay Premium = 46.06 x (200,000 / 1,000) = 9,212
If cumulative premiums within the first 7 years exceed the sum of the 7-Pay Premiums through that policy year, then the policy will be a MEC. For example, if $8,000 of Premium is paid in Policy Years 1 through 5 and then $12,000 of premium is paid in Policy Year 6, the cumulative premiums ($8,000 x 5 + $12,000 = $52,000) would not exceed the sum of the 7-Pay Premiums ($9,212 x 6 = $55,272) and the policy would not become a MEC. If, however, $16,000 was paid in Policy Year 6 instead, the cumulative premiums would equal $56,000 and the policy would become a MEC.
OPTION 2
MEC EXAMPLE.
For purposes of this example, assume that the Insured is a male, standard nonsmoker class and the Insured's Attained Age is 40. Under Option 2, a Policy with a Face Amount of $100,000 will generally provide a Death Benefit of $100,000 plus Policy Value Account. Thus, for example, a Policy with a Policy Value Account of $10,000 will have a Death Benefit of $110,000 ($100,000 + $10,000); a Policy Value Account of $20,000 will provide a Death Benefit of $120,000 ($100,000 + $20,000). Similarly to the Option 1 examples however, the Death Benefit must be at least 491% of the Cash Value, based on the Death Benefit Factors provided. Cash Value is the Policy Value Account plus any Return of Expense Charge. For example, assume the Policy Value Account is $25,000 and assume a 5% Return of Expense Charge. Then the Cash Value is $26,250 ($25,000 + 5% x $25,000). The Death Benefit is the greater of the Face Amount plus Policy Value Account, or 491% of the Cash Value. Face Amount plus Policy Value Account is $125,000. 491% of the Cash Value is $128,888. Therefore, the Death Benefit is $128,888.
Calculations:
Death Benefit is equal to the greater of (a) and (b), where (a) is the sum of the Face Amount and the Policy Value Account, and (b) is the Cash Value multiplied by the applicable Death Benefit Factor. For example, assuming an Insured is male, standard nonsmoker with a Face Amount of $100,000, Attained Age is 40, and current Return of Expense Charge is 5%:
Examples of Death Benefits, Policy Value Accounts, and Face Amounts:
Assume the Policy Value Account = $10,000
Cash Value = Policy Value Account x (1 + Return of Expense Charge) = $10,500
(a) = Face Amount + Policy Value Account = $100,000 + $10,000 = 110,000
(b) = Cash Value x Death Benefit Factor = $10,500 x 4.91 = $51,555
Death Benefit is the greater of (a) and (b), so is therefore $110,000
A-2
Assume the Policy Value Account = $30,000
Cash Value = Policy Value Account x (1 + Return of Expense Charge) = $31,500
(a) = Face Amount + Policy Value Account = $100,000 + $30,000 = 130,000
(b) = Cash Value x Death Benefit Factor = $31,500 x 4.91 = $154,665
Death Benefit is the greater of (a) and (b), so is therefore $154,665
NON-MEC EXAMPLE
For purposes of this example, assume that the Insured is a male, standard nonsmoker class and the Insured's Issue Age is 40. Under Option 2, a Policy with a Face Amount of $100,000 will generally provide a Death Benefit of $100,000 plus Policy Value Account. The 7-Pay Premium equals $3,277 (7-Pay Factor is 32.77 per 1,000 of Face Amount). At issue the Policy Value Account will be the Premium paid less the Expense Charge. Assuming the Premium paid is $3,000 and the Expense Charge is 5%, the Policy Value Account at issue would be $$2,850 ($3,000 x (1 5%)). Because the Return of Expense Charge is equal to the Expense Charge plus 1%, the Return of Expense Charge would equal 6% and the Cash Value would equal $3,021 ($2,850 x (1 + 6%)).
The Death Benefit is equal to the greater of (a) and (b), where (a) is the sum of the Face Amount and the Policy Value Account, and (b) is the Cash Value multiplied by the applicable Death Benefit Factor. In this example, the death benefit is the greater of (a) $102,850 ($100,000 Face Amount plus $2,850 Policy Value Account), and (b) $14,833 ($3,021 Cash Value multiplied by 4.91 Death Benefit Factor). The Death Benefit in this example is therefore $102,850.
Other examples of 7-Pay Premiums determined from Face Amount:
Male, standard nonsmoker, Issue Age of 30, initial premium of $2,000, Expense Charge of 5%
Face Amount = 100,000
7-Pay Factor = 23.00
7-Pay Premium = 23.00 x (100,000 / 1,000) = 2,300
Policy Value Account at issue = Premium x (1 Expense Charge) = $2,000 x (1 5%) = $1,900
Cash Value at issue = Policy Value Account x (1 + Return of Expense Charge) = $1,900 x (1 + 6%) = $2,014
Death Benefit at issue = Max (Face Amount + Policy Value Account, Cash Value x Death Benefit Factor)
= Max ($100,000 + $1,900, $2,014 x 6.97) = Max ($101,900, $14,038) = $101,900
If cumulative premiums within the first 7 years exceed the sum of the 7-Pay Premiums through that policy year, then the policy will be a MEC. For example, if $2,000 of Premium is paid in Policy Year 1 and then $3,000 of premium is paid in Policy Year 2, the cumulative premiums ($2,000 + $3,000 = $5,000) would exceed the sum of the 7-Pay Premiums ($2,300 + $2,300 = $4,600) and the policy would become a MEC.
Male, standard nonsmoker, Issue Age of 50, initial premium of $9,000, Expense Charge of 5%
Face Amount = 200,000
7-Pay Factor = 46.06
7-Pay Premium = 46.06 x (200,000 / 1,000) = 9,212
Policy Value Account at issue = Premium x (1 Expense Charge) = $9,000 x (1 5%) = $8,550
Cash Value at issue = Policy Value Account x (1 + Return of Expense Charge) = $8,550 x (1 + 6%) = $9,063
Death Benefit at issue = Max (Face Amount + Policy Value Account, Cash Value x Death Benefit Factor)
= Max ($200,000 + $8,550, $9,063 x 3.50) = Max ($208,550, $31,721) = $208,550
If cumulative premiums within the first 7 years exceed the sum of the 7-Pay Premiums through that policy year, then the policy will be a MEC. For example, if $8,000 of Premium is paid in Policy Years 1 through 5 and then $12,000 of premium is paid in Policy Year 6, the cumulative premiums ($8,000 x 5 + $12,000 = $52,000) would not exceed the sum of the 7-Pay Premiums ($9,212 x 6 = $55,272) and the policy would not become a MEC. If, however, $16,000 was paid in Policy Year 6 instead, the cumulative premiums would equal $56,000 and the policy would become a MEC.
A-3
APPENDIX B
RIGHT TO CANCEL (FREE LOOK) TIME PERIODS |
|||||||
States | |||||||
AL, AK, AZ, AR, CO, CT, DE, DC, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NC, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY |
There is a 10 day right to cancel period that starts on the date the Owner receives the Policy. If the Policy is issued as a replacement of existing life insurance or annuity coverage, the right to cancel period is extended to 30 days from the date of receiving it. If you are not satisfied with the Policy, you can return it to the Company or an agent of the Company. The Policy will be void from the start, and the Company will refund the Policy Value plus any fees and charges. The Owner bears the investment risk during the right to cancel period. |
||||||
CA |
There is a 10 day right to cancel period that starts on the date the Owner receives the Policy. If the Policy is issued as a replacement of existing life insurance or annuity coverage, the right to cancel period is extended to 30 days from the date of receiving it. If you are not satisfied with the Policy, you can return it to the Company or an agent of the Company. The Policy will be void from the start, and the Company will refund the Policy Value plus any fees and charges. The Owner bears the investment risk during the right to cancel period.
(The above right to cancel period is varied for individual Policy Owners aged 60 years or over as follows) The Policy may be returned within 30 days from the date you received it. During that 30-day period, your money will be placed in a fixed account or money-market fund, unless you direct that the premium be invested in a stock or bond portfolio underlying the policy during the 30-day period. If you do not direct that the premium be invested in a stock or bond portfolio, and if you return the Policy within the 30-day period, you will be entitled to a refund of the premium and any Policy fees paid. If you direct that the premium be invested in a stock or bond portfolio during the 30-day period, and if you return the Policy during that period, you will be entitled to a refund of the Policy Value on the day the Policy is received by the Company or agent who sold you the Policy, which could be less than the premium you paid for the Policy, plus any Policy fees paid. |
||||||
FL |
There is a 21 day right to cancel period that starts on the date the Owner receives the Policy. If the Policy is issued as a replacement of existing life insurance or annuity coverage, the right to cancel period is extended to 30 days from the date of receiving it. If you are not satisfied with the Policy, you can return it to the Company or an agent of the Company. The Policy will be void from the start, and the Company will refund the Policy Value plus any fees and charges. The Owner bears the investment risk during the right to cancel period.
The Death Benefit Payment Provision is varied as follows: The Company will pay interest on the Death Benefit Proceeds from the date of death, to the date of settlement with interest at an annual rate equal to or greater than the Moody's Corporate Bond Yield Average-Monthly Corporate as of the day the claim was received |
||||||
MT |
All Policies issued in Montana are based on unisex tables and rates. Any reference in this prospectus to sex distinctions should be disregarded for this state. |
B-1
APPENDIX B
B-2
APPENDIX B
ENDORSEMENT/RIDER VARIATIONS FOR TERM LIFE INSURANCE RIDER |
|||||||
States | |||||||
ND |
The Suicide Exclusion Provision for the Term Life Insurance Rider is varied as follows:
If the Insured commits suicide, while sane or insane, within 1 year of the Issue Date of this Rider, the payment will be limited to an amount equal to the cost of insurance deducted for this Rider. |
B-3
The statement of additional information includes additional information about the Protective COLI VUL separate account. The statement of additional information and other information are available upon request at 1-800-265-1545 or by emailing gwexecbenefits@protective.com. Please send me a free copy of the SAI for the Protective Executive Benefits Registered VUL.
Name: |
|||
Address: |
|||
City, State, Zip: |
|||
Daytime Telephone Number: |
Reports and other information regarding the Protective COLI VUL separate account are available on the SEC's internet site at http://www.sec.gov.
Investment Company Act File No.: 811-23604 |
PROTECTIVE COLI VUL
(Registrant)
PROTECTIVE LIFE INSURANCE COMPANY
(Depositor)
2801 Highway 280 South
Birmingham, Alabama 35223
(800) 265-1545
STATEMENT OF ADDITIONAL INFORMATION
Individual Flexible Premium Variable Universal Life Insurance Policy
This Statement of Additional Information ("SAI") contains additional information regarding the individual flexible premium variable universal life insurance policy (the "Policy") offered by Protective Life Insurance Company ("Protective Life"). The Policy is designed for use by corporations and employers and certain individuals. This SAI is not a prospectus, and should be read together with the Prospectus for the Policy dated __________, 2020 and the prospectuses for the Funds. You may obtain a copy of these prospectuses by writing or calling us at our address or phone number shown above. Capitalized terms in this SAI have the same meanings as in the Prospectus for the Policy.
__________, 2020
STATEMENT OF ADDITIONAL INFORMATION
TABLE OF CONTENTS
Page |
|||||||
Additional Policy Information |
1 |
||||||
Limits on Policy Rights |
1 |
||||||
Misstatement of Age or Sex |
1 |
||||||
Settlement Options |
1 |
||||||
Illustrations |
1 |
||||||
Additional Information |
1 |
||||||
CEFLI |
1 |
||||||
Other Investors in the Funds |
1 |
||||||
Assignment |
2 |
||||||
State Regulation |
2 |
||||||
Reports to Owners |
2 |
||||||
Legal Matters |
2 |
||||||
Experts |
3 |
||||||
Reinsurance |
3 |
||||||
Additional Information |
3 |
||||||
Financial Statements |
3 |
||||||
Index to Financial Statements |
ADDITIONAL POLICY INFORMATION
Limits on Policy Rights
Incontestability. Unless fraud is involved, Protective Life will not contest the Policy, or any supplemental rider, after the Policy or rider has been in force during the Insured's lifetime for two years from the Policy Effective Date or the effective date of the rider. Likewise, unless fraud is involved, Protective Life will not contest an increase in the Face Amount with respect to statements made in the evidence of insurability for that increase after the increase has been in force during the life of the Insured for two years after the effective date of the increase.
Suicide Exclusion. If the Insured dies by suicide, while sane or insane, within two years after the Policy Effective Date, the Death Benefit will be limited to the premium payments made before death, less any Policy Debt, liens (including accrued interest) and any withdrawals. If the Insured dies by suicide within two years after an increase in Face Amount, the Death Benefit with respect to the increase will be limited to the sum of the monthly cost of insurance charges made for that increase.
Misstatement of Age or Sex
If the Insured's age or sex has been misstated in the application for the Policy or in any application for supplemental riders, the Death Benefit under the Policy or such supplemental riders is the amount which would have been provided by the most recent cost of insurance charge, and the cost of such supplemental riders, at the correct age and sex.
Settlement Options
Payment of Death Benefit proceeds will be paid in a lump sum unless the Beneficiary chooses to receive the proceeds under a settlement option that the Company is then offering.
Policy Owner Control
For a variable life insurance policy to qualify for tax deferral, assets in the separate accounts supporting the Policy must be considered to be owned by the insurance company and not by the policy owner. Under current U.S. tax law, if a policy owner has excessive control over the investments made by a separate account, or the underlying fund, the policy owner will be taxed currently on income and gains from the account or fund. In other words, in such a case of "investor control" the policy owner would not derive the tax benefits normally associated with variable life insurance. We urge you to consult your own tax advisor with respect to the application of the investor control doctrine.
ILLUSTRATIONS
We may provide illustrations for Death Benefit, Policy Value, and Surrender Value based on hypothetical rates of return that are not guaranteed. The illustrations also assume costs of insurance for a hypothetical person. These illustrations are illustrative only and are not a representation of past or future performance. Your rates of return and insurance charges may be higher or lower than these illustrations. The actual return on your policy account value will depend on factors such as the amounts you allocate to particular Funds, the amounts deducted for the Policy's monthly charges, the Funds' expense ratios, and your policy loan and partial withdrawal history.
Before you purchase the Policy and upon request thereafter, we will provide illustrations of future benefits under the Policy based upon the proposed insured's age and underwriting class, face amount, planned premiums, and riders requested. We reserve the right to charge a reasonable fee for this service to persons who request more than one illustration during a Policy Year.
ADDITIONAL INFORMATION
CEFLI
Protective Life is a member of the Compliance & Ethics Forum for Life Insurers ("CEFLI"), and as such may include the CEFLI logo and information about CEFLI membership in Protective advertisements. Companies that belong to CEFLI subscribe to a set of ethical standards covering the various aspects of sales and service for individually sold life insurance and annuities.
Other Investors in the Funds
Shares of the AIM Variable Insurance Funds (Invesco Variable Insurance Funds), Alger Portfolios, American Century Variable Portfolios, Inc., American Funds Insurance Series, Blackrock Variable Series Funds, Inc., Columbia Funds Variable Insurance Trust, Davis Variable Account Fund, Inc., Delaware VIP Trust, Deutsche DWS Investments VIT Funds, Deutsche DWS Variable Series I, Deutsche DWS Variable Series II, BNY Mellon Stock Index Fund, Inc., BNY
1
Mellon Variable Investment Fund, Eaton Vance Variable Trust, Federated Insurance Series, Fidelity Variable Insurance Products, Fidelity Variable Insurance Products Fund III, Goldman Sachs Variable Insurance Trust, Great-West Funds, Inc., Great-West Profile Funds, Janus Aspen Series, JPMorgan Insurance Trust, Legg Mason Partners Variable Equity Trust, Lord Abbett Series Fund, Inc., MFS Variable Insurance Trust, MFS Variable insurance Trust II, MFS Variable Insurance Trust III, Neuberger Berman Advisers Management Trust, PIMCO Variable Insurance Trust, Pioneer Variable Contracts Trust, Putnam Variable Trust, Royce Capital Funds, T. Rowe Price Equity Series, Inc., VanEck VIP Trust, and Victory Variable Insurance Funds are sold to separate accounts of insurance companies, which may or may not be affiliated with Protective Life or each other, a practice known as "shared funding." They may also be sold to separate accounts to serve as the underlying investment for both variable annuity contracts and variable life insurance policies, a practice known as "mixed funding." Shares of some of these Funds may also be sold to certain qualified pension and retirement plans. As a result, there is a possibility that a material conflict may arise among and between the interests of Policy Owners and other of the Fund's various investors. In the event of any such material conflicts, Protective Life will consider what action may be appropriate, including removing the Fund from the Variable Account or replacing the Fund with another Fund. The board of directors (or trustees) of each of the AIM Variable Insurance Funds (Invesco Variable Insurance Funds), Alger Portfolios, American Century Variable Portfolios, Inc., American Funds Insurance Series, Blackrock Variable Series Funds, Inc., Columbia Funds Variable Insurance Trust, Davis Variable Account Fund, Inc., Delaware VIP Trust, Deutsche DWS Investments VIT Funds, Deutsche DWS Variable Series I, Deutsche DWS Variable Series II, BNY Mellon Stock Index Fund, Inc., BNY Mellon Variable Investment Fund, Eaton Vance Variable Trust, Federated Insurance Series, Fidelity Variable Insurance Products, Fidelity Variable Insurance Products Fund III, Goldman Sachs Variable Insurance Trust, Great-West Funds, Inc., Great-West Profile Funds, Janus Aspen Series, JPMorgan Insurance Trust, Legg Mason Partners Variable Equity Trust, Lord Abbett Series Fund, Inc., MFS Variable Insurance Trust, MFS Variable insurance Trust II, MFS Variable Insurance Trust III, Neuberger Berman Advisers Management Trust, PIMCO Variable Insurance Trust, Pioneer Variable Contracts Trust, Putnam Variable Trust, Royce Capital Funds, T. Rowe Price Equity Series, Inc., VanEck VIP Trust, and Victory Variable Insurance Funds monitors events related to their Funds to identify possible material irreconcilable conflicts among and between the interests of the Fund's various investors. There are certain risks associated with mixed and shared funding and with the sale of shares to qualified pension and retirement plans, as disclosed in each Fund's prospectus.
Assignment
The Policy may be assigned in accordance with its terms. An assignment is binding upon Protective Life only if it is in writing and filed at the Home Office. Once Protective Life has received a signed copy of the assignment, the Owner's rights and the interest of any beneficiary (or any other person) will be subject to the assignment. Protective Life assumes no responsibility for the validity or sufficiency of any assignment. An assignment is subject to any Policy Debt and any liens. An assignment may result in certain amounts being subject to income tax and a 10% penalty tax. (See "Tax Considerations" in the prospectuses.)
State Regulation
Protective Life is subject to regulation by the Department of Insurance of the State of Tennessee, which periodically examines the financial condition and operations of Protective Life. Protective Life is also subject to the insurance laws and regulations of all jurisdictions where it does business. The Policy has been filed with and, where required, approved by, insurance officials in those jurisdictions where it is sold.
Protective Life is required to submit annual statements of operations, including financial statements, to the insurance departments of the various jurisdictions where it does business to determine solvency and compliance with applicable insurance laws and regulations.
Reports to Owners
Each year you will be sent a report at your last known address showing, as of the end of the current report period: the Death Benefit; Policy Value; Fixed Account Value; Variable Account Value; Loan Account Value; Sub-Account Values; premiums paid since the last report; withdrawals since the last report; any Policy loans and accrued interest; Surrender Value; current Net Premium allocations; charges deducted since the last report; any liens and accrued interest; and any other information required by law. You will also be sent an annual and a semi-annual report for each Fund underlying a Sub-Account to which you have allocated Policy Value, including a list of the securities held in each Fund, as required by the Investment Company Act of 1940. In addition, when you pay premiums or request any other financial transaction under your Policy you will receive a written confirmation of these transactions.
Legal Matters
Faegre Drinker Biddle & Reath LLP has provided advice on certain matters relating to the federal securities laws.
2
Experts
There are no financial statements for Protective COLI VUL separate account because it had not commenced operations as of December 31, 2019.
The consolidated financial statements of Protective Life Insurance Company as of December 31, 2019 and for the year then ended have been included herein in this Statement of Additional Information in reliance upon the report of KPMG LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing.
The business address for KPMG LLP is 420 20th Street North, Suite 1800, Birmingham, Alabama 35203.
The consolidated financial statements of Protective Life Insurance Company as of December 31, 2018 and for each of the two years in the period ended December 31, 2018 included in this SAI have been so included in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.
The principal business address of PricewaterhouseCoopers LLP is 569 Brookwood Village Suite 851, Birmingham, Alabama 35209.
Reinsurance
The Company may reinsure a portion of the risks assumed under the Policies.
Additional Information
A registration statement has been filed with the SEC under the Securities Act of 1933, as amended, with respect to the Policies. Not all the information set forth in the registration statement, and the amendments and exhibits thereto, has been included in the prospectus and this SAI. Statements contained in this SAI concerning the content of the Policies and other legal instruments are intended to be summaries. For a complete statement of the terms of these documents, reference should be made to the instruments filed with the SEC at 100 F Street, N.E., Washington, DC 20549. The instruments may also be accessed using the SEC's website at http://www.sec.gov.
Pursuant to Commodity Futures Trading Commission Rule 4.5, Protective Life has claimed an exclusion from the definition of a the term "Commodity Pool Operator" under the Commodity Exchange Act ("CEA"). Therefore it is not subject to regulation as a Commodity Pool Operator under the CEA.
Financial Statements
There are no financial statements for Protective COLI VUL separate account because it had not commenced operations as of December 31, 2019.
The audited consolidated balance sheets for Protective Life as of December 31, 2019 and 2018 and the related consolidated statements of income, comprehensive income (loss), shareowner's equity and cash flows for the three years in the period ended December 31, 2019 as well as the Reports of Independent Registered Public Accounting Firms are contained herein. Protective Life's consolidated financial statements should be considered only as bearing on its ability to meet its obligations under the Contracts. They should not be considered as bearing on the investment performance of the assets held in Protective COLI VUL separate account.
Financial Statements follow this page.
3
Report of Independent Registered Public Accounting Firm
To the Shareowner and Board of Directors
Protective Life Insurance Company:
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated balance sheet of Protective Life Insurance Company and subsidiaries (the Company) as of December 31, 2019, the related consolidated statements of income, comprehensive income (loss), shareowner's equity, and cash flows for the year ended December 31, 2019, and the related notes and financial statement schedules III to V (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019, and the results of its operations and its cash flows for the year ended December 31, 2019, in conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.
/s/ KPMG LLP
We have served as the Company's auditor since 2019.
Birmingham, Alabama
March 25, 2020
F-1
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareowner of Protective Life Insurance Company
Opinion on the Financial Statements
We have audited the consolidated balance sheet of Protective Life Insurance Company and its subsidiaries (the "Company") as of December 31, 2018, and the related consolidated statements of income, comprehensive income (loss), shareowner's equity and cash flows for each of the two years in the period ended December 31, 2018, including the related notes and financial statement schedules as of and for each of the two years in the period ended December 31, 2018 listed in the index appearing under Item 15(2) (collectively referred to as the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2018, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2018 in conformity with accounting principles generally accepted in the United States of America.
Change in Accounting Principle
As described in Note 2 to the consolidated financial statements, the Company changed the manner in which it accounts for administrative fees associated with certain property and casualty insurance products in 2018.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
/s/PricewaterhouseCoopers LLP
March 25, 2019
Birmingham, AL
We served as the Company's auditor from 1974 to 2019.
F-2
PROTECTIVE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF INCOME
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Revenues |
|||||||||||||||
Premiums and policy fees |
$ |
4,056,202 |
$ |
3,656,508 |
$ |
3,456,362 |
|||||||||
Reinsurance ceded |
(1,517,204 |
) |
(1,383,510 |
) |
(1,367,096 |
) |
|||||||||
Net of reinsurance ceded |
2,538,998 |
2,272,998 |
2,089,266 |
||||||||||||
Net investment income |
2,818,830 |
2,338,902 |
1,923,056 |
||||||||||||
Realized investment gains (losses) |
211,539 |
(144,179 |
) |
(15,954 |
) |
||||||||||
Other-than-temporary impairment losses |
(67,161 |
) |
(56,578 |
) |
(1,332 |
) |
|||||||||
Portion recognized in other comprehensive income
(before taxes) |
32,708 |
26,854 |
(7,780 |
) |
|||||||||||
Net impairment losses recognized in earnings |
(34,453 |
) |
(29,724 |
) |
(9,112 |
) |
|||||||||
Other income |
417,155 |
321,019 |
325,411 |
||||||||||||
Total revenues |
5,952,069 |
4,759,016 |
4,312,667 |
||||||||||||
Benefits and expenses |
|||||||||||||||
Benefits and settlement expenses, net of
reinsurance ceded: (2019 $1,244,379; 2018 $1,185,929; 2017 $1,235,227) |
4,256,062 |
3,511,252 |
2,955,005 |
||||||||||||
Amortization of deferred policy acquisition costs and
value of business acquired |
175,653 |
226,066 |
79,443 |
||||||||||||
Other operating expenses, net of reinsurance ceded:
(2019 $229,851; 2018 $210,816; 2017 $226,578) |
836,906 |
774,110 |
814,211 |
||||||||||||
Total benefits and expenses |
5,268,621 |
4,511,428 |
3,848,659 |
||||||||||||
Income before income tax |
683,448 |
247,588 |
464,008 |
||||||||||||
Income tax expense (benefit) |
|||||||||||||||
Current |
390,314 |
123,624 |
36,565 |
||||||||||||
Deferred |
(259,850 |
) |
(69,963 |
) |
(754,974 |
) |
|||||||||
Total income tax expense (benefit) |
130,464 |
53,661 |
(718,409 |
) |
|||||||||||
Net income |
$ |
552,984 |
$ |
193,927 |
$ |
1,182,417 |
See Notes to Consolidated Financial Statements
F-3
PROTECTIVE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Net income |
$ |
552,984 |
$ |
193,927 |
$ |
1,182,417 |
|||||||||
Other comprehensive income (loss): |
|||||||||||||||
Change in net unrealized gains (losses) on investments,
net of income tax: (2019 $753,312; 2018 $(375,256); 2017 $332,593) |
2,833,888 |
(1,411,674 |
) |
705,859 |
|||||||||||
Reclassification adjustment for investment amounts
included in net income, net of income tax: (2019 $(2,784); 2018 $4,174; 2017 $(397)) |
(10,474 |
) |
15,699 |
(944 |
) |
||||||||||
Change in net unrealized gains (losses) relating to
other-than-temporary impaired investments for which a portion has been recognized in earnings, net of income tax: (2019 $(950); 2018 $(5,517); 2017 $762) |
(3,574 |
) |
(20,751 |
) |
391 |
||||||||||
Change in accumulated (loss) gain derivatives,
net of income tax: (2019 $(2,600); 2018 $(501); 2017 $(303)) |
(9,781 |
) |
(1,884 |
) |
(563 |
) |
|||||||||
Reclassification adjustment for derivative amounts
included in net income, net of income tax: (2019 $479; 2018 $301; 2017 $243) |
1,799 |
1,130 |
451 |
||||||||||||
Total other comprehensive income (loss) |
2,811,858 |
(1,417,480 |
) |
705,194 |
|||||||||||
Total comprehensive income (loss) |
$ |
3,364,842 |
$ |
(1,223,553 |
) |
$ |
1,887,611 |
See Notes to Consolidated Financial Statements
F-4
PROTECTIVE LIFE INSURANCE COMPANY
CONSOLIDATED BALANCE SHEETS
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Assets |
|||||||||||
Fixed maturities, at fair value (amortized cost: 2019 $63,268,660; 2018 $54,233,151) |
$ |
66,043,992 |
$ |
51,679,226 |
|||||||
Fixed maturities, at amortized cost (fair value: 2019 $3,025,790; 2018 $2,547,210) |
2,823,881 |
2,633,474 |
|||||||||
Equity securities, at fair value (cost: 2019 $534,463; 2018 $589,221) |
553,720 |
557,708 |
|||||||||
Mortgage loans (related to securitizations: 2019 $; 2018 $134) |
9,379,401 |
7,724,733 |
|||||||||
Investment real estate, net of accumulated depreciation (2019 $203; 2018 $251) |
10,321 |
6,816 |
|||||||||
Policy loans |
1,675,121 |
1,695,886 |
|||||||||
Other long-term investments |
2,479,520 |
798,342 |
|||||||||
Short-term investments |
1,320,864 |
666,301 |
|||||||||
Total investments |
84,286,820 |
65,762,486 |
|||||||||
Cash |
171,752 |
151,400 |
|||||||||
Accrued investment income |
715,388 |
633,087 |
|||||||||
Accounts and premiums receivable |
174,202 |
97,033 |
|||||||||
Reinsurance receivables |
4,181,100 |
4,486,029 |
|||||||||
Deferred policy acquisition costs and value of business acquired |
3,519,555 |
3,026,330 |
|||||||||
Goodwill |
825,511 |
825,511 |
|||||||||
Other intangibles, net of accumulated amortization (2019 $253,759; 2018 $197,368) |
583,426 |
612,854 |
|||||||||
Property and equipment, net of accumulated depreciation (2019 $49,357; 2018 $30,989) |
211,745 |
183,843 |
|||||||||
Other assets |
499,309 |
377,845 |
|||||||||
Assets related to separate accounts |
|||||||||||
Variable annuity |
12,730,090 |
12,288,919 |
|||||||||
Variable universal life |
1,135,666 |
937,732 |
|||||||||
Reinsurance assumed |
11,443,105 |
|
|||||||||
Total assets |
$ |
120,477,669 |
$ |
89,383,069 |
|||||||
Liabilities |
|||||||||||
Future policy benefits and claims |
$ |
53,943,962 |
$ |
41,900,618 |
|||||||
Unearned premiums |
794,832 |
769,620 |
|||||||||
Total policy liabilities and accruals |
54,738,794 |
42,670,238 |
|||||||||
Stable value product account balances |
5,443,752 |
5,234,731 |
|||||||||
Annuity account balances |
14,289,907 |
13,720,081 |
|||||||||
Other policyholders' funds |
1,576,856 |
1,128,379 |
|||||||||
Other liabilities |
2,977,278 |
1,939,718 |
|||||||||
Income tax payable |
34,224 |
27,189 |
|||||||||
Deferred income taxes |
1,371,970 |
898,339 |
|||||||||
Debt |
968 |
1,319 |
|||||||||
Subordinated debt |
110,000 |
110,000 |
|||||||||
Non-recourse funding obligations |
3,082,753 |
2,888,329 |
|||||||||
Secured financing liabilities |
335,480 |
495,307 |
|||||||||
Liabilities related to separate accounts |
|||||||||||
Variable annuity |
12,730,090 |
12,288,919 |
|||||||||
Variable universal life |
1,135,666 |
937,732 |
|||||||||
Reinsurance assumed |
11,443,105 |
|
|||||||||
Total liabilities |
109,270,843 |
82,340,281 |
|||||||||
Commitments and contingencies Note 15 |
|||||||||||
Shareowner's equity |
|||||||||||
Preferred Stock; $1 par value, shares authorized: 2,000; Liquidation preference: $2,000 |
2 |
2 |
|||||||||
Common Stock, $1 par value, shares authorized and issued: 2019 and 2018 5,000,000 |
5,000 |
5,000 |
|||||||||
Additional paid-in-capital |
8,260,537 |
7,410,537 |
|||||||||
Retained earnings |
1,533,645 |
1,031,465 |
|||||||||
Accumulated other comprehensive income (loss): |
|||||||||||
Net unrealized gains (losses) on investments, net of income tax:
(2019 $(383,311); 2018 $(367,217)) |
1,441,978 |
(1,381,436 |
) |
||||||||
Net unrealized losses relating to other-than-temporary impaired investments for which a portion
has been recognized in earnings, net of income tax: (2019 $(7,004); 2018 $(6,054)) |
(26,347 |
) |
(22,773 |
) |
|||||||
Accumulated gain (loss) derivatives, net of income tax: (2019 $(2,123); 2018 $(2)) |
(7,989 |
) |
(7 |
) |
|||||||
Total shareowner's equity |
11,206,826 |
7,042,788 |
|||||||||
Total liabilities and shareowner's equity |
$ |
120,477,669 |
$ |
89,383,069 |
See Notes to Consolidated Financial Statements
F-5
PROTECTIVE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF SHAREOWNER'S EQUITY
Preferred
Stock |
Common
Stock |
Additional
Paid-in- Capital |
Retained
Earnings (Deficit) |
Accumulated
Other Comprehensive Income (Loss) |
Total
Shareowner's Equity |
||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||||||
Balance, December 31, 2016 |
$ |
2 |
$ |
5,000 |
$ |
7,422,407 |
$ |
(32,695 |
) |
$ |
(655,040 |
) |
$ |
6,739,674 |
|||||||||||||
Net income for 2017 |
1,182,417 |
1,182,417 |
|||||||||||||||||||||||||
Other comprehensive income |
705,194 |
705,194 |
|||||||||||||||||||||||||
Comprehensive income for 2017 |
1,887,611 |
||||||||||||||||||||||||||
Cumulative effect adjustments |
26,338 |
(26,338 |
) |
|
|||||||||||||||||||||||
Dividends paid to the parent
company |
(259,089 |
) |
(259,089 |
) |
|||||||||||||||||||||||
Return of capital |
(43,911 |
) |
(43,911 |
) |
|||||||||||||||||||||||
Balance, December 31, 2017 |
$ |
2 |
$ |
5,000 |
$ |
7,378,496 |
$ |
916,971 |
$ |
23,816 |
$ |
8,324,285 |
|||||||||||||||
Net income for 2018 |
193,927 |
193,927 |
|||||||||||||||||||||||||
Other comprehensive loss |
(1,417,480 |
) |
(1,417,480 |
) |
|||||||||||||||||||||||
Comprehensive loss for 2018 |
(1,223,553 |
) |
|||||||||||||||||||||||||
Cumulative effect adjustments |
(79,433 |
) |
(10,552 |
) |
(89,985 |
) |
|||||||||||||||||||||
Prior period adjustment |
32,041 |
32,041 |
|||||||||||||||||||||||||
Balance, December 31, 2018 |
$ |
2 |
$ |
5,000 |
$ |
7,410,537 |
$ |
1,031,465 |
$ |
(1,404,216 |
) |
$ |
7,042,788 |
||||||||||||||
Net income for 2019 |
552,984 |
552,984 |
|||||||||||||||||||||||||
Other comprehensive income |
2,811,858 |
2,811,858 |
|||||||||||||||||||||||||
Comprehensive income for 2019 |
3,364,842 |
||||||||||||||||||||||||||
Cumulative effect adjustments |
(50,804 |
) |
(50,804 |
) |
|||||||||||||||||||||||
Capital contributions from parent |
850,000 |
850,000 |
|||||||||||||||||||||||||
Balance, December 31, 2019 |
$ |
2 |
$ |
5,000 |
$ |
8,260,537 |
$ |
1,533,645 |
$ |
1,407,642 |
$ |
11,206,826 |
See Notes to Consolidated Financial Statements
F-6
PROTECTIVE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF CASH FLOWS
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Cash flows from operating activities |
|||||||||||||||
Net income |
$ |
552,984 |
$ |
193,927 |
$ |
1,182,417 |
|||||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
|||||||||||||||
Realized investment losses (gains) |
(177,086 |
) |
173,903 |
25,066 |
|||||||||||
Amortization of deferred policy acquisition costs and value of business acquired |
175,653 |
226,066 |
79,443 |
||||||||||||
Capitalization of deferred policy acquisition costs |
(407,556 |
) |
(446,594 |
) |
(335,603 |
) |
|||||||||
Depreciation and amortization expense |
74,216 |
67,125 |
61,740 |
||||||||||||
Deferred income tax |
(259,850 |
) |
(69,963 |
) |
(754,974 |
) |
|||||||||
Accrued income tax |
7,035 |
104,175 |
19,377 |
||||||||||||
Interest credited to universal life and investment products |
1,342,563 |
963,471 |
692,993 |
||||||||||||
Policy fees assessed on universal life and investment products |
(1,729,044 |
) |
(1,553,994 |
) |
(1,354,685 |
) |
|||||||||
Change in reinsurance receivables |
304,929 |
315,134 |
269,294 |
||||||||||||
Change in accrued investment income and other receivables |
(45,117 |
) |
50,112 |
(19,148 |
) |
||||||||||
Change in policy liabilities and other policyholders' funds of traditional life
and health products |
(543,963 |
) |
(550,367 |
) |
(331,880 |
) |
|||||||||
Trading securities: |
|||||||||||||||
Maturities and principal reductions of investments |
113,543 |
155,692 |
165,575 |
||||||||||||
Sale of investments |
399,288 |
493,141 |
281,441 |
||||||||||||
Cost of investments acquired |
(368,369 |
) |
(589,379 |
) |
(355,410 |
) |
|||||||||
Other net change in trading securities |
(47,635 |
) |
38,346 |
9,151 |
|||||||||||
Amortization of premiums and accretion of discounts on investments and
mortgage loans |
319,467 |
308,407 |
319,264 |
||||||||||||
Change in other liabilities |
408,700 |
103,465 |
265,595 |
||||||||||||
Other, net |
(28 |
) |
(15,655 |
) |
(45,961 |
) |
|||||||||
Net cash provided by (used in) operating activities |
119,730 |
(32,988 |
) |
173,695 |
|||||||||||
Cash flows from investing activities |
|||||||||||||||
Maturities and principal reductions of investments, available-for-sale |
1,980,966 |
1,189,366 |
695,349 |
||||||||||||
Sale of investments, available-for-sale |
4,242,259 |
2,573,826 |
1,801,173 |
||||||||||||
Cost of investments acquired, available-for-sale |
(6,421,411 |
) |
(4,865,104 |
) |
(4,013,245 |
) |
|||||||||
Change in investments, held-to-maturity |
(195,000 |
) |
81,000 |
47,000 |
|||||||||||
Mortgage loans: |
|||||||||||||||
New lendings |
(1,322,981 |
) |
(1,589,459 |
) |
(1,671,929 |
) |
|||||||||
Repayments |
1,016,899 |
1,068,552 |
923,347 |
||||||||||||
Change in investment real estate, net |
(3,366 |
) |
978 |
(104 |
) |
||||||||||
Change in policy loans, net |
64,767 |
51,218 |
34,625 |
||||||||||||
Change in other long-term investments, net |
(35,536 |
) |
(169,293 |
) |
(91,934 |
) |
|||||||||
Change in short-term investments, net |
(594,314 |
) |
(164,384 |
) |
(207,722 |
) |
|||||||||
Net unsettled security transactions |
(184,963 |
) |
13,384 |
(19,023 |
) |
||||||||||
Purchase of property and equipment |
(33,306 |
) |
(91,972 |
) |
(33,718 |
) |
|||||||||
Cash received (paid) related to reinsurance transactions |
(815,574 |
) |
38,456 |
|
|||||||||||
Net cash used in investing activities |
(2,301,560 |
) |
(1,863,432 |
) |
(2,536,181 |
) |
|||||||||
Cash flows from financing activities |
|||||||||||||||
Borrowings under subordinated debt |
|
110,000 |
|
||||||||||||
Issuance (repayment) of non-recourse funding obligations |
195,000 |
(63,890 |
) |
(16,070 |
) |
||||||||||
Secured financing liabilities |
(159,826 |
) |
(522,442 |
) |
220,028 |
||||||||||
Capital Contributions from parent/Dividends/Return of capital to the parent
company |
850,000 |
|
(303,000 |
) |
|||||||||||
Investment product and universal life deposits |
5,183,845 |
5,650,100 |
4,683,121 |
||||||||||||
Investment product and universal life withdrawals |
(3,865,961 |
) |
(3,304,415 |
) |
(2,256,981 |
) |
|||||||||
Other financing activities, net |
(876 |
) |
(388 |
) |
(196 |
) |
|||||||||
Net cash provided by financing activities |
2,202,182 |
1,868,965 |
2,326,902 |
||||||||||||
Change in cash |
20,352 |
(27,455 |
) |
(35,584 |
) |
||||||||||
Cash at beginning of period |
151,400 |
178,855 |
214,439 |
||||||||||||
Cash at end of period |
$ |
171,752 |
$ |
151,400 |
$ |
178,855 |
See Notes to Consolidated Financial Statements
F-7
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. BASIS OF PRESENTATION
Basis of Presentation
Protective Life Insurance Company (the "Company"), a stock life insurance company, was founded in 1907. The Company is a wholly owned subsidiary of Protective Life Corporation ("PLC"), an insurance holding company. On February 1, 2015, PLC became a wholly owned subsidiary of The Dai-ichi Life Insurance Company, Limited, a kabushiki kaisha organized under the laws of Japan (now known as Dai-ichi Life Holdings, Inc., "Dai-ichi Life"), when DL Investment (Delaware), Inc. a wholly owned subsidiary of Dai-ichi Life, merged with and into PLC (the "Merger"). Prior to February 1, 2015, PLC's stock was publicly traded on the New York Stock Exchange. Subsequent to the Merger date, PLC remained as an SEC registrant within the United States until January 23, 2020, when it suspended its reporting obligations with the SEC under the Securities Exchange Act of 1934. Subsequent to the Merger date, the Company has continued to be an SEC registrant for financial reporting purposes in the United States. The Company markets individual life insurance, credit life and disability insurance, guaranteed investment contracts, guaranteed funding agreements, fixed and variable annuities, and extended service contracts throughout the United States. The Company also maintains a separate segment devoted to the acquisition of insurance policies from other companies. PLC is a holding company with subsidiaries that provide financial services through the production, distribution, and administration of insurance and investment products.
These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). Such accounting principles differ from statutory reporting practices used by insurance companies in reporting to state regulatory authorities (see also Note 22, Statutory Reporting Practices and Other Regulatory Matters).
The operating results of companies in the insurance industry have historically been subject to significant fluctuations due to changing competition, economic conditions, interest rates, investment performance, insurance ratings, claims, persistency, and other factors.
During the fourth quarter of 2018, the Company recorded an adjustment related to prior periods to correct an error pertaining to the tax deductibility of certain deferred compensation following the Dai-ichi acquisition and application of purchase accounting in 2015. The adjustment resulted in a $32.0 million increase to goodwill, with a corresponding increase in additional paid-in-capital. The Company concluded that the adjustment was not quantitatively or qualitatively material to previously reported annual or interim periods or the current interim period. As a result, this adjustment was recorded by the Company within the presented annual consolidated financial statements for the year ended December 31, 2018.
During the second quarter of 2019, the Company recorded an adjustment related to prior periods to correct an error pertaining to the deferred policy acquisitions costs ("DAC") tax reimbursements paid under reinsurance agreements the Company entered in previous years. The adjustment resulted in an $8.96 million increase to accounts and premiums receivable on the Company's consolidated balance sheet, with a corresponding increase to other income. The Company concluded that the adjustment was not quantitatively or qualitatively material to previously reported periods or the second quarter of 2019 interim period. As a result, this adjustment was recorded by the Company within the consolidated financial statements as of and for the period ended June 30, 2019.
F-8
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. BASIS OF PRESENTATION (Continued)
Entities Included
The consolidated financial statements include the accounts of Protective Life Insurance Company and its affiliate companies in which the Company holds a majority voting or economic interest. Intercompany balances and transactions have been eliminated.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The most significant estimates include those used in determining deferred policy acquisition costs ("DAC") and related amortization periods, goodwill recoverability, value of business acquired ("VOBA"), investments and certain derivatives fair values, other-than-temporary impairments, future policy benefits, pension and other postretirement benefits, provisions for income taxes, reserves for contingent liabilities, reinsurance risk transfer assessments, and reserves for losses in connection with unresolved legal matters.
Significant Accounting Policies
Valuation of Investment Securities
The Company determines the appropriate classification of investment securities at the time of purchase and periodically re-evaluates such designations. Investment securities are classified as either trading, available-for-sale, or held-to-maturity securities. Investment securities classified as trading are recorded at fair value with changes in fair value recorded in realized gains (losses). Investment securities purchased for long term investment purposes are classified as available-for-sale and are recorded at fair value with changes in unrealized gains and losses, net of taxes, reported as a component of other comprehensive income (loss). Investment securities are classified as held-to-maturity when the Company has the intent and ability to hold the securities to maturity and are reported at amortized cost. Interest income on available-for-sale and held-to-maturity securities includes the amortization of premiums and accretion of discounts and are recorded in investment income.
The fair value of fixed maturity, short-term, and equity securities is determined by management after considering one of three primary sources of information: third party pricing services, non-binding independent broker quotations, or pricing matrices. Security pricing is applied using a "waterfall" approach whereby publicly available prices are first sought from third party pricing services, the remaining unpriced securities are submitted to independent brokers for non-binding prices, or lastly, securities are priced using a pricing matrix. Typical inputs used by these three pricing methods include, but are not limited to: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications. Based on the typical trading volumes and the lack of quoted market prices for available-for-sale and trading fixed maturities, third party pricing services derive the majority of security prices from observable market inputs such as recent reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information as
F-9
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
outlined above. If there are no recent reported trades, the third party pricing services and brokers may use matrix or model processes to develop a security price where future cash flow expectations are developed based upon collateral performance and discounted at an estimated market rate. Certain securities are priced via independent non-binding broker quotations. Where multiple broker quotes are obtained, the Company reviews the quotes and selects the quote that provides the best estimate of the price a market participant would pay for these specific assets in an arm's length transaction. A pricing matrix is used to price securities for which the Company is unable to obtain or effectively rely on either a price from a third party service or an independent broker quotation. Included in the pricing of other asset-backed securities, collateralized mortgage obligations ("CMOs"), and mortgage-backed securities ("MBS") are estimates of the rate of future prepayments of principal and underlying collateral support over the remaining life of the securities. Such estimates are derived based on the characteristics of the underlying structure and rates of prepayments previously experienced at the interest rate levels projected for the underlying collateral. The basis for the cost of securities sold was determined at the Committee on Uniform Securities Identification Procedures ("CUSIP") level on a first in first out basis. The committee supplies a unique nine-character identification, called a CUSIP number, for each class of security approved for trading in the U.S., to facilitate clearing and settlement. These numbers are used when any buy and sell orders are recorded.
Each quarter the Company reviews investments with unrealized losses and tests for other-than-temporary impairments. The Company analyzes various factors to determine if any specific other-than-temporary asset impairments exist. These include, but are not limited to: 1) actions taken by rating agencies, 2) default by the issuer, 3) the significance of the decline, 4) an assessment of the Company's intent to sell the security (including a more likely than not assessment of whether the Company will be required to sell the security) before recovering the security's amortized cost, 5) the duration of the decline, 6) an economic analysis of the issuer's industry, and 7) the financial strength, liquidity, and recoverability of the issuer. Management performs a security by security review each quarter in evaluating the need for any other-than-temporary impairments. Although no set formula is used in this process, the investment performance, collateral position, and continued viability of the issuer are significant measures considered, and in some cases, an analysis regarding the Company's expectations for recovery of the security's entire amortized cost basis through the receipt of future cash flows is performed. Once a determination has been made that a specific other-than-temporary impairment exists, the security's basis is adjusted and an other-than-temporary impairment is recognized. Other-than-temporary impairments to debt securities that the Company does not intend to sell and does not expect to be required to sell before recovering the security's amortized cost are written down to discounted expected future cash flows ("post impairment cost") and credit losses are recorded in earnings. The difference between the securities' discounted expected future cash flows and the fair value of the securities on the impairment date is recognized in other comprehensive income (loss) as a non-credit portion impairment. When calculating the post impairment cost for residential mortgage-backed securities ("RMBS"), commercial mortgage-backed securities ("CMBS"), and other asset-backed securities (collectively referred to as asset-backed securities or "ABS"), the Company considers all known market data related to cash flows to estimate future cash flows. When calculating the post impairment cost for corporate debt securities, the Company considers all contractual cash flows to estimate expected future cash flows. To calculate the post impairment cost, the expected future cash flows are discounted at the original purchase yield. Debt securities that the
F-10
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Company intends to sell or expects to be required to sell before recovery are written down to fair value with the change recognized in earnings.
Cash
Cash includes all demand deposits reduced by the amount of outstanding checks and drafts. As a result of the Company's cash management system, checks issued from a particular bank but not yet presented for payment may create negative book cash balances with the bank at certain reporting dates. Such negative balances are included in other liabilities and were $183.7 million as of December 31, 2019 and $153.3 million as of December 31, 2018, respectively. The Company has deposits with certain financial institutions which exceed federally insured limits. The Company has reviewed the creditworthiness of these financial institutions and believes there is minimal risk of a material loss.
Policy Loans
Policy loans are stated at unpaid principal balances. Interest income is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy's anniversary date. Any unpaid principal and accrued interest is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy.
Deferred Policy Acquisition Costs
The incremental direct costs associated with successfully acquired insurance policies, are deferred to the extent such costs are deemed recoverable from future profits. Such costs include commissions and other costs of acquiring traditional life and health insurance, credit insurance, universal life insurance, and investment products. DAC are subject to recoverability testing at the end of each accounting period. Traditional life and health insurance acquisition costs are amortized over the premium-payment period of the related policies in proportion to the ratio of annual premium income to the present value of the total anticipated premium income. Credit insurance acquisition costs are being amortized in proportion to earned premium. Acquisition costs for universal life and investment products are amortized over the lives of the policies in relation to the present value of estimated gross profits before amortization. Acquisition costs for stable value contracts are amortized over the term of the contracts using the effective yield method.
The Company makes certain assumptions regarding the mortality, persistency, expenses, and interest rates (equal to the rate used to compute liabilities for future policy benefits, currently 1.00% to 7.08%) the Company expects to experience in future periods when determining the present value of estimated gross profits. These assumptions are best estimates and are periodically updated whenever actual experience and/or expectations for the future change from that assumed. Additionally, these costs have been adjusted by an amount equal to the amortization that would have been recorded if unrealized gains or losses on investments associated with our universal life and investment products had been realized.
Value of Businesses Acquired
In conjunction with the Merger and the acquisition of insurance policies or investment contracts, a portion of the purchase price is allocated to the right to receive future gross profits from cash flows and
F-11
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
earnings of associated insurance policies and investment contracts. This intangible asset, called VOBA, is based on the actuarially estimated present value of future cash flows from associated insurance policies and investment contracts acquired. The estimated present value of future cash flows used in the calculation of the VOBA is based on certain assumptions, including mortality, persistency, expenses, and interest rates that the Company believes to be those of a market participant. The Company amortizes VOBA in proportion to gross premiums for traditional life products, or estimated gross margins ("EGMs") for participating traditional life products within the MONY Life Insurance Company ("MONY") block. For interest sensitive products, the Company uses various amortization bases including expected gross profits ("EGPs"), revenues, account values, or insurance in-force. VOBA is subject to annual recoverability testing.
Included within the deferred policy acquisition costs and value of business acquired line of the Company's consolidated balance sheets are amounts related to certain contracts or blocks of business that have negative VOBA. These amounts are presented on a net basis with positive VOBA amounts within this line on the Company's consolidated balance sheets. Negative VOBA is amortized over the life of the related policies based on the amount of insurance in-force (for life insurance) or account values (for annuities). Such amortization is recorded in the amortization of deferred policy acquisition costs and value of business acquired line of the Company's consolidated statements of income on a net basis with any positive VOBA amortization.
Intangible Assets
Intangible assets with definite lives are amortized over the estimated useful life of the asset and reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Amortizable intangible assets primarily consist of distribution relationships, trade names, technology, and software. Intangible assets with indefinite lives, primarily insurance licenses, are not amortized, but are reviewed for impairment on an annual basis or whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Software is generally amortized over a three five year useful life.
Intangible assets recognized by the Company included the following (excluding goodwill):
As of December 31, |
Estimated |
||||||||||||||
2019 |
2018 |
Useful Life |
|||||||||||||
(Dollars In Thousands) |
(In Years) |
||||||||||||||
Distribution relationships |
$ |
366,423 |
$ |
377,441 |
14-22 |
||||||||||
Trade names |
71,918 |
78,629 |
13-17 |
||||||||||||
Technology |
85,454 |
93,433 |
7-14 |
||||||||||||
Other |
27,631 |
31,351 |
|||||||||||||
Total intangible assets subject to amortization |
551,426 |
580,854 |
|||||||||||||
Insurance licenses |
32,000 |
32,000 |
Indefinite |
||||||||||||
Total intangible assets |
$ |
583,426 |
$ |
612,854 |
Identified intangible assets were valued using the excess earnings method, relief from royalty method or cost approach, as appropriate.
F-12
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Amortizable intangible assets will be amortized straight line over their assigned useful lives. The following is a schedule of future estimated aggregate amortization expense:
Year |
Amount |
||||||
(Dollars In Thousands) |
|||||||
2020 |
$ |
54,350 |
|||||
2021 |
51,746 |
||||||
2022 |
48,206 |
||||||
2023 |
46,519 |
||||||
2024 |
45,406 |
Property and Equipment
In conjunction with the Merger, property and equipment was recorded at fair value as of the Merger date and will be depreciated from this basis in future periods based on the respective estimated useful lives. Real estate assets were recorded at appraised values as of the acquisition date. The Company has estimated the remaining useful life of the home office building, as of the date of the Merger, to be 25 years. Land is not depreciated.
The Company depreciates its assets using the straight-line method over the estimated useful lives of the assets. The Company's furniture is depreciated over a ten year useful life, office equipment and machines are depreciated over a five year useful life, and computers are depreciated over a four year useful life. Major repairs or improvements are capitalized and depreciated over the estimated useful lives of the assets. Other repairs are expensed as incurred. The cost and related accumulated depreciation of property and equipment sold or retired are removed from the accounts, and resulting gains or losses are included in income.
In 2019, the Company adopted Accounting Standards Update ("ASU" or "Update") No. 2016-02 Leases which addressed certain aspects of recognition, measurement, presentation, and disclosure of leases. The Update required all leases with terms greater than 12 months to be recorded on the balance sheet in the form of a lease asset and liability. The Company recorded a cumulative effect adjustment as of the date of adoption, January 1, 2019, establishing a right of use asset and lease liability of $18.2 million on its consolidated balance sheet reflected in the property and equipment, net of accumulated depreciation and other liabilities line items, respectively.
Property and equipment consisted of the following:
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Home office building |
$ |
153,456 |
$ |
144,669 |
|||||||
Data processing equipment |
37,303 |
28,793 |
|||||||||
Capital leases |
24,941 |
1,863 |
|||||||||
Other, principally furniture and equipment |
20,482 |
14,587 |
|||||||||
Total property and equipment subject to depreciation |
236,182 |
189,912 |
|||||||||
Accumulated depreciation |
(49,357 |
) |
(30,989 |
) |
|||||||
Land |
24,920 |
24,920 |
|||||||||
Total property and equipment |
$ |
211,745 |
$ |
183,843 |
F-13
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Separate Accounts
The separate account assets represent funds for which the Company does not bear the investment risk. These assets are carried at fair value and are equal to the separate account liabilities, which represent the policyholder's equity in those assets. The investment income and investment gains and losses on the separate account assets accrue directly to the policyholder. These amounts are reported separately as assets and liabilities related to separate accounts in the accompanying consolidated financial statements. Amounts assessed against policy account balances for the costs of insurance, policy administration, and other services are included in premiums and policy fees in the accompanying consolidated statements of income. Fees are generally based on the daily net assets of the policyholder's account value and recognized as revenue when assessed. Beginning in 2019, assets and liabilities related to separate accounts include balances related to separate accounts assumed through reinsurance. These balances relate to variable annuity and variable life policies that we have reinsured on a modified coinsurance basis.
Stable Value Product Account Balances
The Stable Value Products segment sells fixed and floating rate funding agreements directly to qualified institutional investors. The segment also issues funding agreements to the Federal Home Loan Bank ("FHLB"), and markets guaranteed investment contracts ("GICs") to 401(k) and other qualified retirement savings plans. GICs are contracts which specify a return on deposits for a specified period and often provide flexibility for withdrawals at book value in keeping with the benefits provided by the plan.
The Company records its stable value contract liabilities in the consolidated balance sheets in stable value product account balances at the deposit amount plus accrued interest, adjusted for any unamortized premium or discount. Interest on the contracts is accrued based upon contract terms. Any premium or discount is amortized using the effective yield method.
The segment's products complement the Company's overall asset/liability management in that the terms may be tailored to the needs of the Company as the seller of the contracts. Stable value product account balances include GICs and funding agreements the Company has issued. As of December 31, 2019 and 2018, the Company had $3,876.6 million and $4,083.8 million, respectively, of stable value product account balances marketed through structured programs. Most of the Company's outstanding GICs and funding agreements have maturities of one to twelve years.
As of December 31, 2019, future maturities of stable value products were as follows:
Year of Maturity |
Amount |
||||||
(Dollars In Millions) |
|||||||
2020 |
$ |
1,765.2 |
|||||
2021-2022 |
2,535.1 |
||||||
2023-2024 |
1,029.1 |
||||||
Thereafter |
114.0 |
Derivative Financial Instruments
GAAP requires that all derivative instruments be recognized in the balance sheet at fair value. The Company records its derivative financial instruments in the consolidated balance sheet in other long-term investments and other liabilities. The change in the fair value of derivative financial
F-14
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
instruments is reported either in the statement of income or in the statement of other comprehensive income (loss), depending upon whether the derivative instrument qualified for and also has been properly identified as being part of a hedging relationship, and also on the type of hedging relationship that exists. For cash flow hedges, the effective portion of their gain or loss is reported as a component of other comprehensive income (loss) and reclassified into earnings in the period during which the hedged item impacts earnings. Any remaining gain or loss, the ineffective portion, is recognized in current earnings. For fair value hedge derivatives, their gain or loss as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings. Effectiveness of the Company's hedge relationships is assessed on a quarterly basis. The Company reports changes in fair values of derivatives that are not part of a qualifying hedge relationship in earnings. Changes in the fair value of derivatives that are recognized in current earnings are reported in Realized investment gains (losses). For additional information, see Note 7, Derivative Financial Instruments.
Insurance Liabilities and Reserves
Establishing an adequate liability for the Company's obligations to policyholders requires the use of certain assumptions. Estimating liabilities for future policy benefits on life and health insurance products requires the use of assumptions relative to future investment yields, mortality, morbidity, persistency, and other assumptions based on the Company's historical experience, modified as necessary to reflect anticipated trends and to include provisions for possible adverse deviation. Determining liabilities for the Company's property and casualty insurance products also requires the use of assumptions, including the projected levels of used vehicle prices, the frequency and severity of claims, and the effectiveness of internal processes designed to reduce the level of claims. The Company's results depend significantly upon the extent to which its actual claims experience is consistent with the assumptions the Company used in determining its reserves and pricing its products. The Company's reserve assumptions and estimates require significant judgment and, therefore, are inherently uncertain. The Company cannot determine with precision the ultimate amounts that it will pay for actual claims or the timing of those payments.
Guaranteed Living Withdrawal Benefits
The Company also establishes reserves for guaranteed living withdrawal benefits ("GLWB") on its variable annuity ("VA") products. The GLWB is valued in accordance with FASB guidance under the ASC Derivatives and Hedging Topic which utilizes the valuation technique prescribed by the ASC Fair Value Measurements and Disclosures Topic, which requires the embedded derivative to be recorded at fair value using current interest rates and implied volatilities for the equity indices. The fair value of the GLWB is impacted by equity market conditions and can result in the GLWB embedded derivative being in an overall net asset or net liability position. In times of favorable equity market conditions the likelihood and severity of claims is reduced and expected fee income increases. Since claims are generally expected later than fees, these favorable equity market conditions can result in the present value of fees being greater than the present value of claims, which results in a net GLWB embedded derivative asset. In times of unfavorable equity market conditions the likelihood and severity of claims is increased and expected fee income decreases and can result in the present value of claims exceeding the present value of fees resulting in a net GLWB embedded derivative liability. The methods used to estimate the embedded derivative employ assumptions about mortality, lapses, policyholder behavior, equity market returns, interest rates, and market volatility. The Company
F-15
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
assumes age-based mortality from the Ruark 2015 ALB table adjusted for company experience. Differences between the actual experience and the assumptions used result in variances in profit and could result in losses. The Company reinsures certain risks associated with the GLWB to Shades Creek Captive Insurance ("Shades Creek"), a direct wholly owned insurance subsidiary of PLC. As of December 31, 2019 and 2018, the Company's net GLWB liability held, including the impact of reinsurance, was $186.0 million and $43.3 million, respectively.
Goodwill
The balance recognized as goodwill is not amortized, but is reviewed for impairment on an annual basis, or more frequently as events or circumstances may warrant, including those circumstances which would more likely than not reduce the fair value of the Company's reporting units below its carrying amount. Accounting for goodwill requires an estimate of the future profitability of the associated lines of business within the Company's operating segments to assess the recoverability of the capitalized goodwill. The Company's material goodwill balances are attributable to certain of its operating segments (which are each considered to be reporting units). The Company evaluates the carrying value of goodwill at the segment (or reporting unit) level at least annually and between annual evaluations if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Such circumstances could include, but are not limited to: 1) a significant adverse change in legal factors or in business climate, 2) unanticipated competition, or 3) an adverse action or assessment by a regulator. When evaluating whether goodwill is impaired, the Company first determines through qualitative analysis whether relevant events and circumstances indicate that it is more likely than not that segment goodwill balances are impaired as of the testing date. If the qualitative analysis does not indicate that an impairment of segment goodwill is more likely than not then no other specific quantitative impairment testing is required.
If it is determined that it is more likely than not that impairment exists, the Company performs a quantitative assessment and compares its estimate of the fair value of the reporting unit to which the goodwill is assigned to the reporting unit's carrying amount, including goodwill. The Company utilizes a fair value measurement (which includes a discounted cash flows analysis) to assess the carrying value of the reporting units in consideration of the recoverability of the goodwill balance assigned to each reporting unit as of the measurement date. The cash flows used to determine the fair value of the Company's reporting units are dependent on a number of significant assumptions. The Company's estimates, which consider a market participant view of fair value, are subject to change given the inherent uncertainty in predicting future results and cash flows, which are impacted by such things as policyholder behavior, competitor pricing, capital limitations, new product introductions, and specific industry and market conditions.
Income Taxes
The Company's income tax returns are included in PLC's consolidated U.S. income tax return.
On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (the "Tax Reform Act"). Further information on the tax impacts of the Tax Reform Act is included in Note 19, Income Taxes.
The Company uses the asset and liability method of accounting for income taxes. Generally, most items in pretax book income are also included in taxable income in the same year. However, some
F-16
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
items are recognized for book purposes and for tax purposes in different years or are never recognized for either book or tax purposes. Those differences that will never be recognized for either book or tax purposes are permanent differences (e.g., the investment income not subject to tax). As a result, the effective tax rate reflected in the financial statements may differ from the statutory rate reflected in the tax return. Those differences that are reported in different years for book and tax purposes are temporary and will reverse over time (e.g., the valuation of future policy benefits). These temporary differences are accounted for in the intervening periods as deferred tax assets and liabilities. Deferred tax assets generally represent revenue that is taxable before it is recognized in financial income and expenses that are deductible after they are recognized in financial income. Deferred tax liabilities generally represent revenues that are taxable after they are recognized in financial income or expenses or losses that are deductible before they are recognized in financial income. Components of accumulated other comprehensive income (loss) ("AOCI") are presented net of tax, and it is the Company's policy to use the aggregate portfolio approach to clear the disproportionate tax effects that remain in AOCI as a result of tax rate changes and certain other events. Under the aggregate portfolio approach, disproportionate tax effects are cleared only when the portfolio of investments that gave rise to the deferred tax item is sold or otherwise disposed of in its entirety.
The application of GAAP requires the Company to evaluate the recoverability of the Company's deferred tax assets and establish a valuation allowance, if necessary, to reduce the Company's deferred tax assets to an amount that is more likely than not to be realized. Considerable judgment is required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. In evaluating the need for a valuation allowance the Company may consider many factors, including: (1) the nature of the deferred tax assets and liabilities; (2) whether they are ordinary or capital; (3) in which tax jurisdictions they were generated and the timing of their reversal; (4) taxable income in prior carryback years as well as projected taxable earnings exclusive of reversing temporary differences and carryforwards; (5) the length of time that carryovers can be utilized in the various taxing jurisdictions; (6) any unique tax rules that would impact the utilization of the deferred tax assets; and (7) any tax planning strategies that the Company would employ to avoid a tax benefit from expiring unused. Although realization is not assured, management believes it is more likely than not that the deferred tax assets, net of valuation allowances, will be realized.
GAAP prescribes a comprehensive model for how a company should recognize, measure, present, and disclose in its financial statements uncertain tax positions that a company has taken or expects to take on tax returns. The application of this guidance is a two-step process, the first step being recognition. The Company determines whether it is more likely than not, based on the technical merits, that the tax position will be sustained upon examination. If a tax position does not meet the more likely than not recognition threshold, the benefit of that position is not recognized in the financial statements. The second step is measurement. The Company measures the tax position as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate resolution with a taxing authority that has full knowledge of all relevant information. This measurement considers the amounts and probabilities of the outcomes that could be realized upon ultimate settlement using the facts, circumstances, and information available at the reporting date.
The Company's liability for income taxes includes the liability for unrecognized tax benefits which relate to tax years still subject to review by the Internal Revenue Service ("IRS") or other taxing jurisdictions. Audit periods remain open for review until the statute of limitations expires. Generally, for tax years
F-17
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
which produce net operating losses, capital losses or tax credit carryforwards, the statute of limitations does not close until the expiration of the statute of limitations for the tax year in which they are fully utilized. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the liability for income taxes. The Company classifies all interest and penalties related to tax uncertainties as income tax expense. See Note 19, Income Taxes, for additional information regarding income taxes.
Variable Interest Entities
The Company holds certain investments in entities in which its ownership interests could possibly be considered variable interests under Topic 810 of the FASB ASC (excluding debt and equity securities held as trading, available-for-sale, or held-to-maturity). The Company reviews the characteristics of each of these applicable entities and compares those characteristics to applicable criteria to determine whether the entity is a Variable Interest Entity ("VIE"). If the entity is determined to be a VIE, the Company then performs a detailed review to determine whether the interest would be considered a variable interest under the guidance. The Company then performs a qualitative review of all variable interests with the entity and determines whether the Company is the primary beneficiary. ASC 810 provides that an entity is the primary beneficiary of a VIE if the entity has 1) the power to direct the activities of the VIE that most significantly impact the VIE's economic performance, and 2) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the entity that could potentially be significant to the VIE, which is recorded on the balance sheet as fixed maturities at amortized cost. For more information on the Company's investment in a VIE refer to Note 5, Investment Operations, to the consolidated financial statements.
Policyholder Liabilities, Revenues, and Benefits Expense
Future Policy Benefits and Claims
Future policy benefit liabilities for the years indicated are as follows:
As of December 31, |
|||||||||||||||||||
2019 |
2018 |
2019 |
2018 |
||||||||||||||||
Total Policy Liabilities
and Accruals |
Reinsurance
Receivable |
||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
Life and annuity benefit reserves |
$ |
52,478,019 |
$ |
40,883,229 |
$ |
3,279,374 |
$ |
3,573,500 |
|||||||||||
Unpaid life claim liabilities |
810,585 |
654,077 |
373,942 |
383,620 |
|||||||||||||||
Life and annuity future policy benefits |
53,288,604 |
41,537,306 |
3,653,316 |
3,957,120 |
|||||||||||||||
Other policy benefits reserves |
422,579 |
142,855 |
69,316 |
80,688 |
|||||||||||||||
Other policy benefits unpaid claim liabilities |
232,779 |
220,457 |
170,603 |
175,591 |
|||||||||||||||
Future policy benefits and claims and
associated reinsurance receivable |
53,943,962 |
41,900,618 |
3,893,235 |
4,213,399 |
|||||||||||||||
Unearned premiums |
794,832 |
769,620 |
287,865 |
272,630 |
|||||||||||||||
Total policy liabilities and accruals and
associated reinsurance receivable |
$ |
54,738,794 |
$ |
42,670,238 |
$ |
4,181,100 |
$ |
4,486,029 |
F-18
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Liabilities for life and annuity benefit reserves consist of liabilities for traditional life insurance, cash values associated with universal life insurance, immediate annuity benefit reserves, and other benefits associated with life and annuity benefits. The unpaid life claim liabilities consist of current pending claims as well as an estimate of incurred but not reported life insurance claims.
Other policy benefit reserves consist of certain health insurance policies that are in runoff. The unpaid claim liabilities associated with other policy benefits includes current pending claims, the present value of estimated future claim payments for policies currently receiving benefits and an estimate of claims incurred but not yet reported.
Traditional Life, Health, and Credit Insurance Products
Traditional life insurance products consist principally of those products with fixed and guaranteed premiums and benefits, and they include whole life insurance policies, term and term-like life insurance policies, limited payment life insurance policies, and certain annuities with life contingencies. In accordance with ASC 805, the liabilities for future policy benefits on traditional life insurance products, when combined with the associated VOBA, were recorded at fair value on the date of the Merger. These values, subsequent to the Merger, are computed using assumptions that include interest rates, mortality, lapse rates, expense estimates, and other assumptions based on the Company's experience, modified as necessary to reflect anticipated trends and to include provisions for possible adverse deviation.
Liabilities for future policy benefits on traditional life insurance products have been computed using a net level method including assumptions as to investment yields, mortality, persistency, and other assumptions based on the Company's experience, modified as necessary to reflect anticipated trends and to include provisions for possible adverse deviation. Reserve investment yield assumptions on December 31, 2019, range from approximately 2.50% to 5.50%. The liability for future policy benefits and claims on traditional life, health, and credit insurance products includes estimated unpaid claims that have been reported to us and claims incurred but not yet reported. Policy claims are charged to expense in the period in which the claims are incurred.
Traditional life insurance premiums are recognized as revenue when due. Health and credit insurance premiums are recognized as revenue over the terms of the policies. Benefits and expenses are associated with earned premiums so that profits are recognized over the life of the contracts. This is accomplished by means of the provision for liabilities for future policy benefits and the amortization of DAC and VOBA. Gross premiums in excess of net premiums related to immediate annuities are deferred and recognized over the life of the policy.
Universal Life and Investment Products
Universal life and investment products include universal life insurance, guaranteed investment contracts, guaranteed funding agreements, deferred annuities, and annuities without life contingencies. Premiums and policy fees for universal life and investment products consist of fees that have been assessed against policy account balances for the costs of insurance, policy administration, and surrenders. Such fees are recognized when assessed and earned. Benefit reserves for universal life and investment products represent policy account balances before applicable surrender charges plus
F-19
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
certain deferred policy initiation fees that are recognized in income over the term of the policies. Policy benefits and claims that are charged to expense include benefit claims incurred in the period in excess of related policy account balances and interest credited to policy account balances. Interest rates credited to universal life products ranged from 1.0% to 8.75% and investment products ranged from 0.18% to 11.25% in 2019.
The Company establishes liabilities for fixed indexed annuity ("FIA") products. These products are deferred fixed annuities with a guaranteed minimum interest rate plus a contingent return based on equity market performance. The FIA product is considered a hybrid financial instrument under the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC" or "Codification") Topic 815 Derivatives and Hedging which allows the Company to make the election to value the liabilities of these FIA products at fair value. This election was made for the FIA products issued prior to 2010 as the policies were issued. These products are no longer being marketed. The future changes in the fair value of the liability for these FIA products are recorded in Benefit and settlement expenses with the liability being recorded in Annuity account balances. For more information regarding the determination of fair value of annuity account balances please refer to Note 6, Fair Value of Financial Instruments. Premiums and policy fees for these FIA products consist of fees that have been assessed against the policy account balances for surrenders. Such fees are recognized when assessed and earned.
The Company currently markets a deferred fixed annuity with a guaranteed minimum interest rate plus a contingent return based on equity market performance and the products are considered hybrid financial instruments under the FASB's ASC Topic 815 Derivatives and Hedging. The Company did not elect to value these FIA products at fair value. As a result, the Company accounts for the provision that provides for a contingent return based on equity market performance as an embedded derivative. The embedded derivative is bifurcated from the host contract and recorded at fair value in Other liabilities. Changes in the fair value of the embedded derivative are recorded in Realized investment gains (losses). For more information regarding the determination of fair value of the FIA embedded derivative refer to Note 6, Fair Value of Financial Instruments. The host contract is accounted for as a UL Type insurance contract in accordance with ASC Topic 944 Financial Services-Insurance and is recorded in Annuity account balances with any discount to the minimum account value being accreted using the effective yield method.
The Company markets universal life products with a guaranteed minimum interest rate plus a contingent return based on equity market performance and the products are considered hybrid financial instruments under the FASB's ASC Topic 815 Derivatives and Hedging. The Company did not elect to value these indexed universal life ("IUL") products at fair value prior to the Merger date. As a result, the Company accounts for the provision that provides for a contingent return based on equity market performance as an embedded derivative. The embedded derivative is bifurcated from the host contract and recorded at fair value in Other liabilities. Changes in the fair value of the embedded derivative are recorded in Realized investment gains (losses). For more information regarding the determination of fair value of the IUL embedded derivative refer to Note 6, Fair Value of Financial Instruments. The host contract is accounted for as a debt instrument in accordance with ASC Topic 944 Financial Services Insurance and is recorded in Future policy benefits and claims with any discount to the minimum account value being accreted using the effective yield method.
F-20
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Benefits and settlement expenses include accrued interest and benefit claims incurred during the period.
The Company's accounting policies with respect to variable universal life ("VUL") and VA are identical to those noted above for universal life and investment products except that policy account balances (excluding account balances that earn a fixed rate) are valued at fair value and reported as components of assets and liabilities related to separate accounts.
The Company establishes liabilities for guaranteed minimum death benefits ("GMDB") on its VA products. The methods used to estimate the liabilities employ assumptions about mortality and the performance of equity markets. The Company assumes age-based mortality from the Ruark 2015 ALB table adjusted for company experience. Future declines in the equity market would increase the Company's GMDB liability. Differences between the actual experience and the assumptions used result in variances in profit and could result in losses. Our GMDB, as of December 31, 2019, is subject to a dollar-for-dollar reduction upon withdrawal of related annuity deposits on contracts issued prior to January 1, 2003. The Company reinsures certain risks associated with the GMDB to Shades Creek. As of December 31, 2019 and 2018, the GMDB reserve, including the impact of reinsurance, was $30.2 million and $34.7 million.
Property and Casualty Insurance Products
Property and casualty insurance products include service contract business, surety bonds, and guaranteed asset protection ("GAP"). Premiums and fees associated with service contracts and GAP products are recognized based on expected claim patterns. For all other products, premiums are generally recognized over the terms of the contract on a pro-rata basis. Commissions and fee income associated with other products are recognized as earned when the related services are provided to the customer. Unearned premium reserves are maintained for the portion of the premiums that is related to the unexpired period of the policy. Such reserves are computed by pro rata methods or methods related to anticipated claims. Benefit reserves are recorded when insured events occur. Benefit reserves include case basis reserves for known but unpaid claims as of the balance sheet date as well as incurred but not reported ("IBNR") reserves for claims where the insured event has occurred but has not been reported to the Company as of the balance sheet date. The case basis reserves and IBNR are calculated based on historical experience and on assumptions relating to claim severity and frequency, the level of used vehicle prices, and other factors. These assumptions are modified as necessary to reflect anticipated trends.
Effective January 1, 2018, the Company adopted Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers. In consideration of the amendments in this Update, the Company revised its recognition pattern for administrative fees associated with certain vehicle service and GAP products. Previously, these fees were recognized based on the work effort involved in satisfying the Company's contract obligations. The Company has recognized these fees on a claims occurrence basis in future periods. To reflect this change in accounting principle, the Company recorded a cumulative effect adjustment as of January 1, 2018 that resulted in a decrease in retained
F-21
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
earnings of $90.0 million. The pre-tax impact to each affected line item on the Company's financial statements is reflected in the table below:
As of December 31, 2018 |
|||||||||||
As
Reported |
Previous
Accounting Method |
||||||||||
(Dollars In Millions) |
|||||||||||
Financial Statement Line Item: |
|||||||||||
Balance Sheet |
|||||||||||
Deferred policy acquisition costs and value of business acquired |
$ |
3,026.3 |
$ |
2,887.3 |
|||||||
Other liabilities |
$ |
1,939.7 |
$ |
1,683.3 |
|||||||
For The Year Ended
December 31, 2018 |
|||||||||||
As
Reported |
Previous
Accounting Method |
||||||||||
(Dollars In Millions) |
|||||||||||
Financial Statement Line Item: |
|||||||||||
Statements of Income |
|||||||||||
Other income |
$ |
321.0 |
$ |
322.1 |
|||||||
Amortization of deferred policy acquisition costs and
value of business acquired |
$ |
226.1 |
$ |
178.1 |
|||||||
Other operating expenses, net of reinsurance ceded |
$ |
774.1 |
$ |
825.1 |
Reinsurance
The Company uses reinsurance extensively in certain of its segments and accounts for reinsurance and the recognition of the impact of reinsurance costs in accordance with the ASC Financial Services Insurance Topic. The following summarizes some of the key aspects of the Company's accounting policies for reinsurance.
Reinsurance Accounting Methodology Ceded premiums of the Company's traditional life insurance products are treated as an offset to direct premium and policy fee revenue and are recognized when due to the assuming company. Ceded claims are treated as an offset to direct benefits and settlement expenses and are recognized when the claim is incurred on a direct basis. Ceded policy reserve changes are also treated as an offset to benefits and settlement expenses and are recognized during the applicable financial reporting period. Expense allowances paid by the assuming companies which are allocable to the current period are treated as an offset to other operating expenses. Since reinsurance treaties typically provide for allowance percentages that decrease over the lifetime of a policy, allowances in excess of the "ultimate" or final level allowance are capitalized. Amortization of capitalized reinsurance expense allowances representing recovery of acquisition costs is treated as an offset to direct amortization of DAC or VOBA. Amortization of deferred expense allowances is calculated as a level percentage of expected premiums in all durations given expected future lapses and mortality and accretion due to interest.
F-22
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
The Company utilizes reinsurance on certain short duration insurance contracts (primarily issued through the Asset Protection segment). As part of these reinsurance transactions the Company receives reinsurance allowances which reimburse the Company for acquisition costs such as commissions and premium taxes. A ceding fee is also collected to cover other administrative costs and profits for the Company. As a component of reinsurance costs, reinsurance allowances are accounted for in accordance with the relevant provisions of ASC Financial Services Insurance Topic, which state that reinsurance costs should be amortized over the contract period of the reinsurance if the contract is short-duration. Accordingly, reinsurance allowances received related to short-duration contracts are capitalized and charged to expense in proportion to premiums earned. Ceded unamortized acquisition costs are netted with direct unamortized acquisition costs in the balance sheet.
Ceded premiums and policy fees on the Company's fixed universal life ("UL"), VUL, bank-owned life insurance ("BOLI"), and annuity products reduce premiums and policy fees recognized by the Company. Ceded claims are treated as an offset to direct benefits and settlement expenses and are recognized when the claim is incurred on a direct basis. Ceded policy reserve changes are also treated as an offset to benefits and settlement expenses and are recognized during the applicable valuation period.
Since reinsurance treaties typically provide for allowance percentages that decrease over the lifetime of a policy, allowances in excess of the "ultimate" or final level allowance are capitalized. Amortization of capitalized reinsurance expense allowances are amortized based on future expected gross profits. Assumptions regarding mortality, lapses, and interest rates are continuously reviewed and may be periodically changed. These changes will result in "unlocking" that changes the balance in the ceded deferred acquisition cost and can affect the amortization of DAC and VOBA. Ceded unearned revenue liabilities are also amortized based on expected gross profits. Assumptions are based on the best current estimate of expected mortality, lapses and interest spread.
The Company has also assumed certain policy risks written by other insurance companies through reinsurance agreements. Premiums and policy fees as well as Benefits and settlement expenses include amounts assumed under reinsurance agreements and are net of reinsurance ceded. Assumed reinsurance is accounted for in accordance with ASC Financial Services Insurance Topic.
Reinsurance Allowances Long-Duration Contracts Reinsurance allowances are intended to reimburse the ceding company for some portion of the ceding company's commissions, expenses, and taxes. The amount and timing of reinsurance allowances (both first year and renewal allowances) are contractually determined by the applicable reinsurance contract and do not necessarily bear a relationship to the amount and incidence of expenses actually paid by the ceding company in any given year.
Ultimate reinsurance allowances are defined as the lowest allowance percentage paid by the reinsurer in any policy duration over the lifetime of a universal life policy (or through the end of the level term period for a traditional life policy). Ultimate reinsurance allowances are determined during the negotiation of each reinsurance agreement and will differ between agreements.
The Company determines its "cost of reinsurance" to include amounts paid to the reinsurer (ceded premiums) net of amounts reimbursed by the reinsurer (in the form of allowances). As noted within ASC Financial Services Insurance Topic, "The difference, if any, between amounts paid for a reinsurance contract and the amount of the liabilities for policy benefits relating to the underlying reinsured contracts is part of the estimated cost to be amortized". The Company's policy is to amortize
F-23
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
the cost of reinsurance over the life of the underlying reinsured contracts (for long-duration policies) in a manner consistent with the way in which benefits and expenses on the underlying contracts are recognized. For the Company's long-duration contracts, it is the Company's practice to defer reinsurance allowances as a component of the cost of reinsurance and recognize the portion related to the recovery of acquisition costs as a reduction of applicable unamortized acquisition costs in such a manner that net acquisition costs are capitalized and charged to expense in proportion to net revenue recognized. The remaining balance of reinsurance allowances are included as a component of the cost of reinsurance and those allowances which are allocable to the current period are recorded as an offset to operating expenses in the current period consistent with the recognition of benefits and expenses on the underlying reinsured contracts. This practice is consistent with the Company's practice of capitalizing direct expenses (e.g. commissions), and results in the recognition of reinsurance allowances on a systematic basis over the life of the reinsured policies on a basis consistent with the way in which acquisition costs on the underlying reinsured contracts would be recognized. In some cases reinsurance allowances allocable to the current period may exceed non-deferred direct costs, which may cause net other operating expenses (related to specific contracts) to be negative.
Amortization of Reinsurance Allowances Reinsurance allowances do not affect the methodology used to amortize DAC and VOBA, or the period over which such DAC and VOBA are amortized. Reinsurance allowances offset the direct expenses capitalized, reducing the net amount that is capitalized. DAC and VOBA on traditional life policies are amortized based on the pattern of estimated gross premiums of the policies in force. Reinsurance allowances do not affect the gross premiums, so therefore they do not impact traditional life amortization patterns. DAC and VOBA on universal life products are amortized based on the pattern of estimated gross profits of the policies in force. Reinsurance allowances are considered in the determination of estimated gross profits, and therefore do impact amortization patterns.
Reinsurance Assets and Liabilities Claim liabilities and policy benefits are calculated consistently for all policies, regardless of whether or not the policy is reinsured. Once the claim liabilities and policy benefits for the underlying policies are estimated, the amounts recoverable from the reinsurers are estimated based on a number of factors including the terms of the reinsurance contracts, historical payment patterns of reinsurance partners, and the financial strength and credit worthiness of reinsurance partners and recorded as Reinsurance receivables on the balance sheet. The reinsurance receivables as of the Merger date, were recorded in the balance sheet using current accounting policies and the most current assumptions. As of the Merger date, the Company also calculated the ceded VOBA associated with the reinsured policies. The reinsurance receivables combined with the associated ceded VOBA represent the fair value of the reinsurance assets as of the Merger date.
Liabilities for unpaid reinsurance claims are produced from claims and reinsurance system records, which contain the relevant terms of the individual reinsurance contracts. The Company monitors claims due from reinsurers to ensure that balances are settled on a timely basis. Incurred but not reported claims are reviewed to ensure that appropriate amounts are ceded.
The Company analyzes and monitors the credit worthiness of each of its reinsurance partners to minimize collection issues. For newly executed reinsurance contracts with reinsurance companies that do not meet predetermined standards, the Company requires collateral such as assets held in trusts or letters of credit.
F-24
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Components of Reinsurance Cost The following income statement lines are affected by reinsurance cost:
Premiums and policy fees ("reinsurance ceded" on the Company's financial statements) represent consideration paid to the assuming company for accepting the ceding company's risks. Ceded premiums and policy fees increase reinsurance cost.
Benefits and settlement expenses include incurred claim amounts ceded and changes in ceded policy reserves. Ceded benefits and settlement expenses decrease reinsurance cost.
Amortization of deferred policy acquisition cost and VOBA reflects the amortization of capitalized reinsurance allowances representing recovery of acquisition costs. Ceded amortization decreases reinsurance cost.
Other expenses include reinsurance allowances paid by assuming companies to the Company less amounts representing recovery of acquisition costs. Reinsurance allowances decrease reinsurance cost.
The Company's reinsurance programs do not materially impact the other income line of the Company's income statement. In addition, net investment income generally has no direct impact on the Company's reinsurance cost. However, it should be noted that by ceding business to the assuming companies, the Company forgoes investment income on the reserves ceded to the assuming companies. Conversely, the assuming companies will receive investment income on the reserves assumed which will increase the assuming companies' profitability on business assumed from the Company.
Accounting Pronouncements Recently Adopted
ASU No. 2016-02 Leases. The amendments in this Update address certain aspects of recognition, measurement, presentation, and disclosure of leases. The most significant change relates to the accounting model used by lessees. The Update requires all leases with terms greater than 12 months to be recorded on the balance sheet in the form of a lease asset and liability. The lease asset and liability are measured at the present value of the minimum lease payments less any upfront payments or fees. The amendments in the Update became effective for annual and interim periods beginning after December 15, 2018 on a modified retrospective basis. The Company recorded a cumulative effect adjustment as of the date of adoption, January 1, 2019, establishing a right of use asset and lease liability of $18.2 million on its consolidated balance sheet reflected in the property and equipment and other liabilities, net of accumulated depreciation line items, respectively.
ASU No. 2017-08 Receivables Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities. The amendments in this Update require that premiums on callable debt securities be amortized to the first call date. This is a change from previous guidance, under which premiums are amortized to the maturity date of the security. The amendments became effective for annual and interim periods beginning after December 15, 2018. The Company recorded a cumulative effect adjustment as of the adoption date, January 1, 2019, resulting in a $50.8 million reduction to retained earnings, net of income tax.
ASU No. 2017-12 Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities. The amendments in this Update are designed to permit hedge accounting to be applied to a broader range of hedging strategies as well as to more closely align hedge accounting
F-25
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
and risk management objectives. Specific provisions include requiring changes in the fair value of a hedging instrument be recorded in the same income statement line as the hedged item when it affects earnings. In addition, after a hedge has initially qualified as an effective hedge, the Update permits the use of a qualitative hedge effectiveness test in subsequent periods. The amendments in this Update became effective for annual and interim periods beginning after December 15, 2018 and early adoption is permitted. At adoption, January 1, 2019, this standard did not have an impact on the Company's operations or financial results.
Accounting Pronouncements Not Yet Adopted
ASU No. 2016-13 Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments. The amendments in this Update introduce a new current expected credit loss ("CECL") model for certain financial assets, including mortgage loans and reinsurance receivables. The new model will not apply to debt securities classified as available-for-sale. For assets within the scope of the new model, an entity will recognize as an allowance against earnings its estimate of the contractual cash flows not expected to be collected on day one of the asset's acquisition. The allowance may be reversed through earnings if a security recovers in value. This differs from the current impairment model, which requires recognition of credit losses when they have been incurred and recognizes a security's subsequent recovery in value in other comprehensive income. The Update also makes targeted changes to the current impairment model for available-for-sale debt securities, which comprise the majority of the Company's invested assets. Similar to the CECL model, credit loss impairments will be recorded in an allowance against earnings that may be reversed for subsequent recoveries in value. The amendments in this Update, along with related amendments in ASU No. 2018-19, ASU No. 2019-04, and ASU No. 2019-11 Codification Improvements to Topic 326, Financial Instruments-Credit Losses, are effective for annual and interim periods beginning after December 15, 2019 on a modified retrospective basis. A vendor-provided credit loss model will be used to measure the allowance for the majority of the Company's commercial mortgage loans and unfunded mortgage loan commitments, and the Company will use an internally-developed model to measure the allowance for amounts recoverable from reinsurers. The Company has completed the development and testing of the models to calculate the allowance for credit losses for these assets, and implemented new processes and controls with respect to the measurement and recognition of the allowance and related disclosures. Based on current estimates, the Company expects that the cumulative effect adjustment reported in its first quarter 2020 financial statements will reflect a reduction in retained earnings of approximately $172.0 million, excluding the offsetting impact to deferred taxes, DAC, VOBA, and other items.
ASU No. 2018-12 Financial Services Insurance (Topic 944): Targeted Improvements to Accounting for Long-Duration Contracts. The amendments in this Update are designed to make improvements to the existing recognition, measurement, presentation, and disclosure requirements for certain long-duration contracts issued by an insurance company. The new amendments require insurance entities to provide a more current measure of the liability for future policy benefits for traditional and limited-payment contracts by regularly refining the liability for actual past experience and updated future assumptions. This differs from current requirements where assumptions are locked-in at contract issuance for these contract types. In addition, the updated liability will be discounted using an upper-medium grade (low-credit-risk) fixed income instrument yield that reflects the characteristics of the liability which differs from currently used rates based on the invested assets supporting the
F-26
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
liability. In addition, the amendments introduce new requirements to assess market-based insurance contract options and guarantees for Market Risk Benefits and measure them at fair value. This Update also requires insurance entities to amortize deferred acquisition costs on a constant-level basis over the expected life of the contract. Finally this Update requires new disclosures including liability rollforwards and information about significant inputs, judgments, assumptions, and methods used in the measurement. The amendments in this Update were originally effective for periods beginning after December 15, 2020. However, in November 2019, the Financial Accounting Standards Board (the "FASB") issued ASU No. 2019-09 Financial Services Insurance (Topic 944): Effective Date which extended the implementation deadline by one year to periods beginning after December 15, 2021. The Company is currently reviewing its policies, processes, and applicable systems to determine the impact this standard will have on its operations and financial results.
ASU No. 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this Update remove certain exceptions to the general principles in Topic 740 related to intraperiod tax allocations, interim tax calculations, and outside basis differences. The amendments also clarify and amend guidance in certain other areas of Topic 740 in order to eliminate diversity in practice. The amendments in this Update are effective for public business entities in fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The Company is reviewing its accounting policies and processes to ensure compliance with the revised guidance, upon adoption.
3. SIGNIFICANT TRANSACTIONS
On May 1, 2018, The Lincoln National Life Insurance Company ("Lincoln Life") completed the acquisition (the "Closing") of Liberty Mutual Group Inc.'s ("Liberty Mutual") Group Benefits Business and Individual Life and Annuity Business (the "Liberty Individual Life Business") through the acquisition of all of the issued and outstanding capital stock of Liberty Life Assurance Company of Boston ("Liberty"). In connection with the Closing and pursuant to the Master Transaction Agreement, dated January 18, 2018 (the "Liberty Master Transaction Agreement") the Company and Protective Life and Annuity Insurance Company ("PLAIC"), a wholly owned subsidiary, entered into reinsurance agreements (the "Reinsurance Agreements") and related ancillary documents (including administrative services agreements and transition services agreements) providing for the reinsurance and administration of the Liberty Individual Life Business.
Pursuant to the Reinsurance Agreements, Liberty ceded to the Company and PLAIC the insurance policies related to the Life Business on a 100% coinsurance basis. The aggregate ceding commission for the reinsurance of the Life Business was $422.4 million, which is the purchase price.
All policies issued in states other than New York were ceded to the Company under a reinsurance agreement between Liberty and the Company, and all policies issued in New York were ceded to PLAIC under a reinsurance agreement between Liberty and PLAIC. The aggregate statutory reserves of Liberty ceded to the Company and PLAIC as of the closing of the Transaction were approximately $13.2 billion, which amount was based on initial estimates. The final reserve amount determined on a GAAP basis, as adjusted during the measurement period, was $13.7 billion. Pursuant to the terms of the Liberty Reinsurance Agreements, each of the Company and PLAIC are required to maintain assets in trust for the benefit of Liberty to secure their respective obligations to Liberty under the Liberty
F-27
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT TRANSACTIONS (Continued)
Reinsurance Agreements. The trust accounts were initially funded by each of the Company and PLAIC principally with the investment assets that were received from Liberty. Additionally, the Company and PLAIC have each agreed to provide, on behalf of Liberty, administration and policyholder servicing of the Life Business reinsured by it pursuant to administrative services agreements between Liberty and each of the Company and PLAIC.
The terms of the Reinsurance Agreements resulted in an acquisition of the Life Business by the Company in accordance with ASC Topic 805, Business Combinations.
The following table details the purchase consideration and allocation of assets acquired and liabilities assumed from the Life Business reinsurance transaction as of the transaction date.
Fair Value
As of May 1, 2018 |
|||||||
(Dollars in Thousands) |
|||||||
Assets |
|||||||
Fixed maturities |
$ |
12,588,512 |
|||||
Mortgage loans |
435,405 |
||||||
Policy loans |
131,489 |
||||||
Total investments |
13,155,406 |
||||||
Cash |
38,457 |
||||||
Accrued investment income |
152,030 |
||||||
Reinsurance receivables |
272 |
||||||
Value of business acquired |
374,739 |
||||||
Other assets |
916 |
||||||
Total assets |
$ |
13,721,820 |
|||||
Liabilities |
|||||||
Future policy benefits and claims |
$ |
11,750,196 |
|||||
Unearned premiums |
|
||||||
Total policy liabilities and accruals |
11,750,196 |
||||||
Annuity account balances |
1,864,141 |
||||||
Other policyholders' funds |
41,936 |
||||||
Other liabilities |
65,547 |
||||||
Total liabilities |
13,721,820 |
||||||
Net assets acquired |
$ |
|
The following unaudited pro forma condensed consolidated results of operations assumes that the aforementioned transactions of the Life Business were completed as of January 1, 2017. The unaudited pro forma condensed results of operations are presented solely for information purposes
F-28
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT TRANSACTIONS (Continued)
and are not necessarily indicative of the consolidated condensed results of operations that might have been achieved had the transaction been completed as of the date indicated:
Unaudited
For The Year Ended December 31, |
|||||||||||
2018 |
2017 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Revenue |
$ |
5,082,755 |
$ |
5,548,132 |
|||||||
Net income |
240,071 |
1,309,876 |
The amount of revenue and income before income tax of the Life Business since the transaction date, May 1, 2018, included in the consolidated statements of income for the year ended December 31, 2018, amounted to $578.0 million and $49.8 million, respectively. Also, included in the income before income tax for the year ended December 31, 2018, is approximately $5.5 million of non-recurring transaction costs.
Great-West Life & Annuity Insurance Company
On January 23, 2019, the Company entered into a Master Transaction Agreement (the "GWL&A Master Transaction Agreement") with Great-West Life & Annuity Insurance Company ("GWL&A"), Great-West Life & Annuity Insurance Company of New York ("GWL&A of NY"), The Canada Life Assurance Company ("CLAC") and The Great-West Life Assurance Company ("GWL" and, together with GWL&A, GWL&A of NY and CLAC, the "Sellers"), pursuant to which the Company will acquire via reinsurance (the "Transaction") substantially all of the Sellers' individual life insurance and annuity business (the "GW Individual Life Business").
On June 3, 2019, the Company and PLAIC completed the Transaction (the "GWL&A Closing"). Pursuant to the GWL&A Master Transaction Agreement, the Company and PLAIC entered into reinsurance agreements (the "GWL&A Reinsurance Agreements") and related ancillary documents at the GWL&A Closing. On the terms and subject to the conditions of the GWL&A Reinsurance Agreements, the Sellers ceded to the Company and PLAIC, effective as of the date of the GWL&A Closing, substantially all of the insurance policies related to the Individual Life Business on a 100% indemnity basis net of reinsurance recoveries. The aggregate ceding commission for the reinsurance of the Individual Life Business paid at the GWL&A Closing was $765.7 million, which amount is subject to adjustment in accordance with the GWL&A Master Transaction Agreement. All policies issued in states other than New York were ceded to the Company under reinsurance agreements between the applicable Seller and the Company, and all policies issued in New York were ceded to PLAIC under a reinsurance agreement between GWL&A of NY and PLAIC. The aggregate statutory reserves of the Sellers ceded to the Company and PLAIC as of the GWL&A Closing were approximately $20.4 billion, which amount was based on initial estimates and is subject to adjustment following the GWL&A Closing. To support its obligations under the GWL&A Reinsurance Agreements, the Company established trust accounts for the benefit of GWL&A, CLAC and GWL, and PLAIC established a trust account for the benefit of GWL&A of NY. The Sellers retained a block of participating policies, which will be administered by PLC.
As of the purchase date, the Company recorded an estimate in the amount of $49.5 million related to contingent consideration. The final ceding commission will be adjusted based on any changes in
F-29
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT TRANSACTIONS (Continued)
contingent consideration. These amounts are accrued within other liabilities in the Company's consolidated condensed balance sheet.
The contingent consideration is comprised of a holdback provision and a post-closing sales adjustment. The holdback amount is related to the performance of certain blocks of business for a specified period of time after the close of the transaction. The range of amounts payable to Great West under this provision is $0 $40 million. The Company established a liability of $37.6 million as of the transaction date, which represents the Company's best estimate of the present value of future payments.
Great West is also entitled to a payment for certain post-closing sales occurring between June 1, 2019 and December 31, 2019. The liability as of December 31, 2019 was $0.5 million, which represents the Company's best estimate of the present value of future payments.
The GWL&A Master Transaction Agreement and other transaction documents contain certain customary representations and warranties made by each of the parties, and certain customary covenants regarding the Sellers and the Individual Life Business, and provide for indemnification, among other things, for breaches of those representations, warranties, and covenants. The terms of the GWL&A Reinsurance Agreements resulted in an acquisition of the Individual Life Business by PLC in accordance with ASC Topic 805, Business Combinations.
The following table details the preliminary allocation of assets acquired and liabilities assumed from the Individual Life Business reinsurance transaction as of the date of the GWL&A Closing. The Company has not completed the process of determining the fair value of assets acquired and liabilities assumed, but will do so in the twelve month measurement period subsequent to the date of the GWL&A Closing. These estimates are provisional and subject to adjustment. Any adjustments to these fair value estimates will be reflected, retroactively, as of the date of the acquisition, and may result in adjustments to the value of business acquired.
Fair Value
As of June 1, 2019 |
|||||||
(Dollars In Thousands) |
|||||||
Assets |
|||||||
Fixed maturities |
$ |
8,697,966 |
|||||
Mortgage loans |
1,386,228 |
||||||
Policy loans |
44,002 |
||||||
Other long-term investments |
1,521,965 |
||||||
Total investments |
11,650,161 |
||||||
Cash |
34,835 |
||||||
Accrued investment income |
101,452 |
||||||
Accounts and premiums receivable |
62 |
||||||
Premium due and deferred |
1,642 |
||||||
Value of business acquired |
514,124 |
||||||
Other intangibles |
21,300 |
||||||
Other assets |
5,525 |
||||||
Assets related to separate accounts |
9,583,217 |
||||||
Total assets |
$ |
21,912,318 |
F-30
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT TRANSACTIONS (Continued)
Fair Value
As of June 1, 2019 |
|||||||
(Dollars In Thousands) |
|||||||
Liabilities |
|||||||
Future policy benefits and claims |
$ |
11,000,822 |
|||||
Annuity account balances |
220,064 |
||||||
Other policyholders' funds |
220,117 |
||||||
Other liabilities |
75,456 |
||||||
Liabilities related to separate accounts |
9,583,217 |
||||||
Total liabilities |
21,099,676 |
||||||
Net assets acquired |
$ |
812,642 |
Assets related to separate accounts and liabilities related to separate accounts represent amounts receivable and payable for variable annuity and variable universal life products reinsured on a modified co-insurance basis.
The following unaudited pro forma condensed consolidated results of operations assumes that the aforementioned transactions of the Individual Life Business were completed as of January 1, 2018. The unaudited pro forma condensed results of operations are presented solely for information purposes and are not necessarily indicative of the consolidated condensed results of operations that might have been achieved had the transaction been completed as of the date indicated:
Unaudited
For The Year Ended December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Revenue |
$ |
6,322,962 |
$ |
5,592,419 |
|||||||
Net income |
570,079 |
253,238 |
The amount of revenue and income before income tax of the GW Individual Life Business since the transaction date, June 1, 2019, included in the consolidated statements of income for the year ended December 31, 2019, amounted to $539.8 million and $98.8 million, respectively. The Company incurred approximately $12.2 million of non-recurring transaction costs for the year ended December 31, 2019.
Intangible assets recognized by the Company included the following (excluding goodwill):
Estimated Fair
Value on Acquisition Date |
Estimated
Useful Life |
||||||||||
(Dollars In Thousands) |
(In Years) |
||||||||||
Distribution relationships |
$ |
15,000 |
18 |
||||||||
Technology |
6,300 |
10 |
|||||||||
Total intangible assets |
$ |
21,300 |
F-31
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT TRANSACTIONS (Continued)
Amortizable intangible assets will be amortized on a straight line basis over their assigned useful lives. The following is a schedule of future estimated aggregate amortization expense:
Year |
Amount |
||||||
(Dollars In Thousands) |
|||||||
2020 |
$ |
1,463 |
|||||
2021 |
1,463 |
||||||
2022 |
1,463 |
||||||
2023 |
1,463 |
||||||
2024 |
1,463 |
Based on the balance recorded as of June 1, 2019, the expected amortization of value of business acquired ("VOBA") for the next five years is as follows:
Year |
Amount |
||||||
(Dollars In Thousands) |
|||||||
2020 |
$ |
(19,741 |
) |
||||
2021 |
(12,153 |
) |
|||||
2022 |
(5,090 |
) |
|||||
2023 |
1,143 |
||||||
2024 |
6,184 |
VOBA is calculated at a product level and can either be positive or negative depending on the underlying fair values of the associated product lines. VOBA is amortized in accordance with ASC 944-805-35-1, which requires that the amortization should be on a basis consistent with the related reinsurance liability. As such, the net amortization related to a specific transaction in a given year can be either positive or negative as amortization patterns differ between the product lines.
4. MONY CLOSED BLOCK OF BUSINESS
In 1998, MONY Life Insurance Company ("MONY") converted from a mutual insurance company to a stock corporation ("demutualization"). In connection with its demutualization, an accounting mechanism known as a closed block (the "Closed Block") was established for certain individuals' participating policies in force as of the date of demutualization. Assets, liabilities, and earnings of the Closed Block are specifically identified to support its participating policyholders. The Company acquired the Closed Block in conjunction with the acquisition of MONY in 2013.
Assets allocated to the Closed Block inure solely to the benefit of each Closed Block's policyholders and will not revert to the benefit of MONY or the Company. No reallocation, transfer, borrowing or lending of assets can be made between the Closed Block and other portions of MONY's general account, any of MONY's separate accounts or any affiliate of MONY without the approval of the Superintendent of The New York State Department of Financial Services (the "Superintendent"). Closed Block assets and liabilities are carried on the same basis as similar assets and liabilities held in the general account.
The excess of Closed Block liabilities over Closed Block assets (adjusted to exclude the impact of related amounts in AOCI) at the acquisition date of October 1, 2013, represented the estimated maximum future post-tax earnings from the Closed Block that would be recognized in income from continuing operations over the period the policies and contracts in the Closed Block remain in force. In
F-32
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
4. MONY CLOSED BLOCK OF BUSINESS (Continued)
connection with the acquisition of MONY, the Company developed an actuarial calculation of the expected timing of MONY's Closed Block's earnings as of October 1, 2013. Pursuant to the acquisition of the Company by Dai-ichi Life, this actuarial calculation of the expected timing of MONY's Closed Block earnings was recalculated and reset as February 1, 2015, along with the establishment of a policyholder dividend obligation as of such date.
If the actual cumulative earnings from the Closed Block are greater than the expected cumulative earnings, only the expected earnings will be recognized in the Company's net income. Actual cumulative earnings in excess of expected cumulative earnings at any point in time are recorded as a policyholder dividend obligation because they will ultimately be paid to Closed Block policyholders as an additional policyholder dividend, unless offset by future performance that is less favorable than originally expected. If a policyholder dividend obligation has been previously established and the actual Closed Block earnings in a subsequent period are less than the expected earnings for that period, the policyholder dividend obligation would be reduced (but not below zero). If, over the period the policies and contracts in the Closed Block remain in force, the actual cumulative earnings of the Closed Block are less than the expected cumulative earnings, only actual earnings would be recognized in income from continuing operations. If the Closed Block has insufficient funds to make guaranteed policy benefit payments, such payments will be made from assets outside the Closed Block.
Many expenses related to Closed Block operations, including amortization of VOBA, are charged to operations outside of the Closed Block; accordingly, net revenues of the Closed Block do not represent the actual profitability of the Closed Block operations. Operating costs and expenses outside of the Closed Block are, therefore, disproportionate to the business outside of the Closed Block.
Summarized financial information for the Closed Block as of December 31, 2019 and December 31, 2018 and is as follows:
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Closed block liabilities | |||||||||||
Future policy benefits, policyholders' account balances and
other policyholder liabilities |
$ |
5,836,815 |
$ |
5,679,732 |
|||||||
Policyholder dividend obligation |
278,505 |
|
|||||||||
Other liabilities |
11,247 |
22,505 |
|||||||||
Total closed block liabilities |
6,126,567 |
5,702,237 |
|||||||||
Closed block assets |
|||||||||||
Fixed maturities, available-for-sale, at fair value |
4,682,731 |
4,257,437 |
|||||||||
Mortgage loans on real estate |
72,829 |
75,838 |
|||||||||
Policy loans |
640,134 |
672,213 |
|||||||||
Cash and other invested assets |
44,877 |
116,225 |
|||||||||
Other assets |
107,177 |
136,388 |
|||||||||
Total closed block assets |
5,547,748 |
5,258,101 |
F-33
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
4. MONY CLOSED BLOCK OF BUSINESS (Continued)
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Excess of reported closed block liabilities over closed
block assets |
$ |
578,819 |
$ |
444,136 |
|||||||
Portion of above representing accumulated other
comprehensive income: |
|||||||||||
Net unrealized investments gains (losses) net of policyholder
dividend obligation: $167,285 and $(141,128); and net of income tax: $(35,130) and $61,676 |
|
(120,528 |
) |
||||||||
Future earnings to be recognized from closed block assets
and closed block liabilities |
$ |
578,819 |
$ |
323,608 |
Reconciliation of the policyholder dividend obligation is as follows:
For The Year Ended
December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Policyholder dividend obligation, beginning balance |
$ |
|
$ |
160,712 |
|||||||
Applicable to net revenue (losses) |
(29,908 |
) |
(33,014 |
) |
|||||||
Change in net unrealized investment gains (losses) allocated
to policyholder dividend obligation |
308,413 |
(127,698 |
) |
||||||||
Policyholder dividend obligation, ending balance |
$ |
278,505 |
$ |
|
Closed Block revenues and expenses were as follows:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Revenues |
|||||||||||||||
Premiums and other income |
$ |
162,288 |
$ |
171,117 |
$ |
180,097 |
|||||||||
Net investment income |
206,523 |
202,282 |
203,964 |
||||||||||||
Net investment gains |
(1,603 |
) |
(1,970 |
) |
910 |
||||||||||
Total revenues |
367,208 |
371,429 |
384,971 |
||||||||||||
Benefits and other deductions |
|||||||||||||||
Benefits and settlement expenses |
336,736 |
337,352 |
335,200 |
||||||||||||
Other operating expenses |
1,161 |
714 |
1,940 |
||||||||||||
Total benefits and other deductions |
337,897 |
338,066 |
337,140 |
||||||||||||
Net revenues before income taxes |
29,311 |
33,363 |
47,831 |
||||||||||||
Income tax expense |
6,081 |
7,006 |
27,718 |
||||||||||||
Net revenues |
$ |
23,230 |
$ |
26,357 |
$ |
20,113 |
F-34
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. INVESTMENT OPERATIONS
Investment income is recognized when earned, net of applicable management or other fees. Investment income on fixed maturity securities includes coupon interest, amortization of any premium and accretion of any discount. Investment income on equity securities includes dividend income and preferred coupons interest.
Investment income on mortgage-backed and asset-backed securities is initially based upon yield, cash flow and prepayment assumptions at the date of purchase. Subsequent revisions in those assumptions are recorded using the retrospective or prospective method. Under the retrospective method used primarily for mortgage-backed and asset-backed securities of high credit quality which cannot be contractually prepaid in such a manner that we would not recover a substantial portion of the initial investment, amortized cost of the security is adjusted to the amount that would have existed had the revised assumptions been in place at the date of purchase. The adjustments to amortized cost are recorded as a charge or credit to net investment income. Under the prospective method, which is used for all other mortgage-backed and asset-backed securities, future cash flows are estimated and interest income is recognized going forward using the new internal rate of return.
Major categories of net investment income are summarized as follows:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Fixed maturities |
$ |
2,465,902 |
$ |
2,043,183 |
$ |
1,610,768 |
|||||||||
Equity securities |
30,647 |
35,282 |
40,506 |
||||||||||||
Mortgage loans |
388,656 |
322,206 |
298,387 |
||||||||||||
Investment real estate |
1,045 |
1,778 |
2,405 |
||||||||||||
Short-term investments |
118,172 |
103,676 |
114,280 |
||||||||||||
3,004,422 |
2,506,125 |
2,066,346 |
|||||||||||||
Investment expenses |
185,592 |
167,223 |
143,290 |
||||||||||||
Net investment income |
$ |
2,818,830 |
$ |
2,338,902 |
$ |
1,923,056 |
Realized investment gains (losses) includes realized gains and losses from the sales of investments, write-downs for other-than-temporary impairments of investments, changes in fair value of equity securities, certain derivative and embedded derivative gains and losses, gains and losses on reinsurance-related embedded derivatives and trading securities. Realized gains and losses on investments are calculated on the basis of specific identification on the trade date.
F-35
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. INVESTMENT OPERATIONS (Continued)
Net realized investment gains (losses) for all other investments are summarized as follows:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Fixed maturities |
$ |
47,711 |
$ |
9,851 |
$ |
12,783 |
|||||||||
Equity securities gains and losses(1) |
46,989 |
(49,275 |
) |
(2,330 |
) |
||||||||||
Modco trading portfolio |
247,331 |
(185,900 |
) |
119,206 |
|||||||||||
Other investments |
967 |
2,048 |
(8,572 |
) |
|||||||||||
Realized gains (losses) all other
investments |
342,998 |
(223,276 |
) |
121,087 |
|||||||||||
Realized gains (losses) derivatives |
(131,459 |
) |
79,097 |
(137,041 |
) |
||||||||||
Realized investment gains (losses) |
$ |
211,539 |
$ |
(144,179 |
) |
$ |
(15,954 |
) |
|||||||
Net impairment losses recognized in
earnings |
$ |
(34,453 |
) |
$ |
(29,724 |
) |
$ |
(9,112 |
) |
(1) Beginning January 1, 2018, all changes in the fair value of equity securities are recorded as a realized gain (loss) as a result of the adoption of ASU No. 2016-01.
Gross realized gains and gross realized losses on investments available-for-sale (fixed maturities and short-term investments) are as follows:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Gross realized gains |
$ |
61,608 |
$ |
28,034 |
$ |
18,868 |
|||||||||
Gross realized losses: |
|||||||||||||||
Impairments losses |
$ |
(34,453 |
) |
$ |
(29,724 |
) |
$ |
(9,112 |
) |
||||||
Other realized losses |
$ |
(13,897 |
) |
$ |
(18,183 |
) |
$ |
(8,257 |
) |
The chart below summarizes the fair value proceeds and the gains (losses) realized on securities the Company sold that were in an unrealized gain position and an unrealized loss position.
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Securities in an unrealized gain position: |
|||||||||||||||
Fair value proceeds |
$ |
2,511,764 |
$ |
1,291,826 |
$ |
879,181 |
|||||||||
Gains realized |
$ |
61,608 |
$ |
28,034 |
$ |
18,868 |
|||||||||
Securities in an unrealized loss position(1): |
|||||||||||||||
Fair value proceeds |
$ |
542,733 |
$ |
472,371 |
$ |
185,157 |
|||||||||
Losses realized |
$ |
(13,897 |
) |
$ |
(18,183 |
) |
$ |
(8,257 |
) |
(1) The Company made the decision to exit these holdings in conjunction with its overall asset liability management process.
F-36
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. INVESTMENT OPERATIONS (Continued)
The chart below summarizes the realized gains (losses) on equity securities sold during the period and equity securities still held at the reporting date.
For The Year Ended
December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Net gains (losses) recognized during the period on equity
securities |
$ |
46,989 |
$ |
(49,275 |
) |
||||||
Less: net gains (losses) recognized on equity securities sold
during the period |
$ |
(3,225 |
) |
$ |
(6,165 |
) |
|||||
Gains (losses) recognized during the period on equity
securities still held |
$ |
50,214 |
$ |
(43,110 |
) |
The amortized cost and fair value of the Company's investments classified as available-for-sale are as follows:
Amortized
Cost |
Gross
Unrealized Gains |
Gross
Unrealized Losses |
Fair
Value |
Total OTTI
Recognized in OCI(1) |
|||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
As of December 31, 2019 |
|||||||||||||||||||||||
Fixed maturities: |
|||||||||||||||||||||||
Residential mortgage-backed
securities |
$ |
5,812,170 |
$ |
125,493 |
$ |
(6,322 |
) |
$ |
5,931,341 |
$ |
|
||||||||||||
Commercial mortgage-backed
securities |
2,588,575 |
54,385 |
(3,292 |
) |
2,639,668 |
|
|||||||||||||||||
Other asset-backed securities |
1,764,120 |
32,041 |
(14,926 |
) |
1,781,235 |
(7 |
) |
||||||||||||||||
U.S. government-related
securities |
1,032,048 |
5,664 |
(5,316 |
) |
1,032,396 |
|
|||||||||||||||||
Other government-related
securities |
548,136 |
51,024 |
(1,991 |
) |
597,169 |
|
|||||||||||||||||
States, municipals, and political
subdivisions |
4,415,008 |
225,072 |
(1,230 |
) |
4,638,850 |
1,236 |
|||||||||||||||||
Corporate securities |
44,493,799 |
2,603,636 |
(288,334 |
) |
46,809,101 |
(34,580 |
) |
||||||||||||||||
Redeemable preferred stocks |
87,237 |
3,677 |
(4,249 |
) |
86,665 |
|
|||||||||||||||||
60,741,093 |
3,100,992 |
(325,660 |
) |
63,516,425 |
(33,351 |
) |
|||||||||||||||||
Short-term investments |
1,229,651 |
|
|
1,229,651 |
|
||||||||||||||||||
$ |
61,970,744 |
$ |
3,100,992 |
$ |
(325,660 |
) |
$ |
64,746,076 |
$ |
(33,351 |
) |
F-37
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. INVESTMENT OPERATIONS (Continued)
Amortized
Cost |
Gross
Unrealized Gains |
Gross
Unrealized Losses |
Fair
Value |
Total OTTI
Recognized in OCI(1) |
|||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
As of December 31, 2018 |
|||||||||||||||||||||||
Fixed maturities: |
|||||||||||||||||||||||
Residential mortgage-backed
securities |
$ |
3,641,678 |
$ |
23,248 |
$ |
(61,935 |
) |
$ |
3,602,991 |
$ |
(18 |
) |
|||||||||||
Commercial mortgage-backed
securities |
2,319,476 |
3,911 |
(57,000 |
) |
2,266,387 |
|
|||||||||||||||||
Other asset-backed securities |
1,410,059 |
17,232 |
(35,398 |
) |
1,391,893 |
|
|||||||||||||||||
U.S. government-related
securities |
1,658,433 |
1,794 |
(45,722 |
) |
1,614,505 |
|
|||||||||||||||||
Other government-related
securities |
543,534 |
4,292 |
(33,790 |
) |
514,036 |
|
|||||||||||||||||
States, municipals, and political
subdivisions |
3,682,037 |
25,706 |
(118,902 |
) |
3,588,841 |
876 |
|||||||||||||||||
Corporate securities |
38,467,380 |
112,438 |
(2,378,240 |
) |
36,201,578 |
(29,685 |
) |
||||||||||||||||
Redeemable preferred stocks |
94,362 |
|
(11,560 |
) |
82,802 |
|
|||||||||||||||||
51,816,959 |
188,621 |
(2,742,547 |
) |
49,263,033 |
(28,827 |
) |
|||||||||||||||||
Short-term investments |
635,375 |
|
|
635,375 |
|
||||||||||||||||||
$ |
52,452,334 |
$ |
188,621 |
$ |
(2,742,547 |
) |
$ |
49,898,408 |
$ |
(28,827 |
) |
(1) These amounts are included in the gross unrealized gains and gross unrealized losses columns above.
The Company holds certain investments pursuant to certain modified coinsurance ("Modco") arrangements. The fixed maturities, equity securities, and short-term investments held as part of these arrangements are classified as trading securities. The fair value of the investments held pursuant to these Modco arrangements are as follows:
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Fixed maturities: |
|||||||||||
Residential mortgage-backed securities |
$ |
209,521 |
$ |
241,836 |
|||||||
Commercial mortgage-backed securities |
201,284 |
188,925 |
|||||||||
Other asset-backed securities |
143,361 |
159,907 |
|||||||||
U.S. government-related securities |
47,067 |
59,794 |
|||||||||
Other government-related securities |
28,775 |
44,207 |
|||||||||
States, municipals, and political subdivisions |
293,791 |
286,413 |
|||||||||
Corporate securities |
1,590,936 |
1,423,833 |
|||||||||
Redeemable preferred stocks |
12,832 |
11,277 |
|||||||||
2,527,567 |
2,416,192 |
||||||||||
Equity securities |
6,656 |
9,892 |
|||||||||
Short-term investments |
91,213 |
30,926 |
|||||||||
$ |
2,625,436 |
$ |
2,457,010 |
F-38
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. INVESTMENT OPERATIONS (Continued)
The amortized cost and fair value of available-for-sale and held-to-maturity fixed maturities as of December 31, 2019, by expected maturity, are shown below. Expected maturities of securities without a single maturity date are allocated based on estimated rates of prepayment that may differ from actual rates of prepayment.
Available-for-sale |
Held-to-maturity |
||||||||||||||||||
Amortized
Cost |
Fair
Value |
Amortized
Cost |
Fair
Value |
||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
Due in one year or less |
$ |
1,833,383 |
$ |
1,832,073 |
$ |
|
$ |
|
|||||||||||
Due after one year through five years |
10,513,141 |
10,732,319 |
|
|
|||||||||||||||
Due after five years through ten years |
13,423,688 |
14,018,121 |
|
|
|||||||||||||||
Due after ten years |
34,970,881 |
36,933,912 |
2,823,881 |
3,025,790 |
|||||||||||||||
$ |
60,741,093 |
$ |
63,516,425 |
$ |
2,823,881 |
$ |
3,025,790 |
The chart below summarizes the Company's other-than-temporary impairments of investments. All of the impairments were related to fixed maturities or equity securities.
Fixed
Maturities |
Equity
Securities |
Total
Securities |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
For The Year Ended December 31, 2019 |
|||||||||||||||
Other-than-temporary impairments |
$ |
(67,161 |
) |
$ |
|
$ |
(67,161 |
) |
|||||||
Non-credit impairment losses recorded in other
comprehensive income |
32,708 |
|
32,708 |
||||||||||||
Net impairment losses recognized in earnings |
$ |
(34,453 |
) |
$ |
|
$ |
(34,453 |
) |
|||||||
For The Year Ended December 31, 2018 |
|||||||||||||||
Other-than-temporary impairments |
$ |
(56,578 |
) |
$ |
|
$ |
(56,578 |
) |
|||||||
Non-credit impairment losses recorded in other
comprehensive income |
26,854 |
|
26,854 |
||||||||||||
Net impairment losses recognized in earnings |
$ |
(29,724 |
) |
$ |
|
$ |
(29,724 |
) |
|||||||
For The Year Ended December 31, 2017 |
|||||||||||||||
Other-than-temporary impairments |
$ |
(1,332 |
) |
$ |
|
$ |
(1,332 |
) |
|||||||
Non-credit impairment losses recorded in other
comprehensive income |
(7,780 |
) |
|
(7,780 |
) |
||||||||||
Net impairment losses recognized in earnings |
$ |
(9,112 |
) |
$ |
|
$ |
(9,112 |
) |
There were no other-than-temporary impairments related to fixed maturities or equity securities that the Company intended to sell or expected to be required to sell for the years ended December 31, 2019, 2018, and 2017.
F-39
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. INVESTMENT OPERATIONS (Continued)
The following chart is a rollforward of available-for-sale credit losses on fixed maturities held by the Company for which a portion of an other-than-temporary impairment was recognized in other comprehensive income (loss):
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Beginning balance |
$ |
24,868 |
$ |
3,268 |
$ |
12,685 |
|||||||||
Additions for newly impaired securities |
30,299 |
24,858 |
734 |
||||||||||||
Additions for previously impaired securities |
3,553 |
12 |
3,175 |
||||||||||||
Reductions for previously impaired securities due
to a change in expected cash flows |
(21,332 |
) |
|
(12,726 |
) |
||||||||||
Reductions for previously impaired securities that
were sold in the current period |
(7,294 |
) |
(3,270 |
) |
(600 |
) |
|||||||||
Ending balance |
$ |
30,094 |
$ |
24,868 |
$ |
3,268 |
The following table includes the gross unrealized losses and fair value of the Company's investments that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position as of December 31, 2019:
Less Than 12 Months |
12 Months or More |
Total |
|||||||||||||||||||||||||
Fair
Value |
Unrealized
Loss |
Fair
Value |
Unrealized
Loss |
Fair
Value |
Unrealized
Loss |
||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||||||
Residential mortgage-
backed securities |
$ |
851,333 |
$ |
(4,231 |
) |
$ |
220,843 |
$ |
(2,091 |
) |
$ |
1,072,176 |
$ |
(6,322 |
) |
||||||||||||
Commercial mortgage-
backed securities |
371,945 |
(1,721 |
) |
115,566 |
(1,571 |
) |
487,511 |
(3,292 |
) |
||||||||||||||||||
Other asset-backed
securities |
482,547 |
(6,516 |
) |
214,058 |
(8,410 |
) |
696,605 |
(14,926 |
) |
||||||||||||||||||
U.S. government-related
securities |
383,451 |
(3,373 |
) |
353,517 |
(1,943 |
) |
736,968 |
(5,316 |
) |
||||||||||||||||||
Other government-related
securities |
22,962 |
(669 |
) |
6,230 |
(1,322 |
) |
29,192 |
(1,991 |
) |
||||||||||||||||||
States, municipalities, and
political subdivisions |
56,470 |
(1,001 |
) |
12,907 |
(229 |
) |
69,377 |
(1,230 |
) |
||||||||||||||||||
Corporate securities |
3,176,489 |
(68,289 |
) |
2,886,648 |
(220,045 |
) |
6,063,137 |
(288,334 |
) |
||||||||||||||||||
Redeemable preferred
stocks |
|
|
16,689 |
(4,249 |
) |
16,689 |
(4,249 |
) |
|||||||||||||||||||
$ |
5,345,197 |
$ |
(85,800 |
) |
$ |
3,826,458 |
$ |
(239,860 |
) |
$ |
9,171,655 |
$ |
(325,660 |
) |
F-40
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. INVESTMENT OPERATIONS (Continued)
RMBS and CMBS had gross unrealized losses greater than twelve months of $2.1 million and $1.6 million, respectively, as of December 31, 2019. Factors such as the credit enhancement within the deal structure, the average life of the securities, and the performance of the underlying collateral support the recoverability of these investments.
The other asset-backed securities have a gross unrealized loss greater than twelve months of $8.4 million as of December 31, 2019. This category predominately includes student-loan backed auction rate securities, the underlying collateral, of which is at least 97% guaranteed by the Federal Family Education Loan Program ("FFELP"). At this time, the Company has no reason to believe that the U.S. Department of Education would not honor the FFELP guarantee, if it were necessary.
The U.S. government-related securities and the other government-related securities had gross unrealized losses greater than twelve months of $1.9 million and $1.3 million as of December 31, 2019, respectively. These declines were related to changes in interest rates.
The states, municipalities, and political subdivisions categories had gross unrealized losses greater than twelve months of $0.2 million as of December 31, 2019. The aggregate decline in fair value of these securities was deemed temporary due to positive factors supporting the recoverability of the respective investments. Positive factors considered include credit ratings, the financial health of the issuer, the continued access of the issuer to capital markets, and other pertinent information.
The corporate securities category has gross unrealized losses greater than twelve months of $220.0 million as of December 31, 2019. The aggregate decline in fair value of these securities was deemed temporary due to positive factors supporting the recoverability of the respective investments. Positive factors considered include credit ratings, the financial health of the issuer, the continued access of the issuer to capital markets, interest rate movement, and other pertinent information.
As of December 31, 2019, the Company had a total of 876 positions that were in an unrealized loss position, but the Company does not consider these unrealized loss positions to be other-than-temporary. This is based on the aggregate factors discussed previously and because the Company has the ability and intent to hold these investments until the fair values recover, and the Company does not intend to sell or expect to be required to sell the securities before recovering the Company's amortized cost of the securities.
F-41
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. INVESTMENT OPERATIONS (Continued)
The following table includes the gross unrealized losses and fair value of the Company's investments that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position as of December 31, 2018:
Less Than 12 Months |
12 Months or More |
Total |
|||||||||||||||||||||||||
Fair
Value |
Unrealized
Loss |
Fair
Value |
Unrealized
Loss |
Fair
Value |
Unrealized
Loss |
||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||||||
Residential
mortgage- backed securities |
$ |
1,485,009 |
$ |
(31,302 |
) |
$ |
795,765 |
$ |
(30,633 |
) |
$ |
2,280,774 |
$ |
(61,935 |
) |
||||||||||||
Commercial
mortgage- backed securities |
419,420 |
(7,398 |
) |
1,405,690 |
(49,602 |
) |
1,825,110 |
(57,000 |
) |
||||||||||||||||||
Other asset-
backed securities |
687,271 |
(30,963 |
) |
148,871 |
(4,435 |
) |
836,142 |
(35,398 |
) |
||||||||||||||||||
U.S. government-
related securities |
130,290 |
(4,668 |
) |
1,085,654 |
(41,054 |
) |
1,215,944 |
(45,722 |
) |
||||||||||||||||||
Other
government- related securities |
224,273 |
(15,207 |
) |
131,569 |
(18,583 |
) |
355,842 |
(33,790 |
) |
||||||||||||||||||
States,
municipalities, and political subdivisions |
1,004,262 |
(27,180 |
) |
1,129,152 |
(91,722 |
) |
2,133,414 |
(118,902 |
) |
||||||||||||||||||
Corporate
securities |
18,225,656 |
(966,825 |
) |
12,824,024 |
(1,411,415 |
) |
31,049,680 |
(2,378,240 |
) |
||||||||||||||||||
Redeemable
preferred stocks |
41,147 |
(4,467 |
) |
41,655 |
(7,093 |
) |
82,802 |
(11,560 |
) |
||||||||||||||||||
$ |
22,217,328 |
$ |
(1,088,010 |
) |
$ |
17,562,380 |
$ |
(1,654,537 |
) |
$ |
39,779,708 |
$ |
(2,742,547 |
) |
As of December 31, 2019, the Company had securities in its available-for-sale portfolio which were rated below investment grade with a fair value of $1.6 billion and had an amortized cost of $1.7 billion. In addition, included in the Company's trading portfolio, the Company held $124.4 million of securities which were rated below investment grade. Approximately $227.0 million of the below investment grade securities held by the Company were not publicly traded.
F-42
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. INVESTMENT OPERATIONS (Continued)
The change in unrealized gains (losses), net of income tax, on fixed maturities classified as available-for-sale is summarized as follows:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Fixed maturities |
$ |
4,210,114 |
$ |
(2,032,573 |
) |
$ |
1,083,865 |
The amortized cost and fair value of the Company's investments classified as held-to-maturity as of December 31, 2019 and 2018, are as follows:
Amortized
Cost |
Gross
Unrecognized Holding Gains |
Gross
Unrecognized Holding Losses |
Fair
Value |
Total OTTI
Recognized in OCI |
|||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
As of December 31, 2019 |
|||||||||||||||||||||||
Fixed maturities: |
|||||||||||||||||||||||
Securities issued by affiliates: |
|||||||||||||||||||||||
Red Mountain LLC |
$ |
795,881 |
$ |
81,022 |
$ |
|
$ |
876,903 |
$ |
|
|||||||||||||
Steel City LLC |
2,028,000 |
120,887 |
|
2,148,887 |
|
||||||||||||||||||
$ |
2,823,881 |
$ |
201,909 |
$ |
|
$ |
3,025,790 |
$ |
|
||||||||||||||
As of December 31, 2018 |
|||||||||||||||||||||||
Fixed maturities: |
|||||||||||||||||||||||
Securities issued by affiliates: |
|||||||||||||||||||||||
Red Mountain LLC |
$ |
750,474 |
$ |
|
$ |
(81,657 |
) |
$ |
668,817 |
$ |
|
||||||||||||
Steel City LLC |
1,883,000 |
|
(4,607 |
) |
1,878,393 |
|
|||||||||||||||||
$ |
2,633,474 |
$ |
|
$ |
(86,264 |
) |
$ |
2,547,210 |
$ |
|
During the years ended December 31, 2019, 2018, and 2017, the Company did not record any other-than-temporary impairments on held-to-maturity securities.
The Company's held-to-maturity securities had $201.9 million of gross unrecognized holding gains as of December 31, 2019. These held-to-maturity securities are issued by affiliates of the Company which are considered VIE's. The Company is not the primary beneficiary of these entities and thus the securities are not eliminated in consolidation. These securities are collateralized by non-recourse funding obligations issued by captive insurance companies that are affiliates of the Company.
The Company's held-to-maturity securities had $86.3 million of gross unrecognized holding losses as of December 31, 2018. The Company does not consider these unrecognized holding losses to be other-than-temporary based on certain positive factors associated with the securities which include credit ratings of the guarantor, financial health of the issuer and guarantor, continued access of the issuer to capital markets and other pertinent information.
The Company held $155.1 million and $140.5 million of non-income producing securities for the year ended December 31, 2019 and 2018, respectively.
F-43
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. INVESTMENT OPERATIONS (Continued)
Included in the Company's invested assets are $1.7 billion of policy loans as of December 31, 2019. The interest rates on standard policy loans range from 3.0% to 8.0%. The collateral loans on life insurance policies have an interest rate of 13.64%.
Variable Interest Entities
The Company holds certain investments in entities in which its ownership interests could possibly be considered variable interests under Topic 810 of the FASB ASC (excluding debt and equity securities held as trading, available for sale, or held to maturity). The Company reviews the characteristics of each of these applicable entities and compares those characteristics to applicable criteria to determine whether the entity is a Variable Interest Entity ("VIE"). If the entity is determined to be a VIE, the Company then performs a detailed review to determine whether the interest would be considered a variable interest under the guidance. The Company then performs a qualitative review of all variable interests with the entity and determines whether the Company is the primary beneficiary. ASC 810 provides that an entity is the primary beneficiary of a VIE if the entity has 1) the power to direct the activities of the VIE that most significantly impact the VIE's economic performance, and 2) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the entity that could potentially be significant to the VIE.
Based on this analysis, the Company had an interest in one wholly owned subsidiary, Red Mountain, LLC ("Red Mountain"), that was determined to be a VIE as of December 31, 2019 and 2018.
The activity most significant to Red Mountain is the issuance of a note in connection with a financing transaction involving Golden Gate V Vermont Captive Insurance Company ("Golden Gate V") and the Company in which Golden Gate V issued non-recourse funding obligations to Red Mountain and Red Mountain issued the note to Golden Gate V. Credit enhancement on the Red Mountain Note is provided by an unrelated third party. For details of this transaction, see Note 14, Debt and Other Obligations. The Company has the power, via its 100% ownership, to direct the activities of the VIE, but does not have the obligation to absorb losses related to the primary risks or sources of variability to the VIE. The variability of loss would be borne primarily by the third party in its function as provider of credit enhancement on the Red Mountain Note. Accordingly, it was determined that the Company is not the primary beneficiary of the VIE. The Company's risk of loss related to the VIE is limited to its investment of $10,000. Additionally, PLC, the holding company, has guaranteed Red Mountain's payment obligation for the credit enhancement fee to the unrelated third party provider. As of December 31, 2019, no payments have been made or required related to this guarantee.
6. FAIR VALUE OF FINANCIAL INSTRUMENTS
The Company determined the fair value of its financial instruments based on the fair value hierarchy established in FASB guidance referenced in the Fair Value Measurements and Disclosures Topic which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company has adopted the provisions from the FASB guidance that is referenced in the Fair Value Measurements and Disclosures Topic for non-financial assets and liabilities (such as property and equipment, goodwill, and other intangible assets) that are required to be measured at fair value on a periodic basis. The effect on the Company's periodic fair value measurements for non-financial assets and liabilities was not material.
F-44
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
The Company has categorized its financial instruments, based on the priority of the inputs to the valuation technique, into a three level hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the fair value measurement of the instrument.
Financial assets and liabilities recorded at fair value on the consolidated balance sheets are categorized as follows:
• Level 1: Unadjusted quoted prices for identical assets or liabilities in an active market.
• Level 2: Quoted prices in markets that are not active or significant inputs that are observable either directly or indirectly. Level 2 inputs include the following:
a) Quoted prices for similar assets or liabilities in active markets;
b) Quoted prices for identical or similar assets or liabilities in non-active markets;
c) Inputs other than quoted market prices that are observable; and
d) Inputs that are derived principally from or corroborated by observable market data through correlation or other means.
• Level 3: Prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. They reflect management's own estimates about the assumptions a market participant would use in pricing the asset or liability.
The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2019:
Measurement
Category |
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
Assets: |
|||||||||||||||||||||||
Fixed maturity securities available-for-sale
Residential mortgage-backed securities |
4 |
$ |
|
$ |
5,931,341 |
$ |
|
$ |
5,931,341 |
||||||||||||||
Commercial mortgage-backed securities |
4 |
|
2,629,639 |
10,029 |
2,639,668 |
||||||||||||||||||
Other asset-backed securities |
4 |
|
1,360,016 |
421,219 |
1,781,235 |
||||||||||||||||||
U.S. government-related securities |
4 |
662,581 |
369,815 |
|
1,032,396 |
||||||||||||||||||
State, municipalities, and political
subdivisions |
4 |
|
4,638,850 |
|
4,638,850 |
||||||||||||||||||
Other government-related securities |
4 |
|
597,169 |
|
597,169 |
||||||||||||||||||
Corporate securities |
4 |
|
45,435,387 |
1,373,714 |
46,809,101 |
||||||||||||||||||
Redeemable preferred stocks |
4 |
69,976 |
16,689 |
|
86,665 |
||||||||||||||||||
Total fixed maturity securities
available-for-sale |
732,557 |
60,978,906 |
1,804,962 |
63,516,425 |
F-45
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
Measurement
Category |
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
Fixed maturity securities trading
Residential mortgage-backed securities |
3 |
$ |
|
$ |
209,521 |
$ |
|
$ |
209,521 |
||||||||||||||
Commercial mortgage-backed securities |
3 |
|
201,284 |
|
201,284 |
||||||||||||||||||
Other asset-backed securities |
3 |
|
77,954 |
65,407 |
143,361 |
||||||||||||||||||
U.S. government-related securities |
3 |
24,810 |
22,257 |
|
47,067 |
||||||||||||||||||
State, municipalities, and political
subdivisions |
3 |
|
293,791 |
|
293,791 |
||||||||||||||||||
Other government-related securities |
3 |
|
28,775 |
|
28,775 |
||||||||||||||||||
Corporate securities |
3 |
|
1,579,565 |
11,371 |
1,590,936 |
||||||||||||||||||
Redeemable preferred stocks |
3 |
12,832 |
|
|
12,832 |
||||||||||||||||||
Total fixed maturity securities trading |
37,642 |
2,413,147 |
76,778 |
2,527,567 |
|||||||||||||||||||
Total fixed maturity securities |
770,199 |
63,392,053 |
1,881,740 |
66,043,992 |
|||||||||||||||||||
Equity securities |
3 |
480,750 |
|
72,970 |
553,720 |
||||||||||||||||||
Other long-term investments(1) |
3 |
&4 |
52,225 |
733,425 |
209,843 |
995,493 |
|||||||||||||||||
Short-term investments |
3 |
1,255,384 |
65,480 |
|
1,320,864 |
||||||||||||||||||
Total investments |
2,558,558 |
64,190,958 |
2,164,553 |
68,914,069 |
|||||||||||||||||||
Cash |
3 |
171,752 |
|
|
171,752 |
||||||||||||||||||
Assets related to separate accounts |
|||||||||||||||||||||||
Variable annuity |
3 |
12,730,090 |
|
|
12,730,090 |
||||||||||||||||||
Variable universal life |
3 |
1,135,666 |
|
|
1,135,666 |
||||||||||||||||||
Total assets measured at fair value on a
recurring basis |
$ |
16,596,066 |
$ |
64,190,958 |
$ |
2,164,553 |
$ |
82,951,577 |
|||||||||||||||
Liabilities: |
|||||||||||||||||||||||
Annuity account balances(2) |
3 |
$ |
|
$ |
|
$ |
69,728 |
$ |
69,728 |
||||||||||||||
Other liabilities(1) |
3 |
&4 |
19,561 |
509,645 |
1,017,972 |
1,547,178 |
|||||||||||||||||
Total liabilities measured at fair value on a
recurring basis |
$ |
19,561 |
$ |
509,645 |
$ |
1,087,700 |
$ |
1,616,906 |
(1) Includes certain freestanding and embedded derivatives.
(2) Represents liabilities related to fixed indexed annuities.
(3) Fair Value through Net Income.
(4) Fair Value through Other Comprehensive Income.
F-46
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2018:
Measurement
Category |
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
Assets: |
|||||||||||||||||||||||
Fixed maturity securities available-for-sale
Residential mortgage-backed securities |
4 |
$ |
|
$ |
3,602,991 |
$ |
|
$ |
3,602,991 |
||||||||||||||
Commercial mortgage-backed securities |
4 |
|
2,266,387 |
|
2,266,387 |
||||||||||||||||||
Other asset-backed securities |
4 |
|
970,251 |
421,642 |
1,391,893 |
||||||||||||||||||
U.S. government-related securities |
4 |
985,485 |
629,020 |
|
1,614,505 |
||||||||||||||||||
State, municipalities, and political
subdivisions |
4 |
|
3,588,841 |
|
3,588,841 |
||||||||||||||||||
Other government-related securities |
4 |
514,036 |
|
514,036 |
|||||||||||||||||||
Corporate securities |
4 |
|
35,563,302 |
638,276 |
36,201,578 |
||||||||||||||||||
Redeemable preferred stocks |
4 |
65,536 |
17,266 |
|
82,802 |
||||||||||||||||||
Total fixed maturity securities
available-for-sale |
1,051,021 |
47,152,094 |
1,059,918 |
49,263,033 |
|||||||||||||||||||
Fixed maturity securities trading |
|||||||||||||||||||||||
Residential mortgage-backed securities |
3 |
|
241,836 |
|
241,836 |
||||||||||||||||||
Commercial mortgage-backed securities |
3 |
|
188,925 |
|
188,925 |
||||||||||||||||||
Other asset-backed securities |
3 |
|
133,851 |
26,056 |
159,907 |
||||||||||||||||||
U.S. government-related securities |
3 |
27,453 |
32,341 |
|
59,794 |
||||||||||||||||||
State, municipalities, and political
subdivisions |
3 |
|
286,413 |
|
286,413 |
||||||||||||||||||
Other government-related securities |
3 |
|
44,207 |
|
44,207 |
||||||||||||||||||
Corporate securities |
3 |
|
1,417,591 |
6,242 |
1,423,833 |
||||||||||||||||||
Redeemable preferred stocks |
3 |
11,277 |
|
|
11,277 |
||||||||||||||||||
Total fixed maturity securities trading |
38,730 |
2,345,164 |
32,298 |
2,416,192 |
|||||||||||||||||||
Total fixed maturity securities |
1,089,751 |
49,497,258 |
1,092,216 |
51,679,225 |
|||||||||||||||||||
Equity securities |
3 |
494,287 |
|
63,421 |
557,708 |
||||||||||||||||||
Other long-term investments(1) |
3 |
&4 |
83,047 |
180,438 |
151,342 |
414,827 |
|||||||||||||||||
Short-term investments |
3 |
589,084 |
77,217 |
|
666,301 |
||||||||||||||||||
Total investments |
2,256,169 |
49,754,913 |
1,306,979 |
53,318,061 |
|||||||||||||||||||
Cash |
3 |
151,400 |
|
|
151,400 |
||||||||||||||||||
Assets related to separate accounts |
|||||||||||||||||||||||
Variable annuity |
3 |
12,288,919 |
|
|
12,288,919 |
||||||||||||||||||
Variable universal life |
3 |
937,732 |
|
|
937,732 |
||||||||||||||||||
Total assets measured at fair value on a
recurring basis |
$ |
15,634,220 |
$ |
49,754,913 |
$ |
1,306,979 |
$ |
66,696,112 |
|||||||||||||||
Liabilities: |
|||||||||||||||||||||||
Annuity account balances(2) |
3 |
$ |
|
$ |
|
$ |
76,119 |
$ |
76,119 |
||||||||||||||
Other liabilities(1) |
3 |
&4 |
56,018 |
164,643 |
438,127 |
658,788 |
|||||||||||||||||
Total liabilities measured at fair value on a
recurring basis |
$ |
56,018 |
$ |
164,643 |
$ |
514,246 |
$ |
734,907 |
(1) Includes certain freestanding and embedded derivatives.
(2) Represents liabilities related to fixed indexed annuities.
(3) Fair Value through Net Income.
(4) Fair Value through Other Comprehensive Income.
F-47
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
Determination of Fair Values
The valuation methodologies used to determine the fair values of assets and liabilities reflect market participant assumptions and are based on the application of the fair value hierarchy that prioritizes observable market inputs over unobservable inputs. The Company determines the fair values of certain financial assets and financial liabilities based on quoted market prices, where available. The Company also determines certain fair values based on future cash flows discounted at the appropriate current market rate. Fair values reflect adjustments for counterparty credit quality, the Company's credit standing, liquidity, and where appropriate, risk margins on unobservable parameters. The following is a discussion of the methodologies used to determine fair values for the financial instruments as listed in the above table.
The fair value of fixed maturity, short-term, and equity securities is determined by management after considering one of three primary sources of information: third party pricing services, non-binding independent broker quotations, or pricing matrices. Security pricing is applied using a "waterfall" approach whereby publicly available prices are first sought from third party pricing services, the remaining unpriced securities are submitted to independent brokers for non-binding prices, or lastly, securities are priced using a pricing matrix. Typical inputs used by these three pricing methods include, but are not limited to: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications. Third party pricing services price 92.3% of the Company's available-for-sale and trading fixed maturity securities. Based on the typical trading volumes and the lack of quoted market prices for available-for-sale and trading fixed maturities, third party pricing services derive the majority of security prices from observable market inputs such as recent reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information outlined above. If there are no recent reported trades, the third party pricing services and brokers may use matrix or model processes to develop a security price where future cash flow expectations are developed based upon collateral performance and discounted at an estimated market rate. Certain securities are priced via independent non-binding broker quotations. When using non-binding independent broker quotations, when available the Company obtains two quotes per security. Where multiple broker quotes are obtained, the Company reviews the quotes and selects the quote that provides the best estimate of the price a market participant would pay for these specific assets in an arm's length transaction. A pricing matrix is used to price securities for which the Company is unable to obtain or effectively rely on either a price from a third party pricing service or an independent broker quotation.
The pricing matrix used by the Company begins with current spread levels to determine the market price for the security. The credit spreads, assigned by brokers, incorporate the issuer's credit rating, liquidity discounts, weighted- average of contracted cash flows, risk premium, if warranted, due to the issuer's industry, and the security's time to maturity. The Company uses credit ratings provided by nationally recognized rating agencies.
For securities that are priced via non-binding independent broker quotations, the Company assesses whether prices received from independent brokers represent a reasonable estimate of fair value. The Company's assessment incorporates various metrics (yield curves, credit spreads, prepayment rates, etc.) along with other information available to the Company from both internal and external sources to determine the valuation of such holdings. As a result of this analysis, if the Company determines there
F-48
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
is a more appropriate fair value based upon the analytics, the price received from the independent broker is adjusted accordingly. The Company did not adjust any quotes or prices received from brokers during the years ended December 31, 2019 and 2018.
The Company has analyzed the third party pricing services' valuation methodologies and related inputs and has also evaluated the various types of securities in its investment portfolio to determine an appropriate fair value hierarchy level based upon trading activity and the observability of market inputs that is in accordance with the Fair Value Measurements and Disclosures Topic of the ASC. Based on this evaluation and investment class analysis, each price was classified into Level 1, 2, or 3. Most prices provided by third party pricing services are classified into Level 2 because the significant inputs used in pricing the securities are market observable and the observable inputs are corroborated by the Company. Since the matrix pricing of certain debt securities includes significant non-observable inputs, they are classified as Level 3.
Asset-Backed Securities
This category mainly consists of residential mortgage-backed securities, commercial mortgage-backed securities, and other asset-backed securities (collectively referred to as asset-backed securities or "ABS"). As of December 31, 2019, the Company held $10.4 billion of ABS classified as Level 2. These securities are priced from information provided by a third party pricing service and independent broker quotes. The third party pricing services and brokers mainly value securities using both a market and income approach to valuation. As part of this valuation process they consider the following characteristics of the item being measured to be relevant inputs: 1) weighted-average coupon rate, 2) weighted-average years to maturity, 3) types of underlying assets, 4) weighted-average coupon rate of the underlying assets, 5) weighted-average years to maturity of the underlying assets, 6) seniority level of the tranches owned, and 7) credit ratings of the securities.
After reviewing these characteristics of the ABS, the third party pricing service and brokers use certain inputs to determine the value of the security. For ABS classified as Level 2, the valuation would consist of predominantly market observable inputs such as, but not limited to: 1) monthly principal and interest payments on the underlying assets, 2) average life of the security, 3) prepayment speeds, 4) credit spreads, 5) treasury and swap yield curves, and 6) discount margin. The Company reviews the methodologies and valuation techniques (including the ability to observe inputs) in assessing the information received from external pricing services and in consideration of the fair value presentation.
As of December 31, 2019, the Company held $496.6 million of Level 3 ABS, which included $431.2 million of other asset-backed securities classified as available-for-sale and $65.4 million of other asset-backed securities classified as trading. These securities are predominantly ARS whose underlying collateral is at least 97% guaranteed by the FFELP. As a result of the ARS market collapse during 2008, the Company prices its ARS using an income approach valuation model. As part of the valuation process the Company reviews the following characteristics of the ARS in determining the relevant inputs: 1) weighted-average coupon rate, 2) weighted-average years to maturity, 3) types of underlying assets, 4) weighted-average coupon rate of the underlying assets, 5) weighted-average years to maturity of the underlying assets, 6) seniority level of the tranches owned, 7) credit ratings of the securities, 8) liquidity premium, and 9) paydown rate. In periods where market activity increases and there are transactions at a price that is not the result of a distressed or forced sale we consider those prices as part of our valuation. If the market activity during a period is solely the result of the
F-49
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
issuer redeeming positions we consider those transactions in our valuation, but still consider them to be level three measurements due to the nature of the transaction.
Corporate Securities, Redeemable Preferred Stocks, U.S. Government-Related Securities, States, Municipals, and Political Subdivisions, and Other Government Related Securities
As of December 31, 2019, the Company classified approximately $53.0 billion of corporate securities, redeemable preferred stocks, U.S. government-related securities, states, municipals, and political subdivisions, and other government-related securities as Level 2. The fair value of the Level 2 securities is predominantly priced by broker quotes and a third party pricing service. The Company has reviewed the valuation techniques of the brokers and third party pricing service and has determined that such techniques used Level 2 market observable inputs. The following characteristics of the securities are considered to be the primary relevant inputs to the valuation: 1) weighted- average coupon rate, 2) weighted-average years to maturity, 3) seniority, and 4) credit ratings. The Company reviews the methodologies and valuation techniques (including the ability to observe inputs) in assessing the information received from external pricing services and in consideration of the fair value presentation.
The brokers and third party pricing service utilize valuation models that consist of a hybrid methodology that utilizes a cash flow analysis and market approach to valuation. The pricing models utilize the following inputs: 1) principal and interest payments, 2) treasury yield curve, 3) credit spreads from new issue and secondary trading markets, 4) dealer quotes with adjustments for issues with early redemption features, 5) liquidity premiums present on private placements, and 6) discount margins from dealers in the new issue market.
As of December 31, 2019, the Company classified approximately $1.4 billion of corporate securities as Level 3 valuations. Level 3 securities primarily represent investments in illiquid bonds for which no price is readily available. To determine a price, the Company uses a discounted cash flow model with both observable and unobservable inputs. These inputs are entered into an industry standard pricing model to determine the final price of the security. These inputs include: 1) principal and interest payments, 2) coupon rate, 3) sector and issuer level spread over treasury, 4) underlying collateral, 5) credit ratings, 6) maturity, 7) embedded options, 8) recent new issuance, 9) comparative bond analysis, and 10) an illiquidity premium.
Equities
As of December 31, 2019, the Company held approximately $73.0 million of equity securities classified as Level 3. Of this total, $73.0 million represents FHLB stock. The Company believes that the cost of the FHLB stock approximates fair value.
Other Long-Term Investments and Other Liabilities
Derivative Financial Instruments
Other long-term investments and other liabilities include free-standing and embedded derivative financial instruments. Refer to Note 7, Derivative Financial Instruments for additional information related to derivatives. Derivative financial instruments are valued using exchange prices, independent broker quotations, or pricing valuation models, which utilize market data inputs. Excluding embedded
F-50
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
derivatives, as of December 31, 2019, 85.9% of derivatives based upon notional values were priced using exchange prices or independent broker quotations. Inputs used to value derivatives include, but are not limited to, interest swap rates, credit spreads, interest rate and equity market volatility indices, equity index levels, and treasury rates. The Company performs monthly analysis on derivative valuations that includes both quantitative and qualitative analyses.
Derivative instruments classified as Level 1 generally include futures and options, which are traded on active exchange markets.
Derivative instruments classified as Level 2 primarily include swaps, options, and swaptions, which are traded over-the-counter. Level 2 also includes certain centrally cleared derivatives. These derivative valuations are determined using independent broker quotations, which are corroborated with observable market inputs.
Derivative instruments classified as Level 3 were embedded derivatives and include at least one significant non-observable input. A derivative instrument containing Level 1 and Level 2 inputs will be classified as a Level 3 financial instrument in its entirety if it has at least one significant Level 3 input.
The Company utilizes derivative instruments to manage the risk associated with certain assets and liabilities. However, the derivative instruments may not be classified within the same fair value hierarchy level as the associated assets and liabilities. Therefore, the changes in fair value on derivatives reported in Level 3 may not reflect the offsetting impact of the changes in fair value of the associated assets and liabilities.
The embedded derivatives are carried at fair value in other long-term investments and other liabilities on the Company's consolidated balance sheet. The changes in fair value are recorded in earnings as Realized investment gains (losses). Refer to Note 7, Derivative Financial Instruments for more information related to each embedded derivatives gains and losses.
The fair value of the GLWB embedded derivative is derived through the income method of valuation using a valuation model that projects future cash flows using multiple risk neutral stochastic equity scenarios and policyholder behavior assumptions. The risk neutral scenarios are generated using the current swap curve and projected equity volatilities and correlations. The projected equity volatilities are based on a blend of historical volatility and near- term equity market implied volatilities. The equity correlations are based on historical price observations. For policyholder behavior assumptions, expected lapse and utilization assumptions are used and updated for actual experience, as necessary. The Company assumes age-based mortality from the Ruark 2015 ALB table with attained age factors varying from 87% 100% based on company experience. The present value of the cash flows is determined using the discount rate curve, which is based upon LIBOR plus a credit spread (to represent the Company's non-performance risk). For expected lapse and utilization, assumptions are used and updated for actual experience, as necessary, using an internal predictive model developed by the Company. As a result of using significant unobservable inputs, the GLWB embedded derivative is categorized as Level 3. Policyholder assumptions are reviewed on an annual basis.
The balance of the FIA embedded derivative is impacted by policyholder cash flows associated with the FIA product that are allocated to the embedded derivative in addition to changes in the fair value of the embedded derivative during the reporting period. The fair value of the FIA embedded derivative is derived through the income method of valuation using a valuation model that projects future cash flows
F-51
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
using current index values and volatility, the hedge budget used to price the product, and policyholder assumptions (both elective and non-elective). For policyholder behavior assumptions are used and updated for actual experience, as necessary. The Company assumes age-based mortality from the 2015 Ruark ALB mortality table, with attained age factors varying from 87% 100% based on company experience. The present value of the cash flows is determined using the discount rate curve, which is based upon LIBOR up to one year and constant maturity treasury rates plus a credit spread (to represent the Company's non-performance risk) thereafter. Policyholder assumptions are reviewed on an annual basis. As a result of using significant unobservable inputs, the FIA embedded derivative is categorized as Level 3.
The balance of the indexed universal life ("IUL") embedded derivative is impacted by policyholder cash flows associated with the IUL product that are allocated to the embedded derivative in addition to changes in the fair value of the embedded derivative during the reporting period. The fair value of the IUL embedded derivative is derived through the income method of valuation using a valuation model that projects future cash flows using current index values and volatility, the hedge budget used to price the product, and policyholder assumptions (both elective and non-elective). For policyholder behavior assumptions, expected lapse and withdrawal assumptions are used and updated for actual experience, as necessary. The Company assumes age-based mortality from the SOA 2015 VBT Primary Tables, with attained age factors varying from 37% 156% based on company experience. The present value of the cash flows is determined using the discount rate curve, which is based upon LIBOR up to one year and constant maturity treasury rates plus a credit spread (to represent the Company's non-performance risk) thereafter. Policyholder assumptions are reviewed on an annual basis. As a result of using significant unobservable inputs, the IUL embedded derivative is categorized as Level 3.
The Company has assumed and ceded certain blocks of policies under modified coinsurance agreements in which the investment results of the underlying portfolios inure directly to the reinsurers. Funds withheld arrangements related to such agreements contain embedded derivatives that are reported at fair value. Changes in their fair value are reported in earnings. The fair value of embedded derivatives related to funds withheld under modified coinsurance agreements are a function of the unrealized gains or losses on the underlying assets and are calculated in a manner consistent with the terms of the agreements. The investments supporting certain of these agreements are designated as "trading securities"; therefore changes in their fair value are also reported in earnings. As of December 31, 2019, the fair value of the embedded derivatives associated with modified coinsurance agreements was a net liability of $199.6 million. The fair value of embedded derivatives is estimated based on market standard valuation methodology and is considered a Level 3 valuation.
The Company and certain of its subsidiaries have entered into interest support, yearly renewable term ("YRT") premium support, and portfolio maintenance agreements with PLC. These agreements meet the definition of a derivative and are accounted for at fair value and are considered Level 3 valuations. The fair value of these derivatives as of December 31, 2019, was $115.4 million and is included in Other long-term investments. For information regarding realized gains on these derivatives please refer to Note 7, Derivative Financial Instruments.
The Interest Support Agreement provides that PLC will make payments to Golden Gate II if actual investment income on certain of Golden Gate II's asset portfolios falls below a calculated investment income amount as defined in the Interest Support Agreement. The calculated investment income amount is a level of investment income deemed to be sufficient to support certain of Golden Gate II's
F-52
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
obligations under a reinsurance agreement with the Company, dated July 1, 2007. The derivative is valued using an internal valuation model that assumes a conservative projection of investment income under an adverse interest rate scenario and the probability that the expectation falls below the calculated investment income amount. This derivative had a fair value of $61.6 million as of December 31, 2019, however, interest support agreement obligations to Golden Gate II of approximately $4.9 million have been collateralized by PLC. Re-evaluation, if necessary, of the adjustments of any support agreement collateralization amounts occur annually during the first quarter pursuant to the terms of the support agreement. For the year ended December 31, 2019, Golden Gate II recognized $1.0 million in gains related to payments made under this agreement.
The YRT Premium support agreements provide that PLC will make payments to Golden Gate and Golden Gate II in the event that YRT premium rates increase. The derivatives are valued using an internal valuation model. The valuation model is a probability weighted discounted cash flow model. The value is primarily a function of the likelihood and severity of future YRT premium increases. The fair value of these derivatives as of December 31, 2019, was $51.1 million. As of December 31, 2019, Golden Gate II recognized $0.7 million in gains related to payments made under this agreement.
The portfolio maintenance agreements provide that PLC will make payments to Golden Gate, Golden Gate V, and West Coast Life Insurance Company ("WCL") in the event of other-than-temporary impairments on investments that exceed defined thresholds. The derivatives are valued using an internal discounted cash flow model. The significant unobservable inputs are the projected probability and severity of credit losses used to project future cash flows on the investment portfolios. The fair value of the portfolio maintenance agreements as of December 31, 2019, was $2.7 million. As of December 31, 2019, no payments have been triggered under this agreement.
The Funds Withheld derivative results from a reinsurance agreement with Shades Creek where the economic performance of certain hedging instruments held by the Company is ceded to Shades Creek. The value of the Funds Withheld derivative is directly tied to the value of the hedging instruments held in the funds withheld account. The hedging instruments predominantly consist of derivative instruments the fair values of which are classified as a Level 2 measurement; as such, the fair value of the Funds Withheld derivative has been classified as a Level 2 measurement. The fair value of the Funds Withheld derivative as of December 31, 2019, was a liability of $70.6 million.
Annuity Account Balances
The Company records a certain legacy block of FIA reserves at fair value. Based on the characteristics of these reserves, the Company believes that the fund value approximates fair value. The fair value measurement of these reserves is considered a Level 3 valuation due to the unobservable nature of the fund values. The Level 3 fair value as of December 31, 2019 is $69.7 million.
Separate Accounts
Separate account assets are invested in open-ended mutual funds and are included in Level 1.
F-53
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
Valuation of Level 3 Financial Instruments
The following table presents the valuation method for material financial instruments included in Level 3, as well as the unobservable inputs used in the valuation of those financial instruments:
Fair Value
As of December 31, 2019 |
Valuation
Technique |
Unobservable
Input |
Range
(Weighted Average) |
||||||||||||||||
(Dollars In
Thousands) |
|||||||||||||||||||
Assets: |
|||||||||||||||||||
Commercial mortgage-backed securities |
$ 10,029
|
Discounted cash flow
|
Spread over treasury
|
2.5%
|
|||||||||||||||
Other asset-backed securities |
421,219
|
Liquidation
|
Liquidation value
|
$95.39 - $99.99 ($97.95)
|
|||||||||||||||
Discounted cash flow |
Liquidity premium |
0.34% - 2.28% (1.44%) | |||||||||||||||||
|
|
|
Paydown Rate |
8.99% - 12.45% (11.28%) | |||||||||||||||
Corporate securities
|
1,373,714 |
Discounted cash flow
|
Spread over treasury |
0.00% - 4.03% (1.60%) | |||||||||||||||
Liabilities:(1) |
|||||||||||||||||||
Embedded derivatives GLWB(2) |
$ 186,038
|
Actuarial cash flow model
|
Mortality
|
87% to 100% of Ruark 2015 ALB Table
|
|||||||||||||||
Lapse |
Ruark Predictive Model |
||||||||||||||||||
|
|
|
Utilization
|
99%. 10% of policies have a one-time over-utilization of 400% |
|||||||||||||||
|
|
|
Nonperformance risk |
0.12% - 0.82%
|
|||||||||||||||
Embedded derivative FIA |
336,826
|
Actuarial cash flow model |
Expenses
|
$195 per policy
|
|||||||||||||||
|
|
|
Withdrawal rate
|
0.4% - 1.2% prior to age 70 RMD for ages 70+ or WB withdrawal rate Assume underutilized RMD for nonWB policies age 70-81 |
|||||||||||||||
|
|
|
Mortality |
87% to 100% of Ruark 2015 ALB table |
F-54
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
Fair Value
As of December 31, 2019 |
Valuation
Technique |
Unobservable
Input |
Range
(Weighted Average) |
||||||||||||||||
(Dollars In
Thousands) |
|||||||||||||||||||
|
|
|
Lapse
|
0.5% - 50.0%, depending on duration/surrender charge period. Dynamically adjusted for WB moneyness and projected market rates vs credited rates. |
|||||||||||||||
|
|
|
Nonperformance risk |
0.12% - 0.82%
|
|||||||||||||||
Embedded derivative IUL
|
151,765
|
|
Actuarial cash flow model
|
Mortality
|
37% - 156% of 2015 VBT Primary Tables 94% - 248% of duration 8 point in scale 2015 VBT Primary Tables, depending on type of business |
||||||||||||||
|
|
|
Lapse
|
0.5% - 10%, depending on duration/distribution channel and smoking class |
|||||||||||||||
|
|
|
Nonperformance risk |
0.21% - 0.82%
|
(1) Excludes modified coinsurance arrangements.
(2) The fair value for the GLWB embedded derivative is presented as a net liability.
The chart above excludes Level 3 financial instruments that are valued using broker quotes and those which book value approximates fair value.
The Company has considered all reasonably available quantitative inputs as of December 31, 2019, but the valuation techniques and inputs used by some brokers in pricing certain financial instruments are not shared with the Company. This resulted in $76.8 million of financial instruments being classified as Level 3 as of December 31, 2019. Of the $76.8 million, $65.4 million are other asset-backed securities, and $11.4 million are corporate securities.
In certain cases the Company has determined that book value materially approximates fair value. As of December 31, 2019, the Company held $73.0 million of financial instruments where book value approximates fair value which are predominantly FHLB stock.
F-55
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
The following table presents the valuation method for material financial instruments included in Level 3, as well as the unobservable inputs used in the valuation of those financial instruments:
Fair Value
As of December 31, 2018 |
Valuation
Technique |
Unobservable
Input |
Range
(Weighted Average) |
||||||||||||||||
(Dollars In
Thousands) |
|||||||||||||||||||
Assets: |
|||||||||||||||||||
Other asset-backed securities |
$ |
421,458 |
|
Liquidation
|
Liquidation value |
$85.75 - $99.99 ($95.36)
|
|||||||||||||
Discounted cash flow |
Liquidity premium |
0.02% - 1.25% (0.64%) | |||||||||||||||||
|
|
|
Paydown rate |
10.96% - 13.11% (12.03%) | |||||||||||||||
Corporate securities |
631,068
|
Discounted cash flow
|
Spread over treasury |
0.84% - 3.00% (1.84%) | |||||||||||||||
Liabilities:(1) |
|||||||||||||||||||
Embedded derivatives GLWB(2) |
$ |
43,307 |
|
Actuarial cash flow model
|
Mortality
|
87% to 100% of Ruark 2015 ALB Table
|
|||||||||||||
Lapse |
Ruark Predictive Model |
||||||||||||||||||
|
|
|
Utilization
|
99%. 10% of policies have a one-time over-utilization of 400% |
|||||||||||||||
|
|
|
Nonperformance risk |
0.21% - 1.16%
|
|||||||||||||||
Embedded derivative FIA |
217,288
|
Actuarial cash flow model |
Expenses
|
$145 per policy
|
|||||||||||||||
|
|
|
Withdrawal rate
|
1.5% prior to age 70, 100% of the RMD for ages 70+ |
|||||||||||||||
|
|
|
Mortality |
87% to 100% of Ruark 2015 ALB table |
|||||||||||||||
|
|
|
Lapse
|
1.0% - 30.0%, depending on duration/surrender charge period |
|||||||||||||||
|
|
|
Nonperformance risk |
0.21% - 1.16%
|
F-56
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
Fair Value
As of December 31, 2018 |
Valuation
Technique |
Unobservable
Input |
Range
(Weighted Average) |
||||||||||||||||
(Dollars In
Thousands) |
|||||||||||||||||||
Embedded derivative IUL |
$ |
90,231 |
|
Actuarial cash flow model |
Mortality
|
37% - 577% of 2015 VBT Primary Tables |
|||||||||||||
|
|
|
Lapse
|
0.5% - 10.0%, depending on duration/distribution channel and smoking class |
|||||||||||||||
|
|
|
Nonperformance risk |
0.21% - 1.16% |
(1) Excludes modified coinsurance arrangements.
(2) The fair value for the GLWB embedded derivative is presented as a net liability.
The chart above excludes Level 3 financial instruments that are valued using broker quotes and those which book value approximates fair value.
The Company has considered all reasonably available quantitative inputs as of December 31, 2018, but the valuation techniques and inputs used by some brokers in pricing certain financial instruments are not shared with the Company. This resulted in $39.7 million of financial instruments being classified as Level 3 as of December 31, 2018. Of the $39.7 million, $26.2 million are other asset backed securities, and $13.5 million are corporate securities.
In certain cases the Company has determined that book value materially approximates fair value. As of December 31, 2018, the Company held $63.4 million of financial instruments where book value approximates fair value which are predominantly FHLB stock.
The asset-backed securities classified as Level 3 are predominantly ARS. A change in the paydown rate (the projected annual rate of principal reduction) of the ARS can significantly impact the fair value of these securities. A decrease in the paydown rate would increase the projected weighted average life of the ARS and increase the sensitivity of the ARS' fair value to changes in interest rates. An increase in the liquidity premium would result in a decrease in the fair value of the securities, while a decrease in the liquidity premium would increase the fair value of these securities. The liquidation value for these securities are sensitive to the issuer's available cash flows and ability to redeem the securities, as well as the current holders' willingness to liquidate at the specified price.
The fair value of corporate bonds classified as Level 3 is sensitive to changes in the interest rate spread over the corresponding U.S. Treasury rate. This spread represents a risk premium that is impacted by company specific and market factors. An increase in the spread can be caused by a perceived increase in credit risk of a specific issuer and/or an increase in the overall market risk premium associated with similar securities. The fair values of corporate bonds are sensitive to changes in spread. When holding the treasury rate constant, the fair value of corporate bonds increases when spreads decrease, and decreases when spreads increase.
F-57
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
The fair value of the GLWB embedded derivative is sensitive to changes in the discount rate which includes the Company's nonperformance risk, volatility, lapse, and mortality assumptions. The volatility assumption is an observable input as it is based on market inputs. The Company's nonperformance risk, lapse, and mortality are unobservable. An increase in the three unobservable assumptions would result in a decrease in the fair value of the liability and conversely, if there is a decrease in the assumptions the fair value would increase. The fair value is also dependent on the assumed policyholder utilization of the GLWB where an increase in assumed utilization would result in an increase in the fair value of the liability and conversely, if there is a decrease in the assumption, the fair value would decrease.
The fair value of the FIA embedded derivative is predominantly impacted by observable inputs such as discount rates and equity returns. However, the fair value of the FIA embedded derivative is sensitive to non-performance risk, which is unobservable. The value of the liability increases with decreases in the discount rate and non-performance risk and decreases with increases in the discount rate and nonperformance risk. The value of the liability increases with increases in equity returns and the liability decreases with a decrease in equity returns.
The fair value of the IUL embedded derivative is predominantly impacted by observable inputs such as discount rates and equity returns. However, the fair value of the IUL embedded derivative is sensitive to non-performance risk, which is unobservable. The value of the liability increases with decreases in the discount rate and non-performance risk and decreases with increases in the discount rate and non-performance risk. The value of the liability increases with increases in equity returns and the liability decreases with a decrease in equity returns.
F-58
(This page has been left blank intentionally.)
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
The following table presents a reconciliation of the beginning and ending balances for fair value measurements for the year ended December 31, 2019, for which the Company has used significant unobservable inputs (Level 3):
Total
Realized and Unrealized Gains |
Total
Realized and Unrealized Losses |
||||||||||||||||||||||
Beginning
Balance |
Included in
Earnings |
Included in
Other Comprehensive Income |
Included in
Earnings |
Included In
Other Comprehensive Income |
|||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
Assets: |
|||||||||||||||||||||||
Fixed maturity securities available-for-sale |
|||||||||||||||||||||||
Residential mortgage-backed securities |
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||
Commercial mortgage-backed securities |
|
|
730 |
|
(91 |
) |
|||||||||||||||||
Other asset-backed securities |
421,642 |
904 |
26,034 |
(71 |
) |
(8,075 |
) |
||||||||||||||||
Corporate securities |
638,276 |
82 |
72,881 |
|
(14,827 |
) |
|||||||||||||||||
Total fixed maturity securities
available-for-sale |
1,059,918 |
986 |
99,645 |
(71 |
) |
(22,993 |
) |
||||||||||||||||
Fixed maturity securities trading |
|||||||||||||||||||||||
Other asset-backed securities |
26,056 |
9,295 |
|
(3,695 |
) |
|
|||||||||||||||||
Corporate securities |
6,242 |
239 |
|
(35 |
) |
|
|||||||||||||||||
Total fixed maturity securities trading |
32,298 |
9,534 |
|
(3,730 |
) |
|
|||||||||||||||||
Total fixed maturity securities |
1,092,216 |
10,520 |
99,645 |
(3,801 |
) |
(22,993 |
) |
||||||||||||||||
Equity securities |
63,421 |
(1,829 |
) |
(244 |
) |
(18 |
) |
|
|||||||||||||||
Other long-term investments(1) |
151,342 |
90,078 |
|
(31,448 |
) |
|
|||||||||||||||||
Short-term investments |
|
|
|
|
|
||||||||||||||||||
Total investments |
1,306,979 |
98,769 |
99,401 |
(35,267 |
) |
(22,993 |
) |
||||||||||||||||
Total assets measured at fair value on a
recurring basis |
$ |
1,306,979 |
$ |
98,769 |
$ |
99,401 |
$ |
(35,267 |
) |
$ |
(22,993 |
) |
|||||||||||
Liabilities: |
|||||||||||||||||||||||
Annuity account balances(2) |
$ |
76,119 |
$ |
|
$ |
|
$ |
(2,550 |
) |
$ |
|
||||||||||||
Other liabilities(1) |
438,127 |
108,438 |
|
(617,395 |
) |
|
|||||||||||||||||
Total liabilities measured at fair value on a
recurring basis |
$ |
514,246 |
$ |
108,438 |
$ |
|
$ |
(619,945 |
) |
$ |
|
(1) Represents certain freestanding and embedded derivatives.
(2) Represents liabilities related to fixed indexed annuities.
For the year ended December 31, 2019, $195.4 million of securities were transferred into Level 3.
For the year ended December 31, 2019, $58.4 million of securities were transferred into Level 2. This amount was transferred from Level 3. These transfers resulted from securities that were priced internally using significant unobservable inputs where market observable inputs were not available in previous periods but were priced by independent pricing services or brokers as of December 31, 2019.
For the year ended December 31, 2019, there were no transfers from Level 2 to Level 1.
For the year ended December 31, 2019, no securities were transferred from Level 1.
F-60
Total Gains
(losses) included in Earnings related to |
|||||||||||||||||||||||||||||||||||
Purchases |
Sales |
Issuances |
Settlements |
Transfers
in/out of Level 3 |
Other |
Ending
Balance |
Instruments
still held at the Reporting Date |
||||||||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||||||||||||||
Assets: |
|||||||||||||||||||||||||||||||||||
Fixed maturity securities available-for-sale |
|||||||||||||||||||||||||||||||||||
Residential mortgage-backed securities |
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Commercial mortgage-backed securities |
9,359 |
(46 |
) |
|
|
95 |
(18 |
) |
10,029 |
|
|||||||||||||||||||||||||
Other asset-backed securities |
|
(20,031 |
) |
|
|
|
816 |
421,219 |
|
||||||||||||||||||||||||||
Corporate securities |
752,929 |
(179,604 |
) |
|
|
106,368 |
(2,391 |
) |
1,373,714 |
|
|||||||||||||||||||||||||
Total fixed maturity securities
available-for-sale |
762,288 |
(199,681 |
) |
|
|
106,463 |
(1,593 |
) |
1,804,962 |
|
|||||||||||||||||||||||||
Fixed maturity securities trading |
|||||||||||||||||||||||||||||||||||
Other asset-backed securities |
32,182 |
(24,496 |
) |
|
|
26,267 |
(202 |
) |
65,407 |
1,829 |
|||||||||||||||||||||||||
Corporate securities |
1,700 |
(1,035 |
) |
|
|
4,363 |
(103 |
) |
11,371 |
35 |
|||||||||||||||||||||||||
Total fixed maturity securities trading |
33,882 |
(25,531 |
) |
|
|
30,630 |
(305 |
) |
76,778 |
1,864 |
|||||||||||||||||||||||||
Total fixed maturity securities |
796,170 |
(225,212 |
) |
|
|
137,093 |
(1,898 |
) |
1,881,740 |
1,864 |
|||||||||||||||||||||||||
Equity securities |
9,567 |
2,073 |
|
|
|
|
72,970 |
426 |
|||||||||||||||||||||||||||
Other long-term investments(1) |
1,579 |
|
|
(1,708 |
) |
|
|
209,843 |
56,922 |
||||||||||||||||||||||||||
Short-term investments |
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total investments |
807,316 |
(223,139 |
) |
|
(1,708 |
) |
137,093 |
(1,898 |
) |
2,164,553 |
59,212 |
||||||||||||||||||||||||
Total assets measured at fair value on a
recurring basis |
$ |
807,316 |
$ |
(223,139 |
) |
$ |
|
$ |
(1,708 |
) |
$ |
137,093 |
$ |
(1,898 |
) |
$ |
2,164,553 |
$ |
59,212 |
||||||||||||||||
Liabilities: |
|||||||||||||||||||||||||||||||||||
Annuity account balances(2) |
$ |
|
$ |
|
$ |
|
$ |
365 |
$ |
9,306 |
$ |
|
$ |
69,728 |
$ |
|
|||||||||||||||||||
Other liabilities(1) |
70,888 |
|
|
|
|
|
1,017,972 |
(508,957 |
) |
||||||||||||||||||||||||||
Total liabilities measured at fair value on a
recurring basis |
$ |
70,888 |
$ |
|
$ |
|
$ |
365 |
$ |
9,306 |
$ |
|
$ |
1,087,700 |
$ |
(508,957 |
) |
F-61
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
The following table presents a reconciliation of the beginning and ending balances for fair value measurements for the year ended December 31, 2018, for which the Company has used significant unobservable inputs (Level 3):
Total
Realized and Unrealized Gains |
Total
Realized and Unrealized Losses |
||||||||||||||||||||||
Beginning
Balance |
Included in
Earnings |
Included in
Other Comprehensive Income |
Included in
Earnings |
Included in
Other Comprehensive Income |
|||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
Assets: |
|||||||||||||||||||||||
Fixed maturity securities available-for-sale |
|||||||||||||||||||||||
Residential mortgage-backed securities |
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(995 |
) |
||||||||||||
Commercial mortgage-backed securities |
|
|
50 |
|
(2,497 |
) |
|||||||||||||||||
Other asset-backed securities |
504,365 |
3,716 |
16,503 |
(159 |
) |
(25,578 |
) |
||||||||||||||||
Corporate securities |
626,901 |
|
12,537 |
|
(29,017 |
) |
|||||||||||||||||
Total fixed maturity securities
available-for-sale |
1,131,266 |
3,716 |
29,090 |
(159 |
) |
(58,087 |
) |
||||||||||||||||
Fixed maturity securities trading |
|||||||||||||||||||||||
Other asset-backed securities |
35,222 |
464 |
|
(3,798 |
) |
|
|||||||||||||||||
Corporate securities |
5,442 |
45 |
|
(145 |
) |
|
|||||||||||||||||
Total fixed maturity securities trading |
40,664 |
509 |
|
(3,943 |
) |
|
|||||||||||||||||
Total fixed maturity securities |
1,171,930 |
4,225 |
29,090 |
(4,102 |
) |
(58,087 |
) |
||||||||||||||||
Equity securities |
65,518 |
1 |
|
(30 |
) |
|
|||||||||||||||||
Other long-term investments(1) |
160,466 |
39,118 |
|
(47,615 |
) |
|
|||||||||||||||||
Short-term investments |
|
|
|
|
|
||||||||||||||||||
Total investments |
1,397,914 |
43,344 |
29,090 |
(51,747 |
) |
(58,087 |
) |
||||||||||||||||
Total assets measured at fair value on a
recurring basis |
$ |
1,397,914 |
$ |
43,344 |
$ |
29,090 |
$ |
(51,747 |
) |
$ |
(58,087 |
) |
|||||||||||
Liabilities: |
|||||||||||||||||||||||
Annuity account balances(2) |
$ |
83,472 |
$ |
|
$ |
|
$ |
(3,505 |
) |
$ |
|
||||||||||||
Other liabilities(1) |
597,562 |
299,366 |
|
(139,931 |
) |
|
|||||||||||||||||
Total liabilities measured at fair value on a
recurring basis |
$ |
681,034 |
$ |
299,366 |
$ |
|
$ |
(143,436 |
) |
$ |
|
(1) Represents certain freestanding and embedded derivatives.
(2) Represents liabilities related to fixed indexed annuities.
For the year ended December 31, 2018, $39.7 million of securities were transferred into Level 3.
For the year ended December 31, 2018, $85.7 million of securities were transferred into Level 2. This amount was transferred from Level 3. These transfers resulted from securities that were priced internally using significant unobservable inputs where market observable inputs were not available in previous periods but were priced by independent pricing services or brokers as of December 31, 2018.
For the year ended December 31, 2018, there were no transfers from Level 2 to Level 1.
For the year ended December 31, 2018, no securities were transferred out of Level 1.
F-62
Total Gains
(losses) included in Earnings related to |
|||||||||||||||||||||||||||||||||||
Purchases |
Sales |
Issuances |
Settlements |
Transfers
in/out of Level 3 |
Other |
Ending
Balance |
Instruments
still held at the Reporting Date |
||||||||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||||||||||||||
Assets: |
|||||||||||||||||||||||||||||||||||
Fixed maturity securities available-for-sale |
|||||||||||||||||||||||||||||||||||
Residential mortgage-backed securities |
$ |
22,225 |
$ |
|
$ |
|
$ |
|
$ |
(21,281 |
) |
$ |
51 |
$ |
|
$ |
|
||||||||||||||||||
Commercial mortgage-backed securities |
48,621 |
(292 |
) |
|
|
(45,832 |
) |
(50 |
) |
|
|
||||||||||||||||||||||||
Other asset-backed securities |
|
(80,050 |
) |
|
|
222 |
2,623 |
421,642 |
|
||||||||||||||||||||||||||
Corporate securities |
108,491 |
(97,676 |
) |
|
|
20,721 |
(3,681 |
) |
638,276 |
|
|||||||||||||||||||||||||
Total fixed maturity securities
available-for-sale |
179,337 |
(178,018 |
) |
|
|
(46,170 |
) |
(1,057 |
) |
1,059,918 |
|
||||||||||||||||||||||||
Fixed maturity securities trading |
|||||||||||||||||||||||||||||||||||
Other asset-backed securities |
8,728 |
(14,511 |
) |
|
|
164 |
(213 |
) |
26,056 |
(3,179 |
) |
||||||||||||||||||||||||
Corporate securities |
999 |
|
|
|
|
(99 |
) |
6,242 |
(101 |
) |
|||||||||||||||||||||||||
Total fixed maturity securities trading |
9,727 |
(14,511 |
) |
|
|
164 |
(312 |
) |
32,298 |
(3,280 |
) |
||||||||||||||||||||||||
Total fixed maturity securities |
189,064 |
(192,529 |
) |
|
|
(46,006 |
) |
(1,369 |
) |
1,092,216 |
(3,280 |
) |
|||||||||||||||||||||||
Equity securities |
36 |
(2,103 |
) |
|
|
|
(1 |
) |
63,421 |
282 |
|||||||||||||||||||||||||
Other long-term investments(1) |
|
|
|
(627 |
) |
|
|
151,342 |
(9,124 |
) |
|||||||||||||||||||||||||
Short-term investments |
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total investments |
189,100 |
(194,632 |
) |
|
(627 |
) |
(46,006 |
) |
(1,370 |
) |
1,306,979 |
(12,122 |
) |
||||||||||||||||||||||
Total assets measured at fair value on a
recurring basis |
$ |
189,100 |
$ |
(194,632 |
) |
$ |
|
$ |
(627 |
) |
$ |
(46,006 |
) |
$ |
(1,370 |
) |
$ |
1,306,979 |
$ |
(12,122 |
) |
||||||||||||||
Liabilities: |
|||||||||||||||||||||||||||||||||||
Annuity account balances(2) |
$ |
|
$ |
|
$ |
623 |
$ |
11,481 |
$ |
|
$ |
|
$ |
76,119 |
$ |
|
|||||||||||||||||||
Other liabilities(1) |
|
|
|
|
|
|
438,127 |
159,435 |
|||||||||||||||||||||||||||
Total liabilities measured at fair value on a
recurring basis |
$ |
|
$ |
|
$ |
623 |
$ |
11,481 |
$ |
|
$ |
|
$ |
514,246 |
$ |
159,435 |
F-63
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
Total realized and unrealized gains (losses) on Level 3 assets and liabilities are primarily reported in either realized investment gains (losses) within the consolidated statements of income (loss) or other comprehensive income (loss) within shareowner's equity based on the appropriate accounting treatment for the item.
Purchases, sales, issuances, and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily relates to purchases and sales of fixed maturity securities and issuances and settlements of fixed indexed annuities.
The Company reviews the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. The asset transfers in the table(s) above primarily related to positions moved from Level 3 to Level 2 as the Company determined that certain inputs were observable.
The amount of total gains (losses) for assets and liabilities still held as of the reporting date primarily represents changes in fair value of trading securities and certain derivatives that exist as of the reporting date and the change in fair value of fixed indexed annuities.
Estimated Fair Value of Financial Instruments
The carrying amounts and estimated fair values of the Company's financial instruments as of the periods shown below are as follows:
As of December 31, |
|||||||||||||||||||||||
2019 |
2018 |
||||||||||||||||||||||
Fair Value
Level |
Carrying
Amounts |
Fair Values |
Carrying
Amounts |
Fair Values |
|||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
Assets: |
|||||||||||||||||||||||
Mortgage loans on real estate |
3 |
$ |
9,379,401 |
$ |
9,584,487 |
$ |
7,724,733 |
$ |
7,447,702 |
||||||||||||||
Policy loans |
3 |
1,675,121 |
1,675,121 |
1,695,886 |
1,695,886 |
||||||||||||||||||
Fixed maturities, held-to-maturity(1) |
3 |
2,823,881 |
3,025,790 |
2,633,474 |
2,547,210 |
||||||||||||||||||
Other long-term investments(2) |
3 |
1,216,996 |
1,246,889 |
|
|
||||||||||||||||||
Liabilities: |
|||||||||||||||||||||||
Stable value product account balances |
3 |
$ |
5,443,752 |
$ |
5,551,195 |
$ |
5,234,731 |
$ |
5,200,723 |
||||||||||||||
Future policy benefits and claims(3) |
3 |
1,701,324 |
1,705,235 |
1,671,414 |
1,671,434 |
||||||||||||||||||
Other policyholders' funds(4) |
3 |
127,084 |
130,259 |
131,150 |
131,782 |
||||||||||||||||||
Debt:(5) |
|||||||||||||||||||||||
Non-recourse funding obligations(6) |
3 |
$ |
3,082,753 |
$ |
3,298,580 |
$ |
2,888,329 |
$ |
2,801,399 |
||||||||||||||
Subordinated funding obligations |
3 |
110,000 |
113,286 |
110,000 |
95,476 |
Except as noted below, fair values were estimated using quoted market prices.
(1) Securities purchased from unconsolidated subsidiaries, Red Mountain LLC and Steel City LLC.
(2) Other long-term investments represents a modco receivable, which is related to invested assets such as fixed income and structured securities, which are legally owned by the ceding company. The fair value is determined in a manner consistent with other similar invested assets held by the Company.
(3) Single premium immediate annuity without life contingencies.
F-64
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
(4) Supplementary contracts without life contingencies.
(5) Excludes capital lease obligations of $1.0 million and $1.3 million as of December 31, 2019 and 2018, respectively.
(6) As of December 31, 2019, carrying amount $2.8 billion and a fair value of $3.0 billion related to non-recourse funding obligations issued by Golden Gate and Golden Gate V. As of December 31, 2018, carrying amount of $2.6 billion and fair value of $2.5 billion related to non-recourse funding obligations issued by Golden Gate and Golden Gate V.
Fair Value Measurements
Mortgage Loans on Real Estate
The Company estimates the fair value of mortgage loans using an internally developed model. This model includes inputs derived by the Company based on assumed discount rates relative to the Company's current mortgage loan lending rate and an expected cash flow analysis based on a review of the mortgage loan terms. The model also contains the Company's determined representative risk adjustment assumptions related to credit and liquidity risks.
Policy Loans
The Company believes the fair value of policy loans approximates book value. Policy loans are funds provided to policyholders in return for a claim on the policy. The funds provided are limited to the cash surrender value of the underlying policy. The nature of policy loans is to have a negligible default risk as the loans are fully collateralized by the value of the policy. Policy loans do not have a stated maturity and the balances and accrued interest are repaid either by the policyholder or with proceeds from the policy. Due to the collateralized nature of policy loans and unpredictable timing of repayments, the Company believes the carrying value of policy loans approximates fair value.
Fixed Maturities, Held-to-Maturity
The Company estimates the fair value of its fixed maturity, held-to-maturity securities using internal discounted cash flow models. The discount rates used in the model are based on a current market yield for similar financial instruments.
Other Long-Term Investments
In addition to free-standing and embedded derivative financial instruments discussed above, other long-term investments includes approximately $1.2 billion of amounts receivable under certain modified coinsurance agreements. These amounts represent funds withheld in connection with certain reinsurance agreements in which the Company acts as the reinsurer. Under the terms of these agreements, assets equal to statutory reserves are withheld and legally owned by the ceding company, and any excess or shortfall is settled periodically. In some cases, these modified coinsurance agreements contain embedded derivatives which are discussed in more detail above. The fair value of amounts receivable under modified coinsurance agreements, including the embedded derivative component, correspond to the fair value of the underlying assets withheld.
Stable Value Product and Other Investment Contract Balances
The Company estimates the fair value of stable value product account balances and other investment contract balances (included in Future policy benefits and claims as well as Other policyholders' funds line items on our consolidated balance sheet) using models based on discounted expected cash flows.
F-65
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
6. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
The discount rates used in the models are based on a current market rate for similar financial instruments.
Funding Obligations
The Company estimates the fair value of its subordinated and non-recourse funding obligations using internal discounted cash flow models. The discount rates used in the model are based on a current market yield for similar financial instruments.
7. DERIVATIVE FINANCIAL INSTRUMENTS
Types of Derivative Instruments and Derivative Strategies
The Company utilizes a risk management strategy that incorporates the use of derivative financial instruments to reduce exposure to certain risks, including but not limited to, interest rate risk, currency exchange risk, volatility risk, and equity market risk. These strategies are developed through the Company's analysis of data from financial simulation models and other internal and industry sources, and are then incorporated into the Company's risk management program.
Derivative instruments expose the Company to credit and market risk and could result in material changes from period to period. The Company attempts to minimize its credit in connection with its overall asset/liability management programs and risk management strategies. In addition, all derivative programs are monitored by our risk management department.
Derivatives Related to Interest Rate Risk Management
Derivative instruments that are used as part of the Company's interest rate risk management strategy include interest rate swaps, interest rate futures, interest rate caps, and interest rate swaptions.
Derivatives Related to Foreign Currency Exchange Risk Management
Derivative instruments that are used as part of the Company's foreign currency exchange risk management strategy include foreign currency swaps, foreign currency futures, foreign equity futures, and foreign equity options.
Derivatives Related to Risk Mitigation of Certain Annuity Contracts
The Company may use the following types of derivative contracts to mitigate its exposure to certain guaranteed benefits related to VA contracts, fixed indexed annuities, and indexed universal life contracts:
• Foreign Currency Futures
• Variance Swaps
• Interest Rate Futures
• Equity Options
• Equity Futures
• Credit derivatives
• Interest Rate Swaps
• Interest Rate Swaptions
F-66
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
7. DERIVATIVE FINANCIAL INSTRUMENTS (Continued)
• Volatility Futures
• Volatility Options
• Funds Withheld Agreement
• Total Return Swaps
• Foreign Currency Options
Other Derivatives
The Company and certain of its subsidiaries have derivatives with PLC. These derivatives consist of an interest support agreement, YRT premium support agreements, and portfolio maintenance agreements with PLC.
The Company has a funds withheld account that consists of various derivative instruments held by us that is used to hedge the GLWB and GMDB riders. The economic performance of derivatives in the funds withheld account is ceded to Shades Creek. The funds withheld account is accounted for as a derivative financial instrument.
Accounting for Derivative Instruments
GAAP requires that all derivatives be recognized in the balance sheet at fair value. The Company records its derivative financial instruments in the consolidated balance sheet in other long-term investments and other liabilities. The change in the fair value of derivative financial instruments is reported either in the statement of income or in other comprehensive income (loss), depending upon whether it qualified for and also has been properly identified as being part of a hedging relationship, and also on the type of hedging relationship that exists.
It is the Company's policy not to offset assets and liabilities associated with open derivative contracts. However, the Chicago Mercantile Exchange ("CME") rules characterize variation margin transfers as settlement payments, as opposed to adjustments to collateral. As a result, derivative assets and liabilities associated with centrally cleared derivatives for which the CME serves as the central clearing party are presented as if these derivatives had been settled as of the reporting date.
For a derivative financial instrument to be accounted for as an accounting hedge, it must be identified and documented as such on the date of designation. For cash flow hedges, the effective portion of their realized gain or loss is reported as a component of other comprehensive income and reclassified into earnings in the same period during which the hedged item impacts earnings. Any remaining gain or loss, the ineffective portion, is recognized in current earnings. For fair value hedge derivatives, their gain or loss as well as the offsetting loss or gain attributable to the hedged risk of the hedged item is recognized in current earnings. Effectiveness of the Company's hedge relationships is assessed on a quarterly basis.
The Company reports changes in fair values of derivatives that are not part of a qualifying hedge relationship through earnings in the period of change. Changes in the fair value of derivatives that are recognized in current earnings are reported in Realized investment gains (losses).
F-67
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
7. DERIVATIVE FINANCIAL INSTRUMENTS (Continued)
Derivative Instruments Designated and Qualifying as Hedging Instruments
Cash-Flow Hedges
• To hedge a fixed rate note denominated in a foreign currency, the Company entered into a fixed-to-fixed foreign currency swap in order to hedge the foreign currency exchange risk associated with the note. The cash flows received on the swap are identical to the cash flow paid on the note.
• To hedge a floating rate note, the Company entered into an interest rate swap to exchange the floating rate on the note for a fixed rate in order to hedge the interest rate risk associated with the note. The cash flows received on the swap are identical to the cash flow variability paid on the note.
Derivative Instruments Not Designated and Not Qualifying as Hedging Instruments
The Company uses various other derivative instruments for risk management purposes that do not qualify for hedge accounting treatment. Changes in the fair value of these derivatives are recognized in earnings during the period of change.
Derivatives Related to Variable Annuity Contracts
• The Company uses equity futures, equity options, total return swaps, interest rate futures, interest rate swaps, interest rate swaptions, currency futures, currency options, volatility futures, volatility options, and variance swaps to mitigate the risk related to certain guaranteed minimum benefits, including GLWB, within its VA products. In general, the cost of such benefits varies with the level of equity and interest rate markets, foreign currency levels, and overall volatility.
• The Company markets certain VA products with a GLWB rider. The GLWB component is considered an embedded derivative, not considered to be clearly and closely related to the host contract.
• The Company has a funds withheld account that consists of various derivative instruments held by the Company that are used to hedge the GLWB and GMDB riders. The economic performance of derivatives in the funds withheld account is ceded to Shades Creek. The funds withheld account is accounted for as a derivative financial instrument.
Derivatives Related to Fixed Annuity Contracts
• The Company uses equity futures and options to mitigate the risk within its fixed indexed annuity products. In general, the cost of such benefits varies with the level of equity and overall volatility.
• The Company markets certain fixed indexed annuity products. The FIA component is considered an embedded derivative as it is, not considered to be clearly and closely related to the host contract.
Derivatives Related to Indexed Universal Life Contracts
• The Company uses equity futures and options to mitigate the risk within its indexed universal life products. In general, the cost of such benefits varies with the level of equity markets.
F-68
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
7. DERIVATIVE FINANCIAL INSTRUMENTS (Continued)
• The Company markets certain IUL products. The IUL component is considered an embedded derivative as it is, not considered to be clearly and closely related to the host contract.
Other Derivatives
• The Company and certain of its subsidiaries have an interest support agreement, YRT premium support agreements, and portfolio maintenance agreements with PLC.
• The Company uses various swaps and other types of derivatives to manage risk related to other exposures.
• The Company is involved in various modified coinsurance arrangements and funds withheld which contain embedded derivatives. Changes in their fair value are recorded in current period earnings. The investment portfolios that support the related modified coinsurance reserves and funds withheld arrangements had fair value changes which substantially offset the gains or losses on these embedded derivatives.
The following table sets forth realized investments gains and losses for the periods shown:
Realized investment gains (losses) derivative financial instruments
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Derivatives related to VA contracts: |
|||||||||||||||
Interest rate futures |
$ |
(20,012 |
) |
$ |
(25,473 |
) |
$ |
26,015 |
|||||||
Equity futures |
5,069 |
(88,208 |
) |
(91,776 |
) |
||||||||||
Currency futures |
3,095 |
10,275 |
(23,176 |
) |
|||||||||||
Equity options |
(149,700 |
) |
38,083 |
(94,791 |
) |
||||||||||
Currency options |
(94 |
) |
|
|
|||||||||||
Interest rate swaptions |
|
(14 |
) |
(2,490 |
) |
||||||||||
Interest rate swaps |
229,641 |
(45,185 |
) |
27,981 |
|||||||||||
Total return swaps |
(78,014 |
) |
77,225 |
(32,240 |
) |
||||||||||
Embedded derivative GLWB |
(107,108 |
) |
(27,761 |
) |
(8,526 |
) |
|||||||||
Funds withheld derivative |
145,140 |
(25,541 |
) |
138,228 |
|||||||||||
Total derivatives related to VA contracts |
28,017 |
(86,599 |
) |
(60,775 |
) |
||||||||||
Derivatives related to FIA contracts: |
|||||||||||||||
Embedded derivative |
(85,573 |
) |
35,397 |
(55,878 |
) |
||||||||||
Equity futures |
1,717 |
330 |
642 |
||||||||||||
Equity options |
84,079 |
(38,885 |
) |
44,585 |
|||||||||||
Total derivatives related to FIA contracts |
223 |
(3,158 |
) |
(10,651 |
) |
||||||||||
Derivatives related to IUL contracts: |
|||||||||||||||
Embedded derivative |
(12,894 |
) |
9,062 |
(14,117 |
) |
||||||||||
Equity futures |
420 |
261 |
(818 |
) |
|||||||||||
Equity options |
14,882 |
(6,338 |
) |
9,580 |
|||||||||||
Total derivatives related to IUL contracts |
2,408 |
2,985 |
(5,355 |
) |
F-69
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
7. DERIVATIVE FINANCIAL INSTRUMENTS (Continued)
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Embedded derivative Modco reinsurance treaties |
$ |
(187,004 |
) |
$ |
166,757 |
$ |
(103,009 |
) |
|||||||
Derivatives with PLC(1) |
27,038 |
(902 |
) |
42,699 |
|||||||||||
Other derivatives |
(2,141 |
) |
14 |
50 |
|||||||||||
Total realized gains (losses) derivatives |
$ |
(131,459 |
) |
$ |
79,097 |
$ |
(137,041 |
) |
(1) These derivatives include an interest support, YRT premium support, and portfolio maintenance agreements between certain of the Company's subsidiaries and PLC.
The following tables present the components of the gain or loss on derivatives that qualify as a cash flow hedging relationship:
Gain (Loss) on Derivatives in Cash Flow Relationship
Amount of Gains (Losses)
Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives |
Amount and Location of
Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) |
Amount and Location of
(Losses) Recognized in Income (Loss) on Derivatives |
|||||||||||||
(Effective Portion) |
(Effective Portion) |
(Ineffective Portion) |
|||||||||||||
|
Benefits and settlement
expenses |
Realized investment
gains (losses) |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
For The Year Ended December 31, 2019 |
|||||||||||||||
Foreign currency swaps |
$ |
(9,638 |
) |
$ |
(1,031 |
) |
$ |
|
|||||||
Interest rate swaps |
(2,743 |
) |
(1,247 |
) |
|
||||||||||
Total |
$ |
(12,381 |
) |
$ |
(2,278 |
) |
$ |
|
|||||||
For The Year Ended December 31, 2018 |
|||||||||||||||
Foreign currency swaps |
$ |
(812 |
) |
$ |
(798 |
) |
$ |
|
|||||||
Interest rate swaps |
(1,574 |
) |
(633 |
) |
|
||||||||||
Total |
$ |
(2,386 |
) |
$ |
(1,431 |
) |
$ |
|
|||||||
For The Year Ended December 31, 2017 |
|||||||||||||||
Foreign currency swaps |
$ |
(867 |
) |
$ |
(694 |
) |
$ |
|
|||||||
Total |
$ |
(867 |
) |
$ |
(694 |
) |
$ |
|
Based on expected cash flows of the underlying hedged items, the Company expects to reclassify $2.7 million out of accumulated other comprehensive income (loss) into earnings during the next twelve months.
F-70
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
7. DERIVATIVE FINANCIAL INSTRUMENTS (Continued)
The table below presents information about the nature and accounting treatment of the Company's primary derivative financial instruments and the location in and effect on the consolidated financial statements for the periods presented below:
As of December 31, |
|||||||||||||||||||
2019 |
2018 |
||||||||||||||||||
Notional
Amount |
Fair
Value |
Notional
Amount |
Fair
Value |
||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
Other long-term investments |
|||||||||||||||||||
Derivatives not designated as hedging instruments: |
|||||||||||||||||||
Interest rate swaps |
$ |
2,228,000 |
$ |
98,655 |
$ |
1,515,500 |
$ |
28,501 |
|||||||||||
Total return swaps |
269,772 |
941 |
138,070 |
3,971 |
|||||||||||||||
Derivatives with PLC(1) |
2,830,889 |
115,379 |
2,856,351 |
90,049 |
|||||||||||||||
Embedded derivative Modco reinsurance treaties |
1,280,189 |
31,926 |
585,294 |
7,072 |
|||||||||||||||
Embedded derivative GLWB |
1,147,436 |
62,538 |
1,919,861 |
54,221 |
|||||||||||||||
Interest rate futures |
896,073 |
7,557 |
286,208 |
10,302 |
|||||||||||||||
Equity futures |
159,901 |
2,109 |
12,633 |
483 |
|||||||||||||||
Currency futures |
72,593 |
131 |
|
|
|||||||||||||||
Equity options |
6,685,670 |
676,257 |
5,624,081 |
220,092 |
|||||||||||||||
Other |
|
|
157 |
136 |
|||||||||||||||
$ |
15,570,523 |
$ |
995,493 |
$ |
12,938,155 |
$ |
414,827 |
||||||||||||
Other liabilities |
|||||||||||||||||||
Cash flow hedges: |
|||||||||||||||||||
Interest rate swaps |
$ |
350,000 |
$ |
|
$ |
350,000 |
$ |
|
|||||||||||
Foreign currency swaps |
117,178 |
11,373 |
117,178 |
904 |
|||||||||||||||
Derivatives not designated as hedging instruments: |
|||||||||||||||||||
Interest rate swaps |
50,000 |
|
775,000 |
11,367 |
|||||||||||||||
Total return swaps |
579,675 |
3,229 |
768,177 |
23,054 |
|||||||||||||||
Embedded derivative Modco reinsurance treaties |
2,263,685 |
231,516 |
1,795,287 |
32,828 |
|||||||||||||||
Funds withheld derivative |
1,845,649 |
70,583 |
1,992,562 |
95,142 |
|||||||||||||||
Embedded derivative GLWB |
2,892,926 |
248,577 |
4,071,322 |
97,528 |
|||||||||||||||
Embedded derivative FIA |
2,892,803 |
332,869 |
2,576,033 |
217,288 |
|||||||||||||||
Embedded derivative IUL |
301,598 |
151,765 |
233,550 |
90,231 |
|||||||||||||||
Interest rate futures |
669,223 |
10,375 |
863,706 |
20,100 |
|||||||||||||||
Equity futures |
174,743 |
2,376 |
659,357 |
33,753 |
|||||||||||||||
Currency futures |
192,306 |
1,836 |
202,747 |
2,163 |
|||||||||||||||
Equity options |
4,827,714 |
429,434 |
4,199,687 |
34,178 |
|||||||||||||||
Other |
199,387 |
53,245 |
3,288 |
252 |
|||||||||||||||
$ |
17,356,887 |
$ |
1,547,178 |
$ |
18,607,894 |
$ |
658,788 |
(1) These derivatives include an interest support, YRT premium support, and portfolio maintenance agreements between certain of the Company's subsidiaries and PLC.
8. OFFSETTING OF ASSETS AND LIABILITIES
Certain of the Company's derivative instruments are subject to enforceable master netting arrangements that provide for the net settlement of all derivative contracts between the Company and a counterparty in the event of default or upon the occurrence of certain termination events. Collateral support agreements associated with each master netting arrangement provide that the Company will receive or pledge financial collateral in the event either minimum thresholds, or in certain cases ratings levels, have been reached. Additionally, certain of the Company's repurchase agreements provide for
F-71
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
8. OFFSETTING OF ASSETS AND LIABILITIES (Continued)
net settlement on termination of the agreement. Refer to Note 14, Debt and Other Obligations for details of the Company's repurchase agreement programs.
Collateral received includes both cash and non-cash collateral. Cash collateral received by the Company is recorded on the consolidated balance sheet as "cash", with a corresponding amount recorded in "other liabilities" to represent the Company's obligation to return the collateral. Non-cash collateral received by the Company is not recognized on the consolidated balance sheet unless the Company exercises its right to sell or re-pledge the underlying asset. As of December 31, 2019 and 2018, the fair value of non-cash collateral received was $21.3 million and $45.0 million, respectively.
The tables below present the derivative instruments by assets and liabilities for the Company as of December 31, 2019:
Gross
Amounts of |
Gross
Amounts Offset in the Statement of |
Net Amounts
of Assets Presented in the Statement of |
Gross Amounts
Not Offset in the Statement of Financial Position |
|
|||||||||||||||||||||||
Recognized
Assets |
Financial
Position |
Financial
Position |
Financial
Instruments |
Collateral
Received |
Net Amount |
||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||||||
Offsetting of Derivative Assets |
|||||||||||||||||||||||||||
Derivatives: |
|||||||||||||||||||||||||||
Free-Standing
derivatives |
$ |
785,650 |
$ |
|
$ |
785,650 |
$ |
452,562 |
$ |
215,587 |
$ |
117,501 |
|||||||||||||||
Total derivatives, subject to
a master netting arrangement or similar arrangement |
785,650 |
|
785,650 |
452,562 |
215,587 |
117,501 |
|||||||||||||||||||||
Derivatives not subject to
a master netting arrangement or similar arrangement |
|||||||||||||||||||||||||||
Embedded derivative
Modco reinsurance treaties |
31,926 |
|
31,926 |
|
|
31,926 |
|||||||||||||||||||||
Embedded derivative
GLWB |
62,538 |
|
62,538 |
|
|
62,538 |
|||||||||||||||||||||
Derivatives with PLC |
115,379 |
|
115,379 |
|
|
115,379 |
|||||||||||||||||||||
Other |
|
|
|
|
|
|
|||||||||||||||||||||
Total derivatives, not subject
to a master netting arrangement or similar arrangement |
209,843 |
|
209,843 |
|
|
209,843 |
|||||||||||||||||||||
Total derivatives |
995,493 |
|
995,493 |
452,562 |
215,587 |
327,344 |
|||||||||||||||||||||
Total Assets |
$ |
995,493 |
$ |
|
$ |
995,493 |
$ |
452,562 |
$ |
215,587 |
$ |
327,344 |
F-72
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
8. OFFSETTING OF ASSETS AND LIABILITIES (Continued)
Gross
Amounts of |
Gross
Amounts Offset in the Statement of |
Net Amounts
of Liabilities Presented in the Statement of |
Gross Amounts
Not Offset in the Statement of Financial Position |
|
|||||||||||||||||||||||
Recognized
Liabilities |
Financial
Position |
Financial
Position |
Financial
Instruments |
Collateral
Posted |
Net Amount |
||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||||||
Offsetting of Derivative Liabilities |
|||||||||||||||||||||||||||
Derivatives: |
|||||||||||||||||||||||||||
Free-Standing
derivatives |
$ |
458,623 |
$ |
|
$ |
458,623 |
$ |
452,562 |
$ |
4,791 |
$ |
1,270 |
|||||||||||||||
Total derivatives, subject to
a master netting arrangement or similar arrangement |
458,623 |
|
458,623 |
452,562 |
4,791 |
1,270 |
|||||||||||||||||||||
Derivatives not subject to
a master netting arrangement or similar arrangement |
|||||||||||||||||||||||||||
Embedded derivative
Modco reinsurance treaties |
231,516 |
|
231,516 |
|
|
231,516 |
|||||||||||||||||||||
Funds withheld derivative |
70,583 |
|
70,583 |
|
|
70,583 |
|||||||||||||||||||||
Embedded derivative
GLWB |
248,577 |
|
248,577 |
|
|
248,577 |
|||||||||||||||||||||
Embedded derivative
FIA |
332,869 |
|
332,869 |
|
|
332,869 |
|||||||||||||||||||||
Embedded derivative
IUL |
151,765 |
|
151,765 |
|
|
151,765 |
|||||||||||||||||||||
Other |
53,245 |
|
53,245 |
|
|
53,245 |
|||||||||||||||||||||
Total derivatives, not subject
to a master netting arrangement or similar arrangement |
1,088,555 |
|
1,088,555 |
|
|
1,088,555 |
|||||||||||||||||||||
Total derivatives |
1,547,178 |
|
1,547,178 |
452,562 |
4,791 |
1,089,825 |
|||||||||||||||||||||
Repurchase agreements(1) |
270,000 |
|
270,000 |
|
|
270,000 |
|||||||||||||||||||||
Total Liabilities |
$ |
1,817,178 |
$ |
|
$ |
1,817,178 |
$ |
452,562 |
$ |
4,791 |
$ |
1,359,825 |
(1) Borrowings under repurchase agreements are for a term less than 90 days.
F-73
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
8. OFFSETTING OF ASSETS AND LIABILITIES (Continued)
The tables below present the derivative instruments by assets and liabilities for the Company as of December 31, 2018.
Gross
Amounts of |
Gross
Amounts Offset in the Statement of |
Net Amounts
of Assets Presented in the Statement of |
Gross Amounts
Not Offset in the Statement of Financial Position |
|
|||||||||||||||||||||||
Recognized
Assets |
Financial
Position |
Financial
Position |
Financial
Instruments |
Collateral
Received |
Net Amount |
||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||||||
Offsetting of Derivative Assets |
|||||||||||||||||||||||||||
Derivatives: |
|||||||||||||||||||||||||||
Free-Standing
derivatives |
$ |
263,349 |
$ |
|
$ |
263,349 |
$ |
70,322 |
$ |
99,199 |
$ |
93,828 |
|||||||||||||||
Total derivatives, subject to
a master netting arrangement or similar arrangement |
263,349 |
|
263,349 |
70,322 |
99,199 |
93,828 |
|||||||||||||||||||||
Derivatives not subject to
a master netting arrangement or similar arrangement |
|||||||||||||||||||||||||||
Embedded derivative
Modco reinsurance treaties |
7,072 |
|
7,072 |
|
|
7,072 |
|||||||||||||||||||||
Embedded derivative
GLWB |
54,221 |
|
54,221 |
|
|
54,221 |
|||||||||||||||||||||
Derivatives with PLC |
90,049 |
|
90,049 |
|
|
90,049 |
|||||||||||||||||||||
Other |
136 |
|
136 |
|
|
136 |
|||||||||||||||||||||
Total derivatives, not subject
to a master netting arrangement or similar arrangement |
151,478 |
|
151,478 |
|
|
151,478 |
|||||||||||||||||||||
Total derivatives |
414,827 |
|
414,827 |
70,322 |
99,199 |
245,306 |
|||||||||||||||||||||
Total Assets |
$ |
414,827 |
$ |
|
$ |
414,827 |
$ |
70,322 |
$ |
99,199 |
$ |
245,306 |
F-74
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
8. OFFSETTING OF ASSETS AND LIABILITIES (Continued)
Gross
Amounts of |
Gross
Amounts Offset in the Statement of |
Net Amounts
of Liabilities Presented in the Statement of |
Gross Amounts
Not Offset in the Statement of Financial Position |
|
|||||||||||||||||||||||
Recognized
Liabilities |
Financial
Position |
Financial
Position |
Financial
Instruments |
Collateral
Posted |
Net Amount |
||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||||||
Offsetting of Derivative Liabilities |
|||||||||||||||||||||||||||
Derivatives: |
|||||||||||||||||||||||||||
Free-Standing
derivatives |
$ |
125,519 |
$ |
|
$ |
125,519 |
$ |
70,322 |
$ |
47,856 |
$ |
7,341 |
|||||||||||||||
Total derivatives, subject to
a master netting arrangement or similar arrangement |
125,519 |
|
125,519 |
70,322 |
47,856 |
7,341 |
|||||||||||||||||||||
Derivatives not subject to
a master netting arrangement or similar arrangement |
|||||||||||||||||||||||||||
Embedded derivative
Modco reinsurance treaties |
32,828 |
|
32,828 |
|
|
32,828 |
|||||||||||||||||||||
Funds withheld derivative |
95,142 |
|
95,142 |
|
|
95,142 |
|||||||||||||||||||||
Embedded derivative
GLWB |
97,528 |
|
97,528 |
|
|
97,528 |
|||||||||||||||||||||
Embedded derivative
FIA |
217,288 |
|
217,288 |
|
|
217,288 |
|||||||||||||||||||||
Embedded derivative
IUL |
90,231 |
|
90,231 |
|
|
90,231 |
|||||||||||||||||||||
Other |
252 |
|
252 |
|
|
252 |
|||||||||||||||||||||
Total derivatives, not subject
to a master netting arrangement or similar arrangement |
533,269 |
|
533,269 |
|
|
533,269 |
|||||||||||||||||||||
Total derivatives |
658,788 |
|
658,788 |
70,322 |
47,856 |
540,610 |
|||||||||||||||||||||
Repurchase agreements(1) |
418,090 |
|
418,090 |
|
|
418,090 |
|||||||||||||||||||||
Total Liabilities |
$ |
1,076,878 |
$ |
|
$ |
1,076,878 |
$ |
70,322 |
$ |
47,856 |
$ |
958,700 |
(1) Borrowings under repurchase agreements are for a term less than 90 days.
F-75
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
9. MORTGAGE LOANS
Mortgage Loans
The Company invests a portion of its investment portfolio in commercial mortgage loans. As of December 31, 2019, the Company's mortgage loan holdings were approximately $9.4 billion. The Company has specialized in making loans on credit-oriented commercial properties, credit-anchored strip shopping centers, senior living facilities, and apartments. The Company's underwriting procedures relative to its commercial loan portfolio are based, in the Company's view, on a conservative and disciplined approach. The Company concentrates on a small number of commercial real estate asset types associated with the necessities of life (retail, multi-family, senior living, professional office buildings, and warehouses). The Company believes that these asset types tend to weather economic downturns better than other commercial asset classes in which it has chosen not to participate. The Company believes this disciplined approach has helped to maintain a relatively low delinquency and foreclosure rate throughout its history. The majority of the Company's mortgage loans portfolio was underwritten by the Company. From time to time, the Company may acquire loans in conjunction with an acquisition.
The Company's commercial mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, and net of valuation allowances. Interest income is accrued on the principal amount of the loan based on the loan's contractual interest rate. Amortization of premiums and discounts is recorded using the effective yield method. Interest income, amortization of premiums and discounts and prepayment fees are reported in net investment income.
The following table includes a breakdown of the Company's commercial mortgage loan portfolio by property type as of December 31, 2019 and 2018:
The Company specializes in originating mortgage loans on either credit-oriented or credit-anchored commercial properties. No single tenant's exposure represents more than 1.0% of mortgage loans. As
F-76
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
9. MORTGAGE LOANS (Continued)
of December 31, 2019 and 2018, approximately 60.2% and 62.5% of the mortgage loans are on properties located in the following states, respectively:
Percentage of Mortgage
Loans on Real Estate |
|||||||
State |
As of December 31, 2019 |
||||||
California |
11.9 |
% |
|||||
Texas |
7.7 |
||||||
Alabama |
7.2 |
||||||
Florida |
6.5 |
||||||
Georgia |
5.7 |
||||||
North Carolina |
5.0 |
||||||
Utah |
4.2 |
||||||
Michigan |
4.1 |
||||||
Illinois |
4.0 |
||||||
Ohio |
3.9 |
||||||
60.2 |
% |
||||||
Percentage of Mortgage
Loans on Real Estate |
|||||||
State |
As of December 31, 2018 |
||||||
Florida |
8.8 |
% |
|||||
Alabama |
8.6 |
||||||
Texas |
7.5 |
||||||
Georgia |
7.3 |
||||||
California |
7.2 |
||||||
Michigan |
4.8 |
||||||
Tennessee |
4.7 |
||||||
Utah |
4.7 |
||||||
Ohio |
4.5 |
||||||
North Carolina |
4.4 |
||||||
62.5 |
% |
During the year ended December 31, 2019, the Company funded approximately $1.2 billion of new loans, with an average loan size of $7.9 million. The average size mortgage loan in the portfolio as of December 31, 2019, was $5.1 million and the weighted-average interest rate was 4.5%. The largest single mortgage loan at December 31, 2019 was $78.0 million.
Certain of the mortgage loans have call options that occur within the next 10 years. However, if interest rates were to significantly increase, the Company may be unable to exercise the call options on its existing mortgage loans commensurate with the significantly increased market rates. Assuming the loans are called at their next call dates, approximately $134.0 million would become due in 2020, $683.1 million in 2021 through 2025, and $58.2 million in 2026 through 2029.
The Company offers a type of commercial mortgage loan under which the Company will permit a loan-to-value ratio of up to 85% in exchange for a participating interest in the cash flows from the
F-77
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
9. MORTGAGE LOANS (Continued)
underlying real estate. As of December 31, 2019 and 2018, approximately $717.0 million and $700.6 million, respectively, of the Company's total mortgage loans principal balance have this participation feature. Cash flows received as a result of this participation feature are recorded as interest income. During the years ended December 31, 2019, 2018, and 2017, the Company recognized $23.4 million, $29.4 million, and $37.2 million of participating mortgage loan income, respectively.
As of December 31, 2019, approximately $3.0 million of invested assets consisted of nonperforming mortgage loans, restructured mortgage loans, or mortgage loans that were foreclosed and were converted to real estate properties. The Company does not expect these investments to adversely affect its liquidity or ability to maintain proper matching of assets and liabilities. During the year ended December 31, 2019, the Company recognized four troubled debt restructurings as a result of the granting concessions to borrowers which included loan terms unavailable from other lenders. These concessions were the result of agreements between the creditor and the debtor. The Company did not identify any loans whose principal was permanently impaired during the year ended December 31, 2019.
As of December 31, 2018, approximately $3.0 million of invested assets consisted of nonperforming mortgage loans, restructured mortgage loans, or mortgage loans that were foreclosed and were converted to real estate properties. The Company does not expect these investments to adversely affect its liquidity or ability to maintain proper matching of assets and liabilities. During the year ended December 31, 2018, certain mortgage loan transactions occurred that were accounted for as troubled debt restructurings. For all mortgage loans, the impact of troubled debt restructurings is generally reflected in our investment balance and in the allowance for mortgage loan credit losses. During the year ended December 31, 2018, the Company recognized one troubled debt restructuring transaction as a result of the Company granting a concession to a borrower which included loan terms unavailable from other lenders. This concession was the result of an agreement between the creditor and the debtor. The Company did not identify any loans whose principal was permanently impaired during the year ended December 31, 2018.
As of December 31, 2017, approximately $6.5 million of invested assets consisted of nonperforming, restructured, or mortgage loans that were foreclosed and were converted to real estate properties. The Company does not expect these investments to adversely affect its liquidity or ability to maintain proper matching of assets and liabilities. During the year ended December 31, 2017, certain mortgage loan transactions occurred that were accounted for as troubled debt restructurings. For all mortgage loans, the impact of troubled debt restructurings is generally reflected in our investment balance and in the allowance for mortgage loan credit losses. During the year ended December 31, 2017, the Company recognized two troubled debt restructurings as a result of the Company granting concessions to borrowers which included loans terms unavailable from other lenders. These concessions were the result of agreements between the creditor and the debtor. The Company did not identify any loans whose principal was permanently impaired during the year ended December 31, 2017.
As of December 31, 2019 and December 31, 2018, there was an allowance for mortgage loan credit losses of $4.9 million and $1.3 million, respectively. Due to the Company's loss experience and nature of the loan portfolio, the Company believes that a collectively evaluated allowance would be inappropriate. The Company believes an allowance calculated through an analysis of specific loans that are believed to have a higher risk of credit impairment provides a more accurate presentation of expected losses in the portfolio and is consistent with the applicable guidance for loan impairments in ASC Subtopic 310. Since the Company uses the specific identification method for calculating the allowance, it is necessary to review the economic situation of each borrower to determine those that
F-78
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
9. MORTGAGE LOANS (Continued)
have higher risk of credit impairment. The Company has a team of professionals that monitors borrower conditions such as payment practices, borrower credit, operating performance, and property conditions, as well as ensuring the timely payment of property taxes and insurance. Through this monitoring process, the Company assesses the risk of each loan. When issues are identified, the severity of the issues are assessed and reviewed for possible credit impairment. If a loss is probable, an expected loss calculation is performed and an allowance is established for that loan based on the expected loss. The expected loss is calculated as the excess carrying value of a loan over either the present value of expected future cash flows discounted at the loan's original effective interest rate, or the current estimated fair value of the loan's underlying collateral. A loan may be subsequently charged off at such point that the Company no longer expects to receive cash payments, the present value of future expected payments of the renegotiated loan is less than the current principal balance, or at such time that the Company is party to foreclosure or bankruptcy proceedings associated with the borrower and does not expect to recover the principal balance of the loan.
A charge off is recorded by eliminating the allowance against the mortgage loan and recording the renegotiated loan or the collateral property related to the loan as investment real estate on the balance sheet, which is carried at the lower of the appraised fair value of the property or the unpaid principal balance of the loan, less estimated selling costs associated with the property.
As of December 31, 2019 and 2018, the Company had allowances for mortgage loan credit losses of $4.9 million and $1.3 million, respectively, which is shown in the chart below.
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Beginning balance |
$ |
1,296 |
$ |
|
|||||||
Charge offs |
(350 |
) |
|
||||||||
Recoveries |
|
(209 |
) |
||||||||
Provision |
3,938 |
1,505 |
|||||||||
Ending balance |
$ |
4,884 |
$ |
1,296 |
It is the Company's policy to cease to carry accrued interest on loans that are over 90 days delinquent. For loans less than 90 days delinquent, interest is accrued unless it is determined that the accrued interest is not collectible. If a loan becomes over 90 days delinquent, it is the Company's general policy to initiate foreclosure proceedings unless a workout arrangement to bring the loan current is in place.
The carrying value of the delinquent loans is shown in the following chart:
30-59
Days Delinquent |
60-89
Days Delinquent |
Greater
than 90 Days Delinquent |
Total
Delinquent |
||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
As of December 31, 2019 |
|||||||||||||||||||
Commercial mortgage loans |
$ |
6,455 |
$ |
|
$ |
710 |
$ |
7,165 |
|||||||||||
Number of delinquent commercial mortgage loans |
2 |
|
3 |
5 |
|||||||||||||||
As of December 31, 2018 |
|||||||||||||||||||
Commercial mortgage loans |
$ |
1,044 |
$ |
|
$ |
1,234 |
$ |
2,278 |
|||||||||||
Number of delinquent commercial mortgage loans |
4 |
|
1 |
5 |
F-79
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
9. MORTGAGE LOANS (Continued)
The Company's commercial mortgage loan portfolio consists of mortgage loans that are collateralized by real estate. Due to the collateralized nature of the loans, any assessment of impairment and ultimate loss given a default on the loans is based upon a consideration of the estimated fair value of the real estate. The Company limits accrued interest income on loans to 90 days of interest. Once accrued interest on a non accrual loan is received, interest income is recognized on a cash basis.
The following table for delinquent loans includes the recorded investment, unpaid principal balance, related allowance, average recorded investment, interest income recognized, and cash basis interest income of the commercial loan portfolio as of December 31, 2019 and 2018.
Recorded
Investment |
Unpaid
Principal Balance |
Related
Allowance |
Average
Recorded Investment |
Interest
Income Recognized |
Cash Basis
Interest Income |
||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||||||
As of December 31, 2019 |
|||||||||||||||||||||||||||
Commercial mortgage loans: |
|||||||||||||||||||||||||||
With no related allowance
recorded |
$ |
710 |
$ |
702 |
$ |
|
$ |
237 |
$ |
20 |
$ |
28 |
|||||||||||||||
With an allowance recorded |
16,209 |
16,102 |
4,884 |
3,242 |
841 |
838 |
|||||||||||||||||||||
As of December 31, 2018 |
|||||||||||||||||||||||||||
Commercial mortgage loans: |
|||||||||||||||||||||||||||
With no related allowance
recorded |
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
With an allowance recorded |
5,684 |
5,309 |
1,296 |
1,895 |
267 |
293 |
Mortgage loans that were modified in a troubled debt restructuring as of December 31, 2019 and 2018 were as follows:
Number of
contracts |
Pre-Modification
Outstanding Recorded Investment |
Post-Modification
Outstanding Recorded Investment |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
As of December 31, 2019 |
|||||||||||||||
Troubled debt restructuring: |
|||||||||||||||
Commercial mortgage loans |
2 |
$ |
3,771 |
$ |
3,771 |
||||||||||
As of December 31, 2018 |
|||||||||||||||
Troubled debt restructuring: |
|||||||||||||||
Commercial mortgage loans |
1 |
$ |
2,688 |
$ |
1,742 |
F-80
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
10. DEFERRED POLICY ACQUISITION COSTS AND VALUE OF BUSINESS ACQUIRED
Deferred Policy Acquisition Costs
The balances and changes in DAC are as follows:
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Balance, beginning of period |
$ |
1,348,613 |
$ |
843,448 |
|||||||
Capitalization of commissions, sales, and issue expenses |
407,556 |
446,593 |
|||||||||
Amortization |
(157,280 |
) |
(133,500 |
) |
|||||||
Change due to unrealized investment gains and losses |
(119,358 |
) |
56,153 |
||||||||
Implementation of ASU 2014-09 |
|
135,919 |
|||||||||
Balance, end of period |
$ |
1,479,531 |
$ |
1,348,613 |
Value of Business Acquired
The balances and changes in VOBA are as follows:
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Balance, beginning of period |
$ |
1,677,717 |
$ |
1,361,953 |
|||||||
Acquisitions |
551,892 |
336,862 |
|||||||||
Amortization |
(18,373 |
) |
(92,566 |
) |
|||||||
Change due to unrealized investment gains and losses |
(171,212 |
) |
71,468 |
||||||||
Balance, end of period |
$ |
2,040,024 |
$ |
1,677,717 |
Based on the balance recorded as of December 31, 2019, the expected amortization of VOBA for the next five years is as follows:
Years |
Expected
Amortization |
||||||
(Dollars In Thousands) |
|||||||
2020 |
$ |
113,345 |
|||||
2021 |
108,152 |
||||||
2022 |
107,321 |
||||||
2023 |
103,926 |
||||||
2024 |
102,264 |
11. GOODWILL
During the fourth quarter of 2019, the Company performed its annual qualitative evaluation of goodwill based on the circumstances that existed as of October 1, 2019 and determined that there was no indication that its segment goodwill was more likely than not impaired and no adjustment to impair goodwill was necessary. The Company has assessed whether events have occurred subsequent to October 1, 2019 that would impact the Company's conclusion and no such events were identified. After consideration of applicable factors and circumstances noted as part of the annual assessment, the
F-81
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
11. GOODWILL (Continued)
Company determined that no triggering events had occurred and it was more likely than not that the increase in the fair value of the reporting units would exceed the increase in the carrying value of the reporting units.
As of December 31, 2019, the balance of goodwill for the Company was $825.5 million.
12. CERTAIN NONTRADITIONAL LONG-DURATION CONTRACTS
The Company issues variable universal life and VA products through its separate accounts for which investment income and investment gains and losses accrue directly to, and investment risk is borne by, the contract holder. The Company also offers, for our VA products, certain GMDB riders. The most significant of these guarantees involve 1) return of the highest anniversary date account value, or 2) return of the greater of the highest anniversary date account value or the last anniversary date account value compounded at 5% interest or 3) return of premium. The GLWB rider provides the contract holder with protection against certain adverse market impacts on the amount they can withdraw and is classified as an embedded derivative and is carried at fair value on the Company's balance sheet. The VA separate account balances subject to GLWB were $8.4 billion and $8.4 billion as of December 31, 2019 and 2018, respectively. For more information regarding the valuation of and income impact of GLWB, please refer to Note 2, Summary of Significant Accounting Policies, Note 6, Fair Value of Financial Instruments, and Note 7, Derivative Financial Instruments.
The GMDB reserve is calculated by applying a benefit ratio, equal to the present value of total expected GMDB claims divided by the present value of total expected contract assessments, to cumulative contract assessments. This amount is then adjusted by the amount of cumulative GMDB claims paid and accrued interest. Assumptions used in the calculation of the GMDB reserve were as follows: mean investment performance of 6.71%, age-based mortality from the Ruark 2015 ALB table adjusted for company and industry experience, lapse rates determined by a dynamic formula, and an average discount rate of 4.8%. Changes in the GMDB reserve are included in benefits and settlement expenses in the accompanying consolidated statements of income.
The VA separate account balances subject to GMDB were $12.2 billion and $11.8 billion as of December 31, 2019 and 2018, respectively. The total GMDB amount payable based on VA account balances as of December 31, 2019, was $116.1 million (including $42.5 million in the Annuities segment and $73.6 million in the Acquisitions segment) with a GMDB reserve of $25.5 million and $4.7 million in the Annuities and Acquisitions segment, respectively. The average attained age of contract holders as of December 31, 2019 for the Company was 72.
These amounts exclude certain VA business which has been 100% reinsured to Commonwealth Annuity and Life Insurance Company (formerly known as Allmerica Financial Life Insurance and Annuity Company) ("CALIC") under a Modco agreement. The guaranteed amount payable associated with the annuities reinsured to CALIC was $7.1 million and is included in the Acquisitions segment. The average attained age of contract holders as of December 31, 2019, was 68.
F-82
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
12. CERTAIN NONTRADITIONAL LONG-DURATION CONTRACTS (Continued)
Activity relating to GMDB reserves (excluding those 100% reinsured under the Modco agreement) is as follows:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Beginning balance |
$ |
34,700 |
$ |
26,934 |
$ |
27,835 |
|||||||||
Incurred guarantee benefits |
(809 |
) |
11,065 |
(181 |
) |
||||||||||
Less: Paid guarantee benefits |
3,664 |
3,299 |
720 |
||||||||||||
Ending balance |
$ |
30,227 |
$ |
34,700 |
$ |
26,934 |
Account balances of variable annuities with guarantees invested in variable annuity separate accounts are as follows:
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Equity mutual funds |
$ |
8,074,490 |
$ |
5,300,024 |
|||||||
Fixed income mutual funds |
4,167,158 |
6,568,575 |
|||||||||
Total |
$ |
12,241,648 |
$ |
11,868,599 |
Certain of the Company's fixed annuities and universal life products have a sales inducement in the form of a retroactive interest credit ("RIC"). In addition, certain annuity contracts provide a sales inducement in the form of a bonus interest credit. The Company maintains a reserve for all interest credits earned to date. The Company defers the expense associated with the RIC and bonus interest credits each period and amortizes these costs in a manner similar to that used for DAC.
Activity in the Company's deferred sales inducement asset, recorded on the balance sheet in other assets was as follows:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Deferred asset, beginning of period |
$ |
39,577 |
$ |
30,956 |
$ |
22,497 |
|||||||||
Amounts deferred |
5,813 |
13,336 |
14,246 |
||||||||||||
Amortization |
(2,860 |
) |
(4,715 |
) |
(5,787 |
) |
|||||||||
Deferred asset, end of period |
$ |
42,530 |
$ |
39,577 |
$ |
30,956 |
13. REINSURANCE
The Company reinsures certain of its risks with (cedes), and assumes risks from, other insurers under yearly renewable term, coinsurance, and modified coinsurance agreements. Under yearly renewable term agreements, the Company reinsures only the mortality risk, while under coinsurance the Company reinsures a proportionate share of all risks arising under the reinsured policy. Under coinsurance, the reinsurer receives a proportionate share of the premiums less commissions and is liable for a corresponding share of all benefit payments. Modified coinsurance is accounted for in a
F-83
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
13. REINSURANCE (Continued)
manner similar to coinsurance except that the liability for future policy benefits is held by the ceding company, and settlements are made on a net basis between the companies.
Reinsurance ceded arrangements do not discharge the Company as the primary insurer. Ceded balances would represent a liability of the Company in the event the reinsurers were unable to meet their obligations to us under the terms of the reinsurance agreements. The Company monitors the concentration of credit risk the Company has with any reinsurer, as well as the financial condition of its reinsurers. As of December 31, 2019, the Company had reinsured approximately 28% of the face value of its life insurance in-force. The Company has reinsured approximately 12% of the face value of its life insurance in-force with the following three reinsurers:
• Security Life of Denver Insurance Co. (currently administered by Hannover Re)
• Swiss Re Life & Health America Inc.
• The Lincoln National Life Insurance Co. (currently administered by Swiss Re Life & Health America Inc.)
The Company has not experienced any credit losses for the years ended December 31, 2019, 2018, or 2017 related to these reinsurers. The Company has set limits on the amount of insurance retained on the life of any one person. The amount of insurance retained by the Company on any one life on traditional life insurance was $500,000 in years prior to mid-2005. In 2005, this retention amount was increased to $1,000,000 for certain policies, and during 2008, it was increased to $2,000,000 for certain policies. During 2016, the retention amount was increased to $5,000,000.
Reinsurance premiums, commissions, expense reimbursements, benefits, and reserves related to reinsured long-duration contracts are accounted for over the life of the underlying reinsured contracts using assumptions consistent with those used to account for the underlying contracts. The cost of reinsurance related to short-duration contracts is accounted for over the reinsurance contract period. Amounts recoverable from reinsurers, for both short- and long-duration reinsurance arrangements, are estimated in a manner consistent with the claim liabilities and policy benefits associated with reinsured policies.
The following table presents the net life insurance in-force:
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Direct life insurance in-force |
$ |
766,196,760 |
$ |
765,986,223 |
|||||||
Amounts assumed from other companies |
212,573,612 |
135,407,408 |
|||||||||
Amounts ceded to other companies |
(271,600,818 |
) |
(302,149,614 |
) |
|||||||
Net life insurance in-force |
$ |
707,169,554 |
$ |
599,244,017 |
|||||||
Percentage of amount assumed to net |
30 |
% |
23 |
% |
F-84
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
13. REINSURANCE (Continued)
The following table reflects the effect of reinsurance on life, accident/health, and property and liability insurance premiums written and earned:
Gross
Amount |
Ceded to
Other Companies |
Assumed
from Other Companies |
Net
Amount |
||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
For The Year Ended December 31, 2019 |
|||||||||||||||||||
Premiums and policy fees: |
|||||||||||||||||||
Life insurance |
$ |
2,852,899 |
$ |
(1,383,822 |
) |
$ |
835,677 |
$ |
2,304,754 |
(1) |
|||||||||
Accident/health insurance |
42,248 |
(26,952 |
) |
41,406 |
56,702 |
||||||||||||||
Property and liability insurance |
280,734 |
(106,430 |
) |
3,238 |
177,542 |
||||||||||||||
Total |
$ |
3,175,881 |
$ |
(1,517,204 |
) |
$ |
880,321 |
$ |
2,538,998 |
||||||||||
For The Year Ended December 31, 2018 |
|||||||||||||||||||
Premiums and policy fees: |
|||||||||||||||||||
Life insurance |
$ |
2,681,191 |
$ |
(1,249,906 |
) |
$ |
626,283 |
$ |
2,057,568 |
(1) |
|||||||||
Accident/health insurance |
47,028 |
(30,126 |
) |
12,826 |
29,728 |
||||||||||||||
Property and liability insurance |
284,323 |
(103,478 |
) |
4,857 |
185,702 |
||||||||||||||
Total |
$ |
3,012,542 |
$ |
(1,383,510 |
) |
$ |
643,966 |
$ |
2,272,998 |
||||||||||
For The Year Ended December 31, 2017 |
|||||||||||||||||||
Premiums and policy fees: |
|||||||||||||||||||
Life insurance |
$ |
2,655,846 |
$ |
(1,230,258 |
) |
$ |
435,113 |
$ |
1,860,701 |
(1) |
|||||||||
Accident/health insurance |
51,991 |
(33,052 |
) |
14,946 |
33,885 |
||||||||||||||
Property and liability insurance |
288,809 |
(103,786 |
) |
9,657 |
194,680 |
||||||||||||||
Total |
$ |
2,996,646 |
$ |
(1,367,096 |
) |
$ |
459,716 |
$ |
2,089,266 |
(1) Includes annuity policy fees of $164.3 million, $177.1 million, and $173.5 million, for the years ended December 31, 2019, 2018, and 2017, respectively.
As of December 31, 2019 and 2018, policy and claim reserves relating to insurance ceded of $4.4 billion and $4.5 billion, respectively, are included in reinsurance receivables. Should any of the reinsurers be unable to meet its obligation at the time of the claim, the Company would be obligated to pay such claims. As of December 31, 2019 and 2018, the Company had paid $86.3 million and $116.1 million, respectively, of ceded benefits which are recoverable from reinsurers. In addition, as of December 31, 2019 and 2018, the Company had receivables of $64.6 million and $64.8 million, respectively, related to insurance assumed.
F-85
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
13. REINSURANCE (Continued)
The Company's third party reinsurance receivables amounted to $4.2 billion and $4.5 billion as of December 31, 2019 and 2018, respectively. These amounts include ceded reserve balances and ceded benefit payments. The ceded benefit payments are recoverable from reinsurers. The following table sets forth the receivables attributable to our more significant reinsurance partners:
As of December 31, |
|||||||||||||||||||
2019 |
2018 |
||||||||||||||||||
Reinsurance
Receivable |
A.M. Best
Rating |
Reinsurance
Receivable |
A.M. Best
Rating |
||||||||||||||||
(Dollars In Millions) |
|||||||||||||||||||
Security Life of Denver Insurance
Company |
$ |
631.4 |
NR |
$ |
722.2 |
A |
|||||||||||||
Swiss Re Life & Health America, Inc. |
560.0 |
A+ |
603.8 |
A+ |
|||||||||||||||
Lincoln National Life Insurance Co. |
463.5 |
A+ |
461.1 |
A+ |
|||||||||||||||
Transamerica Life Insurance Co. |
330.3 |
A |
301.0 |
A+ |
|||||||||||||||
American United Life Insurance
Company |
273.3 |
A+ |
242.8 |
A+ |
|||||||||||||||
RGA Reinsurance Company |
261.2 |
A+ |
260.5 |
A+ |
|||||||||||||||
Employers Reassurance Corporation |
187.4 |
NR |
178.4 |
B+ |
|||||||||||||||
Centre Reinsurance (Bermuda) Ltd |
181.4 |
NR |
197.4 |
NR |
|||||||||||||||
SCOR Global Life(1) |
181.2 |
A+ |
317.2 |
A+ |
|||||||||||||||
The Canada Life Assurance Company |
168.3 |
A+ |
188.2 |
A+ |
(1) Includes SCOR Global Life Americas Reinsurance Company, SCOR Global Life USA Reinsurance Co, and SCOR Global Life Reinsurance Co of Delaware
The Company's reinsurance contracts typically do not have a fixed term. In general, the reinsurers' ability to terminate coverage for existing cessions is limited to such circumstances as material breach of contract or non-payment of premiums by the ceding company. The reinsurance contracts generally contain provisions intended to provide the ceding company with the ability to cede future business on a basis consistent with historical terms. However, either party may terminate any of the contracts with respect to future business upon appropriate notice to the other party.
Generally, the reinsurance contracts do not limit the overall amount of the loss that can be incurred by the reinsurer. The amount of liabilities ceded under contracts that provide for the payment of experience refunds is immaterial.
14. DEBT AND OTHER OBLIGATIONS
Under a revolving line of credit arrangement that was in effect until May 3, 2018 (the "2015 Credit Facility"), the Company had the ability to borrow on an unsecured basis up to an aggregate principal amount of $1.0 billion. The Company had the right in certain circumstances to request that the commitment under the 2015 Credit Facility be increased up to a maximum principal amount of $1.25 billion. Balances outstanding under the 2015 Credit Facility accrued interest at a rate equal to, at the option of the Borrowers, (i) LIBOR plus a spread based on the ratings of PLC's Senior Debt, or (ii) the sum of (A) a rate equal to the highest of (x) the Administrative Agent's prime rate, (y) 0.50% above the Funds rate, or (z) the one-month LIBOR plus 1.00% and (B) a spread based on the ratings of PLC's Senior Debt. The 2015 Credit Facility also provided for a facility fee at a rate that varies with
F-86
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
14. DEBT AND OTHER OBLIGATIONS (Continued)
the ratings of the PLC's Senior Debt and that is calculated on the aggregate amount of commitments under the 2015 Credit Facility, whether used or unused. The annual facility fee rate was 0.125% of the aggregate principal amount. The Credit Facility provided that PLC was liable for the full amount of any obligations for borrowings or letters of credit, including those of the Company, under the 2015 Credit Facility. The maturity date of the 2015 Credit Facility was February 2, 2020.
On May 3, 2018, the Company amended the 2015 Credit Facility (as amended, the "Credit Facility"). Under the Credit Facility, the Company has the ability to borrow on an unsecured basis up to an aggregate principal amount of $1.0 billion. The Company has the right in certain circumstances to request that the commitment under the Credit Facility be increased up to a maximum principal amount of $1.5 billion. Balances outstanding under the Credit Facility accrue interest at a rate equal to, at the option of the Borrowers, (i) LIBOR plus a spread based on the ratings of PLC's Senior Debt, or (ii) the sum of (A) a rate equal to the highest of (x) the Administrative Agent's Prime rate, (y) 0.50% above the Funds rate, or (z) the one-month LIBOR plus 1.00% and (B) a spread based on the ratings of PLC's Senior Debt. The Credit Facility also provided for a facility fee at a rate that varies with the ratings of PLC's Senior Debt and that is calculated on the aggregate amount of commitments under the Credit Facility, whether used or unused. The annual facility fee rate is 0.125% of the aggregate principal amount. The Credit Facility provides that PLC is liable for the full amount of any obligations for borrowings or letters of credit, including those of the Company, under the Credit Facility. The maturity date of the Credit Facility is May 3, 2023. The Company is not aware of any non-compliance with the financial debt covenants of the Credit Facility as of December 31, 2019. PLC did not have an outstanding balance on the Credit Facility as of December 31, 2019.
During 2018, the Company issued $110.0 million of Subordinated Funding Obligations at a rate of 3.55% due 2038.
Non-Recourse Funding Obligations
Golden Gate Captive Insurance Company
On January 15, 2016, Golden Gate Captive Insurance Company ("Golden Gate"), a Vermont special purpose financial insurance company and a wholly owned subsidiary of the Company, and Steel City, LLC ("Steel City"), a newly formed wholly owned subsidiary of PLC, entered into an 18-year transaction to finance $2.188 billion of "XXX" reserves related to the acquired GLAIC Block and the other term life insurance business reinsured to Golden Gate by the Company and WCL, a direct wholly owned subsidiary of the Company. Steel City issued notes (the "2016 Steel City Notes") with an aggregate initial principal amount of $2.188 billion to Golden Gate in exchange for a surplus note issued by Golden Gate (the "2016 Surplus Notes") with an initial principal amount of $2.188 billion. Through the structure, Hannover Life Reassurance Company of America (Bermuda) Ltd., The Canada Life Assurance Company (Barbados Branch) and Nomura Americas Re Ltd. (collectively, the "Risk-Takers") provide credit enhancement to the 2016 Steel City Notes in exchange for credit enhancement fees. The transaction is "non-recourse" to PLC, WCL, and the Company, meaning that none of these companies, other than Golden Gate, are liable to reimburse the Risk-Takers for any credit enhancement payments required to be made. On December 31, 2019, in connection with the amendments discussed below, the 2016 Surplus Note was cancelled and replaced by a newly issued fixed rate surplus note (the "Surplus Note") and the 2016 Steel City Notes were cancelled and replaced by three newly issued fixed rate surplus notes (the "Steel City Notes").
F-87
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
14. DEBT AND OTHER OBLIGATIONS (Continued)
On December 31, 2019, the transaction was amended and restated whereby the Company ceded certain acquired term life insurance policies to Golden Gate. These policies were originally coinsured by the Company from Liberty Life Assurance Company of Boston (the "LLAC Block") and were then retroceded from the Company to Golden Gate concurrent with this amendment and restatement. The cession from the Company to Golden Gate included the initial estimated transfer of approximately $76.4 million of policyholder liabilities. As a result of this amendment and restatement, Golden Gate recorded an estimated initial ceding allowance payable to the Company of approximately $76.4 million and initial premium transfers from the Company of approximately $76.4 million. There was no change to the reinsurance arrangement with respect to the policies originally ceded under the original 2016 transaction.
As of December 31, 2019, the aggregate principal balance of the Steel City Notes was $2.028 billion. In connection with this transaction, PLC has entered into certain support agreements under which it guarantees or otherwise supports certain obligations of Golden Gate or Steel City including a guarantee of the fees to the Risk-Takers. The support agreements provide that amounts would become payable by PLC if Golden Gate's annual general corporate expenses were higher than modeled amounts, certain reinsurance rates applicable to the subject business increase beyond modeled amounts or in the event write-downs due to other-than-temporary impairments on assets held in certain accounts exceed defined threshold levels. Additionally, PLC has entered into a separate agreement to guarantee payment of certain fee amounts in connection with the credit enhancement of the Steel City Notes. As of December 31, 2019, no payments have been made under these agreements.
In connection with the transaction outlined above, Golden Gate had a $2.028 billion outstanding non-recourse funding obligation as of December 31, 2019. This non-recourse funding obligation matures in 2039 and accrues interest at a fixed annual rate of 4.70%.
Golden Gate II Captive Insurance Company
Golden Gate II Captive Insurance Company ("Golden Gate II"), a South Carolina special purpose financial captive insurance company and wholly owned subsidiary, had $575 million of non-recourse funding obligations as of December 31, 2019. These outstanding non-recourse funding obligations were issued to special purpose trusts, which in turn issued securities to third parties. Certain of our affiliates own a portion of these securities. As of December 31, 2019, securities related to $20.6 million of the balance of the non-recourse funding obligations were held by external parties, securities related to $309.3 million of the non-recourse funding obligations were held by nonconsolidated affiliates, and $245.1 million were held by consolidated subsidiaries of the Company. PLC has entered into certain support agreements with Golden Gate II obligating it to make capital contributions or provide support related to certain of Golden Gate II's expenses and in certain circumstances, to collateralize certain of PLC's obligations to Golden Gate II. These support agreements provide that amounts would become payable by PLC to Golden Gate II if its annual general corporate expenses were higher than modeled amounts or if Golden Gate II's investment income on certain investments or premium income was below certain actuarially determined amounts. PLC made a payment of $1.0 million under the Interest Support Agreement during the second quarter of 2019. In addition, certain Interest Support Agreement obligations to the Company of approximately $4.9 million have been collateralized by PLC under the terms of that agreement. PLC made a payment of approximately $1.0 million under the YRT Premium Support Agreement. Re-evaluation and, if necessary, adjustments of any support agreement
F-88
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
14. DEBT AND OTHER OBLIGATIONS (Continued)
collateralization amounts occur annually during the first quarter pursuant to the terms of the support agreements.
During the year ended December 31, 2019, the Company and its affiliates did not repurchase any of its outstanding non-recourse obligations, at a discount. During the year ended December 31, 2018, the Company and its affiliates repurchased $38.0 million of its outstanding non-recourse funding obligations, at a discount.
Golden Gate V Vermont Captive Insurance Company
On October 10, 2012, Golden Gate V Vermont Captive Insurance Company ("Golden Gate V"), a Vermont special purpose financial insurance company and Red Mountain, LLC ("Red Mountain"), both wholly owned subsidiaries, entered into a 20-year transaction to finance up to $945 million of "AXXX" reserves related to a block of universal life insurance policies with secondary guarantees issued by the Company and its subsidiary, West Coast Life Insurance Company ("WCL"). Golden Gate V issued non-recourse funding obligations to Red Mountain, and Red Mountain issued a note with an initial principal amount of $275 million, increasing to a maximum of $945 million in 2027, to Golden Gate V for deposit to a reinsurance trust supporting Golden Gate V's obligations under a reinsurance agreement with WCL, pursuant to which WCL cedes liabilities relating to the policies of WCL and retrocedes liabilities relating to the policies of the Company. Through the structure, Hannover Life Reassurance Company of America ("Hannover Re"), the ultimate risk taker in the transaction, provides credit enhancement to the Red Mountain note for the 20-year term in exchange for a fee. The transaction is "non-recourse" to Golden Gate V, Red Mountain, WCL, PLC, and the Company, meaning that none of these companies are liable for the reimbursement of any credit enhancement payments required to be made. As of December 31, 2019, the principal balance of the Red Mountain note was $720 million. Future scheduled capital contributions to prefund credit enhancement fees amount to approximately $107.3 million and will be paid in annual installments through 2031. In connection with the transaction, PLC has entered into certain support agreements under which it guarantees or otherwise supports certain obligations of Golden Gate V or Red Mountain. The support agreements provide that amounts would become payable by PLC if Golden Gate V's annual general corporate expenses were higher than modeled amounts or in the event write-downs due to other-than-temporary impairments on assets held in certain accounts exceed defined threshold levels. Additionally, PLC has entered into separate agreements to indemnify Golden Gate V with respect to material adverse changes in non-guaranteed elements of insurance policies reinsured by Golden Gate V and to guarantee payment of certain fee amounts in connection with the credit enhancement of the Red Mountain note. As of December 31, 2019, no payments have been made under these agreements.
In connection with the transaction outlined above, Golden Gate V had a $720 million outstanding non-recourse funding obligation as of December 31, 2019. This non-recourse funding obligation matures in 2037, has scheduled increases in principal to a maximum of $945 million, and accrues interest at a fixed annual rate of 6.25%.
F-89
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
14. DEBT AND OTHER OBLIGATIONS (Continued)
Non-recourse funding obligations outstanding, on a consolidated basis, are shown in the following table:
Issuer |
Outstanding
Principal |
Carrying
Value(1) |
Maturity Year |
Year-to-Date
Weighted-Avg Interest Rate |
|||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
As of December 31, 2019 |
|||||||||||||||||||
Golden Gate Captive Insurance
Company(2)(3) |
$ |
2,028,000 |
$ |
2,028,000 |
2039 |
4.70 |
% |
||||||||||||
Golden Gate II Captive Insurance
Company |
329,949 |
274,955 |
2052 |
5.06 |
% |
||||||||||||||
Golden Gate V Vermont Captive
Insurance Company(2)(3) |
720,000 |
777,527 |
2037 |
5.12 |
% |
||||||||||||||
MONY Life Insurance
Company(3) |
1,091 |
2,271 |
2024 |
6.19 |
% |
||||||||||||||
Total |
$ |
3,079,040 |
$ |
3,082,753 |
|
||||||||||||||
Issuer |
Outstanding
Principal |
Carrying
Value(1) |
Maturity Year |
Year-to-Date
Weighted-Avg Interest Rate |
|||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
As of December 31, 2018 |
|||||||||||||||||||
Golden Gate Captive Insurance
Company(2)(3) |
$ |
1,883,000 |
$ |
1,883,000 |
2039 |
4.75 |
% |
||||||||||||
Golden Gate II Captive Insurance
Company |
329,949 |
273,535 |
2052 |
4.24 |
% |
||||||||||||||
Golden Gate V Vermont Captive
Insurance Company(3) |
670,000 |
729,454 |
2037 |
5.12 |
% |
||||||||||||||
MONY Life Insurance Company(3) |
1,091 |
2,340 |
2024 |
6.19 |
% |
||||||||||||||
Total |
$ |
2,884,040 |
$ |
2,888,329 |
(1) Carrying values include premiums and discounts and do not represent unpaid principal balances.
(2) Obligations are issued to non-consolidated subsidiaries of PLC. These obligations collateralize certain held-to-maturity securities issued by wholly owned subsidiaries of the Company.
(3) Fixed rate obligations
Letters of Credit
Golden Gate III Vermont Captive Insurance Company
On April 23, 2010, Golden Gate III Vermont Captive Insurance Company ("Golden Gate III"), a Vermont special purpose financial insurance company and wholly owned subsidiary of PLICO, entered into a Reimbursement Agreement (the "Reimbursement Agreement") with UBS AG, Stamford Branch ("UBS"), as issuing lender. Under the Reimbursement Agreement, UBS issued a letter of credit (the "LOC)") to a trust for the benefit of WCL. The Reimbursement Agreement has undergone three separate amendments and restatements. The Reimbursement Agreement's current effective date is June 25, 2014. The LOC balance reached its scheduled peak of $935.0 million in 2015. As of December 31, 2019, the LOC balance was $800.0 million. The term of the LOC is expected to be
F-90
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
14. DEBT AND OTHER OBLIGATIONS (Continued)
approximately 15 years from the original issuance date. This transaction is "non-recourse" to WCL, PLC, and the Company, meaning that none of these companies other than Golden Gate III are liable for reimbursement on a draw of the LOC. PLC has entered into certain support agreements with Golden Gate III obligating PLC to make capital contributions or provide support related to certain of Golden Gate III's expenses and in certain circumstances, to collateralize certain of PLC's obligations to Golden Gate III. The future scheduled capital contribution amount of approximately $20.0 million will be paid in 2021. These contributions may be subject to potential offset against dividend payments as permitted under the terms of the Reimbursement Agreement. The support agreements provide that amounts would become payable by PLC to Golden Gate III if Golden Gate III's annual general corporate expenses were higher than modeled amounts or if specified catastrophic losses occur during defined time periods with respect to the policies reinsured by Golden Gate III. Pursuant to the terms of an amended and restated letter agreement with UBS, PLC has continued to guarantee the payment of fees to UBS as specified in the Reimbursement Agreement. As of December 31, 2019, no payments have been made under these agreements.
Golden Gate IV Vermont Captive Insurance Company
Golden Gate IV Vermont Captive Insurance Company ("Golden Gate IV"), a Vermont special purpose financial insurance company and wholly owned subsidiary, is party to a Reimbursement Agreement with UBS AG, Stamford Branch, as issuing lender. Under the Reimbursement Agreement, dated December 10, 2010, UBS issued a LOC in the initial amount of $270.0 million to a trust for the benefit of WCL. Pursuant to the terms of the Reimbursement Agreement, the LOC reached its scheduled peak amount of $790 million in 2016. As of December 31, 2019, the LOC balance was $755 million. The term of the LOC is expected to be 12 years from the original issuance date (stated maturity of December 30, 2022). The LOC was issued to support certain obligations of Golden Gate IV to WCL under an indemnity reinsurance agreement, pursuant to which WCL cedes liabilities relating to the policies of WCL and retrocedes liabilities relating to the policies of the Company. This transaction is "non-recourse" to WCL, PLC, and the Company, meaning that none of these companies other than Golden Gate IV are liable for reimbursement on a draw of the LOC. PLC has entered into certain support agreements with Golden Gate IV obligating PLC to make capital contributions or provide support related to certain of Golden Gate IV's expenses and in certain circumstances, to collateralize certain of PLC's obligations to Golden Gate IV. The support agreements provide that amounts would become payable by PLC to Golden Gate IV if Golden Gate IV's annual general corporate expenses were higher than modeled amounts or if specified catastrophic losses occur during defined time periods with respect to the policies reinsured by Golden Gate IV. PLC has also entered into a separate agreement to guarantee the payments of LOC fees under the terms of the Reimbursement Agreement. As of December 31, 2019, no payments have been made under these agreements.
Secured Financing Transactions
Repurchase Program Borrowings
While the Company anticipates that the cash flows of its operating subsidiaries will be sufficient to meet its investment commitments and operating cash needs in a normal credit market environment, the Company recognizes that investment commitments scheduled to be funded may, from time to time, exceed the funds then available. Therefore, the Company has established repurchase agreement programs for certain of its insurance subsidiaries to provide liquidity when needed. The Company
F-91
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
14. DEBT AND OTHER OBLIGATIONS (Continued)
expects that the rate received on its investments will equal or exceed its borrowing rate. Under this program, the Company may, from time to time, sell an investment security at a specific price and agree to repurchase that security at another specified price at a later date. These borrowings are typically for a term less than 90 days. The fair value of securities to be repurchased is monitored and collateral levels are adjusted where appropriate to protect the counterparty against credit exposure. Cash received is invested in fixed maturity securities, and the agreements provided for net settlement in the event of default or on termination of the agreements. As of December 31, 2019, the fair value of securities pledged under the repurchase program was $282.2 million and the repurchase obligation of $270.0 million was included in the Company's consolidated balance sheets (at an average borrowing rate of 163 basis points). During the year ended December 31, 2019, the maximum balance outstanding at any one point in time related to these programs was $900.0 million. The average daily balance was $212.2 million (at an average borrowing rate of 214 basis points) during the year ended December 31, 2019. During 2018, the maximum balance outstanding at any one point in time related to these programs was $885.0 million. The average daily balance was $511.4 million (at an average borrowing rate of 184 basis points) during the year ended December 31, 2018.
Securities Lending
The Company participates in securities lending, primarily as an investment yield enhancement, whereby securities that are held as investments are loaned out to third parties for short periods of time. The Company requires collateral at least equal to 102% of the fair value of the loaned securities to be separately maintained. The loaned securities' fair value is monitored on a daily basis and collateral is adjusted accordingly. The Company maintains ownership of the securities at all times and is entitled to receive from the borrower any payments for interest received on such securities during the loan term. Securities lending transactions are accounted for as secured borrowings. As of December 31, 2019, securities with a fair value of $62.8 million were loaned under this program. As collateral for the loaned securities, the Company receives cash, which is primarily reinvested in short term repurchase agreements, which are also collateralized by U.S. Government or U.S. Government Agency securities, and government money market funds. These investments recorded in "short-term investments" with a corresponding liability recorded in "secured financing liabilities" to account for its obligation to return the collateral. As of December 31, 2019, the fair value of the collateral related to this program was $65.5 million and the Company has an obligation to return $65.5 million of collateral to the securities borrowers.
F-92
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
14. DEBT AND OTHER OBLIGATIONS (Continued)
The following table provides the fair value of collateral pledged for repurchase agreements, grouped by asset class, as of December 31, 2019 and 2018:
Repurchase Agreements, Securities Lending Transactions, and Repurchase-to-Maturity Transactions Accounted for as Secured Borrowings
Remaining Contractual Maturity of the Agreements |
|||||||||||||||||||||||
As of December 31, 2019 |
|||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
Overnight and
Continuous |
Up to 30 days |
30-90 days |
Greater Than
90 days |
Total |
|||||||||||||||||||
Repurchase agreements and
repurchase-to-maturity transactions |
|||||||||||||||||||||||
U.S. Treasury and agency
securities |
$ |
282,198 |
$ |
|
$ |
|
$ |
|
$ |
282,198 |
|||||||||||||
Mortgage loans |
|
|
|
|
|
||||||||||||||||||
Total repurchase agreements
and repurchase-to-maturity transactions |
$ |
282,198 |
$ |
|
$ |
|
$ |
|
$ |
282,198 |
|||||||||||||
Securities lending transactions |
|||||||||||||||||||||||
Fixed maturity securities |
55,720 |
|
|
|
55,720 |
||||||||||||||||||
Equity securities |
7,120 |
|
|
|
7,120 |
||||||||||||||||||
Redeemable preferred stocks |
|
|
|
|
|
||||||||||||||||||
Total securities lending
transactions |
62,840 |
|
|
|
62,840 |
||||||||||||||||||
Total securities |
$ |
345,038 |
$ |
|
$ |
|
$ |
|
$ |
345,038 |
F-93
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
14. DEBT AND OTHER OBLIGATIONS (Continued)
Repurchase Agreements, Securities Lending Transactions, and Repurchase-to-Maturity Transactions Accounted for as Secured Borrowings
Remaining Contractual Maturity of the Agreements |
|||||||||||||||||||||||
As of December 31, 2018 |
|||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
Overnight and
Continuous |
Up to 30 days |
30-90 days |
Greater Than
90 days |
Total |
|||||||||||||||||||
Repurchase agreements and
repurchase-to-maturity transactions |
|||||||||||||||||||||||
U.S. Treasury and agency
securities |
$ |
433,182 |
$ |
18,713 |
$ |
|
$ |
|
$ |
451,895 |
|||||||||||||
Mortgage loans |
|
|
|
|
|
||||||||||||||||||
Total repurchase agreements
and repurchase-to-maturity transactions |
$ |
433,182 |
$ |
18,713 |
$ |
|
$ |
|
$ |
451,895 |
|||||||||||||
Securities lending transactions |
|||||||||||||||||||||||
Fixed maturity securities |
71,285 |
|
|
|
71,285 |
||||||||||||||||||
Equity securities |
891 |
|
|
|
891 |
||||||||||||||||||
Redeemable preferred stocks |
|
|
|
|
|
||||||||||||||||||
Total securities lending
transactions |
72,176 |
|
|
|
72,176 |
||||||||||||||||||
Total securities |
$ |
505,358 |
$ |
18,713 |
$ |
|
$ |
|
$ |
524,071 |
Other Obligations
The Company routinely receives from or pays to affiliates, under the control of PLC, reimbursements for expenses incurred on one another's behalf. Receivables and payables among affiliates are generally settled monthly.
Interest Expense
Interest expense, included in other operating expenses, is summarized as follows:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Millions) |
|||||||||||||||
Subordinated funding obligations |
$ |
3.9 |
$ |
2.6 |
$ |
|
|||||||||
Non-recourse funding obligations, other obligations,
and repurchase agreements |
$ |
175.8 |
$ |
181.9 |
$ |
177.7 |
|||||||||
Total interest expense |
$ |
179.7 |
$ |
184.5 |
$ |
177.7 |
F-94
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. COMMITMENTS AND CONTINGENCIES
The Company leases administrative and marketing office space in approximately 16 cities (excluding the home office building), as well as various office equipment. Most leases have terms ranging from two to twenty-five years. Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheet. The Company accounts for lease components separately from non-lease components (e.g., common area maintenance). Certain of the Company's lease agreements include options to renew at the Company's discretion. Management has concluded that the Company is not reasonably certain to elect any of these renewal options. The Company will use the interest rates received on its funding agreement backed notes as the collateralized discount rate when calculating the present value of remaining lease payments when the rate implicit in the lease is unavailable. Additionally, the Company previously leased a building contiguous to its home office. The lease was renewed in December 2013 and was extended to December 2018. At the end of the lease term in December 2018, the Company purchased the building for approximately $75.0 million. The building is recorded in property and equipment, net of accumulated depreciation on the consolidated balance sheet.
The Company had rental expense of $6.3 million, and $11.3 million, and $11.7 million for the years ended December 31, 2019, 2018, and 2017, respectively. The aggregate annualized rent was approximately $6.3 million for the year ended December 31, 2019. The following is a schedule by year of future minimum rental payments required under these leases:
Year |
Amount |
||||||
(Dollars In Thousands) |
|||||||
2020 |
$ |
5,001 |
|||||
2021 |
3,986 |
||||||
2022 |
3,066 |
||||||
2023 |
3,035 |
||||||
2024 |
3,094 |
||||||
Thereafter |
1,496 |
As of December 31, 2019 and 2018, the Company had outstanding mortgage loan commitments of $757.4 million at an average rate of 3.99% and $685.3 million at an average rate of 4.42%, respectively.
Under the insurance guaranty fund laws in most states, insurance companies doing business therein can be assessed up to prescribed limits for policyholder losses incurred by insolvent companies. From time to time, companies may be asked to contribute amounts beyond prescribed limits. It is possible that the Company could be assessed with respect to product lines not offered by the Company. In addition, legislation may be introduced in various states with respect to guaranty fund assessment laws related to insurance products, including long term care insurance and other specialty products, that increases the cost of future assessments or alters future premium tax offsets received in connection with guaranty fund assessments. The Company cannot predict the amount, nature or timing of any future assessments or legislation, any of which could have a material and adverse impact on the Company's financial condition or results of operations.
A number of civil jury verdicts have been returned against insurers, broker dealers and other providers of financial services involving sales, refund or claims practices, alleged agent misconduct, failure to properly supervise representatives, relationships with agents or persons with whom the insurer does
F-95
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. COMMITMENTS AND CONTINGENCIES (Continued)
business, and other matters. Often these lawsuits have resulted in the award of substantial judgments that are disproportionate to the actual damages, including material amounts of punitive and non-economic compensatory damages. In some states, juries, judges, and arbitrators have substantial discretion in awarding punitive and non-economic compensatory damages which creates the potential for unpredictable material adverse judgments or awards in any given lawsuit or arbitration. Arbitration awards are subject to very limited appellate review. In addition, in some class action and other lawsuits, companies have made material settlement payments. The financial services and insurance industries in particular are also sometimes the target of law enforcement and regulatory investigations relating to the numerous laws and regulations that govern such companies. Some companies have been the subject of law enforcement or regulatory actions or other actions resulting from such investigations. The Company, in the ordinary course of business, is involved in such matters.
The Company establishes liabilities for litigation and regulatory actions when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. For matters where a loss is believed to be reasonably possible, but not probable, no liability is established. For such matters, the Company may provide an estimate of the possible loss or range of loss or a statement that such an estimate cannot be made. The Company reviews relevant information with respect to litigation and regulatory matters on a quarterly and annual basis and updates its established liabilities, disclosures and estimates of reasonably possible losses or range of loss based on such reviews.
The Company and certain of its insurance subsidiaries, as well as certain other insurance companies for which the Company has coinsured blocks of life insurance and annuity policies, are under audit for compliance with the unclaimed property laws of a number of states. The audits are being conducted on behalf of the treasury departments or unclaimed property administrators in such states. The focus of the audits is on whether there have been unreported deaths, maturities, or policies that have exceeded limiting age with respect to which death benefits or other payments under life insurance or annuity policies should be treated as unclaimed property that should be escheated to the state. The Company is presently unable to estimate the reasonably possible loss or range of loss that may result from the audits due to a number of factors, including the early stages of the audits being conducted, and uncertainty as to whether the Company or other companies are responsible for the liabilities, if any, arising in connection with certain co-insured policies. The Company will continue to monitor the matter for any developments that would make the loss contingency associated with the audits reasonably estimable.
Advance Trust & Life Escrow Services, LTA, as Securities Intermediary of Life Partners Position Holder Trust v. Protective Life Insurance Company, Case No. 2:18-CV-01290, is a putative class action that was filed on August 13, 2018 in the United States District Court for the Northern District of Alabama. Plaintiff alleges that the Company required policyholders to pay unlawful and excessive cost of insurance charges. Plaintiff seeks to represent all owners of universal life and variable universal life policies issued or administered by the Company or its predecessors that provide that cost of insurance rates are to be determined based on expectations of future mortality experience. The plaintiff seeks class certification, compensatory damages, pre-judgment and post-judgment interest, costs, and other unspecified relief. The Company is vigorously defending this matter and cannot predict the outcome of or reasonably estimate the possible loss or range of loss that might result from this litigation.
Scottish Re (U.S.), Inc. ("SRUS") was placed in rehabilitation on March 6, 2019 by the State of Delaware. Under the related order, the Insurance Commissioner of the State of Delaware has been appointed the
F-96
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. COMMITMENTS AND CONTINGENCIES (Continued)
receiver of SRUS and provided with authority to conduct and continue the business of SRUS in the interest of its cedents, creditors, and stockholder. The order was accompanied by an injunction requiring the continued payment of reinsurance premiums to SRUS and temporarily prohibiting cedents, including the Company, from offsetting premiums payable against receivables from SRUS. On June 20, 2019, the Delaware Court of Chancery entered an order approving a Revised Offset Plan, which allows cedents, including the Company, to offset premiums under certain circumstances.
As of December 31, 2019, the Company had outstanding claims receivable from SRUS of $15.2 million, and other exposures associated with reinsurance receivables of approximately $118.4 million and statutory reserve credit of approximately $134.7 million. The Company continues to monitor SRUS and the actions of the receiver through discussions with legal counsel and review of publicly available information. However, management does not have sufficient information about the current assets or capital position of SRUS. Additionally, it is unclear how the rehabilitation process will proceed or whether or to what extent the ultimate outcome of the rehabilitation process will be unfavorable to the Company.
The Company considered whether the accrual of a loss contingency under FASB ASC Topic 450, Contingencies, was appropriate with respect to amounts receivable from SRUS for ceded claims and reserves as of December 31, 2019. Due to the lack of sufficient information to support an analysis of SRUS's financial condition as of December 31, 2019 and uncertainty regarding whether and to what extent the ultimate outcome of the rehabilitation process will result in an outcome unfavorable to the Company, management concluded that any possible impairment of its reinsurance receivables balance could not be reasonably estimated.
16. SHAREOWNER'S EQUITY
PLC owns all of the 2,000 shares of non-voting preferred stock issued by the Company's subsidiary, Protective Life and Annuity Insurance Company ("PLAIC"). The stock pays, when and if declared, noncumulative participating dividends to the extent PLAIC's statutory earnings for the immediately preceding fiscal year exceeded $1.0 million. In 2019, 2018, and 2017, PLAIC paid no dividends to PLC on its preferred stock.
17. EMPLOYEE BENEFIT PLANS
Qualified Pension Plan and Nonqualified Excess Pension Plan
PLC sponsors the Qualified Pension Plan covering substantially all of its employees, including those of the Company. Benefits are based on years of service and the employee's compensation.
Effective January 1, 2008, PLC made the following changes to its Qualified Pension Plan. These changes have been reflected in the computations within this note.
• Employees hired after December 31, 2007 and any former employee hired after that date, will receive a cash balance benefit.
• Employees active on December 31, 2007, with age plus years of vesting service less than 55 years, will receive a final pay-based pension benefit for service through December 31, 2007, plus a cash balance benefit for service after December 31, 2007.
F-97
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
17. EMPLOYEE BENEFIT PLANS (Continued)
• Employees active on December 31, 2007, with age plus years of vesting service equaling or exceeding 55 years, will receive a final pay-based pension benefit for service both before and after December 31, 2007, with a modest reduction in the formula for benefits earned after December 31, 2007.
• All participants terminating employment on or after December of 2007 may elect to receive a lump sum benefit.
PLC also sponsors a Nonqualified Excess Pension Plan, which is an unfunded nonqualified plan that provides defined pension benefits in excess of limits imposed on the Qualified Pension Plan by federal tax law.
The following table presents the benefit obligation, fair value of plan assets, funded status, and amounts not yet recognized as components of net periodic pension costs for PLC's defined benefit pension plan and unfunded excess benefit plan as of December 31, 2019 and 2018:
December 31, 2019 |
December 31, 2018 |
||||||||||||||||||
Qualified
Pension Plan |
Nonqualified
Excess Pension Plan |
Qualified
Pension Plan |
Nonqualified
Excess Pension Plan |
||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
Accumulated benefit obligation, end of year |
$ |
320,023 |
$ |
49,446 |
$ |
269,802 |
$ |
46,299 |
|||||||||||
Change in projected benefit obligation: |
|||||||||||||||||||
Projected benefit obligation at beginning of year |
$ |
288,129 |
$ |
47,345 |
$ |
300,423 |
$ |
54,590 |
|||||||||||
Service cost |
13,277 |
1,148 |
13,185 |
1,415 |
|||||||||||||||
Interest cost |
11,380 |
1,572 |
9,830 |
1,436 |
|||||||||||||||
Amendments |
|
|
|
|
|||||||||||||||
Actuarial (gain)/loss |
47,913 |
4,569 |
(15,608 |
) |
(2,001 |
) |
|||||||||||||
Benefits paid |
(17,841 |
) |
(3,967 |
) |
(19,701 |
) |
(8,095 |
) |
|||||||||||
Projected benefit obligation at end of year |
342,858 |
50,667 |
288,129 |
47,345 |
|||||||||||||||
Change in plan assets: |
|||||||||||||||||||
Fair value of plan assets at beginning of year |
253,955 |
|
260,926 |
|
|||||||||||||||
Actual return on plan assets |
51,308 |
|
(6,070 |
) |
|
||||||||||||||
Employer contributions(1) |
17,400 |
3,967 |
18,800 |
8,095 |
|||||||||||||||
Benefits paid |
(17,841 |
) |
(3,967 |
) |
(19,701 |
) |
(8,095 |
) |
|||||||||||
Fair value of plan assets at end of year |
304,822 |
|
253,955 |
|
|||||||||||||||
After reflecting FASB guidance: |
|||||||||||||||||||
Funded status |
(38,036 |
) |
(50,667 |
) |
(34,174 |
) |
(47,345 |
) |
|||||||||||
Amounts recognized in the balance sheet: |
|||||||||||||||||||
Other liabilities |
(38,036 |
) |
(50,667 |
) |
(34,174 |
) |
(47,345 |
) |
|||||||||||
Amounts recognized in accumulated other comprehensive
income: |
|||||||||||||||||||
Net actuarial (gain)/loss |
25,082 |
13,041 |
10,370 |
9,025 |
|||||||||||||||
Prior service cost/(credit) |
|
|
|
|
|||||||||||||||
Total amounts recognized in AOCI |
$ |
25,082 |
$ |
13,041 |
$ |
10,370 |
$ |
9,025 |
(1) Employer contributions are shown based on the calendar year in which contributions were made to each plan.
F-98
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
17. EMPLOYEE BENEFIT PLANS (Continued)
Weighted-average assumptions used to determine benefit obligations as of December 31 are as follows:
Qualified Pension Plan |
Nonqualified Excess Pension Plan |
||||||||||||||||||
2019 |
2018 |
2019 |
2018 |
||||||||||||||||
Discount
rate |
3.12 |
% |
4.21 |
% |
2.76 |
% |
3.93 |
% |
|||||||||||
Rate of
compensation increase |
4.75% prior to age 40/
3.75% for age 40 and above |
4.75% prior to age 40/
3.75% for age 40 and above |
4.75% prior to age 40/
3.75% for age 40 and above |
4.75% prior to age 40/
3.75% for age 40 and above |
Weighted-average assumptions used to determine the net periodic benefit cost for the years ended December 31, 2019, 2018, and 2017, are as follows:
Qualified Pension Plan |
Nonqualified Excess Pension Plan |
||||||||||||||||||||||||||
For The Year Ended December 31, |
|||||||||||||||||||||||||||
2019 |
2018 |
2017 |
2019 |
2018 |
2017 |
||||||||||||||||||||||
Discount rate |
4.21 |
% |
3.55 |
% |
4.04 |
% |
3.94 |
% |
3.25 |
% |
3.60 |
% |
|||||||||||||||
Rate of compensation
increase |
4.75
prior to age 40/ 3.75% for age 40 and above |
% |
4.75
prior to age 40/ 3.75% for age 40 and above |
% |
4.75
prior to age 40/ 3.75% for age 40 and above |
% |
4.75
prior to age 40/ 3.75% for age 40 and above |
% |
4.75
prior to age 40/ 3.75% for age 40 and above |
% |
4.75
prior to age 40/ 3.75% for age 40 and above |
% |
|||||||||||||||
Expected long-term
return on plan assets |
7.00 |
% |
7.00 |
% |
7.00 |
% |
N/A |
N/A |
N/A |
The assumed discount rates used to determine the benefit obligations were based on an analysis of future benefits expected to be paid under the plans. The assumed discount rate reflects the interest rate at which an amount that is invested in a portfolio of high-quality debt instruments on the measurement date would provide the future cash flows necessary to pay benefits when they come due.
To determine an appropriate long-term rate of return assumption, PLC received evaluations of market performance based on its asset allocation as provided by external consultants.
F-99
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
17. EMPLOYEE BENEFIT PLANS (Continued)
Components of the net periodic benefit cost for the years ended December 31, 2019, 2018, and 2017 are as follows:
Qualified Pension Plan |
Nonqualified
Excess Pension Plan |
||||||||||||||||||||||||||
For The Year Ended December 31, |
|||||||||||||||||||||||||||
2019 |
2018 |
2017 |
2019 |
2018 |
2017 |
||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||||||
Service cost benefits earned during
the period |
$ |
13,277 |
$ |
13,185 |
$ |
12,011 |
$ |
1,148 |
$ |
1,415 |
$ |
1,350 |
|||||||||||||||
Interest cost on projected benefit
obligation |
11,380 |
9,830 |
9,846 |
1,572 |
1,436 |
1,480 |
|||||||||||||||||||||
Expected return on plan assets |
(18,106 |
) |
(17,058 |
) |
(13,570 |
) |
|
|
|
||||||||||||||||||
Amortization of prior service cost |
|
|
|
|
|
|
|||||||||||||||||||||
Amortization of actuarial
losses(1) |
|
|
|
553 |
969 |
634 |
|||||||||||||||||||||
Preliminary net periodic benefit cost |
6,551 |
5,957 |
8,287 |
3,273 |
3,820 |
3,464 |
|||||||||||||||||||||
Settlement/curtailment
expense(2) |
|
|
|
|
1,526 |
|
|||||||||||||||||||||
Total net periodic benefit cost |
$ |
6,551 |
$ |
5,957 |
$ |
8,287 |
$ |
3,273 |
$ |
5,346 |
$ |
3,464 |
(1) 2019 average remaining service period used is 8.69 years and 7.68 years for the defined benefit pension plan and unfunded excess benefit plan, respectively.
(2) The excess pension plan triggered settlement accounting for the year ended December 31, 2018 since the total lump sum payments exceeded the settlement threshold of service cost plus interest cost.
For the Qualified Pension Plan, PLC does not expect to amortize approximately $1.2 million of net actuarial loss from other comprehensive income into net periodic benefit cost during 2019. For the unfunded excess benefit plan, PLC expects to amortize approximately $1.0 million of net actuarial loss from other comprehensive income into net periodic benefit cost during 2019.
Estimated future benefit payments under the Qualified Pension Plan and Nonqualified Excess Pension Plan are as follows:
Years |
Qualified
Pension Plan |
Nonqualified
Excess Pension Plan |
|||||||||
(Dollars In Thousands) |
|||||||||||
2020 |
$ |
22,026 |
$ |
6,832 |
|||||||
2021 |
22,831 |
5,654 |
|||||||||
2022 |
25,577 |
6,005 |
|||||||||
2023 |
23,965 |
5,126 |
|||||||||
2024 |
25,489 |
4,387 |
|||||||||
2025-2029 |
129,165 |
19,648 |
F-100
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
17. EMPLOYEE BENEFIT PLANS (Continued)
Qualified Pension Plan Assets
Allocation of plan assets of the Qualified Pension Plan by category as of December 31, are as follows:
Asset Category |
Target
Allocation |
2018 |
2019 |
||||||||||||
Return-Seeking |
60 |
% |
61 |
% |
61 |
% |
|||||||||
Liability-Hedging Fixed Income |
40 |
39 |
39 |
||||||||||||
Total |
100 |
% |
100 |
% |
100 |
% |
PLC's target asset allocation is designed to provide an acceptable level of risk and balance between return-seeking assets and liability-hedging fixed income assets. The weighting towards return-seeking securities is designed to help provide for an increased level of asset growth potential and liquidity.
PLC's investment policy includes various guidelines and procedures designed to ensure assets are invested in a manner necessary to meet expected future benefits earned by participants. The investment guidelines consider a broad range of economic conditions. Central to the policy are target allocation ranges (shown above) by major asset categories. The Company's investment policy also has sub category allocation ranges within the return seeking and liability hedging fixed income asset portfolios. The objectives of the target allocations are to maintain investment portfolios that diversify risk through prudent asset allocation parameters, achieve asset returns that meet or exceed the plans' actuarial assumptions, and achieve asset returns that are competitive with like institutions employing similar investment strategies.
The Qualified Pension Plan's return seeking assets are in a Russell 3000 index fund that invests in a domestic equity index collective trust managed by Northern Trust Corporation, a Spartan 500 index fund managed by Fidelity, and a Collective All Country World ex-US index fund managed by Northern Trust. The Plan's cash is invested in a collective trust managed by Northern Trust Corporation. The Plan's liability-hedging fixed income assets are invested in a group deposit administration annuity contract with the Company and a Long Government Credit Bond index fund managed by BlackRock. The Northern Trust Collective All Country World ex-US index fund and the BlackRock Long Government Credit Bond index fund were added to the Plan's investment portfolio during 2018.
Plan assets of the Qualified Pension Plan by category as of December 31, 2019 and 2018 are as follows:
As of December 31, |
|||||||||||
Asset Category |
2019 |
2018 |
|||||||||
(Dollars In Thousands) |
|||||||||||
Cash and cash equivalents |
$ |
3,713 |
$ |
1,225 |
|||||||
Equity securities: |
|||||||||||
Collective Russell 3000 equity index fund |
100,673 |
70,599 |
|||||||||
Fidelity Spartan 500 index fund |
31,693 |
46,300 |
|||||||||
Northern Trust ACWI ex-US Fund |
56,996 |
41,924 |
|||||||||
Liability-hedging fixed income: |
|||||||||||
Group Deposit Administration Annuity Contract |
75,052 |
78,707 |
|||||||||
BlackRock Long Government Credit Bond Index Fund |
36,695 |
15,200 |
|||||||||
Total investments |
304,822 |
253,955 |
|||||||||
Employer contribution receivable |
|
|
|||||||||
Total |
$ |
304,822 |
$ |
253,955 |
F-101
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
17. EMPLOYEE BENEFIT PLANS (Continued)
The valuation methodologies used to determine the fair values reflect market participant assumptions and are based on the application of the fair value hierarchy that prioritizes observable market inputs over unobservable inputs. The following is a description of the valuation methodologies used for assets measured at fair value. The Qualified Pension Plan's group deposit administration annuity contract with the Company is recorded at contract value, which PLC believes approximates fair value. Contract value represents contributions made under the contract, plus interest at the contract rate, less funds used to purchase annuities. For the remaining investments, PLC determines the fair values based on quoted market prices. While PLC believes its valuation method is appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine fair value could result in a different fair value measurement at the reporting date.
The following table sets forth by level, within the fair value hierarchy, the Qualified Pension Plan's assets at fair value as of December 31, 2019:
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
Cash |
$ |
3,713 |
$ |
|
$ |
|
$ |
3,713 |
|||||||||||
Equity securities |
189,362 |
|
|
189,362 |
|||||||||||||||
Fixed income |
36,695 |
|
|
36,695 |
|||||||||||||||
Group deposit administration annuity contract |
|
|
75,052 |
75,052 |
|||||||||||||||
Total investments |
$ |
229,770 |
$ |
|
$ |
75,052 |
$ |
304,822 |
The following table sets forth by level, within the fair value hierarchy, the Qualified Pension Plan's assets at fair value as of December 31, 2018:
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
Cash |
$ |
1,225 |
$ |
|
$ |
|
$ |
1,225 |
|||||||||||
Equity securities |
158,823 |
|
|
158,823 |
|||||||||||||||
Fixed income |
15,200 |
|
|
15,200 |
|||||||||||||||
Group deposit administration annuity contract |
|
|
78,707 |
78,707 |
|||||||||||||||
Total investments |
$ |
175,248 |
$ |
|
$ |
78,707 |
$ |
253,955 |
For the year ended December 31, 2019, $7.5 million transferred into Level 1 from Level 3. This transfer was made to maintain an acceptable asset allocation as determined by the Company's investment policy statement. For the year ended December 31, 2018, there were no transfers between levels.
F-102
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
17. EMPLOYEE BENEFIT PLANS (Continued)
The following table presents a reconciliation of the beginning and ending balances for the fair value measurements for the year ended December 31, 2019 and for the year ended December 31, 2018 for which PLC has used significant unobservable inputs (Level 3):
December 31, 2019 |
December 31, 2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Balance, beginning of year |
$ |
78,707 |
$ |
74,886 |
|||||||
Interest income |
3,845 |
3,821 |
|||||||||
Transfers from collective short-term
investments fund |
|
|
|||||||||
Transfers to collective short-term
investments fund |
(7,500 |
) |
|
||||||||
Balance, end of year |
$ |
75,052 |
$ |
78,707 |
The following table represents the Plan's Level 3 financial instrument, the valuation technique used, and the significant unobservable input and the ranges of values for that input as of December 31, 2019:
Instrument |
Fair Value |
Principal
Valuation Technique |
Significant
Unobservable Inputs |
Range of
Significant Input Values |
|||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
Group deposit administration
annuity contract |
$ |
75,052 |
Contract Value |
Contract Rate |
5.01 |
% - 5.08% |
Investment securities are exposed to various risks, such as interest rate, market, and credit risks. Due to the level of risk associated with certain investment securities and the level of uncertainty related to changes in the value of investment securities, it is at least reasonably possible that changes in risks in the near term could materially affect the amounts reported.
Qualified Pension Plan Funding Policy
PLC's funding policy is to contribute amounts to the Qualified Pension Plan sufficient to meet the minimum funding requirements of the Employee Retirement Income Security Act ("ERISA") plus such additional amounts as PLC may determine to be appropriate from time to time. Contributions are intended to provide not only for benefits attributed to service to date, but also for those expected to be earned in the future.
Under the Pension Protection Act of 2006 ("PPA"), a plan could be subject to certain benefit restrictions if the plan's adjusted funding target attainment percentage ("AFTAP") drops below 80%. Therefore, PLC may make additional contributions in future periods to maintain an AFTAP of at least 80%. In general, the AFTAP is a measure of how well a plan is funded and is obtained by dividing a plan's assets by its funding liabilities. AFTAP is based on participant data, plan provisions, plan methods and assumptions, funding credit balances, and plan assets as of the plan valuation date. Some of the assumptions and methods used to determine a plan's AFTAP may be different from the assumptions and methods used to measure a plan's funded status on a GAAP basis.
F-103
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
17. EMPLOYEE BENEFIT PLANS (Continued)
In July of 2012, the Moving Ahead for Progress in the 21st Century Act ("MAP-21"), which includes pension funding stabilization provisions, was signed into law. These provisions establish an interest rate corridor which is designed to stabilize the segment rates used to determine funding requirements from the effects of interest rate volatility. In August of 2014, the Highway and Transportation Funding Act of 2014 ("HATFA") was signed into law. HAFTA extends the funding relief provided by MAP-21 by delaying the interest rate corridor expansion. The funding stabilization provisions of MAP-21 and HATFA reduced the Company's minimum required Qualified Pension Plan contributions. Since the funding stabilization provisions of MAP-21 and HATFA do not apply for Pension Benefit Guaranty Corporation ("PBGC") reporting purposes, PLC may also make additional contributions in future periods to avoid certain PBGC reporting triggers.
During the twelve months ended December 31, 2019, PLC contributed $17.4 million to the Qualified Pension Plan for the 2018 plan year. PLC has not yet determined what amount it will fund during 2020, but may contribute an amount that would eliminate the PBGC variable-rate premium payable in 2020. PLC currently estimates that amount will be between $10 million and $25 million.
Other Postretirement Benefits
In addition to pension benefits, PLC provides limited healthcare benefits to eligible retired employees until age 65. This postretirement benefit is provided by an unfunded plan. As of December 31, 2019 and 2018, the accumulated postretirement benefit obligation and projected benefit obligation were immaterial.
For a closed group of retirees over age 65, PLC provides a prescription drug benefit. As of December 31, 2019 and 2018, PLC's liability related to this benefit was immaterial.
PLC also offers life insurance benefits for retirees from $10,000 up to a maximum of $75,000 which are provided through the payment of premiums under a group life insurance policy. This plan is partially funded at a maximum of $50,000 face amount of insurance. The benefit obligation associated with these benefits is as follows:
As of December 31, |
|||||||||||
Postretirement Life Insurance Plan |
2019 |
2018 |
|||||||||
(Dollars In Thousands) |
|||||||||||
Change in Benefit Obligation |
|||||||||||
Benefit obligation, beginning of year |
$ |
10,012 |
$ |
10,978 |
|||||||
Service cost |
124 |
153 |
|||||||||
Interest cost |
405 |
366 |
|||||||||
Actuarial (gain)/loss |
2,285 |
(1,045 |
) |
||||||||
Benefits paid |
(404 |
) |
(440 |
) |
|||||||
Benefit obligation, end of year |
$ |
12,422 |
$ |
10,012 |
For the postretirement life insurance plan, PLC's discount rate assumption used to determine the benefit obligation and the net periodic benefit cost as of December 31, 2019 is 3.38% and 4.38%, respectively.
PLC's expected long-term rate of return assumption used to determine the net periodic benefit cost as of December 31, 2019 is 2.5%. To determine an appropriate long-term rate of return assumption, PLC utilized 25 year average and annualized return results on the Barclay's short treasury index.
F-104
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
17. EMPLOYEE BENEFIT PLANS (Continued)
Investments of PLC's group life insurance plan are held by Wells Fargo Bank, N.A. and are invested in a money market fund.
Investments are stated at fair value and are based on the application of the fair value hierarchy that prioritizes observable market inputs over unobservable inputs. The money market funds are valued based on historical cost, which represents fair value, at year end. This method of valuation may produce a fair value calculation that may not be reflective of future fair values. Furthermore, while PLC believes its valuation method is appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine fair value could result in a different fair value measurement at the reporting date.
The following table sets forth by level, within the fair value hierarchy, the life insurance plan's assets at fair value as of December 31, 2019:
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
Money market fund |
$ |
4,610 |
$ |
|
$ |
|
$ |
4,610 |
The following table sets forth by level, within the fair value hierarchy, the life insurance plan's assets at fair value as of December 31, 2018:
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
Money market fund |
$ |
4,854 |
$ |
|
$ |
|
$ |
4,854 |
For the year ended December 31, 2019 and 2018, there were no transfers between levels.
Investments are exposed to various risks, such as interest rate and credit risks. Due to the level of risk associated with investments and the level of uncertainty related to credit risks, it is at least reasonably possible that changes in risk in the near term could materially affect the amounts reported.
401(k) Plan
PLC sponsors a tax qualified 401(k) Plan ("401(k) Plan") which covers substantially all employees. Employee contributions are made on a before-tax basis as provided by Section 401(k) of the Internal Revenue Code or as after-tax "Roth" contributions. Employees may contribute up to 25% of their eligible annual compensation to the 401(k) Plan, limited to a maximum annual contribution amount as set periodically by the Internal Revenue Service ($19,000 for 2019). The Plan also provides a "catch-up" contribution provision which permits eligible participants (age 50 or over at the end of the calendar year), to make additional contributions that exceed the regular annual contribution limits up to a limit periodically set by the Internal Revenue Service ($6,000 for 2019). PLC matches the sum of all employee contributions dollar for dollar up to a maximum of 4% of an employee's pay per year per person. All matching contributions vest immediately. For the year ended December 31, 2019 and December 31, 2018, the Company recorded an expense of $9.3 million and $9.2 million associated with 401(k) Plan matching contributions, respectively.
PLC also has a supplemental matching contribution program, which is a nonqualified plan that provides supplemental matching contributions in excess of the limits imposed on qualified defined contribution plans by federal tax law. The expense recorded by PLC for this employee benefit was $1.0 million, $1.3 million, and $1.1 million, respectively, in 2019, 2018, and 2017.
F-105
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
18. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The following table summarizes the changes in the accumulated balances for each component of AOCI as of December 31, 2019, 2018, and 2017.
Changes in Accumulated Other Comprehensive Income (Loss) by Component
Unrealized
Gains and Losses on Investments(2) |
Accumulated
Gain and Loss on Derivatives |
Total
Accumulated Other Comprehensive Income (Loss) |
|||||||||||||
(Dollars In Thousands, Net of Tax) |
|||||||||||||||
Balance, December 31, 2016 |
$ |
(655,767 |
) |
$ |
727 |
$ |
(655,040 |
) |
|||||||
Other comprehensive income (loss) before
reclassifications |
705,859 |
(563 |
) |
705,296 |
|||||||||||
Other comprehensive income (loss) relating to
other-than-temporary impaired investments for which a portion has been recognized in earnings |
391 |
|
391 |
||||||||||||
Amounts reclassified from accumulated other
comprehensive income (loss)(1) |
(944 |
) |
451 |
(493 |
) |
||||||||||
Cumulative effect adjustments |
(26,470 |
) |
132 |
(26,338 |
) |
||||||||||
Balance, December 31, 2017 |
$ |
23,069 |
$ |
747 |
$ |
23,816 |
|||||||||
Other comprehensive income (loss) before
reclassifications |
(1,411,674 |
) |
(1,884 |
) |
(1,413,558 |
) |
|||||||||
Other comprehensive income (loss) relating to other-
than-temporary impaired investments for which a portion has been recognized in earnings |
(20,751 |
) |
|
(20,751 |
) |
||||||||||
Amounts reclassified from accumulated other
comprehensive income (loss)(1) |
15,699 |
1,130 |
16,829 |
||||||||||||
Cumulative effect adjustments |
(10,552 |
) |
|
(10,552 |
) |
||||||||||
Balance, December 31, 2018 |
$ |
(1,404,209 |
) |
$ |
(7 |
) |
$ |
(1,404,216 |
) |
||||||
Other comprehensive income (loss) before
reclassifications |
2,833,888 |
(9,781 |
) |
2,824,107 |
|||||||||||
Other comprehensive income (loss) relating to other-
than-temporary impaired investments for which a portion has been recognized in earnings |
(3,574 |
) |
|
(3,574 |
) |
||||||||||
Amounts reclassified from accumulated other
comprehensive income (loss)(1) |
(10,474 |
) |
1,799 |
(8,675 |
) |
||||||||||
Balance, December 31, 2019 |
$ |
1,415,631 |
$ |
(7,989 |
) |
$ |
1,407,642 |
(1) See Reclassification table below for details.
(2) As of December 31, 2017, 2018 and 2019, net unrealized losses reported in AOCI were offset by $(6.3) million, $613.4 million and $(776.9) million, respectively, due to the impact those net unrealized losses would have had on certain of the Company's insurance assets and liabilities if the net unrealized losses had been recognized in net income.
F-106
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
18. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Continued)
The following tables summarize the reclassifications amounts out of AOCI for the years ended December 31, 2019, 2018, and 2017.
Gains/(losses) in net income: |
Affected Line Item in the Consolidated
Statements of Income |
For The Year Ended December 31, |
|||||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
Derivative instruments |
Benefits and settlement expenses,
net of reinsurance ceded(1) |
$ |
(2,278 |
) |
$ |
(1,431 |
) |
$ |
(694 |
) |
|||||||||
Tax (expense) benefit |
479 |
301 |
243 |
||||||||||||||||
$ |
(1,799 |
) |
$ |
(1,130 |
) |
$ |
(451 |
) |
|||||||||||
Unrealized gains and losses on
available-for-sale securities |
Realized investment gains (losses):
All other investments |
$ |
47,711 |
$ |
9,851 |
$ |
10,453 |
||||||||||||
Net impairment losses recognized
in earnings |
(34,453 |
) |
(29,724 |
) |
(9,112 |
) |
|||||||||||||
Tax (expense) or benefit |
(2,784 |
) |
4,174 |
(397 |
) |
||||||||||||||
$ |
10,474 |
$ |
(15,699 |
) |
$ |
944 |
(1) See Note 7, Derivative Financial Instruments for additional information
19. INCOME TAXES
The Company's effective income tax rate related to continuing operations varied from the maximum federal income tax rate as follows:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
Statutory federal income tax rate applied to pre-tax income |
21.0 |
% |
21.0 |
% |
35.0 |
% |
|||||||||
State income taxes |
0.4 |
4.2 |
0.3 |
||||||||||||
Investment income not subject to tax |
(1.6 |
) |
(4.5 |
) |
(4.7 |
) |
|||||||||
Prior period adjustments |
0.1 |
1.6 |
(1.1 |
) |
|||||||||||
Federal Tax law changes |
|
|
(184.8 |
) |
|||||||||||
Other |
(0.8 |
) |
(0.6 |
) |
0.5 |
||||||||||
19.1 |
% |
21.7 |
% |
(154.8 |
)% |
The annual provision for federal income tax in these financial statements differs from the annual amounts of income tax expense reported in the respective income tax returns. Certain significant revenues and expenses are appropriately reported in different years with respect to the financial statements and the tax returns.
F-107
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
19. INCOME TAXES (Continued)
The components of the Company's income tax are as follows:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Current income tax expense: |
|||||||||||||||
Federal |
$ |
381,202 |
$ |
113,925 |
$ |
39,042 |
|||||||||
State |
9,112 |
9,699 |
(2,477 |
) |
|||||||||||
Total current |
$ |
390,314 |
$ |
123,624 |
$ |
36,565 |
|||||||||
Deferred income tax expense: |
|||||||||||||||
Federal |
$ |
(254,184 |
) |
$ |
(73,364 |
) |
$ |
(757,748 |
) |
||||||
State |
(5,666 |
) |
3,401 |
2,774 |
|||||||||||
Total deferred |
$ |
(259,850 |
) |
$ |
(69,963 |
) |
$ |
(754,974 |
) |
The components of the Company's net deferred income tax liability are as follows:
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Thousands) |
|||||||||||
Deferred income tax assets: |
|||||||||||
Loss and credit carryforwards |
$ |
132,295 |
$ |
127,168 |
|||||||
Deferred compensation |
55,559 |
58,533 |
|||||||||
Deferred policy acquisition costs |
217,967 |
113,959 |
|||||||||
Premium on non-recourse funding obligations |
784 |
905 |
|||||||||
Net unrealized loss on investments |
|
373,292 |
|||||||||
Valuation allowance |
(9,153 |
) |
(8,629 |
) |
|||||||
397,452 |
665,228 |
||||||||||
Deferred income tax liabilities: |
|||||||||||
Premium receivables and policy liabilities |
211,458 |
339,555 |
|||||||||
VOBA and other intangibles |
596,756 |
478,561 |
|||||||||
Invested assets (other than unrealized gains (losses)) |
557,763 |
720,108 |
|||||||||
Net unrealized gains on investments |
376,288 |
|
|||||||||
Other |
27,157 |
25,343 |
|||||||||
1,769,422 |
1,563,567 |
||||||||||
Net deferred income tax liability |
$ |
(1,371,970 |
) |
$ |
(898,339 |
) |
The deferred tax assets reported above include certain deferred tax assets related to nonqualified deferred compensation and other employee benefit liabilities that were assumed by AXA and they were not acquired by the Company in connection with the acquisition of MONY. The future tax deductions stemming from these liabilities will be claimed by the Company on MONY's tax returns in its post-acquisition periods. These deferred tax assets have been estimated as of the MONY acquisition date (and through the December 31, 2019 reporting date) based on all available information. However, it is possible that these estimates may be adjusted in future reporting periods based on actuarial changes
F-108
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
19. INCOME TAXES (Continued)
to the projected future payments associated with these liabilities. Any such adjustments will be recognized by the Company as an adjustment to income tax expense during the period in which they are realized.
On December 22, 2017, the President of the United States signed into law the Tax Reform Act. The legislation significantly changes U.S. tax law by, among other things, lowering the corporate income tax rate. The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018.
As a result of the reduction in the U.S. corporate income tax rate from 35% to 21% and changes to tax law related to the deductibility of certain deferred tax assets under the Tax Reform Act, we revalued our ending net deferred tax liabilities at December 31, 2017, and recognized a provisional $857.5 million tax benefit in our consolidated statement of income for the year ended December 31, 2017.
Also on December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 ("SAB 118") to address the application of GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Reform Act. The Company recognized the provisional tax impacts based on reasonable estimates made by the Company as to the effects of tax reform on deferred assets due to the application and interpretation of Section 162(m) and included those amounts in its consolidated financial statements for the year ended December 31, 2017. The accounting was completed by December 22, 2018 and there were no material adjustments to the provisional tax benefit.
In management's judgment, the gross deferred income tax asset as of December 31, 2019 will more likely than not be fully realized with the exception of certain federal and state deductible temporary differences. The Company has recognized a valuation allowance of $9.6 million and $9.1 million as of December 31, 2019 and 2018, respectively, related to certain intercompany non-life federal NOL's and state-based future deductible temporary differences that it has determined are more likely than not to expire unutilized. This resulting unfavorable change of $0.5 million, before the federal benefit of state income taxes, increased income tax expense in 2019 by the same amount.
At December 31, 2019, the Company has intercompany loss carryforwards of $581.3 million that are available to offset future taxable income of certain non-life subsidiaries under the terms of the tax sharing agreement with PLC. Approximately $54.8 million of these loss carryforwards will expire between 2036 and 2037 and the remaining loss carryforwards of $526.5 million have no expiration.
Included in the deferred income tax assets above are approximately $12.9 million in state net operating loss carryforwards attributable to certain jurisdictions, which are available to offset future taxable income in the respective state jurisdictions, expiring between 2020 and 2039.
As of December 31, 2019 and 2018, some of the Company's fixed maturities were reported at an unrealized loss, although the net amount is an unrealized gain at December 31, 2019. If the Company were to realize a tax-basis net capital loss for a year, then such loss could not be deducted against that year's other taxable income. However, such a loss could be carried back and forward against any prior year or future year tax-basis net capital gains. Therefore, the Company has relied upon a prudent and feasible tax-planning strategy regarding its fixed maturities that were reported at an unrealized loss. The Company has the ability and the intent to either hold such fixed maturities to maturity, thereby
F-109
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
19. INCOME TAXES (Continued)
avoiding a realized loss, or to generate an offsetting realized gain from unrealized gain fixed maturities if such unrealized loss fixed maturities are sold at a loss prior to maturity.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Balance, beginning of period |
$ |
7,134 |
$ |
11,353 |
$ |
9,856 |
|||||||||
Additions for tax positions of the current year |
|
|
1,857 |
||||||||||||
Additions for tax positions of prior years |
|
|
70 |
||||||||||||
Reductions of tax positions of prior years: |
|||||||||||||||
Changes in judgment |
|
(4,219 |
) |
(430 |
) |
||||||||||
Settlements during the period |
(5,343 |
) |
|
|
|||||||||||
Lapses of applicable statute of limitations |
|
|
|
||||||||||||
Balance, end of period |
$ |
1,791 |
$ |
7,134 |
$ |
11,353 |
Included in the end of period balance above, as of December 31, 2019 and 2018, there were no unrecognized tax benefits for which the ultimate deductibility is certain but for which there is uncertainty about the timing of such deductions. As of December 31, 2017, there were approximately $0.7 million, of such unrecognized tax benefits. Other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective income tax rate but would accelerate to an earlier period the payment of cash to the taxing authority. The total amount of unrecognized tax benefits, if recognized, that would affect the effective income tax rate is approximately $1.8 million, $7.1 million, and $10.7 million, for the years ended December 31, 2019, 2018, and 2017, respectively.
Any accrued interest related to the unrecognized tax benefits and other accrued income taxes have been included in income tax expense. There were no amounts included in any period ending in 2019, 2018, or 2017, as the parent company maintains responsibility for the interest on unrecognized tax benefits.
In April 2019, the IRS proposed favorable and unfavorable adjustments to the Company's 2014 through 2016 reported taxable income. The Company agreed to these adjustments. The resulting taxes have been settled, other than interest, and the settlement of interest will not materially impact the Company or its effective tax rate.
This agreement with the IRS and the change in federal tax rate under the Tax Reform Act are the primary causes for the reductions of unrecognized tax benefits shown in the above chart. The Company believes that in the next 12 months, none of the unrecognized tax benefits will be reduced. In general, the Company is no longer subject to income tax examinations by taxing authorities for tax years that began before 2017.
Due to the aforementioned IRS adjustments to the Company's pre-2017 taxable income, the Company has amended certain of its 2014 through 2016 state income tax returns. Such amendments will cause such years to remain open, pending the states' acceptances of the returns.
F-110
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
20. SUPPLEMENTAL CASH FLOW INFORMATION
The following table sets forth supplemental cash flow information:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Cash paid / (received) during the year: |
|||||||||||||||
Interest expense |
$ |
181,768 |
$ |
186,295 |
$ |
178,787 |
|||||||||
Income taxes |
383,085 |
11,703 |
20,507 |
21. RELATED PARTY TRANSACTIONS
The Company provides furnished office space and computers to affiliates through an intercompany agreement. Revenues from this agreement were $6.4 million, $6.0 million, and $6.2 million, for the years ended December 31, 2019, 2018, and 2017, respectively. The Company purchases data processing, legal, investment, and management services from affiliates. The costs of such services were $277.7 million, $249.3 million, and $240.9 million, for the years ended December 31, 2019, 2018, and 2017, respectively. In addition, the Company has an intercompany payable with affiliates as of December 31, 2019 and 2018 of $50.9 million and $36.4 million, respectively. There was a $8.0 million and $11.3 million intercompany receivable balance as of December 31, 2019 and 2018, respectively.
Certain corporations with which PLC's directors were affiliated paid us premiums and policy fees or other amounts for various types of insurance and investment products, interest on bonds we own and commissions on securities underwritings in which our affiliates participated. Such amounts totaled $6.4 million, $6.8 million, and $6.8 million, for the years ended December 31, 2019, 2018, and 2017, respectively. The Company and/or PLC paid commissions, interest on debt and investment products, and fees to these same corporations totaling $1.9 million, $2.3 million, and $2.4 million for the years ended December 31, 2019, 2018, and 2017, respectively.
The Company has joint venture interests in real estate for which the Company holds the underlying real estate's loan. During 2019, 2018, and 2017, the Company received $23.2 million, $6.8 million, and $41.2 million, respectively, in mortgage loan payments corresponding to the joint venture interests and $15.6 million in principal was collected on loans that paid off in December 2019.
Prior to the Merger, PLC and the Company had no related party transactions with Dai-ichi Life. During the periods ending December 31, 2019, 2018, and 2017, PLC paid a management fee to Dai-ichi Life of $11.1 million, $12.2 million, and $10.9 million, respectively, for certain services provided to the company.
PLC has guaranteed the Company's obligations for borrowings or letters of credit under the revolving line of credit arrangement to which PLC is also a party. PLC has also issued guarantees, entered into support agreements and/or assumed a duty to indemnify its indirect wholly owned captive insurance companies in certain respects.
PLC guaranteed the obligations of the Company under a synthetic lease entered into by the Company, as lessee, with a non-affiliated third party, as lessor. Under the terms of the synthetic lease, financing of $75 million was available to the Company for construction of an office building and parking deck which was completed on February 1, 2000. The synthetic lease was amended and restated as of
F-111
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
21. RELATED PARTY TRANSACTIONS (Continued)
December 19, 2013 and was extended to December 31, 2018. At the end of the lease term, the Company purchased the building for approximately $75.0 million.
The Company has agreements with certain of its subsidiaries under which it provides administrative services for a fee. These services include but are not limited to accounting, financial reporting, compliance, policy administration, reserve computations, and projections. In addition, the Company and its subsidiaries pay PLC for investment, legal and data processing services.
The Company and/or certain of its affiliates have reinsurance agreements in place with companies owned by PLC. These agreements relate to certain portions of our service contract business which is included within the Asset Protection segment. These transactions are eliminated at the PLC consolidated level.
The Company has reinsured GLWB and GMDB riders related to our variable annuity contracts to Shades Creek, a wholly owned insurance subsidiary of PLC. Also during 2012, PLC entered into an intercompany capital support agreement with Shades Creek which provides through a guarantee that PLC will contribute assets or purchase surplus notes (or cause an affiliate or third party to contribute assets or purchase surplus notes) in amounts necessary for Shades Creek's regulatory capital levels to equal or exceed minimum thresholds as defined by the agreement. No additional capital was provided to Shades Creek by PLC during the year ended December 31, 2019. As of December 31, 2019, Shades Creek maintained capital levels in excess of the required minimum thresholds. The maximum potential future payment amount which could be required under the capital support agreement will be dependent on numerous factors, including the performance of equity markets, the level of interest rates, performance of associated hedges, and related policyholder behavior.
22. STATUTORY REPORTING PRACTICES AND OTHER REGULATORY MATTERS
The Company and its insurance subsidiaries prepare statutory financial statements for regulatory purposes in accordance with accounting practices prescribed by the NAIC and the applicable state insurance department laws and regulations. These financial statements vary materially from GAAP. Statutory accounting practices include publications of the NAIC, state laws, regulations, general administrative rules as well as certain permitted accounting practices granted by the respective state insurance department. Generally, the most significant differences are that statutory financial statements do not reflect 1) deferred acquisition costs and VOBA, 2) benefit liabilities that are calculated using Company estimates of expected mortality, interest, and withdrawals, 3) deferred income taxes that are not subject to statutory limits, 4) recognition of realized gains and losses on the sale of securities in the period they are sold, and 5) fixed maturities recorded at fair values, but instead at amortized cost.
Statutory net income (loss) for the Company was $(619.9) million, $321.1 million, and $731.2 million for the years ended December 31, 2019, 2018, and 2017, respectively. Statutory capital and surplus for the Company was $4.9 billion and $4.3 billion as of December 31, 2019 and 2018, respectively.
The Company and its insurance subsidiaries are subject to various state statutory and regulatory restrictions on the insurance subsidiaries' ability to pay dividends to Protective Life Corporation. In general, dividends up to specified levels are considered ordinary and may be paid without prior approval of the insurance commissioner of the state of domicile. Dividends in larger amounts are considered extraordinary and are subject to affirmative prior approval by such commissioner. The
F-112
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
22. STATUTORY REPORTING PRACTICES AND OTHER REGULATORY MATTERS (Continued)
maximum amount that would qualify as ordinary dividends to the Company from our insurance subsidiaries in 2020 is approximately $138.4 million. Additionally, as of December 31, 2019, approximately $1.0 billion of consolidated shareowner's equity, excluding net unrealized gains on investments, represented restricted net assets of the Company's insurance subsidiaries needed to maintain the minimum capital required by the insurance subsidiaries' respective state insurance departments.
State insurance regulators and the National Association of Insurance Commissioners ("NAIC") have adopted risk-based capital ("RBC") requirements for life insurance companies to evaluate the adequacy of statutory capital and surplus in relation to investment and insurance risks. The requirements provide a means of measuring the minimum amount of statutory surplus appropriate for an insurance company to support its overall business operations based on its size and risk profile. A company's risk-based statutory surplus is calculated by applying factors and performing calculations relating to various asset, premium, claim, expense, and reserve items. Regulators can then measure the adequacy of a company's statutory surplus by comparing it to RBC. The Company manages its capital consumption by using the ratio of its total adjusted capital, as defined by the insurance regulators, to the Company's action level RBC (known as the RBC ratio), also defined by insurance regulators. As of December 31, 2019 and 2018, the Company's insurance subsidiaries all exceeded the minimum RBC requirements.
Additionally, the Company has certain assets that are on deposit with state regulatory authorities and restricted from use. As of December 31, 2019, the Company and its insurance subsidiaries had on deposit with regulatory authorities, fixed maturity and short-term investments with a fair value of approximately $42.9 million.
The states of domicile of the Company and its insurance subsidiaries have adopted prescribed accounting practices that differ from the required accounting outlined in NAIC Statutory Accounting Principles ("SAP"). The insurance subsidiaries also have certain accounting practices permitted by the states of domicile that differ from those found in NAIC SAP.
Certain prescribed and permitted practices impact the statutory surplus of the Company. These practices include the non-admission of goodwill as an asset for statutory reporting.
The favorable (unfavorable) effects of the Company and its statutory surplus, compared to NAIC statutory surplus, from the use of these prescribed and permitted practices were as follows:
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Millions) |
|||||||||||
Non-admission of goodwill |
$ |
(143 |
) |
$ |
(181 |
) |
|||||
Total (net) |
$ |
(143 |
) |
$ |
(181 |
) |
The Company also has certain prescribed and permitted practices which are applied at the subsidiary level and do not have a direct impact on the statutory surplus of the Company. These practices include permission to follow the actuarial guidelines of the domiciliary state of the ceding insurer for certain captive reinsurers, accounting for the face amount of all issued and outstanding letters of credit, and notes issued by affiliates as an asset in the statutory financial statements of certain wholly owned
F-113
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
22. STATUTORY REPORTING PRACTICES AND OTHER REGULATORY MATTERS (Continued)
subsidiaries that are considered "Special Purpose Financial Captives," and a reserve difference related to a captive insurance company.
The favorable (unfavorable) effects on the statutory surplus of the Company's insurance subsidiaries, compared to NAIC statutory surplus, from the use of these prescribed and permitted practices were as follows:
As of December 31, |
|||||||||||
2019 |
2018 |
||||||||||
(Dollars In Millions) |
|||||||||||
Accounting for Letters of Credit as admitted assets |
$ |
1,555 |
$ |
1,630 |
|||||||
Accounting for certain notes as admitted assets |
$ |
2,748 |
$ |
2,553 |
|||||||
Reserving based on state specific actuarial practices |
$ |
116 |
$ |
121 |
|||||||
Reserving difference related to a captive insurance company |
$ |
(71 |
) |
$ |
(50 |
) |
|||||
Total (net) |
$ |
4,348 |
$ |
4,254 |
23. OPERATING SEGMENTS
The Company has several operating segments, each having a strategic focus. An operating segment is distinguished by products, channels of distribution, and/or other strategic distinctions. The Company periodically evaluates its operating segments and makes adjustments to its segment reporting as needed. A brief description of each segment follows.
• The Life Marketing segment markets fixed UL, IUL, VUL, BOLI, and level premium term insurance ("traditional") products on a national basis primarily through networks of independent insurance agents and brokers, broker-dealers, financial institutions, independent distribution organizations, and affinity groups.
• The Acquisitions segment focuses on acquiring, converting, and servicing policies and contracts acquired from other companies. The segment's primary focus is on life insurance policies and annuity products that were sold to individuals. The level of the segment's acquisition activity is predicated upon many factors, including available capital, operating capacity, potential return on capital, and market dynamics. Policies acquired through the Acquisitions segment are typically blocks of business where no new policies are being marketed, however, some recent acquisitions have included ongoing new business activities. Ongoing new product sales written by the Company from these acquisitions are included in the Life Marketing and/or Annuities segment. As a result, earnings and account values are expected to decline as the result of lapses, deaths, and other terminations of coverage unless new acquisitions are made.
• The Annuities segment markets fixed and VA products. These products are primarily sold through broker-dealers, financial institutions, and independent agents and brokers.
• The Stable Value Products segment sells fixed and floating rate funding agreements directly to the trustees of municipal bond proceeds, money market funds, bank trust departments, and other institutional investors. This segment also issues funding agreements to the FHLB, and markets GICs to 401(k) and other qualified retirement savings plans. The Company also has an unregistered funding agreement-backed notes program which provides for offers of notes to both domestic and international institutional investors.
F-114
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
23. OPERATING SEGMENTS (Continued)
• The Asset Protection segment markets extended service contracts, GAP products, credit life and disability insurance, and other specialized ancillary products to protect consumers' investments in automobiles and recreational vehicles. GAP covers the difference between the loan pay-off amount and an asset's actual cash value in the case of a total loss. Each type of specialized ancillary product protects against damage or other loss to a particular aspect of the underlying asset.
• The Corporate and Other segment primarily consists of net investment income on assets supporting our equity capital, unallocated corporate overhead and expenses not attributable to the segments above. This segment includes earnings from several non-strategic or runoff lines of business, various financing and investment related transactions, and the operations of several small subsidiaries.
The Company's management and Board of Directors analyzes and assesses the operating performance of each segment using "pre-tax adjusted operating income (loss)" and "after-tax adjusted operating income (loss)". Consistent with GAAP accounting guidance for segment reporting, pre-tax adjusted operating income (loss) is the Company's measure of segment performance. Pre-tax adjusted operating income (loss) is calculated by adjusting "income (loss) before income tax", by excluding the following items:
• realized gains and losses on investments and derivatives,
• changes in the GLWB embedded derivatives exclusive of the portion attributable to the economic cost of the GLWB,
• actual GLWB incurred claims, and
• the amortization of DAC, VOBA, and certain policy liabilities that is impacted by the exclusion of these items.
The items excluded from adjusted operating income (loss) are important to understanding the overall results of operations. Pre-tax adjusted operating income (loss) and after-tax adjusted operating income (loss) are not substitutes for income before income taxes or net income (loss), respectively. These measures may not be comparable to similarly titled measures reported by other companies. The Company believes that pre-tax and after-tax adjusted operating income (loss) enhances management's and the Board of Directors' understanding of the ongoing operations, the underlying profitability of each segment, and helps facilitate the allocation of resources.
After-tax adjusted operating income (loss) is derived from pre-tax adjusted operating income (loss) with the inclusion of income tax expense or benefits associated with pre-tax adjusted operating income. Income tax expense or benefits is allocated to the items excluded from pre-tax adjusted operating income (loss) at the statutory federal income tax rate for the associated period. For periods ending on and prior to December 31, 2017, a rate of 35% was used. Beginning in 2018, a statutory federal income tax rate of 21% was used to allocate income tax expense or benefits to items excluded from pre-tax adjusted operating income (loss). Income tax expense or benefits allocated to after-tax adjusted operating income (loss) can vary period to period based on changes in the Company's effective income tax rate.
In determining the components of the pre-tax adjusted operating income (loss) for each segment, premiums and policy fees, other income, benefits and settlement expenses, and amortization of DAC
F-115
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
23. OPERATING SEGMENTS (Continued)
and VOBA are attributed directly to each operating segment. Net investment income is allocated based on directly related assets required for transacting the business of that segment. Realized investment gains (losses) and other operating expenses are allocated to the segments in a manner that most appropriately reflects the operations of that segment. Investments and other assets are allocated based on statutory policy liabilities net of associated statutory policy assets, while DAC/VOBA and goodwill are shown in the segments to which they are attributable.
There were no significant intersegment transactions during the years ended December 31, 2019, 2018, and 2017.
The following tables present a summary of results and reconciles pre-tax adjusted operating income (loss) to consolidated income before income tax and net income:
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Revenues |
|||||||||||||||
Life Marketing |
$ |
1,694,618 |
$ |
1,567,857 |
$ |
1,556,207 |
|||||||||
Acquisitions |
2,901,650 |
2,027,195 |
1,569,083 |
||||||||||||
Annuities |
623,854 |
478,114 |
486,847 |
||||||||||||
Stable Value Products |
246,587 |
219,501 |
190,006 |
||||||||||||
Asset Protection |
353,896 |
355,501 |
370,449 |
||||||||||||
Corporate and Other |
131,464 |
110,848 |
140,075 |
||||||||||||
Total revenues |
$ |
5,952,069 |
$ |
4,759,016 |
$ |
4,312,667 |
|||||||||
Pre-tax Adjusted Operating Income (Loss) |
|||||||||||||||
Life Marketing |
$ |
(26,697 |
) |
$ |
(13,726 |
) |
$ |
55,152 |
|||||||
Acquisitions |
346,825 |
282,715 |
249,749 |
||||||||||||
Annuities |
145,578 |
129,155 |
171,269 |
||||||||||||
Stable Value Products |
93,183 |
102,328 |
105,261 |
||||||||||||
Asset Protection |
37,205 |
24,371 |
17,638 |
||||||||||||
Corporate and Other |
(161,248 |
) |
(156,722 |
) |
(189,645 |
) |
|||||||||
Pre-tax adjusted operating income |
434,846 |
368,121 |
409,424 |
||||||||||||
Realized gains (losses) on investments and derivatives |
248,602 |
(120,533 |
) |
54,584 |
|||||||||||
Income before income tax |
683,448 |
247,588 |
464,008 |
||||||||||||
Income tax expense (benefit) |
130,464 |
53,661 |
(718,409 |
) |
|||||||||||
Net income |
$ |
552,984 |
$ |
193,927 |
$ |
1,182,417 |
|||||||||
Pre-tax adjusted operating income |
$ |
434,846 |
$ |
368,121 |
$ |
409,424 |
|||||||||
Adjusted operating income tax (expense) benefit |
(78,257 |
) |
(78,973 |
) |
737,513 |
||||||||||
After-tax adjusted operating income |
356,589 |
289,148 |
1,146,937 |
||||||||||||
Realized gains (losses) on investments and derivatives |
248,602 |
(120,533 |
) |
54,584 |
|||||||||||
Income tax (expense) benefit on adjustments |
(52,207 |
) |
25,312 |
(19,104 |
) |
||||||||||
Net income |
$ |
552,984 |
$ |
193,927 |
$ |
1,182,417 |
|||||||||
Realized investment gains (losses): |
|||||||||||||||
Derivative financial instruments |
$ |
(131,459 |
) |
$ |
79,097 |
$ |
(137,041 |
) |
|||||||
All other investments |
342,998 |
(223,276 |
) |
121,087 |
|||||||||||
Net impairment losses recognized in earnings |
(34,453 |
) |
(29,724 |
) |
(9,112 |
) |
|||||||||
Less: related amortization(1) |
(23,021 |
) |
(11,856 |
) |
(39,480 |
) |
|||||||||
Less: VA GLWB economic cost |
(48,495 |
) |
(41,514 |
) |
(40,170 |
) |
|||||||||
Realized gains (losses) on investments and derivatives |
$ |
248,602 |
$ |
(120,533 |
) |
$ |
54,584 |
(1) Includes amortization of DAC/VOBA and benefits and settlement expenses that are impacted by realized gains (losses).
F-116
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
23. OPERATING SEGMENTS (Continued)
For The Year Ended December 31, |
|||||||||||||||
2019 |
2018 |
2017 |
|||||||||||||
(Dollars In Thousands) |
|||||||||||||||
Net investment income |
|||||||||||||||
Life Marketing |
$ |
571,654 |
$ |
552,697 |
$ |
550,714 |
|||||||||
Acquisitions |
1,532,605 |
1,108,218 |
752,520 |
||||||||||||
Annuities |
367,650 |
335,382 |
316,582 |
||||||||||||
Stable Value Products |
243,775 |
217,778 |
186,576 |
||||||||||||
Asset Protection |
28,291 |
25,070 |
22,298 |
||||||||||||
Corporate and Other |
74,855 |
99,757 |
94,366 |
||||||||||||
Total net investment income |
$ |
2,818,830 |
$ |
2,338,902 |
$ |
1,923,056 |
|||||||||
Amortization of DAC and VOBA |
|||||||||||||||
Life Marketing |
$ |
157,854 |
$ |
116,917 |
$ |
120,753 |
|||||||||
Acquisitions |
10,693 |
18,690 |
(6,939 |
) |
|||||||||||
Annuities |
(58,907 |
) |
24,274 |
(54,471 |
) |
||||||||||
Stable Value Products |
3,382 |
3,201 |
2,354 |
||||||||||||
Asset Protection |
62,631 |
62,984 |
17,746 |
||||||||||||
Corporate and Other |
|
|
|
||||||||||||
Total amortization of DAC and VOBA |
$ |
175,653 |
$ |
226,066 |
$ |
79,443 |
Operating Segments
As of December 31, 2019 |
|||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
Life
Marketing |
Acquisitions |
Annuities |
Stable Value
Products |
||||||||||||||||
Investments and other assets |
$ |
16,013,892 |
$ |
54,074,450 |
$ |
21,434,347 |
$ |
5,317,885 |
|||||||||||
DAC and VOBA |
1,486,699 |
924,090 |
929,917 |
5,221 |
|||||||||||||||
Other intangibles |
243,210 |
36,321 |
157,968 |
6,722 |
|||||||||||||||
Goodwill |
215,254 |
23,862 |
343,247 |
113,924 |
|||||||||||||||
Total assets |
$ |
17,959,055 |
$ |
55,058,723 |
$ |
22,865,479 |
$ |
5,443,752 |
|||||||||||
Asset
Protection |
Corporate
and Other |
Total
Consolidated |
|||||||||||||||||
Investments and other assets |
$ |
878,386 |
$ |
17,830,217 |
$ |
115,549,177 |
|||||||||||||
DAC and VOBA |
173,628 |
|
3,519,555 |
||||||||||||||||
Other intangibles |
112,032 |
27,173 |
583,426 |
||||||||||||||||
Goodwill |
129,224 |
|
825,511 |
||||||||||||||||
Total assets |
$ |
1,293,270 |
$ |
17,857,390 |
$ |
120,477,669 |
F-117
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
23. OPERATING SEGMENTS (Continued)
Operating Segment Assets
As of December 31, 2018 |
|||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
Life
Marketing |
Acquisitions |
Annuities |
Stable Value
Products |
||||||||||||||||
Investments and other assets |
$ |
14,607,822 |
$ |
31,859,520 |
$ |
20,160,279 |
$ |
5,107,334 |
|||||||||||
DAC and VOBA |
1,499,386 |
458,977 |
889,697 |
6,121 |
|||||||||||||||
Other intangibles |
262,181 |
31,975 |
156,785 |
7,389 |
|||||||||||||||
Goodwill |
215,254 |
23,862 |
343,247 |
113,924 |
|||||||||||||||
Total assets |
$ |
16,584,643 |
$ |
32,374,334 |
$ |
21,550,008 |
$ |
5,234,768 |
|||||||||||
Asset
Protection |
Corporate
and Other |
Total
Consolidated |
|||||||||||||||||
Investments and other assets |
$ |
827,416 |
$ |
12,356,003 |
$ |
84,918,374 |
|||||||||||||
DAC and VOBA |
172,149 |
|
3,026,330 |
||||||||||||||||
Other intangibles |
122,590 |
31,934 |
612,854 |
||||||||||||||||
Goodwill |
129,224 |
|
825,511 |
||||||||||||||||
Total assets |
$ |
1,251,379 |
$ |
12,387,937 |
$ |
89,383,069 |
24. CONSOLIDATED QUARTERLY RESULTS UNAUDITED
The Company's unaudited consolidated quarterly operating data for the year ended December 31, 2019 and 2018 is presented below. In the opinion of management, all adjustments (consisting only of normal recurring items) necessary for a fair statement of quarterly results have been reflected in the following data. It is also management's opinion, however, that quarterly operating data for insurance enterprises are not necessarily indicative of results that may be expected in succeeding quarters or years. In order to obtain a more accurate indication of performance, there should be a review of operating results, changes in shareowner's equity, and cash flows for a period of several quarters.
First
Quarter |
Second
Quarter |
Third
Quarter |
Fourth
Quarter |
||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
For The Year Ended December 31, 2019 |
|||||||||||||||||||
Premiums and policy fees |
$ |
923,686 |
$ |
939,097 |
$ |
1,021,152 |
$ |
1,172,267 |
|||||||||||
Reinsurance ceded |
(315,971 |
) |
(337,077 |
) |
(314,234 |
) |
(549,922 |
) |
|||||||||||
Net of reinsurance ceded |
607,715 |
602,020 |
706,918 |
622,345 |
|||||||||||||||
Net investment income |
641,422 |
685,194 |
739,711 |
752,503 |
|||||||||||||||
Realized investment gains (losses) |
56,220 |
44,243 |
130,503 |
(19,427 |
) |
||||||||||||||
Net impairment losses recognized
in earnings |
(3,142 |
) |
(698 |
) |
(10,818 |
) |
(19,795 |
) |
|||||||||||
Other income |
78,136 |
104,172 |
115,679 |
119,168 |
|||||||||||||||
Total revenues |
1,380,351 |
1,434,931 |
1,681,993 |
1,454,794 |
|||||||||||||||
Total benefits and expenses |
1,203,624 |
1,249,208 |
1,442,152 |
1,373,637 |
|||||||||||||||
Income before income tax |
176,727 |
185,723 |
239,841 |
81,157 |
|||||||||||||||
Income tax expense |
34,629 |
31,309 |
49,417 |
15,109 |
|||||||||||||||
Net income |
$ |
142,098 |
$ |
154,414 |
$ |
190,424 |
$ |
66,048 |
F-118
PROTECTIVE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
24. CONSOLIDATED QUARTERLY RESULTS (Continued)
First
Quarter |
Second
Quarter |
Third
Quarter |
Fourth
Quarter |
||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||
For The Year Ended December 31, 2018 |
|||||||||||||||||||
Premiums and policy fees |
$ |
883,413 |
$ |
935,928 |
$ |
871,892 |
$ |
965,275 |
|||||||||||
Reinsurance ceded |
(345,624 |
) |
(391,864 |
) |
(267,910 |
) |
(378,112 |
) |
|||||||||||
Net of reinsurance ceded |
537,789 |
544,064 |
603,982 |
587,163 |
|||||||||||||||
Net investment income |
489,418 |
578,414 |
631,955 |
639,115 |
|||||||||||||||
Realized investment gains (losses) |
(40,725 |
) |
(32,583 |
) |
(46,866 |
) |
(24,005 |
) |
|||||||||||
Net impairment losses recognized
in earnings |
(3,645 |
) |
(5 |
) |
(14 |
) |
(26,060 |
) |
|||||||||||
Other income |
80,674 |
79,754 |
80,906 |
79,685 |
|||||||||||||||
Total revenues |
1,063,511 |
1,169,644 |
1,269,963 |
1,255,898 |
|||||||||||||||
Total benefits and expenses |
1,041,575 |
1,108,750 |
1,174,793 |
1,186,310 |
|||||||||||||||
Income before income tax |
21,936 |
60,894 |
95,170 |
69,588 |
|||||||||||||||
Income tax expense |
3,661 |
8,626 |
16,646 |
24,728 |
|||||||||||||||
Net income |
$ |
18,275 |
$ |
52,268 |
$ |
78,524 |
$ |
44,860 |
25. SUBSEQUENT EVENTS
The Company has evaluated the effects of events subsequent to December 31, 2019, and through the date we filed our consolidated financial statements with the United States Securities and Exchange Commission. Subsequent to December 31, 2019, equity and financial markets have experienced significant volatility and interest rates have continued to decline due to the COVID-19 pandemic. The Company is currently unable to determine the extent of the impact of the pandemic to its operations and financial condition. All accounting and disclosure requirements related to subsequent events are included in our consolidated financial statements.
F-119
SCHEDULE III SUPPLEMENTARY INSURANCE INFORMATION
PROTECTIVE LIFE INSURANCE COMPANY AND SUBSIDIARIES
Segment |
Deferred
Policy Acquisition Costs and Value of Businesses Acquired |
Future Policy
Benefits and Claims |
Unearned
Premiums |
Stable Value
Products, Annuity Contracts and Other Policyholders' Funds |
Net
Premiums and Policy Fees |
Net
Investment Income(1) |
Benefits
and Settlement Expenses |
Amortization
of Deferred Policy Acquisitions Costs and Value of Businesses Acquired |
Other
Operating Expenses(1) |
Premiums
Written(2) |
|||||||||||||||||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||||||||||||||||||||||
For The Year Ended December 31, 2019 |
|||||||||||||||||||||||||||||||||||||||||||
Life Marketing |
$ |
1,486,699 |
$ |
16,527,876 |
$ |
91 |
$ |
397,758 |
$ |
1,105,531 |
$ |
571,654 |
$ |
1,498,024 |
$ |
157,854 |
$ |
55,888 |
$ |
92 |
|||||||||||||||||||||||
Acquisitions |
924,090 |
36,175,786 |
1,991 |
6,386,506 |
1,172,557 |
1,532,605 |
2,236,701 |
10,693 |
232,169 |
42,290 |
|||||||||||||||||||||||||||||||||
Annuities |
929,917 |
1,145,693 |
|
9,004,199 |
65,744 |
367,650 |
267,368 |
(58,907 |
) |
152,700 |
|
||||||||||||||||||||||||||||||||
Stable Value
Products |
5,221 |
|
|
5,443,752 |
|
243,775 |
144,448 |
3,382 |
2,774 |
|
|||||||||||||||||||||||||||||||||
Asset
Protection |
173,628 |
43,604 |
792,104 |
|
183,445 |
28,291 |
92,655 |
62,631 |
161,405 |
180,095 |
|||||||||||||||||||||||||||||||||
Corporate
and Other |
|
51,003 |
646 |
78,300 |
11,721 |
74,855 |
16,866 |
|
231,970 |
11,768 |
|||||||||||||||||||||||||||||||||
Total |
$ |
3,519,555 |
$ |
53,943,962 |
$ |
794,832 |
$ |
21,310,515 |
$ |
2,538,998 |
$ |
2,818,830 |
$ |
4,256,062 |
$ |
175,653 |
$ |
836,906 |
$ |
234,245 |
|||||||||||||||||||||||
For The Year Ended December 31, 2018 |
|||||||||||||||||||||||||||||||||||||||||||
Life Marketing |
$ |
1,499,386 |
$ |
15,318,019 |
$ |
98 |
$ |
422,037 |
$ |
1,043,228 |
$ |
552,697 |
$ |
1,412,001 |
$ |
116,917 |
$ |
69,758 |
$ |
93 |
|||||||||||||||||||||||
Acquisitions |
458,976 |
25,427,730 |
2,206 |
6,018,954 |
952,315 |
1,108,218 |
1,636,697 |
18,690 |
143,698 |
13,864 |
|||||||||||||||||||||||||||||||||
Annuities |
889,697 |
1,050,161 |
|
8,324,931 |
71,321 |
335,382 |
223,912 |
24,274 |
148,615 |
|
|||||||||||||||||||||||||||||||||
Stable Value
Products |
6,121 |
|
|
5,234,731 |
|
217,778 |
109,747 |
3,201 |
2,798 |
|
|||||||||||||||||||||||||||||||||
Asset
Protection |
172,150 |
51,702 |
766,641 |
|
193,936 |
25,070 |
111,249 |
62,984 |
156,897 |
189,283 |
|||||||||||||||||||||||||||||||||
Corporate
and Other |
|
53,006 |
675 |
82,538 |
12,198 |
99,757 |
17,646 |
|
252,344 |
12,191 |
|||||||||||||||||||||||||||||||||
Total |
$ |
3,026,330 |
$ |
41,900,618 |
$ |
769,620 |
$ |
20,083,191 |
$ |
2,272,998 |
$ |
2,338,902 |
$ |
3,511,252 |
$ |
226,066 |
$ |
774,110 |
$ |
215,431 |
|||||||||||||||||||||||
For The Year Ended December 31, 2017 |
|||||||||||||||||||||||||||||||||||||||||||
Life Marketing |
$ |
1,320,776 |
$ |
15,438,739 |
$ |
107 |
$ |
424,204 |
$ |
1,011,911 |
$ |
550,714 |
$ |
1,319,138 |
$ |
120,753 |
$ |
60,877 |
$ |
111 |
|||||||||||||||||||||||
Acquisitions |
74,862 |
14,323,713 |
2,423 |
4,377,020 |
785,188 |
752,520 |
1,204,084 |
(6,939 |
) |
110,607 |
15,964 |
||||||||||||||||||||||||||||||||
Annuities |
772,633 |
1,080,629 |
|
7,308,354 |
73,617 |
316,582 |
216,324 |
(54,471 |
) |
146,407 |
|
||||||||||||||||||||||||||||||||
Stable Value
Products |
6,864 |
|
|
4,698,371 |
|
186,576 |
74,578 |
2,354 |
4,407 |
|
|||||||||||||||||||||||||||||||||
Asset
Protection |
30,266 |
55,030 |
747,945 |
|
205,814 |
22,298 |
124,487 |
17,746 |
210,579 |
199,741 |
|||||||||||||||||||||||||||||||||
Corporate
and Other |
|
58,681 |
655 |
78,810 |
12,736 |
94,366 |
16,396 |
|
281,334 |
12,749 |
|||||||||||||||||||||||||||||||||
Total |
$ |
2,205,401 |
$ |
30,956,792 |
$ |
751,130 |
$ |
16,886,759 |
$ |
2,089,266 |
$ |
1,923,056 |
$ |
2,955,007 |
$ |
79,443 |
$ |
814,211 |
$ |
228,565 |
(1) Allocations of Net Investment Income and Other Operating Expenses are based on a number of assumptions and estimates and results would change if different methods were applied.
(2) Excludes Life Insurance.
See Report of Independent Registered Public Accounting Firm
S-1
SCHEDULE IV REINSURANCE
PROTECTIVE LIFE INSURANCE COMPANY AND SUBSIDIARIES
Gross
Amount |
Ceded to
Other Companies |
Assumed
from Other Companies |
Net
Amount |
Percentage of
Amount Assumed to Net |
|||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
For The Year Ended December 31, 2019: |
|||||||||||||||||||||||
Life insurance in-force |
$ |
766,196,760 |
$ |
(271,600,818 |
) |
$ |
212,573,612 |
$ |
707,169,554 |
30.1 |
% |
||||||||||||
Premiums and policy fees: |
|||||||||||||||||||||||
Life insurance |
2,852,899 |
(1,383,822 |
) |
835,677 |
2,304,754 |
(1) |
36.3 |
% |
|||||||||||||||
Accident/health insurance |
42,248 |
(26,952 |
) |
41,406 |
56,702 |
73.0 |
|||||||||||||||||
Property and liability
insurance |
280,734 |
(106,430 |
) |
3,238 |
177,542 |
1.8 |
|||||||||||||||||
Total |
$ |
3,175,881 |
$ |
(1,517,204 |
) |
$ |
880,321 |
$ |
2,538,998 |
||||||||||||||
For The Year Ended December 31, 2018: |
|||||||||||||||||||||||
Life insurance in-force |
$ |
765,986,223 |
$ |
(302,149,614 |
) |
$ |
135,407,408 |
$ |
599,244,017 |
22.6 |
% |
||||||||||||
Premiums and policy fees: |
|||||||||||||||||||||||
Life insurance |
2,681,191 |
(1,249,906 |
) |
626,283 |
2,057,568 |
(1) |
30.4 |
% |
|||||||||||||||
Accident/health insurance |
47,028 |
(30,126 |
) |
12,826 |
29,728 |
43.1 |
|||||||||||||||||
Property and liability
insurance |
284,323 |
(103,478 |
) |
4,857 |
185,702 |
2.6 |
|||||||||||||||||
Total |
$ |
3,012,542 |
$ |
(1,383,510 |
) |
$ |
643,966 |
$ |
2,272,998 |
||||||||||||||
For The Year Ended December 31, 2017: |
|||||||||||||||||||||||
Life insurance in-force |
$ |
751,512,468 |
$ |
(328,377,398 |
) |
$ |
110,205,190 |
$ |
533,340,260 |
21.0 |
% |
||||||||||||
Premiums and policy fees: |
|||||||||||||||||||||||
Life insurance |
2,655,846 |
(1,230,258 |
) |
435,113 |
1,860,701 |
(1) |
23.4 |
% |
|||||||||||||||
Accident/health insurance |
51,991 |
(33,052 |
) |
14,946 |
33,885 |
44.1 |
|||||||||||||||||
Property and liability
insurance |
288,809 |
(103,786 |
) |
9,657 |
194,680 |
5.0 |
|||||||||||||||||
Total |
$ |
2,996,646 |
$ |
(1,367,096 |
) |
$ |
459,716 |
$ |
2,089,266 |
(1) Includes annuity policy fees of $164.3 million, $177.1 million, and $173.5 million, and for the years ended December 31, 2019, 2018, and 2017, respectively.
See Report of Independent Registered Public Accounting Firm
S-2
SCHEDULE V VALUATION AND QUALIFYING ACCOUNTS
PROTECTIVE LIFE INSURANCE COMPANY AND SUBSIDIARIES
Additions |
|||||||||||||||||||||||
Description |
Balance
at beginning of period |
Charged to
costs and expenses |
Charges
to other accounts |
Deductions |
Balance
at end of period |
||||||||||||||||||
(Dollars In Thousands) |
|||||||||||||||||||||||
As of December 31, 2019 |
|||||||||||||||||||||||
Allowance for losses on commercial
mortgage loans |
$ |
1,296 |
$ |
3,938 |
$ |
|
$ |
(350 |
) |
$ |
4,884 |
||||||||||||
As of December 31, 2018 |
|||||||||||||||||||||||
Allowance for losses on commercial
mortgage loans |
$ |
|
$ |
1,505 |
$ |
|
$ |
(209 |
) |
$ |
1,296 |
See Report of Independent Registered Public Accounting Firm
S-3
PART C
OTHER INFORMATION
1. |
|
|
|
2. |
Not Applicable. |
|
|
3.(a) |
|
|
|
3.(a)(ii) |
|
|
|
3.(a)(iii) |
|
|
|
3.(a)(iv) |
|
|
|
4.(a) |
|
|
|
4.(b) |
|
|
|
4.(c) |
4.(d) |
|
|
|
5. |
|
|
|
6.(a) |
|
|
|
6.(b) |
|
|
|
7.(a) |
|
|
|
7.(b) |
|
|
|
7.(c) |
List of Reinsurers, to be filed by Post-Effective Amendment. |
|
|
8. (a)(i) |
8 (a)(ii) |
Amendment to Fund Participation Agreement (American Century) is filed herein. |
|
|
8. (b)(i) |
|
|
|
8. (b)(ii) |
|
|
|
8. (b)(iii) |
Amendment No. 2 to Fund Participation and Service Agreement (American Funds) is filed herein. |
|
|
8.(c) |
|
|
|
8.(d) |
|
|
|
8.(d)(ii) |
|
|
|
8.(e) |
|
|
|
8.(f) |
|
|
|
8.(f)(ii) |
Amendment No.1 to Amended and Restated Participation Agreement (DWS) is filed herein. |
|
|
8.(g) |
|
|
|
8.(h) |
|
|
|
8.(i) |
|
|
|
8.(i)(ii) |
8(i)(iii) |
|
|
|
8(i)(iiii) |
Amendment to Fund Participation Agreement (Fidelity) is filed herein. |
|
|
8(j) |
|
|
|
8(k) |
|
|
|
8.(l) |
|
|
|
8.(m) |
|
|
|
8.(n) |
|
|
|
8.(n)(iiii) |
Amendment No. 4 to Fund Participation Agreement (Legg Mason) is filed herein. |
|
|
8.(o) |
|
|
|
8.(p) |
|
|
|
8.(p)(ii) |
Amendment to Fund Participation Agreement (MFS) is filed herein. |
|
|
8.(q) |
8.(r) |
|
|
|
8.(r)(ii) |
|
|
|
8.(r)(iii) |
|
|
|
8.(r)(iiii) |
Amendment No. 3 to the Fund Participation Agreement (PIMCO) is filed herein. |
|
|
8.(s) |
|
|
|
8.(t) |
|
|
|
8.(u) |
|
|
|
8.(v) |
|
|
|
8.(v)(ii) |
Amendment to Fund Participation Agreement (Van Eck) is filed herein. |
|
|
8.(w) |
9. Not applicable
10. Not applicable
12. Not applicable
13. Not applicable
14. (a) Consent of Faegre Drinker Biddle & Reath LLP, filed herein.
14. (b) Consent of PricewaterhouseCoopers LLP, filed herein.
14. (c) Consent of KPMG LLP, filed herein.
15. No Financial Statements are omitted from Item 24.
16. Not applicable
18. Powers of Attorney, filed herein.
Item 27. Directors and Officers of Depositor.
Name and Principal Business Address* |
|
Position and Offices with Depositor |
Adams, D. Scott |
|
Executive Vice President, Chief Digital and Innovation Officer |
Bartlett, Malcolm Lee |
|
Senior Vice President, Corporate Tax |
Bedwell, Robert R. III |
|
Senior Vice President, Mortgage Loans |
Bielen, Richard J. |
|
Director, Chairman of the Board, Chief Executive Officer, President, Executive Committee |
Black, Lance P. |
|
Senior Vice President, Treasurer |
Borie, Kevin B. |
|
Appointed Actuary, Chief Valuation Actuary, Senior Vice President |
Callaway, Steve M. |
|
Secretary, Senior Counsel, Senior Vice President |
Casey, Sean |
|
Actuary, Senior Vice President |
Cirulli, Vincent |
|
Senior Vice President, Derivatives and VA Hedging |
Cramer, Steve |
|
Chief Product Officer, Senior Vice President |
Creutzmann, Scott E. |
|
Chief Compliance Officer, Senior Vice President |
Drew, Mark L. |
|
Chief Legal Officer, Executive Vice President |
Evesque, Wendy L. |
|
Chief Human Resources Officer, Senior Vice President |
Goyer, Stephane |
|
Head of Annuity Product Development, Senior Vice President |
Harrison, Wade V. |
|
President, Protection Division, Senior Vice President |
Herring, Derry W |
|
Chief Auditor, Senior Vice President |
Kane, Nancy |
|
Executive Vice President, Acquisitions and Corporate Development |
Karchunas, M. Scott |
|
President, Asset Protection Division, Senior Vice President |
Kohler, Matthew |
|
Chief Technology Officer, Senior Vice President |
Laeyendecker, Ronald |
|
Senior Vice President, Executive Benefit Markets |
Lawrence, Mary Pat |
|
Senior Vice President, Government Affairs |
Loper, David M |
|
Senior Counsel, Senior Vice President |
McDonald, Laura Y. |
|
Chief Mortgage and Real Estate Officer, Senior Vice President |
Moloney, Michelle |
|
Chief Risk Officer, Senior Vice President, Senior Vice President |
Moschner, Christopher |
|
Chief Marketing Officer, Senior Vice President |
Passafiume, Philip E. |
|
Chief Investment Officer, Senior Vice President |
Radnoti, Francis |
|
Chief Product Officer,Senior Vice President |
Ray, Webster M. |
|
Senior Vice President, Investments |
Riebel, Matthew A. |
|
Chief Distribution Officer, Senior Vice President |
Seurkamp, Aaron C. |
|
President, Retirement Division, Senior Vice President |
Temple, Michael G. |
|
Director, Chief Operating Officer, Vice Chairman, Executive Committee |
Wagner, James |
|
Chief Distribution Officer, Senior Vice President |
Walker, Steven G. |
|
Director, Chief Financial Officer, Executive Vice President |
Wells, Paul R. |
|
Chief Accounting Officer, Senior Vice President |
Whitcomb, John |
|
Senior Vice President, Distribution Operations |
Williams, Lucinda S. |
|
Chief Customer Officer, Senior Vice President |
* Unless otherwise indicated, principal business address is 2801 Highway 280 South, Birmingham, Alabama 35223.
Item 28. Persons Controlled by or Under Common Control With the Depositor or Registrant.
The registrant is a segregated asset account of the Company and is therefore owned and controlled by the Company. All of the Companys outstanding voting common stock is owned by Protective Life Corporation, a subsidiary of The Dai-ichi Life Insurance Company, Limited. Protective Life Corporation is described more fully in the prospectus included in this registration statement. The following companies are wholly-owned subsidiaries of Protective Life Insurance Company: West Coast Life Insurance Company(1), Protective Life and Annuity Insurance Company(2), MONY Life Insurance Company(3), Protective Property & Casualty Insurance Company(4), Golden Gate Captive Insurance Company(5), Golden Gate II Captive Insurance Company(6), Golden Gate III Vermont Captive Insurance Company(5), Golden Gate IV Vermont Captive Insurance Company(5), Golden Gate V Vermont Captive Insurance Company(5), New World Re(7), United States Warrant Corp.(8), New World Warranty Corp.(8), Western General Warranty Corporation(8), First Protection Corporation of Florida(8), and the Advantage Warranty Corporation(8). The financial statements of these entities are included in the consolidated financial statements of Protective Life Insurance Company, filed as part of the Companys Form 10-K on March 25, 2020.
(1) Incorporated in Nebraska
(2) Incorporated in Alabama
(3) Incorporated in New York
(4) Incorporated in Missouri
(5) Incorporated in Vermont
(6) Incorporated in South Carolina
(7) Incorporated in Nevada
(8) Incorporated in Florida
Item 29. Indemnification.
Article XI of the By-laws of Protective Life provides, in substance, that any of Protective Lifes directors and officers, who is a party or is threatened to be made a party to any action, suit or proceeding, other than an action by or in the right of Protective Life, by reason of the fact that he is or was an officer or director, shall be indemnified by Protective Life against expenses (including attorneys fees), judgments,
fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such claim, action, suit or proceeding if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of Protective Life and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. If the claim, action or suit is or was by or in the right of Protective Life to procure a judgment in its favor, such person shall be indemnified by Protective Life against expenses (including attorneys fees) actually and reasonably incurred by him in connection with the defense or settlement of such action or suit if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of Protective Life, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable for negligence or misconduct in the performance of his duty to Protective Life unless and only to the extent that the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper. To the extent that a director or officer has been successful on the merits or otherwise in defense of any such action, suit or proceeding, or in defense of any claim, issue or matter therein, he shall be indemnified by Protective Life against expenses (including attorneys fees) actually and reasonably incurred by him in connection therewith, not withstanding that he has not been successful on any other claim issue or matter in any such action, suit or proceeding. Unless ordered by a court, indemnification shall be made by Protective Life only as authorized in the specific case upon a determination that indemnification of the officer or director is proper in the circumstances because he has met the applicable standard of conduct. Such determination shall be made (a) by the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to, or who have been successful on the merits or otherwise with respect to, such claim action, suit or proceeding, or (b) if such a quorum is not obtainable, or, even if obtainable a quorum of disinterested directors so directs, by independent legal counsel in a written opinion or (c) by the shareholders.
In addition, the executive officers and directors are insured by PLCs Directors and Officers Liability Insurance Policy including Company Reimbursement and are indemnified by a written contract with PLC which supplements such coverage.
Insofar as indemnification for liability arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification may be against public policy as expressed in the Act and may be, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than payment by the Registrant of expenses incurred or paid by a director, officer, or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.
Item 30. Principal Underwriter.
(a) Other Activity. Investment Distributors, Inc. (IDI) is the principal underwriter of the Policies as defined in the Investment Company Act of 1940. IDI is also principal underwriter for the Protective Variable Annuity Separate Account, Protective Variable Life Separate Account and the Variable Annuity Separate Account A of Protective Life.
(b) Management. The following information is furnished with respect to the officers and directors of Investment Distributors, Inc.
Name and Principal
|
|
Position and Offices |
|
Position and Offices with Registrant |
Brown, Barry K. |
|
President and Director |
|
Vice President, Operations |
Callaway, Steve M. |
|
Secretary and Director |
|
Senior Vice President, Senior Counsel and Secretary |
Creutzmann, Scott E. |
|
Chief Compliance Officer |
|
Senior Vice President and Chief Compliance Officer |
Debnar, Lawrence J. |
|
Assistant Financial Officer |
|
Vice President, Financial Reporting, Chase |
Gilmer, Joseph F. |
|
Assistant Financial Officer and Director |
|
Assistant Vice President, Financial Reporting |
Johnson, Julena G. |
|
Assistant Compliance Officer |
|
Compliance Director |
Leopard, Ramona M. |
|
Assistant Secretary |
|
Paralegal III |
Majewski, Carol L. |
|
Assistant Compliance Officer |
|
Assistant Vice President, Compliance |
Morsch, Letitia |
|
Assistant Secretary |
|
Vice President, New Business Operations |
Tennent, Rayburn |
|
Chief Financial Officer |
|
Financial Analyst III |
* Unless otherwise indicated, principal business address is 2801 Highway 280 South, Birmingham, Alabama 35223.
(c) Compensation From the Registrant. The following commissions were received by each principal underwriter, directly or indirectly, from the Registrant during the Registrants last fiscal year:
(1) Name of Principal
|
|
(2) Net Underwriting
|
|
(3) Compensation on
|
|
(4) Brokerage
|
|
(5) Other
|
|
Investments Distributors, Inc. |
|
None |
|
None |
|
N/A |
|
N/A |
|
Item 31. Location of Accounts and Records.
All accounts and records required to be maintained by Section 31(a) of the Investment Company Act of 1940 and the rules thereunder are maintained by Protective Life Insurance Company at 2801 Highway 280 South, Birmingham, Alabama, 35223.
Item 32. Management Services.
All management contracts are discussed in Part A or Part B.
Item 33. Fee Representation.
Protective Life hereby represents that the fees and charges deducted under the variable life insurance policies described herein are, in the aggregate, reasonable in relation to the services rendered, the expenses expected to be incurred and the risks assumed by it under such policies.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant has duly caused this amendment to its Registration Statement on Form N-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Birmingham, State of Alabama on December 16, 2020.
|
PROTECTIVE COLI VUL |
|
|
(Registrant) |
|
|
|
|
|
By: |
* |
|
|
Richard J. Bielen, President, |
|
|
Protective Life Insurance Company |
|
|
|
|
PROTECTIVE LIFE INSURANCE COMPANY |
|
|
(Depositor) |
|
|
|
|
|
By: |
* |
|
|
Richard J. Bielen, President, |
|
|
Protective Life Insurance Company |
As required by the Securities Act of 1933, this pre-effective amendment to the Registration Statement on Form N-6 has been signed by the following persons in the capacities and on the dates indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
* |
|
President, Chief Executive Officer Chairman of the Board and Director (Principal Executive Officer) |
|
December 16, 2020 |
Richard J. Bielen |
|
|
|
|
|
|
|
|
|
* |
|
Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) |
|
December 16, 2020 |
Steven G. Walker |
|
|
|
|
|
|
|
|
|
* |
|
Vice Chairman, Chief Operating Officer and Director |
|
December 16, 2020 |
Michael G. Temple |
|
|
|
|
|
|
|
|
|
*BY: |
/S/ ALYSON SAAD |
|
|
|
December 16, 2020 |
Alyson Saad |
|
|
|
|
|
Attorney-in-Fact |
|
|
|
|
Exhibits
3(a)(iv) |
|
|
|
8(a)(i) |
|
|
|
8(a)(ii) |
Amendment to Fund Participation Agreement (American Century). |
|
|
8(b)(iii) |
Amendment No. 2 to Fund Participation and Service Agreement (American Funds). |
|
|
8(c) |
|
|
|
8(d) |
|
|
|
8(d)(ii) |
|
|
|
8(e) |
|
|
|
8(f) |
|
|
|
8(f)(ii) |
Amendment No.1 to Amended and Restated Participation Agreement (DWS). |
|
|
8(g) |
|
|
|
8(h) |
|
|
|
8(i)(iiii) |
|
|
|
8(j) |
|
|
|
8(l) |
|
|
|
8(m) |
|
|
|
8(n)(iiii) |
Amendment No. 4 to Fund Participation Agreement (Legg Mason). |
|
|
8(p) |
|
|
|
8(p)(ii) |
|
|
|
8(q) |
|
|
|
8(r)(iiii) |
Amendment No. 3 to the Fund Participation Agreement (PIMCO). |
|
|
8(s) |
|
|
|
8(t) |
|
|
|
8(u) |
|
|
|
8(v) |
|
|
|
8(v)(ii) |
|
|
|
8(w) |
|
|
|
14(a) |
|
|
|
14(b) |
|
|
|
14(c) |
|
|
|
17(a) |
|
|
|
18 |
Form of Broker-Dealer Selling Agreement
For Sales of Protective Life Insurance Company
Corporate Owned Registered Variable Universal Life Insurance
Broker-Dealer: (Broker-Dealer)
Insurance Agency: (Insurance Agency)
Effective Date: (Effective Date)
1. PURPOSE
Protective Life Insurance Company (Protective) has appointed Investment Distributors, Inc. (IDI, and together with Protective, the Company), a registered broker-dealer under the Securities and Exchange Act of 1934, as amended, and member of the Financial Industry Regulatory Authority, Inc. (FINRA), as the principal underwriter of the variable life insurance contracts that are issued by Protective. This Broker-Dealer Selling Agreement (the Agreement) allows IDI to compensate Selling Firm for the sale by Selling Firm and Licensed Personnel (defined below) of certain Protective life corporate owned variable universal life insurance contracts (individually, a Contract and collectively, the Contracts) set forth on the Product and Compensation Schedule(s), Schedule A, of this Agreement. The Product and Compensation Schedule is subject to change at any time upon notice to Selling Firm.
2. AGREEMENT
Selling Firm agrees to represent Company in sales of the Contracts in accordance with the terms of this Agreement, the rules of Company provided to Selling Firm in writing, as amended from time to time by Company in its sole discretion (Company Rules), the rules, regulations, and requirements of FINRA, the Securities Exchange Act of 1934, as amended, the Securities Act of 1933, as amended (the 1933 Act), the Investment Company Act of 1940, as amended (the 1940 Act), and all other applicable state insurance laws, federal and state laws governing the activities of broker-dealers, and the laws and regulations of the jurisdiction(s) in which Selling Firm operates, including the regulations of any agency authorized under such laws, both federal and state, that are in effect as of the Effective Date and as such laws and regulations may be amended thereafter, and that may be adopted after the Effective Date and apply to Selling Firm, Licensed Personnel and/or the activities conducted hereunder (Applicable Laws).
3. LICENSING
a. Selling Firm will be at all times: duly registered as a broker-dealer under the Securities Exchange Act of 1934, as amended, and in each state or other jurisdiction in which Selling Firm acts hereunder in connection with sales of the Contracts, and a member of FINRA. Selling Firm is or is affiliated with the Insurance Agency that is licensed under the insurance laws of the various states in which it operates. The Insurance Agency is identified at the beginning of this Agreement and is considered a party to this Agreement. In this Agreement, references to Selling Firm shall be construed so as to include or refer
solely to Insurance Agency, if such duty, responsibility, or obligation has been delegated to or assumed by Insurance Agency, regardless of whether Insurance Agency and Selling Firm are separate entities.
b. Selling Firm agrees, on its behalf and on behalf of Licensed Personnel, to obtain and maintain any state insurance license(s) necessary to solicit business on behalf of Protective in the jurisdiction(s) in which Selling Firm operates while this Agreement is in effect, and agree further not to solicit business on behalf of Protective in any jurisdiction until Selling Firm and Licensed Personnel have obtained such licenses. For purposes of this Agreement, the term Licensed Personnel means any registered representative who is duly licensed and qualified under applicable securities and insurance laws, rules, and regulations to perform such activities on Selling Firms behalf and is appointed by Protective to sell the Contracts. Protective may appoint, terminate or decline to renew the appointment of any person so designated in Protectives sole discretion.
c. Selling Firm shall promptly notify Company if any insurance license held by Selling Firm or any of Licensed Personnel lapses or is terminated, revoked or not renewed by any jurisdiction, or if Selling Firm or any of Licensed Personnel withdraw or elect not to renew any insurance license in any jurisdiction that had been previously identified to Company as a jurisdiction in which Selling Firm or Licensed Personnel had been licensed. Selling Firm represents and warrants that neither Selling Firm nor any of its officers, directors, employees, agents, subcontractors, nor any Licensed Personnel or other person authorized to act on its behalf has ever been convicted of any state or federal criminal felony involving dishonesty or breach of trust or any crime under Violent Crime Control and Law Enforcement Act of 1994, 18 U.S.C. § 1033. Selling Firm agrees to report to Company any criminal convictions that occur after the Effective Date against Selling Firm or any other person listed in the preceding sentence.
4. APPOINTMENT
a. Selling Firm is hereby appointed as an insurance producer entity authorized to solicit the Contracts on behalf of Protective. Selling Firm is authorized to promote sales of the Contracts through Licensed Personnel. Selling Firm shall promptly notify Company whenever the association between Selling Firm and any Licensed Personnel is terminated for whatever reason.
b. Selling Firm is authorized under this Agreement with power and authority to select and recommend individuals associated with Selling Firm for appointment as an agent of Protective, and only such individuals so recommended by Selling Firm shall become Licensed Personnel, provided that the conditions of Section 3 are satisfied. Protective may appoint, terminate or decline to renew the appointment of any person so designated in Protectives sole discretion. Initial and renewal state appointment fees for Licensed Personnel will be paid by Protective in accordance with its then-applicable requirements.
5. RELATIONSHIP
a. Selling Firm is an independent contractor. Nothing in this Agreement or any other agreement between Selling Firm and Company shall be construed to create the relationship of employee and employer between Selling Firm and Company or between any Licensed Personnel and Company.
b. As an independent contractor, Selling Firm is free to operate its business in the manner Selling Firm deems appropriate and Selling Firm is solely responsible for all expenses incurred in its operation, including expenses incurred in the performance of this Agreement. Further, Selling Firm will not be treated as an employee for purposes of the Federal Insurance Contribution Act, the Social Security Act, the Federal Unemployment Tax Act, or income tax withholding. The filing and payment of self-employment and income taxes with the Federal and appropriate state governments are Selling Firms sole responsibility. Selling Firm agrees to comply with the requirements of the federal and appropriate state government(s) with respect to the filings and payment of self-employment and income taxes on any remuneration from Company.
c. As an independent contractor, it is contemplated that Selling Firm and Licensed Personnel may engage in non-insurance business, and Selling Firm may represent insurance companies other than Protective.
6. COMPENSATION
a. So long as this Agreement is in force, IDI agrees to pay Selling Firm a commission on Contracts sold by Selling Firm and Licensed Personnel for which Selling Firm and Licensed Personnel are designated agent of record. Such commissions shall be paid in accordance with Product and Compensation Schedule(s) attached hereto and made a part hereof as if set forth in full at this point, which is in effect when a contract is issued. Unless otherwise specified in the Product and Compensation Schedule(s), commissions are paid only on premiums paid to and actually received by Company and will be paid in accordance with Company rules and procedures then in effect. The Product and Compensation Schedule(s) is (are) subject to change at any time upon not less than thirty (30) days prior written notice to Selling Firm by Company and will affect business issued on and after the effective date of the change. If a premium is refunded for any reason by Company on any Contract on which Selling Firm received any commission, Selling Firm agrees to repay any amounts received on that Contract to Company, and such amount that remains unpaid may be offset against compensation owed to Selling Firm in the future. Selling Firm will be responsible for all expenses Selling Firm incurs in the performance of this Agreement with no right of reimbursement, except for any expense allowance payment provided hereunder or under any separate agreement between Company and Selling Firm. Selling Firm agrees that it will not share or otherwise pay any commissions received under this Agreement with a person who is not duly licensed, appointed and qualified to receive such commissions.
b. Company will designate Selling Firm and the applicable Licensed Personnel as agent of record on all Contracts issued on applications submitted by Selling Firm and such Licensed Personnel, thereby entitling Selling Firm and such Licensed Personnel to the
compensation payable by Company to an agent of record with respect to such Contracts. Selling Firm acknowledges and agrees that the owner(s) of any Contract(s) may request a change in, or termination of, the agent of record designated for their Contract(s), and further may request that another duly licensed person be designated as agent of record for their Contract(s) in place of Selling Firm. Selling Firm further acknowledges and agrees that Company reserves the right, in its sole discretion, to make the requested change, upon receipt of a valid written request from such owner(s). Selling Firm hereby waives any right to compensation that may become payable to Selling Firm as agent of record with respect to a Contract(s) on or after the date on which Company makes any such change.
c. Selling Firm shall be solely responsible for the payment of any commission or consideration of any kind to Licensed Personnel with respect to the sales of the Contracts.
7. LIMITATION OF AUTHORITY
Selling Firm agrees, on its behalf and on behalf of Licensed Personnel, not to perform in the name of Company any acts for which Selling Firm is not authorized, including but not limited to the following:
a. Accept risks, incur debt or liability, or make contracts for Company;
b. Waive, alter, modify, or change any Company policy, terms, rates, or customary requirements;
c. Endorse checks payable to Company;
d. Accept premium payments, except in accordance with written Company procedures;
e. Extend, or offer to extend, the time for payment of premium payments, or rebate, or offer to rebate, any premium payments;
f. Make any misrepresentation or make an incomplete comparison in connection with the purchase, sale, offer to purchase or sell, conversion, exchange, lapse, or forfeiture of a Contract;
g. Solicit sales of the Contracts in any jurisdiction where such Contracts may not lawfully be sold;
h. Solicit applications for Contracts without delivering to the applicant a current prospectus or other offering documents as required by Applicable Laws;
i. Represent that Selling Firm or Licensed Personnel are an employee, associate, joint venture, or partner of Company; and
j. Use personal or business checks or funds (either Selling Firm or those of Licensed Personnel) for the applicants or Contract holders premium payment.
8. DUTIES OF THE PARTIES
a. On behalf of Selling Firm and Licensed Personnel, Selling Firm agrees as follows:
i. To transmit or submit, promptly upon receipt, all applications for Contracts directly to Company, all applications for Contracts solicited and premiums received on behalf of Company;
ii. To comply with and ensure compliance by Licensed Personnel with all Company Rules and Applicable Laws, including Applicable Laws of each jurisdiction where Selling Firm and/or Licensed Personnel are authorized to solicit sales of the Contracts;
iii. To ensure that Licensed Personnel do not offer or sell the Contracts until such individuals are associated, licensed, and duly registered with FINRA and any applicable state securities and insurance authorities;
iv. To establish such rules and procedures as required to ensure diligent supervision of Licensed Personnel with regards to the offer or sale of the Contracts;
v. In the event Licensed Personnel fails to observe the standards and rules imposed by Selling Firm and Company regarding the sales of the Contracts, to notify Company immediately that such Licensed Personnel is no longer authorized to sell the Contracts and to take whatever action is necessary to terminate the sales activities or services of such Licensed Personnel regarding the Contracts;
vi. To be solely responsible for training and supervising Licensed Personnel regarding solicitation and sales of the Contracts;
vii. To obtain written approval from a duly authorized officer of Company prior to the publication, broadcast or other dissemination of any material whatsoever regarding Company, the Contracts or any products offered by Company, unless such material has been furnished to Selling Firm by Company for such purpose;
viii. To become fully informed as to the provisions and benefits of each Contract and to represent such products adequately and fairly to prospects;
ix. To use best efforts to provide service to customers and to maintain in force any business in place with Protective;
x. To cooperate fully in any securities or insurance regulatory investigation or proceeding or judicial proceeding arising in connection with the Contracts marketed or sold under this Agreement;
xi. To provide prompt notice and reasonable cooperation to Company in the event that any paper is served upon Selling Firm and/or Licensed Personnel in connection with any complaint or legal proceeding against or involving Company;
xii. To submit all applications on forms authorized by Company and review all applications for completeness, and correctness;
xiii. With respect to recommendations and advice involving Contracts sold or serviced by Selling Firm and/or Licensed Personnel, to comply with, and ensure that Licensed Personnel comply with, all standards and requirements for recommendations and/or advice as defined therein with respect to Contracts and/or transactions in connection
therewith in effect as of the Effective Date or that may be adopted and/or amended by federal or state legislatures, federal or state regulators, and/or various self-regulatory organizations (SROs) after the Effective Date of this Agreement (Other Standard of Care Initiatives), commencing with the respective effective date of each such Other Standard of Care Initiative, and Section 8.c. of this Agreement, including without limitation compliance with all applicable training, disclosure, information collection, documentation, determination, supervision, supervision system, reporting, audit and surveillance requirements imposed by such Other Standard of Care Initiative;
xiv. To deliver Contracts only in accordance with Companys instructions as previously provided in writing to Selling Firm;
xv. To keep accurate records on behalf of Protective and to make such records available for examination at any time by authorized representatives of Protective; and
xvi. In the event that Company chooses, or is required, to return premium or make some other accommodation for a policy or contract owner on any policy or contract written on an application Selling Firm or Licensed Personnel placed with Company, Selling Firm agrees to return to Company any commission, service fee, and expense allowance payment Selling Firm received from Company with respect to that premium. This obligation to repay commission, service fees and expense allowance payments shall apply even if the applicant does not accept the premium refund.
b. Company agrees as follows:
i. Company shall make training about the Contracts available to Selling Firm and Licensed Personnel;
ii. Company shall, subject to applicable regulatory requirements and approvals, make the Contracts available for sale by Selling Firm and Licensed Personnel, and shall provide standard Contract brochures, prospectuses, forms, and support material necessary in its sole discretion, to solicit and process sales of the Contracts;
iii. Company or its affiliates shall provide all administrative, accounting, and policyholder services necessary in its sole discretion to support the Contracts; and
iv. Company and its affiliates shall comply with all Applicable Laws related to the offer and sale of the Contracts.
c. Other Standard of Care Initiatives.
i. To the extent that any Other Standard of Care Initiative that takes effect after the Effective Date imposes a supervision responsibility on Company and permits Company to delegate certain or all of its supervision obligations to a third party, Company hereby delegates to Selling Firm, to the fullest extent possible, all supervision responsibility for activities conducted by Selling Firm and Licensed Personnel with respect to the Contracts, which shall include but not be limited to, establishing, maintaining, enforcing and auditing reasonable and appropriate written policies, procedures and controls to perform such obligations and responsibilities. Such delegation to take effect upon the effective date of such Other Standard of Care Initiative. Before the effective date, Company will send a communication to Selling
Firm describing any limitations or restrictions on the delegation. Selling Firm shall be deemed to have accepted and agreed to such delegation if Selling Firm has not objected in writing within thirty (30) days after the date of such communication. Communications pursuant to this Section shall be governed by the notice provisions of the Agreement.
ii. To the extent that Company delegates to Selling Firm pursuant to Section 8.c.i. of this Agreement any of Companys obligations and responsibilities under Other Standard of Care Initiatives that take effect after the Effective Date, Selling Firm hereby certifies, and shall hereafter annually certify in writing, the following or a substantially similar certification: Selling Firm has established and maintains a system of supervision for recommendations of sales transactions involving both new and in-force Contracts, and such system of supervision includes, but is not limited to, standards and procedures for: (i) the collection of a consumers suitability information with respect to sales transactions involving the Contracts; (ii) the documentation and disclosure of the basis for any recommendation with respect to sales transactions involving the Contracts; and (iii) the auditing and/or contemporaneous review of recommendations of sales transactions involving the Contracts to monitor Licensed Personnels compliance with the obligation to act in the best interest of consumers. It is understood and agreed by the parties that Company, at its election, may rely upon the written certification Selling Firm provides pursuant to this Section to satisfy Companys supervision and audit obligations with respect to sales transactions that result from the exercise of contractual rights under the Contracts.
iii. Certifications provided pursuant to Sections 8.c.ii. shall be signed by an authorized senior officer or manager of Selling Firm with responsibility for overseeing the relevant sales practices and who has a reasonable basis on which to make the certification on its behalf.
iv. Selling Firm shall cooperate with Company in connection with reasonable requests related to Companys audits of supervision functions delegated to Selling Firm by Company under Other Standard of Care Initiatives. Selling Firm shall maintain and make available upon reasonable request by Company any and all records relating to supervision functions delegated to Selling Firm under this Agreement.
v. To the extent that Company is required to provide training or otherwise make training available to Licensed Personnel under any Other Standard of Care Initiative that takes effect after the Effective Date and Selling Firm desires to utilize training other than Company-approved training to satisfy such training requirement, Selling Firm shall provide information about such other training to Company for consideration, and shall not implement such training without Companys prior written approval, which shall not be unreasonably withheld.
9. CONFIDENTIALITY
a. Company may furnish Selling Firm with Confidential Information (as defined below), and Selling Firm may furnish Company with Confidential Information. Except as required in order to perform its obligations and duties under this Agreement, to perform joint marketing efforts with Company, or as required by law, (i) Selling Firm shall not use or
disclose such Confidential Information received from Company, and (ii) Company shall not use or disclose such Confidential Information received from Selling Firm.
b. Selling Firm and Company will each maintain and enforce safety and physical security procedures with respect to its access and maintenance of nonpublic personal information (NPI) of customers or potential customers that provide reasonably appropriate technical and organizational safeguards against accidental or unlawful destruction, loss, alteration or unauthorized disclosure or access. NPI includes, but is not limited to, names, addresses, account balances, account numbers, account activity, social security numbers, taxpayer identification numbers, and financial and health information. NPI includes information on each partys forms or in a database of any kind, information created by each party, and information collected on behalf of a party or by a party. Each party will notify the other party of any breach of security and use diligent efforts to remedy any breach of security or unauthorized access in a timely manner. Selling Firm and Company each agrees to cooperate with the other partys efforts to remedy any breach of security or unauthorized access.
c. Confidential Information of any party shall mean ideas, expressions, trade secrets, customer lists, products, policies, forms, business methods, business plans, software and information from third parties (such as software and its related documentation) for which such party has a duty of confidentiality, and treasury or securities information which the protected party considers confidential, as well as information which from all relevant circumstances should reasonably be assumed by a party to be confidential information, whether any of which is marked Confidential Information or not, including without limitation the following: (i) employee or customer or lists, employee, customer or supplier identities or characteristics, details of products or contracts, marketing knowledge or information, sales figures, pricing information, marketing or business plans, strategies, forecasts or projections, legal documents, financial information, budgets, software, source and object code, research papers, procedures, processes, formulas, copyrighted matter, patented or patentable inventions, trade secrets, innovations, improvements or discoveries, research or development, test results, specifications, data, know-how, plans, sketches, drawings or models; (ii) information that is designated secret, private or confidential by the disclosing party or its customers or potential customers; (iii) information which the disclosing party is obligated to maintain confidential or otherwise safeguard in accordance with (a) United States Public Law 106-102 (the Gramm-Leach-Bliley Financial Services Modernization Act of 1999), (b) United States Public Law 104-191 (the Health Insurance Portability and Accountability Act of 1996), or (c) any regulations adopted pursuant to (a) or (b), as (a)-(c) may be amended; and (iv) personal information regarding a disclosing partys employees, including without limitation information regarding any such employees insurance coverage, benefits or claims, physical or mental disability, health or medical information, credit rating or history and background investigation(s).
d. Confidential Information relating to a party shall be held in confidence by the other party to the same extent and in at least the same manner as such party protects its own Confidential Information, but in no case to a lesser extent or manner than a reasonable degree of care under the circumstances. Confidential Information shall not be disclosed to
third parties without specific written permission of the protected party. Each party shall, however, be permitted to disclose relevant aspects of the other partys Confidential Information to its officers, agents, subcontractors and employees to the extent that such disclosure is reasonably necessary for the performance of its duties and obligations under this Agreement; provided, however that such party shall take all reasonable measures to ensure that Confidential Information of the other party is not disclosed or duplicated in contravention of the provisions of this Agreement by such officers, agents, subcontractors and employees. A disclosing party shall retain all rights, title and interest in the Confidential Information disclosed by it. Where in doubt or necessary for the receiving partys compliance or other purposes, the receiving party shall promptly notify the disclosing party and provide a reasonable opportunity and period of time for the disclosing party to object or seek to limit disclosure of Confidential Information.
e. The obligations in this Section 9 shall not restrict any disclosure by either party pursuant to any applicable state or federal laws, or by order of any court or government agency (provided that the disclosing party shall give prompt notice to the non-disclosing party of such order) and shall not apply with respect to information which (i) is independently developed by the other party without violating the disclosing partys proprietary rights and without any use of Confidential Information of the disclosing party or any of its customers or potential customers, (ii) is or becomes publicly known (other than through unauthorized disclosure, including a breach of any duty to the disclosing party or any of its customers or potential customers), (iii) is intentionally disclosed by the owner of such information to a third party free of any obligation of confidentiality, (iv) is already known by such party without an obligation of confidentiality other than pursuant to this Agreement or any confidentiality agreements entered into before the Effective Date of this Agreement as evidenced by the written records of such party, or (v) is rightfully received by a party free of any obligation of confidentiality. In the event of service upon the receiving party of any subpoena, request for production or other legal process seeking the disclosure of any Confidential Information, the receiving party shall promptly notify the disclosing party of such service in writing, and provide a reasonable opportunity and period of time for the disclosing party to object to or seek the limitation of such disclosure.
f. In addition to protecting Confidential Information as described above, the parties mutually agree that in accordance with Applicable Laws and the terms of this Agreement they shall keep private and confidential any NPI of customers or potential customers. There will be instances where each party will have the same NPI that may be subject to different privacy policies and procedures according to the notices provided to the customer by the respective parties to this Agreement. All NPI which either party obtains from the other as a result of this relationship shall not be used, disclosed, reused or redisclosed to any third party, except to carry out the purposes for which the information was disclosed. The parties agree that they shall abide by the provisions of the Gramm-Leach-Bliley Act and other applicable privacy laws and shall establish and maintain policies and procedures designed to ensure the confidentiality and security of the NPI. This would include procedures to protect against any anticipated threats or hazards to the security or integrity of the information and unauthorized access to or use of the information.
g. The receiving party shall promptly notify the disclosing party, in writing, of any use or disclosure of Confidential Information in breach of this Agreement. The receiving partys obligations arising pursuant to this Agreement shall survive any termination or expiration of this Agreement.
h. The receiving party agrees and acknowledges that unauthorized use or disclosure of Confidential Information may result in immediate and irreparable injury to the disclosing party or its customers or employees for which monetary damages would be inadequate relief. Accordingly, in the event that the disclosing party proves any actual or threatened use or disclosure of Confidential Information in breach of this Agreement by the receiving party, its employees or agents, the disclosing party shall be entitled to injunctive and other equitable relief (e.g., specific performance) in accordance with Applicable Laws and judicial procedures, in addition to any and all other rights and remedies available to the disclosing party.
i. In accordance with Regulation S-P, if any NPI of customers is disclosed to either party in connection with this Agreement, the party receiving such information shall not disclose or use that information other than as necessary to carry out the purposes of this Agreement. Any privacy notice that Selling Firm delivers to customers shall comply with Title V of the Gramm-Leach-Bliley Act and Regulations S-P, as each may be amended, and shall notify customers that NPI may be provided to financial service providers such as Selling Firm as permitted by law.
j. Upon request, each party shall return to the other party or destroy (and provide an appropriate written destruction certificate) all Confidential Information in its possession or control unless such information is stored on an electronic backup system for ordinary business purposes or if the receiving party is required to maintain a copy of the information pursuant to any applicable law, rule, regulation or regulatory guidance. No disclosure by a party hereto of Confidential Information of such party to the other party shall constitute a grant to the other of any interest or right whatsoever in such Confidential Information, which shall remain the sole property of the disclosing party.
10. OWNERSHIP OF RECORDS; RIGHT TO USE
a. Selling Firms Ownership of Records and Data Regarding Customers; Companys Ownership of Records. It is understood and agreed that, except as otherwise provided in Section 10.b. below, all records and data, in whatever form, of or relating to customers with which Selling Firm or Licensed Personnel independently have relationships (Selling Firm Customers), and who are referred by Selling Firm to Company for the purchase of a Contract, are and shall remain the exclusive and proprietary property of Selling Firm; provided, however, that (i) Contracts, and (ii) data developed and/or maintained by Company in connection with the sale and subsequent servicing of the Contracts by Company (together, Contract Records), in whatever form, are and shall remain the exclusive and proprietary property of Company; and provided further that Companys use of the Contract Records is limited to its performance of its obligations under this Agreement and in connection with the transactions contemplated hereby. Selling Firm
will be allowed to keep a copy of Contracts Records that are deemed necessary for Selling Firms continued servicing of customers, and those of Licensed Personnel and for compliance with regulatory requirements or this Agreement.
b. Use by Company of Contract Records and Other Records and Data. Notwithstanding Section 10.a., in addition to its ownership of the Contract Records, Company shall be entitled to keep a copy of, and to use solely for purposes of this Agreement and the transactions contemplated hereby, any other records and data relating to Selling Firm Customers referred to Company by Selling Firm for the purchase of Contracts (i) that are necessary to enable Company to determine whether and on what terms to sell a Contract to any such Selling Firm Customer, (ii) that are reasonably necessary for Companys continued servicing of such Selling Firm Customers who purchase Contracts from Company, or (iii) for compliance by Company with regulatory requirements related to this Agreement and the transactions contemplated thereby.
11. STATUS AND AUTHORITY OF COMPANY AND SELLING FIRM
a. Company and Selling Firm are each corporations duly organized and validly existing, in good standing, under the laws of the state of its incorporation, and each of Company and the Selling Firm has all requisite corporate power and authority, and all licenses and permits required by any governmental authority, to carry on its business as presently conducted, and to fulfill, satisfy and perform its obligations and responsibilities set forth in this Agreement. Company and Selling Firm will at all times perform its obligations in a manner that complies with all applicable federal, state and local laws and regulations.
b. Each party shall notify the other party immediately in writing in the event of the revocation, termination or discontinuance of any authorization or permit referred to in Section 11.a., or in the event of any material violation of Applicable Laws and, in such event, each party may cancel this Agreement at any time without penalty and without prejudice to any other rights the cancelling party may have as a result of any such event.
12. BUSINESS CONTINUITY/DISASTER RECOVERY PLAN
The parties agree to maintain adequate business continuity/disaster recovery plans covering the records created and maintained with respect to the activities conducted under this Agreement, including provisions that require the parties to test, review and update such plans on an annual basis. In the event that a disaster occurs, each party will fully cooperate with the other party.
13. RECORD RETENTION AND AUDITS; COOPERATION
a. Each party agrees to maintain all books and records arising under this Agreement on a basis consistent with Applicable Laws for record retention in effect from time to time and generally accepted practices in the insurance industry, to safeguard such records for so long as they are held, which shall be for at least the minimum periods prescribed by U.S. law and normal business practice in the U.S. insurance industry, and if any records are disposed of, to dispose of such records only through use of reasonable measures to protect
against unauthorized access to or use of the information in connection with its disposal.
b. To the extent permitted by Applicable Laws, each party will cooperate with the other party and its designees in providing information and records reasonably required by such other party or its designees in connection with such other partys audit functions or examination by regulatory authorities. Any and all such information and records shall be provided in a mutually convenient manner reasonably designed to minimize interference to the providing partys day-to-day business functions, taking into due account: (A) any and all legal obligations or liabilities of the party to whom such information and records are to be provided; and, (B) the parties respective obligations with respect to Confidential Information as more fully set forth in Section 9, above, and Selling Firms recordkeeping obligations pursuant to Sections 8.a. and 8.c. of this Agreement.
14. INTELLECTUAL PROPERTY INDEMNIFICATION
Company represents, warrants and covenants that all deliverables and services provided to Selling Firm, and all intellectual property that is proprietary to Company or a third party, is licensed or made available to Selling Firm and is necessary to enable Selling Firm to use such deliverables or services, does not and will not infringe or misappropriate any third party intellectual property rights. Company will indemnify, defend, and hold Selling Firm harmless if any such representations are false, or warranties or covenants are breached. If Selling Firms use of Companys services or deliverables under this Agreement is, or is reasonably likely to be, enjoined due to such infringement, then Company will make all reasonable efforts to correct or replace the infringing part of the services or deliverables with substantially similar functionality so as to avoid the infringement.
15. ANTI-MONEY LAUNDERING
a. Company and Selling Firm shall each comply with Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, as amended (USA Patriot Act), and the rules promulgated thereunder, and all related federal and state rules and regulations, including compliance with all Applicable Laws and regulations aimed at preventing, detecting, and reporting money laundering and suspicious transactions, including applicable provisions of the Bank Secrecy Act and the USA Patriot Act, as well as regulations administered by the U. S. Department of the Treasurys Office of Foreign Asset Control (OFAC) and the U.S. Department of the Treasurys Financial Crimes Enforcement Network (FinCEN), as further described below (together, Applicable AML Laws).
b. Company and Selling Firm shall each maintain an anti-money laundering (AML) program (AML Program) in compliance with Applicable AML Laws that at a minimum, must include the following elements: (1) policies, procedures, and controls that are tailored to the partys business, including the distribution of Contracts; (2) designation of a compliance officer to administer and oversee the AML Program; (3) employee and agent training, in compliance with Applicable AML Laws; (4) an independent audit function to test the effectiveness of the AML Program; (5) a Customer Identification Program
adopted pursuant to Section 326 of the USA Patriot Act; (6) provisions for the filing of all necessary AML reports, including currency transaction reports and suspicious activity reports; (7) provisions for screening of all new and existing customers against the OFAC list and any other government list that is or becomes required under the Bank Secrecy Act; and (8) provisions to allow appropriate examiners and regulators to examine information, books, and records maintained by each party in connection with its AML Program.
c. The parties acknowledge that Company has established an AML Program. As permitted by Applicable AML Laws, the parties acknowledge that Company will rely on Selling Firm to, and Selling Firm agrees to (1) verify and identify each customers identity and the source(s) of funds to be used to purchase Contracts and (2) provide appropriate AML training to the Licensed Personnel involved in the solicitation, sale, and/or servicing of Contracts. Selling Firm agrees to provide to Company, upon request, written verification of the AML training. Company and the Selling Firm further acknowledge that upon issuance of a Contract to an applicant brought to Company by the Selling Firm, the party to whom the Contract is issued becomes Companys customer, from which point Company has AML duties under Applicable AML Laws.
16. TERMINATION
a. This Agreement may be terminated as follows:
i. By Selling Firm or by Company, without cause, 30 days after the mailing of written notice by either party to the other party;
ii. Automatically upon dissolution of Selling Firm or Company;
iii. By Company if Selling Firm commits a material breach of this Agreement and Selling Firm fails to cure said breach to Companys reasonable satisfaction within ten (10) days of its receipt of written notice from Company setting forth the nature of the breach; or
iv. By the Selling Firm if Company commits a material breach of this Agreement and Company fails to cure said breach to the Selling Firms reasonable satisfaction within ten (10) days of its receipt of written notice from the Selling Firm setting forth the nature of the breach.
b. In the event of termination of this Agreement, Company will pay Selling Firm all amounts due and payable under this Agreement through the date of termination, in accordance with the applicable Product and Compensation Schedule(s). Unless termination is due to Selling Firms bankruptcy, dissolution, failure to obtain or maintain the proper licenses with appropriate state, federal or self-regulatory authorities, or other material breach of the Agreement, at the termination of this Agreement the parties agree that all commissions and trail commissions payable to Selling Firm will be governed at all times by the Product and Compensation Schedule in effect at the time the Contract was issued and, regardless of whether the compensation schedule is thereafter amended, such commissions will continue to be payable to the Selling Firm for as long as it is listed as the broker-dealer of record associated with such Contract.
c. Except as provided in Section 16.d., termination of this Agreement shall automatically terminate any schedules, supplements, addenda or amendments made a part of this Agreement. Upon termination of this Agreement, Selling Firm agrees to return to Company all supplies, marketing materials and equipment in its possession that are the property of Company, and Company agrees to return to Selling Firm all supplies and equipment in its possession that are the property of the Selling Firm.
d. Upon termination of this Agreement, all authorizations, rights and obligations shall cease, except Sections 5.a. [Relationship], 8.a.xii. [Other Standard of Care Initiatives], 9 [Confidentiality], 13 [Record Retention and Audits; Cooperation], 16 [Termination], 17 [Indemnification for Third Party Claims, Contractual Claims, Including Breaches, Etc.], 18.b. [Advertising and Sales Materials], 20.c. [Prior Agreements], 22 [Arbitration; Judicial Proceedings], and 24 [New York Law Governs].
17. INDEMNIFICATION FOR THIRD PARTY CLAIMS, CONTRACTUAL CLAIMS, INCLUDING BREACHES, ETC.
a. By the Selling Firm: Selling Firm agrees to indemnify and hold harmless Company, its affiliates and their respective directors, officers, employees, and agents (collectively Indemnified Parties) from any and all losses, claims, damages, or liabilities (excluding any consequential damages of Indemnified Parties), fines, penalties, costs, or expenses, including attorneys fees, joint or several (including but not limited to any investigative, legal, and other expenses reasonably incurred in connection with, and any amounts paid in settlement of, any action, suit or proceeding or any claim asserted) (together, Losses), to which any of such Indemnified Parties becomes subject based on, resulting from, or arising out of any of the following:
i. Any material violation or alleged material violation by Selling Firm or Licensed Personnel of any Applicable Laws, including without limitation insurance laws and regulations, or Company Rules in regard to this Agreement or the Contracts;
ii. Any unauthorized use or alleged unauthorized use by Selling Firm or Licensed Personnel of promotional, sales or advertising material relating to the Contracts;
iii. Claims by Licensed Personnel for commissions or other compensation or remuneration of any type;
iv. Any failure by Selling Firm or Licensed Personnel to submit premium or applications to Company, or to submit the correct amount of premium, on a timely basis and in accordance with this Agreement and Companys written procedures provided to Selling Firm in advance by Company, subject to Applicable Laws;
v. Any material breach by Selling Firm or Licensed Personnel of any provision of this Agreement;
vi. Any unauthorized act or transaction by Selling Firm, its agents, employees, or representatives, or Licensed Personnel; or
vii. Any claim asserted by a third party (a Third Party Claim) caused by or resulting from any negligence, negligent error, negligent omission, misconduct or unauthorized act by Selling Firm, Licensed Personnel, or Selling Firms employees
or representatives, including but not limited to independent contractors engaged by the indemnifying party to perform any of its duties under this Agreement.
This indemnification will be in addition to any liability that the Selling Firm or its associated persons may otherwise have. Company may withhold commissions or any other payments owed to Selling Firm, and/or to apply such amounts against the indemnification amounts owed by, or claimed to be owed by, Selling Firm under this Agreement.
b. By Company: Company agrees to indemnify and hold harmless the Selling Firm, Licensed Personnel, and its respective directors, officers, employees, and agents (collectively Indemnified Parties) from any and all Loss to which any of such Indemnified Parties becomes subject based on, resulting from or arising out of any of the following:
i. Any Material violation or alleged material violation by Company, or its directors, officers or employees (Company associated persons), of any Applicable Laws, including without limitation insurance laws and regulations, in regard to this Agreement or the Contracts;
ii. Any material breach by Company or Company associated persons of any provision of this Agreement;
iii. Any unauthorized act or transaction by Company or Company associated persons; or
iv. Any Third Party Claim caused by or resulting from any negligence, negligent error, negligent omission, misconduct or unauthorized act by Company or Company associated persons.
This indemnification will be in addition to any liability that the Company or their associated persons may otherwise have.
c. Limitation. No person otherwise required to provide indemnification under the terms of this Section 17 shall be liable under this Section with respect to any Loss to which an Indemnified Party under this Section would otherwise be subject solely by reason of willful misfeasance, bad faith or negligence in the performance of such Indemnified Partys duties, or solely by reason of such Indemnified Partys reckless disregard of its obligations or duties under this Agreement.
d. Notification of Third Party Claims. The Indemnified Parties shall notify the indemnifying party (Indemnitor) in writing promptly after they become aware of any Third Party Claim threatened or brought against any Indemnified Parties that the Indemnified Parties reasonably believe may trigger an obligation of Indemnitor pursuant to this Section 17, provided that any delay or failure to so notify shall not affect any Indemnified Partys rights to indemnification hereunder unless, and then only to the extent that, Indemnitor has been materially prejudiced thereby. Company and Selling Firm will cooperate in defending any such Third Party Claim, reserving until resolution of each Third Party Claim any issues between them concerning allocation of responsibility, liability or obligations to indemnify such Third Party Claim. Except to the extent necessary to
preserve claims against each other, Company and Selling Firm will present a united defense to such Third Party Claims. All issues relating to whether the Third Party Claim is covered by Section 17, or the relative responsibility, liability or blameworthiness of Company and Selling Firm for such Third Party Claim will be resolved in a separate arbitration proceeding after the Third Party Claim is resolved. The parties acknowledge and agree that any statute of limitations relating to claims, actions or causes of action between each other under this Section 17 relating to a Third Party Claim will be tolled during the pendency of such Third Party Claim.
18. ADVERTISING AND SALES MATERIALS; MARKS
a. Company and Selling Firm, on its behalf and on behalf of its Licensed Personnel, each agrees not to conduct any advertising or distribute any sales materials involving the other party, its name or products, including the Contracts, without the prior written approval of the other party, except that the Selling Firm may distribute advertising and sales materials that were provided to it by Company for that purpose and Company may distribute advertising and sales materials that were provided to it by the Selling Firm for that purpose. Advertising and sales materials include, but are not limited to, printed material, television, radio, print media, Internet and other electronic or information networks, and computer or electronic demonstrations or Contract illustrations.
b. Company and Selling Firm each represents and warrants that all such sales advertising and sales materials it provides to the other conforms to Applicable Laws in all material respects.
c. In the advertising and solicitation of any Contract, Selling Firm agrees to provide on behalf of Company, the customer disclosures required by law, rule, regulation, or pursuant to Company Rules. Such disclosures include, but are not limited to, Contract illustrations, and other miscellaneous notices.
d. Company represents and warrants that Company and its affiliates are the owner of all right, title and interest in and to: (i) the names of the Contracts, as may be amended by Company from time to time; (ii) the trademarked names and service marks used in any of the marketing or advertising materials; (iii) any words or phrases that include the names of the Contracts; and (iv) all of Companys and its affiliates trademarks, service marks, trade names, logos or other commercial or product designation(s), whether or not registered with a governmental entity (collectively, the Marks).
e. Company and its affiliates hereby grant Selling Firm a non-exclusive limited license to use the Marks, solely in connection with Selling Firms performance of the services contemplated under this Agreement.
f. Selling Firm shall not use Marks in any written, oral or electronic material or communication without the prior written consent of Company. Any material developed by Selling Firm proposed to contain any of the Marks shall be furnished to Company for such consent prior to its use. Company shall endeavor to respond to any request for written consent within 10 calendar days; provided, however, that failure to respond shall
not relieve Selling Firm of the obligation to obtain Companys prior written consent. After receiving Companys consent to the use of any such material, no changes may be made to such material without obtaining Companys consent to such changes. Company may at any time in its sole discretion revoke such written consent, and upon notification of such revocation, Selling Firm shall no longer use, publish, or distribute the material subject to such revocation.
19. COLLECTION OF PREMIUM PAYMENTS
Selling Firm agrees, on its behalf and on behalf of Licensed Personnel, to hold any and all monies collected on behalf of Company and/or in the name of Company in trust and to remit them promptly to IDI.
20. GENERAL PROVISIONS
a. Waiver. Failure of either party to insist upon strict compliance with any provision of this Agreement or rule shall not constitute a waiver of the provision.
b. Modification, Amendment and Assignment. No modification or amendment of this Agreement will be valid unless it is in writing signed by an authorized officer of Company, except that Company can revise the Schedule(s) to this Agreement from time to time and any such changes shall be effective upon delivery to Selling Firm. Selling Firm shall be deemed to have consented to any amendment to this Agreement signed by Company if Selling Firm accepts compensation or submits an application after delivery of such amendment to Selling Firm by or on behalf of Company. This Agreement shall be binding upon and inure to the benefit of Selling Firm and Company and their respective successors and assigns; provided, however, that except as provided in the following sentence neither this Agreement nor any rights or obligations under this Agreement may be assigned or delegated by Selling Firm without the prior written consent of Company. This Agreement may be assigned by Selling Firm to, and shall be binding on (i) any affiliate of Selling Firm, and (ii) any successor to Selling Firm by merger, consolidation, conversion or other reorganization, including an assignment in connection with the sale or conveyance of all or substantially all of the assets of Selling Firm to an assignee, provided the assignee assumes in writing the obligations of Selling Firm hereunder.
c. Prior Agreements. This Agreement supersedes any and all previous agreements between Selling Firm and Company regarding the subject matter hereof. Any superseded agreement under which commissions or overrides are payable to Selling Firm shall be considered as continuing in force solely for the purpose of such payments. This Agreement does not release Selling Firm from obligations, which are owed by Selling Firm to Company nor does it release Company from any obligations covered by it to Selling Firm under any prior agreement.
d. Notices. All notices or communications shall be sent to the parties at the addresses shown in this Agreement. Any changes to these addresses must be made in writing and sent to the other party in accordance with this paragraph.
e. Severability. If any provision of this Agreement is held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.
21. LIMITATION OF LIABILITY
a. Limitation of LiabilityCaused Beyond a Partys Control. Neither party will be liable for any failure to perform any obligation hereunder, or from any delay in the performance thereof, due to causes beyond its control, including industrial disputes of whatever nature, acts of God, public enemy, acts of government, failure of telecommunications, fire or other casualty.
b. Limitation of LiabilityNo Consequential Damages, etc. Except for (i) breach of the provisions of Section 9 [Confidentiality], (ii) Companys breach of Section 14 [Intellectual Property Indemnification], or (iii) indemnification by a party under Section 17 [Indemnification for Third Party Claims, Contractual Claims, Including Breaches, Etc.], under no circumstances will either party, its affiliates or their respective officers, directors, employees be liable for any indirect, incidental, special, or consequential damages with respect to its obligations under this Agreement, regardless of whether such damages could have been foreseen or prevented.
22. ARBITRATION; JUDICIAL PROCEEDINGS
a. Arbitration. Any dispute between IDI and the Selling Firm, or any dispute between Protective and/or IDI, on the one hand, and the Selling Firm, on the other hand, arising pursuant to this Agreement that involves a policy with a face amount of less than $100,000, shall be settled under FINRA arbitration rules. The determination of the arbitrators shall be final and binding on all parties. The costs of arbitration shall be borne equally by the parties to the arbitration, provided however, that the arbitrators may assess one party more heavily than the other for these costs upon a finding that such party did not make a good faith effort to settle the dispute informally when it first arose.
b. Judicial Proceedings for Certain Controversies. Protective and the Selling Firm agree that in the event of any controversy between them (a) arising out of their business or pursuant to this Agreement that involves a policy with a face amount of $100,000 or more, or (b) involving a controversy between Protective and the Selling Firm that is not based on a specific policy, and that in either case cannot be settled by agreement, the parties may commence litigation against the other party in any state or federal court having jurisdiction over the matter and the parties. Venue for any such action between the parties shall be in Alabama. IN ANY SUCH JUDICIAL PROCEEDINGS BOTH COMPANY AND THE SELLING FIRM KNOWINGLY WAIVE ANY RIGHT TO TRIAL BY A JURY.
23. INSURANCE
Selling Firm agrees to obtain and maintain at least $1,000,000 in errors and omissions insurance covering acts and omissions by Selling Firm and/or by Licensed Personnel, and to add Company as an additional insured under such insurance coverage.
24. NEW YORK LAW GOVERNS
It is mutually agreed that all questions and issues relating to the validity of or performance under this Agreement shall be governed by the laws of the State of New York.
SELLING FIRM UNDERSTANDS THAT THIS AGREEMENT CONTAINS A BINDING ARBITRATION PROVISION THAT MAY BE ENFORCED BY THE PARTIES, AND THAT BY SIGNING BELOW SELLING FIRM IS GIVING UP ANY RIGHTS IT MAY POSSESS TO HAVE CERTAIN DISPUTES UNDER THIS AGREEMENT DECIDED IN A COURT OR JURY TRIAL.
[Remainder of page intentionally left blank; Signature Page to follow]
The parties hereto have caused their duly authorized officers to execute this Agreement and deliver it to the other as of the Effective Date.
INSURANCE COMPANY: |
|
UNDERWRITING FIRM: |
||
PROTECTIVE LIFE INSURANCE COMPANY
|
|
INVESTMENT DISTRIBUTORS, INC.
|
||
|
|
|
||
By: |
|
|
By: |
|
Name: |
|
|
Name: |
|
BROKER-DEALER: |
|
INSURANCE AGENCY: |
||
|
|
|
||
By: |
|
|
By: |
|
Name: |
|
|
Name: |
|
Title: |
|
|
Title: |
|
PRODUCT AND COMPENSATION SCHEDULE
Schedule A
to Selling Agreement
for Protective Life Insurance Company
Product and Compensation Schedule
FUND PARTICIPATION AGREEMENT
THIS AGREEMENT is effective as of this lst day of May, 2018 by and among Protective Life Insurance Company, a life insurance company organized under the laws of the State of Tennessee (the Company), acting herein for and on behalf of the Company and on behalf of each separate account set forth on attached Schedule A, as the same may be amended from time to time (the Separate Accounts); American Century Investment Services, Inc., (the Distributor); and American Century Services, LLC, (the Transfer Agent and collectively With Distributor, American Century).
WITNESSETH:
WHEREAS, the Distributor serves as the distributor and Transfer Agent serves as transfer agent for American Century Variable Portfolios, Inc. (the Issuer), an open-end management investment company registered under the Investment Company Act of 1940 that is available to act as the investment vehicle for separate accounts established by insurance companies for life insurance policies and annuity contracts; and
WHEREAS, the Distributor is registered as a broker/dealer under the Securities Exchange Act of 1934, as amended (the 1934 Act), is a member in good standing of the Financial Industry Regulatory Authority (FINRA) and serves as. principal underwriter of the shares of the Issuer; and
WHEREAS, the Distributor intends to make available shares of the series of the Issuer and any applicable class thereof as set forth in Separate Account registration statements for the Company, as filed with the Securities and Exchange Commission from time to time (the Series); and
WHEREAS, the Company has registered or will register the variable annuities and/or variable life insurance policies funded through the Separate Account under the Securities Act of 1933, as amended (the 1933 Act) and the Investment Company Act of 1940, as amended (the. 1940 Act), unless exempt from such registration, to be issued by the Company for distribution (the Contracts).
NOW, THEREFORE, in consideration of their mutual promises, the parties hereby agree as follows:
ARTICLE I
SERIES SHARES
1.1 The Distributor agrees to make shares of the Series available for purchase by the Company on behalf of the Separate Accounts on each Business Day (as hereafter defined). Transfer Agent will execute orders placed for each Separate Account on a daily basis at the net asset value of each Series next computed after receipt by the Issuer, or its designee, of such order prior to the price time for each Series as set forth in its then current prospectus (Prospectus), generally the close of regular trading on the New York Stock Exchange on any given Business Day and transmitted to the Transfer Agent as set forth below, or to the extent appropriate as provided in Schedule C attached hereto.
A. For purposes of this Agreement, the. Company shall be the designee of the Issuer and Distributor for receipt of orders from each Separate Account and receipt by Company constitutes receipt by the Issuer, provided that the Transfer Agent receives notice of such orders by 9:30 a.m. (Eastern time) on the next following Business Day.
B. For purposes of this Agreement, Business Day shall mean any day on which and for so long as the New York Stock Exchange is open for trading and on which the Issuer calculates the net asset value of each Series pursuant to the rules of the Securities and Exchange Commission (SEC) or as set forth in the Series prospectus.
1.2 The parties recognize that the Board of Directors of the Issuer (the Board), acting in good faith and in the exercise of its fiduciary responsibilities, may refuse to permit the Issuer to sell shares of any Series to any person, or suspend or terminate the offering of shares of any Series if such action is required by law or by regulatory authorities having jurisdiction over the sale of shares.
1.3 The Distributor agrees, oh behalf of the Issuer, that shares of the Issuer of any of its Series will be sold only to insurance companies for use in conjunction with variable life insurance policies or variable annuities. No shares of the Issuer or any of its Series will be sold to the general public.
1.4 The Distributor agrees, on behalf of the Issuer, to redeem for cash, at the Companys request, any full or fractional shares of the Series held by the Separate Accounts, oh a daily basis at the net asset value next computed after receipt by the Issuer or its designee of the request for redemption.
A. For the purposes of this Agreement, the Distributor appoints Company as the designee of the Issuer for receipt of redemption requests from each Separate Account and receipt by the Company constitutes receipt by the Issuer, provided that the Transfer Agent receives notice of the redemption request by 9:30 a.m. (Eastern time) on the next following Business Day
1.5 Except as otherwise provided herein, the Company agrees that purchases and redemptions of Series shares offered by the Prospectus of the Series shall be made in accordance with the provisions of the prospectus.
A The Company will place separate orders to purchase or redeem shares of each Series. Each order shall describe the net amount of shares and dollar amount of each class of a Series to be. purchased or redeemed.
B. In. the event of net purchases, the Company will pay for shares before 3:00 p.m. (Eastern time) on the next Business Day after receipt of an order to purchase shares.
C. In the event of net redemptions, American Century shall cause the Issuer shall pay the redemption proceeds in federal funds transmitted by wire before 3:00 p.m. (Eastern time) on the next Business Day after an order to redeem Series shares is made.
1.6 Issuance and transfer of the Series shares will be by book entry only. Share certificates will not be issued to the Company or any Separate Account. Shares purchased will be recorded in an appropriate title for each Separate Account or the appropriate sub-account of each Separate Account. The Distributor shall furnish to the Company the CUSIP number assigned to each Series as may be amended from time to time.
1.7 The Distributor shall notify the Company in advance of any dividends or capital gain distributions payable on the Series shares, but by no later than same day notice by 6:30 p.m. Eastern time on the declaration date (by wire or telephone, followed by written confirmation). The Company elects to reinvest all such dividends and capital gain distributions in additional shares of that Series. The Distributor shall notify the Company of the number of shares issued as payment of dividends and distributions. The Company reserves the right to revoke this election and to receive all such dividends and capital gain distributions in cash.
1.8 The Distributor shall provide, in a form acceptable to the Company, the net asset value per share of each Series to the Company on a daily basis as soon as reasonably practical after the net asset value per share is calculated. The Distributor shall use its best efforts to make such net asset value per share available by 6:30 p.m. Eastern time. Information specified in this Section and Section 1 7 will be substantially in the form as set forth in Schedule C.
A. If the Distributor provides materially incorrect share net asset value information through no fault of the Company, the Separate Accounts shall be entitled to an adjustment with respect to the Series shares purchased or redeemed to reflect the correct net asset value per share.
B. Any material error in the calculation or reporting of net asset value per share, dividend or capital gain information shall be reported promptly to the Company upon discovery. The Distributor shall indemnify and hold harmless the Company against any amount the Company is legally required to pay annuity or life insurance contract owners that have selected a Series as an investment option (Contract owners), and which amount is due to the issuers or its agents material miscalculation and/or incorrect reporting of the daily net asset value, dividend rate or capital gains distribution rate. The Distributor shall reimburse the Company for any and all out of pocket costs and expenses that result from the Distributor providing a materially incorrect share net asset value the Company shall submit an invoice to the Distributor or its agents for such losses incurred as a result of the above which shall be payable within sixty (60) days of receipt. Should a material miscalculation by the Issuer or its agents result in a gain to the Company, subject to the immediately following sentence, the Company shall immediately reimburse the Issuer, the applicable Series or its agents for any material losses incurred by the Issuer, the applicable Series or its agents as a result of the incorrect calculation. Should a material miscalculation by the Issuer or its agents result in a gain Contract owners, the Company will consult with the Distributor or its designee as to what reasonable efforts shall be made to recover the money and repay the Issuer, the applicable Series or its agents. The Company shall then make such reasonable effort, at the expense of the Distributor or its agents, to recover the money and repay the Issuer, the applicable Series or its agents; provided, however, the Company shall not be obligated to initiate or otherwise pursue any legal action or rights of set off against Contract owners for any such reimbursements.
With respect to the material errors or omissions described above, this section shall control over other indemnification provisions in this Agreement.
C The Distributor shall also provide any additional information relating to each Series, including the non-fair market net asset value, in the time and mariner reasonably requested by the Company.
1.9 The Company agrees to use its best efforts to provide information to the Distributor solely for the purpose of facilitating its compliance with Rule 22c-2 in accordance with that certain Rule 22c-2 Shareholder Information Agreement between the Company arid the Distributor. Nothing herein, nor any action by the Company, shall be construed as, or infer that the Company has undertaken any duty or obligation, whether express or implied, at law or in equity, to detect abusive trading activities pursuant to the Fund Policies.
ARTICLE II
REPRESENTATIONS AND WARRANTIES
2.1 The Company represents and warrants that:
A. The Contracts are or will be registered under the 1933 Act unless exempt and that the
registrations will be maintained to the extent required by law.
B. The Contracts will be issued in material compliance with all applicable federal and state laws and regulations.
C. The Company is duly organized and in good standing under applicable law.
D. The Company has legally and validly established each Separate Account prior to any issuance or sale as a segregated asset account under the Connecticut Insurance Code and has registered or, prior to any issuance or sale of the Contracts, will register and will maintain the registration of each Separate Account as a unit investment trust in accordance with the 1940 Act, unless exempt from such registration.
E. The Contracts provide for the allocation of net amounts received by the Company to a Separate Account for investment in the shares of one or more specified investment companies selected among those companies available through the Separate Account to act as underlying investment media and selection of a particular investment company is made by the Contract owner under a particular Contract, who may change such selection from time to time in accordance with the terms of the applicable Contract.
2.2 The Distributor and Transfer Agent, on behalf of the Issuer, represent and warrant that;
A. Series shares sold pursuant to this Agreement shall be registered under the 1933 Act and the regulations thereunder to the extent required.
B. Series shares shall be duly authorized for issuance in accordance with the laws of each jurisdiction in which shares will be offered.
C. Series shares shall be sold in material compliance with all applicable federal and state securities laws and regulations.
D. The Issuer is and shall remain registered under the 1940 Act and the regulations thereunder to the extent required.
E. The Issuer shall amend its registration statement under the 1933 Act and the 1940 Act, from time to time, as required in order to effect the continuous offering of the Series shares.
F. The Issuer is currently qualified as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended, (the Code) and complies with Section 817(h) of the Code and regulations there under. The Issuer will make every effort to maintain such qualification and the Distributor will notify the Company immediately in writing upon having a reasonable basis for believing that the Issuer has ceased to qualify or that the Issuer might not qualify in the future.
G. The Issuer is duly organized and validly existing under the laws of the state of its organization.
H. The Issuer does and will comply in all material respects with the 1940 Act.
I. The Issuer has obtained an order from the SEC granting participating insurance companies and variable insurance product separate accounts exemptions from the provisions of the 1940 Act, as amended, and the rules thereunder, to the extent necessary to permit shares of the Issuer or its
Series to be sold to and held by variable insurance product separate accounts of both affiliated and unaffiliated life insurance companies.
J. The Distributor shall remain duly registered under all applicable federal, state laws and regulations and that it will perform its obligations for the Issuer and the Company in material compliance with all applicable laws and regulations.
ARTICLE III
PROSPECTUSES, REPORTS TO SHAREHOLDERS AND PROXY STATEMENTS; VOTING
3.1 The Distributor shall provide the Company with as many printed copies of the current. Prospectus(es), statement of additional information, proxy statements, annual reports and semiannual reports of each Series (and no other series), and any supplements or amendments to any of the foregoing, as the Company may reasonably request. If requested by the Company in lieu of the foregoing printed documents, the Distributor shall provide such documents in the form of camera-ready film, computer diskettes or typeset electronic document files, all as the Company may reasonably request, and such other assistance as is reasonably necessary in order for the Company to have any of the prospectus(es), statement of additional information, proxy statements, annual reports and semiannual reports of each Series (and no other series), and any supplements or amendments to any of the foregoing; and may be printed in combination with such documents of other fund companies and/or such documents for the Contracts. At the discretion of the Company, the Company may distribute summary prospectuses or statutory prospectuses for a Series. Expenses associated with providing, printing, processing and distributing such documents shall be allocated in accordance with Schedule B attached hereto. Provided, however, that to the extent that Distributor is required under Schedule B to reimburse the Company for applicable printing and mailing costs associated with distribution of the Fund Documents, the parties agree that Distributor will only be required to reimburse printing and mailing costs associated with distribution of the Summary Prospectuses. If the Company determines, in its discretion, to distribute Statutory Prospectuses to underlying investors in the Funds, the Company will be responsible for all printing and mailing costs for Statutory Prospectus distribution that are in excess of the costs that would have been incurred had the Company distributed Summary Prospectuses to underlying investors in the Funds. The Distributor agrees to use best efforts to resolve any billing discrepancy detected by the Company and remit any corrective payment promptly upon demand.
3.2 The Distributor or its designee will provide the Company 60 days notice of any change for a Series, including but not limited to, (a) fund objective changes, (b) anticipated fund mergers/substitutions, (c) no-action or exemptive requests from the SEC, (d) fund name changes, (e) fund adviser or sub-adviser changes; and/or (f) conditions or undertakings that affect the Companys rights or obligations hereunder. If the Distributor fails to provide the Company with the required notice, the Distributor will reimburse the Company for all reasonable expenses for facilitating the changes and for notifying Contract owners. Notwithstanding anything to the contrary, the Distributor will provide all registration statement supplements to the Company in hand as soon as reasonably possible following the filing such document with the Securities and Exchange Commission; time being of the essence. The Distributor will provide the Company with updated shareholder reports no later than 45 days after the end of the reporting period. The Company reserves the right, in its sole discretion, to combine the delivery of Issuer supplements to coordinate with other Company variable product supplements and to levy a surcharge for its administrative costs and expenses incurred in connection with circulating, supplements that do not coincide with scheduled variable product prospectus updates.
3.3 The Distributor will provide the Company with copies of its proxy solicitations applicable to the Series. The Company will, to the extent required by law, (a) distribute proxy materials applicable to the Series to eligible Contract owners, (b) solicit voting instructions from eligible Contract owners, (c) vote
the Series shares in accordance with instructions received from Contract owners; and (d) if required by law, vote Series shares for which no instructions have been received in the same proportion as. shares of the Series for which instructions have been received.
A. To the extent permitted by. applicable law, the Company reserves the right to vote Series shares held in any Separate Account in its own right.
B. Unregistered separate accounts subject to the Employee Retirement Income Security Act of 1974 (ERISA) will refrain from voting shares for which no instructions are received if such shares are held subject to the provisions of ERISA.
3.4 American Century shall cause the Issuer to comply with all provisions of the 1940 Act and the rules thereunder requiring voting by shareholders.
ARTICLE IV
SALES MATERIAL AND INFORMATION
4.1 The Company shall furnish, or shall cause to be furnished, to the Distributor prior to use, each piece of sales literature or advertising prepared by the Company in which the Issuer, its investment adviser or the Distributor is described. No sales literature or advertising will be used if the Distributor reasonably objects to its use within ten (10) Business Days following receipt by the Distributor.
4.2 The Company will not, without the permission of the Distributor, make any representations or statements on behalf of the Distributor or concerning the Issuer or its investment adviser in connection with the advertising or sale of the Contracts, other than information of representations contained in: (a) the registration statement or Series prospectus(es), (b) Series annual and semiannual reports to shareholders, (c) proxy statements for the Series, or, (d) sales literature or other promotional material approved by the Distributor.
4.3 The Distributor shall furnish, or shall cause to be furnished, to the Company prior to use, each piece of sales literature or advertising prepared by the Distributor in which the Company, the Contracts or Separate Accounts, are described. No sales literature or advertising will be used if the Company reasonably objects to its use within ten (10) Business Days following receipt by the Company.
4.4 Neither American Century nor the Issuer or its investment adviser will, without the permission of the Company, make any representations or statements on behalf of the Company, the Contracts, or the Separate Accounts or concerning the Company, the Contracts or the Separate Accounts, in connection with the advertising or sale of the Contracts, other than the information or representations contained in: (a) the registration statement or prospectus for the Contracts, (b) Separate Account reports to shareholders, (c) in sales literature or other promotional material approved by the Company.
4.5. The Distributor will provide to the Company at least one complete copy of all registration statements, prospectuses, statements of additional information, reports to shareholders, proxy statements, solicitations for voting instructions, sales literature and other promotional materials, applications for exemptions and requests for no-action letters, and all amendments, that relate to the Series or its shares.
4.6 The Company will provide to the Distributor, upon the Distributors request, at least one complete copy of all registration statements, prospectuses, statements of additional information, reports, solicitations for voting instructions, sales literature and. other promotional materials, applications for exemptions, and requests for no action letters, and all amendments, that relate to the Contracts.
4.7 The Company is hereby granted, during the term of this Agreement, a royalty-free, worldwide license to use, print, broadcast and otherwise display in any print or electronic medium the Issuers arid American Centurys service marks, trade names and logos in approved sales literature or other promotional material. For the purposes of this Agreement, the phrase sales literature or other promotional material includes, but is not limited to, advertisements (such as material published, or designed for use in a newspaper, magazine, or other periodical, radio, television, telephone, Internet, or tape recording, videotape display, signs, video streams, computerized media, websites or other public media), sales literature or other promotional material (i.e., any written communication distributed or made generally available to key firms, customers or the public, including brochures, circulars, pitch books, information provided on a website, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sale literature or other promotional material), educational or training materials or other communications distributed or made generally available to some or all agents, wholesalers or employees.
ARTICLE V
DIVERSIFICATION
5.1 The Distributor, on behalf of the Issuer, represents and warrants that, at all times, each Series will comply with Section 817(h) of the Code and all regulations thereunder, relating to the diversification requirements for variable annuity, endowment, or life insurance contracts and any amendments or other modifications to such Section or regulations. In the event a Series ceases to so qualify, the. Distributor will notify the Company immediately of such event and will cause the Issuer or its investment adviser will take all steps necessary to adequately diversify the Series so as to achieve compliance within the grace period afforded by Treasury Regulation § 1.817-5.
ARTICLE VI
POTENTIAL CONFLICTS
6.1 The Board will monitor the Series for the existence of any material irreconcilable conflict between the interests of the Contract owners of all separate accounts investing in the Series. The Board shall promptly inform the Company if it determines that an irreconcilable material conflict exists and the implications thereof.
6.2 The Company will report any potential or existing material irreconcilable conflict of which it is actually aware to the Board. This includes, but is not limited to, an obligation by the Company to inform the Board whenever Contract owner voting instructions are disregarded.
6.3 If it is determined by a majority of the Board, or a majority of its independent Directors, that a material irreconcilable conflict exists due to issues relating to the Contracts, the Company will, at its expense and to the extent reasonably practicable, take whatever steps it can which are necessary to remedy or eliminate the irreconcilable material conflict, including, without limitation, withdrawal of the affected Separate Accounts investment in the Series. No charge or penalty Will be imposed as a result of such withdrawal.
6.4 The Company, at the request of the Distributor will, at least annually, submit to the Board such reports, materials or data as the Board may reasonably request so that the Board may fully carry out the obligations imposed upon them. All reports received by the Board of potential or existing conflicts, and all Board action with regard to determining the existence of a conflict, and determining whether any proposed action adequately remedies a conflict, shall be properly recorded in the minutes of the Board or other appropriate records, and such minutes or other records shall be made available to the SEC upon request.
ARTICLE VII
INDEMNIFICATION
7.1 Indemnification by the Company
A. The Company agrees to indemnify and hold harmless American. Century, the Issue and each of their directors, Trustees or (if applicable), officers, employees and agents and each person, if any, who controls American Century or the Issuer within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties and individually, an Indemnified Party for purposes of this Section 7.1) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Company, which consent shall not be unreasonably withheld) or expenses (including the reasonable costs of investigating or defending any alleged loss, claim, damage, liability or expense and reasonable legal counsel fees incurred in connection therewith) (collectively, Losses), to which the Indemnified Parties may become subject under any statute or regulation, or at common law or otherwise, insofar as such Losses are related to the sale or acquisition of Series shares or the Contracts and:
1. Arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in a disclosure document for the Contracts or in the Contracts themselves or in sales literature generated or approved by the Company applicable to the Contracts or Separate Accounts (or any amendment or supplement to any of the foregoing) (collectively, Company Documents for the purposes of this Article VII), or arise out of or are based upon the omission or the alleged omission to .state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this indemnity shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and was accurately derived from written information furnished to the Company by or on behalf of the Issuer for use in Company Documents or otherwise for use in connection with the sale of the Contracts or Series shares; or
2. Arise out of or result from statements or representations (other than statements or representations contained in and accurately derived from the registration statement, prospectus, statement of additional information or sales literature of the Issuer applicable to the Series (or any amendment or supplement to any of the foregoing) (collectively, Issuer Documents for purposes of this Article VII)) or wrongful conduct of the Company or persons under its control, with respect to the sale or acquisition of the Contracts or Series shares; or
3. Arise out of or result from any untrue statement or alleged untrue statement of a material fact contained in Issuer Documents or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such statement or omission was made in reliance upon and accurately derived from written information furnished to the American Century by or on behalf of the Company; or
4. Arise out of or result from any failure by the Company to provide the services or furnish the materials required under the terms of this Agreement; or
5. Arise out of or result from any material breach of any representation and/or warranty made by the. Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Company.
B. The Company shall not be liable under this indemnification provision with respect to any Losses Which are due to an Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement or to the Issuer or American Century, whichever is applicable.
C. The Company shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Company in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shah have received notice of such service on any designated agent), but failure to notify the Company of any such claim shall not relieve the Company from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than oh account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Company shall be entitled to participate, at its own expense, in the defense of such action, the Company also shall be entitled to assume the defense thereof, with counsel reasonably satisfactory to the party named in the action. After notice from the Company to such party of the Companys election to assume the defense thereof, the Indemnified Party shall bear the fees and expanses of any additional counsel retained by it, and the Company will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.
D. The Indemnified Parties will promptly notify the Company of the commencement of any litigation or proceedings against them or any of their officers or directors in connection with the issuance or sale of the Series shares or the Contracts or the operation of the Issuer.
7.2 Indemnification by American Century
A. American Century agrees to indemnify and hold harmless the Company and each of its directors, officers, employees and agents and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties and individually, an Indemnified Party for purposes of this Section 7.2) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of American Century, which consent shall not be unreasonably withheld) or expenses (including the reasonable costs of investigating or defending any alleged loss, claim, damage, liability or expense and reasonable legal counsel fees incurred in connection therewith) (collectively, Losses), to which the Indemnified Parties may become subject under any statute or regulation, or at common law or otherwise, insofar as such Losses are related to the sale or acquisition of the Series shares or the Contracts and:
1. Arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in Issuer Documents or arise out of or art based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this indemnity shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and was accurately derived from written information furnished to the Issuer or American Century by or on behalf of the Company for use in Issuer Documents or otherwise for use in connection with the sale of the Contracts or Series shares; or
2. Arise out of or result from statements or representations (other than statements or representations contained in and accurately derived from Company Documents) or wrongful conduct of
American Century or persons under its control, with respect to the sale or distribution of the Contracts or Series shares; or
3. Arise out of or result from any untrue statement or alleged untrue statement of a material fact contained in Company Documents, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such statement or omission was made in reliance upon and accurately derived from written information furnished to the Company by or on behalf of the American Century or the Issuer; or
4. Arise out of or result from any failure by American Century to provide the services or furnish the, materials required under the terms of this Agreement; or
5. Arise out of or result from any material breach of any representation and/or Warranty made by American Century in this Agreement or arise out of or result from any other material breach of this Agreement by American Century.
B. American Century shall not be liable under this indemnification provision with respect to any Losses which are due to ah Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement or to the Company or the. Separate Account, whichever is applicable.
C. American Century shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified American Century in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify American Century of any such claim shall not relieve American Century from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, American Century shall be entitled to participate, at its own expense, in the defense thereof. American Century also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action. After notice from American Century to such party of its election to assume the defense thereof, the Indemnified Party shall bear the expenses of any additional counsel retained by it, and American Century will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.
D. The Indemnified Parties shall promptly notify American Century of the commencement of any litigation or proceedings against them or any of their officers or directors in connection with the issuance or sale of the Contracts or the operation of a Separate Account.
7.5 Any party seeking indemnification (the Potential Indemnitee) will promptly notify any party from whom they intend to seek indemnification (each a Potential Indemnitor) of all demands made and/or actions commenced against the Potential Indemnitee which may require a Potential Indemnitor to provide such indemnification. At its option and expense, a Potential Indemnitor may retain counsel and control any litigation for which it may be responsible to indemnify a Potential Indemnitee under this Agreement.
7.6 With respect to any claim, the parties each shall give the others reasonable access during normal business hours to its books, records, and employees and those books, records, and employees within its
control pertaining to such claim, and shall otherwise cooperate with one and other in the defense of any claim. Regardless of which party defends a particular claim, the defending party shall give the other parties written notice of any significant development in the case as soon as practicable, and such other parties, at all times, shall have the right to intervene in the defense of the case.
7.7 If a party is defending a claim and indemnifying another party hereto, and: (i) a settlement proposal is made by the claimant, or (ii) the defending party desires to present a settlement proposal to the claimant, then the defending party promptly shall notify the Indemnified Party Of such settlement proposal together with its counsels recommendation. If the defending party desires to enter into the settlement and the Indemnified Party fails to consent within thirty (30) Business Days (unless such period is extended, in writing, by mutual agreement of the parties hereto), then the Indemnified Party, from the time it fails to consent forward, shall defend the claim and shall indemnify the defending party for all costs associated with the claim which are in excess of the proposed settlement amount.
Regardless of which party is defending the claim: (i) if a settlement requires an admission of liability by the non-defending party or would require the non-defending party to either take action (other than purely ministerial action) or refrain from taking action (due to an injunction or otherwise) (a Specific Performance Settlement), the defending party may agree to such settlement only after obtaining the express, written consent of the non-defending party. If a non-defending party fails to consent to a Specific Performance Settlement, the consequences described in the last sentence of the first paragraph of this Section 7.7 shall not apply.
7.8 The parties shall use good faith efforts to resolve any dispute concerning this indemnification obligation. Should those efforts fail to resolve the dispute, the ultimate resolution shall be determined in a de novo proceeding, separate and apart from the underlying matter complained of, before a court of competent jurisdiction. Either party may initiate such proceedings with a court of competent jurisdiction at any time following the termination of the efforts by such parties to resolve the dispute (termination of such efforts shall be deemed to have occurred thirty (30) days from the commencement of the same unless such time period is extended by the written agreement of the parties). The prevailing party in such a proceeding shall be entitled to recover reasonable attorneys fees, costs, and expenses.
ARTICLE VIII
TERMINATION
8.1 This Agreement shall continue in full force and effect until the first to occur of:
A. Termination by any party for any reason upon 60 days advance written notice delivered to the other parties; or
B. Termination by the Company by written notice to American Century with respect to any Series in the event any of the Series shares are not registered, issued or sold in accordance with applicable state and/or federal law, or such law precludes the use of such shares as the underlying investment medium of the Contracts issued or to be issued by the Company; or
C. Termination by the Company upon written notice to American Century with respect to any Series in the. event that such Series ceases to qualify as a regulated investment company under Subchapter M of the Code or under any successor or similar provision, or
D. Termination by the Company upon written notice to American Century with respect to any Series in the event that such Series fails to meet the diversification requirements specified in Section 5.1 of this Agreement; or
E. Termination upon a vote of a majority of the independent directors of the Issuer; or
F. Termination upon mutual written agreement of the parties to this Agreement; or
G. Notwithstanding the above, the parties recognize that the Issuer reserves the right, without prior notice, to suspend sales of shares of any Series, in whole or in part, or to. make a limited offering of shares of any of the Series in the event that .(1) any regulatory body commences formal proceedings against the Company, American Century or the Issuer, which proceedings American Century reasonably believes may have a material adverse impact on the ability of American Century, on. behalf of the Issuer, or the Company to perform its obligations under this Agreement or (B) in the judgment of American Century, declining to accept any additional instructions for the purchase or sale of shares of any such Fund is warranted by market, economic or political conditions.
8.2 Effect of Termination
A. Notwithstanding any termination of this Agreement, the Distributor shall, upon the mutual agreement of American Century and the Company, continue to make available additional shares of the Series pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (the Existing Contracts) unless such further sale of Series shares is proscribed by law, regulation or applicable regulatory body. Specifically, without limitation, the owners of the Existing Contracts will be permitted to direct allocation and reallocation of investments in the Series, redeem investments in the Series and invest in the Series through additional purchase payments.
B. The Company agrees not to redeem Series shares attributable to the Contracts except (i) as necessary to implement Contract owner initiated or approved transactions, or (ii) as required by state and/or federal laws or regulations or judicial or other legal precedent of general application or (iii) as permitted by an order of the SEC. Upon request, the Company will promptly furnish to American. Century the opinion of counsel for the Company to the effect that any redemption pursuant to clause (ii) above is a legally required redemption.
C. In addition to the foregoing, Article VII Indemnification shall survive any termination of this Agreement.
ARTICLE IX
NOTICES
9.1 Any notice shall be sufficiently given when sent by registered or certified mail to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other party.
If to the American Century:
American Century Investment Services, Inc.
American Century Services, LLC
4500 Main Street
Kansas City, Missouri 64111
Attention: General Counsel
If to the Company:
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, AL 35223
Attn: Chief Product Actuary
With a copy to;
Protective Life Insurance Company
2801 Highway.280 South
Birmingham, AL 35223
Attn: Senior Counsel, Variable Products
ARTICLE X
MISCELLANEOUS
10.1 Each party will treat as confidential any and all Nonpublic Personal Financial Information, Shareholder Information and all information reasonably expected to be treated as confidential (collectively, Confidential Information) and not release any Confidential Information unless (a) the other party provides written consent to do so; (b) a party is compelled to do so by court order, subpoena or comparable request issued by any governmental agency, regulator or other competent authority; or (c) permitted by applicable law. Each party shall safeguard Confidential Information as required by applicable law and provide reasonable confirmation upon request. As used above, (i) Nonpublic Personal Financial Information shall refer to personally identifiable financial information about any prospective or then existing customer of the Company including customer lists, names, addresses, account numbers and any other data provided by customers to the Company in connection with the purchase or maintenance of a product or service that is not. Publicly Available; and (ii) Publicly Available shall mean any information that the disclosing party has a reasonable basis to believe is lawfully made available to the general public from federal, state, or local government records, widely distributed media, or disclosures made to the general public that are required by federal, state, or local law. American Century and its affiliates agree that it and they shall not use the information received pursuant to this Agreement, including any Confidential Information, for marketing or solicitation purposes.
10.2 The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect the construction or effect.
10.3 This Agreement may be executed simultaneously in two or more counterparts, each of which taken together shall constitute one and the same instrument.
10.4 If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of this Agreement shall not be affected thereby.
10.5 Each party shall cooperate with each other party and all appropriate governmental authorities (including, without limitation, the SEC, FINRA and state insurance regulators) and shall permit such authorities (and other parties) reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.
10.7 This Agreement or any of the rights and obligations hereunder may not be assigned by any party without the prior written consent of all patties.
10.8 The waiver of, or failure to exercise, any right provided for in this Agreement shall not be deemed a waiver of any further or future right under this Agreement.
[Remainder of page intentionally left blank]
IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its name and on its behalf by its duly authorized representative as of the 17th day of May, 2018.
PROTECTIVE LIFE INSURANCE COMPANY
|
AMERICAN CENTURY INVESTMENT SERVICES, INC. |
|||
|
|
|||
By: |
/s/ Wade V. Harrison |
|
By |
/s/ Cindy A. Johnson |
Name: |
Wade V. Harrison |
|
Name: |
Cindy A. Johnson |
Title: |
Senior VP, Chief Product Actuary |
|
Title: |
Vice President |
|
|
|
|
|
|
|
AMERICAN CENTURY SERVICES, LLC |
||
|
|
|
|
|
|
|
By: |
/s/ Ryan L. Blaine |
|
|
|
Name: |
Ryan L. Blaine |
|
|
|
Title: |
Vice President |
SCHEDULE A
SEPARATE ACCOUNTS & Funds available
Separate Account |
|
Funds |
First Variable Annuity Fund A |
|
VP Income & Growth
|
First Variable Annuity Fund E |
|
VP Income & Growth
|
First Variable Separate Account VL |
|
VP Income & Growth
|
Proactive Acquired Variable Annuity Separate Account |
|
VP Income & Growth
|
SCHEDULE B
REGULATORY REPORT EXPENSES
The Distributor and the Company will coordinate the functions and pay the costs of the completing these functions based upon an allocation of costs in the tables below. The term Current is defined as an existing Contract owner with value allocated to one or more Portfolios. The term Prospective is defined as a potential new Contract owner.
Costs shall be allocated to reflect the Funds share of the total costs determined according to the number of pages of the Funds respective portions of the documents. Notwithstanding anything to the contrary, the parties agree that in the event the Company undertakes to print and/or distribute Fund materials itself, ACIS will only be required to reimburse Companys expenses up to the amount ACIS would have paid its own shareholder communications vendor for such printing and distribution, and this cost will be determined annually.
Company shall send invoices for such expense to the ACIS within 90 days of the event, along with such other supporting data as may be reasonably requested. The invoice will reference the applicable Item and Function, along with the ACISs number of pages printed. The Company invoices should be sent to the following email message group: INTOPS@americancentury.com. Fees will be payable within 45 days of receipt of the invoice, as long as such supporting data defines the appropriate expenses.
Item |
|
Function |
|
Party Responsible for Expense |
Fund Prospectus* |
|
Printing and Distribution (including postage) |
|
Current and Prospective Distributor (Company may choose to do the printing at ACISs expense) |
Fund Prospectus and Statement of Additional Information Supplements |
|
Printing and Distribution (including postage) |
|
Distributor (Company may choose to do the printing at ACISs expense) |
Fund Statement of Additional Information |
|
Printing and. Distribution (including postage) |
|
Distributor |
Proxy Material for Fund |
|
Printing, Distribution to Current (including postage), tabulation and solicitation |
|
Distributor |
Fund Annual & Semi-Annual Report |
|
Printing and Distribution (including postage) |
|
ACIS (Company may choose to do the printing at ACISs expense) |
Contract Prospectus |
|
Printing and Distribution (including postage) |
|
Company |
Contract Prospectus and Statement of Additional Information Supplements |
|
Printing and Distribution (including postage) |
|
Company |
Contract Statement of Additional Information |
|
Printing and Distribution (including postage) |
|
Company |
*Fund Prospectus means the funds Summary Prospectus.
SCHEDULE C
Processing Specifications
I. NSCC Transactions
The following terms and conditions hereby amend Article I of the Agreement with respect to the receipt and transmission of orders routed through the National Securities Clearing Corporation (NSCC) in accordance with the NSCCs Defined Contribution Clearance & Settlement (DCC&S) platform cycle file:
A. American Century will accept all orders to purchase shares of the Series available using the NSCCs DCC&S platform. The Trust will also provide the Company with account positions and activity data using the NSCCs Networking platform. The Company shall pay for Series shares by federal funds wire using the NSCCs Fund/SERV System in accordance with the rules and regulations of the NSCC, as the same may be amended from time to time.
B. The Company shall use best efforts to promptly notify American Century of its inability to use the NSCCs DCC&S platform by telephone and/or facsimile.
C. American Century will provide the Company with account positions and activity data using the NSCCs Networking platform (i.e., the NSCCs product that allows funds, distributors and companies to exchange account level information electronically).
D. Payment for Series shares redeemed in accordance with this Schedule shall be effectuated using the NSCCs FundSERV System. Payment shall be in federal funds transmitted by wire to the Trusts designated Settling Bank. For the purposes of the foregoing, a Settling Bank shall mean the entity appointed by the Trust to perform such settlement services on behalf of the Series and which entity agrees to abide by the NSCCs Rules and Procedures insofar as they relate to the same day funds settlement.
E. The Distributor shall furnish notice to the Company of any income, dividends or capital gain distributions payable on the Series snares through the NSCCs FundSERV System.
AMENDMENT NO. 1 TO FUND PARTICIPATION AGREEMENT
THIS AMENDMENT NO. 1 TO FUND PARTICIPATION AGREEMENT (the Amendment) is made as of the day of November, 2020, by and among PROTECTIVE LIFE INSURANCE COMPANY, a life insurance company organized under the laws of the State of Tennessee (the Company), acting herein for and on behalf of the Company and on behalf of each separate account set forth on attached Schedule A, as the same may be amended from time to time (the Separate Accounts); AMERICAN CENTURY INVESTMENT SERVICES, INC., (the Distributor); and AMERICAN CENTURY SERVICES, LLC, (the Transfer Agent and collectively with Distributor, American Century).
RECITALS
WHEREAS, the Company and American Century are parties to a certain Fund Participation Agreement dated May 1, 2018 (the Agreement);
WHEREAS, the parties desire to amend the Agreement to update the separate accounts and funds listed in Schedule A; and
WHEREAS, the parties now desire to further modify the Agreement as provided herein.
NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants and conditions set forth herein, and for other good and valuable consideration, the parties agree to amend the Agreement as follows:
1. Schedule A. Schedule A to the Agreement is hereby deleted in its entirety and replaced with Schedule A attached hereto.
2. Ratification and Confirmation of Agreement. In the event of a conflict between the terms of this Amendment and the Agreement, it is the intention of the parties that the terms of this Amendment shall control and the Agreement shall be interpreted on that basis. To the extent the provisions of the Agreement have not been amended by this Amendment, the parties hereby confirm and ratify the Agreement.
3. Counterparts. This Amendment may be executed in two or more counterparts, each of which shall be an original and all of which together shall constitute one instrument.
4. Full Force and Effect. Except as expressly supplemented, amended or consented to hereby, all of the representations, warranties, terms, covenants and conditions of the Agreement shall remain unamended and shall continue to be in full force and effect.
[Remainder of Page Intentionally Left Blank]
IN WITNESS WHEREOF, the undersigned have executed this Amendment No. 1 as of the date first above written.
|
PROTECTIVE LIFE INSURANCE COMPANY |
|
|
On its behalf and each Separate Account named in |
|
|
Schedule A |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
AMERICAN CENTURY INVESTMENT SERVICES, INC. |
|
|
|
|
|
By: |
|
|
Name: |
Kyle Langan |
|
Title: |
Vice President |
|
AMERICAN CENTURY SERVICES, LLC |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
SCHEDULE A
SEPARATE ACCOUNTS & Funds available
Separate Account |
|
Funds |
First Variable Annuity Fund A |
|
VP Income & Growth
|
First Variable Annuity Fund E |
|
VP Income & Growth
|
First Variable Separate Account VL |
|
VP Income & Growth
|
Protective Acquired Variable Annuity Separate Account |
|
VP Income & Growth
|
Protective COLI PPVUL |
|
VP Value
|
Protective VUL COLI VUL |
|
VP Value
|
EXECUTION COPY
Amendment No. 2 to Fund Participation and Service Agreement
between
Protective Life Insurance Company
American Funds Distributors, Inc.
American Funds Service Company
Capital Research and Management Company
And American Funds Insurance Series
Protective Life Insurance Company (Insurance Company) on its behalf and on behalf of one or more separate accounts of the Insurance Company, American Funds Distributors, Inc., American Funds Service Company, Capital Research and Management Company and American Funds Insurance Series, have previously entered into a Fund Participation and Service Agreement dated June 18, 2015 (as amended to date, the Agreement). The parties now desire to amend the Agreement by this amendment (the Amendment).
Except as modified hereby, all other terms and conditions of the Agreement shall remain in full force and effect. Unless otherwise indicated, the terms defined in the Agreement shall have the same meaning in this Amendment.
AMENDMENT
For good and valuable consideration, the receipt of which is acknowledged, the parties agree to amend the Agreement as follows:
1. Exhibit A is deleted and replaced with the attached Exhibit A.
2. Except as specifically set forth herein, all other provisions of the Agreement shall remain in full force and effect.
[Remainder of Page Intentionally Left Blank]
IN WITNESS WHEREOF, the undersigned has caused this amendment to be executed as of November 25, 2020.
|
PROTECTIVE LIFE INSURANCE COMPANY |
|
|
for itself and on behalf of the Separate Accounts |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
AMERICAN FUNDS DISTRIBUTORS, INC. |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
AMERICAN FUNDS INSURANCE SERIES |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
AMERICAN FUNDS SERVICE COMPANY |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
CAPITAL RESEARCH AND MANAGEMENT COMPANY |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
Amendment #2 to FPSA Protective Life Ins. Co.
EXHIBIT A
Insurance Company Accounts
Protective Variable Annuity Separate Account
Protective Variable Life Separate Account
Protective COLI VUL Separate Account
Protective COLI PPVUL Separate Account
FUND PARTICIPATION AGREEMENT
THIS AGREEMENT is effective as of December 1, 2020 (the Effective Date), by and among each of BLACKROCK VARIABLE SERIES FUNDS, INC. AND BLACKROCK VARIABLE SERIES FUNDS II, Inc., each an open-end management investment company (each, the Fund), BLACKROCK INVESTMENTS, LLC (BRIL or the Underwriter), a broker-dealer registered as such under the Securities Exchange Act of 1934, as amended (the 1934 Act), Protective Life Insurance Company, a life insurance company organized under the laws of the state of Tennessee (the Company), on its own behalf and on behalf of each separate account of the Company set forth on Schedule A, as may be amended from time to time (each separate account hereinafter referred to individually as an Account and collectively as the Accounts).
W I T N E S S E T H:
WHEREAS, the Fund has filed a registration statement with the Securities and Exchange Commission (the SEC) to register itself as an open-end management investment company under the Investment Company Act of 1940, as amended (the 1940 Act), and to register the offer and sale of its shares under the Securities Act of 1933, as amended (the 1933 Act); and
WHEREAS, the Fund desires to act as an investment vehicle for separate accounts established for variable life insurance policies and variable annuity contracts to be offered by insurance companies that have entered into participation agreements with the Fund (the Participating Insurance Companies); and
WHEREAS, the Underwriter is registered as a broker-dealer with the SEC under the 1934 Act, is a member in good standing of the Financial Industry Regulatory Authority, Inc. (FINRA) and acts as principal underwriter of the shares of the Fund; and
WHEREAS, the capital stock of the Fund is divided into several series of shares, each series representing an interest in a particular managed portfolio of securities and other assets; and
WHEREAS, the several series of shares of the Fund offered now or in the future by the Fund to the Company and the Accounts are described on Schedule B attached hereto (each, a Portfolio, and, collectively, the Portfolios); and
WHEREAS, the Fund has received an order from the SEC granting Participating Insurance Companies and their separate accounts exemptions from the provisions of sections 9(a), 13(a), 15(a) and 15(b) of the 1940 Act, and rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the Fund to be sold to and held by variable annuity and variable life insurance separate accounts of both affiliated and unaffiliated life insurance companies (the Mixed and Shared Funding Order); and
WHEREAS, BlackRock Advisors, LLC (BAL) is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and is the Funds investment adviser; and
WHEREAS, the Company has registered or will register under the 1933 Act certain variable life insurance policies and/or variable annuity contracts funded or to be funded through one or more of the Accounts (the Contracts), unless the Contracts are exempt from registration under the 1933 Act, and will sell the Contracts to owners of the Contracts (Contract Owners); and
WHEREAS, the Company has registered or will register each Account as a unit investment trust under the 1940 Act, unless excepted from registration pursuant to Section 3(c)(7) or Section 3(c)(11) of the 1940 Act; and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company intends to purchase shares in one or more of the Portfolios (the Shares) on behalf of the Accounts to fund the Contracts, and the Fund intends to sell such Shares to the relevant Accounts at such Shares net asset value.
NOW, THEREFORE, in consideration of their mutual promises, the parties agree as follows:
ARTICLE 1
Sale of the Fund Shares
1.1 BRIL hereby appoints the Company as its agent for the limited purpose of accepting orders for an Account, and the Company hereby accepts such appointment. The Company shall have no authority to act as agent for the Fund, the Underwriter or BAL (collectively, Fund Parties) for any other purpose.
1.2 Subject to the terms of this Article 1 and the other provisions of this Agreement, the Fund shall make Shares of the Portfolios available to the Accounts, and the Company shall engage in transactions with respect to such Shares, at net asset value in accordance with the operational procedures mutually agreed to by the Fund and the Company from time to time and the provisions of the then current prospectuses and statements of additional information of the Portfolios (collectively, the Prospectus). Shares of a particular Portfolio of the Fund shall be ordered in such quantities and at such times as determined by the Company to be necessary to meet the requirements of the Contracts. The Fund may refuse to sell Shares of any Portfolio to any person (including the Company and the Accounts) or suspend or terminate the offering of Shares of any Portfolio or take any action it reasonably may deem appropriate or advisable in connection with all matters relating to the operation of the Fund and/or sale of Shares of the Portfolios. The Fund may require the Company to refuse redemption orders for a Portfolio if permitted by the Funds Prospectus or if the Fund has suspended redemptions with respect to such Portfolio in accordance with Section 22(e) of the 1940 Act, Rule 2a-7 under the 1940 Act or any other applicable rule or regulation. Fund Parties shall have no liability for any such action. It is understood that for purposes of this Agreement, an exchange involves a redemption order and a purchase order for Shares of a Portfolio.
1.3 (a) Fund/SERV Transactions. If the parties choose to use the National Securities Clearing Corporations Mutual Fund Settlement, Entry and Registration Verification (Fund/SERV) or any other NSCC service, the following provisions shall apply:
The Company and the Fund or their designees will each be bound by the rules of the National Securities Clearing Corporation (NSCC) and the terms of any NSCC agreement filed by it or its designee with the NSCC. Without limiting the generality of the following provisions of this section, the Company and the Fund or its designee will each perform any and all duties, functions, procedures and responsibilities assigned to it and as otherwise established by the NSCC applicable to Fund/SERV, the Mutual Fund Profile Service, the Networking Matrix Level utilized and any other relevant NSCC service or system (collectively, the NSCC Systems).
Any information transmitted through the NSCC Systems by any party or its designee to the other or its designee and pursuant to this Agreement will be accurate, complete, and in the format
prescribed by the NSCC. Each party or its designee will adopt, implement and maintain procedures reasonably designed to ensure the accuracy of all transmissions through the NSCC Systems and to limit the access to, and the inputting of data into, the NSCC Systems to persons specifically authorized by such party.
On each day on which the New York Stock Exchange is open for trading and on which the Fund calculates its net asset value pursuant to the rules of the SEC (Business Day), the Company shall aggregate and calculate the net purchase and redemption orders for each Account received by the Company by the close of the New York Stock Exchange (generally, 4:00 p.m. Eastern Time) (the Close of Trading) on the Business Day. The Company shall communicate to the Fund or its designee for that Business Day, by Fund/SERV, the net aggregate purchase or redemption orders (if any) for each Account received by the Close of Trading on such Business Day (the Trade Date) no later than 7:00 a.m. Eastern Time (or such other time as may be agreed by the parties from time to time) (the Fund/SERV Transactions Deadline) on the Business Day following the Trade Date. All such aggregated orders communicated to the Fund or its designee by the Fund/SERV Transactions Deadline on the Business Day following the Trade Date shall be treated by the Fund or its designee as if received prior to the Close of Trading on the Trade Date.
All orders received by the Company after the Close of Trading on a Business Day shall not be aggregated with Orders received by the Company prior to the Close of Trading on such Business Day and shall be communicated to BRIL or its designee as part of an aggregated order no sooner than after the FUND/SERV Transactions Deadline or such other time as may be agreed by the parties from time to time) the following Business Day.
Cash settlement shall be transmitted pursuant to the normal NSCC settlement process. In the case of delayed settlement, the Fund or its designee shall make arrangements for the settlement of redemptions by wire no later than the time permitted for settlement of redemption orders by the 1940 Act. Unless otherwise informed in writing, such redemption wires should be sent to an account specified by the Company and agreed to by Fund Parties.
(b) Manual Transactions. If the parties choose not to use Fund/SERV, if there are technical problems with Fund/SERV, or if the parties are not able to transmit or receive information through Fund/SERV, the following provisions shall apply:
Next Day Transmission of Orders. On each Business Day, the Company shall aggregate and calculate the net purchase and redemption orders for each Account received by the Company by the Close of Trading on such Business Day. By 9:00 a.m. Eastern Time (or such other time as may be agreed by the parties from time to time) (the Manual Transactions Deadline) on the next following Business Day, the Company shall communicate to the Fund or its designee by facsimile or, in the Companys discretion, by telephone or any other method agreed upon by the parties, the net aggregate purchase or redemption orders (if any) for each Account received by the Close of Trading on the prior Business Day. All orders communicated to the Fund or its designee by the Manual Transactions Deadline on the Business Day following the Trade Date shall be treated by the Fund or its designee as if received prior to the Close of Trading on the Trade Date.
All orders received by the Company after the Close of Trading on a Business Day shall not be aggregated with orders received by the Company prior to the Close of Trading on such Business Day and shall be communicated to BRIL or its designee as part of an aggregated order no sooner than after the Manual Transactions Deadline (or such other time as may be agreed by the parties from time to time) the following Business Day.
Purchases. The Company will use commercially reasonable efforts to transmit each purchase order to the Fund or its designee in accordance with written instructions provided by the Fund or its designee to the Company. The Company will use commercially reasonable efforts to initiate by wire transfer to BRIL or its designee through the Federal Reserve Wire Transfer System (the Fedwire System) purchase amounts prior to 1:00 p.m. Eastern Time on the next Business Day following the Trade Date.
Redemptions. The Company will use commercially reasonable efforts to transmit each redemption order to the Fund in accordance with written instructions provided by the Fund or its designee to the Company. With respect to redemption orders submitted by the Company by 9:00 a.m. Eastern Time (or such other time as may be agreed by the parties from time to time) on the next Business Day following the Trade Date, the Fund or its designee will use commercially reasonable efforts to initiate by wire transfer to the Company proceeds of such redemptions no later than the close of the Fedwire System on the next Business Day following the Trade Date.
Unless otherwise informed in writing, such redemption wires should be sent to an account specified by the Company and agreed to by Fund Parties.
(c) All Transactions.
The Company shall be responsible for the accuracy and completeness of any orders submitted by it through any means. All orders are subject to acceptance by the Fund or its designee and become effective only upon confirmation by the Fund or its designee.
The Company shall use its best efforts to provide BRIL with 24-hour advance notice prior to submitting any large trades of over $1 million.
Orders submitted on an as-of basis subsequent to the Trade Date for the Order, including post-settlement trade correction orders (hereinafter defined as an As-of Order), shall be acceptable only as permitted by the Fund and shall be subject to the Funds policies pertaining thereto. The Company shall be responsible for any loss or liability to Fund Parties or any of their respective affiliates, including any costs or expenses incurred by any of them, caused by an As-of Order and will promptly pay any such amount to Fund Parties upon demand therefor. The Company agrees that any gains from one As-of Order shall not be netted against losses generated from another.
1.4 Subject to this Article 1, the Fund will redeem any full or fractional Shares of any Portfolio when requested by the Company on behalf of an Account pursuant to a redemption order meeting the requirements of this Agreement at net asset value in accordance with the operational procedures mutually agreed to by the Fund and the Company from time to time and the provisions of the Prospectus of the Portfolios. In no event shall payment be delayed for a greater period than is permitted by the 1940 Act (including any Rule or order of the SEC thereunder).
1.5 (a) The Company represents and warrants that its internal control structure concerning the processing and transmission of orders is suitably designed to prevent or detect on a timely basis orders received after the Close of Trading from being aggregated with orders received before the Close of Trading and to minimize errors that could result in late transmission of orders. Orders received by the Company before the Close of Trading are eligible to receive that Business Days net asset value, and orders received by the Company after the Close of Trading are eligible to receive the next Business Days net asset value.
(b) The Fund may reject purchase and redemption orders which are not in the form prescribed in the Funds Prospectus. In the event that the Company and the Fund agree to use a form of written or electronic communication which is not capable of recording the time, date and recipient of any communication and confirming good transmission, the Company agrees that it shall be responsible for confirming that any communication sent by the Company was in fact received by the Fund or its designee, in good order and in accordance with the terms of this Agreement. The Fund and its agents or designees shall be entitled to rely upon, and shall be fully protected from all liability in acting upon, instructions reasonably believed by them to be from the Company or its designee.
1.6 In the event that the Company shall fail to pay in a timely manner for any purchase order validly received by the Fund or its designee pursuant to this Article 1, the Company shall hold the Fund or its designee harmless from any losses reasonably sustained by the Fund or its designee as the result of acting in reliance on such purchase order. In the event that the Fund or its designee shall fail to pay in a timely manner for any redemption order validly received by the Fund or its designee pursuant to this Article 1, the Fund or its designee shall hold the Company harmless from any losses reasonably sustained by the Company as the result of acting in reliance on such redemption order.
1.7 Issuance and transfer of Shares of the Portfolios will be by book entry only. Share certificates will not be issued to the Company or the Account. Shares ordered from the Fund will be recorded in the appropriate title for each Account or the appropriate sub-account of each Account.
1.8 The Fund or its designee shall furnish prompt notice to the Company of any income, dividends or capital gain distribution payable on Shares. The Company hereby elects to receive all such income, dividends and capital gain distributions as are payable on a Portfolios Shares in additional Shares of that Portfolio, unless the Fund or its designee is otherwise notified in writing by the Company. The Fund shall notify the Company of the number of Shares so issued as payment of such income, dividends and distributions.
1.9 (a) The Fund shall use commercially reasonable efforts to make the net asset value per Share for each Portfolio available to the Company on a daily basis after the Close of Trading and by 7:30 p.m. Eastern Time.
(b) If the Fund provides materially incorrect net asset value information, it shall make an adjustment to the number of Shares purchased or redeemed for any affected Account to reflect the correct net asset value. The Company shall make such corresponding adjustments to the Accounts as are necessary to complete the sub-accounting for the adjustment. If an adjustment is necessary to correct a pricing error which has caused the Account to receive less than the amount to which it is entitled, the number of Shares of the Account will be adjusted and the amount of any underpayments shall be credited by the Fund to the Company for crediting of such amounts to the Account. Upon notification by BRIL or the Fund of any overpayment due to an error, the Company shall promptly remit to BRIL or the Fund any overpayment that has not been paid to Contract owners If the Account has underpaid for Shares due to a pricing error, the number of Shares of the Account will be adjusted.
Fund Parties shall not be liable for any reprocessing costs or out-of-pocket costs associated with a price correction.
1.10 The Company agrees that it will not take any action to operate an Account as a management investment company under the 1940 Act without the Funds and the Underwriters prior written consent.
1.11 The Fund agrees that its Shares will be sold only to Participating Insurance Companies and their separate accounts. No Shares of any Portfolio will be sold directly to the general public. The Company agrees that Shares will be used only for the purposes of funding the Contracts and Accounts listed in Schedule A, as amended from time to time.
1.12 The Fund agrees that all Participating Insurance Companies shall have the obligations and responsibilities regarding conflicts of interest corresponding to those contained in Article 4 of this Agreement.
1.13 The Fund reserves the right to reject any purchase orders, including exchanges, for any reason, as set forth in Rule 22c-2 under the 1940 Act and the provisions of Schedule C to this Agreement, if the Fund, in its sole opinion, believes the Company or any of the Companys Contract Owners is engaging in short-term or excessive trading into and out of a Portfolio or otherwise engaging in trading that may be disruptive to a Portfolio, other than a money market Portfolio (Market Timing). In addition, in the event that the Company or any of its Contract Owners are determined by the Fund, in its sole opinion, to be engaged in Market Timing, the Fund may terminate this Agreement, suspend the Companys trading privileges, cancel any order and/or take other appropriate actions that the Fund, in its sole discretion, may determine. Fund Parties will not be responsible for any losses that the Company, the Account or the Contract Owners may suffer as a result of any of the foregoing actions. In the event a trade is cancelled for any reason, the Company agrees to be responsible for any loss or liability resulting to the Fund Parties or any of their respective affiliates, including any costs and expenses incurred by any of them, and shall promptly pay any such amount to the Fund or BRIL upon demand therefor. The Company and the Account shall not be entitled to retain any gains generated thereby.
1.14 The Company agrees to cooperate with the Underwriter and the Fund to monitor for Market Timing by its Contract Owners, to provide such relevant information about Market Timing to the Fund as it may reasonably request, including, but not limited to, such Contract Owners identity, and to prevent Market Timing from occurring by or because of Contract Owners. Failure of the Fund to reject any purchase orders that might be deemed to be Market Timing shall not constitute a waiver of the Funds rights under this section. Pursuant to Rule 22c-2 of the 1940 Act, on behalf of the Fund, the Underwriter and the Company agree to comply with the terms included in the attached Schedule C as of the effective date of this Agreement.
1.15 Liquidity Fees and Redemption Gates.
(a) Nothing in this Agreement shall prevent a money market Portfolio from suspending the right of redemption or postponing the date of payment or satisfaction upon redemption in accordance with the provisions of the 1940 Act and the rules thereunder. Notwithstanding the previous sentence, a money market Portfolio will not implement a temporary suspension of redemptions under Rule 2a-7 under the 1940 Act unless such Portfolios Prospectus permits it to do so.
(b) With respect to a money market Portfolio, the Company agrees to promptly take such actions reasonably requested by the Portfolio, to assist the Portfolio in imposing, lifting, or modifying a liquidity fee on redemptions (liquidity fee) or a temporary suspension of redemptions (a redemption gate).
(c) If a money market Portfolio implements a liquidity fee, the Company authorizes the Portfolio to calculate the liquidity fees owed to the Portfolio as a result of redemptions submitted through the Company (the Fee Amount) following the imposition of the
liquidity fee and to withhold an amount equal to the Fee Amount from any redemption proceeds or other payments that the Portfolio owes to the Company in its sole discretion. The Company acknowledges and agrees that at any time a Portfolio implements a liquidity fee, redemption orders shall be transmitted to such Portfolio or its designee on behalf of the Accounts on a gross basis, i.e. purchases and redemptions will be transmitted separately and not combined into one aggregate net trade (for avoidance of doubt, the Company shall utilize an f code if it submits the orders via the NSCC Systems).
(d) If the Board of Directors of the Fund (the Directors) were to rely on Section 2a-7(c)(2) of the 1940 Act in connection with a money market Portfolio, and notice of such reliance had been given pursuant to a prospectus supplement or other generally accepted means:
(i)The Company may be notified by a money market Portfolio that a liquidity fee or redemption gate has been implemented via facsimile, email, phone call, website disclosure, or the filing of a supplement to the prospectus. If a redemption gate is implemented by a money market Portfolio, and the Company has been notified in accordance with this paragraph, the Company agrees not to transmit any purchase, redemption and exchange orders to the money market Portfolio that it receives while the redemption gate is in effect.
(ii) Upon a Fund Partys reasonable request, the Company agrees to promptly provide a Fund Party or its designee with information separating orders received before and after each calculation of the net asset value or a time after which a money market Portfolio imposed, lifted, or modified a liquidity fee or redemption gate for the money market Portfolio or its designee to validate the timing of the Companys receipt of orders in good order.
(iii) The Company acknowledges that a money market Portfolio may, but is not obligated to, pay a redemption request that the money market Portfolio determines in its sole discretion has been received in good order by the money market Portfolio or its agent before the imposition of a liquidity fee or redemption gate, provided however, that a Fund Party may require the Company to promptly provide evidence of receipt of the redemption request in good order prior to the applicable implementation time in its sole discretion.
1.16 (a) The Company shall notify Fund Parties in the event any overpayment or payment not intended for the recipient in connection with an order (each, an incorrect payment) is made to the Company or an Account. If requested by Fund Parties and pursuant to a plan for collection that is agreed to by Fund Parties and the Company (each party being under the obligation not to unreasonably withhold its agreement), the Company shall use good faith efforts to collect any portion of the incorrect payment made to an Account or a Contract Owner. Upon receipt of such incorrect payment, the Company shall promptly repay such amount to the Fund or its designee. In the event the Company is still in control of some or all of the incorrect payment, the Company shall promptly repay such amount to the Fund or its designee after the Company becomes aware of such payment.
(b) In the event any incorrect payment is made to the Fund by the Company, the Fund or its designee shall promptly repay such amount to the Account after the Fund or its designee becomes aware of such payment.
(c) This Section 1.16 applies to incorrect payments made in connection with this Agreement or any Related Agreement (as defined below).
1.17 The Company shall be responsible for properly signing up to receive electronic transmissions (Electronic Communications) from Fund Parties and for notifying Fund Parties of changes to the Companys contact information.
1.18 The Company will not transmit orders for purchases of Shares for an Account unless it has first provided the Fund with evidence satisfactory to the Fund regarding backup withholding in the United States in connection with the Account. The Company agrees to provide or cause to be provided to BRIL and the Fund all necessary information for them to comply properly with all federal, state and local tax reporting and backup withholding requirements in connection with the Accounts.
ARTICLE 2
Obligations of the Parties
2.1 The Fund shall prepare and be responsible for filing with the SEC and any state securities regulators requiring such filing, all shareholder reports, notices, proxy materials (or similar materials such as voting instruction solicitation materials), and Prospectuses of the Fund required to be so filed. The Fund shall bear the costs of registration and qualification of its Shares, preparation and filing of the documents listed in this Section 2.1 and all taxes to which an issuer is subject on the issuance and transfer of its Shares.
2.2 At least annually, the Underwriter or its designee shall provide the Company with a PDF of the current prospectus of the applicable Portfolio(s) suitable for duplication by the Company for distribution to owners of Contracts whose cash values are invested, through the Accounts, in Shares of such Portfolio(s) (referred to in this Article 2 as Existing Contract Owners) and to prospective purchasers of Contracts including owners of Contracts whose cash values are not funded by Shares of the Portfolio(s) (collectively, Prospective Purchasers). The Underwriter or its designee will pay the Companys usual, customary and reasonable costs for printing and distributing prospectuses for Existing Contract Owners. The Company will bear the costs of printing and distributing prospectuses for Prospective Purchasers.
The Underwriter or its designee shall provide the Company free of charge with copies of any supplement to the current prospectus of the relevant Portfolio(s) in such quantity as the Company shall reasonably request (or a PDF if requested by the Company) for distribution to Existing Contract Owners, where applicable. The Underwriter or its designee will pay the Companys usual, customary and reasonable costs for printing and distributing supplements for Existing Contract Owners. The Company will bear the costs of printing and distributing supplements for Prospective Purchasers.
If any of these documents are printed in combination with such documents of other fund families (a Combined Prospectus/Supplement), the Underwriter or its designee will pay a pro rata portion of the printing and distribution costs based on the number of pages in the Combined Prospectus/Supplement that is attributable to the Portfolio(s) prospectus(es) or supplement(s); provided, however, that the Underwriter or its designee will only pay the costs described above with respect to Existing Contract Owners and will not pay any costs in connection with printing or distributing such materials to Prospective Purchasers.
The Company may use such PDF described above to assist with the updating of any of its Contract prospectuses or related materials in order to have the prospectuses of the Portfolios conform to the Companys Contract prospectuses or related materials, with the costs of such updating, including printing, to be borne by the Company.
For purposes of this Section 2.2 only, references to a Portfolios prospectus shall exclude the related statement of additional information.
2.3 The Underwriter or its designee, at its expense, shall provide a master PDF of the statement of additional information for the Portfolios to the Company (suitable for duplication by the Company at the Companys expense) for distribution at the Companys expense to any Existing Contract Owner or Prospective Purchaser.
2.4 The Underwriter or its designee shall provide the Company free of charge copies (or a PDF if requested by the Company), if and to the extent applicable to the Shares, of the Funds reports to shareholders and other communications to shareholders not described above in this Article 2 (collectively, Reports) in such quantity as the Company shall reasonably request for distribution to Existing Contract Owners. The Underwriter or its designee will pay the Companys usual, customary and reasonable costs of printing and distributing Reports for Existing Contract Owners.
If a Report is printed in combination with such documents of other fund families (a Combined Report), the Underwriter or its designee will pay a pro rata portion of the printing and distribution costs based on the number of pages of the Combined Report that is attributable to the Funds Report, provided, however, that the Underwriter or its designee will only pay the costs described above with respect to Existing Contract Owners and will not pay any costs in connection with printing or distributing such materials to Prospective Purchasers.
2.5 The Company will provide the Underwriter or its designee with supporting documentation which is sufficient in the reasonable opinion of the Underwriter or its designee to enable the Underwriter or its designee to verify the printing and distribution costs for which the Company requests reimbursement in respect of Existing Contract Owners. The Company agrees to use its best efforts to minimize any printing and distribution costs. If the Company prints such documents, Company agrees that any printer it selects shall be a reputable printer within the industry.
2.6 The Company shall furnish, or cause to be furnished, to the Fund or its designee, a copy of language that would be used in any prospectus or statement of additional information for the Contracts in which the name, logos, trademarks or service marks (whether registered or unregistered) of the Fund, any Portfolio, BRIL, BAL or any of their respective affiliates (the Marks) are used at least fifteen Business Days prior to the filing of such document with the SEC. The Company shall furnish, or shall cause to be furnished, to the Fund or its designee, each piece of sales literature or other promotional material in which any of the Marks are used (such materials together with Contract prospectuses and statements of additional information, Company Materials), at least fifteen Business Days prior to its use. No Company Materials shall be used if any of the Fund Parties reasonably objects to such use within ten Business Days after receipt of such material. Notwithstanding the foregoing, the Company need not furnish, or cause to be furnished, to the Fund or its designee (i) materials for internal use only by the Company in connection with performing its obligations under this Agreement or any Related Agreement (as hereinafter defined) or which include the names of the Fund or the Portfolios solely in a list of mutual funds available through the Company or (ii) revisions to Company Materials previously approved by the Fund or its designee (Updated Company Materials) unless the Company Materials on which they are based have been materially changed. The Fund or its designee also reserves the right to review Company Materials and Updated Company Materials at any time upon request made by the Fund or its designee to the Company. The Fund or its designee may reasonably object to the continued use of any Company
Materials or Updated Company Materials. No Company Materials or Updated Company Materials shall be used if the Fund or its designee so objects.
2.7 At the reasonable request of a Party (the Requesting Party) or its designee, another Party (the Responding Party) shall furnish, or shall cause to be furnished, as soon as practical, to the Requesting Party its designee copies of the following reports:
(a) the Responding Partys annual financial statements (prepared under generally accepted accounting principles (GAAP)), if any;
(b) the Responding Partys quarterly statements, if any;
(c) any financial statement, proxy statement, notice or report of the Responding Party sent to its policyholders or shareholders, as applicable; and
(d) any registration statement (without exhibits) and annual and quarterly financial reports of the Responding Party filed with any federal or state insurance or securities regulator.
2.8 Notwithstanding anything to the contrary in this Agreement, the Company shall not give any information or make any representations or statements on behalf of the Fund or Underwriter or concerning the Fund, the Underwriter or BAL in connection with the Contracts other than information or representations contained in and accurately derived from the registration statement or Prospectus for the Shares, reports of the Fund, Fund-sponsored proxy statements, or in sales literature or other promotional material approved by the Fund or Underwriter (as such documents may be amended or supplemented from time to time), except with the written permission of the Fund or Underwriter.
2.9 Neither the Fund nor the Underwriter shall give any information or make any representations or statements on behalf of the Company or concerning the Company, the Accounts or the Contracts other than information or representations contained in and accurately derived from the registration statements or Contract prospectuses (as such registration statements or Contract prospectuses may by amended or supplemented from time to time), except with the written permission of the Company.
2.10 The Company shall register and qualify the Contracts for sale to the extent required by applicable securities laws and insurance laws of the various states, unless the Contracts are exempt from registration under Applicable Law. To the extent required by Applicable Law, the Company shall amend the registration statement of the Contracts under the 1933 Act and the registration statement for each Account under the 1940 Act from time to time as required in order to effect the continuous offering of the Contracts or as may otherwise be required by applicable laws and rules and regulations. All applicable laws, rules and regulations including, without limitation, the rules and regulations of any regulatory or self-regulatory authority with jurisdiction over a party are collectively referred to herein as Applicable Law. The Company shall register and qualify the Contracts for sale to the extent required by applicable securities laws and insurance laws of the various states.
2.11 The Underwriter or its designee will provide the Company with copies of its proxy materials applicable to the Fund. The Underwriter or its designee shall bear the reasonable costs of soliciting Fund proxies from the Existing Contract Owners, including the reasonable costs of mailing proxy materials and tabulating proxy voting instructions, including reasonable costs charged by any
service provider engaged by the Company for this purpose. The Company will (i) distribute proxy materials applicable to the Fund to Existing Contract Owners and (ii) solicit voting instructions from Existing Contract Owners. Solely with respect to Contracts and Accounts that are subject to the 1940 Act, so long as, and to the extent that the SEC interprets the 1940 Act to require pass-through voting privileges for Contract Owners: (a) the Company will provide pass-through voting privileges to Existing Contract Owners and vote the Shares of the Fund in accordance with instructions received from the Existing Contract Owners; (b) the Fund shall require all Participating Insurance Companies to calculate voting privileges in the same manner and the Company shall be responsible for assuring that the Accounts calculate voting privileges in the manner established by the Fund; (c) with respect to each Account, the Company will vote Shares of the Fund held by the Account and for which no timely voting instructions from Existing Contract Owners are received, as well as Shares held by the Account that are owned by the Company for its general accounts, in the same proportion as the Company votes Shares held by the Account for which timely voting instructions are received from Existing Contract Owners; and (d) the Company and its agents will in no way recommend or oppose or interfere with the solicitation of proxies for Fund Shares held by Existing Contract Owners without the prior written consent of the Fund, which consent may be withheld in the Funds sole discretion.
2.12 (a) The Company will furnish the Fund or its designee (including, without limitation, any auditors designated by the Fund) with such information in connection with this Agreement and/or any agreement for the provision of administrative services or distribution-related services by the Company for the Fund (the Related Agreements) as it may reasonably request (including, without limitation, periodic certifications confirming the Companys provision of services for the Fund) and will cooperate with the Fund or its designee in connection with the preparation of reports to the Directors concerning this Agreement and/or any Related Agreement and the monies paid or payable pursuant to this Agreement or any Related Agreement, as well as any other reports or filings that may be required by law, including at the request of a regulatory or self-regulatory authority (including, without limitation, the SEC, FINRA and state insurance regulators).
(b) The Company and its employees will, upon reasonable request, be available during normal business hours to consult with the Fund or its designee concerning this Agreement and/or any Related Agreement.
(c) Each party will maintain and preserve all records as required by law to be maintained and preserved by it in connection with the performance of its obligations under this Agreement and any Related Agreement. Upon the reasonable request of another party, a party will provide copies of such records, including without limitation, copies of historical records relating to the transactions effected pursuant to this Agreement. Without limiting the generality of the foregoing, the Company shall maintain and preserve all records necessary for it to fulfill its obligations under this Agreement or which would enable Fund Parties to substantiate the services provided and fees charged by the Company, compliance with the terms of the Agreement, and the internal controls over services provided by the Company as well as written communications regarding the Fund to or from the Existing Contract Owners and any other records reasonably required by the Fund or its designee. Upon reasonable request, the Company agrees to make these records available to the Fund or its designee.
(d) From time-to-time, the Fund or its designee may submit a due diligence questionnaire to the Company, and the Company shall complete and return such due diligence questionnaire within a reasonable timeframe.
(e) Upon request, the Company provide a Financial Intermediary Controls and Compliance Assessment (FICCA) and a Statement on Standards for Attestation Engagements 18
Report (SSAE 18) or other report(s) that is/are substantially similar and acceptable to Fund Parties, each issued by a recognized independent accounting firm selected by the Company.
(f) The Company shall permit the Fund or its designee, at the Funds expense, to conduct one physical on-site due diligence review per calendar year to ensure compliance with the terms of this Agreement and the Related Agreements. The Fund or its designee will provide the Company with reasonable notice of its intention to conduct such a review. For purposes of these review privileges, the Company shall permit the authorized personnel of the Fund or its designees to have access to its books, records, information, systems, employees and agents pertinent to the Companys performance under this Agreement and/or any Related Agreement. The Fund or its designee will not perform any activity that materially interferes with any activities of the Company or its systems during the audit. The Company is entitled to observe all review activity of the Fund or its designee, and the review will be subject to such reasonable security and confidentiality measures as the Company may require. The Fund shall reimburse the Company for its reasonable expenses, including its employees time, incurred in connection with the review.
(g) Nothing in this Agreement will impose upon the Fund or its designee the obligation to review the Companys practices, procedures or controls.
2.13 (a) The Company represents and warrants that, to the best of its knowledge, the various procedures and systems which the Company has implemented with regard to safeguarding its records, data, equipment, facilities and other property used in the performance of its obligations hereunder or under the Related Agreements from loss or damage attributable to fire, theft, cyber security threat or any other cause are adequate, and the Company will make such changes therein from time to time as in its reasonable judgment are required for the secure performance of the Companys obligations hereunder. The parties shall review such systems and procedures on a periodic basis, and Fund Parties may from time to time specify the types of records to be safeguarded in accordance with this Section 2.13, provided that such request is not unreasonable.
(b) The Company shall maintain a commercially reasonable disaster recovery plan that meets commercially reasonable standards for systems backup and will provide a copy of its then-current plan to BRIL or its designee upon its request.
ARTICLE 3
Representations; Warranties; Covenants
3.1 The Company represents and warrants that it is and will remain an insurance company duly organized and in good standing under the laws of the State of Tennessee, with full power, authority and legal right to execute, deliver and perform its duties and comply with its obligations under this Agreement, and each Account has been established as a separate account under such law, and the Accounts shall comply in all material respects with Applicable Law.
3.2 The Company represents and warrants that it has registered or, prior to any issuance or sale of the Contracts, will register each Account as a unit investment trust in accordance with the provisions of the 1940 Act to serve as a separate account for the Contracts, unless the Account is exempt from registration under the 1940 Act. The Company further represents and warrants that the Contracts will be registered under the 1933 Act, or exempt from registration under the 1933 Act, prior to any issuance or sale of the Contracts, and the Contracts will be issued in compliance in all material respects with Applicable Law.
3.3 The Company represents and warrants that the Contracts are currently and at the time of issuance will be treated as annuity contracts or life insurance policies, whichever is
appropriate, under applicable provisions of the Internal Revenue Code of 1986, as amended (the Code). The Company shall make every effort to maintain such treatment and shall notify the Fund and the Underwriter immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future.
3.4 The Company represents and warrants that it will have the full right, power and authority to effect transactions on behalf of the Accounts and that all orders submitted by it to the Fund on behalf of the Accounts will be made to cover instructions already received from the Contract Owners to fund the Contracts.
3.5 (a) As long as Shares of the Fund are held on behalf of Contract Owners, the Company shall comply with Applicable Law (including, but not limited to, any disclosure regarding fees or other compensation paid to the Company pursuant to this Agreement or any Related Agreement). The Company shall have policies and procedures in place which the Company reasonably believes to be appropriate and sufficient with regard to the handling of orders on a timely basis and which the Company believes provide adequate controls and procedures to ensure ongoing compliance with the requirements of this Section 3.5 as applicable and effective. Subject to legal restrictions, the Company will, upon request, promptly provide to Fund Parties evidence of those policies and procedures and the Companys compliance therewith. The Company will, upon request, annually certify to compliance with Applicable Law. The Company acknowledges and agrees that Fund Parties are not responsible for the Companys compliance with Applicable Law and have no responsibility for determining whether the Fund Shares are suitable for the Accounts or Contract Owners.
(b) Without limiting the generality of Section 3.5(a) above, as long as Shares of the Fund are held on behalf of Contract Owners, the Company has adopted, implemented and shall maintain and comply with a reasonable risk-based program to comply with all applicable economic, trade and financial sanctions laws, resolutions, executive orders and regulations enacted by the United States (including as administered and/or enforced by the Office of Foreign Assets Control), the European Union, the United Nations and other applicable jurisdictions (collectively, Sanctions Laws). The Company shall maintain and comply with policies, procedures and controls that are reasonably designed to ensure compliance with Sanctions Laws and limit the risk of transactions that could be regarded as circumventing Sanctions Laws and that it, the Accounts, the Contract Owners and, to the extent required by law, its and their owners and controllers (i) are not in violation of any Sanctions Laws or on any list of prohibited individuals or entities enacted under Sanctions Laws (collectively, Sanctions Lists) and (ii) are not located, organized or doing business in a country or territory that is, or whose government is, the target of embargo or countrywide sanctions under any Sanctions Laws. The Company agrees that it will take reasonable steps to ensure that Account and Contract Owner funds shall not be directly or indirectly derived from, invested for the benefit of or related in any way to, persons, entities or countries that are subject to any country embargoes, in violation of any Sanctions Laws or on any Sanctions Lists. The Company will promptly inform BRIL in writing if with respect to the transactions in the shares or the Companys services, the Company becomes aware of any violations of Sanctions Laws by itself or any of the Accounts or Contract Owners or to the extent required by Applicable Law, any of their owners or controllers or if it or any of the Accounts or Contract Owners or any of their owners or controllers are the target of embargo or identified on any Sanctions Lists or if the Company is otherwise unable to comply with its obligations under this Section 3.5(b).
(c) Without limiting the generality of Section 3.5(a) above, as long as Shares of the Fund are held on behalf of Contract Owners, the Company has adopted, implemented and shall maintain and comply with an anti-money laundering program to comply with (i) all applicable United
States laws and regulations relating to anti-money laundering, including the Uniting and Strengthening America by Providing Appropriate Tools to Intercept and Obstruct Terrorism Act of 2001 (the USA PATRIOT Act) and the Bank Secrecy Act, as amended by the USA PATRIOT Act, and SEC and FINRA rules and regulations and (ii) all applicable laws and regulations relating to anti-money laundering from other applicable jurisdictions (collectively, AML Laws). The Company shall maintain and comply with written policies, procedures and controls designed to detect, prevent and report money laundering or other suspicious activity and prohibit dealings with shell banks. The Company shall have a written customer identification program that complies with AML Laws, including the FinCEN CDD rule (31 CFR Parts 1010, 1020, 1023, 1024 and 1026) which outlines requirements to identify and verify the identity of beneficial owners. In addition, the Company shall have a designated anti-money laundering compliance officer, and the Company shall provide anti-money laundering training to its staff on an annual basis. Finally, the Companys anti-money laundering program shall provide for an independent audit of its anti-money laundering program on an annual basis. The Company will promptly inform BRIL in writing, to the extent not prohibited by Applicable Law, if the Company becomes aware of any violations of AML Laws by it or any Account or Contract Owner with respect to the Companys services or transactions in Shares or if the Company is otherwise unable to comply with its obligations under this Section 3.5(c).
(d) As long as Shares of the Fund are held on behalf of Contract Owners, the Company shall provide BRIL with such information as it may reasonably request, including, but not limited to, the filling out of questionnaires, attestations and other documents, to enable Fund Parties to fulfill their obligations under Sanctions Laws and AML Laws (including maintaining records for at least five years). Without limiting the generality of the foregoing, and subject to legal restrictions, the Company will, upon request, promptly provide to Fund Parties evidence of (i) its policies and procedures that are designed to comply with AML Laws and Sanctions Laws and (ii) the Companys compliance therewith.
(e) As long as Shares of the Fund are held on behalf of Contract Owners, the Company represents and warrants that neither it nor any of its Executive leadership have been previously indicted with respect to or convicted of any criminal charges, including money laundering, and neither it nor any of its principals is the subject of any criminal action of any nature or of any regulatory or self-regulatory action relating to money laundering.
(f) As long as Shares of the Fund are held on behalf of Contract Owners, the Company represents and warrants that it is aware of Sanctions Laws, and it has not violated and shall not violate any Sanctions Laws.
3.6 As long as Shares of the Fund are held on behalf of Contract Owners, each Party (the Notifying Party) agrees to notify the other Parties immediately in the event of the Notifying Partys expulsion or suspension from any regulatory or self-regulatory authority with jurisdiction over it or of any pending or threatened action or proceeding by any regulatory or self-regulatory authority bearing on its membership. The Notifying Party agrees to promptly advise the other Parties if it receives notice of any of the following: (1) any investor complaint, litigation initiated or threatened, or communication by a regulatory or self-regulatory authority which relates to the Fund, in the case of the Company, or a Contract or Separate Account in the case of BRIL, or to a transaction in shares by it or (2) any examination by any regulatory or self-regulatory authority that may or has resulted in a material compliance deficiency, and the Notifying Party agrees to promptly provide the other Parties with such information and documentation thereon as the other Parties may request.
3.7 The Company acknowledges and agrees that it is the responsibility of the Company to determine investment restrictions under state insurance law applicable to any Portfolio, and that the Fund shall bear no responsibility to the Company for any such determination or the correctness
of such determination. The Company has determined that the investment restrictions set forth in the current Prospectus are sufficient to comply with all investment restrictions under state insurance laws that are currently applicable to the Portfolios as a result of the Accounts investment therein. The Company shall inform the Fund of any additional investment restrictions imposed by state insurance law after the date of this Agreement that may become applicable to the Fund or any Portfolio from time to time as a result of the Accounts investment therein. Upon receipt of any such information from the Company, the Fund shall determine whether it is in the best interests of shareholders to comply with any such restrictions. If the Fund determines that it is not in the best interests of shareholders to comply with a restriction determined to be applicable by the Company, the Fund shall so inform the Company, and the Fund and the Company shall discuss alternative accommodations in the circumstances.
3.8 The Company represents and warrants that each Account is a segregated asset account and that interests in each Account are offered exclusively through the purchase of or transfer into a variable contract, within the meaning of such terms under Section 817 of the Code and the regulations thereunder. The Company will use its best efforts to continue to meet such definitional requirements, and it will notify the Fund immediately upon having a reasonable basis for believing that such requirements have ceased to be met or that they might not be met in the future.
3.9 As long as Shares of the Fund are held on behalf of Contract Owners, the Company shall maintain reasonable insurance coverage against all liabilities that may arise in connection with the performance of its duties and other obligations hereunder, including a fidelity bond covering employees and agents and a professional liability policy, and it shall provide Fund Parties with information with respect to the extent of such coverage upon request.
3.10 As long as Shares of the Fund are held on behalf of Contract Owners, the Company represents and warrants that with respect to the purchase, redemption or exchange of shares for Contract Owners accounts with respect to which the Company is a fiduciary under State or federal trust law or comparable fiduciary requirements, the purchase, redemption or exchange of such Shares, and the Companys receipt of any fees, is permissible under all such applicable laws, including ERISA, and complies with any restrictions, limitations or procedures under such laws.
3.11 As long as Shares of the Fund are held on behalf of Contract Owners, each Party will promptly notify the other Parties if for any reason it is unable to perform fully and promptly any of its obligations under this Agreement or any of the Related Agreements or if any of its representations, warranties or covenants become untrue; provided, however, that such notice shall not excuse any non-performance by it.
3.12 The Fund represents and warrants that it is and will remain duly organized and validly existing under the laws of the State of Maryland.
3.13 The Fund represents and warrants that the Fund Shares offered and sold pursuant to this Agreement will be registered under the 1933 Act and the Fund is registered under the 1940 Act. The Fund shall amend its registration statement under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its shares. If the Fund determines that notice filings are appropriate, the Fund shall use its best efforts to make such notice filings in accordance with the laws of such jurisdictions reasonably requested by the Company.
3.14 The Fund has adopted a Distribution Plan (the Plan) with regard to the Class II and Class III shares of each Portfolio, pursuant to Rule 12b-1 under the 1940 Act. The Plan permits the Underwriter to pay to each Participating Insurance Company that enters into an agreement with the
Underwriter to provide distribution-related services to contract owners, a fee, at the end of each month, of equal to 0.15% of the average daily net asset value of the Class II shares and equal to 0.25% of the average daily net asset value of Class III shares of each Portfolio held by such Participating Insurance Company. The Company agrees to waive the payment of any such distribution fee unless and until Underwriter has received such fees from the Fund.
3.15 The Fund represents that it will comply and maintain each Portfolios compliance with the diversification requirements set forth in Section 817(h) of the Code and Section 1.817-5 of the regulations under the Code. The Fund will notify the Company immediately upon having a reasonable basis for believing that a Portfolio has ceased to so comply or that a Portfolio might not so comply in the future. In the event of a breach of this Section 3.15 by the Fund, it will take all reasonable steps to adequately diversify the Portfolio so as to achieve compliance within the grace period afforded by Section 1.817-5 of the regulations under the Code. No later than 60 days following the end of each calendar quarter, each Fund or BRIL will provide the Company with a certificate of compliance by each Fund with Section 817(h) of the Code.
3.16 The Fund represents and warrants that each Portfolio is currently qualified as a regulated investment company (RIC) under Subchapter M of the Code and represents that it will use its best efforts to qualify and to maintain qualification of each Portfolio as a RIC. The Fund will notify the Company immediately in writing upon having a reasonable basis for believing that a Portfolio has ceased to so qualify or that it might not so qualify in the future.
3.17 Each party represents and warrants to the other parties that the person executing this Agreement on its behalf is duly authorized and empowered to execute and deliver this Agreement.
3.18 Each party represents and warrants that the execution, performance and delivery of this Agreement by it will not result in it violating any Applicable Law or breaching or otherwise impairing any of its contractual obligations.
3.19 Each party covenants that this Agreement constitutes a legal, valid and binding obligation, enforceable against it in accordance with its terms, subject to applicable bankruptcy, reorganization, insolvency, moratorium or similar laws affecting creditors rights generally and subject, as to enforceability, to equitable principles of general application regardless of whether enforcement is sought in a proceeding in equity or law.
3.20 Nothing contained in this Agreement is intended to operate as, and the provisions of this Agreement shall not in any way whatsoever constitute, a waiver by the Company of compliance with any applicable provision of the 1933 Act or of the rules and regulations of the SEC issued thereunder.
ARTICLE 4
Potential Conflicts
4.1 The parties acknowledge that the Funds Shares may be made available for investment to other Participating Insurance Companies. In such event, the Directors of the Fund will monitor the Fund for the existence of any material irreconcilable conflict between the interests of the contract owners of all Participating Insurance Companies. A material irreconcilable conflict may arise for a variety of reasons, including: (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling, no-action or interpretative letter, or any similar action by insurance,
tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the investments of any Portfolio are being managed; (e) a difference in voting instructions given by variable annuity contract and variable life insurance contract owners; or (f) a decision by a Participating Insurance Company to disregard the voting instructions of contract owners. The Directors shall promptly inform the Company in writing if they determine that an irreconcilable material conflict exists and the implications thereof.
4.2 The Company agrees to promptly report any potential or existing conflicts of which it is aware to the Directors. The Company will assist the Directors in carrying out their responsibilities under the Mixed and Shared Funding Order by providing the Directors with all information reasonably necessary for them to consider any issues raised including, but not limited to, information as to a decision by the Company to disregard Contract Owner voting instructions.
4.3 If it is determined by a majority of the Directors, or a majority of the Directors who are not affiliated with BAL or the Underwriter (the Disinterested Directors), that a material irreconcilable conflict exists that affects the interests of Contract Owners, the Company shall, in cooperation with other Participating Insurance Companies whose contract owners are also affected, at its expense and to the extent reasonably practicable (as determined by the Directors) take whatever steps are necessary to remedy or eliminate the irreconcilable material conflict, which steps could include: (a) withdrawing the assets allocable to some or all of the Accounts from the Fund or any Portfolio and reinvesting such assets in a different investment medium, including (but not limited to) another Portfolio of the Fund, or submitting the question of whether or not such segregation should be implemented to a vote of all affected Contract Owners and, as appropriate, segregating the assets of any appropriate group (i.e., annuity contract owners, life insurance contract owners, or variable contract owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected Contract Owners the option of making such a change; and (b) establishing a new registered management investment company or managed separate account.
4.4 If a material irreconcilable conflict arises because of a decision by the Company to disregard Contract Owner voting instructions and that decision represents a minority position or would preclude a majority vote, the Company may be required, at the Funds election, to withdraw the affected Accounts investment in the Fund and terminate this Agreement with respect to such Account; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the Disinterested Directors. Any such withdrawal and termination must take place within 30 days after the Fund gives written notice that this provision is being implemented, subject to Applicable Law but in any event consistent with the terms of the Mixed and Shared Funding Order. Until the end of such 30-day period, the Fund shall continue to accept and implement orders by the Company for the purchase and redemption of Shares.
4.5 If a material irreconcilable conflict arises because a particular state insurance regulators decision applicable to the Company conflicts with the majority of other state regulators, then the Company will withdraw the affected Accounts investment in the Fund and terminate this Agreement with respect to such Account within 60 days after the Fund informs the Company in writing that it has determined that such decision has created an irreconcilable material conflict; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the Disinterested Directors. Until the end of such 60-day period, the Fund shall continue to accept and implement orders by the Company for the purchase and redemption of Shares.
4.6 For purposes of Sections 4.3 through 4.6 of this Agreement, a majority of the Disinterested Directors shall determine whether any proposed action adequately remedies any irreconcilable material conflict, but in no event will the Company be required to establish a new funding medium for the Contracts if an offer to do so has been declined by vote of a majority of Contract Owners materially adversely affected by the irreconcilable material conflict. In the event that the Directors determine that any proposed action does not adequately remedy any irreconcilable material conflict, then the Company will withdraw the Accounts investment in the Fund and terminate this Agreement within 30 days after the Directors inform the Company in writing of the foregoing determination; provided, however, that such withdrawal and termination shall be limited to the extent required by any such material irreconcilable conflict as determined by a majority of the Disinterested Directors.
4.7 Upon request, the Company shall submit to the Directors such reports, materials or data as the Directors may reasonably request so that the Directors may fully carry out the duties imposed upon them by the Mixed and Shared Funding Order, and said reports, materials and data shall be submitted more frequently if deemed appropriate by the Directors.
4.8 If and to the extent that (a) Rule 6e-2 and Rule 6e-3 (T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the application for the Mixed and Shared Funding Order) on terms and conditions materially different from those contained in the application for the Mixed and Shared Funding Order, or (b) the Mixed and Shared Funding Order is granted on terms and conditions that differ from those set forth in this Article 4, then the Fund and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary (a) to comply with Rules 6e-2 and 6e-3 (T), as amended, and Rule 6e-3, as adopted, to the extent such rules are applicable, or (b) to conform this Article 4 to the terms and conditions contained in the Mixed and Shared Funding Order, as the case may be.
ARTICLE 5
Indemnification
5.1 The Company agrees to indemnify and hold harmless the Fund Parties, their affiliates, and each of their respective Directors, officers, employees and agents and each person, if any, who controls a Fund Party within the meaning of Section 15 of the 1933 Act (collectively the Indemnified Parties for purposes of this Section 5.1) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Company) or expenses (including the reasonable costs of investigating or defending any loss, claim, damage, liability or expense and reasonable legal counsel fees incurred in connection therewith) (collectively, Losses), to which the Indemnified Parties may become subject under any statute or regulation, or common law or otherwise, to the extent that such Losses:
(a) arise out of or are based upon any untrue statements of any material fact contained in the registration statement, prospectus(es) or statements of additional information (as amended or supplemented) for the Contracts or in the Contracts themselves or in sales literature or other promotional material generated or approved by the Company on behalf of the Contracts or Accounts (or any amendment or supplement to any of the foregoing) (collectively, Company Documents for the purposes of this Article 5), or arise out of or are based upon the omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this indemnity shall not apply as to any Indemnified Party if such statement or
omission was made in reliance upon and was accurately derived from written information furnished to the Company by or on behalf of the Fund or Underwriter for use in such Company Documents or otherwise for use at such time in connection with the sale of the Contracts or Shares unless the Company has failed to update the Company Documents to conform to then-current Fund Documents or other then-current written materials available from the Fund Parties for use in connection with the sale of the Contracts or Shares if such failure would be likely to have an impact on a Contract Owners investment decision); or
(b) arise out of or result from statements or representations (other than statements or representations contained in and accurately derived from then-current Fund Documents as defined in Section 5.2(a) or other then-current written material furnished to the Company by or on behalf of Fund Parties for use in connection with the sale of the Contracts or Shares), or wrongful conduct, of the Company or persons under its control, with respect to the sale or acquisition of the Contracts or Shares; or
(c) arise out of or result from any untrue statement of a material fact contained in Fund Documents as defined in Section 5.2(a) or the omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such statement or omission was made in reliance upon and accurately derived from written information furnished to the Fund or Underwriter by or on behalf of the Company for use in such Fund Documents or otherwise for use at such time in connection with the sale of the Contracts or Shares; or
(d) arise out of or result from any failure by the Company to provide the services or furnish the materials required under the terms of this Agreement or any Related Agreement; or
(e) arise out of or result from any material breach of any representation and/or warranty made by the Company in this Agreement or any Related Agreement or arise out of or result from any other material breach of this Agreement or any Related Agreement by the Company; or
(f) arise out of or result from any bad faith, gross negligence or willful misconduct in the performance of the Companys services or other obligations under this Agreement or any Related Agreement; or
(g) arise out of any violation of Applicable Law in any material respect by the Company in connection with the performance of its services or other obligations under this Agreement or any Related Agreement.
This indemnity provision is in addition to any other liability that the Company may otherwise have to the Indemnified Parties.
5.2 The Underwriter and the Fund agree severally to indemnify and hold harmless the Company and each of its directors, officers, employees and agents and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 5.2) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Fund Parties) or
expenses (including the reasonable costs of investigating or defending any loss, claim, damage liability or expense and reasonable legal counsel fees incurred in connection therewith) (collectively, Losses), to which the Indemnified Parties may become subject under any statute or regulation, or at common law or otherwise, to the extent that such Losses:
(a) arise out of or are based upon any untrue statements of any material fact contained in the registration statement or Prospectus for the Fund (as amended or supplemented) (collectively, Fund Documents for the purposes of this Article 5), or arise out of or are based upon the omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this indemnity shall not apply as to any Indemnified Party if such statement or omission was made in reliance upon and was accurately derived from written information furnished to the Fund Parties by or on behalf of the Company for use in such Fund Documents or otherwise at such time for use in connection with the sale of the Contracts or Shares; or
(b) arise out of or result from statements or representations (other than statements or representations contained in and accurately derived from then-current Company Documents or other then-current written material furnished to the Fund Parties by or on behalf of the Company for use in connection with the sale of the Contracts or Shares), or wrongful conduct, of a Fund Party or persons under its respective control, with respect to the sale or acquisition of the Contracts or Shares; or
(c) arise out of or result from any untrue statement of a material fact contained in Company Documents or the omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such statement or omission was made in reliance upon and accurately derived from written information furnished to the Company by or on behalf of the Fund Parties for use in such Company Documents or otherwise at such time in connection with the sale of the Contracts or Shares (provided that the Company has not failed to update the Company Documents to conform to then-current Fund Documents or other then-current written materials available from the Fund Parties for use in connection with the sale of the Contracts or Shares if such failure would be likely to have an impact on a Contract Owners investment decision); or
(d) arise out of or result from any material breach of any representation and/or warranty made by the Underwriter or the Fund in this Agreement or any Related Agreement or arise out of or result from any other material breach of this Agreement or any Related Agreement by the Underwriter or the Fund; or
(e) arise out of or result from any bad faith, gross negligence or willful misconduct by a Fund Party in the performance of its obligations under this Agreement or any Related Agreement; or
(f) arise out of any violation of Applicable Law in any material respect by a Fund Party in connection with the performance of its obligations under this Agreement or any Related Agreement.
This indemnity provision is in addition to any other liability that the Underwriter may otherwise have to the Indemnified Parties.
5.3 The Company shall not be liable under the indemnification provisions of Section 5.1 with respect to any Losses incurred or assessed against any Indemnified Party to the extent such Losses arise out of or result from such Indemnified Partys bad faith, gross negligence or willful misconduct in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement.
Neither the Underwriter nor the Fund shall be liable under the indemnification provisions of Section 5.2 with respect to any Losses incurred or assessed against any Indemnified Party to the extent such Losses arise out of or result from such Indemnified Partys bad faith, negligence or willful misconduct in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement.
5.4 Neither the Company, the Underwriter nor the Fund shall be liable under the indemnification provisions of Section 5.1 or 5.2, as applicable, with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the other parties in writing within a reasonable time after the summons, or other first written notification, giving information of the nature of the claim shall have been served upon or otherwise received by such Indemnified Party (or after such Indemnified Party shall have received notice of service upon or other notification to any designated agent), but failure to notify the party against whom indemnification is sought of any such claim shall not relieve that party from any liability which it may have to the Indemnified Party in the absence of Sections 5.1 and 5.2.
5.5 In case any such action is brought against the Indemnified Parties, the indemnifying party shall be entitled to participate, at its own expense, in the defense of such action. The indemnifying party also shall be entitled to assume the defense thereof, with counsel reasonably satisfactory to the party named in such action. After notice from the indemnifying party to the Indemnified Party of an election to assume such defense, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the indemnifying party will not be liable to the Indemnified Party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.
5.6 Except with the prior written consent of the indemnifying party, which consent shall not be unreasonably withheld or delayed, the indemnified party shall not settle any claim or make any compromise in any proceeding. In addition, the indemnifying party shall not, without the prior written consent of the Indemnified Parties, which consent shall not be unreasonably withheld or delayed, settle or compromise the liability of the Indemnified Parties.
ARTICLE 6
Confidentiality
6.1 Confidential Information is defined as: information that a disclosing party reasonably considers non-public, confidential or proprietary in nature, including a formula, pattern, compilation, program, device, method or process that derives independent economic value (actual or potential) from not being generally known to or readily ascertainable through appropriate means by other persons who might obtain economic value from its disclosure or use, and is the subject of efforts that are reasonable under the circumstances to maintain its confidentiality. Except as expressly permitted by this Agreement, each party hereto will: (i) keep and maintain all Confidential
Information of the other party in strict confidence, using such degree of care as is appropriate to avoid unauthorized use or disclosure and (ii) not, directly or indirectly, disclose any Confidential Information of the other party to any third party, except with the other partys prior written consent.
6.2 Prior to disclosure of any of its Confidential Information to the other party, a party shall comply with all legal, regulatory or other notice and/or consent requirements permitting the disclosure of Confidential Information by it to the other party and the processing/use of such Confidential Information by the other party and its Recipients (as defined below) in accordance with this Agreement.
6.3 Each party will be permitted to use, reproduce and create derivative works of the other partys Confidential Information and disclose such Confidential Information (and any derivative works thereof) to its employees, legal counsel, auditors, affiliates, agents, vendors and other third parties (collectively, Recipients) having a need to know such information in connection with or related to this Agreement. In addition, any party may disclose the others Confidential Information to the extent required to comply with law, regulatory request or a court order; provided, however, that each party must (where legally permitted to do so) promptly notify the other party of receipt of a request for Confidential Information made pursuant to law, regulatory request or court order, give the other party a reasonable opportunity to prevent the disclosure of the Confidential Information, and reasonably cooperate with the other party in any efforts it makes to prevent the disclosure of the Confidential Information. Without limiting the generality of the foregoing and despite any contrary provision in this Agreement, Fund Parties will be permitted to disclose trade data and other information to Recipients for sales reporting, business analytics, distribution strategy, product development, research, analysis, trade attribution, scrubbing, processing, customer relationship management, regulatory and/or other similar purposes.
6.4 Despite any contrary provision in this Agreement, Confidential Information of a party will not include information that: (i) is or becomes generally known to the public not as a result of a disclosure by the other party, (ii) is rightfully in the possession of the other party before disclosure by the first party, (iii) is independently developed by the other party without reliance on the Confidential Information, or (iv) is received by the other party in good faith and without restriction from a third party not under a confidentiality obligation to the first party and having the right to make such disclosure. Each party acknowledges that the disclosure of the others Confidential Information may cause irreparable injury to the other party and damages which may be difficult to ascertain. Therefore, each party will be entitled to injunctive relief upon a disclosure or threatened disclosure of any of its Confidential Information that would violate the terms of this Agreement. Each party hereto shall notify the other party promptly (unless not legally permitted to do so) upon discovery of unauthorized use or disclosure of Confidential Information, and reasonably cooperate with the owner of the Confidential Information to help the owner of the Confidential Information regain possession of the Confidential Information and prevent its further unauthorized use and disclosure.
6.5 For purposes of this Article 6, Fund Parties shall be considered to be a party, and the Company shall be considered a party.
6.6 Each party has adopted policies and practices in compliance with Applicable Law regarding privacy of customer information, including, if applicable, the protection of non-public personal information pursuant to the Gramm-Leach-Bliley Act of 1999, SEC Regulation S-P, appropriate banking regulations and/or the Massachusetts Standards for the Protection of Personal Information. These policies and practices are designed to comply with applicable data security
regulations in all material respects, including, but not limited to, the obligation to provide appropriate administrative, technical and physical safeguards reasonably designed to (i) provide for the security and confidentiality of customer records and information; (ii) protect against any anticipated threats or hazards to the security or integrity of customer records and information; and (iii) protect against unauthorized access to or use of customer records or information that could result in substantial harm or inconvenience to any customer.
ARTICLE 7
Termination
7.1 This Agreement may be terminated by any party for any reason by sixty (60) days advance written notice to the other parties or upon such shorter notice as is required by Applicable Law, order, or instruction by a court of competent jurisdiction or a regulatory or self-regulatory authority with jurisdiction over any party.
7.2 This Agreement may be terminated immediately upon written notice to the other parties at the option of the Company, Underwriter or the Fund (the Terminating Party) upon institution of formal proceedings against the Company, Underwriter, or the Fund by FINRA, the SEC, the insurance commission of any state or any other regulatory authority regarding the Companys duties under this Agreement or any Related Agreement or related to the sale of the Contracts, the operation of the Account(s), the administration of the Contracts or the purchase of the Shares, or an expected or anticipated ruling, judgment or outcome which would, in the Funds or the Underwriters respective reasonable judgment, materially impair the Companys ability to meet and perform the Companys obligations and duties hereunder.
7.3 This Agreement may be terminated immediately upon written notice to the other parties at the option of the Fund or the Underwriter if the Internal Revenue Service determines that the Contracts cease to qualify as annuity contracts or life insurance policies, as applicable, under the Code, or if the Fund or Underwriter reasonably believes that the Contracts may fail to so qualify or if interests in an Account under the Contracts are not registered, where required, and, in all material respects, are not issued or sold in accordance with any Applicable Law.
7.4 This Agreement may be terminated immediately upon written notice to the other parties by the Fund or the Underwriter, at eithers option, if either the Fund or the Underwriter shall determine, in its sole judgment exercised in good faith, that either (A) the Company shall have suffered a material adverse change in its business or financial condition, (B) the Company shall have been the subject of material adverse publicity which is likely to have a material adverse impact upon the business and operations of either the Fund or the Underwriter, (C) the Company shall have breached any obligation under this Agreement or any Related Agreement in a material respect and such breach continued unremedied for thirty (30) days after receipt by the Company of notice in writing from the Fund or Underwriter of such breach, (D) the Company shall have violated Applicable Law in a material respect, including, without limitation, any AML Laws or Sanctions Laws, or is unable to comply with the compliance obligations set forth in this Agreement regarding anti-money laundering or sanctions or (E) the Company or any of the Contract Owners have engaged in Market Timing.
7.5 This Agreement may be terminated immediately upon written notice to the other parties at the option of the Company if (A) the Internal Revenue Service determines that any Portfolio fails to qualify as a RIC under the Code or fails to comply with the diversification requirements of Section 817(h) of the Code and the Fund, upon written request fails to provide reasonable assurance that it will take action to cure such failure, or (B) the Company shall determine,
in its sole judgment exercised in good faith, that either (1) the Fund or the Underwriter shall have been the subject of material adverse publicity which is likely to have a material adverse impact upon the business and operations of the Company, or (2) the Fund or Underwriter shall have breached any obligation under this Agreement or any Related Agreement in a material respect and such breach continued unremedied for thirty (30) days after receipt of notice in writing to the Fund or the Underwriter from the Company of such breach.
7.6 This Agreement may be terminated by any party immediately upon written notice to the other parties if (A) another party attempts to assign this Agreement in contravention of the terms hereof, (B) another party files a petition for bankruptcy, a trustee or receiver is appointed for any party or its assets under federal bankruptcy laws, or an application for a protective decree under the provisions of the Securities Investor Protection Act of 1970 is filed against any party, or (C) with respect to a particular Portfolio, Shares of the Portfolio are not registered, issued or sold in conformity with federal or State law or such law precludes the use of Shares of the Portfolio as an underlying investment medium for the Accounts.
7.7 Notwithstanding any termination of this Agreement, the Fund and the Underwriter may continue to make available additional Shares of the Fund pursuant to the terms and conditions of this Agreement, for all existing Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as Existing Contracts). Specifically, without limitation, if the Fund and Underwriter so agree to make additional Shares available, the owners of the Existing Contracts will be permitted to reallocate investments in the Fund (as in effect on such date), redeem investments in the Fund and/or invest in the Fund upon the making of additional purchase payments under the Existing Contracts. In the event of a termination of this Agreement pursuant to this Article 7, the Fund and the Underwriter shall promptly notify the Company in writing whether the Underwriter and the Fund will continue to make Shares available to Existing Contracts after such termination; if the Underwriter and the Fund continue to make Shares so available, the provisions of this Agreement shall remain in effect with respect to transactions in Shares by such Existing Contracts except for Section 7.1 and thereafter either the Fund, Underwriter or the Company may terminate the Agreement as so continued pursuant to this Section 7.7 upon prior written notice to the other parties, such notice to be for a period that is reasonable under the circumstances but need not be greater than six months.
7.8 The provisions of Section 2.12 and this Section 7.8, Articles 5 (Indemnification), 6 (Confidentiality), 8 (Notices) and 9 (Miscellaneous) and Section 9 of Schedule C shall survive the termination of this Agreement; Section 7.7 shall survive the termination of the Agreement if the Fund and the Underwriter elect to continue to make available additional Shares of the Portfolios as specified therein; the provisions of Articles 1 (Sale of Fund Shares) (to the extent that they apply to redemptions or exchanges), 2 (Obligations of the Parties), and 4 (Potential Conflicts) shall survive the termination of this Agreement as long as Shares of the Fund are held on behalf of Contract Owners; and the provisions of Article 3 (Representations; Warranties and Covenants) that by their terms continue as long as Shares of the Fund are held on behalf of Contract Owners shall survive for that period.
ARTICLE 8
Notices
Unless otherwise specified in this Agreement, all notices shall be in writing and shall be deemed to have been given (a) when delivered by hand (with written confirmation of delivery); (b) when delivered if sent by a nationally recognized overnight courier (with written or electronic confirmation of delivery); or (c) on the third day after the date mailed, by certified or registered
mail, return receipt requested, postage prepaid. Notices must be sent to the respective parties at the address(es) indicated below (or at such other address for a party as shall be specified in a notice given in accordance with this Article 8).
To the Fund:
c/o BlackRock Advisors, LLC Attn: Ariana Brown Global Client Services-Onboarding- Contracting 40 East 52nd Street New York, NY 10022
|
With a copy to:
BlackRock, Inc. Attn: General Counsel 40 East 52nd Street New York, NY 10022 |
To BRIL:
BlackRock Investments, LLC Attn: Anne Ackerley Managing Director, USCA DC Mgmt. 55 East 52nd Street New York, NY 10055 |
With a copy to:
BlackRock Investments, LLC Attn: Chief Compliance Officer 55 East 52nd Street New York, NY 10055 |
|
|
To the Company:
Protective Life Insurance Company 2801 Highway 280 South Birmingham, AL 35223 Attn: SVP, Chief Product Officer |
With a copy to:
Senior Counsel - Variable Product Protective Life Corporation 2801 Highway 280 South Birmingham, AL 35223 |
Notwithstanding the foregoing, (i) notices which are customarily sent via NSCC Systems may be sent by those means and shall be effective as specified in the NSCC rules, or if not specified therein, when sent, and (ii) notices which are customarily sent by Electronic Communications may be sent in that manner and shall be effective when sent.
ARTICLE 9
Miscellaneous
9.1 The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
9.2 This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which shall together constitute one and the same instrument.
9.3 If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect insofar as the foregoing can be accomplished without materially affecting the benefits anticipated by the parties to this Agreement. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect
the original intent of the parties as closely as possible to the fullest extent permitted by Applicable Law in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the greatest extent possible.
9.4 This Agreement, including the attached schedules, shall be interpreted, construed, and enforced in accordance with the laws of the State of New York, without reference to any conflict of laws provisions thereof that would cause the application of laws of any jurisdiction other than those of the State of New York, and shall, to the extent applicable, be subject to the provisions of the 1933, 1934, and 1940 Acts, and the rules, regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the SEC may grant and the terms hereof shall be interpreted and construed in accordance therewith.
9.5 The parties to this Agreement acknowledge and agree that the Fund is a Maryland corporation, and that all liabilities of the Fund arising, directly or indirectly, under this Agreement, of any and every nature whatsoever, shall be satisfied solely out of the assets of the relevant Portfolio(s) of the Fund and that no Director, officer, agent or holder of Shares of the Fund shall be personally liable for any such liabilities.
9.6 Each party shall reasonably cooperate with each other party and all appropriate regulatory and self-regulatory authorities (including without limitation the SEC, FINRA and state insurance regulators) and shall permit such authorities reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.
9.7 The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, to which the parties hereto are entitled under Applicable Law.
9.8 The parties to this Agreement acknowledge and agree that this Agreement shall not be exclusive in any respect.
9.9 This Agreement shall be binding upon and shall inure to the benefit of the parties and their respective successors and permitted assigns; provided, however, that neither this Agreement nor any rights, privileges, duties or obligations of the parties may be assigned by a party without the written consent of the other parties. Any attempted assignment in violation of this Section 9.9 shall be null and void.
9.10 No provisions of this Agreement may be amended or modified in any manner except by a written agreement properly authorized and executed by all parties.
9.11 This Agreement, including all attachments hereto, constitutes the entire agreement between the parties with respect to the subject matter contained herein, and supersedes all prior or contemporaneous understandings and agreements, both written and oral, express or implied, with respect to such subject matter.
9.12 Nothing in this Agreement shall be construed to give any person or entity other than the parties hereto any legal or equitable claim, right or remedy. Rather, this Agreement is intended to be for the sole and exclusive benefit of the parties hereto.
9.13 If a party utilizes a designee or other agent in connection with this Agreement or any Related Agreement, it shall be liable for the acts/omissions of that person or entity to the same extent as if it itself had acted or failed to act.
9.14 THE PARTIES HEREBY IRREVOCABLY WAIVE ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
9.15 NOTWITHSTANDING ANYTHING IN THIS AGREEMENT TO THE CONTRARY, IN NO EVENT SHALL THE COMPANY, FUND PARTIES OR ANY OF THEIR RESPECTIVE AFFILIATES BE LIABLE TO THE OTHERS OR TO THIRD PARTIES FOR SPECIAL, CONSEQUENTIAL, INDIRECT, INCIDENTAL, EXEMPLARY OR PUNITIVE DAMAGES, INCLUDING, BUT NOT LIMITED TO, BUSINESS INTERRUPTION, LOSS OF BUSINESS REPUTATION OR OPPORTUNITY AND LOST PROFITS, WHETHER ARISING OUT OF OR RESULTING FROM BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER OR NOT SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
IN WITNESS WHEREOF, the parties have caused their duly authorized officers to execute this Fund Participation Agreement as of the Effective Date.
BLACKROCK VARIABLE SERIES FUNDS, INC. |
||
|
|
|
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
|
|
|
Date Executed: |
|
|
|
||
BLACKROCK VARIABLE SERIES FUNDS II, INC. |
||
|
||
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
|
|
|
Date Executed: |
|
|
|
||
BLACKROCK INVESTMENTS, LLC |
||
|
||
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
|
|
|
Date Executed: |
|
|
|
||
PROTECTIVE LIFE INSURANCE COMPANY |
||
|
||
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
|
|
|
Date Executed: |
|
|
Schedule A
Separate Accounts of the Company participating in Portfolios of BlackRock Variable Series Funds, Inc. and/or BlackRock Variable Series Funds II, Inc.
Protective COLI VUL Separate Account
Protective COLI PPVUL Separate Account
Schedule B
Portfolios and Share Classes of each Fund now or in the future offered to Separate Accounts of the Company, including, but not limited to:
BlackRock Variable Series Funds, Inc.
Portfolio Name |
|
Class |
|
CUSIP |
|
Ticker |
Equity Portfolios |
|
|
|
|
|
|
BlackRock Advantage Large Cap Core V.I. Fund |
|
I |
|
09253L611 |
|
LGCCI |
BlackRock Advantage Large Cap Core V.I. Fund |
|
II |
|
09253L595 |
|
LGCII |
BlackRock Advantage Large Cap Core V.I. Fund |
|
III |
|
09253L587 |
|
LCIII |
BlackRock Advantage Large Cap Value V.I. Fund |
|
I |
|
09253L546 |
|
LCATT |
BlackRock Advantage Large Cap Value V.I. Fund |
|
II |
|
09253L538 |
|
LCBTT |
BlackRock Advantage Large Cap Value V.I. Fund |
|
III |
|
09253L520 |
|
LVIII |
BlackRock Advantage U.S. Total Market V.I. Fund |
|
I |
|
09253L470 |
|
SMCPI |
BlackRock Advantage U.S. Total Market V.I. Fund |
|
II |
|
09253L462 |
|
SMCII |
BlackRock Advantage U.S. Total Market V.I. Fund |
|
III |
|
09253L454 |
|
SCIII |
BlackRock Basic Value V.I. Fund |
|
I |
|
09253L405 |
|
BAVLI |
BlackRock Basic Value V.I. Fund |
|
II |
|
09253L504 |
|
BAVII |
BlackRock Basic Value V.I. Fund |
|
III |
|
09253L603 |
|
BVIII |
BlackRock Capital Appreciation V.I. Fund |
|
I |
|
09253L843 |
|
FDGRI |
BlackRock Capital Appreciation V.I. Fund |
|
III |
|
09253L827 |
|
FGIII |
BlackRock Equity Dividend V.I. Fund |
|
I |
|
09253L512 |
|
UTTLI |
BlackRock Equity Dividend V.I. Fund |
|
III |
|
09253L488 |
|
UTIII |
BlackRock Global Allocation V.I. Fund |
|
I |
|
09253L777 |
|
GLALI |
BlackRock Global Allocation V.I. Fund |
|
II |
|
09253L769 |
|
GLAII |
BlackRock Global Allocation V.I. Fund |
|
III |
|
09253L751 |
|
GAIII |
BlackRock International V.I. Fund |
|
I |
|
09253L645 |
|
IVVVI |
BlackRock 60/40 Target Allocation ETF V.I. Fund |
|
I |
|
09253L371 |
|
BVDAX |
BlackRock 60/40 Target Allocation ETF V.I. Fund |
|
III |
|
09253L363 |
|
BDAVX |
BlackRock Large Cap Focus Growth V.I. Fund |
|
I |
|
09253L579 |
|
LGGGI |
BlackRock Large Cap Focus Growth V.I. Fund |
|
III |
|
09253L553 |
|
LGIII |
BlackRock Managed Volatility V.I. Fund |
|
I |
|
09253L108 |
|
AMBLI |
BlackRock Managed Volatility V.I. Fund |
|
III |
|
09253L306 |
|
ABIII |
|
|
|
|
|
|
|
Index Portfolios |
|
|
|
|
|
|
BlackRock International Index V.I. Fund |
|
I |
|
09253L355 |
|
BIIVX |
BlackRock S&P 500 Index V.I. Fund |
|
I |
|
09253L678 |
|
IDXVI |
BlackRock S&P 500 Index V.I. Fund |
|
II |
|
09253L660 |
|
IXVII |
BlackRock S&P 500 Index V.I. Fund |
|
III |
|
09253L652 |
|
IVIII |
BlackRock Small Cap Index V.I. Fund |
|
I |
|
09253L348 |
|
BSIVX |
|
|
|
|
|
|
|
Money Market Portfolios |
|
|
|
|
|
|
BlackRock Government Money Market V.I. Fund* |
|
I |
|
09253L876 |
|
DMMKI |
*No payments for administrative services will be made on this Portfolio.
BlackRock Variable Series Funds II, Inc. |
||||||
|
|
|
|
|
|
|
Portfolio Name |
|
Class |
|
CUSIP |
|
Ticker |
|
|
|
|
|
|
|
Fixed Income Portfolios |
|
|
|
|
|
|
BlackRock High Yield V.I. Fund |
|
I |
|
09258X107 |
|
HICUI |
BlackRock High Yield V.I. Fund |
|
III |
|
09258X206 |
|
HCIII |
BlackRock Total Return V.I. Fund |
|
I |
|
09258X305 |
|
CRBDI |
BlackRock Total Return V.I. Fund |
|
III |
|
09258X404 |
|
CBIII |
BlackRock U.S. Government Bond V.I. Fund |
|
I |
|
09258X503 |
|
GVBDI |
BlackRock U.S. Government Bond V.I. Fund |
|
III |
|
09258X602 |
|
GBIII |
Schedule C
Shareholder Information Schedule entered into by and between BlackRock Investments, LLC and its successors, assigns and designees (BRIL) and the Intermediary.
For Schedule C, the following terms shall have the following meanings, unless a different meaning is clearly required by the context:
The term Business Day shall have the meaning ascribed to it in the Fund Participation Agreement.
The term Intermediary shall mean Protective Life Insurance Company, which is (i) a broker, dealer, bank, or other entity that holds securities of record issued by the Fund in nominee name; (ii) in the case of a participant directed employee benefit plan that owns securities issued by the Fund (1) a retirement plan administrator under ERISA or (2) any entity that maintains the plans participant records; or (iii) an insurance company separate account.
The term Fund shall mean any open-ended management investment company that is registered or required to register under Section 8 of the Investment Company Act of 1940 and for which BRIL acts as distributor and includes (i) an investment adviser to or administrator for the Fund; and (ii) the transfer agent for the Fund. The term not does include any excepted funds as defined in SEC Rule 22c-2(b) under the Investment Company Act of 1940.(1)
The term Shares means the interests of Shareholders corresponding to the redeemable securities of record issued by the Fund under the Investment Company Act of 1940 that are held by the Intermediary.
The term Shareholder means the holder of interests in a variable annuity or variable life insurance contract issued by the Intermediary (Contract), or a participant in an employee benefit plan with a beneficial interest in a contract.
The term Shareholder-Initiated Transfer Purchase means a transaction that is initiated or directed by a Shareholder that results in a transfer of assets within a Contract to a Fund, but does not include the following: (i) transactions that are executed automatically pursuant to a contractual or systematic program or enrollment such as transfer of assets within a Contract to a Fund as a result of dollar cost averaging programs, insurance company approved asset allocation programs, or automatic rebalancing programs; (ii) transactions that are executed pursuant to a Contract death benefit; (iii) one-time step-up in Contract value pursuant to a Contract death benefit; (iv) allocation of assets to a Fund through a Contract as a result of payments such as loan repayments, scheduled contributions, retirement plan salary reduction contributions, or planned premium payments to the Contract; or (v) prearranged transfers at the conclusion of a required free look period.
The term Shareholder-Initiated Transfer Redemption means a transaction that is initiated or directed by a Shareholder that results in a transfer of assets within a Contract out of a Fund, but does not include transactions that are executed: (i) automatically pursuant to a contractual or systematic program or enrollments such as transfers of assets within a Contract out of a Fund as a result of annuity payouts, loans, systematic withdrawal programs, insurance company approved asset allocation programs and automatic rebalancing programs; (ii) as a result of any deduction of
(1) As defined in SEC Rule 22c-2(b), term excepted fund means any: (1) money market fund; (2) fund that issues securities that are listed on a national exchange; and (3) fund that affirmatively permits short-term trading of its securities, if its prospectus clearly and prominently discloses that the fund permits short-term trading of its securities and that such trading may result in additional costs for the fund.
charges or fees under a Contract; (iii) within a Contract out of a Fund as a result of scheduled withdrawals or surrenders from a Contract; or (iv) as a result of payment of a death benefit from a Contract.
BRIL and the Intermediary hereby agree as follows:
Shareholder Information
1. Agreement to Provide Information. Intermediary agrees to provide to the Fund or its designee, upon written request of BRIL or the Fund, the taxpayer identification number (TIN), the Individual/International Taxpayer Identification Number (ITIN), or other government issued identifier (GII) and the Contract Owner number or participant account number associated with the Shareholder, if known, of any or all Shareholder(s) of the account, and the amount, date, name or other identifier of any investment professional(s) associated with the Shareholder(s) or the account (if known) and transaction type (purchase, redemption, transfer, or exchange) of every purchase, redemption, transfer, or exchange of Shares held through an account maintained by the Intermediary during the period covered by the request. Unless otherwise specifically requested by the Fund, the Intermediary shall only be required to provide information relating to Shareholder-Initiated Transfer Purchases or Shareholder-Initiated Transfer Redemptions.
2. Period Covered by Request. Requests must set forth a specific period, which generally will not exceed 90 days from the date of the request, for which transaction information is sought. BRIL and/or the Fund may request transaction information older than 90 days from the date of the request as they deem necessary to investigate compliance with policies (including, but not limited to, policies of the Fund regarding market-timing and the frequent purchasing and redeeming or exchanging of Fund Shares or any other inappropriate trading activity) established or utilized by the Fund for the purpose of eliminating or reducing any dilution of the value of the outstanding Shares issued by the Fund.
3. Form and Timing of Response. (a) Intermediary agrees to provide promptly, but in any event not later than five (5) Business Days after receipt of a request from the Fund, BRIL or their designee, the requested information specified in Section 1. If requested by the Fund, BRIL or their designee, Intermediary agrees to use best efforts to determine promptly, but in any event not later than five (5) Business Days after receipt of a request, whether any specific person about whom it has received the identification and transaction information specified in Section 1 is itself a financial intermediary (as defined in Rule 22c-2) (indirect intermediary) and, upon further request of the Fund, BRIL or their designee, promptly, but in any event not later than five (5) Business Days after receipt of a request, shall either (i) provide (or arrange to have provided) the information set forth in Section 1 for those Shareholders who hold an account with an indirect intermediary or (ii) restrict or prohibit the indirect intermediary from purchasing, in nominee name on behalf of other persons, securities issued by the Fund. Intermediary additionally agrees to inform the Fund whether it plans to perform (i) or (ii).
(b) Responses required by this paragraph must be communicated in writing and in a format mutually agreed upon by the Fund, BRIL or their designee and the Intermediary; and
(c) To the extent practicable, the format for any transaction information provided to the Fund, BRIL or their designee will be consistent with the NSCC Standardized Data Reporting Format.
4. Agreement to Restrict Trading. Intermediary agrees to execute written instructions from BRIL or the Fund to restrict or prohibit further purchases or exchanges of Shares by a Shareholder that has
been identified by BRIL or the Fund, in their sole discretion, as having engaged in transactions of the Funds Shares (directly or indirectly through the Intermediarys account) that violate policies (including, but not limited to, policies of the Fund regarding market-timing and the frequent purchasing and redeeming or exchanging of Fund Shares or any other inappropriate trading activity) established or utilized by the Fund for the purpose of eliminating or reducing any dilution of the value of the outstanding Shares issued by the Fund. Unless otherwise directed by the Fund, any such restrictions or prohibitions shall only apply to Shareholder-Initiated Transfer Purchases or Shareholder-Initiated Transfer Redemptions that are effected directly or indirectly through Intermediary.
5. Form of Instructions. Instructions to restrict or prohibit trading must include the TIN, ITIN, or GII and the specific individual Contract Owner number or participant account number associated with the Shareholder, if known, and the specific restriction(s) to be executed, including how long the restriction(s) is(are) to remain in place. If the TIN, ITIN, GII or the specific individual Contract Owner number or participant account number associated with the Shareholder is not known, the instructions must include an equivalent identifying number of the Shareholder(s) or account(s) or other agreed upon information to which the instruction relates.
6. Timing of Response. Intermediary agrees to execute instructions to restrict or prohibit trading as soon as reasonably practicable, but not later than five (5) Business Days after receipt of the instructions by the Intermediary.
7. Confirmation by Intermediary. Intermediary must provide written confirmation to BRIL and the Fund that instructions to restrict or prohibit trading have been executed. Intermediary agrees to provide confirmation as soon as reasonably practicable, but not later than ten (10) Business Days after the instructions have been executed.
8. Construction of the Schedule; Fund Participation Agreement. This Schedule C supplements the Fund Participation Agreement. To the extent the terms of this Schedule C conflict with the terms of the Fund Participation Agreement, the terms of this Schedule C shall control.
9. Termination. This Schedule C will terminate upon the termination of the Fund Participation Agreement (except for obligations arising from trading activities that occurred prior to such termination and transactions in Shares by Existing Contracts pursuant to Section 7.7 of the Fund Participation Agreement).
AMENDED AND RESTATED FUND PARTICIPATION AGREEMENT
This Agreement is entered into as of the 1st day of February, 2015, between PROTECTIVE LIFE INSURANCE COMPANY, a life insurance company organized under the laws of the State of Tennessee (Insurance Company), on behalf of itself and on behalf of the separate accounts set forth on Exhibit A, and each Participating Fund (as defined below).
ARTICLE I
DEFINITIONS
1.1 1933 Act shall mean the Securities Act of 1933, as amended.
1.2 1940 Act shall mean the Investment Company Act of 1940, as amended.
1.3 Board shall mean the Board of Directors or Trustees, as the case may be, of a Participating Fund, which has the responsibility for management and control of the Participating Fund.
1.4 Business Day shall mean any day for which a Participating Fund calculates net asset value per Share (as defined below) as described in the Participating Funds Prospectus (as defined below).
1.5 Close of Trading shall mean the close of trading on the New York Stock Exchange (usually 4:00 p.m. Eastern time.)
1.6 Commission shall mean the Securities and Exchange Commission.
1.7 Contract shall mean a variable annuity or variable life insurance contract that uses any Participating Fund as an underlying investment medium. Individuals who participate under a group Contract are Participants.
1.8 Contractholder shall mean any entity that is a party to a Contract (including any Participants thereunder) with a Participating Company (as defined below).
1.9 Disinterested Board Members shall mean those members of the Board of a Participating Fund that are not deemed to be interested persons (as defined in the 1940 Act) of the Participating Fund.
1.10 Dreyfus shall mean The Dreyfus Corporation and its affiliates, including MBSC Securities Corporation (MBSC), the distributor of each Participating Fund.
1.11 FINRA shall mean the Financial Industry Regulatory Authority.
1.12 Insurance Companys General Account(s) shall mean the general account(s) of Insurance Company and its affiliates that invest in Shares of a Participating Fund.
1.13 Marketing Materials shall mean advertisements (such as material published, or designed for use, in a newspaper, magazine or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures or other public media), sales literature (such as any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, or reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available
to financial intermediaries or prospective investors in connection with distribution or servicing activities, and any other material constituting sales literature or advertising under FINRA rules, the 1940 Act or the 1933 Act.
1.14 Participating Companies shall mean any insurance company (including Insurance Company) that offers variable annuity and/or variable life insurance contracts to the public and that has entered into an agreement with one or more of the Participating Funds for the purpose of making Participating Fund Shares available to serve as the underlying investment medium for the aforesaid Contracts.
1.15 Participating Fund shall mean each investment company including, as applicable, any series thereof, specified in Exhibit B, as such Exhibit may be amended from time to time by agreement of the parties hereto, the Shares of which are available to serve as the underlying investment medium for the aforesaid Contracts.
1.16 Prospectus shall mean the currently effective prospectus and statement of additional information of a Participating Fund, relating to its Shares.
1.17 Separate Account shall mean a separate account duly established by Insurance Company and set forth on Exhibit A, as such Exhibit may be revised from time to time.
1.18 Shares shall mean (i) each class of shares of a Participating Fund set forth on Exhibit B next to the name of such Participating Fund, as such Exhibit may be revised from time to time, or (ii) if no class of shares is set forth on Exhibit B next to the name of such Participating Fund, the shares of the Participating Fund.
ARTICLE II
REPRESENTATIONS
2.1 Insurance Company represents and warrants that (a) it is an insurance company duly organized and in good standing under applicable law; (b) it has legally and validly established each Separate Account pursuant to applicable insurance laws and regulations; (c) it has, to the extent required under applicable law, registered each Separate Account as a unit investment trust under the 1940 Act to serve as the segregated investment account for its Contracts; and (d) each Separate Account is eligible to invest in Shares of each Participating Fund without such investment disqualifying any Participating Fund as an underlying investment medium for insurance company separate accounts supporting variable annuity contracts or variable life insurance contracts.
2.2 Insurance Company represents and warrants that (a) to the extent required under applicable law, its Contracts will be described in a registration statement filed under the 1933 Act; (b) its Contracts will be issued and sold in compliance in all material respects with all applicable federal and state laws; and (c) the sale of its Contracts shall comply in all material respects with applicable state insurance law requirements. Insurance Company agrees to notify each Participating Fund promptly of any investment restrictions imposed by state insurance law and applicable to the Participating Fund.
2.3 Insurance Company represents and warrants that the income, gains and losses, whether or not realized, from assets allocated to the Separate Account are, in accordance with the applicable Contracts, to be credited to or charged against such Separate Account without regard to other income, gains or losses from assets allocated to any other accounts of Insurance Company. Insurance Company represents and warrants that the assets of the Separate Account are and will
be kept separate from Insurance Companys General Account(s) and any other separate accounts Insurance Company may have, and will not be charged with liabilities from any business that Insurance Company may conduct or the liabilities of any companies affiliated with Insurance Company.
2.4 To the extent that Insurance Company is a broker-dealer or is otherwise subject to the rules of FINRA:
a. Insurance Company shall inform MBSC promptly of any pending or threatened action or proceeding by FINRA bearing on Insurance Companys membership with FINRA and of any suspension or termination of such membership. Insurance Company further agrees to maintain all records required by applicable laws or that are otherwise reasonably requested by MBSC in the event Insurance Companys status as a member of FINRA or the Securities Investor Protection Corporation changes. Insurance Company recognizes that it will be treated as a non-member of the Association, as defined by FINRA rules, during the period of any suspension of Insurance Companys membership in FINRA. Accordingly, no payments required by FINRA regulations to be paid solely to a registered broker or dealer shall be paid by MBSC while Insurance Company is suspended from FINRA.
b. To the extent that Insurance Company makes a recommendation to Contractholders regarding a transaction in Shares, Insurance Company agrees that it is its responsibility to fulfill its obligations under FINRA rules and to determine the suitability of any Shares as investments for Contractholders, and that MBSC has no responsibility for such determination.
2.5 Insurance Company understands and acknowledges that the Participating Funds may offer Shares in multiple classes, and Insurance Company represents and warrants that, to the extent Insurance Company is recommending transactions in Shares, it has established compliance procedures designed to ensure that, in offering more than one Share class of Participating Funds to Contractholders, Contractholders are made aware of the terms of each class of Shares offered, to ensure that its representatives recommend only Shares that are appropriate investments for each Contractholder and to ensure proper supervision of Insurance Companys representatives in recommending and offering different classes of Participating Fund Shares to Contractholders.
2.6 Pursuant to Regulation S-P promulgated by the Commission under the Gramm-Leach-Bliley Act (Reg. S-P), Insurance Company agrees to deliver the Participating Funds then current consumer privacy notice to any Contractholder who purchases Shares from or through Insurance Company, at or prior to the time of the initial purchase, if the Contractholder would be considered a consumer or customer (each as defined in Reg. S-P) of the Participating Funds.
2.7 Each Participating Fund represents that it is registered with the Commission under the 1940 Act as an open-end, management investment company and possesses, and shall maintain, all legal and regulatory licenses, approvals, consents and/or exemptions required for the Participating Fund to operate and offer its Shares as an underlying investment medium for Participating Companies.
2.8 Each Participating Fund represents that it is currently or will be qualified as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the Code), and that it will make every effort to maintain such qualification (under Subchapter M or any successor or similar provision) and that it will notify Insurance Company promptly upon
having a reasonable basis for believing that it has ceased to so qualify or that it might not so qualify in the future.
2.9 Insurance Company represents and agrees that the Contracts are currently, and at the time of issuance will be, treated as life insurance policies or annuity contracts, whichever is appropriate, under applicable provisions of the Code, and that it will make every effort to maintain such treatment and that it will notify each Participating Fund and Dreyfus immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future. Insurance Company agrees that any prospectus offering a Contract that is a modified endowment contract, as that term is defined in Section 7702A of the Code, will identify such Contract as a modified endowment contract (or policy).
2.10 Each Participating Fund represents that it will maintain its assets such that, at the close of each calendar quarter (or within 30 days thereafter), it will be adequately diversified within the naming of Section 817(h) of the Code and Treasury Regulation 1.817-5.
2.11 Insurance Company agrees that each Participating Fund shall be permitted (subject to the other terms of this Agreement) to make its Shares available to other Participating Companies and Contractholders.
2.12 Each Participating Fund represents and warrants that any of its officers and employees who deal with the money and/or securities of the Participating Fund are and shall continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Participating Fund in an amount not less than that required by Rule 17g-1 under the 1940 Act. The aforesaid bond shall include coverage for larceny and embezzlement and shall be issued by a reputable fidelity insurance company.
2.13 Insurance Company represents and warrants that all of its employees and agents who deal with the money and/or securities of each Participating Fund are and shall continue to be at all times covered by a blanket fidelity bond or similar coverage in an amount not less than the coverage required to be maintained by the Participating Fund. The aforesaid bond shall include coverage for larceny and embezzlement and shall be issued by a reputable fidelity insurance company.
2.14 Insurance Company represents and warrants that it has reviewed each Participating Funds policy regarding market timing and frequent trading of shares, and none of its Contractholders is or will be permitted to engage in trading activity which would violate such policy.
2.15 Insurance Company represents and warrants that, to the extent required by applicable law, it has adopted policies and procedures to comply with all applicable anti-money laundering, customer identification, suspicious activity, currency transaction reporting and similar laws and regulations including the Bank Secrecy Act, as amended by the USA PATRIOT Act, and the regulations thereunder, and FINRA rules governing its members, if applicable. Insurance Company also represents and warrants that it will not purchase or sell Shares on behalf of any person on the list of Specially Designated Nationals and Blocked Persons maintained by the Office of Foreign Assets Control (OFAC), or other similar governmental lists, or in contravention of any OFAC maintained sanctions program. Insurance Company agrees to share information with each Participating Fund for purposes of ascertaining whether a suspicious activity report (SAR) is warranted with respect to any suspicious transaction involving Shares, provided that neither Insurance Company nor the Participating Fund is the subject of the SAR. Insurance Company, if required to maintain an anti-money laundering program, also represents and warrants that it has
filed the requisite certification with the Financial Crimes Enforcement Network to allow Insurance Company to share information pursuant to Section 314(b) of the USA PATRIOT Act.
ARTICLE III
PARTICIPATING FUND SHARES
3.1 The Contracts funded through the Separate Account will provide for the investment of certain amounts in Shares of each Participating Fund.
3.2 Each Participating Fund agrees to make its Shares available for purchase at the then applicable net asset value per Share by Insurance Company and the Separate Accounts on each Business Day pursuant to rules of the Commission. Notwithstanding the foregoing, each Participating Fund may refuse to sell its Shares to any person, or suspend or terminate the offering of its Shares.
3.3 Each Participating Fund agrees that Shares of the Participating Fund will be sold only to (a) Participating Companies and their separate accounts or (b) qualified pension or retirement plans as determined under Section 817(h)(4) of the Code. Except as otherwise set forth in this Section 3.3, no shares of any Participating Fund will be sold to the general public.
3.4 Each Participating Fund shall use its best efforts to provide closing net asset value, dividend and capital gain information on a per Share basis to Insurance Company by 6:00 p.m. Eastern time on each Business Day. Any material errors in the calculation of net asset value, dividend and capital gain information shall be reported immediately upon discovery to Insurance Company. Non-material errors will be corrected in the next Business Days net asset value per Share.
3.5 At the end of each Business Day, Insurance Company will use the information described in Section 3.4 to calculate the unit values of the Separate Accounts for the day. Using this unit value, Insurance Company will process the days Separate Account transactions received by it by the Close of Trading to determine the net dollar amount of the Shares of each Participating Fund that will be purchased or redeemed at that days closing net asset value per Share. The net purchase or redemption orders will be transmitted to each Participating Fund by Insurance Company by 11:00 a.m. Eastern time on the Business Day next following Insurance Companys receipt of the corresponding Separate Account transactions. Subject to Sections 3.6 and 3.8, all purchase and redemption orders for Insurance Companys General Account(s) shall be effected at the net asset value per Share of each Participating Fund next calculated after receipt of the order by the Participating Fund or its transfer agent.
3.6 Each Participating Fund appoints Insurance Company as its agent for the limited purpose of accepting orders for the purchase and redemption of Shares of the Participating Fund for the Separate Account. Each Participating Fund will execute orders at the applicable net asset value per Share determined as of the Close of Trading on the day of receipt of such orders by Insurance Company acting as agent (effective trade date), provided that the Participating Fund receives notice of such orders by 11:00 a.m. Eastern time on the next following Business Day and, if such orders request the purchase of Shares of the Participating Fund, the conditions specified in Section 3.8, as applicable, are satisfied. A redemption or purchase request that does not satisfy the conditions specified above and in Section 3.8, as applicable, will be effected at the net asset value per Share computed on the Business Day immediately preceding the next following Business Day upon which such conditions have been satisfied in accordance with the requirements of this Section and Section 3.8. Insurance Company represents and warrants that all orders submitted by Insurance Company for execution as of the effective trade date shall
represent purchase or redemption orders received from its Contractholders prior to the Close of Trading on the effective trade date.
3.7 Insurance Company will make its best efforts to notify each applicable Participating Fund in advance of any unusually large purchase or redemption orders.
3.8 If Insurance Companys order requests the purchase of Shares of a Participating Fund, Insurance Company will pay for such purchases by wiring Federal Funds to the Participating Fund or its designated custodial account on the day the order is transmitted. Insurance Company shall make all reasonable efforts to transmit to the applicable Participating Fund payment in Federal Funds by 12:00 noon Eastern time on the Business Day the Participating Fund receives the notice of the order pursuant to Section 3.6. Each applicable Participating Fund will execute such orders at the applicable net asset value per Share determined as of the Close of Trading as of the effective trade date if the Participating Fund receives payment in Federal Funds by 12:00 midnight Eastern time at the end of the Business Day the Participating Fund receives the notice of the order pursuant to Section 3.6. If payment in Federal Funds for any purchase is not received or is received by a Participating Fund after 12:00 noon Eastern time at the end of such Business Day, Insurance Company shall promptly, upon the Participating Funds request, reimburse the Participating Fund for any charges, costs, fees, interest or other expenses incurred by the Participating Fund in connection with any advances to, or borrowings or overdrafts by, the Participating Fund, or any similar expenses incurred by the Participating Fund, as a result of portfolio transactions effected by the Participating Fund based upon such purchase request. If Insurance Companys order requests the redemption of any Shares of a Participating Fund valued at or greater than $1 million dollars, the Participating Fund will wire such amount to Insurance Company within seven days of the order.
3.9 Insurance Company represents that it has adopted, and will at all times during the term of the Agreement maintain, reasonable and appropriate procedures designed to ensure that any and all orders to purchase, redeem, transfer or exchange Shares received by Insurance Company from Contractholders treated as received prior to the Close of Trading on each Business Day are received by Insurance Company prior to the Close of Trading on such Business Day, and are not modified after the Close of Trading, and that all such orders received, but not rescinded, by the Close of Trading are communicated to MBSC or its designee for that Business Day. Each transmission of Share orders by Insurance Company shall constitute a representation that such orders are accurate and complete and are as received by Insurance Company by the Close of Trading on the Business Day for which the orders are to be priced, and that such transmission includes all Share orders received from Contractholders, but not rescinded, by the Close of Trading.
3.10 Each Participating Fund has the obligation to ensure that its Shares are registered with the Commission at all times.
3.11 Each Participating Fund will confirm each purchase or redemption order made by Insurance Company. Transfers of Shares of a Participating Fund will be by book entry only. No share certificates will be issued to Insurance Company. Insurance Company will record Shares ordered from a Participating Fund in an appropriate title for the corresponding account.
3.12 Each Participating Fund shall credit Insurance Company with the appropriate number of Shares.
3.13 On each ex-dividend date of a Participating Fund or, if not a Business Day, on the first Business Day thereafter, each Participating Fund shall communicate to Insurance Company the amount of
dividend and capital gain, if any, per Share. All dividends and capital gains shall be automatically reinvested in additional Shares of the applicable Participating Fund at the net asset value per Share on the ex-dividend date. Each Participating Fund shall, on the day after the ex-dividend date or, if not a Business Day, on the first Business Day thereafter, notify Insurance Company of the number of Shares so issued.
3.14 To the extent that a Separate Account is properly exempt from registration under the 1940 Act, at least once annually, at the request of a Participating Fund, or its designee, Insurance Company will certify the amount of purchases and redemptions of Shares from such Separate Account for the Participating Funds most recent fiscal year end.
3.15 Neither Insurance Company nor any of its agents or assigns shall sell, market, or offer Shares of any Participating Fund in a manner that would require such Shares to be registered in a foreign country or foreign jurisdiction.
ARTICLE IV
STATEMENTS AND REPORTS
4.1 Each Participating Fund shall provide monthly statements of account as of the end of each month for all of Insurance Companys Participating Fund accounts by the fifteenth (15th) Business Day of the following month.
4.2 Each Participating Fund shall distribute to Insurance Company copies of the Participating Funds Prospectus and supplements thereto, proxy materials, notices, financial reports and other printed materials (which the Participating Fund customarily provides to the holders of its Shares) in quantities as Insurance Company may reasonably request for distribution to each of its Contractholders. Insurance Company may elect to print the Participating Funds Prospectus in combination with other fund companies prospectuses and statements of additional information, which are also offered in Insurance Companys insurance product at its own cost. At Insurance Companys request, the Participating Fund will provide, in lieu of printed documents, Prospectuses and financial reports in electronic form for printing by Insurance Company.
4.3 Each Participating Fund will provide to Insurance Company at least one complete copy of all registration statements, Prospectuses, financial reports, proxy statements, applications for exemptions and requests for no-action letters, and all amendments to any of the above, that relate to the Participating Fund or its Shares (except for such materials that are designed only for a class of shares of a Participating Fund not offered to Insurance Company pursuant to this Agreement).
4.4 MBSC agrees to make available to Insurance Company a list of the states or other jurisdictions in which Shares are registered for sale or are otherwise qualified for sale, which may be revised from time to time. Insurance Company will make offers of Shares to Contractholders only in those states, and will ensure that Insurance Company (including its associated persons) is appropriately licensed and qualified to offer and sell Shares in any state or other jurisdiction that requires such licensing or qualification in connection with Insurance Companys activities.
4.5 Insurance Company will provide to each Participating Fund at least one copy of all registration statements, prospectuses, financial reports, proxy statements, applications for exemptions and requests for no-action letters, and all amendments to any of the above, that relate to its Contracts or the Separate Account.
4.6 Insurance Company will provide Participating Funds on a semi-annual basis, or more frequently as reasonably requested by the Participating Funds, with a current tabulation of the number of its existing Contractholders whose Contract values are invested in each Participating Fund. This tabulation will be sent to Participating Funds in the form of a letter signed by a duly authorized officer of Insurance Company attesting to the accuracy of the information contained in the letter.
ARTICLE V
SHAREHOLDER INFORMATION AND IMPOSITION OF TRADING RESTRICTIONS
5.1 Insurance Company agrees to provide promptly, but not later than ten Business Days, to the Participating Fund, upon Written request, the taxpayer identification number (TIN), the Individual/International Taxpayer Identification Number (ITIN) or other government-issued identifier (GII), if known, of any or all Contractholder(s) and the amount, date, name or other identifier of any investment professional(s) associated with the Contractholder(s) or the Separate Account (if known), and transaction type (purchase, redemption, transfer or exchange) of every Shareholder-Initiated Transaction in Shares. To the extent practicable, the format for any Shareholder-Initiated Transaction information provided to the Participating Fund should be consistent with the National Securities Clearing Corporation Standardized Data Reporting Format.
5.2 Requests must set forth a specific period, not to exceed ninety days from the date of the request, for which Shareholder-Initiated Transaction information is sought. The Participating Fund may request Shareholder-Initiated Transaction data older than ninety days from the date of the request as it deems necessary to investigate compliance with policies established by the Participating Fund for the purpose of eliminating or reducing dilution to the value of the outstanding Shares issued by the Participating Fund.
5.3 Insurance Company agrees to use best efforts to determine, promptly upon request of the Participating Fund, but not later than ten days, whether any person that holds Shares through Insurance Company or its Separate Account is an indirect intermediary as defined in Rule 22c-2 under the 1940 Act (an Indirect Intermediary), and upon further request of the Participating Fund, (i) provide or arrange to have provided the information set forth in Section 5.1 of this Article V regarding Contractholders who hold an account with an Indirect Intermediary; or (ii) restrict or prohibit the Indirect Intermediary from purchasing Shares on behalf of itself or other persons. Insurance Company agrees to inform the Participating Fund whether Insurance Company plans to perform (i) or (ii).
5.4 MBSC agrees not to use the Shareholder-Initiated Transaction information received under this Article V for marketing or any other similar purpose without the prior Written consent of Insurance Company.
5.5 Insurance Company agrees to execute Written instructions from the Participating Fund to restrict or prohibit further Shareholder-Initiated Transactions by a Contractholder who has been identified by the Participating Fund as having engaged in transactions of Shares (directly or indirectly through a Separate Account) that violate the policies established by the Participating Fund for the purpose of eliminating or reducing any dilution of the value of its Shares.
5.6 Instructions provided to Insurance Company will include the TIN, ITIN or GII, if known, and the specific restriction(s) to be executed. If the TIN, ITIN or GII is not known, the instructions will include an equivalent identifying number of the Contractholder(s) or account(s) or other agreed-upon information to which the instructions relate.
5.7 Insurance Company must provide Written confirmation to the Participating Fund that instructions have been executed. Insurance Company agrees to provide the confirmation as soon as reasonably practicable, but not later than ten Business Days after the instructions have been executed.
5.8 For purposes of this Article V only,
a. Written communications include electronic communications and facsimile transmissions; and
b. Participating Fund does not include any excepted funds as defined in Rule 22c-2(b) under the 1940 Act; and
c. Contractholder shall include, as applicable, (i) the beneficial owner of Shares, whether the Shares are held directly by Contractholder or by Insurance Company in nominee name; (ii) a Separate Account unit holder, notwithstanding that the Separate Account may be deemed to be the beneficial owner of Shares; or (iii) the holder of interests in a Participating Fund underlying a variable annuity or variable life insurance contract.
d. Shareholder-Initiated Transaction means a transaction that is initiated or directed by a Contractholder that results in a transfer of assets within a Contract into or out of a Participating Fund, but does not include transactions that are executed: (i) automatically pursuant to a contractual or systematic program or enrollments such as transfer of assets within a Contract to a Fund as a result of dollar cost averaging programs, insurance company approved asset allocation programs, or automatic rebalancing programs; (ii) pursuant to a Contract death benefit; (iii) pursuant to a Contract death benefit as a one-time step-up in Contract value; (iv) to allocate assets to a Fund through a Contract as a result of payments such as loan repayments, scheduled contributions, retirement plan salary reduction contributions, or planned premium payments to the Contract; (v) as pre-arranged transfers at the conclusion of a required free look period; (vi) automatically pursuant to a contractual or systematic program or enrollments such as transfer of assets within a Contract out of a Participating Fund as a result of annuity payouts, loans, systematic withdrawal programs, insurance company approved asset allocation programs and automatic rebalancing programs; (vii) as a result of any deduction or charge or fees under a Contract; (iii) within a Contract out of a Participating Fund as a result of scheduled withdrawals or surrenders from a Contract; or (viii) as a result of payment of a death benefit from a Contract.
ARTICLE VI
EXPENSES
6.1 The charge to each Participating Fund for all expenses and costs of the Participating Fund including, but not limited to, management fees, Rule 12b-1 fees, if any, administrative expenses and legal and regulatory costs, will be included in the determination of the Participating Funds daily net asset value per Share.
6.2 Except as otherwise provided in this Agreement and, in particular in the next sentence, Insurance Company shall not be required to pay directly any expenses of any Participating Fund or expenses relating to the distribution of its Shares. Insurance Company shall pay the following expenses or costs:
a. such amount of the production expenses of any Participating Fund materials, including the cost of printing a Participating Funds Prospectus or financial reports, or Marketing Materials for prospective Insurance Company Contractholders as Dreyfus and Insurance Company shall agree from time to time; and
b. distribution expenses of any Participating Fund materials or Marketing Materials for Insurance Company Contractholders or prospective Insurance Company Contractholders.
MBSC may pay Insurance Company, or the broker-dealer acting as principal underwriter for Insurance Companys Contracts, for distribution and other services related to the Shares of the Participating Fund pursuant to any distribution plan adopted by the Participating Fund in accordance with Rule 12b-1 under the 1940 Act, subject to the terms and conditions of an agreement between MBSC and Insurance Company or the principal underwriter for Insurance Companys Contracts, as applicable, related to such plan.
ARTICLE VII
EXEMPTIVE RELIEF
7.1 Insurance Company has reviewed a copy of the Order of the Commission under Section 6(c) of the 1940 Act, dated February 5, 1998, applicable to the Participating Funds (the Order) and, in particular, has reviewed the conditions to the relief set forth in the Notice of Application for the Order (the Conditions). As set forth therein, Insurance Company agrees, as applicable, to report any potential or existing conflicts promptly to the Board, including whenever contract voting instructions are disregarded, and recognizes that it will be responsible for assisting the Board in carrying out its responsibilities under the Conditions by providing the Board with all information reasonably necessary for the Board to consider any issues raised. Insurance Company agrees to carry out such responsibilities with a view only to the interests of Contractholders.
7.2 If a majority of the Board, or a majority of Disinterested Board Members, determines that a material irreconcilable conflict exists with regard to Contractholder investments in a Participating Fund, the Board shall give prompt notice of the material irreconcilable conflict and its implications to all Participating Companies and any other Participating Fund. If the Board determines that Insurance Company is a Participating Company for which such conflict is relevant, Insurance Company shall, at its expense and to the extent reasonably practicable (as determined by a majority of the Disinterested Board Members), take whatever steps are necessary to eliminate the irreconcilable material conflict, including:
a. withdrawing the assets allocable to some or all of the Separate Accounts (as applicable) from the Participating Fund and reinvesting such assets in another Participating Fund (if applicable) or a different investment medium, or submitting the question of whether such segregation should be implemented to a vote of all affected Contractholders and, as appropriate, segregating the assets of any appropriate group (e.g., variable annuity Contractholders or variable life insurance Contractholders of the Insurance Company) that votes in favor or such segregation, or offering to the affected Contractholders the option of making such a change; and
b. establishing a new registered management investment company or managed separate account.
The foregoing responsibility of Insurance Company will be carried out with a view only to the interest of Contractholders.
7.3 If a material irreconcilable conflict arises as a result of a decision by Insurance Company to disregard Contractholder voting instructions and such decision represents a minority position or would preclude a majority vote by all Contractholders having an interest in a Participating Fund, Insurance Company may be required, at the Participating Funds election, to withdraw the investments of the Separate Account in the Participating Fund, without any charge or penalty as a result of such withdrawal.
7.4 For the purpose of this Article VII, a majority of the Disinterested Board Members shall determine whether or not any proposed action adequately remedies any irreconcilable material conflict, but in no event will any Participating Fund or Dreyfus be required to establish, or to bear the costs of establishing, a new funding medium for any Contract. Insurance Company shall not be required by this Article VII to establish a new funding medium for any Contract if an offer to do so has been declined by vote of a majority of the Contractholders materially and adversely affected by the irreconcilable material conflict.
7.5 No action by Insurance Company taken or omitted, and no action by the Separate Account or any Participating Fund taken or omitted as a result of any act or failure to act by Insurance Company pursuant to this Article VII, shall relieve Insurance Company of its obligations under, or otherwise affect the operation of, Article VI.
7.6 If and to the extent Rule 6e-2 and Rule 6e-3(T) under the 1940 Act are amended, or if Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules thereunder with respect to mixed and shared funding on terms and conditions materially different from any exemptions granted in the Order, then the Participating Funds, and/or the Insurance Company, as appropriate, shall take such steps as may be necessary to comply with Rule 6e-2 and Rule 6e- 3(T), as amended, and Rule 6e-3, as adopted, to the extent such rules are applicable.
7.7 Insurance Company shall at least annually (or more frequently if deemed by appropriate by the Board) submit to the Board of each Participating Fund such reports, materials or data as a Board may reasonably request so that the Board may fully carry out obligations imposed upon it by the Conditions.
ARTICLE VIII
VOTING SHARES OF PARTICIPATING FUND
8.1 Insurance Company shall:
a. solicit voting instructions from its Contractholders on a timely basis and in accordance with applicable law; and
b. vote the Shares of the Participating Funds in accordance with instructions received from its Contractholders; and
c. vote the Shares of the Participating Funds for which no instructions have been received in the same proportion as Shares of the Participating Fund for which instructions have been received.
Insurance Company agrees at all times to vote Shares held by Insurance Companys General Account(s) in the same proportion as Shares of the Participating Fund for which instructions have been received from Insurance Companys Contractholders. Insurance Company further agrees to be responsible for assuring that voting privileges of the Shares for the Separate Account are calculated in a manner consistent with other Participating Companies.
8.2 Insurance Company agrees that it shall not, without the prior written consent of each applicable Participating Fund and Dreyfus, solicit, induce or encourage Contractholders to (a) change or supplement the Participating Funds current investment adviser or (b) change, modify, substitute, add to or delete from the current investment media for the Contracts.
ARTICLE IX
MARKETING AND REPRESENTATIONS
9.1 Each Participating Fund or MBSC shall periodically furnish Insurance Company with the following documents relating to the Shares of the Participating Fund, in quantities as Insurance Company may reasonably request:
a. current Prospectus and any supplements thereto; and
b. Marketing Materials.
Expenses for the production of such documents shall be borne by Insurance Company in accordance with Section 6.2 of this Agreement.
9.2 Insurance Company shall designate certain persons or entities that shall have the requisite licenses to solicit applications for the sale of Contracts. No representation is made as to the number or amount of Contracts that are to be sold by Insurance Company. Insurance Company shall make reasonable efforts to market the Contracts and shall comply with all applicable federal and state laws in connection therewith.
9.3 Insurance Company shall furnish, or shall cause to be furnished, to each applicable Participating Fund or its designee, each piece of Marketing Materials in which the Participating Fund, its investment adviser or the administrator, or Dreyfus is named, at least fifteen Business Days prior to its use. No such Marketing Materials shall be used unless the Participating Fund or its designee approves such Marketing Materials. Such approval (if given) must be in writing and shall be presumed not given if not received within ten Business Days after receipt of such Marketing Materials. Each applicable Participating Fund or its designee, as the case may be, shall use all reasonable efforts to respond within ten days of receipt.
9.4 Insurance Company shall not give any information or make any representations or statements on behalf of a Participating Fund or concerning a Participating Fund in connection with the sale of the Contracts other than the information or representations contained in the registration statement or Prospectus of, as may be amended or supplemented from time to time, or in reports or proxy statements for, the applicable Participating Fund, or in Marketing Materials approved by the applicable Participating Fund in accordance with Section 9.3.
9.5 Each Participating Fund shall furnish, or shall cause to be furnished, to Insurance Company, each piece of the Participating Funds Marketing Materials in which Insurance Company or the Separate Account is named, at least fifteen Business Days prior to its use. No such Marketing Materials shall be used unless Insurance Company approves such Marketing Materials. Such
approval (if given) must be in writing and shall be presumed not given if not received within ten Business Days after receipt of such Marketing Materials. Insurance Company shall use all reasonable efforts to respond within ten days of receipt.
9.6 No Participating Fund shall, in connection with the sale of Shares of the Participating Fund, give any information or make any representations on behalf of Insurance Company or concerning Insurance Company, the Separate Account, or the Contracts other than the information or representations contained in a registration statement or prospectus for the Contracts, as may be amended or supplemented from time to time, or in published reports for the Separate Account that are in the public domain or approved by Insurance Company for distribution to Contractholders or Participants, or in Marketing Materials approved by Insurance Company in accordance with Section 9.5.
ARTICLE X
INDEMNIFICATION
10.1 Insurance Company agrees to indemnify and hold harmless each Participating Fund, Dreyfus, each Participating Funds investment adviser and sub-investment adviser (if applicable), each Participating Funds distributor, and their respective affiliates, and each of their directors, trustees, officers, employees, agents and each person, if any, who controls or is associated with any of the foregoing entities or persons within the meaning of the 1933 Act (collectively, Fund Indemnified Parties), against any and all losses, claims, damages or liabilities, joint or several (including any investigative, legal and other expenses reasonably incurred in connection with, and any amounts paid in settlement of, any action, suit or proceeding or any claim asserted and any taxes, penalties or toll charges) (collectively, Fund Party Loss) for which any such Fund Indemnified Party may become subject, under the 1933 Act, the 1940 Act or otherwise, insofar as such Fund Party Loss (or actions in respect thereof) arise out of or are based upon: (a) any untrue statement or alleged untrue statement of any material fact (i) contained in information furnished by Insurance Company for use in the registration statement or Marketing Materials of a Participating Fund or (ii) with respect to the Separate Accounts or Contracts, or the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading; (b) any conduct, statement or representation (other than statements or representations contained in the Prospectus or Marketing Materials of the Participating Fund not made in reliance upon and in conformity with information furnished to the Participating Fund or Dreyfus by on behalf of Insurance Company specifically for use therein) of Insurance Company or its agents, with respect to the sale and distribution of Contracts for which the Shares of the Participating Fund are an underlying investment; (c) wrongful conduct of Insurance Company or persons under its control with respect to the sale or distribution of the Contracts or the Shares of the Participating Fund, including any sale of Shares in a foreign country or jurisdiction that would cause the Participating Funds to have to be registered in such country or jurisdiction; (d) any incorrect calculation and/or untimely reporting by Insurance Company of net purchase or redemption orders; (e) any material breach by Insurance Company of any representation, warranty and/or covenant made by Insurance Company in this Agreement or any other material breach of this Agreement by Insurance Company; or (f) any tax liability under Section 851 of the Code arising from purchases or redemptions by Insurance Companys General Account(s) or the accounts of Insurance Companys affiliates; provided, however, that with respect to clause (a) Insurance Company will not be liable in any such case to the extent that any such Fund Party Loss arises out of or is based upon any untrue statement or omission or alleged omission made in such registration statement or Marketing Materials in conformity with written information furnished to Insurance Company by the Participating Fund specifically for use
therein. This indemnity agreement will be in addition to any liability which Insurance Company may otherwise have.
10.2 Dreyfus agrees to indemnify and hold harmless Insurance Company and each of its directors, officers, employees, agents and each person, if any, who controls Insurance Company within the meaning of the 1933 Act (collectively, Insurance Company Indemnified Parties), against any losses, claims, damages or liabilities, joint or several (including any investigative, legal and other expenses reasonably incurred in connection with, and any amounts paid in settlement of, any action, suit or proceeding or any claim asserted and any taxes, penalties or toll charges) (collectively, Insurance Company Party Loss) to which any such Insurance Company Indemnified Party may become subject, under the 1933 Act or otherwise, insofar as such Insurance Company Indemnified Loss (or actions in respect thereof) arise out of or are based upon: (a) any untrue statement or alleged untrue statement of any material fact contained in the registration statement or Marketing Materials of a Participating Fund, (b) any omission to state in the registration statement or Marketing Materials of the Participating Fund any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading; or (c) any untrue statement or alleged untrue statement of any material fact contained in the registration statement or Marketing Materials with respect to the Separate Account or the Contracts and such statements were based on information provided to Insurance Company by the Participating Fund or Dreyfus; provided, however, that neither Dreyfus nor any Participating Fund will be liable in any such case to the extent that any Insurance Company Party Loss arises out of or is based upon an untrue statement or omission or alleged omission made in such registration statement or Marketing Materials in conformity with written information furnished to the Participating Fund by Insurance Company specifically for use therein. This indemnity agreement will be in addition to any liability which Dreyfus may otherwise have.
10.3 Each Participating Fund severally shall indemnify and hold Insurance Company harmless against any and all losses, claims, damages, liabilities or expenses which Insurance Company may incur, suffer or be required to pay due to the Participating Funds (i) incorrect calculation of the daily net asset value, dividend rate or capital gain distribution rate; or (ii) incorrect or untimely reporting of the daily net asset value, dividend rate or capital gain distribution rate; provided, that the Participating Fund shall have no obligation to indemnify and hold harmless Insurance Company if the incorrect calculation or incorrect or untimely reporting was the result of incorrect information furnished by Insurance Company or information furnished untimely by Insurance Company or otherwise as a result of or relating to a breach of this Agreement by Insurance Company. In no event shall Dreyfus or any Participating Fund be liable for any consequential, incidental, special or indirect damages resulting to an Insurance Company Indemnified Party hereunder.
10.4 Promptly after receipt by a party that may be entitled to indemnification under this Article X (Indemnified Party) of notice of the commencement of any action which may result in Fund Party Loss or Insurance Company Party Loss or losses, claims, damages, liabilities or expenses covered under Section 10.3, such Indemnified Party will, if a claim in respect thereof is to be made against the indemnifying party under this Article X (Indemnifying Party), notify the Indemnifying Party of the commencement thereof. The omission to so notify the Indemnifying Party will not relieve the Indemnifying Party from any liability under this Article X, except to the extent that the omission results in a failure of actual notice to the Indemnifying Party and such Indemnifying Party is damaged solely as a result of the omission to give such notice. In case any such action is brought against any Indemnified Party, and it notified the Indemnifying Party of the commencement thereof, the Indemnifying Party will be entitled to participate therein and, to the
extent that it may wish, assume the defense thereof, with counsel satisfactory to such Indemnified Party, and to the extent that the Indemnifying Party has given notice to such effect to the Indemnified Party and is performing its obligations under this Article X, the Indemnifying Party shall not be liable for any legal or other expenses subsequently incurred by such Indemnified Party in connection with the defense thereof, other than reasonable costs of investigation. Notwithstanding the foregoing, in any such proceeding, any Indemnified Party shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party unless (i) the Indemnifying Party and the Indemnified Party shall have mutually agreed to the retention of such counsel or (ii) the named parties to any such proceeding (including any impleaded parties) include both the Indemnifying Party and the Indemnified Party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. The Indemnifying Party shall not be liable for any settlement of any proceeding effected without its written consent.
10.5 The indemnity agreements contained in this Article X shall not protect any indemnified party against liability to which such party would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such partys office, as the case may be.
10.6 A successor by law of the parties to this Agreement shall be entitled to the benefits of the indemnification contained in this Article X.
ARTICLE XI
COMMENCEMENT AND TERMINATION
11.1 This Agreement shall be effective as of the date hereof and shall continue in force until terminated in accordance with the provisions herein.
11.2 This Agreement shall terminate without penalty:
a. as to any Participating Fund, at the option of Insurance Company or the Participating Fund at any time from the date hereof upon 180 days notice, unless a shorter time is agreed to by the respective Participating Fund and Insurance Company;
b. as to any Participating Fund, at the option of Insurance Company, if Shares of that Participating Fund are not reasonably available to meet the requirements of the Contracts as determined by Insurance Company; prompt notice of election to terminate shall be furnished by Insurance Company, such termination to be effective ten days after receipt of notice unless the Participating Fund makes available a sufficient number of Shares to meet the requirements of the Contracts within such ten-day period;
c. as to a Participating Fund, at the option of Insurance Company, upon the institution of formal proceedings against that Participating Fund by the Commission or any other regulatory body, the expected or anticipated ruling, judgment or outcome of which would, in Insurance Companys reasonable judgment, materially impair that Participating Funds ability to meet and perform the Participating Funds obligations and duties hereunder; prompt notice of election to terminate shall be furnished by Insurance Company with such termination to be effective upon receipt of notice;
d. as to a Participating Fund, at the option of each Participating Fund, upon the institution of formal proceedings against Insurance Company by the Commission, FINRA or any other
regulatory body, the expected or anticipated ruling, judgment or outcome of which would, in the Participating Funds reasonable judgment, materially impair Insurance Companys ability to meet and perform Insurance Companys obligations and duties hereunder; prompt notice of election to terminate shall be furnished by such Participating Fund with such termination to be effective upon receipt of notice;
e. as to a Participating Fund, at the option of that Participating Fund, if the Participating Fund shall determine, in its sole judgment reasonably exercised in good faith, that Insurance Company has suffered a material adverse change in its business or financial condition or is the subject of material adverse publicity and such material adverse change or material adverse publicity is likely to have a material adverse impact upon the business and operation of that Participating Fund or Dreyfus, such Participating Fund shall notify Insurance Company in writing of such determination and its intent to terminate this Agreement, and after considering the actions taken by Insurance Company and any other changes in circumstances since the giving of such notice, such determination of the Participating Fund shall continue to apply on the sixtieth day following the giving of such notice, which sixtieth day shall be the effective date of termination;
f. as to a Participating Fund, at the option of Insurance Company, if Insurance Company shall determine, in its sole judgment reasonably exercised in good faith, that the Participating Fund has suffered a material adverse change in its business or financial condition or is the subject of material adverse publicity and such material adverse change or material adverse publicity is likely to have a material adverse impact upon the business and operations of Insurance Company or its Separate Account, Insurance Company shall notify the Participating Fund in writing of such determination and its intent to terminate this Agreement, and after considering the actions taken by the Participating Fund and any other changes in circumstances since the giving of such notice, such determination of Insurance Company shall continue to apply to the sixtieth day following the giving of such notice, which sixtieth day shall be the effective date of termination;
g. as to a Participating Fund, upon termination of the Investment Advisory Agreement between that Participating Fund and Dreyfus or its successors unless Insurance Company specifically approves the selection of a new Participating Fund investment adviser; such Participating Fund shall promptly furnish notice of such termination to Insurance Company;
h. as to a Participating Fund, in the event that Shares of the Participating Fund are not registered, issued or sold in accordance with applicable federal law, or such law precludes the use of such Shares as the underlying investment medium of Contracts issued or to be issued by Insurance Company; termination shall be effective immediately as to that Participating Fund only upon such occurrence without notice;
i. at the option of a Participating Fund upon a determination by its Board in good faith that it is no longer advisable and in the best interests of shareholders of that Participating Fund to continue to operate pursuant to this Agreement; termination shall be effective upon notice by such Participating Fund to Insurance Company of such termination;
j. at the option of a Participating Fund, if the Contracts cease to qualify as annuity contracts or life insurance policies, as applicable, under the Code, or if such Participating Fund reasonably believes that the Contracts may fail to so qualify;
k. at the option of any party to this Agreement, upon another partys breach of any material provision of this Agreement;
l. at the option of a Participating Fund, if the Contracts are not registered, issued or sold in accordance with applicable federal and/or state law; or
m. upon assignment of this Agreement, unless made with the written consent of every other non-assigning party, except that Insurance Company may assign this Agreement to its successor or any entity acquiring all or substantially all of the assets of Insurance Company.
Any such termination shall not affect the operation of Articles VI or X of this Agreement. To the extent that this Article XI is inconsistent with Article VII or this Agreement, Article VII shall control.
11.3 Notwithstanding any termination of this Agreement, each Participating Fund will, at the option of the Insurance Company, continue to make available additional Shares of that Participating Fund for as long as the Insurance Company desires pursuant to the terms and conditions of this Agreement as provided below, for all Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as Existing Contracts). Specifically, without limitation, if the Insurance Company so elects to have additional Shares of the Participating Fund made available, the owners of the Existing Contracts or Insurance Company, whichever shall have legal authority to do so, shall be permitted to reallocate investments in that Participating Fund, redeem investments in that Participating Fund and/or invest in that Participating Fund upon the making of additional purchase payments under the Existing Contracts. In the event of a termination of this Agreement, the Insurance Company, as promptly as is practicable under the circumstances, shall notify the Participating Fund whether the Participating Fund must continue to make Shares available after such termination. If such Shares of the Participating Fund continue to be made available after such termination, the provisions of this Agreement shall remain in effect and thereafter either of that Participating Fund or Insurance Company may terminate the Agreement as to that Participating Fund, as so continued pursuant to this Section 11.3, upon prior written notice to the other party, such notice to be for a period that is reasonable under the circumstances but, if given by the Participating Fund, need not be for more than six months.
11.4 In the event of any termination of this Agreement in respect of a Participating Fund in connection with which the Participating Fund has not continued to make available additional Shares pursuant to Section 11.3, the parties agree to cooperate and give reasonable assistance to one another in taking all necessary and appropriate steps for the purpose of ensuring that a Separate Account owns no Shares of the Participating Fund beyond six months from the date of termination. Such steps may include, without limitation, substituting other investment company shares for those of the Participating Fund.
11.5 Termination of this Agreement as to any one Participating Fund shall not be deemed a termination as to any other Participating Fund unless Insurance Company or such other Participating Fund, as the case may be, terminates this Agreement as to such other Participating Fund in accordance with this Article XI.
11.6 In the event that the Agreement is terminated, Insurance Company agrees to work cooperatively with MBSC to effect an orderly transition of Contractholder assets if Shares are redeemed or transferred.
ARTICLE XII
AMENDMENTS
12.1 Any other changes in the terms of this Agreement, except for the addition or deletion of any Participating Fund or class of Shares of a Participating Fund as specified in Exhibit B, shall be made by agreement in writing between Insurance Company and each respective Participating Fund.
ARTICLE XIII
NOTICE
13.1 Each notice required by this Agreement shall be given by certified mail, return receipt requested, to the appropriate parties at the following addresses:
Insurance Company: Todd Thompson
Senior Vice President Annuity Sales
Protective Life Insurance Company
600 Vine Street, Suite 1800
Cincinnati, OH 45202
Telephone: 513-362-1525
Fax: 513-357-4421
With copies (which shall not constitute notice) to:
Senior Associate Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223Telephone: 205-268-1000
Fax: 205-268-3597
Participating Funds: Attn: General Counsel
Name of Participating Fund
c/o The Dreyfus Corporation
200 Park Avenue
New York, New York 10166
Telephone: 212-922-6000
Fax: 212-922-6880
with copies to: Attn: David Stephens, Esq.
Stroock & Stroock & Lavan LLP
180 Maiden Lane
New York, New York 10038-4982
Notice shall be deemed to be given on the date of receipt by the addressees as evidenced by the return receipt.
ARTICLE XIV
MISCELLANEOUS
14.1 If any provision of this Agreement is held or made invalid by a court decision, statute, rule, or otherwise, the remainder of this Agreement will not be affected thereby.
14.2 The rights, remedies, indemnities and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies, indemnities and obligations, at law or in equity, to which the parties are entitled.
14.3 This Agreement may be executed simultaneously in two or more counterparts, each of which taken together shall constitute one and the same instrument.
14.4 This Agreement has been executed on behalf of each Participating Fund by the undersigned officer of the Participating Fund in his or her capacity as an officer of the Participating Fund. The obligations of a Participating Fund under this Agreement shall only be binding upon the assets and property of such Participating Fund and shall not be binding upon any director, trustee, officer or shareholder of the Participating Fund individually. It is agreed that the obligations of the Participating Funds are several and not joint, that no Participating Fund shall be liable for any amount owing by another Participating Fund and that the Participating Funds have executed one instrument for convenience only.
14.5 This Agreement supersedes and replaces any previous agreement between the parties concerning the matters discussed herein.
ARTICLE XV
LAW
15.1 This Agreement shall be construed in accordance with the internal laws of the State of New York, without giving effect to principles of conflict of laws.
ARTICLE XVI
FOREIGN TAX CREDITS
16.1 Each Participating Fund agrees to consult in advance with Insurance Company concerning any decision to elect or not to pass through the benefit of any foreign tax credits to the Participating Funds shareholders pursuant to Section 853 of the Code.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement to be duly executed and attested as of the date first above written.
|
|
|
PROTECTIVE LIFE INSURANCE COMPANY |
|
|
|
|
|
|
|
|
|
By: |
/s/ K. Todd Thompson |
|
|
|
Name: |
K. Todd Thompson |
Attest: |
|
|
Its: |
SVP. Annuity sales |
|
|
|
|
|
|
|
|
EACH PARTICIPATING FUND |
|
|
|
|
|
|
|
|
|
By: |
/s/ Janette E. Farragher |
|
|
|
Name: |
Janette E. Farragher |
Attest: |
|
|
Its: |
Vice President and Secretary |
|
|
|
|
|
|
|
|
THE DREYFUS CORPORATION* |
|
|
|
|
|
|
|
|
|
By: |
/s/ Bradley J. Skapyak |
|
|
|
Name: |
Bradley J. Skapyak |
Attest: |
|
|
Its: |
Chief Operating Officer |
|
|
|
|
|
* With respect to Article X only.
EXHIBIT A
Name of Separate Accounts
Protective Acquired Variable Separate Account
Protective Acquired Variable Annuity Separate Account
RetireMAP Variable Account
Titanium Annuity Variable Account
Titanium Universal Life Variable Account
EXHIBIT B
LIST OF PARTICIPATING FUNDS
Fund Name |
|
Share Class |
Dreyfus Variable Investment Fund |
|
|
Appreciation Portfolio |
|
Initial Shares |
Growth and Income Portfolio |
|
Initial Shares |
Money Market Portfolio |
|
|
Opportunistic Small Cap Portfolio |
|
Initial Shares |
Quality Bond Portfolio |
|
Initial Shares |
|
|
|
Dreyfus Investment Portfolios |
|
|
Dreyfus MidCap Stock Portfolio |
|
Service Shares |
Dreyfus Technology Growth Portfolio |
|
Service Shares |
|
|
|
The Dreyfus Socially Responsible Growth Fund, Inc. |
|
Initial and Service Shares |
AMENDMENT
TO
AMENDED AND RESTATED
FUND PARTICIPATION AGREEMENT
This AMENDMENT (the Amendment) amends that certain Amended and Restated Fund Participation Agreement dated as of February 1, 2015, as amended (the Agreement) between Protective Life Insurance Company (Insurance Company), and each Participating Fund. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Agreement
WHEREAS, the parties desire to amend Exhibit A of the Agreement to update the list of Separate Accounts subject to the Agreement;
WHEREAS, the parties further desire to amend Exhibit B of the Agreement to update the list of Participating Funds subject to the Agreement;
WHEREAS, the parties further desire to amend the Agreement to update the names of certain entities referenced in the Agreement.
NOW, THEREFORE, in consideration of the mutual covenants contained in the Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
1. Exhibit A of the Agreement is hereby deleted in its entirety and replaced with the new Exhibit A attached hereto.
2. Exhibit B of the Agreement is hereby deleted in its entirety and replaced with the new Exhibit B attached hereto.
3. The name of The Dreyfus Corporation was changed to BNY Mellon Investment Adviser, Inc., effective June 2019. Accordingly, all references in the Agreement to The Dreyfus Corporation or Dreyfus are hereby deleted and replaced with BNY Mellon Investment Adviser and BNYMIA, respectively.
4. The name of MBSC Securities Corporation was changed to BNY Mellon Securities Corporation, effective June 2019. Accordingly, all references in the Agreement to MBSC Securities Corporation or MBSC are hereby deleted and replaced with BNY Mellon Securities Corporation and BNYMSC, respectively.
5. Accordingly, all references to MBSC Securities Corporation and MBSC in the Agreement are hereby changed to BNY Mellon Securities Corporation and BNYMSC, respectively.
6. This Amendment may be executed in any number of counterparts, each of which shall be deemed to be an original, and all of which taken together shall constitute one and the same Amendment.
7. This Amendment will be effective as of December 1, 2020 (the Effective Date)
8. Except as otherwise specifically provided for herein, the Agreement shall remain in full force and effect.
[SIGNATURES FOLLOW ON NEXT PAGE]
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the Effective Date.
PROTECTIVE LIFE INSURANCE COMPANY |
EACH PARTICIPATING FUND |
||
|
|
||
Signed: |
|
Signed: |
|
|
|
|
|
Name: |
|
Name: |
|
|
|
|
|
Title: |
|
Title: |
|
|
|
||
BNY MELLON INVESTMENT ADVISER, INC. (with respect to Article X only) |
|
||
|
|
||
Signed: |
|
|
|
|
|
|
|
Name: |
|
|
|
|
|
|
|
Title: |
|
|
|
|
|
EXHIBIT A
Name of Separate Accounts
Non-COLI Business:
Protective Acquired Variable Separate Account
Protective Acquired Variable Annuity Separate Account
RetireMap Variable Account
Titanium Annuity Variable Account
Titanium Universal Life Variable Account
COLI Business:
Protective COLI PPVUL
Protective COLI VUL
EXHIBIT B
LIST OF PARTICIPATING FUNDS
The provisions of this Agreement apply exclusively to the dealer code and branch codes specified in this Exhibit B. Insurance Company is solely responsible for providing the correct dealer and branch codes on each account.
Dealer Code: [ ] Branch Code: [ ]
Fund Name |
|
Share Class |
BNY Mellon Investment Portfolios: |
|
|
MidCap Stock Portfolio |
|
Service |
Small Cap Stock Index Portfolio |
|
Service |
Technology Growth Portfolio |
|
Service |
|
|
|
BNY Mellon Stock Index Fund, Inc. |
|
Initial |
|
|
|
BNY Mellon Sustainable U.S. Equity Portfolio, Inc. (formerly, The Socially Responsible Growth Fund, Inc.) |
|
Initial and Service Shares |
|
|
|
BNY Mellon Variable Investment Fund |
|
|
Appreciation Portfolio |
|
Initial Shares |
Growth and Income Portfolio |
|
Initial Shares |
Government Money Market Portfolio (formerly, Money Market Portfolio) |
|
- |
Opportunistic Small Cap Portfolio |
|
Initial Shares |
Dealer Code: [ ] Branch Code: [ ]
Fund Name |
|
Share Class |
BNY Mellon Investment Portfolios: |
|
|
MidCap Stock Portfolio |
|
Initial |
Small Cap Stock Index Portfolio |
|
Service |
Technology Growth Portfolio |
|
Initial |
|
|
|
BNY Mellon Stock Index Fund, Inc. |
|
Initial |
|
|
|
BNY Mellon Sustainable U.S. Equity Portfolio, Inc. (formerly, The Socially Responsible Growth Fund, Inc.) |
|
Initial |
|
|
|
BNY Mellon Variable Investment Fund |
|
|
Government Money Market Portfolio (formerly, Money Market Portfolio) |
|
- |
PARTICIPATION AGREEMENT
Among
DAVIS VARIABLE ACCOUNT FUND, INC.
DAVIS DISTRIBUTORS, LLC
and
PROTECTIVE LIFE INSURANCE COMPANY
THIS AGREEMENT, made and entered into this day of , 2020, by and among Protective Life Insurance Company (hereinafter the Insurance Company), a Tennessee corporation, on its own behalf and on behalf of each segregated asset account of the Insurance Company set forth on Schedule A hereto as may be amended from time to time (each such account hereinafter referred to as the Account), DAVIS VARIABLE ACCOUNT FUND, INC., a Maryland Corporation (the Company) and Davis Distributors, LLC, a Delaware Limited Liability Company (Davis Distributors).
WHEREAS, the Company engages in business as an open-end management investment company and is available to act as the investment vehicle for variable annuity and life insurance contracts to be offered by separate accounts of insurance companies which have entered into participation agreements substantially similar to this Agreement (Participating Insurance Companies) and for qualified retirement and pension plans (Qualified Plans); and
WHEREAS, the beneficial interest in the Company is divided into several series of shares, each designated a Fund and representing the interest in a particular managed portfolio of securities and other assets; and
WHEREAS, the Company has obtained an order from the Securities and Exchange Commission (the SEC), granting Participating Insurance Companies and their separate accounts exemptions from the provisions of Sections 9(a), 13(a), 15(a), and 15(b) of the Investment Company Act of 1940, as amended, (the 1940 Act) and Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the Company to be sold to and held by Qualified Plans and by variable annuity and variable life insurance separate accounts of Participating Insurance Companies that may or may not be affiliated with one another (the Mixed and Shared Funding Exemptive Order); and
WHEREAS, the Company has registered as an open-end management investment company under the 1940 Act and the offering of its shares has been registered under the Securities Act of 1933, as amended (hereinafter the 1933 Act); and
WHEREAS, Davis Distributors is duly registered as a broker-dealer under the Securities Exchange Act of 1934, as amended, (the 1934 Act), and is a member in good standing of the Financial Industry Regulatory Authority (FINRA); and
WHEREAS, Davis Distributors is a wholly owned subsidiary of Davis Selected Advisers, L.P. which is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and any applicable state securities law; and
WHEREAS, the Insurance Company has or will issue certain variable annuity or variable life insurance contracts identified on Schedule B to this Agreement, each of which is or will be registered as securities under the 1933 Act, or is exempt from registration under the 1933 Act, as such Schedule is amended from time to time hereafter by mutual written agreement of all the parties hereto (the Contracts); and
WHEREAS, each Account is a duly organized, validly existing segregated asset account, established by resolution of the board of directors of the Insurance Company on the date shown for that Account on Schedule A hereto, to set aside and invest assets attributable to the Contracts; and
WHEREAS, each Account is or will be registered as a unit investment trust under the 1940 Act, or is exempt from registration under the 1940 Act; and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Insurance Company intends to purchase shares in the Funds listed on Schedule C to this Agreement as amended from time to time, at net asset value on behalf of each Account to fund the Contracts;
NOW, THEREFORE, in consideration of their mutual promises, the Insurance Company, the Company and Davis Distributors agree as follows:
ARTICLE I. Sale of Company Shares
1.1. Davis Distributors agrees to sell to the Insurance Company those shares of the Company which each Account orders, executing such orders on a daily basis at the net asset value next computed after receipt by the Company or its designee of the order for the shares of the Company. For purposes of this Section 1.1, the Insurance Company, or its designee, shall be the designee of the Company for receipt of such orders from the Accounts and receipt by such designee shall constitute receipt by the Company; provided that the Company receives notice of such order by 10:00 a.m., Eastern Time, on the next following Business Day. In this Agreement, Business
Day shall mean any day on which the New York Stock Exchange is open for trading and on which the Company calculates its net asset value pursuant to the rules of the SEC.
1.2. The Company agrees to make its shares available for purchase at the applicable net asset value per share by the Insurance Company and its Accounts on those days on which the Company calculates its Funds net asset values pursuant to rules of the SEC and the Company shall use reasonable efforts to calculate its Funds net asset values on each day on which the New York Stock Exchange is open for trading. Notwithstanding the foregoing, the directors of the Company may refuse to sell shares of any Fund to any person, or suspend or terminate the offering of shares of any Fund if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the directors of the Company acting in good faith and in light of their fiduciary duties under federal and any applicable state laws, necessary in the best interests of the shareholders of that Fund.
1.3. The Company agrees that shares of the Company will be sold only to Accounts of Participating Insurance Companies and to Qualified Plans. No shares of any Fund will be sold to the general public.
1.4. The Company will not sell its shares to any insurance company or separate account unless an agreement containing provisions substantially the same as Sections 2.4, 3.4, 3.5, and Article VIII of this Agreement is in effect to govern such sales.
1.5. The Company agrees to redeem, on the Insurance Companys request, any full or fractional shares of the Company held by the Account, executing such requests on a daily basis at the net asset value next computed after receipt by the Company or its designee of the request for redemption. However, if one or more Funds has determined to settle redemption transactions for all of its shareholders on a delayed basis (more than one business day, but in no event more than three Business Days, after the date on which the redemption order is received, unless otherwise permitted by an order of the SEC under Section 22(e) of the 1940 Act), the Company shall be permitted to delay sending redemption proceeds to the Insurance Company by the same number of days that the Company is delaying sending redemption proceeds to the other shareholders of the Fund. For purposes of this Section 1.5, the Insurance Company shall be the designee of the Company for receipt of requests for redemption from each Account and receipt by that designee shall constitute receipt by the Company; provided that the Company receives notice of the request for redemption by 9:00 a.m., Eastern Time, on the next following Business Day.
1.6. The Insurance Company agrees to purchase and redeem the shares of each Fund listed on Schedule C to this Agreement, as amended from time to time, and offered by the then-current prospectus (or summary prospectus) of the Company in accordance with the provisions of that prospectus.
1.7. Each purchase, redemption and exchange order placed by the Insurance Company shall be placed separately for each Fund and shall not be netted with respect to any Fund. However, with
respect to payment of the purchase price by the Insurance Company and of redemption proceeds by the Company, the Insurance Company and the Company shall net purchase and redemption orders with respect to each Fund and shall transmit one net payment for all of the Funds. Payment shall be in federal funds transmitted by wire. In the event of net purchase, the Insurance Company shall pay for the Funds shares by 3:00 p.m. Eastern time on the next Business Day after an order to purchase shares is made in accordance with the provisions of Section 1.1 hereof. For the purpose of Sections 2.9 and 2.10, upon receipt by the Company of the wired federal funds, such funds shall cease to be the responsibility of the Insurance Company and shall become the responsibility of the Company. In the event of net redemption, the Company shall pay the redemption proceeds by 3:30 p.m. Eastern time on the next Business Day after an order to redeem the shares is made in accordance with the provisions of Section 1.5 hereof. However, payment may be postponed under unusual circumstances, such as when normal trading is not taking place on the New York Stock Exchange, an emergency as defined by the SEC exists, or as permitted by the SEC.
1.8. Issuance and transfer of the Companys shares will be by book entry only. Stock certificates will not be issued to the Insurance Company or any Account. Shares ordered from the Company will be recorded in an appropriate title for each Account or the appropriate subaccount of each Account.
1.9. The Company shall furnish same day notice (by wire or telephone, followed by written confirmation) to the Insurance Company of any income, dividends or capital gain distributions payable on the Funds shares. The Insurance Company hereby elects to receive all income dividends and capital gain distributions payable on a Funds shares in additional shares of that Fund. The Insurance Company reserves the right to revoke this election and to receive all such income dividends and capital gain distributions in cash. The Company shall notify the Insurance Company of the number of shares issued as payment of dividends and distributions.
1.10. The Company shall make the net asset value per share for each Fund available to the Insurance Company on a daily basis as soon as reasonably practical after the net asset value per share is calculated and shall use its best efforts to make those per-share net asset values available by 7:00 p.m., Eastern Time. In the event that the Company is unable to meet the 7:00 p.m. Eastern time stated herein, it shall provide additional time for the Insurance Company to place orders for the purchase and redemption of shares. Such additional time shall be equal to the additional time which the Company takes to make the net asset value available to the Insurance Company. In accordance with Section 9.3(a)(iii) hereof, if the Company provides materially incorrect share net asset value information, the Company may make an adjustment to the number of shares purchased or redeemed for the Account to reflect the correct net asset value per share. Any material error in the calculation or reporting of net asset value per share, dividend or capital gains information shall be reported to the Insurance Company promptly upon discovery.
ARTICLE II. Representations, Warranties and Agreements
2.1. The Insurance Company represents, warrants and agrees that the offerings of the Contracts are, or will be, registered under the 1933 Act or exempt from registration under the 1933 Act; that the Contracts will be issued and sold in compliance in all material respects with all applicable federal and state laws and that the sale of the Contracts shall comply in all material respects with applicable state insurance suitability requirements. The Insurance Company further represents that it is an insurance company duly organized and in good standing under applicable law and that it has legally and validly established the Account prior to any issuance or sale thereof as a segregated asset account under Tennessee insurance law and that prior to any issuance or sale of the Contracts each Account is or will be registered as a unit investment trust under the 1940 Act, or is exempt from registration under the 1940 Act, in accordance with the provisions of the 1940 Act to serve as a segregated investment account for the Contracts.
2.2. The Company warrants and agrees that Company shares sold pursuant to this Agreement shall be registered under the 1933 Act, duly authorized for issuance and sale in compliance with the laws of the State of Maryland and all applicable federal securities laws and that the Company is and shall remain registered under the 1940 Act. The Company warrants and agrees that it shall amend the registration statement for its shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its shares. The Company shall register and qualify the shares for sale in accordance with the laws of the various states only if and to the extent deemed advisable by the Company or Davis Distributors.
2.3. The Company represents that each Fund is currently qualified as a Regulated Investment Company under Subchapter M of the Internal Revenue Code of 1986, as amended (the Code), and warrants and agrees that it will make all reasonable efforts to maintain each Funds qualification (under Subchapter M or any successor or similar provision) and that it will notify the Insurance Company immediately upon having a reasonable basis for believing that any Fund has ceased to so qualify or might not so qualify in the future.
2.4. The Insurance Company represents that the Contracts are currently treated as annuity or life insurance contracts under applicable provisions of the Code and warrants and agrees that it will make all reasonable efforts to maintain such treatment and that it will notify the Company and Davis Distributors immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future.
2.5. The Company may elect to make payments to finance distribution expenses pursuant to Rule 12b-1 under the 1940 Act. To the extent that it decides to finance distribution expenses pursuant to Rule 12b-1, the Company undertakes to have a board of directors, a majority of whom are not interested persons of the Company, formulate and approve any plan under Rule 12b-1 to finance distribution expenses.
2.6. The Company makes no representation or warranty as to whether any aspect of its operations (including, but not limited to, fees and expenses and investment policies) complies or will comply with the insurance laws or regulations of the various states.
2.7. The Company represents that it is lawfully organized and validly existing under the laws of the State of Maryland and represents, warrants and agrees that it does and will comply in all material respects with the 1940 Act and the laws of the State of Maryland.
2.8. Davis Distributors represents that it is and warrants that it shall remain duly registered as a broker-dealer under all applicable federal and state securities laws and agrees that it shall perform its obligations for the Company in compliance in all material respects with any applicable state and federal securities laws.
2.9. The Company and Davis Distributors represent and warrant that all of their officers, employees, investment advisers, investment sub-advisers, and other individuals or entities described in Rule 17g-1 under the 1940 Act dealing with the money and/or securities of the Company are, and shall continue to be at all times, covered by a blanket fidelity bond or similar coverage for the benefit of the Company in an amount not less than the minimum coverage required currently by Rule 17g-1 under the 1940 Act or related provisions as may be promulgated from time to time. That fidelity bond shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company.
2.10. The Insurance Company represents and warrants that all of its officers, employees, investment advisers, and other individuals or entities dealing with the money and/or securities of the Company are and shall continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Company, in an amount not less than $1 million. The aforesaid bond shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company.
ARTICLE III. Disclosure Documents and Voting
3.1. Davis Distributors shall provide the Insurance Company (at the Insurance Companys expense) with as many copies of the current prospectus (or summary prospectus as allowed by regulation) for each Fund listed on Schedule C herein as the Insurance Company may reasonably request for distribution to prospective purchasers of contracts. Davis Distributors shall also provide the Insurance Company (free of charge) with as many copies of the current prospectus (or summary prospectus as allowed by regulation) for each Fund listed on Schedule C herein as the Insurance Company may reasonably request for distribution to existing Contract owners whose Contracts are funded by shares of such Fund(s). If requested by the Insurance Company in lieu thereof, the Company shall provide such documentation (including a final copy of the new prospectus as set in type at the Companys expense) and other assistance as is reasonably necessary in order for the Insurance Company once each year (or more frequently if the prospectus for the Company is amended) to have the prospectus for the Contracts and the Companys prospectus printed together in one document (at the Insurance Companys expense).
3.2. The Companys prospectus shall state that the Statement of Additional Information for the Company (the SAI) is available from the Company, and Davis Distributors (or the Company), at its expense, shall print and provide the SAI free of charge to the Insurance Company and to any owner of a Contract or prospective owner who requests the SAI.
3.3. The Company, at its expense, shall provide the Insurance Company with copies of its proxy material, reports to shareholders and other communications to shareholders in such quantity as the Insurance Company shall reasonably require for distributing to Contract owners.
3.4. If and to the extent required by law, the Insurance Company shall:
(i) solicit voting instructions from Contract owners;
(ii) vote the Company shares of each Fund in accordance with instructions received from Contract owners; and
(iii) vote Company shares for which no instructions have been received in the same proportion as Company shares of that Fund for which instructions have been received;
so long as and to the extent that the SEC continues to interpret the 1940 Act to require pass-through voting privileges for variable contract owners. The Insurance Company reserves the right to vote Company shares held in any segregated asset account in its own right, to the extent permitted by law. Participating Insurance Companies shall be responsible for assuring that each of their separate accounts participating in the Company calculates voting privileges in a manner consistent with the standards set forth on Schedule D attached hereto and incorporated herein by this reference, which standards will also be provided to the other Participating Insurance Companies. The Insurance Company shall fulfill its obligation under, and abide by the terms and conditions of, the Mixed and Shared Funding Exemptive Order.
3.5. The Company will comply with all provisions of the 1940 Act requiring voting by shareholders, and in particular the Company will either provide for annual meetings (except insofar as the SEC may interpret Section 16 of the 1940 Act not to require such meetings) or, as the Company currently intends, comply with Section 16(c) of the 1940 Act as well as with Sections 16(a) and, if and when applicable, 16(b). Further, the Company will act in accordance with the SECs interpretation of the requirements of Section 16(a) with respect to periodic elections of directors and with whatever rules the SEC may promulgate with respect thereto.
ARTICLE IV. Shareholder Information
4.1. Insurance Company agrees to provide the Fund, upon written request, the taxpayer identification number (TIN), if known, of any or all Shareholder(s) of the account and the amount, date, name or other identifier of any investment professional(s) associated with the Shareholder(s) or account (if known), and transaction type (purchase, redemption, transfer, or exchange) of every Shareholder Initiated Transaction involving Shares held through an account maintained by the Insurance Company during the period covered by the request.
(i) Period Covered by Request. Requests must set forth a specific period, not to exceed 90 days from the date of the request, for which transaction information is sought. The Fund may request transaction information older than 90 days from the date of the request as it deems necessary to investigate compliance with policies established by the Fund for the purpose of eliminating or reducing any dilution of the value of the outstanding shares issued by the Fund.
(ii) Form and Timing of Response. Insurance Company agrees to transmit the requested information that is on its books and records to the Fund or its designee promptly, but in any event not later than 10 business days, after receipt of a request. If the requested information is not on the Insurance Companys books and records, Insurance Company agrees to: (i) provide or arrange to provide to the Fund the requested information from shareholders who hold an account with an indirect intermediary; or (ii) if directed by the Fund, block further purchases of Fund Shares from such indirect intermediary. In such instance, Insurance Company agrees to inform the Fund whether it plans to perform (i) or (ii). Responses required by this paragraph must be communicated in writing and in a format mutually agreed upon by the parties. To the extent practicable, the format for any transaction information provided to the Fund should be consistent with the NSCC Standardized Data Reporting Format. For purposes of this provision, an indirect intermediary has the same meaning as in SEC Rule 22c-2 under the Investment Company Act.
(iii) Limitation on Use of Information. The Fund agrees not to use the information received for marketing or any other similar purpose without the prior written consent of the Insurance Company.
4.2. Agreement to Restrict Trading. Insurance Company agrees to execute written instructions from the Fund to restrict or prohibit further Shareholder Initiations in Shares by a Shareholder that has been identified by the Fund as having engaged in transactions of the Funds Shares (directly or indirectly through the Insurance Companys account) that violate policies established by the Fund for the purpose of eliminating or reducing any dilution of the value of the outstanding Shares issued by the Fund.
(i) Form of Instructions. Instructions must include the TIN, if known, and the specific instruction(s) to be executed. If the TIN is not known, the instructions must include an equivalent identifying number of the Shareholder(s) or account(s) or other agreed upon information to which the instruction relates.
(ii) Timing of Response. Insurance Company agrees to execute instructions as soon as reasonably practicable, but not later than five business days after receipt of the instructions by the Insurance Company.
(iii) Confirmation by Insurance Company. Insurance Company must provide written confirmation to the Fund that instructions have been executed. Insurance Company agrees to provide confirmation as soon as reasonably practicable, but not later than ten business days after the instructions have been executed.
4.3. Definitions. For purposes of Article IV:
(i) The term Fund includes the funds principal underwriter and transfer agent. The term does not include any excepted funds as defined in SEC Rule 22c-2(b) under the Investment Company Act of 1940.
(ii) The term Shares means the interests of Shareholders corresponding to the redeemable securities of record issued by the Fund under the Investment Company Act of 1940 that are held by the Insurance Company.
(iii) The term Shareholder means the holder of interests in a variable annuity or variable life insurance contract issued by the Insurance Company.
(iv) The term Shareholder-Initiated Transaction means a transaction that is initiated or directed by a Shareholder that results in a transfer of assets within a Contract into or out of a Fund, but does not include transactions that are executed: (i) automatically pursuant to a contractual or systematic program or enrollments such as transfer of assets within a Contract to a Fund as a result of dollar cost averaging programs, insurance company approved asset allocation programs, or automatic rebalancing
programs; (ii) pursuant to a Contract death benefit; (iii) pursuant to a Contract death benefit as a one-time step-up in Contract value; (iv) to allocate assets to a Fund through a Contract as a result of payments such as loan repayments, scheduled contributions, retirement plan salary reduction contributions, or planned premium payments to the Contract; (v) as pre-arranged transfers at the conclusion of a required free look period; (vi) automatically pursuant to a contractual or systematic program or enrollments such as transfer of assets within a Contract out of a Fund as a result of annuity payouts, loans, systematic withdrawal programs, insurance company approved asset allocation programs and automatic rebalancing programs; (vii) as a result of any deduction or charge or fees under a Contract; (iii) within a Contract out of a Fund as a result of scheduled withdrawals or surrenders from a Contract; or (viii) as a result of payment of a death benefit from a Contract.
(v) The term written includes electronic writings and facsimile transmissions.
ARTICLE V. Sales Material and Information
5.1. The Insurance Company shall furnish, or shall cause to be furnished, to the Company or its designee, each piece of sales literature or other promotional material in which the Company, Davis Selected Advisers, L.P., or Davis Distributors is named, at least five Business Days prior to its use. No such material shall be used if the Company or its designee reasonably objects to such use within five Business Days after receipt of such material.
5.2. The Insurance Company shall not give any information or make any representations or statements on behalf of the Company or concerning the Company in connection with the sale of the Contracts other than the information or representations contained in the Companys registration statement, prospectus (including summary prospectus) or SAI, as that registration statement, prospectus (including summary prospectus) or SAI may be amended or supplemented from time to time, or in reports or proxy statements for the Company, or in sales literature or other promotional material approved by the Company or its designee or by Davis Distributors, except with the permission of the Company or Davis Distributors.
5.3. The Company or its designee, or Davis Distributors shall furnish, or shall cause to be furnished, to the Insurance Company or its designee, each piece of sales literature or other promotional material in which the Insurance Company or the Account is named at least five Business Days prior to its use. No such material shall be used if the Insurance Company or its designee reasonably objects to such use within five Business Days after receipt of that material.
5.4. The Company and Davis Distributors shall not give any information or make any representations on behalf of the Insurance Company or concerning the Insurance Company, any Account, or the Contracts other than the information or representations contained in a registration statement, prospectus or statement of additional information for the Contracts, as that registration statement, prospectus or statement of additional information may be amended or supplemented
from time to time, or in published reports for any Account which are in the public domain or approved by the Insurance Company for distribution to Contract owners, or in sales literature or other promotional material approved by the Insurance Company or its designee, except with the permission of the Insurance Company.
5.5. The Company will provide to the Insurance Company at least one complete copy of each registration statement, prospectus (or summary prospectus as allowed by regulation), statement of additional information, report, proxy statement, piece of sales literature or other promotional material, application for exemption, request for no-action letter, and any amendment to any of the above, that relate to the Company or its shares, contemporaneously with the filing of the document with the SEC, FINRA, or other regulatory authorities.
5.6. The Insurance Company will provide to the Company at least one complete copy of each registration statement, prospectus, statement of additional information, report, solicitation for voting instructions, piece of sales literature and other promotional material, application for exemption, request for no-action letter, and any amendment to any of the above, that relates to the Contracts or the Account, contemporaneously with the filing of the document with the SEC, FINRA, or other regulatory authorities.
5.7. For purposes of this Article V, the phrase sales literature or other promotional material includes, but is not limited to, advertisements, newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media, sales literature (i.e., any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, shareholder newsletters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, and registration statements, prospectuses (including summary prospectus), statements of additional information, shareholder reports, and proxy materials.
5.8. At the request of any party to this Agreement, each other party will make available to the other partys independent auditors and/or representative of the appropriate regulatory agencies, all records, data and access to operating procedures that may be reasonably requested.
ARTICLE VI. Fees and Expenses
6.1. The Company and Davis Distributors shall pay no fee or other compensation to the Insurance Company under this agreement, except as set forth in Section 6.4.
6.2. All expenses incident to performance by the Company under this Agreement shall be paid by the Company. The Company shall see to it that any offering of its shares is registered and that all of its shares are authorized for issuance in accordance with applicable federal law and, if
and to the extent deemed advisable by the Company or Davis Distributors, in accordance with applicable state laws prior to their sale. The Company shall bear the cost of registration and qualification of the Companys shares, preparation and filing of the Companys prospectus and registration statement, proxy materials and reports, setting the prospectus (or in the alternative the summary prospectus) in type, setting in type and printing the proxy materials and reports to shareholders, the preparation of all statements and notices required by any federal or state law, and all taxes on the issuance or transfer of the Companys shares.
6.3. The Insurance Company shall bear the expenses of printing and distributing to Contract owners the Contract prospectuses and of distributing to Contract owners the Companys prospectus (or summary prospectus as allowed by regulation), proxy materials and reports.
6.4. The Insurance Company bears the responsibility and correlative expense for administrative and support services for Contract owners. Davis Distributors recognizes the Insurance Company, on behalf of each Account, as the sole shareholder of shares of the Company issued under this Agreement. From time to time, Davis Distributors may pay amounts from its past profits to the Insurance Company for providing certain administrative services for the Company or for providing other services that relate to the Company. In consideration of the savings resulting from such arrangement, and to compensate the Insurance Company for its costs, Davis Distributors agrees to pay to the Insurance Company an amount equal to 25 basis points (0.25%) per annum of the average aggregate amount invested by the Insurance Company in the Company under this Agreement. Such payments will be made quarterly, and only when the average aggregate amount invested exceeds $1,000,000. The parties agree that such payments are for administrative services and investor support services, and do not constitute payment for investment advisory, distribution or other services. Payment of such amounts by Davis Distributors shall not increase the fees paid by the Company or its shareholders.
ARTICLE VII. Diversification
7.1. The Company will use its best efforts to comply and to maintain compliance with Section 817(h) of the Code and the regulations thereunder relating to the diversification requirements for variable annuity, endowment, modified endowment or life insurance contracts and any amendments or other modifications to that Section or Regulation at all times necessary to satisfy those requirements. In the event of a breach of this requirement by the Company, it will take all reasonable steps to adequately diversify so as to achieve compliance within the grade period afforded by Section 1.817-5 of the regulations under the Code.
ARTICLE VIII. Potential Conflicts
8.1. The directors of the Company will monitor each Fund for the existence of any material irreconcilable conflict between the interests of the variable Contract owners of all separate accounts investing in the Company and the participants of all Qualified Plans investing in the Company. An irreconcilable material conflict may arise for a variety of reasons, including: (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling, no-action or interpretive letter, or any similar action by insurance, tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the investments of any Fund are being managed; (e) a difference in voting instructions given by variable annuity contract and variable life insurance contract owners; or (f) a decision by a Participating Insurance Company to disregard the voting instructions of variable contract owners. The directors of the Company shall promptly inform the Insurance Company if they determine that an irreconcilable material conflict exists and the implications thereof. The directors of the Company shall have sole authority to determine whether an irreconcilable material conflict exists and their determination shall be binding upon the Insurance Company.
8.2. The Insurance Company and Davis Distributors each will report promptly any potential or existing conflicts of which it is aware to the directors of the Company. The Insurance Company and Davis Distributors each will assist the directors of the Company in carrying out their responsibilities under the Mixed and Shared Funding Exemptive Order, by providing the directors of the Company with all information reasonably necessary for them to consider any issues raised. This includes, but is not limited to, an obligation by the Insurance Company to inform the directors of the Company whenever Contract owner voting instructions are to be disregarded. These responsibilities shall be carried out by the Insurance Company with a view only to the interests of the Contract owners and by Davis Distributors with a view only to the interests of Contract owners and Qualified Plan participants.
8.3. If it is determined by a majority of the directors of the Company, or a majority of the directors who are not interested persons of the Company, any of its Funds, or Davis Distributors (the Independent Directors), that a material irreconcilable conflict exists, the Insurance Company and/or other Participating Insurance Companies or Qualified Plans that have executed participation agreements shall, at their expense and to the extent reasonably practicable (as determined by a majority of the Independent Directors), take whatever steps are necessary to remedy or eliminate the irreconcilable material conflict, up to and including: (1) withdrawing the assets attributable to some or all of the separate accounts from the Company or any Fund and reinvesting those assets in a different investment medium, including (but not limited to) another Fund of the Company, or submitting the question whether such segregation should be implemented to a vote of all affected variable contract owners and, as appropriate, segregating the assets of any appropriate group (e.g., annuity contract owners, life insurance contract owners, or variable contract owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected variable contract owners the option of making such a change; and (2) establishing a new
registered management investment company or managed separate account and obtaining any necessary approvals or orders of the SEC in connection therewith.
8.4. If a material irreconcilable conflict arises because of a decision by the Insurance Company to disregard Contract owner voting instructions and that decision represents a minority position or would preclude a majority vote, the Insurance Company may be required, at the Companys election, to withdraw the affected Accounts investment in the Company and terminate this Agreement with respect to that Account; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the Independent Directors. Any such withdrawal and termination must take place within six (6) months after the Company gives written notice that this provision is being implemented, and, until the end of that six month period, the Company shall continue to accept and implement orders by the Insurance Company for the purchase (and redemption) of shares of the Company.
8.5. If a material irreconcilable conflict arises because a particular state insurance regulators decision applicable to the Insurance Company conflicts with the majority of other state regulators, then the Insurance Company will withdraw the affected Accounts investment in the Company and terminate this Agreement with respect to that Account within six months after the directors of the Company inform the Insurance Company in writing that they have determined that the state insurance regulators decision has created an irreconcilable material conflict; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the Independent Directors. Until the end of the foregoing six month period, the Company shall continue to accept and implement orders by the Insurance Company for the purchase (and redemption) of shares of the Company.
8.6. For purposes of Sections 8.3 through 8.6 of this Agreement, a majority of the Independent Directors shall determine whether any proposed action adequately remedies any irreconcilable material conflict, but in no event will the Company be required to establish a new funding medium for the Contracts. The Insurance Company shall not be required by Section 8.3 to establish a new funding medium for the Contracts if an offer to do so has been declined by vote of a majority of Contract owners materially adversely affected by the irreconcilable material conflict. In the event that the directors of the Company determine that any proposed action does not adequately remedy any irreconcilable material conflict, then the Insurance Company will withdraw the Accounts investment in the Company and terminate this Agreement within six (6) months after the directors of the Company inform the Insurance Company in writing of the foregoing determination, provided, however, that the withdrawal and termination shall be limited to the extent required by the material irreconcilable conflict, as determined by a majority of the Independent Directors.
8.7. If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Mixed and Shared Funding
Exemptive Order) on terms and conditions materially different from those contained in the Mixed and Shared Funding Exemptive Order, then (a) the Company and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with Rules 6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent those rules are applicable; and (b) Sections 3.4, 3.5, 8.1, 8.2, 8.3, 8.4, 8.5 and 8.6 of this Agreement shall continue in effect only to the extent that terms and conditions substantially identical to those Sections are contained in the Rule(s) as so amended or adopted.
ARTICLE IX. Indemnification
9.1. Indemnification By The Insurance Company
9.1(a). The Insurance Company agrees to indemnify and hold harmless the Company and each director, officer, employee or agent of the Company, and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 9.1) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Insurance Company) or litigation (including legal and other expenses), to which the Indemnified Parties may become subject under any statute, regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the acquisition or redemption of the Companys shares or the Contracts and:
(i) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the registration statement, prospectus (or summary prospectus) or statement of additional information for the Contracts or contained in the Contracts or sales literature for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to the Insurance Company by or on behalf of the Company for use in the registration statement, prospectus (or summary prospectus) or statement of additional information for the Contracts or in the Contracts or sales literature (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or shares of the Company;
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus (or summary prospectus), statement of additional information or sales literature of the Company not supplied by the Insurance Company, or persons under its control) or wrongful conduct of the Insurance Company or persons under its control, with respect to the sale or distribution of the Contracts or shares of the Company to the Insurance Company;
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus (or summary prospectus), statement of additional information or sales literature of the Company or any amendment thereof or supplement thereto or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such a statement or omission was made in reliance upon information furnished in writing to the Company by or on behalf of the Insurance Company;
(iv) arise as a result of any failure by the Insurance Company to provide the services and furnish the materials under the terms of this Agreement; or
(v) arise out of or result from any material breach of any representation, warranty or agreement made by the Insurance Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Insurance Company,
as limited by and in accordance with the provisions of Sections 9.1(b) and 9.1(c) hereof.
9.1(b). The Insurance Company shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified Party that may arise from that Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of that Indemnified Partys duties or by reason of that Indemnified Partys reckless disregard of obligations or duties under this Agreement or to the Company, whichever is applicable.
9.1(c). The Insurance Company shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless that Indemnified Party shall have notified the Insurance Company in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon that Indemnified Party (or after the Indemnified Party shall have received notice of such service on any designated agent). Notwithstanding the foregoing, the failure of any Indemnified Party to give
notice as provided herein shall not relieve the Insurance Company of its obligations hereunder except to the extent that the Insurance Company has been prejudiced by such failure to give notice. In addition, any failure by the Indemnified Party to notify the Insurance Company of any such claim shall not relieve the Insurance Company from any liability which it may have to the Indemnified Party against whom the action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Insurance Company shall be entitled to participate, at its own expense, in the defense of the action. The Insurance Company also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action; provided, however, that if the Indemnified Party shall have reasonably concluded that there may be defenses available to it which are different from or additional to those available to the Insurance Company, the Insurance Company shall not have the right to assume said defense, but shall pay the costs and expenses thereof (except that in no event shall the Insurance Company be liable for the fees and expenses of more than one counsel for Indemnified Parties in connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances). After notice from the Insurance Company to the Indemnified Party of the Insurance Companys election to assume the defense thereof, and in the absence of such a reasonable conclusion that there may be different or additional defenses available to the Indemnified Party, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Insurance Company will not be liable to that party under this Agreement for any legal or other expenses subsequently incurred by the party independently in connection with the defense thereof other than reasonable costs of investigation.
9.1(d). The Indemnified Parties will promptly notify the Insurance Company of the commencement of any litigation or proceedings against them in connection with the issuance or sale of the Companys shares or the Contracts or the operation of the Company.
9.2. Indemnification by Davis Distributors
9.2(a). Davis Distributors agrees to indemnify and hold harmless the Insurance Company and each of its directors, officers, employees or agents, and each person, if any, who controls the Insurance Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 9.2) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of Davis Distributors) or litigation (including legal and other expenses) to which the Indemnified Parties may become subject under any statute, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale, acquisition or redemption of the Companys shares or the Contracts and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus (or summary prospectus), statement of additional information or sales literature of the Company (or any
amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if the statement or omission or alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to Davis Distributors or the Company by or on behalf of the Insurance Company for use in the registration statement, prospectus (or summary prospectus), or statement of additional information for the Company or in sales literature (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or Company shares;
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus (or summary prospectus), statement of additional information or sales literature for the Contracts not supplied by Davis Distributors or persons under its control) or wrongful conduct of the Company, Davis Distributors or persons under their control, with respect to the sale or distribution of the Contracts or shares of the Company;
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus (or summary prospectus), statement of additional information or sales literature covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished in writing to the Insurance Company by or on behalf of the Company;
(iv) arise as a result of any failure by the Company to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification requirements specified in Article VII of this Agreement); or
(v) arise out of or result from any material breach of any representation, warranty or agreement made by Davis Distributors in
this Agreement or arise out of or result from any other material breach of this Agreement by Davis Distributors;
as limited by and in accordance with the provisions of Sections 9.2(b) and 9.2(c) hereof.
9.2(b) Davis Distributors shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified Party that may arise from the Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of the Indemnified Partys duties or by reason of the Indemnified Partys reckless disregard of obligations and duties under this Agreement or to the Insurance Company or the Account, whichever is applicable.
9.2(c) Davis Distributors shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless the Indemnified Party shall have notified Davis Distributors in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon the Indemnified Party (or after the Indemnified Party shall have received notice of such service on any designated agent). Notwithstanding the foregoing, the failure of any Indemnified Party to give notice as provided herein shall not relieve Davis Distributors of its obligations hereunder except to the extent that Davis Distributors has been prejudiced by such failure to give notice. In addition, any failure by the Indemnified Party to notify Davis Distributors of any such claim shall not relieve Davis Distributors from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, Davis Distributors will be entitled to participate, at its own expense, in the defense thereof. Davis Distributors also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action; provided, however, that if the Indemnified Party shall have reasonably concluded that there may be defenses available to it which are different from or additional to those available to Davis Distributors, Davis Distributors shall not have the right to assume said defense, but shall pay the costs and expenses thereof (except that in no event shall Davis Distributors be liable for the fees and expenses of more than one counsel for Indemnified Parties in connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances). After notice from Davis Distributors to the Indemnified Party of Davis Distributors election to assume the defense thereof, and in the absence of such a reasonable conclusion that there may be different or additional defenses available to the Indemnified Party, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and Davis Distributors will not be liable to that party under this Agreement for any legal or other expenses subsequently incurred by that party independently in connection with the defense thereof other than reasonable costs of investigation.
9.2(d) The Insurance Company agrees to notify Davis Distributors promptly of the commencement of any litigation or proceedings against it or any of its officers or directors in connection with the issuance or sale of the Contracts or the operation of the Account.
9.3 Indemnification By the Company
9.3(a). The Company agrees to indemnify and hold harmless the Insurance Company, and each of its directors, officers, employees and agents, and each person, if any, who controls the Insurance Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 9.3) against any and all losses, claims, damages, liabilities (including legal and other expenses) to which the Indemnified Parties may become subject under any statute, at common law or otherwise, insofar as those losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements result from the gross negligence, bad faith or willful misconduct of any director(s) of the Company, are related to the operations of the Company or:
(i) arise as a result of any failure by the Company to provide the services and furnish the materials under the terms of this Agreement (including a failure to comply with the diversification requirements specified in Article VII of this Agreement);
(ii) arise out of or result from any material breach of any representation, warranty or agreement made by the Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Company; or
(iii) arise out of or result from the materially incorrect or untimely calculation or reporting of the daily net asset value per share or dividend or capital gain distribution rate for any Fund. With respect to net asset value information, the Company will make a determination, in accordance with SEC guidelines, as to whether an error has occurred. Any correction of pricing errors shall be accomplished using the least costly corrective action, as agreed to by the Company in writing. In no event shall the Company be required to reimburse for pricing errors caused by conditions beyond the control of the Company or its agent, including, but not limited to, Acts of God, fires, electrical or phone outages.
as limited by, and in accordance with the provisions of, Sections 9.3(b) and 9.3(c) hereof.
9.3(b). The Company shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified Party that may arise from the Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of the Indemnified Partys duties or by reason of the Indemnified Partys reckless disregard of obligations and duties under this Agreement or to the Insurance Company or the Account, whichever is applicable.
9.3(c). The Company shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless the Indemnified Party shall have notified the Company in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon the Indemnified Party (or after the Indemnified Party shall have received notice of such service on any designated agent). Notwithstanding the foregoing, the failure of any Indemnified Party to give notice as provided herein shall not relieve the Company of its obligations hereunder except to the extent that the Company has been prejudiced by such failure to give notice. In addition, any failure by the Indemnified Party to notify the Company of any such claim shall not relieve the Company from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Company will be entitled to participate, at its own expense, in the defense thereof. The Company also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action; provided, however, that if the Indemnified Party shall have reasonably concluded that there may be defenses available to it which are different from or additional to those available to the Company, the Company shall not have the right to assume said defense, but shall pay the costs and expenses thereof (except that in no event shall the Company be liable for the fees and expenses of more than one counsel for Indemnified Parties in connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances). After notice from the Company to the Indemnified Party of the Companys election to assume the defense thereof, and in the absence of such a reasonable conclusion that there may be different or additional defenses available to the Indemnified Party, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Company will not be liable to that party under this Agreement for any legal or other expenses subsequently incurred by that party independently in connection with the defense thereof other than reasonable costs of investigation.
9.3(d). The Insurance Company and Davis Distributors agree promptly to notify the Company of the commencement of any litigation or proceedings against it or any of its respective officers or directors in connection with this Agreement, the issuance or sale of the Contracts, the operation of the Account, or the sale or acquisition of shares of the Company.
9.4. Notwithstanding anything in this Agreement to the contrary, in no event will a party to this Agreement be liable to any other party for lost profits, exemplary, punitive, special, incidental, indirect, or consequential damages each of which is hereby excluded by the parties.
ARTICLE X. Applicable Law
10.1. This Agreement shall be construed and provisions hereof interpreted under and in accordance with the laws of the State of Maryland.
10.2. This Agreement shall be subject to the provisions of the 1933, 1934, and 1940 Acts, and the rules and regulations and rulings thereunder, including any exemptions from those statutes, rules and regulations the SEC may grant (including, but not limited to, the Mixed and Shared Funding Exemptive Order) and the terms hereof shall be interpreted and construed in accordance therewith.
ARTICLE XI. Termination
11.1. This Agreement shall terminate:
(a) at the option of any party upon one year advance written notice to the other parties; provided, however, such notice shall not be given earlier than one year following the date of this Agreement; or
(b) at the option of the Insurance Company to the extent that shares of Funds are not reasonably available to meet the requirements of the Contracts as determined by the Insurance Company, provided, however, that such a termination shall apply only to the Fund(s) not reasonably available. Prompt written notice of the election to terminate for such cause shall be furnished by the Insurance Company to the Company and Davis Distributors; or
(c) at the option of the Company or Davis Distributors, in the event that formal administrative proceedings are instituted against the Insurance Company by FINRA, the SEC, an insurance commissioner or any other regulatory body regarding the Insurance Companys duties under this Agreement or related to the sale of the Contracts, the operation of any Account, or the purchase of the Companys shares, provided, however, that the Company determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Insurance Company to perform its obligations under this Agreement; or
(d) at the option of the Insurance Company in the event that formal administrative proceedings are instituted against the Company or Davis Distributors by FINRA, the SEC, or any state securities or insurance department or any other regulatory body, provided, however, that the Insurance Company determines in its sole judgement exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Company or Davis Distributors to perform its obligations under this Agreement; or
(e) with respect to any Account, upon requisite vote of the Contract owners having an interest in that Account (or any subaccount) to substitute the shares of another investment company for the corresponding Fund shares in accordance with the terms of the Contracts for which those Fund shares had been selected to serve as the underlying investment media.
The Insurance Company will give at least 30 days prior written notice to the Company of the date of any proposed vote to replace the Companys shares; or
(f) at the option of the Insurance Company, in the event any of the Companys shares are not registered, issued or sold in accordance with applicable state and/or federal law or exemptions therefrom, or such law precludes the use of those shares as the underlying investment media of the Contracts issued or to be issued by the Insurance Company; or
(g) at the option of the Insurance Company, if the Company ceases to qualify as a regulated investment company under Subchapter M of the Code or under any successor or similar provision, or if the Insurance Company reasonably believes that the Company may fail to so qualify; or
(h) at the option of the Insurance Company, if the Company fails to meet the diversification requirements specified in Article VII hereof; or
(i) at the option of either the Company or Davis Distributors, if (1) the Company or Davis Distributors, respectively, shall determine, in their sole judgment reasonably exercised in good faith, that the Insurance Company has suffered a material adverse change in its business or financial condition or is the subject of material adverse publicity and that material adverse change or material adverse publicity will have a material adverse impact upon the business and operations of either the Company or Davis Distributors, (2) the Company or Davis Distributors shall notify the Insurance Company in writing of that determination and its intent to terminate this Agreement, and (3) after considering the actions taken by the Insurance Company and any other changes in circumstances since the giving of such a notice, the determination of the Company or Davis Distributors shall continue to apply on the sixtieth (60th) day following the giving of that notice, which sixtieth day shall be the effective date of termination; or
(j) at the option of the Insurance Company, if (1) the Insurance Company shall determine, inits sole judgment reasonably exercised in good faith, that either the Company or Davis Distributors has suffered a material adverse change in its business or financial condition or is the subject of material adverse publicity and that material adverse change or material adverse publicity will have a material adverse impact upon the business and operations of the Insurance Company, (2) the Insurance Company shall notify the Company and Davis Distributors in writing of the determination and its intent to terminate the Agreement, and (3) after considering the actions taken by the Company and/or Davis Distributors and any other changes in circumstances since the giving of such a notice, the determination shall continue to apply on the sixtieth (60th) day following the giving of the notice, which sixtieth day shall be the effective date of termination.
(k) At the option of any party upon another partys failure to cure a material breach of any
provision of this Agreement within 30 days after written notice thereof.
11.2. It is understood and agreed that the right of any party hereto to terminate this Agreement pursuant to Section 11.1(a) may be exercised for any reason or for no reason.
11.3. No termination of this Agreement shall be effective unless and until the party terminating this Agreement gives prior written notice to all other parties to this Agreement of its intent to terminate, which notice shall set forth the basis for the termination. Furthermore,
(a) In the event that any termination is based upon the provisions of Article VIII, or the provision of Section 11.1(a), 11.1(i) or 11.1(j) of this Agreement, the prior written notice shall be given in advance of the effective date of termination as required by those provisions; and
(b) in the event that any termination is based upon the provisions of Section 11.1(c) or 11.1(d) of this Agreement, the prior written notice shall be given at least ninety (90) days before the effective date of termination; provided that any party may terminate this Agreement immediately with respect to any Fund if such party reasonably determines that continuing to perform under this Agreement would violate any state or federal law.
11.4. Notwithstanding any termination of this Agreement, subject to Section 1.2 of this Agreement and for so long as the Company continues to exist, the Company and Davis Distributors shall at the option of the Insurance Company, continue to make available additional shares of the Company pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (Existing Contracts). Specifically, without limitation, the owners of the Existing Contracts shall be permitted to reallocate investments from any other investment option to any Fund, redeem investments in the Company and/or invest in the Company upon the making of additional purchase payments under the Existing Contracts. The parties agree that this Section 11.4 shall not apply to any terminations under Article VIII and the effect of Article VIII terminations shall be governed by Article VIII of this Agreement.
11.5. The Insurance Company shall not redeem Company shares attributable to the Contracts (as opposed to Company shares attributable to the Insurance Companys assets held in the Account) except (i) as necessary to implement Contract-owner-initiated transactions, or (ii) as required by state and/or federal laws or regulations or judicial or other legal precedent of general application (a Legally Required Redemption). Upon request, the Insurance Company will promptly furnish to the Company and Davis Distributors the opinion of counsel for the Insurance Company (which counsel shall be reasonably satisfactory to the Company and Davis Distributors) to the effect that any redemption pursuant to clause (ii) above is a Legally Required Redemption.
ARTICLE XII. Notices
Any notice shall be sufficiently given when sent by registered or certified mail to the other party at the address of that other party set forth below or at such other address as the other party may from time to time specify in writing.
If to the Company:
2949 East Elvira Road, Suite 101
Tucson, Arizona 85756
Attention: Ryan Charles, Vice President
If to the Insurance Company:
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, AL 35223
Attention: Senior Vice President, Chief Product Officer
With a copy to:
Senior Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
If to Davis Distributors:
2949 East Elvira Road, Suite 101
Tucson, Arizona 85756
Attention: Ryan Charles, Vice President
ARTICLE XIII. Miscellaneous
13.1. Subject to the requirements of legal process and regulatory authority, each party hereto shall treat as confidential the names and addresses of the owners of the Contracts and all information reasonably identified as confidential in writing by any other party hereto and, except as permitted by this Agreement, shall not disclose, disseminate or utilize such names and addresses and other confidential information without the express written consent of the affected party unless and until that information may come into the public domain.
13.2. The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
13.3. This Agreement may be executed simultaneously in two or more counterparts, each of which taken together shall constitute one and the same instrument.
13.4. If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.
13.5. Each party hereto shall cooperate with each other party and all appropriate governmental authorities (including without limitation the SEC, FINRA and state insurance regulators) and shall permit those authorities reasonable access to its books and records in connection with any lawful investigation or inquiry relating to this Agreement or the transactions contemplated hereby.
13.6. The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.
13.7. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns; provided, that no party may assign this Agreement without the prior written consent of the others.
13.8. Except as otherwise expressly provided in this Agreement, neither the Company nor Davis Distributors, nor any affiliate thereof shall use any trademark, trade name, service mark or logo of the Insurance Company or any of its affiliates, or any variation of any such trademark, trade name, service mark or logo, without the Insurance Companys prior written consent, the granting of which shall be at the Insurance Companys sole option.
13.9. Except as otherwise expressly provided in this Agreement, neither the Insurance Company nor any affiliate thereof shall use any trademark, trade name, service mark or logo of the Company or Davis Distributors, or any affiliates thereof, or any variation of any such trademark, trade name, service mark or logo, without the Companys or Davis Distributors prior written consent, the granting of which shall be at the Companys and Davis Distributors sole option.
13.10. Agreement to Arbitrate. Each of the parties agrees that any controversy or claim arising out of or relating to this Agreement, or the breach thereof, shall be settled by arbitration in accordance with the Code of Arbitration Procedure of FINRA (or, in the event that the FINRA refuses to accept jurisdiction, the Commercial Arbitration Rules of the American Arbitration Association), and judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof.
13.11. The Company represents and warrants that it shall comply with any applicable privacy provisions, which include Title V of the Gramm-Leach-Bliley Act, and any regulations adopted thereto, including Regulation S-P of the SEC. The Company agrees that any non-public personal information, as the term is defined in Regulation S-P, which may be disclosed
hereunder is disclosed for the specific purpose of permitting the Company to perform the services set forth in this Agreement.
13.12. The Company represents and warrants that it has implemented, and agrees to maintain an anti-money laundering program reasonably designed to comply with all applicable anti-money laundering laws and regulations, including but not limited to the Bank Secrecy Act of 1970 and the USA PATRIOT Act of 2001, each as amended from time to time, and any rules adopted thereunder and/or any applicable anti-money laundering laws and regulations of other jurisdictions where the Company conducts business, and any rules adopted thereunder or guidelines issued, administered or enforced by any governmental agency. The Company further represents and warrants that its anti-money laundering program includes written policies, a designated Compliance Officer, ongoing training for employees, procedures for detecting and reporting suspicious transactions, and an independent audit to test the implementation of the program.
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and on its behalf by its duly authorized representative as of the date specified below.
|
Protective Life Insurance Company |
|
|
(Insurance Company) |
|
|
By its authorized officer, |
|
|
|
|
|
By: |
|
|
Title: |
|
|
Date: |
|
|
|
|
|
DAVIS VARIABLE ACCOUNT FUND |
|
|
(Company) |
|
|
By its authorized officer, |
|
|
|
|
|
By: |
|
|
Title: |
Vice President |
|
Date: |
|
|
DAVIS DISTRIBUTORS, LLC |
|
|
(Davis Distributors) |
|
|
By its authorized officer, |
|
|
|
|
|
By: |
|
|
Title: |
President |
|
Date: |
|
Schedule A
Accounts
|
|
Date of Resolution of Insurance Companys |
Name of Account |
|
Board which Established the Account |
|
|
|
Protective COLI VUL Separate Account |
|
February 25, 2020 |
Protective COLI PPVUL Separate Account |
|
April 14, 2020 |
Schedule B
Contracts
Protective® Executive Benefits Registered VUL
Protective® Executive Benefits Private Placement VUL
Schedule C
to
Participation Agreement
Name of Fund
Davis Financial Portfolio
Davis Real Estate Portfolio
Davis Value Portfolio
Schedule D
Proxy Voting Procedure
The following is a list of procedures and corresponding responsibilities for the handling of proxies relating to the Company by Davis Distributors, the Company and the Insurance Company. The defined terms herein shall have the meanings assigned in the Participation Agreement except that the term Insurance Company shall also include the department or third party assigned by the Insurance Company to perform the steps delineated below.
1. The number of proxy proposals is given to the Insurance Company by Davis Distributors as early as possible before the date set by the Company for the shareholder meeting to facilitate the establishment of tabulation procedures. At this time Davis Distributors will inform the Insurance Company of the Record, Mailing and Meeting dates. This will be done verbally, with confirmation following promptly in writing, approximately two months before meeting.
2. Promptly after the Record Date, the Insurance Company will perform a tape run, or other activity, which will generate the names, addresses and number of units which are attributed to each contract-owner/policyholder (the Customer) as of the Record Date. Allowance should be made for account adjustments made after this date that could affect the status of the Customers accounts of the Record Date.
Note: The number of proxy statements is determined by the activities described in Step #2. The Insurance Company will use its best efforts to call in the number of Customers to Davis Distributors, as soon as possible, but no later than one week after the Record Date.
3. The text and format for the Voting Instruction Cards (Cards or Card) is provided to the Insurance Company by the Company. The Insurance Company, at its expense, shall produce and personalize the Voting Instruction cards. Davis Distributors must approve the Card before it is printed. Allow approximately 2-4 business days for printing information on the Cards. Information commonly found on the Cards includes:
a. name (legal name as found on account registration)
b. address
c. Fund or account number
d. coding to state number of units
e. individual Card number for use in tracking and verification of votes (already on Cards as printed by the Company).
(This and related steps may occur later in the chronological process due to possible uncertainties relating to the proposals.)
4. During this time, Davis Distributors will develop, produce, and the Company will pay for the Notice of Proxy and the Proxy Statement (one document). Printed and folded notices and statements will be sent to Insurance Company for insertion into envelopes (envelopes
and return envelopes are provided and paid for by the Insurance Company). Contents of envelope sent to customers by Insurance Company will include:
a. |
Voting Instruction Card(s) |
b. |
One proxy notice and statement (one document) |
c. |
Return envelope (postage pre-paid by Insurance Company) addressed to the Insurance Company or its tabulation agent |
d. |
Urge buckslip - optional, but recommended. (This is a small, single sheet of paper that requests Contract owners to vote as quickly as possible and that their vote is important. One copy will be supplied by the Company.) |
e. |
Cover letter - optional, supplied by Insurance Company and reviewed and approved in advance by Davis Distributors. |
5. The above contents should be received by the Insurance Company approximately 3-5 business days before mail date, and in no event later than 3 business days before mail date. Individual in charge at Insurance Company reviews and approves the contents of the mailing package to ensure correctness and completeness. Copy of this approval sent to Davis Distributors.
6. Package mailed by the Insurance Company.
* The Company must allow at least a 15-day solicitation time to the Insurance Company as the shareowner. (A 5-week period is recommended.) Solicitation time is calculated as calendar days from (but not including) the meeting, counting backwards.
7. Collection and tabulation of Cards begins. Tabulation usually takes place in another department or another vendor depending on process used. An often-used procedure is to sort cards on arrival by proposal into vote categories of all yes, no, or mixed replies, and to begin data entry.
Note: Postmarks are not generally needed. A need for postmark information would be due to an insurance companys internal procedure.
8. If Cards are mutilated, or for any reason are illegible or are not signed properly, they are sent back to the Customer with an explanatory letter, a new Card and return envelope. The mutilated or illegible Card is disregarded and considered to be not received for purposes of vote tabulation. Such mutilated or illegible Cards are hand verified, i.e., examined as to why they did not complete the system. Any questions on those Cards are usually remedied individually.
9. There are various control procedures used to ensure proper tabulation of votes and accuracy of that tabulation. The most prevalent is to sort the Cards as they first arrive into categories depending upon their vote; an estimate of how the vote is progressing may then be
calculated. If the initial estimates and the actual vote do not coincide, then an internal audit of that vote should occur. This may entail a recount.
10. The actual tabulation of votes is done in units and then converted to shares. (It is very important that the Company receives the tabulations stated in terms of a percentage and the number of shares.) Davis Distributors must review and approve tabulation format.
11. Final tabulation in shares is verbally given by the Insurance Company to Davis Distributors on the day of the meeting not later than 1:00 p.m. Eastern time. Davis Distributors may request an earlier deadline if required to calculate the vote in time for the meeting.
12. A Certificate of Mailing and Authorization to Vote Shares will be required from the Insurance Company as well as an original copy of the final vote. Davis Distributors will provide a standard form for each Certification.
13. The Insurance Company will be required to box and archive the Cards received from the Customers. In the event that any vote is challenged or if otherwise necessary for legal, regulatory, or accounting purposes, Davis Distributors will be permitted reasonable access to such Cards.
14. All approvals and signing-off may be done orally, but must always be followed up in writing. For this purpose, signatures transmitted by facsimile will be acceptable.
AMENDED AND RESTATED PARTICIPATION AGREEMENT
THIS AMENDED AND RESTATED AGREEMENT, dated as of the 1 day of February, 2015 by and among PROTECTIVE LIFE INSURANCE COMPANY (the Company), a Tennessee life insurance company, on its own behalf and on behalf of each segregated asset account of the Company set forth on Schedule A hereto as may be amended from time to time (each separate account hereinafter referred to as the Account), DEUTSCHE VARIABLE SERIES I, DEUTSCHE VARIABLE SERIES H and DEUTSCHE INVESTMENTS VIT FUNDS (individually, a Fund), each a Massachusetts business trust created under a Declaration of Trust, as amended, DeAWM DISTRIBUTORS, INC. (the Underwriter), a Delaware corporation, and DEUTSCHE INVESTMENT MANAGEMENT AMERICAS INC., a Delaware corporation (the Adviser). The parties understand that effective July 2, 2012 United Investors Life Insurance Company merged into Protective Life Insurance Company with Protective Life Insurance Company remaining as the surviving company. The parties further acknowledge that effective as of February 1, 2015, the Companys parent, Protective Life Corporation, will be acquired by The Dai-ichi Life Insurance Company, Limited. The parties agree that this single document amends and restates any and all previously existing Participation Agreements and amendments or supplements thereto (including, but not limited to, any Participating Contracts and Policy Agreements and Indemnification Agreements) with United Investors Life Insurance Company as well as any and all existing Participation Agreements and amendments or supplements thereto with Protective Life Insurance Company. The parties agree that a single document is being used for ease of administration and that this Agreement shall be treated as if it were a separate agreement with respect to each Fund, and each series thereof, that is a party hereto, severally and not jointly, as if such entity had entered into a separate agreement naming only itself as a party. Without limiting the foregoing, no Fund, or series thereof, shall have any liability under this Agreement for the obligations of any other Fund, or series thereof.
WHEREAS, the Fund engages in business as an open-end management investment company and is or will be available to act as the investment vehicle for separate accounts established for variable life insurance and variable annuity contracts (the Variable Insurance Products) to be offered by insurance companies which have entered into participation agreements with the Fund and Underwriter (Participating Insurance Companies);
WHEREAS, the beneficial interest in the Fund is divided into several series of shares of beneficial interest without par value, and, with respect to certain series, classes thereof (Shares), and additional series of Shares, and classes thereof, may be established, each such series of Shares designated a Portfolio and representing the interest in a particular managed portfolio of securities and other assets;
WHEREAS, the Fund has obtained an order from the Securities and Exchange Commission (the SEC) granting Participating Insurance Companies and variable annuity and variable life insurance separate accounts exemptions from the provisions of sections 9(a), 13(a), 15(a), and 15(b) of the Investment Company Act of 1940, as amended (the 1940 Act) and Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit Shares of the
Fund to be sold to and held by variable annuity and variable life insurance separate accounts of both affiliated and unaffiliated life insurance companies (the Mixed and Shared Funding Exemptive Order);
WHEREAS, the Fund is registered as an open-end management investment company under the 1940 Act and Shares of the Portfolios are registered under the Securities Act of 1933, as amended (the 1933 Act);
WHEREAS, the Adviser, which serves as investment adviser to the Fund, is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and any applicable state securities laws;
WHEREAS, the Company has issued or will issue certain variable life insurance and/or variable annuity contracts supported wholly or partially by the Account (the Contracts), and said Contracts are listed in Schedule A hereto, as it may be amended from time to time by mutual written agreement;
WHEREAS, the Account is duly established and maintained as a segregated asset account, established by resolution of the Board of Directors of the Company, on the date shown for such Account on Schedule A hereto, to set aside and invest assets attributable to the aforesaid Contracts;
WHEREAS, the Underwriter, which serves as distributor to the Fund, is registered as a broker dealer with the SEC under the Securities Exchange Act of 1934, as amended (the 1934 Act), and is a member in good standing of the Financial Industry Regulatory Authority (FINRA); and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company intends to purchase shares in the Portfolios, and classes thereof, listed in Schedule B hereto, as it may be amended from time to time by mutual written agreement (the Designated Portfolios) on behalf of the Account to fund the aforesaid Contracts, and the Underwriter is authorized to sell such Shares to the Account at net asset value;
NOW, THEREFORE, in consideration of their mutual promises, the Company, the Fund, the Adviser and the Underwriter agree as follows:
ARTICLE I. Sale of Fund Shares
1.1. The Fund has granted to the Underwriter exclusive authority to distribute the Funds Shares, and has agreed to instruct, and has so instructed, the Underwriter to make available to the Company for purchase, on behalf of the Account, Fund Shares of those Designated Portfolios selected by the Underwriter. Pursuant to such authority and instructions, and subject to Article X hereof, the Underwriter agrees to make available to the Company for purchase on behalf of the Account, Shares of those Designated Portfolios listed on Schedule B to this Agreement, such purchases to be effected at net asset value in accordance with Section 1.3 of this Agreement. Notwithstanding the foregoing, (i) Fund series (other than those listed on Schedule B) in existence now or that may be established in the future will be made available to the Company only as the Underwriter may so provide, and (ii) the Board of Trustees of the Fund (the Board) may refuse to sell shares of any Designated Portfolio to any person, or suspend or
terminate the offering of Fund Shares of any Designated Portfolio or class thereof, if such action is required by law or by regulatory authorities having jurisdiction or if, in the sole discretion of the Board acting in good faith and in light of its fiduciary duties under federal and any applicable state laws, suspension or termination is in the best interests of the shareholders of such Designated Portfolio.
1.2. The Fund shall redeem, at the Companys request, any full or fractional Designated Portfolio Shares held by the Company on behalf of the Account, such redemptions to be effected at net asset value in accordance with Section 1.3 of this Agreement. Notwithstanding the foregoing, (i) the Company shall not redeem Fund Shares attributable to Contract owners except in the circumstances permitted in Section 10.3 of this Agreement, and (ii) the Fund may suspend the right of redemption or postpone the date of payment or satisfaction upon redemption of Fund Shares of any Designated Portfolio to the extent permitted by the 1940 Act, any rules, regulations or orders thereunder.
1.3. Purchase and Redemption Procedures
(a) The Fund hereby appoints the Company as an agent of the Fund for the limited purpose of receiving purchase and redemption requests on behalf of the Account (but not with respect to any Fund Shares that may be held in the general account of the Company) for Shares of those Designated Portfolios made available hereunder, based on allocations of amounts to the Account or subaccounts thereof under the Contracts and other transactions relating to the Contracts or the Account. Receipt of any such request (or relevant transactional information therefore) on any day the New York Stock Exchange is open for trading and on which the Fund calculates its net asset value pursuant to the rules of the SEC (a Business Day) by the Company as such limited agent of the Fund prior to the time that the Fund calculates its net asset value as described from time to time in the Fund Prospectus (which as of the date of execution of this Agreement is 4:00 p.m. Eastern Time) shall constitute receipt by the Fund on that same Business Day, provided that the Fund receives notice of such request by 9:30 a.m. Eastern Time on the next following Business Day.
(b) The Company shall pay for Shares of each Designated Portfolio on the same day that it notifies the Fund of a purchase request for such Shares. Payment for Designated Portfolio Shares shall be made in federal funds transmitted to the Fund by wire to be received by the Fund by 12:00 p.m. Eastern Time on the same Business Day the Fund is notified of the purchase request for Designated Portfolio Shares pursuant to Section 1.3(a) (unless the Fund determines and so advises the Company that sufficient proceeds are available from redemption of Shares of other Designated Portfolios effected pursuant to redemption requests tendered by the Company on behalf of the Account). If federal funds are not received on time, such funds will be invested, and Designated Portfolio Shares purchased thereby will be issued, as soon as practicable and the Company shall promptly, upon the Funds request, reimburse the Fund for any charges, costs, fees, interest or other expenses incurred by the Fund in connection with any advances to, or borrowing or overdrafts by, the Fund, or any similar expenses incurred by the Fund, as a result of portfolio transactions effected by the Fund based upon such purchase request. Upon receipt of federal funds so wired, such funds shall cease to be the responsibility of the Company and shall become the responsibility of the Fund.
(c) The Fund will redeem Designated Portfolio Shares requested on behalf of the Account, and make payment therefore, in accordance with the provisions of the then current registration statement of the Fund. Payment for Designated Portfolio Shares redeemed by the Account or the Company normally shall be made in federal funds transmitted by wire to the Company or any other designated person on the same Business Day that the Fund is properly notified of the redemption order for such Shares pursuant to Section 1.3(a) (unless redemption proceeds are to be applied to the purchase of Shares of other Designated Portfolios in accordance with Section 1.3(b) of this Agreement). The Fund shall not bear any responsibility whatsoever for the proper disbursement or crediting of redemption proceeds by the Company, the Company alone shall be responsible for such action.
(d) Any purchase or redemption request for Designated Portfolio Shares held or to be held in the Companys general account shall be effected at the net asset value per share next determined after the Funds receipt of such request, provided that, in the case of a purchase request, payment for Fund Shares so requested is received by the Fund in federal funds prior to close of business for determination of such value, as defined from time to time in the Fund Prospectus.
1.4. The Fund shall use its best efforts to make the net asset value per share for each Designated Portfolio available to the Company by 6:30 p.m. Eastern Time each Business Day, and in any event, as soon as reasonably practicable after the net asset value per share for such Designated Portfolio is calculated, and shall calculate such net asset value in accordance with the Funds Prospectus. Any material error in the calculation or reporting of net asset value per share, dividend or capital gain information shall be reported to the Company promptly upon discovery by the Fund. A material error in the calculation of net asset value per share shall be corrected in accordance with the procedures for correcting net asset value errors adopted by the Funds Board of Trustees and in effect at the time of the error. The Fund represents and warrants that its procedures for correcting net asset value errors, including determinations of materiality, currently comply, and will continue to comply, with the 1940 Act and generally industry-wide accepted SEC staff interpretations concerning pricing errors in effect at the time of an error.
1.5. The Fund shall furnish notice (by wire or telephone followed by written confirmation) to the Company as soon as reasonably practicable of any income dividends or capital gain distributions payable on any Designated Portfolio Shares. The Company, on its behalf and on behalf of the Account, hereby elects to receive all such dividends and distributions as are payable on any Designated Portfolio Shares in the form of additional Shares of that Designated Portfolio. The Company reserves the right, on its behalf and on behalf of the Account, to revoke this election and to receive all such dividends and capital gain distributions in cash. The Fund shall notify the Company of the number of Designated Portfolio Shares so issued as payment of such dividends and distributions.
1.6. Issuance and transfer of Fund Shares shall be by book entry only. Stock certificates will not be issued to the Company or the Account. Purchase and redemption orders for Fund Shares shall be recorded in an appropriate ledger for the Account or the appropriate subaccount of the Account.
1.7. The parties hereto acknowledge that the arrangement contemplated by this Agreement is not exclusive; the Funds Shares may be sold to other insurance companies (subject
to Section 1.8 hereof) and to certain qualified retirement plans, and the cash value of the Contracts may be invested in other investment companies.
1.8. The Underwriter and the Fund shall sell Fund Shares only to Participating Insurance Companies and their separate accounts and to persons or plans (Qualified Persons) that qualify to purchase Shares of the Fund under Section 817(h) of the Internal Revenue Code of 1986, as amended (the Code), and the regulations thereunder without impairing the ability of the Account to consider the portfolio investments of the Fund as constituting investments of the Account for the purpose of satisfying the diversification requirements of Section 817(h). The Underwriter and the Fund shall not sell Fund Shares to any insurance company or separate account unless an agreement complying with Article VI of this Agreement is in effect to govern such sales. The Company hereby represents and warrants that it and the Account are Qualified Persons. The Fund reserves the right to cease offering Shares of any Designated Portfolio in the discretion of the Fund.
ARTICLE II. Representations, Warranties and Covenants
2.1. The Company represents and warrants that the Contracts (a) are or, prior to issuance, will be registered under the 1933 Act or, alternatively (b) are not registered because they are properly exempt from registration under the 1933 Act or will be offered exclusively in transactions that are properly exempt from registration under the 1933 Act. The Company further represents and warrants that the Contracts will be issued and sold in compliance in all material respects with all applicable federal securities and state securities and insurance laws and that the sale of the Contracts shall comply in all material respects with state insurance suitability requirements. The Company further represents and warrants that it is an insurance company duly organized and in good standing under applicable law, that it has legally and validly established the Account prior to any issuance or sale thereof as a segregated asset account under applicable insurance laws, and that it (a) has registered or, prior to any issuance or sale of the Contracts, will register the Account as a unit investment trust in accordance with the provisions of the 1940 Act to serve as a segregated investment account for the Contracts, or alternatively (b) has not registered the Account in proper reliance upon an exclusion from registration under the 1940 Act. The Company shall register and qualify the Contracts or interests therein as securities in accordance with the laws of the various states only if and to the extent deemed advisable by the Company.
2.2. The Fund represents and warrants that Fund Shares sold pursuant to this Agreement shall be registered under the 1933 Act, duly authorized for issuance and sold in compliance in all material respects with all applicable federal securities laws and that the Fund is and shall remain registered under the 1940 Act. The Fund shall amend the registration statement for its Shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of the shares of the Designated Portfolios. The Fund shall register and qualify such Shares for sale in accordance with the laws of the various states only if and to the extent deemed advisable by the Fund or the Underwriter after taking into consideration any state insurance law requirements that the Company advises the Fund may be applicable.
2.3. The Fund makes no representations as to whether any aspect of its operations, including, but not limited to, investment policies, fees and expenses, complies with the insurance and other applicable laws of the various states, except that the Fund represents that the
investment policies, fees and expenses of the Designated Portfolios, are and shall at all times remain in compliance with the insurance laws of the state of organization of the Company set forth on the first page (the State) to the extent required to perform this Agreement. The Company will advise the Fund in writing as to any requirements of State insurance law that affect the Designated Portfolios, and the Fund will be deemed to be in compliance with this Section 2.3 so long as the Fund complies with such advice of the Company.
2.4. The Fund represents that it is a Massachusetts business trust duly organized and validly existing under the laws of the Commonwealth of Massachusetts and that the Designated Portfolios do and will comply in all material respects with all applicable provisions of the 1940 Act.
2.5. The Underwriter represents and warrants that it is a member in good standing of FINRA and is registered as a broker-dealer with the SEC. The Underwriter further represents that it will sell and distribute the shares of the Designated Portfolios in accordance with any applicable state and federal securities laws.
2.6. The Adviser represents and warrants that it is and shall remain duly registered as an investment adviser under all applicable federal and state securities laws and that it shall perform its obligations for the Fund in compliance in all material respects with any applicable state and federal securities laws.
2.7. The Fund, the Adviser and the Underwriter represent and warrant that all of their trustees, directors, officers, employees, investment advisers, and other individuals or entities dealing with the money and/or securities of the Fund are and shall continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Fund in an amount not less than the minimum coverage as required currently by Rule 17g-1 of the 1940 Act or such related provisions as may be promulgated from time to time. The aforesaid bond shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company.
2.8. The Company represents and warrants that all of its directors, officers, employees, investment advisers, and other individuals or entities employed or controlled by the Company dealing with the money and/or securities of the Account are covered by a blanket fidelity bond or similar coverage for the benefit of the Account, in an amount not less than $20 million. The aforesaid bond includes coverage for larceny and embezzlement and is issued by a reputable bonding company. The Company agrees to hold for the benefit of the Fund and to pay to the Fund any amounts lost from larceny, embezzlement or other events covered by the aforesaid bond to the extent such amounts properly belong to the Fund pursuant to the terms of this Agreement. The Company agrees to make all reasonable efforts to see that this bond or another bond containing these provisions is always in effect, and agrees to notify the Fund and the Underwriter in the event that such coverage no longer applies.
2.9. The Company represents and warrants that all shares of the Designated Portfolios purchased by the Company will be purchased on behalf of one or more unmanaged separate accounts that offer interests therein that are registered under the 1933 Act and upon which a registration fee has been or will be paid or that are unregistered because the interests are exempt from registration under the 1933 Act, and the Company acknowledges that the Fund intends to rely upon this representation and warranty for purposes of calculating SEC registration fees payable with respect to such Shares of the Designated Portfolios pursuant to Form 24F-2 or any
similar form or SEC registration fee calculation procedure that allows the Fund to exclude Shares so sold for purposes of calculating its SEC registration fee. The Company will certify the amount of any Shares of the Designated Portfolios purchased by the Company on behalf of any separate account offering interests not subject to registration under the 1933 Act. The Company agrees to cooperate with the Fund on no less than an annual basis to certify as to its continuing compliance with this representation and warranty.
2.10. The Company represents and warrants as follows:
1. The Company has in place an anti-money laundering program (AML program) that does now and will continue to comply with applicable laws and regulations, including the relevant provisions of the USA PATRIOT Act (Pub. L. No. 107-56 (2001)) and the regulations issued thereunder by the U.S. Treasury Department and the rules of FINRA, as applicable.
2. The Company has in place - and has conducted due diligence pursuant to policies, procedures and internal controls reasonably designed (a) to verify the identity of the Contract owners that invest in the Account, and (b) to identify those Contract owners sources of funds, and have no reason to believe that any of the invested funds were derived from illegal activities.
3. The Company has, after undertaking reasonable inquiry, no information or knowledge that (a) any Contract owner that invests in the Account, or (b) any person or entity controlling, controlled by or under common control with such Contract owner is an individual or entity or in a country or territory that is on an Office of Foreign Assets Control (OFAC) list or similar list of sanctioned or prohibited persons maintained by a U.S. governmental or regulatory body.
The Company further agrees promptly to notify the Fund and the Underwriter should it become aware of any change in the above representations and warranties.
The Company agrees to require any broker-dealer/insurance agency that distributes the Contracts to have an AML Program in substantial compliance with the foregoing.
In addition, the Underwriter and the Fund hereby provide notice to the Company that the Underwriter and/or the Fund reserve the right to make inquiries of and request additional information from the Company regarding its AML program.
2.11. The Company will develop, implement and maintain policies and procedures reasonably designed to prevent the use of the Accounts by persons engaged in short-term trading or excessive trading, which policies and procedures shall be reasonably acceptable to the Fund, the Adviser and the Underwriter. If the Company proposes to modify such policies and procedures following their implementation, the Company will first discuss its proposal with the Fund, the Adviser and the Underwriter and will not materially modify such policies and procedures without the written consent of the Fund, the Adviser and the Underwriter.
In addition to the foregoing, the Company will develop, implement and maintain procedures as necessary or appropriate to further any specific policies and procedures of the Fund, the Adviser or the Underwriter for one or more Designated Portfolios in regard to short-term trading or excessive trading. The Company agrees to comply with the provisions of Schedule D attached hereto, which are designed to carry out the provisions of Rule 22c-2 of the 1940 Act.
The Company represents and warrants that it has reserved sufficient flexibility in the Contracts to impose such limitations and restrictions on transfers and purchases of the underlying investments for the Contracts, including specifically the Designated Portfolios, as may be necessary to implement the policies and procedures referred in this Section 2.11.
The Company acknowledges that all orders accepted by the Company for the Accounts are subject to the obligations of the Company in this Section 2.11, including the obligation to prevent the use of the Accounts for short-term trading or excessive trading, and that the Fund, the Adviser or the Underwriter may take such actions as it deems to be in the best interests of shareholders of the Designated Portfolios to enforce such obligations and to otherwise prevent such trading in shares of the Designated Portfolios, including, among other things, the right to revoke, reject or cancel purchase orders for shares of the Designated Portfolios made by the Company. Any such revocation, rejection or cancellation may be made in whole or in part, it being understood that the Fund, the Adviser and the Underwriter are not required to isolate objectionable trades.
The Fund, the Adviser and the Underwriter shall not be responsible for any losses or costs incurred by the Company, the Account or Account participants as a result of the revocation, rejection or cancellation orders made by the Company in furtherance of the enforcement of their policy to prevent short-term trading and excessive trading in shares of the Designated Portfolios.
2.12. The Company shall comply with any applicable privacy and notice provisions of 15 U.S.C. §§ 6801-6827 and any applicable regulations promulgated thereunder (including but not limited to 17 C.F.R. Part 248) as they may be amended.
2.13. Neither the Fund, any Designated Portfolio, the Underwriter, nor any of their affiliates shall be liable for any information provided to the Company pursuant to this Agreement which information is based on incorrect information supplied by the Company or any other Participating Insurance Company to the Fund or the Underwriter. The Company agrees that the Fund, the Underwriter and the Adviser shall bear no responsibility for any act of any unaffiliated fund or the investment adviser or underwriter thereof.
ARTICLE III. Prospectuses and Proxy Statements; Voting
3.1. The Underwriter shall provide the Company with as many copies of the Funds current prospectus (describing only the Designated Portfolios listed on Schedule B) as the Company may reasonably request. If requested by the Company in lieu thereof, the Fund shall provide such documentation (including a final copy of the new prospectus on computer diskette or other electronic means at the Funds expense) and other assistance as is reasonably necessary
in order for the Company once each year (or more frequently if the prospectus for a Designated Portfolio is amended) to have the prospectus for the Contracts and the prospectus for the Designated Portfolios printed together in one document. Expenses with respect to the foregoing shall be borne as provided under Article V.
3.2. The Funds prospectus shall state that the current Statement of Additional Information (SAI) for the Fund is available from the Fund and the Fund shall provide a copy of such SAI to any owner of a Contract who requests such SAI and to the Company in such quantities as the Company may reasonably request. Expenses with respect to the foregoing shall be borne as provided under Article V.
3.3. The Fund shall provide the Company with copies of its proxy material, reports to shareholders, and other communications to shareholders of the Designated Portfolios in such quantity as the Company shall reasonably require for distributing to Contract owners. Expenses with respect to the foregoing shall be borne as provided under Article V.
3.4. The Company shall:
(i) solicit voting instructions from Contract owners;
(ii) vote the shares of each Designated Portfolio in accordance with instructions received from Contract owners; and
(iii) vote shares of each Designated Portfolio for which no instructions have been received in the same proportion as fund shares of such Designated Portfolio for which instructions have been received, so long as and to the extent that the SEC continues to interpret the 1940 Act to require pass-through voting privileges for variable contract owners or to the extent otherwise required by law. The Company reserves the right to vote shares of each Designated Portfolio held in any segregated asset account in its own right, to the extent permitted by law.
3.5. The Fund reserves the right, upon prior written notice to the Company (given at the earliest practicable time), to take all actions, including but not limited to, the dissolution, termination, merger and sale of all assets of the Fund or any Designated Portfolio upon the sole authorization of the Board, to the extent permitted by the laws of the Commonwealth of Massachusetts and the 1940 Act.
3.6. Participating Insurance Companies shall be responsible for assuring that each of their separate accounts participating in a Designated Portfolio calculates voting privileges as required by the Mixed and Shared Funding Exemptive Order and consistent with any reasonable standards that the Fund may adopt and provide in writing.
3.7. It is understood and agreed that, except with respect to information regarding the Fund, the Underwriter, the Adviser or Designated Portfolios provided in writing by the Fund, the Underwriter or the Adviser, none of the Fund, the Underwriter or the Adviser is responsible for the content of the prospectus or statement of additional information for the Contracts.
ARTICLE IV. Sales Material and Information
4.1. The Company shall furnish, or shall cause to be furnished, to the Fund or its designee, each piece of sales literature or other promotional material that the Company develops or uses and in which the Fund (or a Designated Portfolio thereof) or the Adviser or the Underwriter is named. No such material shall be used until approved by the Fund or its designee, and the Fund will use its best efforts for it or its designee to review such sales literature or promotional material within ten Business Days after receipt of such material. The Fund or its designee reserves the right to reasonably object to the continued use of any such sales literature or other promotional material in which the Fund (or a Designated Portfolio thereof) or the Adviser or the Underwriter is named, and no such material shall be used if the Fund or its designee so objects.
4.2. The Company shall not give any information or make any representations or statements on behalf of the Fund or concerning the Fund in connection with the sale of the Contracts other than the information or representations contained in the registration statement or prospectus or SAI for the Fund Shares, as such registration statement and prospectus or SAI may be amended or supplemented from time to time, or in reports or proxy statements for the Fund, or in sales literature or other promotional material approved by the Fund or its designee or by the Underwriter, except with the permission of the Fund or the Underwriter or the designee of either.
4.3. The Fund and the Underwriter, or their designee, shall furnish, or shall cause to be, furnished, to the Company, each piece of sales literature or other promotional material that it develops or uses and in which the Company, and/or its Account, is named. No such material shall be used until approved by the Company, and the Company will use its best efforts to review such sales literature or promotional material within ten Business Days after receipt of such material. The Company reserves the right to reasonably object to the continued use of any such sales literature or other promotional material in which the Company and/or its Account is named, and no such material shall be used if the Company so objects.
4.4. The Fund and the Underwriter shall not give any information or make any representations on behalf of the Company or concerning the Company, the Account, or the Contracts other than the information or representations contained in a registration statement, prospectus (which shall include an offering memorandum, if any, if the Contracts issued by the Company or interests therein are not registered under the 1933 Act), or SAI for the Contracts, as such registration statement, prospectus, or SA1 may be amended or supplemented from time to time, or in published reports for the Account which are in the public domain or approved by the Company for distribution to Contract owners, or in sales literature or other promotional material approved by the Company or its designee, except with the permission of the Company.
4.5. The Fund will provide to the Company at least one complete copy of any prospectuses and SAIs, and all amendments to any of the above, that relate to the Designated Portfolio(s) reasonably promptly after the filing of such document(s) with the SEC or NASD or other regulatory authorities. Upon request, the Fund will provide to the Company copies of SEC exemptive orders and no-action letters and sales literature and other promotional material that relate to the Designated Portfolios and to the performance of this Agreement by the parties.
4.6. The Company will provide to the Fund at least one complete copy of any prospectuses (which shall include an offering memorandum, if any, if the Contracts issued by the
Company or interests therein are not registered under the 1933 Act) and SAIs, and all amendments to any of the above, that relate to the Contracts or the Account reasonably promptly after the filing of such document(s) with the SEC or NASD or other regulatory authorities. Upon request, the Company will provide to the Fund copies of SEC exemptive orders and no-action letters, solicitations of voting instructions and sales literature and other promotional material that relate to the Contracts or the Account and the performance of this Agreement by the parties. The Company shall provide to the Fund and the Underwriter any complaints received from the Contract owners pertaining to the Fund or the Designated Portfolios.
4.7. The Fund will provide the Company with as much notice as is reasonably practicable of any proxy solicitation for any Designated Portfolio, and of any material change in the Funds registration statement, particularly any change resulting in a change to the registration statement or prospectus for any Account. The Fund will work with the Company so as to enable the Company to solicit proxies from Contract owners, or to make changes to its prospectus or registration statement, in an orderly manner. The Fund will make reasonable efforts to attempt to have changes affecting Contract prospectuses become effective simultaneously with the annual updates for such prospectuses.
4.8. For purposes of this Article IV, the phrase sales literature and other promotional materials includes, but is not limited to, any of the following that refer to the Fund or any affiliate of the Fund: advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, internet website (or other electronic media), telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media), sales literature (i.e., any written communication distributed or made generally available to customers or the public, including brochures, circulars, reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, and registration statements, prospectuses, SAIs, shareholder reports, proxy materials, and any other communications distributed or made generally available with regard to the Fund.
ARTICLE V. Fees and Expenses
5.1. Except as specifically provided in Section 5.4 of this Agreement related to Class B or Class B2 shares for the Deutsche Variable Series I Fund, the Fund, the Adviser and the Underwriter shall pay no fee or other compensation to the Company under this Agreement, although the parties hereto will bear certain expenses in accordance with Schedule C and other provisions of this Agreement.
5.2. All expenses incident to performance by the Fund under this Agreement shall be paid by the Fund, except and as further provided in Schedule C. The cost of setting the Funds prospectus in type, setting in type and printing the Funds proxy materials and reports to shareholders (including the costs of printing a prospectus that constitutes an annual report), the preparation of all statements and notices relating to the Fund required by any federal or state law, and all taxes on the issuance or transfer of the Funds Shares shall be borne by the parties hereto as set forth in Schedule C.
5.3. The expenses of distributing the Funds prospectus to new and existing owners of Contracts issued by the Company and of distributing the Funds proxy materials and reports to Contract owners shall be borne by the parties hereto as set forth in Schedule C.
5.4. The provisions of this Section 5.4 apply only to Class B Shares and, if applicable, Class B2 Shares of the Deutsche Variable Series I Fund. The Company agrees to provide distribution services (Distribution Services) for the Class B Shares and, if applicable, Class B2 Shares of the Deutsche Variable Series I Designated Portfolios including the following types of services:
(1) Printing and mailing of Fund prospectuses, statements of additional information, any supplements thereto and shareholder reports for prospective Contract owners.
(2) Developing, preparing, printing and mailing of Fund advertisements, sales literature and other promotional materials describing and/or relating to the Fund and including materials intended for use within the Company, or for broker-dealer only use or retail use.
(3) Holding seminars and sales meetings designed to promote the distribution of Fund Shares.
(4) Obtaining information and providing explanations to Contract owners regarding Fund investment objectives and policies and other information about the Fund and its Portfolios, including the performance of the Portfolios.
(5) Training sales personnel regarding the Fund.
(6) Compensating sales personnel and financial services firms in connection with the allocation of cash values and premiums of the Contracts to the Fund.
(7) Personal service with respect to Fund Shares attributable to Contract accounts.
In consideration of the Company performing the Distribution Services and subject to the conditions and limitations provided below, the Underwriter will make quarterly payments to the Company pursuant to the Funds Master Distribution Plan for Class B Shares and, if applicable, for Class B2 Shares, as amended from time to time, at the annual rate of 0.25% of the average daily net asset value of the Class B Shares and, if applicable, of the Class B2 Shares of each Deutsche Variable Series I Designated Portfolio held by the Company pursuant to this Agreement. The payments to the Company under the Master Distribution Plan for Class B or Class B2 Shares, as applicable, pursuant to the foregoing may be reduced or eliminated by action of the Board of Trustees of the Fund, effective upon notice to the Company of such action.
ARTICLE VI. Diversification and Qualification
6.1. The Fund will invest the assets of each Designated Portfolio in such a manner as to ensure that the Contracts will be treated as annuity or life insurance contracts, whichever is appropriate, under the Code and the regulations issued thereunder (or any successor provisions). Without limiting the scope of the foregoing, the Fund will, with respect to each Designated Portfolio, comply with Section 817(h) of the Code and Treasury Regulation §1.817-5, and any Treasury interpretations thereof, relating to the diversification requirements for variable annuity, endowment, or life insurance contracts, and any amendments or other modifications or successor provisions to such Section or Regulations. In the event of a breach of this Article VI by the
Fund, it will take all reasonable steps (a) to notify the Company of such breach and (b) to adequately diversify the affected Designated Portfolio so as to achieve compliance within the grace period afforded by Treasury Regulation §1.817-5.
6.2. The Fund represents that each Designated Portfolio is or will be qualified as a Regulated Investment Company under Subchapter M of the Code, and that it will make every effort to maintain such qualification (under Subchapter M or any successor or similar provisions) and that it will notify the Company immediately upon having a reasonable basis for believing that a Designated Portfolio has ceased to so qualify or that it might not so qualify in the future.
6.3. The Company represents that the Contracts are currently, and at the time of issuance shall be, treated as life insurance or annuity insurance contracts, under applicable provisions of the Code, and that it will make every effort to maintain such treatment, and that it will notify the Fund and the Underwriter immediately upon having a reasonable basis for believing the Contracts have ceased to be so treated or that they might not be so treated in the future. The Company agrees that any prospectus offering a contract that is a modified endowment contract as that term is defined in Section 7702A of the Code (or any successor or similar provision), shall identify such contract as a modified endowment contract.
ARTICLE VII. Potential Conflicts
7.1. The Board will monitor the Fund for the existence of any material irreconcilable conflict among the interests of the Contract owners of all separate accounts investing in the Fund. An irreconcilable material conflict may arise for a variety of reasons, including: (a) an action by any state insurance regulatory authority; (b) a change in applicable insurance laws or regulations; (c) a tax ruling or provision of the Internal Revenue Code or the regulations thereunder; (d) any other development relating to the tax treatment of insurers, Contract or policy owners or beneficiaries of variable annuity contracts or variable life insurance policies; (e) the manner in which the investments of any Designated Portfolio are being managed; (f) a difference in voting instructions given by variable annuity contract holders, on the one hand, and variable life insurance policy owners, on the other hand, or by the contract holders or policy owners of different Participating Insurance Companies; or (g) a decision by a Participating Insurance Company to disregard the voting instructions of its Contract owners. The Board shall promptly inform the Company by written notice if it determines that an irreconcilable material conflict exists and the implications thereof.
7.2. The Company and the Adviser will report any potential or existing conflicts of which it is aware to the Board. The Company will assist the Board in carrying out its responsibilities under the Mixed and Shared Funding Exemptive Order, by providing the Board with all information reasonably necessary for the Board to consider any issues raised. This includes, but is not limited to, an obligation by the Company to inform the Board whenever Contract owner voting instructions are disregarded. At least annually, and more frequently if deemed appropriate by the Board, the Company shall submit to the Adviser, and the Adviser shall at least annually submit to the Board, such reports, materials and data as the Board may reasonably request so that the Board may fully carry out the obligations imposed upon it by the conditions contained in the Mixed and Shared Funding Exemptive Order; and said reports, materials and data shall be submitted more frequently if deemed appropriate by the Board. The
responsibility to report such information and conflicts to the Board will be carried out with a view only to the interests of the Contract owners.
7.3. If it is determined by a majority of the Board, or a majority of its disinterested members, that a material irreconcilable conflict exists, the Company and other Participating Insurance Companies shall, at their expense and to the extent reasonably practicable (as determined by a majority of the disinterested Board members), take whatever steps are necessary to remedy or eliminate the irreconcilable material conflict, up to and including: (1) withdrawing the assets allocable to some or all of the separate accounts from the Fund or any Designated Portfolio and reinvesting such assets in a different investment medium, including (but not limited to) another Designated Portfolio of the Fund, or submitting the question whether such segregation should be implemented to a vote of all affected contract owners and, as appropriate, segregating the assets of any appropriate group (i.e., annuity contract owners, life insurance contract owners, or variable contract owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected contract owners the option of making such a change; and (2) establishing a new registered management investment company or managed separate account.
7.4. If a material irreconcilable conflict arises because of a decision by the Company to disregard Contract owner voting instructions and that decision represents a minority position or would preclude a majority vote, the Company may be required, at the Funds election, to withdraw the affected Accounts investment in any Designated Portfolio and terminate this Agreement with respect to such Account; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the disinterested members of the Board. The Company will bear the cost of any remedial action, including such withdrawal and termination. Any such withdrawal and termination must take place within six (6) months after the Fund gives written notice that this provision is being implemented, and until the end of that six month period the Fund shall continue to accept and implement orders by the Company for the purchase (and redemption) of shares of such Designated Portfolio.
7.5. If a material irreconcilable conflict arises because a particular state insurance regulators decision applicable to the Company conflicts with the majority of other state regulators, then the Company will withdraw the affected Accounts investment in the Fund and terminate this Agreement with respect to such Account within six months after the Board informs the Company in writing that it has determined that such decision has created an irreconcilable material conflict; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the disinterested members of the Board. Until the end of the foregoing six month period, the Fund shall continue to accept and implement orders by the Company for the purchase (and redemption) of shares of such Designated Portfolios.
7.6. For purposes of Sections 7.3 through 7.6 of this Agreement, a majority of the disinterested members of the Board shall determine whether any proposed action adequately remedies any irreconcilable material conflict, but in no event will the Fund be required to establish a new funding medium for the Contracts. The Company shall not be required by Section 7.3 to establish a new funding medium for the Contract if an offer to do so has been declined by vote of a majority of Contract owners materially adversely affected by the
irreconcilable material conflict. In the event that the Board determines that any proposed action does not adequately remedy any irreconcilable material conflict, then the Company will withdraw an Accounts investment in any Designated Portfolio and terminate this Agreement within six (6) months after the Board informs the Company in writing of the foregoing determination; provided, however, that such withdrawal and termination shall be limited to the extent required by any such material irreconcilable conflict as determined by a majority of the disinterested members of the Board.
7.7. If and to the extent the Mixed and Shared Funding Exemption Order or any amendment thereto contains terms and conditions different from Sections 3.4, 3.6, 7.1, 7.2, 7.3, 7.4, and 7.5 of this Agreement, then the Fund and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with the Mixed and Shared Funding Exemptive Order, and Sections 3.4, 3.6, 7.1, 7.2, 7.3, 7.4 and 7.5 of this Agreement shall continue in effect only to the extent that terms and conditions substantially identical to such Sections are contained in the Mixed and Shared Funding Exemptive Order or any amendment thereto. If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 or any similar rule is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Mixed and Shared Funding Exemptive Order) on terms and conditions materially different from those contained in the Mixed and Shared Funding Exemptive Order, then (a) the Fund and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with Rules 6e-2 and 6e-3(T), as amended, and Rule 6e-3 or any similar rule, as adopted, to the extent such rules are applicable; and (b) Sections 3.4, 3.6, 7.1., 7.2, 7.3, 7.4, and 7.5 of this Agreement shall continue in effect only to the extent that terms and conditions substantially identical to such Sections are contained in such Rule(s) as so amended or adopted.
ARTICLE VIII. Indemnification
8.1. Indemnification By the Company
(a) The Company agrees to indemnify and hold harmless the Fund, the Adviser and the Underwriter and each of its trustees, directors and officers, and each person, if any, who controls the Fund, the Adviser or Underwriter within the meaning of Section 15 of the 1933 Act or who is under common control with the Underwriter (collectively, the Indemnified Parties for purposes of this Section 8.1) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Company) or litigation (including legal and other expenses), to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Shares of the Designated Portfolios or the Contracts; and:
(i) arise out of or are based upon any untrue statement or alleged untrue statements of any material fact contained in the registration statement, prospectus (which shall include an offering memorandum, if any), or SAl for the Contracts or contained in the Contracts or sales literature for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to
any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of the Fund for use in the registration statement, prospectus or SAI for the Contracts or in the Contracts or sales literature (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Fund Shares; or
(ii) arise out of or are based upon any untrue statement or alleged untrue statements of any material fact contained in the registration statement, prospectus (which shall include an offering memorandum, if any), or SAI covering insurance products sold by the Company or any insurance company which is an affiliate thereof, or any amendments or supplements thereto, or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of the Fund for use in the registration statement, prospectus or SAI covering insurance products sold by the Company or any insurance company which is an affiliate thereof, or any amendments or supplements thereto; or
(iii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, SAI, or sales literature of the Fund not supplied by the Company or persons under its control) or wrongful conduct of the Company or its agents or persons under the Companys authorization or control, or any affiliate thereof, with respect to the sale or distribution of the Contracts or Fund Shares; or
(iv) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI, or sales literature of the Fund or any amendment thereof or supplement thereto or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such a statement or omission was made in reliance upon information furnished to the Fund by or on behalf of the Company; or
(v) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in any registration statement, prospectus, statement of additional information or sales literature for any fund not affiliated with the Fund (Unaffiliated Fund), or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or otherwise pertain to or arise in connection with the availability of any Unaffiliated Fund as an underlying funding vehicle in respect of the Contracts, or arise out of or are based upon any act or omission on the part of the investment adviser or underwriter of an Unaffiliated Fund; or
(vi) arise out of or result from any material breach of any representation, warranty or agreement made by the Company in this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the qualification requirements specified in Article VI of this Agreement);
as limited by and in accordance with the provisions of Sections 8.1(b), 8.1(c) and 8.1(d) hereof
(b) The Company shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, had faith, or gross negligence in the performance of such Indemnified Partys duties, or by reason of such Indemnified Partys reckless disregard of its obligations or duties either under this Agreement or to the Company, the Fund, the Adviser, the Underwriter or the Account, whichever is applicable.
(c) The Company shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Company in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Company of any such claim shall not relieve the Company from any liability that it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent that the Company has been materially prejudiced by such failure to give notice. In case any such action is brought against an Indemnified Party, the Company shall be entitled to participate, at its own expense, in the defense of such action. The Company also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action and to settle the claim at its own expense; provided, however, that no such settlement shall, without the Indemnified Parties written consent, include any factual stipulation referring to the Indemnified Parties or their conduct. After notice from the Company to such party of the Companys election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Company will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation, but, in case the Company does not elect to assume the defense of any such suit, the Company will reimburse the Indemnified Parties in such suit, for the reasonable fees and expenses of any counsel retained by them.
(d) The Indemnified Parties will promptly notify the Company of the commencement of any litigation or proceedings against them in connection with the issuance or sale of the Fund Shares or the Contracts or the operation of the Fund.
8.2. Indemnification by the Underwriter
(a) The Underwriter agrees to indemnify and hold harmless the Company and each of its directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 8.2) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Underwriter) or litigation (including legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of Shares of the Designated Portfolios or the Contracts; and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement or prospectus or SAI or sales literature of the Fund (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Underwriter or Fund by or on behalf of the Company for use in the registration statement, prospectus or SAI for the Fund or in sales literature (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Fund Shares; or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, SAI or sales literature for the Contracts not supplied by the Underwriter or persons under its control) or wrongful conduct of the Fund or Underwriter or persons under their control, with respect to the sale or distribution of the Contracts or Fund Shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI or sales literature covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished to the Company by or on behalf of the Fund or the Underwriter; or
(iv) arise out of or result from any material breach of any representation, warranty or agreement made by the Underwriter, the Adviser or the Fund in this Agreement (including a failure of the Fund, whether unintentional or in good faith or otherwise, to comply with the diversification and other qualification requirements specified in Article VI of this Agreement);
as limited by and in accordance with the provisions of Sections 8.2(b), 8.2(c) and 8.2(d) hereof.
(b) The Underwriter shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties, or by reason of such Indemnified Partys reckless disregard of obligations and duties either under this Agreement or to the Company, the Fund, the Adviser, the Underwriter or the Account, whichever is applicable.
(c) The Underwriter shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Underwriter in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Underwriter of any such claim shall not relieve
the Underwriter from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent that the Underwriter has been prejudiced by such failure to give notice. In case any such action is brought against the Indemnified Party, the Underwriter will be entitled to participate, at its own expense, in the defense thereof. The Underwriter also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action and to settle the claim at its own expense; provided, however, that no such settlement shall, without the Indemnified Parties written consent, include any factual stipulation to the Indemnified Parties or their conduct. After notice from the Underwriter to such party of the Underwriters election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Underwriter will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation, but, in case the Underwriter does not elect to assume the defense of any such suit, the Underwriter will reimburse the Indemnified Parties in such suit, for the reasonable fees and expenses of any counsel retained by them.
(d) The Indemnified Parties agree promptly to notify the Underwriter of the commencement of any litigation or proceedings against them in connection with the issuance or sale of the Contracts or the operation of the Account.
8.3. Indemnification By the Fund
(a) The Fund agrees to indemnify and hold harmless the Company and each of its directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 8.3) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with the written consent of the Fund) or litigation (including legal and other expenses) to which the Indemnified Parties may be required to pay or may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, expenses, damages, liabilities or expenses (or actions in respect thereof) or settlements, arc related to the operations of the Fund and arise out of or result from any material breach of any representation, warranty or agreement made by the Fund in this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification and other qualification requirements specified in Article VI of this Agreement);
as limited by and in accordance with the provisions of Sections 8.3(b), 8.3(c) and 8.3(d) hereof.
(b) The Fund shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties, or by reason of such Indemnified Partys reckless disregard of obligations and duties either under this Agreement or to the Company, the Fund, the Adviser, the Underwriter or the Account, whichever is applicable.
(c) The Fund shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Fund in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such
Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Fund of any such claim shall not relieve the Fund from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent the Fund has been prejudiced by such failure to give notice. In case any such action is brought against the Indemnified Parties, the Fund will be entitled to participate, at its own expense, in the defense thereof. The Fund also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action and to settle the claim at its own expense; provided, however, that no such settlement shall, without the Indemnified Parties written consent include any factual stipulation referring to the Indemnified Parties or their conduct. After notice from the Fund to such party of the Funds election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Fund will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation, but, in case the Fund does not elect to assume the defense of any such suit, the Fund will reimburse the Indemnified Parties in such suit, for the reasonable fees and expenses of any counsel retained by them.
(d) The Indemnified Parties agree promptly to notify the Fund of the commencement of any litigation or proceeding against it or any of its respective officers or trustees in connection with the Agreement, the issuance or sale of the Contracts, the operation of any Account, or the sale or acquisition of Shares of the Fund.
ARTICLE IX. Applicable Law
9.1. This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of the Commonwealth of Massachusetts.
9.2. This Agreement shall be subject to the applicable provisions of the 1933, 1934 and 1940 Acts, and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the SEC may grant (including, but not limited to, any Mixed and Shared Funding Exemptive Order) and the terms hereof shall be interpreted and construed in accordance therewith. If, in the future, the Mixed and Shared Funding Exemptive Order should no longer be necessary under applicable law, then Article VII shall no longer apply.
ARTICLE X. Termination
10.1. This Agreement shall continue in full force and effect until the first to occur of:
(a) termination by any party, for any reason with respect to some or all Designated Portfolios, by three (3) months advance written notice delivered to the other parties; or
(b) termination by the Company by written notice to the Fund, the Adviser and the Underwriter based upon the Companys reasonable and good faith determination that Shares of any Designated Portfolio are not reasonably available to meet the requirements of the Contracts; or
(c) termination by the Company by written notice to the Fund, the Adviser and the Underwriter in the event any of the Designated Portfolios Shares are not registered, issued or sold in accordance with applicable state and/or federal securities laws or such law precludes the use of such Shares as the underlying investment media of the Contracts issued or to be issued by the Company; or
(d) termination by the Fund, the Adviser or Underwriter in the event that formal administrative proceedings are instituted against the Company or any affiliate by FINRA, the SEC, the Insurance Commissioner or like official of any state or any other regulatory body regarding the Companys duties under this Agreement or related to the sale of the Contracts, the operation of any Account, or the purchase of the Funds Shares; provided, however, that the Fund, the Adviser or Underwriter determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Company to perform its obligations under this Agreement; or
(e) termination by the Company in the event that formal administrative proceedings are instituted against the Fund, the Adviser or Underwriter by FINRA, the SEC, or any state securities or insurance department or any other regulatory body; provided, however, that the Company determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Fund or Underwriter to perform its obligations under this Agreement; or
(f) termination by the Company by written notice to the Fund, the Adviser and the Underwriter with respect to any Designated Portfolio in the event that such Portfolio ceases to qualify as a Regulated Investment Company under Subchapter M or fails to comply with the Section 817(h) diversification requirements specified in Article VI hereof, or if the Company reasonably believes that such Designated Portfolio may fail to so qualify or comply; or
(g) termination by the Fund, the Adviser or Underwriter by written notice to the Company in the event that the Contracts fail to meet the qualifications specified in Article VI hereof; or
(h) termination by any of the Fund, the Adviser or the Underwriter by written notice to the Company, if any of the Fund, the Adviser or the Underwriter respectively, shall determine, in their sole judgment exercised in good faith, that the Company has suffered a material adverse change in its business, operations, financial condition, insurance company rating or prospects since the date of this Agreement or is the subject of material adverse publicity; or
(i) termination by the Company by written notice to the Fund, the Adviser and the Underwriter, if the Company shall determine, in its sole judgment exercised in good faith, that the Fund, the Adviser or the Underwriter has suffered a material adverse change in its business, operations, financial condition or prospects since the date of this Agreement or is the subject of material adverse publicity, and that material adverse change or publicity will have a material effect on the Funds or the Underwriters ability to perform its obligation under this Agreement; or
(j) termination by the Company upon any substitution of the Shares of another investment company or series thereof for Shares of a Designated Portfolio of the Fund in
accordance with the terms of the Contracts, provided that the Company has given at least 45 days prior written notice to the Fund and Underwriter of the date of substitution; or
(k) termination by any party in the event that the Funds Board of Trustees determines that a material irreconcilable conflict exists as provided in Article VII; or
(l) at the option of the Company, as one party, or the Fund, the Adviser and the Underwriter, as one party, upon the other partys material breach of any provision of this Agreement upon 30 days written notice and the opportunity to cure within such notice period; or
(m) at the option of the Fund or the Adviser in the event the Contracts are not treated as life insurance or annuity contracts under applicable provisions of the Code.
10.2. Notwithstanding any termination of this Agreement, the Fund and the Underwriter shall, at the option of the Company, continue, for a one year period from the date of termination and from year to year thereafter if deemed appropriate by the Fund and the Adviser, to make available additional Shares of a Designated Portfolio pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as Existing Contracts), unless the Underwriter elects to compel a substitution of other securities for the Shares of the Designated Portfolios. Specifically, the owners of the Existing Contracts may be permitted to reallocate investments in the Designated Portfolios, redeem investments in the Designated Portfolios and/or invest in the Designated Portfolios upon the making of additional purchase payments under the Existing Contracts (subject to any such election by the Underwriter). The parties agree that this Section 10.2 shall not apply to any terminations under Article VII and the effect of such Article VII terminations shall be governed by Article VII of this Agreement. The parties further agree that this Section 10.2 shall not apply to any terminations under Section 10.1(d),(g) or (m) of this Agreement.
10.3. The Company shall not redeem Fund Shares attributable to the Contracts (as opposed to Fund Shares attributable to the Companys assets held in the Account) except (i) as necessary to implement Contract owner initiated or approved transactions, (ii) as required by state and/or federal laws or regulations or judicial or other legal precedent of general application (hereinafter referred to as a Legally Required Redemption), (iii) as permitted by an order of the SEC pursuant to Section 26(c) of the 1940 Act, but only if a substitution of other securities for the Shares of the Designated Portfolios is consistent with the terms of the Contracts, or (iv) as permitted under the terms of the Contract. Upon request, the Company will promptly furnish to the Fund and the Underwriter reasonable assurance that any redemption pursuant to clause (ii) above is a Legally Required Redemption. Furthermore, except in cases where permitted under the terms of the Contacts, the Company shall not prevent Contract owners from allocating payments to a Designated Portfolio that is otherwise available under the Contracts without first giving the Fund or the Underwriter 45 days notice of its intention to do so.
10.4. In the event of termination of this Agreement, (i) so long as Shares of the Fund are made available to Existing Contracts pursuant to Section 10.2, the provisions of this Agreement shall continue as to Existing Contracts; and (ii) each partys obligations under Article VIII related to indemnification and under Section 12.1 of Article XII related to confidentiality shall survive termination regardless of whether Shares continue to be offered to Existing Contracts.
ARTICLE XI. Notices
Any notice shall be sufficiently given when sent by registered or certified mail or overnight mail through a nationally-recognized delivery service to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other party.
If to the Fund:
Deutsche Variable Series I
Deutsche Variable Series II
Deutsche Investments VIT Funds
One Beacon Street
Boston, MA 02108
Attention: Secretary
Additional copy to:
60 Wall Street
New York, NY 10005
Attention: Legal Department (Retail Division)
If to the Company:
Teri Schultz, Vice President, Marketing
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, Alabama 35223
With a copy to:
Senior Associate Counsel- Variable Insurance Products
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, Alabama 35223
If to Underwriter:
DeAWM Distributors, Inc.
One Beacon Street
Boston, MA 02108
Attention: Secretary
Additional copy to:
60 Wall Street
New York, NY 10005
Attention: Legal Department (Retail Division)
If to the Adviser:
Deutsche Investment Management Americas Inc.
One Beacon Street
Boston, MA 02108
Attention: Secretary
Additional copy to:
60 Wall Street
New York, NY 10005
Attention: Legal Department (Retail Division)
ARTICLE XII. Miscellaneous
12.1. Subject to the requirements of legal process and regulatory authority, each party hereto shall treat as confidential the names and addresses of the owners of the Contracts and all information reasonably identified as confidential in writing by any other party hereto and, except as permitted by this Agreement, shall not disclose, disseminate or utilize such names and addresses and other confidential information without the express written consent of the affected party until such time as such information has come into the public domain.
12.2. The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
12.3. This Agreement may be executed simultaneously in two or more counterparts, each of which taken together shall constitute one and the same instrument.
12.4. This Agreement incorporates the entire understanding and agreement among the parties hereto, and supersedes any and all prior understandings and agreements between the parties hereto with respect to the subject matter hereof.
12.5. If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.
12.6. Each party hereto shall cooperate with each other party and all appropriate governmental authorities (including without limitation the SEC, FINRA, and state insurance
regulators) and shall permit such authorities reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby. Notwithstanding the generality of the foregoing, each party hereto further agrees to furnish the State Insurance Commissioner with any information or reports in connection with services provided under this Agreement which such Commissioner may request in order to ascertain whether the variable annuity operations of the Company are being conducted in a manner consistent with the State variable annuity laws and regulations and any other applicable law or regulations.
12.7. The rights, remedies and obligations contained in this Agreement are cumulative and arc in addition to any and all rights, remedies, and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.
12.8. This Agreement or any of the rights and obligations hereunder may not be assigned by any party without the prior written consent of all parties hereto.
12.9. The Company shall furnish, or shall cause to be furnished, to the Fund or its designee upon request copies of the following reports:
(a) the Companys annual statement (prepared under statutory accounting principles) and annual report (prepared under generally accepted accounting principles) filed with any state or federal regulatory body or otherwise made available to the public, as soon as practicable and in any event within 90 days after the end of each fiscal year; and
(b) any registration statement (without exhibits) and financial reports of the Company filed with the Securities and Exchange Commission or any state insurance regulatory, as soon as practicable after the filing thereof.
12.10. All persons are expressly put on notice of the Funds Agreement and Declaration of Trust and all amendments thereto, all of which are on file with the Secretary of the Commonwealth of Massachusetts, and the limitation of shareholder and trustee liability contained therein. This Agreement has been executed by and on behalf of the Fund by its representatives as such representatives and not individually, and the obligations of the Fund with respect to a Designated Portfolio hereunder are not binding upon any of the trustees, officers or shareholders of the Fund individually, but are binding upon only the assets and property of such Designated Portfolio. All parties dealing with the Fund with respect to a Designated Portfolio shall look solely to the assets of such Designated Portfolio for the enforcement of any claims against the Fund hereunder.
12.11. The Company is expressly put on notice that prospectus disclosure regarding the potential risks of mixed and shared funding may be appropriate.
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and on its behalf by its duly authorized representative and its seal to be hereunder affixed hereto as of the date first above written.
COMPANY: |
PROTECTIVE LIFE INSURANCE COMPANY |
|
|
|
|
|
|
|
|
By: |
[Illegible] |
|
Title: |
SVP - Annuity Sales |
|
|
|
|
|
|
FUND: |
DEUTSCHE VARIABLE SERIES I |
|
|
|
|
|
|
|
|
By: |
[Illegible] |
|
Title: |
President |
|
|
|
|
|
|
|
DEUTSCHE VARIABLE SERIES II |
|
|
|
|
|
|
|
|
By: |
[Illegible] |
|
Title: |
President |
|
|
|
|
|
|
|
DEUTSCHE INVESTMENTS VIT FUNDS |
|
|
|
|
|
|
|
|
By: |
[Illegible] |
|
Title: |
President |
SCHEDULE A
Name of Separate Account and Date Established by Board of Directors
Contracts Funded by Separate Account
SCHEDULE B
DESIGNATED PORTFOLIOS
AND CLASSES THEREOF
Designated Portfolios.
A. |
Deutsche Variable Series I |
|
|
|
Deutsche Capital Growth VIP |
|
A, B |
|
Deutsche Global Small Cap Growth VIP |
|
A, B |
|
Deutsche Core Equity VIP |
A, B |
|
|
Deutsche International VIP |
A, B |
|
|
Deutsche Bond VIP |
A |
|
|
|
|
|
B. |
Deutsche Variable Series II |
|
|
|
Deutsche Alternative Asset Allocation VIP |
A, B |
|
|
Deutsche Global Thematic VIP |
|
A, B |
|
Deutsche Government & Agency Securities VIP |
|
A, B |
|
Deutsche High Income VIP |
A, B |
|
|
Deutsche Diversified International Equity VIP |
|
A |
|
Deutsche Large Cap Value VIP |
|
A, B |
|
Deutsche Money Market VIP |
A |
|
|
Deutsche Small Mid Cap Growth VIP |
|
A |
|
Deutsche Unconstrained Income VIP |
A |
|
|
Deutsche Global Income Builder VIP |
|
A |
|
Deutsche Dreman Small Mid Cap Value VIP |
|
A, B |
|
|
|
|
C. |
Deutsche Investments VIT Funds |
|
|
|
Deutsche Equity 500 Index VIP |
|
A, B, B2 |
|
Deutsche Small Cap Index VIP |
|
A, B |
SCHEDULE C
EXPENSES
ITEM |
|
FUNCTION |
|
PARTY
|
FUND PROSPECTUS |
|
|
|
|
Update |
|
Typesetting |
|
Fund |
New Sales: |
|
Printing
|
|
Company
|
Existing Owners: |
|
Printing
|
|
Fund
|
STATEMENTS OF ADDITIONAL INFORMATION |
|
Same as Prospectus |
|
|
PROXY MATERIALS OF THE FUND |
|
Typesetting
|
|
Fund
|
ANNUAL REPORTS AND OTHER COMMUNICATIONS WITH SHAREHOLDERS OF THE FUND |
|
|
|
|
All |
|
Typesetting |
|
Fund |
Marketing (1) |
|
Printing
|
|
Company
|
Existing Owners: |
|
Printing
|
|
Fund
|
OPERATIONS OF FUND |
|
All operations and related expenses, including the cost of registration and qualification of the Funds shares, preparation and filing of the Funds prospectus and registration statement, proxy materials and reports, the preparation of all statements and notices required by any federal or state law and all taxes on the issuance of the Funds shares, and all costs of management of the business affairs of the Fund. |
|
Fund |
(1) Solely as it relates to the contracts listed on Schedule A, as it is attached to the same Agreement as this Schedule C.
SCHEDULE D
RULE 22C-2 PROVISIONS
1. Agreement to Provide Information. Company agrees to provide the Fund or its designee, upon written request, the taxpayer identification number (TIN), the Individual/International Taxpayer Identification Number (ITIN), or other government-issued identifier (GII) and the Contract owner number or participant account number associated with the Shareholder, if known, of any or all Shareholder(s) of the account, and the amount, date and transaction type (purchase, redemption, transfer, or exchange) of every purchase, redemption, transfer, or exchange of Shares held through an account maintained by the Company during the period covered by the request. Unless otherwise specifically requested by the Fund, the Company shall only be required to provide information relating to Shareholder-Initiated Transfer Purchases or Shareholder-Initiated Transfer Redemptions.
2. Period Covered by Request. Requests must set forth a specific period, not to exceed 90 days from the date of the request, for which transaction information is sought. The Fund may request transaction information older than 90 days from the date of the request as it deems necessary to investigate compliance with policies established by the Fund for the purpose of eliminating or reducing any dilution of the value of the outstanding shares issued by the Fund.
3. Form and Timing of Response.
(a) Company agrees to provide, promptly upon request of the Fund or its designee, the requested information specified in paragraph 1 above. If requested by the Fund or its designee, Company agrees to use best efforts to determine promptly whether any specific person about whom it has received the identification and transaction information specified in paragraph 1 is itself a financial intermediary (indirect intermediary) and, upon further request of the Fund or its designee, promptly either (i) provide (or arrange to have provided) the information set forth in paragraph 1 for those shareholders who hold an account with an indirect intermediary or (ii) restrict or prohibit the indirect intermediary from purchasing, in nominee name on behalf of other persons, securities issued by the Fund. Company additionally agrees to inform the Fund whether it plans to perform (i) or (ii).
(b) Responses required by this paragraph must be communicated in writing and in a format mutually agreed upon by the parties.
(c) To the extent practicable, the format for any transaction information provided to the Fund should be consistent with the NSCC Standardized Data Reporting Format
4. Limitations on Use of Information. The Fund agrees not to use the information received pursuant to this Amendment for any purpose other than as necessary to comply with the provisions of Rule 22c-2 or to fulfill other regulatory or legal requirements subject to the privacy provisions of Title V of the Gramm-Leach-Bliley Act (Public Law 106-102) and comparable state laws.
5. Agreement to Restrict Trading. Company agrees to execute written instructions from the Fund to restrict or prohibit further purchases or exchanges of Shares by a Shareholder that has been identified by the Fund as having engaged in transactions of the Funds Shares (directly or indirectly through the Companys account) that violate policies established by the Fund for the purpose of eliminating or reducing any dilution of the value of the outstanding Shares issued by the Fund. Unless otherwise directed by the Fund, any such restrictions or prohibitions shall only apply to Shareholder-Initiated Transfer Purchases or Shareholder-Initiated Transfer Redemptions that are effected directly or indirectly through Company. Instructions must be received by Company at the address set forth in this Agreement, or such other address that Company may communicate to Fund in writing from time to time, including, if applicable, an e-mail and/or facsimile telephone number:
6. Form of Instructions. Instructions must include the TIN, ITIN, or GII and the specific individual Contract owner number or participant account number associated with the Shareholder, if known, and the specific restriction(s) to be executed, including how long the restriction(s) is(are) to remain in place. If the TIN, ITIN, GII or the specific individual Contract owner number or participant account number associated with the Shareholder is not known, the instructions must include an equivalent identifying number of the Shareholder(s) or account(s) or other agreed upon information to which the instruction relates.
7. Timing of Response. Company agrees to execute instructions from the Fund to restrict or prohibit trading as soon as reasonably practicable, but not later than five business days after receipt of the instructions by the Company.
8. Confirmation by Company. Company must provide written confirmation to the Fund that instructions from the Fund to restrict or prohibit trading have been executed. Company agrees to provide confirmation as soon as reasonably practicable, but not later than ten business days after the instructions have been executed.
9. Construction of the Agreement; Fund Participation Agreement. The parties have entered into a Fund Participation Agreement between or among them for the purchase and redemption of shares of the Funds by the Accounts in connection with the Contracts and this Schedule D is a part thereof. To the extent the terms of this Schedule D conflict with the remainder of the terms of the Fund Participation Agreement, the terms of this Schedule D shall control.
10. Definitions. As used in this Schedule D, the following terms shall have the following meanings, unless a different meaning is clearly required by the contexts:
The term Company shall mean the Company as defined under the Fund Participation Agreement.
The term Fund shall mean the Fund and any Designated Portfolio as defined under the Fund Participation Agreement and includes (i) an investment adviser to or administrator for the Fund; (ii) the principal underwriter or distributor for the Fund; or (iii) the transfer
agent for the Fund. The term not does include any excepted funds as defined in SEC Rule 22c-2(b) under the Investment Company Act of 1940.*
The term Shares means the interests of Shareholders corresponding to the redeemable securities of record issued by the Fund under the Investment Company Act of 1940 that are held by the Company.
The term Shareholder means the holder of interests in a variable annuity or variable life insurance contract issued by the Company (Contract), or a participant in an employee benefit plan with a beneficial interest in a contract.
The term Shareholder-Initiated Transfer Purchase means a transaction that is initiated or directed by a Shareholder that results in a transfer of assets within a Contract to a Fund, but does not include transactions that are executed: (i) automatically pursuant to a contractual or systematic program or enrollment such as transfer of assets within a Contract to a Fund as a result of dollar cost averaging programs, insurance company approved asset allocation programs, or automatic rebalancing programs; (ii) pursuant to a Contract death benefit; (iii) one-time step-up in Contract value pursuant to a Contract death benefit; (iv) allocation of assets to a Fund through a Contract as a result of payments such as loan repayments, scheduled contributions, retirement plan salary reduction contributions, or planned premium payments to the Contract; or (v) pre-arranged transfers at the conclusion of a required free look period.
The term Shareholder-Initiated Transfer Redemption means a transaction that is initiated or directed by a Shareholder that results in a transfer of assets within a Contract out of a Fund, but does not include transactions that are executed: (i) automatically pursuant to a contractual or systematic program or enrollments such as transfers of assets within a Contract out of a Fund as a result of annuity payouts, loans, systematic withdrawal programs, insurance company approved asset allocation programs and automatic rebalancing programs; (ii) as a result of any deduction of charges or fees under a Contract; (iii) within a Contract out of a Fund as a result of scheduled withdrawals or surrenders from a Contract; or (iv) as a result of payment of a death benefit from a Contract.
The term written includes electronic writings and facsimile transmissions. The term purchase does not include the automatic reinvestment of dividends.
The term promptly as used in paragraph 3(a) shall mean as soon as practicable but in no event later than ten business days from the Companys receipt of the request for information from the Fund or its designee.
* As defined in SEC Rule 22c-2(b), the term excepted fund means any: (1) money market fund; (2) fund that issues securities that are listed on a national exchange; and (3) fund that affirmatively permits short-term trading of its securities, if its prospectus clearly and prominently discloses that the fund permits short-term trading of its securities and that such trading may result in additional costs for the fund.
AMENDMENT NO. 1 TO AMENDED AND RESTATED PARTICIPATION AGREEMENT
This Amendment No. 1 made and entered into as of December 9, 2020, to that certain Amended and Restated Participation Agreement dated February 1, 2015 (the Agreement), by and among PROTECTIVE LIFE INSURANCE COMPANY (the Company), on its own and on behalf of each segregated account of the Company that is party to the Agreement (each, an Account), DEUTSCHE DWS VARIABLE SERIES I, DEUTSCHE DWS VARIABLE SERIES II, and DEUTSCHE DWS INVESTMENTS VIT FUNDS (each, a Fund), DWS DISTRIBUTORS, INC. (formerly, DeAWM DISTRIBUTORS, INC.) (the Underwriter) and DWS INVESTMENT MANAGEMENT AMERICAS, INC. (formerly, Deutsche Investment Management Americas Inc.) (the Adviser) (collectively, the Parties).
WHEREAS, the Parties desire to amend the Agreement as provided herein.
NOW, THEREFORE, in consideration of the mutual promises set forth herein, the Parties hereto agree as follows:
1. Effective July 2, 2018, Deutsche Variable Series I, Deutsche Variable Series II and Deutsche Investment VIT Funds were renamed Deutsche DWS Variable Series I, Deutsche DWS Variable Series II and Deutsche DWS Investment VIT Funds, respectively.
2. Effective March 23, 2018, DeAM Distributors, Inc. was renamed DWS Distributors, Inc.
3. Effective July 2, 2018, Deutsche Investment Management Americas Inc. was renamed DWS Investment Management Americas, Inc.
4. Article V. Fees and Expenses, is amended by deleting references to Deutsche Variable Series I Fund, in order to clarify that the provisions of Article V apply to all Funds covered by the Agreement.
5. Article VI. Diversification and Qualification, Section 6.1, is amended by adding to the end of the section the following sentence:
Upon request, the Fund shall provide Company a certification of each Funds compliance with Section 817(h) of the Code and Treasury Regulation 1.817-5 for the preceding calendar quarter.
6. Article XI. Notices, is amended with respect to the Fund, the Underwriter and the Adviser, as follows:
If to the Fund:
Deutsche DWS Variable Series I
Deutsche DWS Variable Series II
Deutsche DWS Investments VIT Funds
100 Summer Street
Suite 800
Boston, MA 02110
Attention: Secretary
If to Underwriter:
DWS Distributors, Inc.
875 Third Avenue
New York, NY 10022
Attn: Secretary
If to the Adviser:
DWS Investment Management Americas, Inc.
100 Summer Street
Suite 800
Boston, MA 02110
Attention: Chief Legal Officer
If to the Company:
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, AL 35223
Attention: Senior Vice President, Chief Product Officer
With a copy to:
Senior Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
7. Schedule A of the Agreement is hereby deleted in its entirety and replaced with the attached Schedule A.
8. Schedule B of the Agreement is hereby deleted in its entirety and replaced with the attached Schedule B.
All other terms and provisions of the Agreement not amended herein shall remain in full force and effect. Unless otherwise specified, all defined terms shall have the same meaning given to them in the Agreement. This Amendment may be executed in counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same Amendment.
[Signature Page Follows]
Effective Date: As of December , 2020
IN WITNESS WHEREOF, each of the parties hereto has caused this Amendment to be executed in its name and on its behalf by its duly authorized officers as of the date set forth above.
SCHEDULE A
Separate Account (Date Established by Board of
|
|
Contracts Funded by Separate Account |
|
|
|
Protective COLI VUL Separate Account
|
|
Protective Executive Benefits Registered VUL |
|
|
|
Protective COLI PPVUL Separate Account
|
|
Protective Executive Benefits Private Placement VUL |
|
|
|
Titanium Universal Life Variable Account |
|
Titanium VUL |
|
|
|
Titanium Annuity Variable Account |
|
Titanium VA |
|
|
|
United Investors RetireMap Variable Account |
|
United Investors RetireMap |
SCHEDULE B
DESIGNATED PORTFOLIOS
AND CLASSES THEREOF
Designated Portfolios.
A. |
Deutsche DWS Variable Series I |
|
|
DWS Capital Growth VIP |
A, B |
|
DWS Global Small Cap VIP |
A, B |
|
(formerly Deutsche Global Small Cap Growth VIP) |
|
|
DWS Core Equity VIP |
A, B |
|
DWS CROCI International VIP |
A, B |
|
(formerly Deutsche International VIP) |
|
|
DWS Bond VIP |
A |
|
|
|
B. |
Deutsche DWS Variable Series II |
|
|
DWS Alternative Asset Allocation VIP |
A, B |
|
DWS CROCI U.S. VIP |
A, B |
|
(formerly Deutsche Large Cap Value VIP) |
|
|
DWS International Growth VIP |
A, B |
|
(formerly Deutsche Global Thematic VIP) |
|
|
DWS High Income VIP |
A, B |
|
DWS Global Equity VIP |
A |
|
(formerly Deutsche Diversified International Equity VIP) |
|
|
DWS Government Money Market VIP |
A |
|
(formerly Deutsche Money Market VIP) |
|
|
DWS Small Mid Cap Growth VIP |
A |
|
DWS Global Income Builder VIP |
A, B |
|
DWS Small Mid Cap Value VIP |
A, B |
|
(formerly Deutsche Dreman Small Mid Cap Value VIP) |
|
|
|
|
C. |
Deutsche DWS Investments VIT Funds |
|
|
DWS Equity 500 Index VIP |
A, B, B2 |
|
DWS Small Cap Index VIP |
A, B |
|
|
|
FUND PARTICIPATION AGREEMENT
THIS FUND PARTICIPATION AGREEMENT (Agreement) made as of the 9th day of November, 2020, by and between Eaton Vance Variable Trust (the Trust), a Massachusetts business trust, on its behalf and on behalf of each separate investment series thereof, whether existing as of the date above or established subsequent thereto, (each a Portfolio and collectively, the Portfolios), Eaton Vance Distributors, Inc. (the Distributor), and Protective Life Insurance Company (the Company), a life insurance company organized under the laws of Tennessee.
WHEREAS, the Trust is registered with the Securities and Exchange Commission (SEC) under the Investment Company Act of 1940, as amended (the 40 Act), as an open-end, diversified management investment company; and
WHEREAS, the Trust is organized as a series fund comprised of separate investment series, namely the Portfolios; and
WHEREAS, the Trust was organized to act as the funding vehicle for certain variable life insurance and/or variable annuity contracts (Variable Contracts) offered by life insurance companies through separate accounts of such life insurance companies and also offers its shares to certain qualified pension and retirement plans, Eaton Vance Management (EVM) and affiliated advisers to the Trust and any other person permitted to hold shares of the Trust pursuant to applicable Treasury regulations and the Mixed and Shared Funding Exemptive Order (defined below); and
WHEREAS, the Trust has obtained, or warrants and agrees that prior to any issuance or sale of shares it will obtain an order from the Securities and Exchange Commission (the SEC), granting Participating Insurance Companies and their separate accounts exemptions from the provisions of Sections 9(a), 13(a), 15(a), and 15(b) of the 40 Act and Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the Trust to be sold to and held by Qualified Plans and by variable annuity and variable life insurance separate accounts of Participating Insurance Companies that may or may not be affiliated with one another (the Mixed and Shared Funding Exemptive Order); and
WHEREAS, the Company has established or will establish one or more separate accounts (Separate Accounts) to offer Variable Contracts and is desirous of having the Trust as one of the underlying funding vehicles for such Variable Contracts; and
WHEREAS, the Distributor is registered with the SEC as a broker-dealer under the Securities Exchange Act of 1934, (the 34 Act) as amended, and acts as the Trusts principal underwriter; and
WHEREAS, EVM, a Massachusetts business trust, which serves as investment adviser to the Trust, is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended, any applicable state securities laws; and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company intends to purchase shares of the Trust to fund the aforementioned Variable Contracts and the Trust is authorized to sell such shares to the Company at net asset value (NAV).
NOW, THEREFORE, in consideration of their mutual promises, the Company, the Trust, and the Distributor agree as follows:
Article I. Sale of Trust Shares
1.1 The Trust agrees to make shares of the Trust (Shares) available to the Separate Accounts of the Company for investment of purchase payments of Variable Contracts allocated to the designated Separate Accounts as provided in the Trusts then current prospectus and statement of additional information. The Company agrees to purchase and redeem the Shares of the Portfolios offered by the then current prospectus and statement of additional information of the Trust in accordance with the provisions of such prospectus and statement of additional information. The Company shall not permit any person other than a Variable Contract owner, or such owners investment adviser, registered representative or attorney-in-fact (Owner) to give instructions to the Company which would require the Company to redeem or exchange Shares of the Trust.
1.2 The Trust agrees to sell to the Company those Shares of the selected Portfolios of the Trust which the Company orders, executing such orders on a daily basis at the NAV next computed after receipt by the Trust or its designee of the order for the Shares of the Fund. For purposes of this Section 1.2, the Company shall be the designee of the Trust for receipt of such orders from the designated Separate Account and receipt by such designee shall constitute receipt by the Trust; provided, to the extent not inconsistent with regulatory requirements, that the Company receives the order by 4:00 p.m. Eastern time (or other applicable closing time of the New York Stock Exchange). Business Day shall mean any day on which the New York Stock Exchange is open for trading and on which the Trust calculates its NAV pursuant to the rules of the SEC. Notwithstanding the foregoing, the directors of the Trust may refuse to sell shares of any Portfolio to any person, or suspend or terminate the offering of shares of any Portfolio if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the directors of the Trust acting in good faith and in light of their fiduciary duties under federal laws, necessary in the best interests of the shareholders of that Portfolio.
1.3 The Trust agrees to redeem on the Companys request, any full or fractional Shares of the Fund held by the Company, executing such requests on a daily basis at the NAV next computed after receipt by the Trust or its designee of the request for redemption, in accordance with the provisions of this agreement and the Trusts then current registration statement. However, if one or more Portfolios has determined to settle redemption transactions for all of its shareholders on a delayed basis, the Trust shall be permitted to delay sending redemption proceeds to the Company by the same number of days that the Trust is delaying sending redemption proceeds to the other shareholders of the Portfolio. For purposes of this Section 1.3, the Company shall be the designee of the Trust for receipt of requests for redemption from the designated Separate Account and receipt by such designee shall constitute receipt by the Trust provided, to the extent not inconsistent with regulatory requirements, that the Company receives the request for redemption by 4:00 p.m. Eastern time (or other applicable closing time of the New York Stock Exchange)..
1.4 The Trust shall furnish notice to the Company of any income dividends or capital gain
distributions payable on the Shares of any Portfolios of the Trust as soon as reasonably practicable. The Company hereby elects to receive all such income dividends and capital gain distributions as are payable on a Portfolios Shares in additional Shares of the Portfolio. The Trust shall notify the Company or its designee of the number of Shares so issued as payment of such dividends and distributions.
1.5 The Trust shall make the NAV per share for the selected Portfolios available to the Company on a daily basis, via a mutually agreeable form, as soon as reasonably practicable after the NAV per share is calculated but shall use its best efforts to make such NAV available by 6:30 p.m. Eastern time. In accordance with Section 9.3 below, if the Trust provides materially incorrect share NAV information, the Trust may make an adjustment to the number of shares purchases or redeemed for the Separate Account to reflect the correct NAV.
1.6 Each purchase, redemption and exchange order placed by the Company shall be placed separately for each Portfolio. However, with respect to payment of the purchase price by the Company and of redemption proceeds by the Trust, the Company and the Trust shall net purchase and redemption orders with respect to each Portfolio and shall transmit one net payment for all of the Portfolios.
1.7 If the Companys order requests the purchase of Fund Shares, the Company shall pay for such purchase by wiring federal funds to the Fund or its designated custodial account on the day the order is transmitted by the Company. If the Companys order requests a net redemption resulting in a payment of redemption proceeds to the Company, the Fund shall wire the redemption proceeds to the Company by the next Business Day. However, payment may be postponed under unusual circumstances, such as when normal trading is not taking place on the New York Stock Exchange, an emergency as defined by the SEC exists, or as permitted by the SEC (including Section 22(e) of the 1940 Act and the rules thereunder and in accordance with the policies and procedures of the Trust as described in the then current prospectus.) The Trust reserves the right to redeem Portfolio shares in assets other than cash in accordance with the procedures and policies of the Trust as described in the then current prospectus.
1.8 The Trust agrees that all Shares of the Portfolios of the Trust will be sold only to Participating Insurance Companies which have agreed to participate in the Trust to fund their Separate Accounts and/or to Plans, all in accordance with the requirements of Section 817(h) of the Code and Treasury Regulation §1.817-5, certain qualified pension and retirement plans, EVM and affiliated advisers to the Trust and any other person permitted to hold shares of the Trust pursuant to applicable Treasury regulations and the Mixed and Shared Funding Exemptive Order; . Shares of the Portfolios of the Trust will not be sold directly to the general public.
1.9 As described in Section 1.2 above, the Trust may refuse to sell Shares of any Portfolios to any person, or suspend or terminate the offering of the Shares of any Portfolios if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Board of Trustees of the Trust (the Board), deemed necessary, desirable or appropriate. Without limiting the foregoing, it has been determined that there is a significant risk that the Fund and its shareholders may be adversely affected by short-term or excessive trading activity, particularly activity used to try and take advantage of short-term swings in the market. Accordingly, the Trust reserves the right to reject any purchase order, including those purchase orders with respect to shareholders or accounts whose trading has been or may be disruptive to
the Trust or that may otherwise adversely affect the Trust. As set forth in Article II of this Agreement, the Company agrees to use its reasonable best efforts to render assistance to, and to cooperate with, the Trust to achieve compliance with the Trusts policies and restrictions on short-term or excessive trading activity as they may be amended from time to time, or to the extent required by applicable regulatory requirements.
1.10 Issuance and transfer of Portfolio Shares will be by book entry only. Stock certificates will not be issued to the Company or the Separate Accounts. Shares ordered from Portfolios will be recorded in appropriate book entry titles for the Separate Accounts.
1.11 NAV errors shall be handled in accordance with Section 9.3 below.
Article II. Owner Transaction Information
2.1 The Company agrees to provide to the Trust or its designee, upon request, the taxpayer identification number (TIN), the Individual/International Taxpayer Identification Number (ITIN), or other government-issued identifier (GII), if known, of any or all Owners underlying an Account and the amount, date, name or other identifier of any investment professional(s) associated with such Owners (if known), and transaction type (purchase, redemption, transfer, or exchange) of every purchase, redemption, transfer, or exchange of Shares held through an Account (the Information). Upon further request by the Trust or its designee, Company agrees to provide the name or other identifier of any investment professionals (if known) associated with any Contract Owner(s) account which has been identified by EVD as having violated policies established by the Trust for the purpose of eliminating or reducing any dilution of the value of the outstanding shares issued by the Trust. In addition:
(i) Requests for Information must set forth a specific period, not to exceed ninety (90) business days from the date of the most recent calendar month-end preceding the request, for which Information is sought. The Trust or its designee may request Information older than ninety (90) business days from the date of the request as they deem necessary to investigate compliance with policies established by the Trust for the purpose of eliminating or reducing any dilution of the value of the outstanding Shares issued by the Trust;
(ii) In accordance with the preceding paragraph, the Company agrees to transmit the Information to the Trust or its designee promptly, but in any event not later than five (5) business days, after receipt of a request for Information or after the last day of a period for which the Information has been requested, unless mutually agreed upon otherwise by the parties. If requested by the Trust or its designee, the Company agrees to use reasonable efforts to determine promptly whether any specific person about whom it has received Information is itself a financial intermediary (Indirect Intermediary) and, upon further request of the Trust or its designee, promptly either: (i) provide or arrange to provide to the Trust or its designee the Information and any other information required to be provided by law, rule, or regulation for those Owners who hold accounts with an Indirect Intermediary; or (ii) restrict or prohibit the Indirect Intermediary from purchasing Shares in nominee name on behalf of other persons. The Company agrees to inform the Trust or its designee whether the Company will perform (i) or (ii). For purposes of this paragraph, an Indirect Intermediary has the same meaning as provided in Rule 22c-2 under the 40 Act (Rule 22c-2);
(iii) Unless otherwise specifically requested by the Fund, this section shall be read to require the Company to provide only that information relating to Shareholder-Initiated Transactions.
(iv) To the extent practicable, the format for any Information provided to the Trust should be consistent with the NSCCs Standardized Data Reporting Format, or if not practicable, in an alternative format mutually agreed upon by the parties; and
(iv) The Trust agrees not to use Information received from the Company solely as a result of entering into this Agreement for marketing or any other similar purpose without the Companys prior written consent, unless otherwise required by law, rule, or regulation. The Trust may, however, use the information received to ensure compliance with the Trusts compliance policies and procedures established by the Trust for the purpose of eliminating or reducing any dilution of the value of the outstanding shares issued by the Portfolios.
2.2 The Company agrees to execute instructions from the Funds or their designee (Instructions) to restrict or prohibit further purchases or exchanges of Shares by Owners that have been identified by the Funds or a designee as having engaged in transactions in Shares (directly or indirectly through the Account) that may violate the Funds policies regarding short term or excessive trading activity. The Funds or their designee will include in the Instructions the TIN, ITIN, or GII, if known, and the specific restriction(s) to be implemented. If the TIN, ITIN, or GII, is not known, the Instructions must include an equivalent identifying number of the Owners or other agreed upon information to which the Instructions relate. In addition, the Company agrees as follows:
(i) To implement Instructions as soon as reasonably practicable, but not later than five (5) business days after receipt of the Instructions by the Company; and
(ii) To provide confirmation to the Funds in a mutually agreed upon format that Instructions have been implemented. The Company agrees to provide confirmation as soon as is reasonably practicable, but not later than ten (10) business days after the Instructions have been implemented.
(iii) Unless otherwise specifically requested by the Fund, any such restrictions or prohibitions shall only apply to Shareholder-Initiated Transactions that are effected directly or indirectly through Company.
2.3 For the purpose of this Article 2:
(i) The term Trust does not include any excepted funds as defined in Rule 22c.
(ii) The term Shares means the interests of Owners corresponding to the redeemable securities of record issued by the Funds under the 1940 Act that are held by the Company.
(iii) The term Owner means the beneficial Owner of Shares, whether the Shares are held directly or by the Company in nominee name.
(iv) The term Shareholder-Initiated Transaction means a transaction that is initiated or directed by a Owner that results in a transfer of assets within a Contract into or out of a Fund, but does not include transactions that are executed: (i) automatically pursuant to a contractual or systematic program or enrollments such as transfer of assets within a Contract to a Fund as a result of dollar cost averaging programs, insurance company approved asset allocation programs, or automatic rebalancing programs; (ii) pursuant to a Contract death benefit; (iii) pursuant to a Contract death benefit as a one-time step-up in Contract value; (iv) to allocate assets to a Fund through a Contract as a result of payments such as loan repayments, scheduled contributions, retirement plan salary reduction contributions, or planned premium payments to the Contract; (v) as pre-arranged transfers at the conclusion of a required free look period; (vi) automatically pursuant to a contractual or systematic program or enrollments such as transfer of assets within a Contract out of a Fund as a result of annuity payouts, loans, systematic withdrawal programs, insurance company approved asset allocation programs and automatic rebalancing programs; (vii) as a result of any deduction or charge or fees under a Contract; (iii) within a Contract out of a Fund as a result of scheduled withdrawals or surrenders
Article III. Fees and Expenses
3.1 Except as otherwise provided under this Agreement, the Trust and the Distributor shall pay no fee or other compensation to the Company under this Agreement, and the Company shall pay no fee or other compensation to the Fund or the Distributor, except as made a part of this Agreement as it may be amended from time to time with the mutual consent of the parties hereto. All expenses incident to performance by each party of its respective duties under this Agreement shall be paid by that party, unless otherwise specified in this Agreement
Article IV. Representations and Warranties
4.1 The Company represents and warrants that it is an insurance company duly organized and in good standing under the laws of Tennessee and that it has legally and validly established each Separate Account as a segregated asset account under such laws.
4.2 The Company represents and warrants that it has registered or, prior to any issuance or sale of the Variable Contracts, will register each Separate Account as a unit investment trust
(UIT) in accordance with the provisions of the 40 Act and cause each Separate Account to remain so registered to serve as a segregated asset account for the Variable Contracts, unless an exemption from registration is available.
4.3 The Company represents and warrants that the income, gains and losses, whether or not realized, from assets allocated to each Separate Account are, in accordance with the applicable Variable Contracts, to be credited to or charged against such Separate Account without regard to other income, gains or losses from assets allocated to any other accounts of the Company. The Company represents and warrants that the assets of the Separate Account are and will be kept separate from the General Account of the Company and any other separate accounts the Company may have, and will not be charged with liabilities from any business that the Company may conduct or the liabilities of any companies affiliated with the Company.
4.4 The Company represents and warrants that the Variable Contracts will be registered under the Securities Act of 1933 (the 33 Act) unless an exemption from registration is
available prior to any issuance or sale of the Variable Contracts and that the Variable Contracts will be issued and sold in compliance in all material respects with all applicable federal and state laws and further that the sale of the Variable Contracts shall comply in all material respects with state insurance law suitability requirements. The Company agrees to notify the Trust promptly of any investment restrictions imposed by state insurance law applicable to the Trust.
4.5 The Company represents and warrants that the Variable Contracts are currently and at the time of issuance will be treated as life insurance, endowment or annuity contracts under applicable provisions of the Code, that it will maintain such treatment and that it will notify the Trust immediately upon having a reasonable basis for believing that the Variable Contracts have ceased to be so treated or that they might not be so treated in the future.
4.6 The Trust represents and warrants that the Portfolio Shares offered and sold pursuant to this Agreement will be registered under the 33 Act and sold in accordance with all applicable federal and state laws, and the Trust shall be registered under the 40 Act prior to and at the time of any issuance or sale of such Shares. The Trust shall amend its registration statement under the 33 Act and the 40 Act from time to time as required in order to effect the continuous offering of its Shares. The Fund shall register and qualify its Shares for sale in accordance with the laws of the various states only if and to the extent deemed advisable by the Trust.
4.7 The Trust represents and warrants that each Portfolio will comply with the diversification requirements set forth in Section 817(h) of the Code, and the rules and regulations thereunder, including without limitation Treasury Regulation §1.817-5, and will notify the Company immediately upon having a reasonable basis for believing any Portfolio has ceased to comply or might not so comply and will immediately take all reasonable steps to adequately diversify the Portfolio to achieve compliance. The Fund shall provide Company a certification of its compliance with Section 817(h) of the Code and Treasury Regulation 1.817-5 within sixty (60) days of the end of each calendar quarter.
4.8 The Fund represents and warrants that each Portfolio invested in by the Separate Account intends to elect to be treated as a regulated investment company under Subchapter M of the Code, and that it will make every effort to maintain each Portfolios qualification (under Subchapter M or an successor or similar provision) and will notify the Company immediately upon having a reasonable basis for believing it has ceased to so qualify or might not so qualify in the future.
4.9 The Distributor represents that it is and warrants that it shall remain duly registered as a broker-dealer under all applicable federal and state securities laws and agrees that it shall perform is obligations for the Trust in compliance in all material respects with the laws of the Commonwealth of Massachusetts and any applicable state and federal securities laws. The Distributor further represents that it is a member in good standing of the Financial Industry Regulatory Authority, Inc. (FINRA).
4.10 The Trust represents and warrants that all its directors, trustees, officers, employees, and other individuals/entities who deal with the money and/or securities of the Trust are and shall continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Trust in an amount not less than that required by Rule 17g-1 under the 40 Act. The
aforesaid bond shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company.
4.12 The Company represents and warrants that all of its employees and agents who deal with the money and/or securities of the Trust are and shall continue to be at all times covered by a blanket fidelity bond or similar coverage in an amount not less than that required to be maintained by entities subject to the requirements of Rule 17g-1 of the 40 Act. The aforesaid bond shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company.
Article V. Prospectus and Proxy Statements
5.1 The Trust shall prepare and be responsible for filing with the SEC and any state regulators requiring such filing all shareholder reports, notices, proxy materials (or similar materials such as voting instruction solicitation materials), prospectuses and statements of additional information of the Portfolios.
5.2 At least annually, the Trust or its designee shall provide the Company, free of charge, in portable document format (i.e., PDF) only (or other electronic means as agreed to by the Distributor and the Company) the current statutory prospectus and summary prospectus (if requested by Company) for the Shares of the Portfolios as the Company may reasonably request for distribution to existing Owners whose Variable Contracts are funded by such Shares. The Trust or its designee shall also provide the Company in PDF only the current prospectus for the Shares as the Company may reasonably request for distribution to prospective purchasers of Variable Contracts. If requested by the Company the Trust or its designee shall provide such documentation in PDF and such other assistance as is reasonably necessary in order for the parties hereto once a year (or more frequently if the prospectus for the Shares is supplemented or amended) to have the prospectus for the Variable Contracts and the prospectus for the Trust Shares and any other fund shares offered as investments for the Variable Contracts printed at the Companys expense together in one document, provided however that the Company shall ensure that, except as expressly authorized in writing by the Trust, no alterations, edits or changes whatsoever are made to prospectuses or other Trust documentation after such documentation has been furnished to the Company or its designee, and the Company shall assume liability for any and all alterations, errors or other changes that occur to such prospectuses or other Trust documentation after it has been furnished to the Company or its designee.
5.3 The Trust, at the Trusts expense, shall provide the Company with copies of the Trusts proxy statements, Trust reports to shareholders, and other Trust communications to shareholders in PDF in such quantity as the Company shall reasonably require for distributing to Owners. Alternatively and in lieu thereof, the Company may elect to print at its own expense any of the Trusts proxy statements, Trust reports to shareholders, and other Trust communications to shareholders.
5.4 Upon reasonable request, the Trust will provide the Company with at least one complete PDF copy of all prospectuses, statements of additional information, annual and semi-annual reports, proxy statements, and all amendments or supplements to any of the above that relate to the Portfolios after the filing of each such document with the SEC or other regulatory authority. Upon reasonable request, the Company will provide the Trust with at least one complete PDF copy of all prospectuses, statements of additional information, annual and semi-annual reports,
proxy statements, and all amendments or supplements to any of the above that relate to a Separate Account after the filing of each such document with the SEC or other regulatory authority.
Article VI. Sales Materials
6.1 The Company will furnish, or will cause to be furnished, to the Trust or the Distributor, each piece of sales literature or other promotional material in which the Trust, the Distributor or any affiliate thereof is named, at least five (5) business days prior to its intended use. No material shall be used if the Trust or its designee reasonably objects to such use within five (5) Business Days after receipt of such material.
6.2 The Trust or the Distributor will furnish, or will cause to be furnished, to the Company, each piece of sales literature or other promotional material in which the Company or its Separate Accounts are named, at least five (5) business days prior to its intended use. No such material shall be used unless the Company approves such material. No material shall be used if the Trust or its designee reasonably objects to such use within five (5) Business Days after receipt of such material.
6.3 Except with the express, prior permission of the Company, neither the Trust nor the Distributor shall give any information or make any representations on behalf of the Company or concerning the Company, the Separate Accounts, or the Variable Contracts other than the information or representations contained in the registration statement or prospectus for such Variable Contracts, as such registration statement and prospectus may be amended or supplemented from time to time, or in reports of the Separate Accounts for distribution to Owners of such Variable Contracts, or in sales literature or other promotional material approved by the Company or its designee. Neither the Trust nor the Distributor shall give such information or make such representations or statements in a context that causes the information, representations or statements to be false or misleading.
6.4 Except with the express, prior permission of the Trust or the Distributor, neither the Company nor its affiliates or agents shall give any information or make any representations or statements on behalf of the Trust, the Distributor or any affiliate thereof or concerning the Trust, the Distributor or any affiliate thereof, other than the information or representations contained in the registration statements or prospectuses for the Trust, as such registration statements and prospectuses may be amended or supplemented from time to time, or in reports to shareholders or proxy statements for the Trust, or in sales literature or other promotional material approved by the Trust or the Distributor or designee thereof. Neither the Company nor its affiliates or agents shall give such information or make such representations or statements in a context that causes the information, representations or statements to be false or misleading.
6.5 At the request of any party to this Agreement, each other party will make available to the other partys independent auditors and/or representative of the appropriate regulatory agencies, all records, data and access to operating procedures that may be reasonably requested.
6.6 For purposes of this Agreement, the phrase sales literature or other promotional material or words of similar import include, without limitation, advertisements (such as material
published, or designed for use, in a newspaper, magazine or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures or other public media), sales literature (such as any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, or reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, registration statements, prospectuses, statements of additional information, shareholder reports and proxy materials, and any other material constituting sales literature or advertising under the National Association of Securities Dealers, Inc. or FINRA rules, the 40 Act or the 33 Act.
Article VII. Potential Conflicts
7.1 The parties acknowledge that the Trust has received the Mixed and Shared Funding Exemptive Order which, requires the Trust and each Participating Company and Plan to comply with conditions and undertakings substantially as provided in this Article. In the event of any inconsistencies between the terms of the Mixed and Shared Funding Exemptive Order and those provided for in this Article, the conditions and undertakings imposed by the Mixed and Shared Funding Exemptive Order shall govern this Agreement.
7.2 The Trusts Board will monitor each Portfolio for the existence of any material irreconcilable conflict between and among the interests of the Owners of all Participating Companies and of Plan Participants and Plans investing in the Portfolio, and determine what action, if any, should be taken in response to such conflicts. An irreconcilable material conflict may arise for a variety of reasons, which may include: (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling or any similar action by insurance, tax or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the investments of the Portfolios are being managed; (e) a difference in voting instructions given by variable annuity and variable life insurance contract Owners; (f) a decision by a Participating Insurance Company to disregard the voting instructions of Owners and (g) if applicable, a decision by a Plan to disregard the voting instructions of plan participants. The Board shall have sole authority to determine whether an irreconcilable material conflict exists and its determination shall be binding upon Company.
7.3 The Company will report promptly any potential or existing conflicts to the Board. The Company will be obligated to assist the Board in carrying out its duties and responsibilities under the Mixed and Shared Funding Exemptive Order by providing the Board with all information reasonably necessary for the Board to consider any issues raised. The responsibility includes, but is not limited to, an obligation by the Company to inform the Board whenever it has determined to disregard Owners voting instructions.
7.4 If a majority of the Board, or a majority of its disinterested Board members, determines that a material irreconcilable conflict exists with regard to contract Owner investments in the Trust, the Board shall give prompt notice of the conflict and the implications thereof to all Participating Companies and Plans. If the Board determines that the Company is a relevant Participating Company or Plan with respect to said conflict, the Company shall at its sole cost and expense, and to the extent reasonably practicable (as determined by a majority of the disinterested Board members), take such action as is necessary to remedy or eliminate the
irreconcilable material conflict. Such necessary action may include but shall not be limited to: (a) withdrawing the assets allocable to some or all of the Separate Accounts from the Trust or any Portfolio thereof and reinvesting those assets in a different investment medium, which may include another Portfolio of the Trust, or another investment company; (b) submitting the question as to whether such segregation should be implemented to a vote of all affected Owners and as appropriate, segregating the assets of any appropriate group (i.e., variable annuity or variable life insurance contract Owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected Owners the option of making such a change; and (c) establishing a new registered management investment company (or series thereof) or managed separate account and obtaining any necessary approvals or orders of the SEC in connection therewith. If a material irreconcilable conflict arises because of the Companys decision to disregard Owner voting instructions, and that decision represents a minority position or would preclude a majority vote, the Company may be required, at the election of the Trust to withdraw the Separate Accounts investment in the Trust, and no charge or penalty will be imposed as a result of such withdrawal. The responsibility to take such remedial action shall be carried out with a view only to the interests of the Owners. For the purposes of this Article, a majority of the disinterested members of the Board shall determine whether or not any proposed action adequately remedies any irreconcilable material conflict but in no event will the Portfolio(s) or its investment adviser (or any other investment adviser of the Portfolio) be required to establish a new funding medium for any Variable Contract. Further, the Company shall not be required by this Article to establish a new funding medium for any Variable Contracts if any offer to do so has been declined by a vote of a majority of Owners materially and adversely affected by the irreconcilable material conflict.
7.5 The Boards determination of the existence of an irreconcilable material conflict and its implications shall be made known promptly and in writing to the Company.
7.6 No less than annually, the Company shall submit to the Board such reports, materials or data as the Board may reasonably request so that the Board may fully carry out its obligations. Such reports, materials, and data shall be submitted more frequently if deemed appropriate by the Board.
7.7 If and to the extent that the SEC promulgates new rules or regulations with respect to mixed or shared funding on terms and conditions materially different from those contained in the Mixed and Shared Funding Exemptive Order, then (a) the Trust and/or the Participating Insurance Companies as appropriate, shall take such steps as may be necessary to comply with such rules and regulations, as adopted, to the extent such rules are applicable; and (b) this Article VI shall be deemed to incorporate such new terms and conditions, and any term or condition of this Article VI that is inconsistent therewith, shall be deemed to be succeeded thereby.
7.8 The Company acknowledges it has been advised by the Trust that it may be appropriate for the Company to disclose the potential risks of mixed and shared funding in prospectuses or other applicable disclosure documents.
Article VIII. Voting
8.1 The Company will provide pass-through voting privileges to all Owners so long as the SEC continues to interpret the 40 Act as requiring pass-through voting privileges for Owners. Accordingly, the Company, where applicable, will vote Shares of the Portfolio held in its
Separate Accounts in a manner consistent with voting instructions timely received from its Owners. The Company will be responsible for assuring that each of its Separate Accounts that participates in the Trust calculates voting privileges in a manner consistent with other Participating Insurance Companies. The Company will vote Shares for which it has not received timely voting instructions, as well as Shares it owns, in the same proportion as its votes those Shares for which it has received voting instructions. The Company and its agents shall not oppose or interfere with the solicitation of proxies for Trust Shares held for such Owners. The Company shall fulfill its obligation under, and abide by the terms and conditions of, the Mixed and Shared Funding Exemptive Order as communicated by the Trust (in addition to those specified in this Agreement) and any reasonable standards that the Trust may adopt and provide in writing.
Article IX. Indemnification
9.1 Indemnification by the Company. Subject to Section 9.3 below, the Company agrees to indemnify and hold harmless the Trust and the Distributor, and each of their trustees, directors, members, principals, officers, partners, employees and agents and each person, if any, who controls the Trust or the Distributor within the meaning of Section 15 of the 33 Act (collectively, the Indemnified Parties for purposes of this Article) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Company, which consent shall not be unreasonably withheld) or litigation (including reasonable legal and other expenses), to which the Indemnified Parties may become subject under any statute, regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Trusts Shares or the Variable Contracts and:
(i) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the registration statement or prospectus for the Variable Contracts or contained in the Variable Contracts (or any amendment or supplement to any of the foregoing) (which shall include a written description of a Variable Contract that is not registered under the 33 Act), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Company by or on behalf of an Indemnified Party for use in the registration statement or prospectus for the Variable Contracts or in the Variable Contracts or sales literature (or any amendment or supplement) or otherwise for use in connection with the sale of the Variable Contracts or Trust Shares; or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus or sales literature of the Trust not supplied by the Company, or persons under its control) or wrongful conduct of the Company or persons under its control, with respect to the sale or distribution of the Variable Contracts or Trust Shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, or sales literature of the Trust or any amendment thereof or supplement thereto or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not
misleading if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Trust by or on behalf of the Company; or
(iv) arise as a result of any failure by the Company to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the qualification requirements specified in Section 4.5 of this Agreement; or
(v) arises out of information or instructions from the Company or its agents concerning the purchase, redemption, transfer or other transaction in Trust Shares; or
(vi) arise out of or result from any material breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Company.
(b) The Company shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified Party as such may arise from such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement.
(c) The Company shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Company in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Company of any such claim shall not relieve the Company from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against an Indemnified Party, the Company shall be entitled to participate at its own expense in the defense of such action. The Company also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action. After notice from the Company to such party of the Companys election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Company will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.
9.2 Indemnification by the Trust and the Distributor.
(a) Subject to Section 9.3 below, the Trust and the Distributor agree to indemnify and hold harmless the Company and each of its directors, officers, employees, and agents and each person, if any, who controls the Company within the meaning of Section 15 of the 33 Act (collectively, the Indemnified Parties for the purposes of this Article) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Trust and the Distributor which consent shall not be unreasonably withheld) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute, or regulation, at common law or otherwise, insofar as such losses,
claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Trusts Shares or the Variable Contracts and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement or prospectus of the Trust (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Trust or the Distributor by or on behalf of the Company for use in the registration statement or prospectus for the Trust (or any amendment or supplement) or otherwise for use in connection with the sale of the Variable Contracts or Shares; or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus or sales literature for the Variable Contracts not supplied by the Trust or the Distributor or persons under its control) or wrongful conduct of the Trust or the Distributor or persons under its control, with respect to the sale or distribution of the Variable Contracts or Shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement or prospectus covering the Variable Contracts, or any amendment thereof or supplement thereto or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Company for inclusion therein by or on behalf of the Trust or the Distributor; or
(iv) arise as a result of a failure by the Trust or the Distributor to provide the services and furnish the materials under the terms of this Agreement; or
(v) arise out of or result from any material breach of any representation and/or warranty made by the Trust or the Distributor in this Agreement or arise out of or result from any other material breach of this Agreement by the Trust or the Distributor.
(b) The Trust or the Distributor shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement.
(c) The Trust or the Distributor, as the case may be, shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Trust or the Distributor, as the case may be, in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Trust or the Distributor of any such claim shall not relieve the Trust or
the Distributor from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Trust or the Distributor shall be entitled to participate at its own expense in the defense thereof. The Trust or the Distributor also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action. After notice from the Trust or the Distributor to such party of the Trusts or the Distributors election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Trust or the Distributor will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.
9.3 Indemnification for Errors. In the event of any error or delay with respect to information regarding the purchase, redemption, transfer or registration of Shares of the Trust, the parties agree that each is obligated to make the Separate Accounts and/or the Trust, respectively, whole for any error or delay that it causes, subject in the case of pricing errors to the related Portfolios policies on materiality of pricing errors. In addition, each party agrees that neither will receive compensation from the other for the administrative costs of any reprocessing necessary as a result of an error or delay. Each party agrees to provide the other with prompt notice of any errors or delays of the type referred to in this Section. The Company and the Trust agree that Eaton Vance Pricing Error Procedures shall govern.
9.4 The Company agrees to notify Trust and the Distributor promptly of the commencement of any litigation or proceedings against it or any of its officers or directors in connection with the issuance or sale of the Variable Contracts or the operation of the Separate Accounts.
Article X. Term; Termination
10.1 This Agreement shall be effective as of the date hereof and shall continue in force until terminated in accordance with the provisions herein.
10.2 This Agreement shall terminate in accordance with the following provisions:
(a) At the option of the Company or the Trust at any time from the date hereof upon ninety (90) days notice, unless a shorter time is agreed to by the parties;
(b) At the option of the Company, if Trust Shares are not reasonably available to meet the requirements of the Variable Contracts as determined by the Company, provided, however, that such termination shall apply only to the Portfolio(s) not reasonably available. Prompt advance notice of election to terminate shall be furnished by the Company, said termination to be effective ten days after receipt of notice unless the Trust makes available a sufficient number of Shares to reasonably meet the requirements of the Variable Contracts within said ten-day period;
(c) At the option of the Company, upon the institution of formal proceedings against the Trust by the SEC, the National Association of Securities Dealers, Inc., FINRA or any other regulatory body, the expected or anticipated ruling, judgment or outcome of which would, in the Companys reasonable judgment, materially impair the Trusts ability to meet and perform the Trusts obligations and duties hereunder. Prompt notice of election to terminate shall be
furnished by the Company with said termination to be effective upon receipt of notice;
(d) At the option of the Trust, upon the institution of formal proceedings against the Company by the SEC, FINRA, or any other regulatory body, the expected or anticipated ruling, judgment or outcome of which would, in the Trusts reasonable judgment, materially impair the Companys ability to meet and perform its obligations and duties hereunder. Prompt notice of election to terminate shall be furnished by the Trust with said termination to be effective upon receipt of notice;
(e) In the event the Trusts Shares are not registered, issued or sold in accordance with applicable state or federal law, or such law precludes the use of such Shares as the underlying investment medium of Variable Contracts issued or to be issued by the Company. Termination shall be effective upon such occurrence without notice;
(f) At the option of the Trust if the Variable Contracts cease to qualify as annuity contracts or life insurance contracts, as applicable, under the Code, or if the Trust reasonably believes that the Variable Contracts may fail to so qualify. Termination shall be effective upon receipt of notice by the Company;
(g) At the option of the Company, upon the Trusts breach of any material provision of this Agreement, which breach has not been cured to the satisfaction of the Company within thirty (30) days after written advance notice of such breach is delivered to the Trust;
(h) At the option of the Trust, upon the Companys breach of any material provision of this Agreement, which breach has not been cured to the satisfaction of the Trust within thirty (30) days after written advance notice of such breach is delivered to the Company;
(i) At the option of the Trust, if the Variable Contracts are not registered or exempt from registration, issued or sold in accordance with applicable federal and/or state law. Termination shall be effective immediately upon such occurrence without notice;
(ii) In the event this Agreement is assigned without the prior written consent of the Company, the Trust, and the Distributor, termination shall be effective immediately upon such occurrence without notice.
10.3 Notwithstanding any termination of this Agreement pursuant to Section 10.2 hereof, the Trust at the option of the Company will continue to make available additional Trust Shares, as provided below, pursuant to the terms and conditions of this Agreement, for all Variable Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as Existing Contracts), unless the Distributor requests that the Company seek an order pursuant to Section 26(c) of the 1940 Act to permit the substitution of other securities for shares of the Portfolio(s) Specifically, without limitation, the Owners of the Existing Contracts or the Company, whichever shall have legal authority to do so, shall be permitted to reallocate investments in the Portfolio(s), redeem investments in the Trust and/or invest in the Trust upon the payment of additional premiums under the Existing Contracts.
Article XI. Notices
11.1 Any notice hereunder shall be given by registered or certified mail return receipt requested or via overnight delivery to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other party.
If to the Trust
c/o Eaton Vance Distributors, Inc.
Two International Place
Boston, MA 02100:
Attention: Chief Legal Officer
If to the Distributor:
Eaton Vance Distributors, Inc.
Two International Place
Boston, MA 02110
Attention: Chief Legal Officer
If to the Company:
Protective Life Insurance Company
2801 Highway 280 South
Birmingham AL 35223
Attention: Senior Vice President, Chief Product Officer
With a copy to:
Senior Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
Notice shall be deemed given on the date of receipt by the addressee as evidenced by the return receipt.
Article XII. MISCELLANEOUS
12.1 Privacy. Each party hereto acknowledges that, by reason of its performance under this Agreement, it shall have access to, and shall receive from the other party (and its affiliates, partners and employees), the confidential information of the other party (and its affiliates, partners and employees), including but not limited to the nonpublic personal information of their consumers within the meaning of SEC Regulation S-P (collectively, Confidential Information). Each party shall hold all such Confidential Information in the strictest confidence and shall use such Confidential Information solely in connection with its performance under this Agreement and for the business purposes set forth in this Agreement. Under no circumstances may a party cause any Confidential Information of the other party to be disclosed to any third party or reused or redistributed without the other partys prior written consent.
12.2 Counterparts. This Agreement may be executed simultaneously in two or more
counterparts, each of which taken together shall constitute one and the same instrument.
12.3 Severability. If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.
12.4 Governing Law. This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of the State of New York. It shall also be subject to the provisions of the federal securities laws and the rules and regulations thereunder and to any orders of the SEC granting exemptive relief therefrom and the conditions of such orders.
12.5 Liability. This Agreement has been executed on behalf of the Trust by the undersigned officer of the Trust in his or her capacity as an officer of the Trust. The obligations of this Agreement shall be binding upon the assets and property of the Trust and each respective Portfolio thereof only and shall not be binding on any Director/Trustee, officer or shareholder of the Trust individually. In addition, notwithstanding any other provision of this Agreement, no Portfolio shall be liable for any loss, expense, fee, charge or liability of any kind relating to or arising from the actions or omissions of any other Portfolio or from the application of this Agreement to any other Portfolio. It is also understood that each of the Portfolios shall be deemed to be entering into a separate Agreement with the Company so that it is as if each of the Portfolios had signed a separate Agreement with the Company and that a single document is being signed simply to facilitate the execution and administration of the Agreement.
12.6 Inquiries and Investigations. Each party shall cooperate with each other party and all appropriate governmental authorities (including without limitation the SEC, FINRA and state insurance regulators) and shall permit such authorities reasonable access to its books and records in connection with any investigation, examination or inquiry relating to this Agreement or the transactions contemplated hereby.
12.7 Subcontractors, Agents or Affiliates. The Company may hire or make arrangements for subcontractors, agents or affiliates to perform the services set forth in this Agreement. The Company shall provide the Trust with written notice of the names of any subcontractors, agents or affiliates the Company hires or arranges to perform such services, and any specific operational
requirements that arise as a result of such arrangement. The Company agrees that it is and will be responsible for the acts and omissions of its subcontractors, affiliates, and agents and that the indemnification provided by the Company in Section 9 of this Agreement shall be deemed to cover the acts and omissions of such subcontractors, affiliates, and agents to the same extent as if they were the acts or omissions of the Company.
12.8 Client Lists. The Company hereby consents to the Distributors, the Trusts, or its investment advisers use or reference to the Companys name in connection with any full, partial or representative list of clients.
12.9 Entire Agreement. This Agreement constitutes the entire agreement and understanding between the parties hereto and supersedes all prior agreement and understandings relating to the subject matter hereof.
12.10 Amendment, Waiver and Other Matters. Neither this Agreement, nor any provision hereof, may be amended, waived, modified or terminated in any manner except by a written instrument properly authorized and executed by all parties hereto. The rights, remedies and
obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.
12.11 The Portfolios are portfolio series of a Massachusetts business trust formed under a declaration of trust. The obligations of this Agreement with respect to each Portfolio are binding only upon the assets and property of such series and are not binding upon any other series of the Trust, and all persons dealing with a Portfolio must look solely to the property of that Portfolio for satisfaction of claims of any nature against the Portfolio, as neither the trustees, officers, employees nor shareholders of the Trust assume any personal liability in connection with its business or for obligations entered into on its behalf.
IN WITNESS WHEREOF, the parties have caused their duly authorized officers to execute this Fund Participation Agreement as of the date and year first above written.
|
Protective Life Insurance Company |
|
|
|
|
|
By: |
|
|
Name: Steve Cramer |
|
|
Title: Chief Product Officer, Retirement Division |
|
|
|
|
|
Eaton Vance Distributors, Inc. |
|
|
|
|
|
By: |
|
|
Name: Brain Taranto |
|
|
Title: Chief Administrative Officer |
|
|
|
|
|
Eaton Vance Variable Trust |
|
|
|
|
|
By: |
|
|
Name: Brian Taranto |
|
|
Title: Treasurer |
FUND PARTICIPATION AGREEMENT
This Agreement is entered into between Protective Life Insurance Company (the Insurer), on its behalf and on behalf of certain segregated asset accounts of the Insurer which may be listed on Exhibit A to this Agreement as updated from time to time by the Insurer (the Separate Accounts); Federated Hermes Insurance Series (the Investment Company); and Federated Securities Corp. (the Distributor).
WHEREAS, the Investment Company is registered with the Securities and Exchange Commission (SEC) as an open-end management investment company under the Investment Company Act of 1940, as amended (1940 Act);
WHEREAS, the Investment Company is authorized to issue separate classes of Shares of beneficial interest (Shares), each representing an interest in a separate portfolio of assets (a Fund) and each Fund has its own investment objective, policies, and limitations; and Shares of the Funds are registered under the Securities Act of 1933, as amended (1933 Act);
WHEREAS, the Investment Company is available to offer Shares of one or more of its Funds to separate accounts of insurance companies that fund variable annuity contracts and variable life insurance policies and to serve as an investment medium for variable annuity contracts and variable life insurance policies offered by insurance companies that have entered into participation agreements substantially similar to this agreement (Participating Insurance Companies);
WHEREAS, the Insurer has issued or will issue variable annuity contracts and variable life insurance policies (Variable Contracts) supported wholly or partially by the Separate Accounts;
WHEREAS, the Separate Accounts are duly established and maintained as segregated asset accounts by the Insurer to set aside and invest assets attributable to the Variable Contracts;
WHEREAS, the Investment Company has obtained an order from the SEC dated December 29, 1993 (File No. 812-8620), granting Participating Insurance Companies and variable annuity and variable life insurance separate accounts exemptions from the provisions of sections 9(a), 13(a), 15(a), and 15(b) of the 1940 Act and Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit Shares of the Investment Company to be sold to and held by variable annuity and variable life insurance separate accounts of life insurance companies that may or may not be affiliated with one another (the Mixed and Shared Funding Exemptive Order);
WHEREAS, the Distributor is registered as a broker-dealer with the SEC under the Securities Exchange Act of 1934, as amended (1934 Act), and is a member in good standing of the Financial Industry Regulatory Authority (FINRA); and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Insurer intends to purchase Shares of one or more of the Funds on behalf of its Separate Accounts to serve as an investment medium for Variable Contracts funded by the Separate Accounts, and the Distributor is authorized to sell Shares of the Funds;
NOW, THEREFORE, in consideration of the foregoing and the mutual promises and covenants set forth, the parties hereby agree as follows:
1. Sales and Transactions of Fund Shares
The Distributor, as agent for the Funds, agrees to sell to the Insurer those Shares of the Funds offered and made available by the Investment Company and identified on Exhibit B to this Agreement that the Insurer orders on behalf of its Separate Accounts upon the following terms and conditions:
(a) Execution. Share purchase orders shall be executed at the net asset value next calculated after the order is received by the Fund or its agent subject to any sales charges or other conditions disclosed in the applicable Prospectus; provided that, Distributor and each Fund reserves the right to reject, in its sole discretion, any purchase order for a Funds Shares. Unless otherwise instructed by Insurer, Distributor agrees to confirm to Insurer in writing (or by electronic or other reasonable means) a Funds acceptance of any purchase order.
(b) Suspension of Sales. The Investment Company agrees to make available on each business day Shares of the Funds for purchase at the applicable net asset value per share by the Insurer on behalf of its Separate Accounts; provided, however, that the Board of Trustees of the Investment Company (the Board) or its designee may refuse to sell Shares of any Fund to any person, or suspend or terminate the offering of Shares of any Fund, if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Board, or their designee, acting in good faith and in light of the Boards fiduciary duties under applicable law, necessary in the best interests of the shareholders of any Fund.
(c) Settlement. Insurer, on behalf of the Separate Accounts, shall settle purchase order transactions in accordance with the applicable Prospectus. If a purchase order is not settled in accordance with the applicable Prospectus, Investment Company may without notice, cancel the sale and Insurer shall be responsible for any resulting loss the Investment Company or the Distributor sustains. In addition, Insurer shall be responsible for any loss sustained by the Investment Company or the Distributor caused by a correction to or cancellation of any order placed by Insurer on behalf of the Separate Accounts, that is made subsequent to the trade date for the order, provided that the order correction or cancellation was not caused by any
gross negligence on the part of Investment Company or the Distributor. Insurer shall immediately pay such losses to the Distributor upon written notification by the Distributor.
(d) Sales to Insurance Companies. The Investment Company and the Distributor agree that Shares of the Funds will be sold only to Participating Insurance Companies, their separate accounts, and other persons consistent with applicable law. Shares of the Funds will not be sold directly to the general public except to the extent permitted by applicable law.
(e) Agreements to Sell. The Investment Company and the Distributor will not sell Shares of the Funds to any insurance company or separate account unless an agreement containing provisions substantially the same as the provisions in Section 4 of this Agreement is in effect to govern such sales.
(f) Redemption. Upon receipt of a request for redemption in proper form from the Insurer, the Investment Company agrees to redeem any full or fractional Shares of the Funds held by the Insurer, ordinarily executing such requests on each Business Day at the net asset value next computed after receipt and acceptance by the Investment Company or its agent of the request for redemption, except that the Investment Company reserves the right to suspend the right of redemption, consistent with Section 22(e) of the 1940 Act and any rules thereunder. Such redemption shall be paid consistent with Section 22(e) of the 1940 Act and any rules, regulations or orders thereunder, and the procedures and policies of the Investment Company as described in the current registration statement for the Investment Company.
(g) Terms of Purchase and Redemption. The Insurer agrees to purchase and redeem Shares of each Fund in accordance with the current Prospectus for the Fund and the Operational Procedures set forth in Exhibit C to this Agreement.
(h) Book Entry. Issuance and transfer of Shares of the Funds will be by book entry only. Share certificates will not be issued to the Insurer or the Separate Accounts. Shares ordered from the Investment Company will be recorded in an appropriate title for the Separate Accounts or the appropriate sub-accounts of the Separate Accounts.
(i) Dividends and Distributions. The Investment Company shall furnish same day notice to the Insurer of any income, dividends or capital gain distributions payable on the Shares of the Funds. The Insurer hereby elects to reinvest in the Fund all such dividends and distributions as are payable on a Funds Shares and to receive such dividends and distributions in additional Shares of that Fund. The Insurer reserves the right to revoke this election in writing and to receive all such dividends and distributions in cash. The Investment Company shall notify the Insurer of the number of Shares so issued as payment of such dividends and distributions.
(j) Transfer Agent Information. The Investment Company shall instruct its transfer agent to advise the Insurer on each Business Day of the net asset value per share for each Fund. None of the Investment Company, any Fund or the Distributor, or any of their affiliates shall be liable for any information provided to the Insurer pursuant to this Agreement which information is based on incorrect information supplied by the Insurer or any other Participating Insurance Company to the Investment Company or the Distributor.
(k) Representations. Insurer shall rely solely on the representations contained in the Funds registration statements and authorized promotional materials and sales literature, and neither Insurer nor any of its representatives will make any representations concerning Shares except as contained therein.
(l) Operational Instructions. Insurer agrees to promptly comply with reasonable operational instructions provided by Distributor, Investment Company or a Fund from time to time (Instructions) with respect to establishing accounts and processing orders.
2. Representations and Warranties
(a) Insurer. The Insurer represents and warrants that:
(i) it is an insurance company duly organized and in good standing under applicable law and that it is taxed as an insurance company under Subchapter L of the Internal Revenue Code of 1986, as amended, (the Code).
(ii) it has legally and validly established each of the Separate Accounts as a segregated asset account under the applicable state insurance code, and that each of the Separate Accounts is a validly existing segregated asset account under applicable federal and state law.
(iii) the Variable Contracts or interests in the Separate Accounts under such Variable Contracts (i) are or, prior to issuance, will be registered as securities under the 1933 Act or, alternatively, (ii) are not registered because they are properly exempt from registration under the 1933 Act or will be offered exclusively in transactions that are properly exempt from registration under the 1933 Act.
(iv) each of the Separate Accounts (A) has been registered as a unit investment trust in accordance with the provisions of the 1940 Act or, alternatively, (B) has not been registered in proper reliance upon an exclusion from registration under the 1940 Act.
(v) it believes, in good faith, that the Variable Contracts are currently
(vi) treated as annuity contracts or life insurance policies (which may include modified endowment contracts), whichever is appropriate, under applicable provisions of the Code.
(vii) In connection with this Agreement, no payments of money or anything of value will be offered, promised or paid to any person, directly or indirectly, to influence the acts of such person to induce such person to use their influence with a government or an instrumentality thereof, to obtain an improper advantage in connection with any business venture or contract in which Insurer is a participant.
(b) Investment Company. The Investment Company represents and warrants that:
(i) it is duly organized as a business trust under the laws of the Commonwealth of Massachusetts, and is in good standing under applicable law.
(ii) Shares of the Funds are duly authorized for issuance in accordance with applicable law and that the Investment Company is registered as an open-end management investment company under the 1940 Act.
(iii) it believes, in good faith, that the Funds currently comply with the diversification provisions of Section 817(h) of the Code and the regulations issued thereunder relating to the diversification requirements for variable life insurance policies and variable annuity contracts.
(iv) all of its trustees, officers, employees, and other individuals or entities dealing with the money and/or securities of the Investment Company are and shall continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Investment Company in an amount not less than the minimum coverage as required currently by Rule 17g-1 of the 1940 Act or related provisions as may be promulgated from time to time. Such bond shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company.
(c) Distributor. The Distributor represents and warrants that it is a member in good standing of the FINRA and is registered as a broker-dealer with the SEC. The parties shall each be deemed to repeat all the foregoing representations and warranties made by it at the time of any transaction subject to this Agreement
(d) ERISA. Insurer further represents and warrants that is not a fiduciary to any Plan Clients
(i) it.
3. General Duties
(a) Registration. The Investment Company shall take all such actions as are necessary to permit the sale of Shares of each Fund to the Separate Accounts, including maintaining its registration as an investment company under the 1940 Act, and registering the Shares of the Funds sold to the Separate Accounts under the 1933 Act for so long as required by applicable law. The Investment Company shall amend its Registration Statement filed with the SEC under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of Shares of the Funds. The Investment Company shall register and qualify Shares for sale in accordance with the laws of the various states to the extent deemed necessary by the Investment Company or the Distributor.
(b) Subchapter M Qualification. The Investment Company shall use its best efforts to maintain qualification of each Fund as a Regulated Investment Company under Subchapter M of the Code (or any successor or similar provision) and shall notify the Insurer immediately upon having a reasonable basis for believing that a Fund has ceased to so qualify or that it might not so qualify in the future.
(c) Diversification. The Investment Company shall use its best efforts to enable each Fund to comply with the diversification provisions of Section 817(h) of the Code and the regulations issued thereunder relating to the diversification requirements for variable life insurance policies and variable annuity contracts and any prospective amendments or other modifications to Section 817 or regulations thereunder, and shall notify the Insurer immediately upon having a reasonable basis for believing that any Fund has ceased to comply. Within 60 days of the end of the preceding calendar quarter, Investment Company shall use best efforts to provide Insurer with a certificate of compliance with Section 817(h) during that quarter. Notwithstanding the foregoing, any failure to provide such certification of compliance within the time period described will not constitute a breach of this agreement.
(d) Variable Contracts Separate Accounts. The Insurer shall take all such actions as are necessary under applicable federal and state law to permit the sale of the Variable Contracts, including registering each Separate Account as an investment company to the extent required under the 1940 Act, and registering the Variable Contracts or interests in the Separate Accounts under the Variable Contracts to the extent required under the 1933 Act, and obtaining all necessary approvals to offer the Variable Contracts from state insurance commissioners.
(e) Variable Annuities Annuity Contracts. The Insurer shall use its best efforts to maintain the treatment of the Variable Contracts as annuity contracts or life insurance policies, whichever is appropriate, under applicable provisions of the Code, and shall notify the Investment Company and the Distributor immediately upon having a reasonable basis for believing that such Variable Contracts have ceased to be so treated or that they might not be so treated in the future.
(f) Insurer Regulations. The Insurer shall offer and sell the Variable Contracts in accordance with applicable provisions of the 1933 Act, the 1934 Act, the 1940 Act, the regulations promulgated by FINRA (FINRA Conduct Rules), and state law respecting the offering of variable life insurance policies and variable annuity contracts.
(g) Distributor Regulations. The Distributor shall sell and distribute the Shares of the Funds of the Investment Company in accordance with the applicable provisions of the 1933 Act, the 1934 Act, the 1940 Act, the FINRA Conduct Rules, and state law.
(h) Disinterested Trustees. During such time as the Investment Company engages in Mixed Funding or Shared Funding, a majority of the Board shall consist of persons who are not interested persons of the Investment Company (Disinterested Trustees), as defined by Section 2(a)(19) of the 1940 Act and the rules thereunder, and as modified by any applicable orders of the SEC, except that if this provision of this paragraph is not met by reason of the death, disqualification, or bona fide resignation of any Trustee or Trustees, then the operation of this provision shall be suspended (i) for a period of 45 days if the vacancy or vacancies may be filled by the Investment Companys Board; (ii) for a period of 60 days if a vote of shareholders is required to fill the vacancy or vacancies; or (iii) for such longer period as the SEC may prescribe by order upon application.
(i) Cooperation. Each party hereto shall cooperate with each other party and all appropriate governmental authorities having jurisdiction (including, without limitation, the SEC, FINRA, and state insurance regulators) and shall permit such authorities
reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.
(j) No Registration Fees. The Insurer acknowledges that, pursuant to Form 24f-2, the Investment Company is not required to pay fees to the SEC for registration of its Shares under the 1933 Act with respect to its Shares issued to Separate Accounts that are unit investment trusts that offer interests that are registered under the 1933 Act and on which a registration fee has been or will be paid to the SEC (Registered Separate Accounts). The Insurer agrees to provide the Investment Company each year within 60 days of the end of the Investment Companys fiscal year, or when reasonably requested by the Investment Company, information as to the number of Shares purchased by Registered Separate Accounts and Separate Accounts the interests of which are not registered under the 1933 Act. The Insurer acknowledges that the Investment Company intends to rely on the information so provided and represents and warrants that such information shall be accurate.
(k) Anti-Money Laundering.
(i) The parties each represent, warrant and certify that they have established, and covenant that at all times during the existence of this Agreement they will maintain, an anti-money laundering (AML) program (Program) reasonably designed to comply with all applicable AML laws and regulations, including applicable provisions of the Bank Secrecy Act and the USA PATRIOT Act, as well as with all regulations administered by the U.S. Department of the Treasurys Office of Foreign Assets Control (AML Regulations).
(ii) Insurer covenants that it will perform all activities, including the establishment and verification of customer identities as required by the AML Regulations and/or its Program, with respect to all customers on whose behalf Insurer maintains an account with the Investment Company.
(iii) The parties agree that (A) accounts in the Investment Company beneficially owned by Insurers customers shall be accounts of the Insurer for all purposes under Insurers Program and (B) Insurers customers will be customers of Insurer for all purposes under Insurers Program.
(iv) Each party agrees to take such actions and cooperate with the other parties as may be reasonably necessary for such party to comply with the AML Regulations or its Program.
(l) Disruptive Activities.
(i) Insurer shall not directly or indirectly offer, adopt, implement, conduct or participate in any program, plan, arrangement, advice or strategy that Distributor or the Investment Company reasonably deem to be harmful to shareholders of a Fund or potentially disruptive to the management of the Funds, as communicated to Insurer by Distributor in writing from time to time, or which violates the policies and procedures of the Funds as disclosed in each Funds Prospectus; including without limitation, any activity involving market timing, programmed transfer, frequent transfer and similar investment programs.
(ii) Insurer, at all times during the term of this Agreement, shall have active, formal policies and procedures aimed at deterring market timers. Such policies and procedures shall provide for Insurers ongoing review of its customers account activity and prescribe effective actions to deter or detect and stop disruptive activities.
(iii) With respect to Shares held by Insurer on an omnibus basis with the Funds, Insurer shall upon Distributors request, promptly provide the Taxpayer Identification Number or other government-issued identifier of each Shareholder that purchased, redeemed, transferred or exchanged Shares of a Fund during the period covered by the request and the amount and dates of such Shareholder purchases, redemptions, transfers and exchanges and Insurers representative name and branch location connected with such purchases, redemptions and exchanges. Unless otherwise specifically requested by Distributor, the Insurer shall only be required to provide information relating to Shareholder-Initiated Transactions.
(iv) The Distributor shall not use the information received pursuant to this Section for marketing or any other similar purpose without Insurers prior written consent.
(v) Insurer agrees to execute the Distributors instructions to restrict or prohibit further purchases or exchanges of Shares by a Shareholder who has been identified by the Distributor as having engaged in transactions of Shares (whether directly or through Insurer) that violate the policies and procedures of the Funds as disclosed in each Funds Prospectus or that are deemed disruptive to the Funds as determined by the Distributor in its sole discretion as soon as reasonably practicable, but not later than five (5) business days after receipt of such instruction from the Distributor. Unless otherwise directed by Distributor, any such restrictions or prohibitions shall only apply to Shareholder-Initiated Transactions that are effected directly or indirectly through Insurer.
(vi) Insurer shall provide written confirmation to the Distributor that the Distributors instructions to restrict or prohibit trading have been executed, as soon as reasonably practicable, but no later than ten (10) business days after execution.
(vii) As used in this subsection, the term Shareholder-Initiated Transaction means a transaction that is initiated or directed by a Shareholder that results in a transfer of assets within a Contract to a Fund, but does not include transactions that are executed: (i) automatically pursuant to a contractual or systematic program or enrollment such as transfer of assets within a Contract to a Fund as a result of dollar cost averaging programs, automatically pursuant to a contractual or systematic program or enrollments such as transfers of assets within a Contract out of a Fund as a result of annuity payouts or loans (ii) as a result of the payment of a death benefit from a Contract; (iii) a one-time step-up in Contract value pursuant to a Contract death benefit; (iv) allocation of assets to a Fund through a Contract as a result of payments such as loan repayments, scheduled contributions, retirement plan salary reduction contributions, or planned premium payments to the
Contract; or (v) prearranged transfers at the conclusion of a required free look period.
(m) Internal Controls. Insurer will forward for processing on each day only those purchase and redemption orders received by Insurer prior to the daily cut-off times disclosed in each Funds Prospectus. Insurer has, and will maintain at all times during the term of this Agreement, appropriate internal controls for the segregation of purchase and redemption orders received prior to the daily cut-off times disclosed in each Funds Prospectus, from purchase and redemption orders received after the daily cut-off times disclosed in each Funds Prospectus.
(n) Fund Registration. Insurer acknowledges that the Funds are only registered for sale in the United States of America and that no action has been taken by or on behalf of Distributor or the Investment Company in any other jurisdiction to permit a public offering or sale of Shares, or the possession or distribution of any Prospectus in any jurisdiction where action for such purposes is required. Insurer further acknowledges that the Funds are not permitted to be sold in the European Union and Insurer shall not offer or sell the Funds in the European Union. Should Insurer undertake to offer and/or sell Shares of the Investment Company in any jurisdiction other than the United States of America or the European Union, Insurer shall inform itself of, and shall comply with, at its own expense, any and all applicable law and regulation relating thereto, and none of Distributor, the Investment Company, or their respective authorized agents shall have any responsibility or liability in connection therewith. As used herein, United States of America shall be deemed to include any state of the United States, the District of Columbia, Puerto Rico, the Virgin Islands, and any other possession of the United States. Insurer shall not make the Funds available for sale to persons in any jurisdiction in which such offer is unlawful.
(o) Other Funds or Portfolios. The Insurer agrees that the Investment Company and the Distributor shall bear no responsibility for any act or omission of any fund or portfolio that serves as an investment option under the Variable Contracts other than the Funds hereunder.
(p) Electronic Means. The parties may perform electronically certain of their obligations under this Agreement, including without limitation, the delivery of Disclosure Documents, opening accounts, transmitting purchase, exchange, and redemption orders, and delivering and maintaining shareholder communications. If Insurer elects to electronically send (e.g. facsimile or any other electronic method approved by the Funds and/or the Funds transfer agent) transaction and account instructions to the Funds or the Funds transfer agent that ordinarily require receipt of an original signature guarantee medallion stamp, Insurer authorizes the transfer agent to accept such electronically transmitted transaction and account instructions and acknowledges and agrees that none of Distributor, Investment Company, the Funds or the transfer agent shall have any liability whatsoever in connection with such electronically transmitted transaction and account instructions believed to be genuine and have been given to any of them by Insurer or its representatives.
(q) Use of the Investment Companys Recordkeeping System. If Insurer accesses the Investment Companys recordkeeping system via any computer hardware or software provided by Distributor or delivers files to the Investment Companys recordkeeping system, Insurer agrees to provide such security as is necessary to prevent any unauthorized use of such system. Insurer represents and warrants that it has examined and tested the internal systems that it has developed to support the services outlined in this Agreement and, as of the date of this Agreement, has no knowledge of any situation or circumstance that will inhibit the systems ability to perform the expected functions or inhibit Insurers ability to provide the expected services.
(r) Compliance Assistance. Insurer shall provide the Investment Company with any assistance or report that the Investment Company may reasonably request in order to meet its compliance obligations under Rule 38a-1 under the 1940 Act.
(s) Records. Insurer shall maintain and preserve all records as required by applicable law to be maintained and preserved in connection with its obligations under this Agreement and shall provide the Investment Company or the Distributor copies of all such records upon reasonable request.
4. Potential Conflicts
(a) Period of Compliance. During such time as the Investment Company engages in Mixed Funding or Shared Funding, the parties hereto shall comply with the conditions in this Section 4. The Insurers responsibilities under this Section 4 shall be carried out with a view only to the interests of the Variable Contract Owners.
(b) Material Irreconcilable Conflict. The Board shall monitor the Investment Company for the existence of any material irreconcilable conflict (i) between the interests of owners of variable annuity contracts (Variable Contract Owners) and variable life insurance policies, and (ii) between the interests of owners of variable annuity contracts and variable life insurance policies issued by different Participating Life Insurance Companies that invest in the Investment Company. A material irreconcilable conflict may arise for a variety of reasons, including: (A) an action by any state insurance regulatory authority; (B) a change in applicable federal or state insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling, no-action or interpretive letter, or any similar action by insurance, tax, or securities regulatory authorities; (C) an administrative or judicial decision in any relevant proceeding; (D) the manner in which the investments of any Fund of the Investment Company are being managed; (E) a difference in voting instructions given by variable annuity and variable life insurance contract owners; or (F) a decision by a Participating Insurance Company to disregard the voting instructions of owners of variable annuity contracts and variable life insurance policies.
(c) Potential or Existing Conflicts. The Insurer agrees that it shall promptly report any potential or existing conflicts of which it is aware to the Board. The Insurer will assist the Board in carrying out its responsibilities under the Mixed and Shared Funding Exemptive Order and this Section 4, or, if the Investment Company is engaged in Mixed Funding or Shared Funding in reliance on Rule 6e-2, 6e-3(T), or any other
regulation under the 1940 Act, the Insurer will be responsible for assisting the Board in carrying out its responsibilities under such regulation, by providing the Board with all information reasonably necessary for the Board to consider any issues raised. This includes, but is not limited to, an obligation by the Insurer to inform the Board whenever Variable Contract Owner voting instructions are disregarded.
(d) Written Notice. The Board shall promptly notify the Insurer in writing of its determination of the existence of an irreconcilable material conflict and its implications.
(e) Remedy or Elimination of Irreconcilable Material Conflict. The Insurer agrees that in the event that it is determined by a majority of the Board or a majority of the Disinterested Trustees that a material irreconcilable conflict exists that affects the interests of the Variable Contract Owners, the Insurer shall, in cooperation with other Participating Insurance Companies whose contract owners are also affected, at its expense and to the extent reasonably practicable (as determined by a majority of the Disinterested Trustees), take whatever steps are necessary to remedy or eliminate the irreconcilable material conflict, up to and including: (i) withdrawing the assets allocable to some or all of the Separate Accounts from the Investment Company or any Fund and reinvesting such assets in a different investment medium, including (but not limited to) another Fund, or submitting the question as to whether such segregation should be implemented to a vote of all affected Variable Contract Owners and, as appropriate, segregating the assets of any appropriate group (i.e., annuity contract owners or life insurance contract owners of contracts issued by one or more Participating Insurance Companies), that votes in favor of such segregation, or offering to the affected Variable Contract Owners the option of making such a change; and (ii) establishing a new registered management investment company or managed separate account and obtaining any necessary approvals or orders of the SEC in connection therewith.
(f) Action by Insurer. If a material irreconcilable conflict arises because of the Insurers decision to disregard Variable Contract Owners voting instructions and that decision represents a minority position or would preclude a majority vote, the Insurer shall be required, at the Investment Companys election, to withdraw the affected Separate Accounts investment in the Investment Company and terminate this Agreement with respect to such Separate Account; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the Disinterested Trustees, and no charge or penalty will be imposed as a result of such withdrawal.
(g) Determination by Disinterested Trustees. For purposes of Sections 4(e) and 4(f), a majority of the Disinterested Trustees of the Investment Company shall determine whether or not any proposed action adequately remedies any material irreconcilable conflict, but in no event will the Investment Company or its investment adviser or the Distributor be required to establish a new funding medium for any Variable Contract. The Insurer shall not be required by this Section 4(g) to establish a new funding medium for any Variable Contract if any offer to do so has been declined by vote of a majority of Variable Contract Owners materially adversely affected by the material irreconcilable conflict.
(h) Reports by Insurer. The Insurer, at least annually, shall submit to the Board such reports, materials, or data as the Board may reasonably request so that the Trustees of the Board may fully carry out the obligations imposed upon the Board by the conditions contained in the application for the Mixed and Shared Funding Exemptive Order and this Section. Such reports, materials, and data shall be submitted more frequently if deemed appropriate by the Board.
(i) Minutes. All reports of potential or existing conflicts received by the Board, and all Board action with regard to determining the existence of a conflict, notifying Participating Insurance Companies of a conflict, and determining whether any proposed action adequately remedies a conflict, shall be properly recorded in the minutes of the Board or other appropriate records, and such minutes or other records shall be made available to the SEC upon request.
(j) Rules 6e-2 and 6e-3. If and to the extent Rule 6e-2 or Rule 6e-3(T) under the 1940 Act are amended or if Rule 6e-3 is adopted in final form, to the extent applicable, the Investment Company and the Insurer shall each take such steps as may be necessary to comply with the Rule as amended or adopted in final form. If, in the future, the Mixed and Shared Funding Exemptive Order should no longer be necessary under applicable law, then this Section 4(j) shall continue in effect, and the remainder of Section 4 shall no longer apply.
5. Prospectuses and Proxy Statements; Voting
(a) Delivery of Disclosure Documents. Insurer shall deliver or cause to be delivered to its customers copies of the current Prospectus for any Shares, (including the Statement of Additional Information (SAI)), periodic reports, proxy materials and other shareholder communications for any Fund (Disclosure Documents) in accordance with applicable regulatory requirements and applicable required time frames except to the extent that Distributor expressly undertakes to do so.
(b) Provisions of Disclosure Documents. The Distributor or the Investment Company, at their expense, shall provide the Insurer with as many copies of Investment Companys current Disclosure Documents in such quantity as the Insurer shall reasonably require for purposes of distributing to owners of Variable Contracts issued by the Insurer in connection with the offerings and transactions contemplated by this Agreement. In addition, the Distributor shall provide the Insurer with as many copies of the Investment Companys proxy materials that are required to be sent. If requested by the Insurer, in lieu of providing the Insurer with printed copies of the Prospectuses, SAI, supplements and proxy materials, the Investment Company shall transmit such materials in an electronic format (including camera-ready copies) and provide other assistance as may be reasonably necessary for the Insurer to either print a stand-alone document or print together in one document the current prospectus for the Variable Contracts and the current Prospectus for the Investment Company, or a document combining the Investment Company Prospectus with prospectuses of other funds in which the Variable Contracts
may be invested. In this case, the Insurer shall be responsible for the expense of printing such documents.
(c) Prospectus. For purposes of this Agreement, Prospectus means with respect to any Shares, the most recent Summary Prospectus (as defined in Rule 498 under the 1933 Act), Statutory Prospectus (as defined in Rule 498) and SAI and any supplement thereto, pursuant to which a Fund publicly offers the Shares; provided however, that this definition shall not be construed to require the Distributor, the Insurer or any Fund to deliver any Statutory Prospectus or SAI other than at the express request of a Variable Contract Owner.
(d) Content of Disclosure Documents. It is understood and agreed that, except with respect to information regarding the Investment Company, the Funds, the Distributor, or an investment adviser to the Investment Company or the Funds (Adviser) provided in writing by the Investment Company, the Distributor or the Adviser and used in conformity therewith, none of the Investment Company, the Funds, the Distributor, or the Adviser is responsible for the content of the prospectuses or statements of additional information for the Variable Contracts.
(e) Voting Privileges. As required by the Mixed and Shared Funding Exemptive Order, the Insurer shall be responsible for calculating voting privileges in a manner consistent with other Participating Insurance Companies. The Investment Company agrees to provide written instructions on the calculation of voting privileges, and the Insurer agrees to vote consistent with any reasonable standards that the Investment Company may adopt and provide in writing (which writing may consist of the Investment Companys proxy statement).
(f) Pass-Through Voting. For so long as the SEC interprets the 1940 Act to require pass-through voting by Participating Insurance Companies whose Separate Accounts are registered as investment companies under the 1940 Act, the Insurer shall vote Shares of each Fund of the Investment Company held in a Separate Account or a sub-account thereof, whether or not registered under the 1940 Act, at regular and special meetings of the Investment Company in accordance with instructions timely received by the Insurer (or its designated agent) from owners of Variable Contracts funded by such Separate Account or sub-account thereof having a voting interest in the Fund. The Insurer shall vote Shares of a Fund of the Investment Company held in a Separate Account or a sub-account thereof that are attributable to the Variable Contracts as to which no timely instructions are received, as well as Shares held in such Separate Account or subaccount thereof that are not attributable to the Variable Contracts and owned beneficially by the Insurer (resulting from charges against the Variable Contracts or otherwise), in the same proportion as the votes cast by owners of the Variable Contracts funded by that Separate Account or subaccount thereof having a voting interest in the Fund from whom instructions have been timely received. The Insurer shall vote Shares of each Fund of the Investment Company held in its general account, if any, in the same proportion as the votes cast with respect to Shares of the Fund held in all Separate Accounts of the Insurer or sub-accounts thereof, in the aggregate.
(g) Specific Disclosures. During such time as the Investment Company engages in Mixed Funding or Shared Funding, the Investment Company shall disclose in its Prospectus that (i) the Investment Company is intended to be a funding vehicle for variable annuity and variable life insurance contracts offered by various insurance companies, (ii) material irreconcilable conflicts possibly may arise, and (iii) the Board will monitor events in order to identify the existence of any material irreconcilable conflicts and to determine what action, if any, should be taken in response to any such conflict. The Investment Company hereby notifies the Insurer that Prospectus disclosure may be appropriate regarding potential risks of offering Shares of the Investment Company to separate accounts funding both variable annuity contracts and variable life insurance policies and to separate accounts funding Variable Contracts of unaffiliated life insurance companies.
6. Sales Material and Information
(a) Advance Review Provided by Insurer. The Insurer shall furnish, or shall cause to be furnished, to the Investment Company or its designee, each piece of sales literature or other promotional material in which the Investment Company (or any Fund thereof) or its investment adviser or the Distributor is named at least 15 days prior to the anticipated use of such material, and no such sales literature or other promotional material shall be used unless the Investment Company and the Distributor or the designee of either approve the material or do not respond with comments on the material within 10 days from receipt of the material.
(b) Representations by Insurer. The Insurer agrees that neither it nor any of its affiliates or agents shall give any information or make any representations or statements on behalf of the Investment Company or concerning the Investment Company other than the information or representations contained in the Investment Companys current registration statement or Prospectus for the Investment Company Shares, as such registration statement and Prospectus may be amended or supplemented from time to time, or in reports or proxy statements for the Investment Company, or in sales literature or other promotional material approved by the Investment Company or its designee and by the Distributor or its designee, except with the permission of the Investment Company or its designee and the Distributor or its designee.
(c) Advance Review Provided by Investment Company or Distributor. The Investment Company or the Distributor or the designee of either shall furnish to the Insurer or its designee, each piece of sales literature or other promotional material in which the Insurer or its Separate Accounts are named at least 15 days prior to the anticipated use of such material, and no such material shall be used unless the Insurer or its designee approves the material or does not respond with comments on the material within 10 days from receipt of the material.
(d) Representations by Investment Company and Distributor. The Investment Company and the Distributor agree that each, and the affiliates and agents of each, shall not give any information or make any representations on behalf of the Insurer or concerning the Insurer, the Separate Accounts, or the Variable Contracts, other than the information or representations contained in a registration statement or prospectus for such Variable Contracts, as such registration statement and prospectus may be amended or supplemented
from time to time, or in reports for the Separate Accounts or prepared for distribution to owners of such Variable Contracts, or in sales literature or other promotional material approved by the Insurer or its designee, except with the permission of the Insurer.
(e) Provision of Disclosure Documents. The Investment Company will provide to the Insurer at least one complete copy of all Prospectuses, SAIs, reports, proxy statements and other voting solicitation materials, and all amendments and supplements to any of the above, that relate to the Investment Company or its Shares, promptly after the filing of such document with the SEC or other regulatory authorities. Upon Insurers request, Distributor will provide a copy of the Mixed and Shared Funding Exemptive Application and any amendments thereto.
(f) Provision of Variable Contracts Documents. The Insurer will provide to the Investment Company all prospectuses (which shall include an offering memorandum if the Variable Contracts or interests therein are not registered under the 1933 Act), Statements of Additional Information, reports, solicitations for voting instructions relating to the Investment Company, and all amendments or supplements to any of the above that relate to the Variable Contracts or the Separate Accounts which utilize the Investment Company as an underlying investment medium, promptly after the filing of such document with the SEC or other regulatory authority.
(g) Sales Literature. For purposes of this Section 6, the phrase sales literature or other promotional material includes, but is not limited to, advertisements (such as material published, or designed for use on the Internet, in a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, computerized media, or other public media), sales literature (i.e., any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees.
7. Administrative Services
(a) Sole Shareholder. Insurer, on behalf of the Separate Accounts will be the sole shareholder of record of Investment Company Shares and shall hold Shares through one or more omnibus or master accounts with Investment Company (each an Account).
(b) Specific Services. In addition to the services described herein, Insurer shall also provide, or cause to be provided, the following administrative services for each sub-account held by a Separate Account. All Recordkeeping Services shall be effected in accordance with each Funds Prospectus.
(i) Sub-Accounting. Insurer shall maintain sub-accounts (each a Sub-Account) for its Separate Accounts with respect to Shares held by Insurer through the Accounts. Insurer shall reconcile the balances and transactions in the Accounts with the Sub-Accounts on each business day.
(ii) Aggregating and processing purchase and redemption orders. Insurer shall execute for its Separate Accounts any purchase, redemption or exchange transactions in the Shares at their net asset value and process the net amount of such transactions through the Accounts on each business day.
(iii) Providing customer confirmations and Sub-Account statements. Insurer shall prepare and deliver trade confirmations and statements showing each Separate Accounts Share activity in their Sub-Account.
(iv) Processing dividend payments. Upon payment by the Funds of any dividend to shareholders, Insurer shall process and pay to the Separate Accounts their respective share of such dividends.
(c) Personal Services and Account Maintenance. Insurer agrees to respond to the reasonable inquiries and requests of any customer that is a shareholder relating to their investment in a Fund, and to take such actions as such customer may reasonably request to maintain the customers account with a Fund.
8. Administrative Services Fee
(a) Service Fees. In consideration of the administrative services described herein, Distributor agrees to pay to Insurer an amount computed at an annual rate equal to the percentage of average daily net asset value set forth in Exhibit B to this Agreement (Administrative Service Fee). The Administrative Service Fees paid to Insurer are for recordkeeping, shareholder and administrative services only and do not constitute payment for any other service.
(b) Payment Terms. The Distributor shall pay any amounts owed under this Agreement systematically no less frequently than quarterly. For the payment period in which this Agreement becomes effective or terminates, there shall be an appropriate proration of all payments, on the basis of the number of days that this Agreement is in effect during the quarter. In connection with such payments, Distributor shall provide the calculation of amounts paid to Insurer. Absent manifest error, any such calculations shall be final unless any party objects thereto within sixty (60) days of the date of the calculation statement. Payments requested by Insurer for periods 180 days or more prior to the current month shall be made at Distributors discretion.
(c) Expenses. Insurer shall perform all of its obligations and duties under this Agreement at its own expense.
(d) Disclosure. Insurer shall disclose the compensation arrangements under this Agreement to each Variable Contract Owner as required by applicable law.
9. Indemnification
(a) Distributor Indemnification. In the absence of willful misfeasance, bad faith, gross negligence or reckless disregard of obligations or duties hereunder on the part of the Distributor, the Investment Company, the Funds, and their respective officers, directors, affiliates or employees (each a Distributor Indemnified Party), Insurer agrees to indemnify and hold harmless each Distributor Indemnified Party against any and all claims, demands, liabilities and reasonable expenses (including
attorneys fees) which any Distributor Indemnified Party may incur arising from, related to, or otherwise connected with: (i) any breach by Insurer of any provision of this Agreement; or (ii) any actions or omissions of any Distributor Indemnified Party in reliance upon any oral, written or electronically transmitted instructions believed to be genuine and have been given to any of them by Insurer or its representatives. In no event shall Insurer be liable for special, indirect or consequential damages, or lost profits or loss of business, arising under or in connection with any event described in (i) and (ii) above.
(b) Insurer Indemnification. In the absence of willful misfeasance, bad faith, gross negligence or reckless disregard of obligations or duties hereunder on the part of Insurer and its officers, directors, affiliates, representatives or employees (each a Insurer Indemnified Party), Distributor and Investment Company agree to indemnify and hold harmless each Insurer Indemnified Party against any and all claims, demands, liabilities and reasonable expenses (including attorneys fees) which any Insurer Indemnified Party may incur arising from, related to, or otherwise connected with: (i) any breach by Distributor or Investment Company of any provision of this Agreement; or (ii) any alleged untrue statement of a material fact contained in any Funds Prospectus, or as a result of or based upon any alleged omission to state a material fact required to be stated therein or necessary to make the statements contained therein not misleading. In no event shall Distributor or Investment Company be liable for special, indirect or consequential damages, or lost profits or loss of business, arising under or in connection with any event described in (i) or (ii) above.
(c) Notice. The parties agreement in this Section to indemnify each other is conditioned upon the party entitled to indemnification (Claimant) giving notice to the party required to provide indemnification (Indemnifier) promptly after the summons or other first legal process for any claim as to which indemnity may be sought is served on the Claimant. The Claimant shall permit the Indemnifier to assume the defense of any such claim or any litigation resulting from it, provided that Indemnifiers counsel that is conducting the defense of such claim or litigation shall be approved by the Claimant (which approval shall not unreasonably be withheld), and that the Claimant may participate in such defense at its expense. The failure of the Claimant to give notice as provided in this paragraph shall not relieve the Indemnifier from any liability other than its indemnity obligation under this Section. No Indemnifier, in the defense of any such claim or litigation, shall, without the consent of the Claimant, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term the giving by the alleging party or plaintiff to the Claimant of a release from all liability in respect to such claim or litigation.
(d) Survival. The provisions of this Section shall survive the termination of this Agreement.
10. Privacy
(a) Non-Public Information. The parties acknowledge that, in connection with the services to be provided hereunder, the Distributor and the Investment Company may come into possession of non-public personal information regarding Insurers customers (Customer NPI).
(b) Limits on Disclosure. The Distributor and the Investment Company hereby covenant that any Customer NPI received from Insurer will be subject to the following limitations and restrictions:
(i) The Distributor and the Investment Company may redisclose Customer NPI to their own affiliates, who will be limited by the same disclosure and use restrictions that are imposed on the parties under this Agreement; and
(ii) The Distributor and the Investment Company may redisclose and use Customer NPI only (A) as necessary in the ordinary course of business to provide the services identified in the Agreement; (B) as permitted under Regulation S-P; and (C) as required by any applicable federal or state law.
(c) Policies and Procedures. Each party represents and warrants that it has implemented, and shall continue to carry out for the term of the Agreement, policies and procedures in compliance with all applicable federal and state laws and regulations regarding privacy of customer information which are reasonably designed to:
(i) Ensure the security and confidentiality of customer records and customers NPI, including but not limited to encrypting such information as required by applicable federal and state laws or regulations;
(ii) Protect against any anticipated threats or hazards to the security or integrity of customer records and Customer NPI;
(iii) Protect against unauthorized access or use of such customer records or Customer NPI that could result in substantial harm or inconvenience to any customer; and
(iv) Notify each other party if required by its policies or applicable law in the event of the unauthorized access or use of such customer records or Customer NPI that could result in substantial harm or inconvenience to any customer.
(d) Survival. The provisions of this Section shall survive the termination of the Agreement.
11. Confidential Information
(a) Definition. Each party shall safeguard and hold confidential from disclosure to unauthorized parties all Confidential Information of each other party. For purposes of this Section, Confidential Information shall mean any and all non-public information which is in any way connected with, derived from or related to the business of each other party which is either designated as confidential or which, by its nature or under the circumstances surrounding its disclosure, reasonably ought to be treated as confidential, including without limitation, any business and financial records, trade secrets, computer programs, technical data, investment information, and any information relating to the pricing or marketing policies of the party and any notes, memoranda, analyses compilations, studies and other documents, whether prepared by the party or others, to the extent they contain or otherwise reflect such information.
(b) Exceptions. Confidential Information shall not include information to the extent such information (i) is already known to the receiving party free of any restriction at the time obtained, including information in the public domain; (ii) is subsequently learned from an independent third party free of restriction; (iii) becomes publicly known through no breach of this Section; or (iv) is independently developed by one party without reference to information which is confidential.
(c) Security. Each party shall take reasonable security precautions, at least as great as the precautions it takes to protect its own confidential information, to keep confidential the Confidential Information.
(d) Use of Information. Confidential Information may be disclosed, reproduced, used, summarized or distributed only as necessary in the ordinary course of business to provide the services identified in the Agreement, and only as otherwise provided hereunder. Each party may disclose Confidential Information only to employees, officers, directors, affiliates, agents, and service providers who have a need to know in connection with the Confidential Information or as required by a partys regulators.
(e) Notice. The receiving party shall notify the disclosing party immediately upon discovery of any unauthorized use or disclosure of Confidential Information, and will cooperate with the disclosing party in every reasonable way to help the disclosing party regain possession of the Confidential Information and prevent its further unauthorized use or disclosure.
(f) Remedies. The receiving party acknowledges that monetary damages may not be a sufficient remedy for unauthorized disclosure of Customer NPI or Confidential Information and that the disclosing party shall be entitled, without waiving any of its other rights or remedies, to such injunctive or equitable relief as may be deemed proper by a court of competent jurisdiction.
(g) Survival. The provisions of this Section shall survive the termination of the Agreement.
12. Notices
(a) Form. Except as otherwise specifically provided in this Agreement, all notices required or permitted to be given under this Agreement shall be given in writing and delivered by postage prepaid registered or certified United States first class mail, return receipt requested, overnight courier services or by email (with a confirming copy by mail).
(b) To Investment Company. Unless otherwise notified in writing, all notices to the Investment Company shall be given or sent to:
Federated Hermes Insurance Series
4000 Ericsson Drive
Warrendale, PA 15086-7561
Attn.: John B. Fisher
E-Mail: contractadmin@federatedinv.com
(c) To Distributor. Unless otherwise notified in writing, all notices to the Distributor shall be given or sent to:
Federated Securities Corp.
1001 Liberty Avenue
Pittsburgh, Pennsylvania 15222-3779
Attn.: Secretary
E-Mail: contractadmin@federatedinv.com
(d) To Insurer. Unless otherwise notified in writing, all notices to Insurer shall be given or sent to :
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, AL 35223
Attention: Senior Vice President, Chief Product Officer
With a copy to:
Senior Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
13. Force Majeure
If any party is unable to carry out any of its obligations under this Agreement because of conditions beyond its reasonable control, including, but not limited to, acts of war or terrorism, work stoppages, fire, civil disobedience, delays associated with hardware malfunction or availability, riots, rebellions, storms, electrical failures, acts of God, and similar occurrences (Force Majeure), this Agreement will remain in effect and the non-performing partys obligations shall be suspended without liability for a period equal to the period of the continuing Force Majeure (which such period shall not exceed fifteen (15) business days), provided that:
(i) the non-performing party gives the other parties prompt notice describing the Force Majeure, including the nature of the occurrence and its expected duration and, where reasonably practicable, continues to furnish regular reports with respect thereto during the period of Force Majeure;
(ii) the suspension of obligations is of no greater scope and of no longer duration than is required by the Force Majeure;
(iii) no obligations of any party that accrued before the Force Majeure are excused as a result of the Force Majeure; and
(iv) the non-performing party uses all reasonable efforts to remedy its inability to perform as quickly as possible.
14. Term and Termination
(a) Types of Termination. This Agreement shall be effective in this form as of the latest date set forth on the signature page and shall continue in full force and effect until terminated as follows:
(i) at the option of any party for any reason upon 180 days advance written notice to the other parties; or
(ii) at the option of the Insurer, immediately upon written notice to the Investment Company, with respect to any Fund based upon the Insurers determination that Shares of such Fund are not reasonably available to meet the
requirements of the Variable Contracts or not consistent with the Insurers obligations to Variable Contract Owners; or
(iii) at the option of the Investment Company or the Distributor, immediately upon written notice to the Insurer, upon institution of formal proceedings against the Insurer or its agent by FINRA, the SEC, any state securities or insurance department or any other regulatory body regarding the Insurers duties under this Agreement or related to the sale of the Variable Contracts, the operation of any Separate Account, or the purchase of the Investment Company Shares; provided, however, that the Investment Company or the Distributor has determined in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Insurer to perform its obligations under this Agreement, including as a result of material adverse publicity, or
(iv) at the option of the Insurer, immediately upon written notice to the Investment Company, upon institution of formal proceedings against the Investment Company or the Distributor by FINRA, the SEC, any state securities or insurance department or any other regulatory body regarding the Investment Companys or Distributors duties under this Agreement or related to the sale of Fund Shares or the operation of the Investment Company or Funds; provided, however, that the Insurer determined in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Distributor or the Investment Company to perform its obligations under this Agreement, including as a result of material adverse publicity; or
(v) upon requisite vote of the Variable Contract Owners having an interest in the Separate Accounts (or any sub-accounts thereof) to substitute the Shares of another investment company for the corresponding Shares of the Investment Company or a Fund in accordance with the terms of the Variable Contracts for which those Shares had been selected or serve as the underlying investment media; or
(vi) at the option of any party to the Agreement, immediately upon written notice to the other parties, with respect to any Fund, in the event that such Funds Shares are not registered, issued or sold in accordance with applicable state and/or federal law, or such law precludes the use of such Shares as the underlying investment media of the Variable Contracts; or
(vii) at the option of any party to the Agreement, immediately upon written notice, in the event of a determination by a majority of the Board, or a majority of its disinterested Trustees, that an irreconcilable conflict, as described in Section 4 hereof, exists; or
(viii) at the option of the Insurer, immediately upon written notice to the Investment Company, if the Investment Company or a Fund fails to meet the requirements under Subchapter M of the Code or any independent or resulting failure under Section 817 of the Code or if the Insurer reasonably believes that the Investment Company or any Fund may fail to so qualify; or
(ix) at the option of the Investment Company or the Distributor, immediately upon written notice, in the event that any or all Variable Contracts fail to meet the qualifications specified in Sections 3(d) and 3(e) hereof; or
(x) at the option of the Investment Company or the Distributor, upon 30 days written notice to the Insurer, if the Investment Company or the Distributor shall determine, in its sole judgment exercised in good faith, that the Insurer and/or its affiliated companies has suffered a material adverse change in its business operations, financial condition, or prospects since the date of this Agreement or is subject of material adverse publicity; or
(xi) at the option of the Insurer, upon 30 days written notice, if the Insurer shall determine, in its sole judgment exercised in good faith, that the Investment Company or the Distributor and/or their affiliated companies have suffered a material adverse change in its business operations, financial condition, or prospects since the date of this Agreement or is the subject of material adverse publicity; or
(xii) at the option of the Insurer upon the Investment Companys or Distributors material breach of any provision of this Agreement, upon 30 days written notice and the opportunity to cure within such notice period; or
(xiii) at the option of the Investment Company or the Distributor upon the Insurers material breach of any provision of this Agreement, upon 30 days written notice and the opportunity to cure within such notice period; or
(xiv) at the option of any party to the Agreement, immediately upon written notice, if the Board has decided to (A) refuse to sell Shares of any Fund to the Insurer and/or any of its Separate Accounts; (B) suspend or terminate the offering of Shares of any Fund; or (C) dissolve or liquidate the Investment Company or any Fund.
(b) Notification. Each party to this Agreement shall promptly notify the other parties to the Agreement of the institution against such party of any such formal proceedings as described in Sections 14(a) (iii) and (iv) hereof. The Insurer shall give 60 days prior written notice to the Investment Company of the date of any proposed vote of Variable Contract Owners to replace the Investment Companys Shares as described in Section 14(a)(v) hereof.
(c) Substitution of Shares. The Investment Company and the Distributor acknowledge that the Insurer may have the right to substitute Shares of other securities for Shares of the Funds under certain circumstances. The Insurer agrees not to exercise this right until after at least 60 days written notice to the Investment Company and the Distributor. In the event that the Insurer exercises its right to substitute Shares of other securities for Shares of the Funds, the Insurer shall furnish, or shall cause to be furnished, to the Investment Company and the Distributor, or their designees, any application for an order seeking approval of the substitution or any other written material related to such substitution, including the notice of the substitution to be sent to Variable Contract Owners, if in any such application or
notice or other written material, the Investment Company or its investment adviser(s) or the Distributor is named, at least 15 days prior to the filing or delivery of such application or written material with the SEC or any other regulatory body or entity or to Variable Contract Owners for the sole purpose of determining the accuracy of information pertaining to the Investment Company, its investment adviser(s) or the Distributor. No such application or other written material shall be filed or delivered unless the Investment Company and the Distributor, or the designee of either, approve the material or do not respond with comments on the material within 10 days from receipt of the material.
(d) Term.
(i) Notwithstanding any termination of this Agreement, and except as provided in paragraph (ii) below, the Investment Company and the Distributor shall, at the option of the Insurer, continue, until the one year anniversary from the date of termination, and from year to year thereafter if deemed appropriate by the Investment Company and the Distributor, to make available additional Shares of the Investment Company pursuant to the terms and conditions of this Agreement, for all Variable Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as Existing Contracts) and to make Administrative Service Fee payments on such Existing Contracts in accordance with Exhibit B. Specifically, based on instructions from the owners of the Existing Contracts, the Separate Accounts shall be permitted to reallocate investments in the Funds of the Investment Company and redeem investments in the Funds, and shall be permitted to invest in the Funds in the event that owners of the Existing Contracts make additional premium payments under the Existing Contracts.
(ii) In the event the Agreement is terminated pursuant to Sections 14(a) (iii), (vii), (ix), (x), and (xiii) at the option of the Investment Company or the Distributor (for cause), the parties acknowledge that the Investment Company and the Distributor shall not make available additional Shares of any Fund to any Existing Contracts and Insurer shall not be entitled to any Administrative Service Fees after such termination for cause.
(iii) In the event (A) the Agreement is terminated for cause as set forth in (d)(ii) above; or (B) the one year anniversary of the termination of the Agreement is reached or, after waiver of termination by the Investment Company or the Distributor as provided in (d)(i) above, such subsequent anniversary is reached, (each of A and B referred to as a triggering event), the Insurer agrees, promptly after such triggering event to take all steps reasonably necessary to redeem the investment of the Variable Contract Owners in the Funds within one year from the date of such triggering event, or, at the Distributors option, such later date as is necessary for the Insurer to obtain a substitution order from the SEC, the application for which the Insurer will diligently pursue.
(e) Application. Termination of this Agreement with respect to any one Fund or class of Shares shall not cause the Agreements termination with respect to any other Fund or class of Shares.
15. Miscellaneous
(a) Entire Agreement. This Agreement supersedes any prior agreements between the parties with respect to its subject matter and constitutes (along with its Exhibits) a complete and exclusive statement of the terms of the agreement between the parties with respect to its subject matter.
(b) Declaration of Trust. A copy of the Investment Companys Declaration of Trust is on file with the Secretary of the Commonwealth of Massachusetts and notice is hereby given that any agreements that are executed on behalf of the Investment Company by any Trustee or officer of the Investment Company are executed in his or her capacity as Trustee or officer and not individually. All liabilities of the Investment Company arising directly or indirectly under this Agreement of any nature whatsoever shall be satisfied solely out of the assets and property of the Investment Company and no Trustee, officer, agent or shareholder of the Investment Company shall be personally liable for any such liabilities. No Fund shall be liable for any obligations properly attributable to any other Fund.
(c) Authority. Nothing in this Agreement shall impede the Investment Companys Trustees or shareholders of Shares of the Investment Companys Funds from exercising any of the rights provided to such Trustees or shareholders in the Investment Companys Declaration of Trust, as amended, a copy of which will be provided to the Insurer upon request.
(d) Reserved Rights. The Investment Company reserves the right, upon written notice to the Insurer (given at the earliest practicable time), to take all actions, including, but not limited to, the dissolution, reorganization, liquidation, merger or sale of all assets of the Investment Company or any Fund upon the sole authorization of the Board, acting in good faith.
(e) Applicable Laws and Regulations. This Agreement shall be subject to the provisions of the 1933, 1934, and 1940 Acts, and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the SEC may grant (including, but not limited to, the Mixed and Shared Funding Exemptive Order), and the terms hereof shall be interpreted and construed in accordance therewith.
(f) Use of Name/Logo. The Investment Company, Distributor and their affiliates are the owners of various trademarks, service marks and Fund names (collectively, the Federated Hermes Logos). The Investment Company and the Distributor grant Insurer a non-exclusive, non-transferable, royalty-free license to use the Federated Hermes Logos in Insurers sales literature and client communications made in the ordinary course of business. Insurer agrees to place all necessary and proper notices and legends on the sales literature and client communications in order to protect the interests of the Investment Company, the Distributor and their affiliates in the Federated Hermes Logos. The license granted herein shall terminate automatically upon the termination of this Agreement or, in whole or in part upon the Distributors written notice in the event of Insurers breach of the terms of this paragraph. Upon termination of this Agreement, Insurer shall cease to use
the Federated Hermes Logos. If Insurer makes any unauthorized use of the Federated Hermes Logos, the parties acknowledge that the Investment Company, the Distributor and their affiliates shall suffer irreparable harm for which monetary damages may be inadequate and therefore, shall be entitled to injunctive relief, as well as any other remedy available under law.
(g) No Agency. Neither this Agreement, nor any terms and conditions contained herein shall be construed as creating or constituting a partnership, joint venture, or agency or permitting Insurer to act as agent on behalf of the Distributor or the Investment Company except that the Insurer is deemed an agent of the Funds for the sole and limited purpose of receiving orders for Fund Shares to the extent that such an agency relationship is required by applicable law.
(h) Counterparts; Electronic Signatures. This Agreement may be executed by different parties on separate counterparts, each of which, when so executed and delivered, shall be an original and taken together shall constitute one and the same instrument. This Agreement may be executed by facsimile or electronic signature in portable document format (.pdf) by any party and such facsimile or electronic signature will be deemed a fully binding original signature hereto.
(i) Captions. The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their meaning.
(j) Severability. If any provision of this Agreement is held invalid or unenforceable, the other provisions of this Agreement shall remain in full force and effect. Any provision of this Agreement held invalid or unenforceable only in part or degree shall remain in full force and effect to the extent not held invalid or unenforceable.
(k) Assignment. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns, provided that, this Agreement may not be assigned by any party to the Agreement except with the written consent of the other parties to the Agreement.
(l) Amendment. Except as provided in this paragraph, this Agreement may be amended only by a writing signed by all parties. The Distributor may amend Exhibit B from time to time by posting an amended Exhibit B on the Funds website. Any such amendment shall be effective as of the date indicated on the amended Exhibit B. Insurer may amend Exhibit A by mailing the amended Exhibit A to the Distributor at the address set forth above. Any such amendment shall be effective as of the later of (i) its receipt by the Distributor or (ii) the date indicated on the amended Exhibit A.
(m) Choice of Law. This Agreement shall be governed by the laws of the Commonwealth of Pennsylvania, without regard to conflicts of laws principles thereof.
(n) Third-Party Rights. Except as specifically provided herein, this Agreement and all of its provisions and conditions are for the sole and exclusive benefit of the parties to this Agreement and nothing expressed or referred to in this Agreement shall be construed to give anyone other than the parties to this Agreement any legal or equitable right, remedy or claim under or with respect to this Agreement or any provision of this Agreement; provided that each Fund is an intended third party beneficiary of this Agreement and each shall be treated as a party to this Agreement solely to the extent necessary for such Fund to enforce its rights under this Agreement. Except as specifically provided herein, neither Distributor, Investment Company nor any Fund, shall be obligated to make any payment under this Agreement to any person other than Insurer.
(o) Non-Exclusivity. Distributor and Investment Company acknowledge and agree that Insurer may enter into agreements similar to this Agreement with other mutual funds and distributors. Insurer acknowledges and agrees that Distributor, Investment Company and the Funds may enter into agreements similar to this Agreement with other financial intermediaries and insurers.
IN WITNESS WHEREOF, this Agreement has been executed as of the date set forth below by a duly authorized officer of each party.
FEDERATED HERMES INSURANCE SERIES
|
|
Name: |
|
|
|
Title: |
|
|
|
Date: |
|
FEDERATED SECURITIES CORP.
|
|
Name: |
|
|
|
Title: |
|
|
|
Date: |
|
PROTECTIVE LIFE INSURANCE COMPANY
|
|
Name: |
|
|
|
Title: |
|
|
|
Date: |
|
|
|
Address: |
|
City |
State |
Zip |
|
Email: |
|
||
|
|
||
Exhibit A
Insurer Accounts
Protective COLI PPVUL Separate Account
Protective COLI VUL Separate Account
Exhibit C
OPERATIONAL PROCEDURES
a) Instructions. Insurer shall, on behalf of the Investment Company, receive instructions from the Separate Accounts for acceptance prior to the applicable cut-off time for a Fund as set forth in such Funds then current Prospectus on any Business Day (Close of Trading). Insurer shall, upon its acceptance of any such instructions, communicate such acceptance to the Separate Accounts.
b) Trade Reports. Insurer or its designee shall communicate to the Investment Company, by means of electronic transmission or other mutually acceptable means, a report of Insurers trading activity in each of the Funds for the most recent Business Day in accordance with each Funds Prospectus. However, if Insurer will be communicating such information after the Close of Trading, then the Insurer shall be considered the Investment Companys agent for purposes of Rule 22c-1 under the 1940 Act, as and to the extent required by applicable law.
c) Use of NSCC. To the extent that each of the parties is a member of, and/or has access to, the National Securities Clearing Corporations (NSCC) systems and services, including Fund/SERV and Networking, the parties may agree to utilize such services for all transactions contemplated hereunder and agree that all such dealings and transactions shall be processed in accordance with, and governed by, the NSCCs Rules and Procedures (as the same may be amended from time to time).
d) Unavailability of NSCC. In the event of the unavailability of the NSCC at any time, the following procedures shall apply:
(i) The Investment Company shall use its best efforts to provide information listed in Sections 1(i) and 1(j) of the Agreement to Insurer by means of electronic transmission or other mutually acceptable means by 7:00 p.m. Eastern Time on each Business Day.
(ii) Insurer or its designee shall communicate to the Investment Company, by means of electronic transmission or other mutually acceptable means, a report of Insurers trading activity in each of the Funds for the most recent Business Day (Trade Date) by 9:00 a.m. Eastern Time on the Business Day following the Trade Date (Settlement Date). The number of Shares to be purchased or redeemed shall be determined based upon the net asset value at the Close of Trading on the Trade Date, provided that, if the Fund receives the trading information called for by this paragraph after 9:00 a.m. Eastern Time on a Settlement Date, the Investment Company shall use its best efforts to enter the Insurers purchase or redemption order at the net asset value at the Close of Trading on the Trade Date, but if Investment Company is unable to do so, the transaction shall be entered at the net asset value next determined after the Investment Company receives the trading information.
(iii) In the event there is a net purchase in any Fund, Insurer or its designee shall exercise its best efforts to direct wire payment in the dollar amount of the net purchase to be received by the Investment Company by the close of the Federal Reserve Wire Transfer System on the Settlement Date. If the wire is not received by the Investment Company by such time, and such delay was not caused by the negligence or willful misconduct of the Investment Company, the Investment Company shall be entitled to receive from Insurer the dollar amount of any overdraft plus any associated bank charges incurred.
(iv) In the event there is a net redemption in any Fund, the Investment Company shall wire the redemption proceeds to the Insurers custodial account, or to the designated depository for the Insurer, specified by Insurer or its designee. If the Investment Company receives the redemption information by 9:00 a.m. Eastern Time on the Settlement Date, the redemption proceeds shall be wired so as to be received on the Settlement Date. If the Investment Company receives the redemption information after that time, the Investment Company shall use its best efforts to wire the redemption proceeds so that they are received by the Close of Trading on the Settlement Date, but if the Investment Company is unable to do so, the redemption proceeds shall be wired so as to be received by the Close of Trading on the Business Day following the Settlement Date. If the wire is not received by the time specified in this paragraph, and such delay was not caused by the negligence or willful misconduct of Insurer or its designee, Insurer or Insurers designee shall be entitled to receive from the Investment Company the dollar amount of any overdraft plus any associated bank charges incurred; provided, however, that if the delay was due to factors beyond the control of the Investment Company and its subsidiaries, the Investment Company shall not be liable for any overdraft or any associated bank charges incurred.
(v) If the dollar amount of the redemption proceeds wired by the Investment Company exceeds the amount that should have been transmitted, Insurer shall use its best efforts to have such excess amount returned to the Investment Company as soon as possible.
(e) Wire Payments. All wire payments referenced in this Agreement shall be transmitted via the Federal Reserve Wire Transfer System. Notwithstanding any other provision of this Agreement, in the event that the Federal Reserve Wire Transfer System is closed on any Business Day, the duties of the Investment Company, Insurer, and their designees under this Agreement shall be suspended, and shall resume on the next Business Day that the Federal Reserve Wire Transfer System is open as if such period of suspension had not occurred.
(f) Pricing Errors. In the event (1) a Fund is required (under the then prevailing pricing error guidelines of the Investment
Company) to recalculate purchases and redemptions of Shares held in Insurers account due to an error in calculating the net asset value of such class of Shares (a NAV Error); or (2) there is a dividend rate error with respect to any Fund held in Insurers account (a Rate Error; Rate Error and NAV Error individually and collectively shall be referred to as a Pricing Error):
(i) The Investment Company shall promptly notify Insurer in writing of the Pricing Error, which written notice shall identify the class of Shares, the Business Day(s) on which the Pricing Error(s) occurred and the corrected net asset value of the Shares on each Business Day.
(ii) Upon such notification, Insurer shall promptly determine, for all Separate Accounts which purchased or redeemed Shares on each Business Day on which a Pricing Error occurred, the correct number of Shares purchased or redeemed using the corrected price and the amount of transaction proceeds actually paid or received. Following such determination, the Insurer shall adjust the number of Shares held in each Separate Account to the extent necessary to reflect the correct number of Shares purchased or redeemed for the Separate Account. Following such determination, Insurer shall notify the Fund of the net changes in transactions for the relevant Separate Account and the Fund shall adjust the Separate Account accordingly.
(iii) If, after taking into account the adjustments required by paragraph (ii) above, Insurer determines that some Separate Account customers were still entitled to additional redemption proceeds (a Redemption Shortfall), it shall notify the Investment Company of the aggregate amount of the Redemption Shortfalls and provide supporting documentation for such amount. Upon receipt of such documentation, the Investment Company shall cause the relevant Fund to remit to Insurer additional redemption proceeds in the amount of such Redemption Shortfalls and Insurer shall apply such funds to payment of the Redemption Shortfalls.
(iv) If, after taking into account the adjustments required by paragraph (iii) above, Insurer determines that a Separate Account customer still received excess redemption proceeds (a Redemption Overage), Insurer shall use its best efforts to collect the balance of such Redemption Overage from such Separate Account. In no event, however, shall Insurer be liable to the Investment Company or any Fund for any Redemption Overage. Nothing in this subsection (f) shall be deemed to limit the right of any Fund to recover any Redemption Overage directly or to be indemnified by any party for losses arising from a Pricing Error.
AMENDMENT TO PROTECTIVE LIFE INSURANCE COMPANY
PARTICIPATION AGREEMENT
Protective Life Insurance Company, Variable Insurance Products Fund, Variable Insurance Products Fund II And Variable Insurance Products Fund III Variable Insurance Products Fund IV, and Variable Insurance Products Fund V and Fidelity Distributors Company LLC hereby amend the Participation Agreement (Agreement) dated April 11, 2007, as amended, by doing the following:
1. Schedule A. Schedule A of the Agreement is hereby deleted in its entirety and replaced with the attached Schedule A:
2. Except as modified and amended hereby, the Agreement is hereby ratified and confirmed in full force and effect in accordance with its terms.
IN WITNESS WHEREOF, the parties have hereto affixed their respective authorized signatures, intending that this Amendment be effective as of the 15th day of October, 2020.
PROTECTIVE LIFE INSURANCE COMPANY |
|
|
|
|
|
By: |
/s/ Steve Cramer |
|
Name: |
Steve Cramer |
|
Title: |
Chief Product Officer Retirement Division |
|
|
|
|
VARIABLE INSURANCE PRODUCTS FUND |
|
|
VARIABLE INSURANCE PRODUCTS FUND II |
|
|
VARIABLE INSURANCE PRODUCTS FUND III |
|
|
VARIABLE INSURANCE PRODUCTS FUND IV |
|
|
VARIABLE INSURANCE PRODUCTS FUND V |
|
|
|
|
|
By: |
/s/ Colm Hogan |
|
Name: |
Colm Hogan |
|
Title: |
Authorized Signatory |
|
|
|
|
FIDELITY DISTRIBUTORS COMPANY LLC |
|
|
|
|
|
By: |
/s/ Robert Bachman |
|
Name: |
Robert Bachman |
|
Title: |
EVP |
|
Schedule A
Separate Accounts and Associated Contracts (PLICO)
(October 1, 2020)
Name of Separate Account and
|
|
Contracts Funded by Separate Account
|
|
|
|
Protective Variable Life Separate Account (2/22/1995) |
|
Protective Premiere I (VUL-04) |
|
|
Protective Premiere II (VUL-06) |
|
|
Protective Transitions (VUL06V2) |
|
|
Protective Premiere Survivor (VUL-07) |
|
|
Protective Premiere Provider (VUL-08) |
|
|
Protective Preserver (VUL-09) |
|
|
Protective Premiere Protector (VUL-10) |
|
|
Protective Premiere Executive (VUL-11) |
|
|
Protective Investors Choice VUL |
|
|
Protective Premiere III |
|
|
Protective Preserver II |
|
|
Protective Single Premium Plus |
|
|
Protective Strategic Objectives VUL |
|
|
Protective Strategic Objectives II VUL |
|
|
Protective Investors Choice VUL |
|
|
|
Protective COLI VUL Separate Account |
|
Protective Executive Benefits Registered VUL |
|
|
|
Protective COLI PPVUL Separate Account |
|
Protective Executive Benefits Private Placement VUL |
|
|
|
Protective Variable Annuity Separate Account (12/23/1993) |
|
Mileage Credit (IPV-2108, 2109) |
|
|
Protective Access (IPV-2112, 2113) |
|
|
ProtectiveRewards (IPV-2112, 2113) |
|
|
ProtectiveAccess XL |
|
|
Protective Dimensions |
|
|
Protective Dimensions II |
|
|
Protective Dimensions III |
|
|
Protective Dimensions IV |
|
|
Elements Access |
|
|
Elements Classic |
|
|
ElementsPlus |
|
|
Protective Investors Series |
|
|
Protective Investors Series- ADV |
|
|
Protective Investors Benefit Advisory |
|
|
Protective Advantage |
|
|
The Protective Variable Annuity |
|
|
Protective Variable Annuity B, C, & L Series |
|
|
Protective Variable Annuity II |
|
|
Protective Variable Annuity II B Series |
|
|
Protective Rewards II |
|
|
ProtectiveRewards Elite Variable Annuity |
|
|
ProtectiveValues Variable Annuity |
|
|
ProtectiveValues Access Variable Annuity |
|
|
Protective Values Advantage Variable Annuity |
|
|
ProtectiveAccess Variable Annuity |
|
|
ProtectiveAccess XL Variable Annuity |
|
|
Protective Dimensions Variable Annuity |
|
|
Protective Dimensions II Variable Annuity |
|
|
Protective Dimensions III Variable Annuity |
|
|
Protective Dimensions IV Variable Annuity |
|
|
Elements Access |
|
|
Elements Classic Variable Annuity |
|
|
ElementsPlus |
|
|
Protective Variable Annuity Investors Series |
|
|
Protective Variable Annuity Investors Series - ADV |
|
|
|
PLICO Variable Annuity Account S |
|
Schwab Genesis Advisory Variable Annuity |
|
|
Schwab Genesis Variable Annuity |
Among
PROTECTIVE LIFE INSURANCE COMPANY
GREAT-WEST FUNDS, INC
GREAT-WEST CAPITAL MANAGEMENT, LLC
and
GWFS EQUITIES, INC.
THIS FUND PARTICIPATION AGREEMENT (the Agreement) is made and entered into as of this 7th day of December, 2020 (the Effective Date) by and among Protective Life Insurance Company (hereinafter PLICO), a Tennessee life insurance company, on its own behalf and on behalf of its separate account(s) listed on Schedule B attached hereto (the Accounts);; Great-West Funds, Inc., a Maryland corporation consisting of the separate series described in Schedule A (hereinafter the Fund); Great-West Capital Management, LLC, a Colorado limited liability company and registered investment adviser under the Investment Advisers Act of 1940 (hereinafter the Adviser), and GWFS Equities, Inc., a Delaware corporation (hereinafter the Distributor) (each a Party and collectively the Parties).
WHEREAS, the Fund is registered as an open-end management investment company under the Investment Company Act of 1940 (the 1940 Act) and its shares are registered under the Securities Act of 1933, as amended (hereinafter the 1933 Act); and
WHEREAS, the Adviser is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and any applicable state securities laws; and
WHEREAS, the Distributor is duly registered as a broker-dealer under the Securities Exchange Act of 1934, as amended (the 1934 Act) and is a member in good standing of the Financial Industry Regulatory Authority, Inc. (the FINRA); and
WHEREAS, PLICO has certain registered and unregistered variable annuity and variable life contracts supported wholly or partially by the Accounts (the Contracts) to be made available to owners thereof, including any participants or employees of such owners as applicable (Contract Owners); and
WHEREAS, to the extent required by applicable law, PLICO has registered the Account(s) as a unit investment trust under the 1940 Act unless excepted from registration pursuant to Section 3(c)(7) or Section 3(c)(11) of the 1940 Act, and has registered the securities deemed to be issued by the Account(s) under the 1933 Act unless exempt from registration; and
WHEREAS, the PLICO Account(s) is a duly organized, validly existing segregated asset account, established by resolution of the Board of Directors of PLICO, under the insurance laws of the State of Tennessee, to set aside and invest assets attributable to the PLICO Contracts; and
WHEREAS, to the extent permitted by applicable laws and regulations, PLICO intends to purchase shares in the Fund(s) listed in Schedule A attached hereto and incorporated herein by reference, as such Schedule may be amended from time to time by mutual written agreement (the Designated Portfolio(s)), on behalf of their respective Accounts to fund the applicable Contracts, and the Fund is authorized to sell such shares to unregistered unit investment trusts such as the Accounts at net asset value; and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Accounts also intend to purchase shares in other open-end investment companies or series thereof not affiliated with the Fund (the Unaffiliated Funds) on behalf of the Accounts to fund the Contracts; and
NOW, THEREFORE, the Parties agree as follows:
ARTICLE I. Sale of Fund Shares
1.1. Except as otherwise provided herein, the Fund agrees to make shares of the Designated Portfolios available for purchase by the Company and its Accounts on each Business Day as defined herein. Shares of the Designated Portfolios shall be sold by the Fund through Distributor and purchased by the Company for the appropriate subaccount of each Account, at the net asset value (NAV) next computed after receipt by the Fund or its designee of each order of the Accounts, in accordance with the provisions of this Agreement, the then current prospectus(es) and statement(s) of additional information of the relevant Designated Portfolio, and the variable annuity contracts or variable life insurance contracts (the Contracts) that use the Designated Portfolio(s) as underlying investment media; provided, however, that if any conflicts exist among any such documents, then the terms of the Funds current prospectus(es) and statement(s) of additional information shall control.
1.2. Distributor and the Fund hereby appoint the Company as agent for the limited purpose of accepting orders for an Account, and the Company hereby accepts such appointment. The Company shall have no authority to act as agent for the Fund or the Distributor for any other purpose.
1.3. Subject to the terms of this Article 1 and the other provisions of this Agreement, the Fund shall make Shares of the Designated Portfolios available to the Accounts, and the Company shall engage in transactions with respect to such Shares, at net asset value in accordance with the operational procedures mutually agreed to by the Fund and the Company from time to time and the provisions of the then current prospectuses and statements of additional information of the Portfolios (collectively, the Prospectus). Shares of a particular Designated Portfolio of the Fund shall be ordered in such quantities and at such times as determined by the Company to be necessary to meet the requirements of the Contracts. The Fund may refuse to sell Shares of any Portfolio to any person (including the Company and the Accounts) or suspend or terminate the offering of Shares of any Portfolio or take any action it reasonably may deem appropriate or advisable in connection with all matters relating to the operation of the Fund and/or sale of Shares of the Portfolios. The Fund may require the Company to refuse redemption orders for a Portfolio if permitted by the Funds Prospectus or if the Fund has suspended redemptions with respect to such Portfolio in accordance with Section 22(e) of the 1940 Act, Rule 2a-7 under the 1940 Act or any other applicable rule or regulation. Fund Parties shall have no liability for any such action. It is understood that for purposes of this Agreement, an exchange involves a redemption order and a purchase order for Shares of a Portfolio.
1.4. Fund/SERV Transactions. If the parties choose to use the National Securities Clearing Corporations Mutual Fund Settlement, Entry and Registration Verification (Fund/SERV) or any other NSCC service, the following provisions shall apply:
(a) The Company and the Fund or their designees will each be bound by the rules of the National Securities Clearing Corporation (NSCC) and the terms of any NSCC agreement filed by it or its designee with the NSCC. Without limiting the generality of the following provisions of this section, the Company and the Fund or its designee will each perform any and all duties, functions, procedures and responsibilities assigned to it and as otherwise established by the NSCC applicable to Fund/SERV, the Mutual Fund Profile Service, the Networking Matrix Level utilized and any other relevant NSCC service or system (collectively, the NSCC Systems).
(b) Any information transmitted through the NSCC Systems by any party or its designee to the other or its designee and pursuant to this Agreement will be accurate, complete, and in the format prescribed by the NSCC. Each party or its designee will adopt, implement and maintain procedures reasonably designed to ensure the accuracy of all transmissions through the NSCC Systems and to limit the access to, and the inputting of data into, the NSCC Systems to persons specifically authorized by such party.
(c) On each day on which the New York Stock Exchange is open for trading and on which the Fund calculates its net asset value pursuant to the rules of the SEC (Business Day), the Company shall aggregate and calculate the net purchase and redemption orders for each Account received by the Company by the close of the New York Stock Exchange (generally, 4:00 p.m. Eastern Time) (the Close of Trading) on the Business Day. The Company shall communicate to the Fund or its designee for that Business Day, by Fund/SERV, the net aggregate purchase or redemption orders (if any) for each Account received by the Close of Trading on such Business Day (the Trade Date) no later than 7:00 a.m. Eastern Time (or such other time as may be agreed by the parties from time to time) (the Fund/SERV Transactions Deadline) on the Business Day following the Trade Date. All such aggregated orders communicated to the Fund or its designee by the Fund/SERV Transactions Deadline on the Business Day following the Trade Date shall be treated by the Fund or its designee as if received prior to the Close of Trading on the Trade Date.
(d) All orders received by the Company after the Close of Trading on a Business Day shall not be aggregated with Orders received by the Company prior to the Close of Trading on such Business Day and shall be communicated to BRIL or its designee as part of an aggregated order no sooner than after the FUND/SERV Transactions Deadline or such other time as may be agreed by the parties from time to time) the following Business Day.
(e) Cash settlement shall be transmitted pursuant to the normal NSCC settlement process. In the case of delayed settlement, the Fund or its designee shall make arrangements for the settlement of redemptions by wire no later than the time permitted for settlement of redemption orders by the 1940 Act. Unless otherwise informed in writing, such redemption wires should be sent to an account specified by the Company and agreed to by Fund Parties.
1.5. Manual Transactions. If the parties choose not to use Fund/SERV, if there are technical problems with Fund/SERV, or if the parties are not able to transmit or receive information through Fund/SERV, the following provisions shall apply:
(a) Next Day Transmission of Orders. On each Business Day, the Company shall aggregate and calculate the net purchase and redemption orders for each Account received by the Company by the Close of Trading on such Business Day. By 8:00 a.m. Eastern Time (or such other time as may be agreed by the parties from time to time) (the Manual Transactions Deadline) on the next following Business Day, the Company shall communicate to the Fund or its designee by facsimile or, in the Companys discretion, by telephone or any other method agreed upon by the parties, the net aggregate purchase or redemption orders (if any) for each Account received by the Close of Trading on the prior
Business Day. All orders communicated to the Fund or its designee by the Manual Transactions Deadline on the Business Day following the Trade Date shall be treated by the Fund or its designee as if received prior to the Close of Trading on the Trade Date.
(b) All orders received by the Company after the Close of Trading on a Business Day shall not be aggregated with orders received by the Company prior to the Close of Trading on such Business Day and shall be communicated to Fund or its designee as part of an aggregated order no sooner than after the Manual Transactions Deadline (or such other time as may be agreed by the parties from time to time) the following Business Day.
(c) Purchases. The Company will use commercially reasonable efforts to transmit each purchase order to the Fund or its designee in accordance with written instructions provided by the Fund or its designee to the Company. The Company will use commercially reasonable efforts to initiate by wire transfer to Fund or its designee through the Federal Reserve Wire Transfer System (the Fedwire System) purchase amounts prior to 1:00 p.m. Eastern Time on the next Business Day following the Trade Date.
(d) Redemptions. The Company will use commercially reasonable efforts to transmit each redemption order to the Fund in accordance with written instructions provided by the Fund or its designee to the Company. With respect to redemption orders submitted by the Company by 9:00 a.m. Eastern Time (or such other time as may be agreed by the parties from time to time) on the next Business Day following the Trade Date, the Fund or its designee will use commercially reasonable efforts to initiate by wire transfer to the Company proceeds of such redemptions no later than the close of the Fedwire System on the next Business Day following the Trade Date.
(e) Unless otherwise informed in writing, such redemption wires should be sent to an account specified by the Company and agreed to by Fund Parties.
1.6. All Transactions.
(a) The Company shall be responsible for the accuracy and completeness of any orders submitted by it through any means. All orders are subject to acceptance by the Fund or its designee and become effective only upon confirmation by the Fund or its designee.
(b) Orders submitted on an as-of basis subsequent to the Trade Date for the Order, including post-settlement trade correction orders (hereinafter defined as an As-of Order), shall be acceptable only as permitted by the Fund and shall be subject to the Funds policies pertaining thereto. The Company shall be responsible for any loss or liability to Fund Parties or any of their respective affiliates, including any costs or expenses incurred by any of them, caused by an As-of Order and will promptly pay any such amount to Fund Parties upon demand therefor. The Company agrees that any gains from one As-of Order shall not be netted against losses generated from another.
(c) Subject to this Article 1, the Fund will redeem any full or fractional Shares of any Portfolio when requested by the Company on behalf of an Account pursuant to a redemption order meeting the requirements of this Agreement at net asset value in accordance with the operational procedures mutually agreed to by the Fund and the Company from time to time and the provisions of the Prospectus of the Portfolios. In no event shall payment be delayed for a greater period than is permitted by the 1940 Act (including any Rule or order of the SEC thereunder).
(d) The Company represents and warrants that its internal control structure concerning the processing and transmission of orders is suitably designed to prevent or detect on a timely basis orders received after the Close of Trading from being aggregated with orders received before the
Close of Trading and to minimize errors that could result in late transmission of orders. Orders received by the Company before the Close of Trading are eligible to receive that Business Days net asset value, and orders received by the Company after the Close of Trading are eligible to receive the next Business Days net asset value.
(e) The Fund may reject purchase and redemption orders which are not in the form prescribed in the Funds Prospectus. In the event that the Company and the Fund agree to use a form of written or electronic communication which is not capable of recording the time, date and recipient of any communication and confirming good transmission, the Company agrees that it shall be responsible for confirming that any communication sent by the Company was in fact received by the Fund or its designee, in good order and in accordance with the terms of this Agreement. The Fund and its agents or designees shall be entitled to rely upon, and shall be fully protected from all liability in acting upon, instructions reasonably believed by them to be from the Company or its designee.
(f) In the event that the Company shall fail to pay in a timely manner for any purchase order validly received by the Fund or its designee pursuant to this Article 1, the Company shall hold the Fund or its designee harmless from any losses reasonably sustained by the Fund or its designee as the result of acting in reliance on such purchase order. In the event that the Fund or its designee shall fail to pay in a timely manner for any redemption order validly received by the Fund or its designee pursuant to this Article 1, the Fund or its designee shall hold the Company harmless from any losses reasonably sustained by the Company as the result of acting in reliance on such redemption order.
(g) Issuance and transfer of Shares of the Portfolios will be by book entry only. Share certificates will not be issued to the Company or the Account. Shares ordered from the Fund will be recorded in the appropriate title for each Account or the appropriate sub-account of each Account.
(h) The Fund or its designee shall furnish prompt notice to the Company of any income, dividends or capital gain distribution payable on Shares. The Company hereby elects to receive all such income, dividends and capital gain distributions as are payable on a Portfolios Shares in additional Shares of that Portfolio, unless the Fund or its designee is otherwise notified in writing by the Company. The Fund shall notify the Company of the number of Shares so issued as payment of such income, dividends and distributions.
(i) The Fund shall use commercially reasonable efforts to make the net asset value per Share for each Portfolio available to the Company on a daily basis after the Close of Trading and by 6:30 p.m. Eastern Time.
(j) If the Fund provides materially incorrect net asset value information, it shall make an adjustment to the number of Shares purchased or redeemed for any affected Account to reflect the correct net asset value. The Company shall make such corresponding adjustments to the Accounts as are necessary to complete the sub-accounting for the adjustment. If an adjustment is necessary to correct a pricing error which has caused the Account to receive less than the amount to which it is entitled, the number of Shares of the Account will be adjusted and the amount of any underpayments shall be credited by the Fund to the Company for crediting of such amounts to the Account. Upon notification by the Fund of any overpayment due to an error, the Company shall promptly remit to the Fund any overpayment that has not been paid to Contract owners. If the Account has underpaid for Shares due to a pricing error, the number of Shares of the Account will be adjusted.
(k) Fund Parties shall not be liable for any reprocessing costs or out-of-pocket costs associated with a price correction.
1.7. The Company agrees that it will not take any action to operate an Account as a management investment company under the 1940 Act without the Funds and the Underwriters prior written consent.
1.8. The Fund agrees that its Shares will be sold only to Participating Insurance Companies and their separate accounts. No Shares of any Portfolio will be sold directly to the general public. The Company agrees that Shares will be used only for the purposes of funding the Contracts and Accounts listed in fees, as amended from time to time.
1.9. The Fund agrees that all Participating Insurance Companies shall have the obligations and responsibilities regarding conflicts of interest corresponding to those contained in Article 4 of this Agreement.
1.10. The Company agrees to cooperate with the Distributor and the Fund to monitor for Market Timing by its Contract Owners, to provide such relevant information about Market Timing to the Fund as it may reasonably request, including, but not limited to, such Contract Owners identity, and to prevent Market Timing from occurring by or because of Contract Owners, in accordance with Schedule E attached hereto. Failure of the Fund to reject any purchase orders that might be deemed to be Market Timing shall not constitute a waiver of the Funds rights under this section.
ARTICLE II. Representations and Warranties
2.1. PLICO represents and warrants that it is an insurance company duly organized and in good standing under applicable law and that it has legally and validly established the PLICO Account prior to any issuance or sale of units thereof as a segregated asset account under Tennessee Law.
2.2. The Fund represents and warrants that Designated Portfolio(s) shares sold pursuant to this Agreement shall be registered under the 1933 Act, duly authorized for issuance and sold in compliance with all applicable federal securities laws including without limitation the 1933 Act, the 1934 Act, and the 1940 Act and that the Fund is and shall remain registered under the 1940 Act. The Fund shall amend the registration statement for its shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its shares.
2.3. The Fund and Adviser agree to comply with applicable provisions and SEC staff interpretations of the 1940 Act to assure that the investment advisory or management fees paid to the Adviser by the Fund are in accordance with the requirements of the 1940 Act. To the extent that the Fund finances distribution expenses pursuant to Rule 12b-1, the Fund undertakes to have its Board, a majority of whom are not interested persons of the Fund, formulate and approve any plan pursuant to Rule 12b-1 under the 1940 Act to finance distribution expenses.
2.4. The Fund represents and warrants that the investment policies, fees and expenses of the Designated Portfolio(s) are and shall at all times remain in compliance with the Funds Prospectus and Applicable Law. The Fund and Distributor represent and warrant that they will make commercially reasonable efforts to ensure that Designated Portfolio(s) shares will be sold in compliance with all Applicable Law. The Fund and Distributor shall register and qualify the shares for sale in accordance with the laws of the various states if and to the extent required by Applicable Law. PLICO will endeavor to keep the Adviser informed of any change in state insurance laws, regulations or interpretations of the foregoing that affect the Designated Portfolio(s) (a Law Change). In the event of a Law Change, the Fund agrees that it may (in its sole discretion) take any action required by a Law Change.
2.5. The Fund represents and warrants that it is lawfully organized and validly existing under the laws of the State of Maryland and that it does and will comply in all material respects with the 1940 Act.
2.6 The Adviser represents and warrants that it is and shall remain duly registered under all applicable federal and state securities laws and that it shall perform its obligations for the Fund in compliance with the laws of the State of Colorado and any applicable state and federal securities laws.
2.7. The Distributor represents and warrants that it is and shall remain duly registered under all applicable federal and state securities laws and that it shall perform its obligations for the Fund in compliance with the laws of the State of Delaware and any applicable state and federal securities laws.
2.8. The Fund will provide PLICO with as much advance notice as is reasonably practicable of any material change affecting the Designated Portfolio(s) (including, but not limited to, any material change in the registration statement or prospectus affecting the Designated Portfolio(s)) and any proxy solicitation affecting the Designated Portfolio(s) and consult with PLICO in order to implement any such change in an orderly manner.
ARTICLE III. Prospectuses and Proxy Statements; Voting
3.1. If applicable state or federal laws or regulations require that prospectuses for the Fund be distributed to all Contract owners, then at least annually, the Adviser or Distributor shall provide PLICO with as many copies of the Funds current prospectus for the Designated Portfolio(s) as PLICO may reasonably request for marketing purposes (including distribution to Contract owners with respect to new sales of a Contract), with expenses to be borne in accordance with Schedule C. If requested by PLICO in lieu thereof, the Adviser, Distributor or Fund shall provide such documentation (including a camera-ready copy and computer diskette of the current prospectus for the Designated Portfolio(s)) and other assistance as is reasonably necessary in order for PLICO once each year (or more frequently if the prospectuses for the Designated Portfolio(s) are amended) to have the prospectus for the Contracts and the Funds prospectus for the Designated Portfolio(s) printed together in one document. The Fund and Adviser agree that in the future, PLICO may request that the prospectus (and semi-annual and annual reports) for the Designated Portfolio(s) describe only the Designated Portfolio(s) and not name or describe any other portfolios or series that may be in the Fund, unless required by law. Should PLICO determine that they will make the prospectuses available in an electronic format, the Fund, Adviser or Distributor, as applicable agree to assist PLICO in obtaining the required information from EDGAR and the expenses associated with this form of distribution will be borne in accordance with Schedule C.
3.2. If applicable state or federal laws or regulations require that the Statement of Additional Information (SAI) for the Fund be distributed to all Contract owners, then the Fund, Distributor and/or the Adviser shall provide PLICO with copies of the Funds SAI or documentation thereof for the Designated Portfolio(s) in such quantities, with expenses to be borne in accordance with Schedule C, as PLICO may reasonably require to permit timely distribution thereof to Contract owners. The Adviser and/or the Fund shall also provide SAIs to any Contract owner or prospective owner who requests such SAI from the Fund (although it is anticipated that such requests will be made to PLICO).
3.3. The Fund, Distributor and/or Adviser shall provide PLICO with copies of the Funds proxy material, reports to stockholders and other communications to stockholders for the Designated Portfolio(s) in such quantity, with expenses to be borne in accordance with Schedule C.
3.4. It is understood and agreed that, except with respect to information regarding PLICO provided in writing by PLICO, PLICO is not responsible for the content of the prospectus or SAI for the Designated Portfolio(s).
3.5. If and to the extent required by law PLICO shall:
(i) solicit voting instructions from Contractowners;
(ii) vote the Designated Portfolio(s) shares held in the Accounts in accordance with instructions received from Contractowners; and
(iii) vote Designated Portfolio shares held in the Accounts for which no instructions have been received in the same proportion as Designated Portfolio(s) shares for which instructions have been received from Contractowners, so long as and to the extent that the SEC continues to interpret the 1940 Act to require pass-through voting privileges for variable contract owners. PLICO reserves the right to vote Fund shares held in any segregated asset account in its own right, to the extent permitted by law.
3.6. The Fund will comply with all provisions of the 1940 Act requiring voting by shareholders, and in particular the Fund will either provide for annual meetings (except insofar as the SEC may interpret Section 16 of the 1940 Act not to require such meetings) or, as the Fund currently intends, comply with Section 16(c) of the 1940 Act (although the Fund is not one of the trusts described in Section 16(c) of that Act) as well as with Sections 16(a) and, if and when applicable, 16(b). Further, the Fund will act in accordance with the SECs interpretation of the requirements of Section 16(a) with respect to periodic elections of directors or trustees and with whatever rules the Commission may promulgate with respect thereto.
ARTICLE IV. Sales Material and Information
4.1. PLICO shall furnish, or shall cause to be furnished, to the Fund or its designee, a copy of each piece of sales literature or other promotional material that PLICO develop or propose to use and in which the Fund (or a Portfolio thereof), its Adviser or one of its sub-advisers or the Distributor is named in connection with the Contracts, at least ten (10) Business Days prior to its use. No such material shall be used if the Fund reasonably objects to such use within five (5) Business Days after receipt of such material.
4.2. PLICO shall not give any information or make any representations or statements on behalf of the Fund in connection with the sale of the Contracts other than the information or representations contained in the registration statement, prospectus or SAI for the Fund shares, as the same may be amended or supplemented from time to time, or in sales literature or other promotional material approved by the Fund, Distributor or Adviser, except with the permission of the Fund, Distributor or Adviser.
4.3. The Fund, the Distributor or the Adviser shall furnish, or shall cause to be furnished, to PLICO, a copy of each piece of sales literature or other promotional material in which PLICO and/or their separate account(s) are named at least ten (10) Business Days prior to its use. No such material shall be used if PLICO reasonably object to such use within five (5) Business Days after receipt of such material.
4.4. The Fund and the Adviser shall not give any information or make any representations on behalf of PLICO or concerning PLICO, the Accounts, or the Contracts other than the information or representations contained in the Contracts, as the same may be amended or supplemented from time to time, or in sales literature or other promotional material approved by PLICO or their designee, except with the permission of PLICO.
4.5. The Fund will provide to PLICO at least one complete copy of all registration statements, prospectuses, SAIs, sales literature and other promotional materials that relate to the Designated Portfolio(s), contemporaneously with the filing of such document(s) with the SEC or FINRA or other regulatory authorities.
4.6. PLICO will provide to the Fund at least one complete copy of all sales literature and other promotional materials, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to the Contracts or the Accounts, contemporaneously with the filing of such document(s) with the SEC, FINRA, or other regulatory authority.
4.7. For purposes of Articles IV and VII, the phrase sales literature and other promotional material includes, but is not limited to, advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media; e.g., on-line networks such as the Internet or other electronic media), sales literature (i.e., any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, and shareholder reports, and proxy materials (including solicitations for voting instructions) and any other material constituting sales literature or advertising under the FINRA rules, the 1933 Act or the 1940 Act.
4.8. At the request of any Party to this Agreement, each other Party will make available to the other Partys independent auditors and/or representative of the appropriate regulatory agencies, all records, data and access to operating procedures that may be reasonably requested in connection with compliance and regulatory requirements related to this Agreement or any Partys obligations under this Agreement.
ARTICLE V. Fees and Expenses
5.1. The Fund and the Adviser will pay certain fees in accordance with Schedule D. In addition, the Parties will bear certain expenses in accordance with Schedule C, as well as Articles III and V of this Agreement.
5.2. All expenses incident to performance by the Fund, Distributor and the Adviser under this Agreement shall be paid by the appropriate Party, as further provided in Schedule C. The Fund shall ensure that all shares of the Designated Portfolio(s) are registered and authorized for issuance in accordance with applicable federal law and, if and to the extent required, in accordance with applicable state laws prior to their sale.
5.3. The Parties shall bear the expenses of routine annual distribution (mailing costs) of the Funds prospectus and distribution (mailing costs) of the Funds proxy materials and reports to owners of Contracts offered by PLICO, which may be required by law, in accordance with Schedule C.
ARTICLE VI. Diversification and Qualification
6.1. The Fund, Distributor and Adviser represent and warrant that the Fund and each Designated Portfolio thereof will at all times invest money from the Contracts in such a manner as to ensure that the Contracts will be treated as variable contracts under the Code and the regulations issued thereunder. Without limiting the scope of the foregoing, the Fund will at all times comply with Section 817(h) of the Code and Treasury Regulation §1.817-5, relating to the diversification requirements for variable annuity, endowment, or life insurance contracts and any amendments or other modifications to such Section or Regulations. In the event of a breach of this Article VII by the Fund, it will take all reasonable steps to adequately diversify the Fund so as to achieve compliance within the grace period afforded by Regulation §1.817-5. Upon request, Find or the Adviser will provide PLICO with a certificate of compliance with Section 817(h) no later than 60 days following the end of each calendar quarter.
6.2. The Fund, the Distributor and the Adviser represent and warrant that the Fund and each Designated Portfolio is currently qualified as a Regulated Investment Company under Subchapter M of the Internal Revenue Code of 1986, as amended (hereinafter the Code), and that each Designated Portfolio will maintain such qualification (under Subchapter M or any successor or similar provisions) as long as this Agreement is in effect.
6.3. The Fund, Distributor or Adviser will notify PLICO promptly upon having a reasonable basis for believing that the Fund or any Designated Portfolio has ceased to comply with the aforesaid Subchapter M qualification requirements or might not so comply in the future.
6.4. Upon reasonable request from PLICO or their designees, the Fund shall provide PLICO with reports certifying compliance with the aforesaid Subchapter M qualification requirements, at the times provided for.
ARTICLE VII. Indemnification
7.1. Indemnification by PLICO
(a) PLICO agrees to indemnify and hold harmless the Fund, the Distributor and the Adviser and each of their respective officers and directors or trustees and each person, if any, who controls the Fund, Distributor or Adviser within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 7.1) against any and all losses, claims, expenses, damages and liabilities (including amounts paid in settlement with the written consent of PLICO) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, expenses, damages or liabilities (or actions in respect thereof) or settlements are related to the sale or acquisition of the Funds shares or the Contracts and:
(i) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the Contracts or sales literature or other promotional material for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this Agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and
in conformity with information furnished in writing to PLICO by or on behalf of the Adviser or Fund for use in the Contracts or sales literature or other promotional material (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or Fund shares; or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in sales literature or other promotional material of the Fund not supplied by PLICO or persons under their control) or wrongful conduct of PLICO or persons under their control, with respect to the sale or distribution of the Contracts or Fund Shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in sales literature or other promotional material of the Fund, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, if such a statement or omission was made in reliance upon information furnished in writing to the Fund by or on behalf of PLICO; or
(iv) arise as a result of any failure by PLICO to provide the services and furnish the materials under the terms of this Agreement; or
(v) arise out of or result from any material breach of any representation and/or warranty made by PLICO in this Agreement or arise out of or result from any other material breach of this Agreement by PLICO,
as limited by and in accordance with the provisions of Sections 7.1(b) and 7.1(c) of this Agreement.
(b) PLICO shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.
(c) PLICO shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party has notified PLICO in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim has been served upon such Indemnified Party (or after such Indemnified Party has received notice of such service on any designated agent), but failure to notify PLICO of any such claim shall not relieve PLICO from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent that PLICO has been prejudiced by such failure to give notice. In case any such action is brought against the Indemnified Parties, PLICO shall be entitled to participate, at its own expense, in the defense of such action. PLICO also shall be entitled to assume the defense thereof, with counsel satisfactory to the Party named in the action. After notice from PLICO to such Party of PLICOs election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and PLICO will not be liable to such Party under this Agreement for any legal or other expenses subsequently incurred by such Party independently in connection with the defense thereof other than reasonable costs of investigation.
(d) The Indemnified Parties will promptly notify PLICO of the commencement of any litigation or proceedings against them in connection with the issuance or sale of the Fund Shares or the Contracts or the operation of the Fund.
7.2. Indemnification by the Adviser
(a) The Adviser agrees to indemnify and hold harmless PLICO and its directors and officers and each person, if any, who controls PLICO within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 7.2) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with the written consent of the Adviser) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Funds shares or the Contracts and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement or prospectus or SAI or sales literature or other promotional material of the Fund prepared by the Fund, the Distributor or the Adviser (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this Agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to the Adviser, the Distributor or the Fund by or on behalf of PLICO for use in the registration statement, prospectus or SAI for the Fund or in sales literature or other promotional material (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or the Fund shares; or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in sales literature or other promotional material for the Contracts not supplied by the Adviser or persons under its control) or wrongful conduct of the Fund, the Distributor or the Adviser or persons under their control, with respect to the sale or distribution of the Contracts or Fund shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in sales literature or other promotional material covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished in writing to PLICO by or on behalf of the Adviser, the Distributor or the Fund; or
(iv) arise as a result of any failure by the Fund, the Distributor or the Adviser to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification and other qualification requirements specified in Article VI of this Agreement); or
(v) arise out of or result from any material breach of any representation and/or warranty made by the Fund, the Distributor or the Adviser in this Agreement or arise out of or result from any other material breach of this Agreement by the Adviser, the Distributor or the Fund; or
(vi) arise out of or result from the incorrect or untimely calculation or reporting by the Fund, the Distributor or the Adviser of the daily net asset value per share or dividend or capital gain distribution rate;
as limited by and in accordance with the provisions of Sections 7.2(b) and 7.2(c). This indemnification is in addition to and apart from the responsibilities and obligations of the Adviser specified in Article VI.
(b) The Adviser shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.
(c) The Adviser shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party has notified the Adviser in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim has been served upon such Indemnified Party (or after such Indemnified Party has received notice of such service on any designated agent), but failure to notify the Adviser of any such claim shall not relieve the Adviser from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent that the Adviser has been prejudiced by such failure to give notice. In case any such action is brought against the Indemnified Parties, the Adviser will be entitled to participate, at its own expense, in the defense thereof. The Adviser also shall be entitled to assume the defense thereof, with counsel satisfactory to the Party named in the action. After notice from the Adviser to such Party of the Advisers election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Adviser will not be liable to such Party under this Agreement for any legal or other expenses subsequently incurred by such Party independently in connection with the defense thereof other than reasonable costs of investigation.
(d) PLICO agrees to promptly notify the Adviser of the commencement of any litigation or proceedings against it or any of its officers or directors in connection with the issuance or sale of the Contracts or the operation of the Accounts.
7.3. Indemnification by the Fund
(a) The Fund agrees to indemnify and hold harmless PLICO and its directors and officers and each person, if any, who controls PLICO within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 7.3) against any and all losses, claims, expenses, damages and liabilities (including amounts paid in settlement with the written consent of the Fund) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may be required to pay or become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, expenses, damages, liabilities or expenses (or actions in respect thereof) or settlements, are related to the operations of the Fund and:
(i) arise as a result of any failure by the Fund to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification and other qualification requirements specified in Article VI of this Agreement); or
(ii) arise out of or result from any material breach of any representation and/or warranty made by the Fund in this Agreement or arise out of or result from any other material breach of this Agreement by the Fund;
as limited by and in accordance with the provisions of Sections 7.3(b) and 7.3(c).
(b) The Fund shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.
(c) The Fund shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party has notified the Fund in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim has been served upon such Indemnified Party (or after such Indemnified Party has received notice of such service on any designated agent), but failure to notify the Fund of any such claim shall not relieve it from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent that the Fund has been prejudiced by such failure to give notice. In case any such action is brought against the Indemnified Parties, the Fund will be entitled to participate, at its own expense, in the defense thereof. The Fund shall also be entitled to assume the defense thereof, with counsel satisfactory to the Party named in the action. After notice from the Fund to such Party of the Funds election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Fund will not be liable to such Party under this Agreement for any legal or other expenses subsequently incurred by such Party independently in connection with the defense thereof other than reasonable costs of investigation.
(d) PLICO agrees to promptly notify the Fund of the commencement of any litigation or proceeding against itself or any of its respective officers or directors in connection with this Agreement, the issuance or sale of the Contracts, the operation of the Accounts, or the sale or acquisition of shares of the Fund.
7.4. Indemnification by the Distributor
(a) The Distributor agrees to indemnify and hold harmless PLICO and its directors and officers and each person, if any, who controls PLICO within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 7.4) against any and all losses, claims, expenses, damages and liabilities (including amounts paid in settlement with the written consent of the Distributor) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Funds shares or the Contracts and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement or prospectus or SAI or sales literature or other promotional material of the Fund prepared by the Fund, Adviser or Distributor (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this Agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in
conformity with information furnished in writing to the Adviser, the Distributor or Fund by or on behalf of PLICO for use in the registration statement or SAI or prospectus for the Fund or in sales literature or other promotional material (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or Fund shares; or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, SAI, sales literature or other promotional material for the Contracts not supplied by the Distributor or persons under its control) or wrongful conduct of the Fund, the Distributor or Adviser or persons under their control, with respect to the sale or distribution of the Contracts or Fund shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI, sales literature or other promotional material covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished in writing to PLICO by or on behalf of the Adviser, the Distributor or Fund; or
(iv) arise as a result of any failure by the Fund, Adviser or Distributor to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification and other qualification requirements specified in Article VI of this Agreement); or
(v) arise out of or result from any material breach of any representation and/or warranty made by the Fund, Adviser or Distributor in this Agreement or arise out of or result from any other material breach of this Agreement by the Fund, Adviser or Distributor; or
(vi) arise out of or result from the incorrect or untimely calculation or reporting of the daily net asset value per share or dividend or capital gain distribution rate;
as limited by and in accordance with the provisions of Sections 7.4(b) and 7.4(c). This indemnification is in addition to and apart from the responsibilities and obligations of the Distributor specified in Article VI.
(b) The Distributor shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or negligence in the performance or such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.
(c) The Distributor shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party has notified the Distributor in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim has been served upon such Indemnified Party (or after such Indemnified Party has received notice of such service on any designated agent), but failure to notify the Distributor of any such claim shall not relieve the Distributor from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent that the Distributor has been prejudiced by such failure to give notice. In case any such action is brought against the Indemnified Parties, the Distributor will be entitled to participate, at its own expense, in
the defense thereof. The Distributor also shall be entitled to assume the defense thereof, with counsel satisfactory to the Party named in the action. After notice from the Distributor to such Party of the Distributors election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Distributor will not be liable to such Party under this Agreement for any legal or other expenses subsequently incurred by such Party independently in connection with the defense thereof other than reasonable costs of investigation.
(d) PLICO agrees to promptly notify the Distributor of the commencement of any litigation or proceedings against it or any of its officers or directors in connection with the issuance or sale of the Contracts or the operation of the Accounts.
ARTICLE VIII. Applicable Law
8.1. This Agreement will be construed and interpreted in accordance with the laws of the State of Colorado, without regard to the Colorado Conflict of Laws provisions.
8.2. This Agreement is subject to the provisions of the 1933, 1934, and 1940 Acts, and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the SEC may grant and the terms of this Agreement will be interpreted and construed in accordance therewith.
ARTICLE IX. Termination
9.1. This Agreement will terminate:
(a) at the option of any Party, with or without cause, with respect to some or all Portfolios, upon six (6) months advance written notice delivered to the other Parties; provided, however, that such notice shall not be given earlier than six (6) months following the Effective Date of this Agreement; or
(b) at the option of PLICO by written notice to the other Parties with respect to any Portfolio in the event any of the Portfolios shares are not registered, issued or sold in accordance with applicable state and/ or federal law or such law precludes the use of such shares as the underlying investment media of the Contracts issued or to be issued by PLICO; or
(c) at the option of the Fund, Distributor or Adviser in the event that formal administrative proceedings are instituted against PLICO by the FINRA, the SEC, the Insurance Commissioner or like official of any state or any other regulatory body regarding PLICOs duties under this Agreement or related to the sale of the Contracts, the operation of any Account, or the purchase of the Fund shares, if, in each case, the Fund, Distributor or Adviser, as the case may be, reasonably determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of PLICO to perform its obligations under this Agreement; or
(d) at the option of PLICO in the event that formal administrative proceedings are instituted against the Fund, the Distributor or the Adviser by the FINRA, the SEC, or any state securities or insurance department or any other regulatory body, if PLICO reasonably determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Fund, the Distributor or the Adviser to perform their obligations under this Agreement; or
(e) at the option of either the Fund, the Distributor or the Adviser, if (i) the Fund, the Distributor or Adviser, respectively, determines, in its sole judgment reasonably exercised in good faith, that PLICO has suffered a material adverse change in its business or financial condition or is the subject of
material adverse publicity and that material adverse change or publicity will have a material adverse impact on PLICOs ability to perform its obligations under this Agreement, (ii) the Fund, the Distributor or Adviser notifies PLICO of that determination and its intent to terminate this Agreement, and (iii) after considering the actions taken by PLICO and any other changes in circumstances since the giving of such a notice, the determination of the Fund, the Distributor or Adviser continues to apply on the sixtieth (60th) day following the giving of that notice, which sixtieth day will be the effective date of termination; or
(f) at the option of PLICO, if (i) PLICO determines, in its sole judgment reasonably exercised in good faith, that the Fund, the Distributor or Adviser has suffered a material adverse change in its business or financial condition or is the subject of material adverse publicity and that material adverse change or publicity will have a material adverse impact on the Funds, Distributors or Advisers ability to perform its obligations under this Agreement, (ii) PLICO notifies the Fund, Distributor or Adviser, as appropriate, of that determination and its intent to terminate this Agreement, and (iii) after considering the actions taken by the Fund, Distributor or Adviser and any other changes in circumstances since the giving of such a notice, the determination of PLICO continues to apply on the sixtieth (60th) day following the giving of that notice, which sixtieth day will be the effective date of termination; or
(g) at the option of any non-defaulting Party in the event of a material breach of this Agreement by any Party (the Defaulting Party) other than as described in 9.1(a)-(f); provided, that the non-defaulting Party gives written notice thereof to the Defaulting Party, with copies of such notice to all other non-defaulting Parties, and if such breach has not been remedied within thirty (30) days after such written notice is given, then the non-defaulting Party giving such written notice may terminate this Agreement by giving thirty (30) days written notice of termination to the Defaulting Party.
9.2. Notice Requirement. No termination of this Agreement will be effective unless the Party terminating this Agreement gives prior written notice to all other Parties of its intent to terminate, which notice must set forth the basis for the termination. Furthermore:
(a) in the event any termination is based upon the provisions of Section 9.1(a), 9.1(e), 9.1(f) or 9.1(g) of this Agreement, the prior written notice must be given in advance of the effective date of termination as required by those provisions unless such notice period is shortened by mutual written agreement of the Parties;
(b) in the event any termination is based upon the provisions of Section 9.1(c) or 9.1(d) of this Agreement, the prior written notice must be given at least sixty (60) days before the effective date of termination; and
(c) in the event any termination is based upon the provisions of Section 9.1(c), the prior written notice must be given in advance of the effective date of termination, which date will be determined by the Party sending the notice.
9.3. Effect of Termination. Notwithstanding any termination of this Agreement, the owners of Contracts in effect on the effective date of termination of the Agreement (hereinafter referred to as Existing Contracts), shall be permitted to reallocate investments in the Designated Portfolio(s), redeem investments in the Designated Portfolio(s) and/or invest in the Designated Portfolio(s) upon the making of additional purchase payments under the Existing Contracts.
9.4. Surviving Provisions. Notwithstanding any termination of this Agreement, each Partys obligations under Article VII, Section 11.1, and Section 11.5 will survive and not be affected by any termination of this Agreement. In addition, with respect to Existing Contracts, all provisions of this Agreement will also survive and not be affected by any termination of this Agreement.
ARTICLE X. Notices
Any notice will be sufficiently given when sent by registered or certified mail to the other Party at the address of such Party set forth below or at such other address as such Party may from time to time specify in writing to the other Parties.
If to PLICO:
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, AL 35223
Attention: Senior Vice President, Chief Product Officer
With a copy to:
Senior Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
If to the Fund:
Great-West Funds, Inc.
8525 East Orchard Road, 2T3
Greenwood Village, CO 80111
Attention: Adam Kavan, Counsel & Assistant Secretary
If to the Adviser:
Great-West Capital Management, LLC
8525 East Orchard Road, 2T3
Greenwood Village, CO 80111
Attention: Adam Kavan, Counsel & Assistant Secretary
If to the Distributor:
GWFS Equities, Inc.
8525 East Orchard Road, 2T3
Greenwood Village, CO 80111
Attention: Mike Kavanagh, Head of Compliance
ARTICLE XI. Miscellaneous
11.1. Subject to the requirements of legal process and regulatory authority, each Party shall treat as confidential the names and addresses of the owners of the Contracts and all information reasonably identified as confidential in writing by any other Party and, except as permitted by this Agreement, shall not disclose, disseminate or utilize such names and addresses and other confidential information without the express written consent of the affected Party until such time as such information may come into the public domain. Without limiting the foregoing, no Party shall disclose any information that another Party has designated as proprietary.
11.2. The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
11.3. This Agreement may be executed simultaneously in two or more counterparts, each of which taken together constitutes one and the same instrument. Any signature that is delivered by facsimile transmission or by email delivery of a pdf format data file will create a valid and binding obligation of the Party executing with the same force and effect as if such facsimile or pdf signature were an original thereof.
11.4. If any provision of this Agreement is held or made invalid by a court decision, statute, rule or otherwise, the remainder of this Agreement will not be affected thereby.
11.5. Each Party shall cooperate with each other Party and all appropriate governmental authorities (including without limitation the SEC, the FINRA and state insurance regulators) and shall permit such other Party and authorities reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.
11.6. The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the Parties are entitled to under state and federal laws.
11.7 This Agreement may not be amended except by a writing signed by each of the Parties. The terms or provisions of this Agreement may be waived only by a writing signed by the Party waiving compliance. No waiver by any Party of any term or provision of this Agreement will be deemed to be a continuing waiver, or deemed to be a waiver of any other term or provision of this Agreement.
11.8. This Agreement or any of the rights and obligations hereunder may not be assigned by any Party without the prior written consent of all Parties.
11.9. PLICO is hereby expressly put on notice of the limitation of liability as set forth in the Declarations of Trust of the Fund and agrees that the obligations assumed by the Fund, the Distributor and the Adviser pursuant to this Agreement are limited in any case to the Fund and Adviser and their respective assets and PLICO shall not seek satisfaction of any such obligation from the shareholders of the Fund, officers, employees or agents of the Fund, if an applicable trust.
11.10. The Fund, the Distributor and the Adviser agree that the obligations assumed by PLICO pursuant to this Agreement are limited in any case to PLICO and its assets and neither the Fund, Distributor nor Adviser shall seek satisfaction of any such obligation from the shareholders of PLICO, the directors, officers, employees or agents of PLICO, or any of them, except to the extent permitted under this Agreement.
11.11. No provision of this Agreement may be deemed or construed to modify or supersede any contractual rights, duties, or indemnifications, as between the Adviser, the Distributor and the Fund.
11.12. None of the Parties shall be liable to the other for any and all losses, damages, costs, charges, counsel fees, payments, expenses or liability due to any failure, delay or interruption in performing its obligations under this Agreement, and without the fault or negligence of such Party, due to causes or conditions beyond its control including, without limitation, labor disputes, strikes (whether legal or illegal), lock outs (whether legal or illegal), civil commotion, riots, war and war-like operations including acts of terrorism, embargoes, epidemics, invasion, rebellion, hostilities, insurrections, explosions, floods, unusually severe weather conditions, earthquakes, military power, sabotage, governmental regulations or controls, failure of power, fire or other casualty, accidents, national or local emergencies, boycotts, picketing, slow-downs, work stoppages, acts of God or natural disasters, provided that such failure or delay was not capable of mitigation pursuant to a prudent business continuity, disaster recovery or similar program.
1A3. This Agreement sets forth the entire agreement and understanding of the Parties relating to the subject matter hereof, and supersedes all other prior agreements, arrangements, and understandings, whether written or oral, between the Parties.
(The remainder of this page intentionally left blank; signature page to follow)
IN WITNESS WHEREOF, each of the Parties has caused this Agreement to be executed on its behalf by its duly authorized representative, to be effective as of the Effective Date.
PROTECTIVE LIFE INSURANCE COMPANY |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
|
|
|
GREAT-WEST FUNDS, INC |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
|
|
|
GREAT-WEST CAPITAL MANAGEMENT, LLC |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
|
|
|
GWFS EQUITIES, INC |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
(Schedule A to follow)
SCHEDULE A
DESIGNATED PORTFOLIOS AND FEES
Designated Portfolios
All available classes of the portfolios or series of the Fund as listed below, or which become available to new investors on or after the Effective Date of this Agreement: |
|
Great-West Aggressive Profile Fund |
Great-West Ariel Mid Cap Value Fund |
Great-West Bond Index Fund |
Great-West Conservative Profile Fund |
Great-West Core Bond Fund |
Great-West Emerging Markets Equity Fund |
Great-West Global Bond Fund |
Great-West Government Money Market Fund |
Great-West Infl-Protd Secs Fd |
Great-West International Growth Fund |
Great-West International Index Fund |
Great-West International Value Fund |
Great-West Invesco Small Cap Value Fund |
Great-West Large Cap Growth Fund |
Great-West Large Cap Value |
Great-West Lifetime 2015 Fund |
Great-West Lifetime 2020 Fund |
Great-West Lifetime 2025 Fund |
Great-West Lifetime 2030 Fund |
Great-West Lifetime 2035 Fund |
Great-West Lifetime 2040 Fund |
Great-West Lifetime 2045 Fund |
Great-West Lifetime 2050 Fund |
Great-West Lifetime 2055 Fund |
Great-West Lifetime 2060 Fund |
Great-West Lifetime Conservative 2015 Fd |
Great-West Lifetime Conservative 2020 Fd |
Great-West Lifetime Conservative 2025 Fd |
Great-West Lifetime Conservative 2030 Fd |
Great-West Lifetime Conservative 2035 Fd |
Great-West Lifetime Conservative 2040 Fd |
Great-West Lifetime Conservative 2045 Fd |
Great-West Lifetime Conservative 2050 Fd |
Great-West Lifetime Conservative 2055 Fd |
Great-West Lifetime Conservative 2060 Fd |
Great-West Mid Cap Value Fund |
Great-West Moderate Profile Fund |
Great-West Moderately Aggressive Prfl Fd |
Great-West Moderately Cnsrv Prfl Fd |
Great-West Multi-Sector Bond Fund |
Great-West Real Estate Index Fund |
Great-West S&P 500® Index Fund |
Great-West S&P Mid Cap 400® Index Fund |
Great-West S&P Small Cap 600® Index Fund |
Great-West Short Duration Bond Fund |
Great-West Small Cap Growth Fund |
Great-West Small Cap Value Fund |
Great-West T. Rowe Price Mid Cp Gr Fd |
Great-West US Government Securities Fund |
Administrative Services and Distribution Fees Paid by Each Class of Shares of the Designated Portfolios |
Share Class |
|
12b-Fee |
|
Administrative Services Fee |
|
Institutional Class |
|
0.00 |
% |
0.00 |
% |
Investor Class |
|
0.00 |
% |
0.35 |
% |
Class L |
|
0.25 |
% |
0.35 |
% |
(Schedule B to follow)
SCHEDULE B
SEPARATE ACCOUNTS
PLICO Accounts
PLICO Variable Annuity Account S
Protective COLI VUL Separate Account
Protective COLI PPVUL Separate Account
(Schedule C to follow)
SCHEDULE C
EXPENSES
The Fund and/or Adviser, and PLICO will coordinate the functions and pay the costs of completing these functions based upon an allocation of costs in the tables below.
Item |
|
Function |
|
Party Responsible
|
|
Party
|
Mutual Fund Prospectus |
|
Printing of combined prospectuses, or compiling of electronic prospectus, if needed in the future |
|
PLICO |
|
Fund or Adviser, as applicable |
|
|
Fund or Adviser shall supply PLICO with such numbers of the Designated Portfolio(s) prospectus(es) as PLICO reasonably requests |
|
PLICO |
|
Fund or Adviser, as applicable |
|
|
Distribution to New and Inforce Clients |
|
PLICO |
|
Fund or Adviser, as applicable |
|
|
Distribution to Prospective Clients |
|
PLICO |
|
PLICO |
Mutual Fund Prospectus Update & Distribution |
|
If Required by Fund or Adviser |
|
Fund or Adviser |
|
Fund or Adviser |
|
|
If Required by PLICO |
|
PLICO |
|
PLICO |
Mutual Fund SAI |
|
Printing |
|
Fund or Adviser |
|
Fund or Adviser |
|
|
Distribution |
|
PLICO |
|
PLICO |
Proxy Material for Mutual Fund: |
|
Printing if proxy required by Law |
|
Fund or Adviser |
|
Fund or Adviser |
|
|
Distribution to Contractowners (including labor, if required) if proxy required by Law |
|
PLICO |
|
Fund or Adviser |
|
|
Printing & distribution if required by PLICO |
|
PLICO |
|
PLICO |
Mutual Fund Annual & Semi-Annual Report |
|
Printing of combined reports |
|
PLICO |
|
Fund or Adviser |
|
|
Distribution |
|
PLICO |
|
PLICO |
Other communication to New and Prospective clients |
|
If Required by the Fund or Adviser |
|
PLICO |
|
Fund or Adviser |
|
|
If Required by PLICO |
|
PLICO |
|
PLICO |
Other communication to Inforce Clients |
|
Distribution (including labor and printing) if required by the Fund or Adviser |
|
PLICO |
|
Fund or Adviser |
|
|
Distribution (including labor and printing) if required by PLICO |
|
PLICO |
|
PLICO |
Errors in Share Price calculation |
|
Cost of error to participants |
|
PLICO |
|
Fund or Adviser |
|
|
Cost of administrative work to correct error |
|
PLICO |
|
Fund or Adviser |
Operations of the Fund |
|
All operations and related expenses, including the cost of registration and qualification of shares, taxes on the issuance or transfer of shares, cost of management of the business affairs of the Fund, and expenses paid or assumed by the fund pursuant to any Rule 12b-1 plan |
|
Fund or Adviser |
|
Fund or Adviser |
(Schedule D to follow)
SCHEDULE D
ADMINISTRATIVE SERVICES
A. PLICO, or an affiliate, will provide the properly registered and licensed personnel and systems needed for all customer servicing and support for both fund and annuity information and questions including:
responding to Contract owner inquiries;
delivering prospectuses both fund and annuity;
entering initial and subsequent orders;
transferring cash to insurance company and/or funds;
explaining fund objectives and characteristics;
entering transfers between funds;
responding to fund balance and allocation inquiries;
mailing fund prospectus.
B. PLICO, or an affiliate, will communicate all purchase, withdrawal, and exchange orders it receives from its customers to each Designated Portfolio.
Administrative Service Fee
(if applicable)
For the services, PLICO or their affiliate shall receive a fee per annum of the average aggregate daily net asset value of shares of the Designated Portfolio(s) held in the Accounts, payable by the Adviser directly to PLICO or their affiliate, as described in Schedule A. If applicable, such fee shall be paid in arrears quarterly. Each quarterly fee will be determined based on assets in the Accounts and each quarterly fee will be independent of every other quarterly fee. Such fee shall be due and payable automatically within 20 (twenty) days after the last day of the quarter to which such payment relates.
12b-1 Distribution Related Fees
(if applicable)
The Adviser, or its designee, agrees to pay PLICO or their affiliate a fee per annum of the average aggregate daily net asset value of shares of Designated Portfolio(s) held in the Accounts, as described in Schedule A. If applicable, such fee shall be paid in arrears, quarterly. Each quarterly fee will be determined based on assets in the Accounts and each quarterly fee will be independent of every other quarterly fee. Such fee shall be due and payable automatically within 20 (twenty) days after the last day of the quarter to which such payment relates.
SCHEDULE E
22c-2 CONTRACTHOLDER INFORMATION
For the purposes of this Schedule E, Intermediary refers to PLICO or its designated agent.
Intermediary has entered into trading and/or fund participation and/or administrative services agreement(s) with the Fund to make certain mutual funds and variable insurance funds available to certain shareholders serviced by Intermediary. The Fund has adopted policies and procedures to protect certain fund(s) and their respective shareholders from potentially harmful trading activity (Frequent Trading). Such policies and procedures include reserving the right to reject certain transactions initiated by Plan Contractholders, beneficiaries, individual annuity owners and beneficiaries, and IRA owners (collectively the Contractholder(s)). The Parties desire to have the Intermediary assist the Fund in meeting its goal of restricting potentially harmful Frequent Trading within the fund(s).
Intermediary agrees to perform standardized Frequent Trading monitoring of Contractholder-Initiated transactions in the Restricted Fund(s) specified by the Fund as outlined below. The Fund agrees that the standardized Frequent Trading monitoring and purchase restriction policies and procedures set out herein satisfy the Funds Frequent Trading standards and hereby instructs Intermediary to implement such monitoring policies and procedures.
1. Definitions specific to this Schedule E.
(a) Contractholder The holder of interests in a variable annuity or variable life insurance contract issued by the Intermediary (Contract), or a participant in an employee benefit plan with a beneficial interest in a contract.
(b) Contractholder-Initiated A voluntary trade or other transaction effected at the direction of the Contractholder rather than the direction of the sponsor or fiduciary of a Plan that results in a transfer of assets within a Contract into or out of a Fund, but does not include the following: (i) transactions that are executed automatically pursuant to a contractual or systematic program or enrollment such as transfer of assets within a Contract to a Fund as a result of dollar cost averaging programs, insurance company approved asset allocation programs, or automatic rebalancing programs; (ii) transactions that are executed pursuant to a Contract death benefit; (iii) one-time step-up in Contract value pursuant to a Contract death benefit; (iv) allocation of assets to a Fund through a Contract as a result of payments such as loan repayments, scheduled contributions, retirement plan salary reduction contributions, or planned premium payments to the Contract; (v) prearranged transfers at the conclusion of a required free-look period; (vi) as a result of any deduction of charges or fees under a Contract; (vii) within a Contract out of a Fund as a result of scheduled withdrawals or surrenders from a Contract; or (viii) as a result of payment of a death benefit from a Contract.
(c) Exchange Purchase A Contractholder-Initiated fund transfer of any portion of a Contractholders assets into a Restricted Fund (not including purchases into the Restricted Fund made with new assets contributed to a Contract).
(d) Exchange Redemption A Contractholder-Initiated fund transfer of any portion of a Contractholders assets in a Contract of a Restricted Fund (not including the withdrawal or distribution of assets out of a Contract).
(e) Purchase Restriction Period The 30 Day period during which a Contractholder will be restricted from initiating Exchange Purchases into the affected Restricted Fund(s).
(f) Restricted Fund(s) Each of the funds subject to the Frequent Trading policy. Restricted Funds do not include any excepted funds as defined in SEC Rule 22c-2(b) under the Investment Company Act of 1940,(1) or any funds identified as such by the Fund.
(f) Round Trip A Contractholder-Initiated transfer into a Restricted Fund(s) followed by a Contractholder-Initiated transfer out of that same Restricted Fund within a 30 calendar day period.
(g) Second Round Trip A Contractholder-Initiated transfer into a Restricted Fund followed by a Contractholder-Initiated transfer out of that same Restricted Fund within a 30 calendar-day period beginning on the calendar day a Round Trip was completed.
(h) Shares The interests of Contractholders corresponding to the securities of record issued by the Restricted Fund(s) held by Intermediary.
(i) Written Includes electronic writings and facsimile transmissions and communications.
2. Intermediary Frequent Trading Monitoring and Purchase Restriction Period. The Fund hereby instructs and directs Intermediary to monitor for Frequent Trading. Intermediary agrees to use reasonable efforts to monitor Contractholder-Initiated Exchange Purchases and Exchange Redemptions in accordance with the terms set forth herein.
(a) Intermediary will monitor Contractholder-Initiated Exchange Purchases and Exchange Redemptions and will identify any Contractholder who initiates a Round Trip in a particular Restricted Fund during a 30 calendar-day period beginning with each Exchange Purchase into such Restricted Fund. Such monitoring will be done on a plan by plan basis (not across multiple plans).
(b) Any Contractholder identified as executing a Round Trip in a particular Restricted Fund(s) will be notified by Intermediary as soon as administratively practicable that a second Round Trip within such Restricted Fund(s) will subject such Contractholder to the Purchase Restriction Period set forth herein.
(c) The Fund hereby instructs Intermediary to notify the Contractholder and to impose the Purchase Restriction Period as soon as administratively possible on any Contractholder identified as completing a Second Round Trip within a particular Restricted Fund(s). Such restriction will apply only with respect to the affected Restricted Fund(s) in the Contractholders account in the Plan.
(d) Intermediary is instructed to restore the Contractholders Exchange Purchase privileges upon the expiration of the Purchase Restriction Period.
(e) The Fund agrees that the Round Trip, Second Round Trip, and Purchase Restriction Period set out within this Agreement are no more restrictive than any other periods agreed to between the Fund and any other intermediary. To the extent the Fund agrees to a shorter Round Trip, Second Round Trip, and/or Purchase Restriction Period with any other Intermediary, the Fund agrees to promptly notify GWFS, and send an amendment to this agreement reflecting the provisions more favorable to GWFS.
(1) As defined in SEC Rule 22c-2(b), the term excepted fund means any: (1) money market fund; (2) fund that issues securities that are listed on a national exchange; and (3) fund that affirmatively permits short-term trading of its securities, if its prospectus clearly and prominently discloses that the fund permits short-term trading of its securities and that such trading may result in additional costs for the fund.
3. Exempt Transactions. The Fund understands and acknowledges that the following transactions will not be subject to monitoring or data requests by Intermediary:
(a) Any and all transactions other than Contractholder-Initiated Exchange Purchases and Exchange Redemptions.
(b) Any transaction that is an error correction or as-of adjustment.
4. Partially Exempt Transactions. The Fund understands and acknowledges that transactions in variable universal life Contracts funded by the Protective Protective COLI PPVUL Separate Account or the Protective COLI VUL Separate Account will not be subject to monitoring by Intermediary. However, notwithstanding the foregoing, such transactions will be subject to data requests by the Fund Company to Intermediary.
5. Monitoring In Lieu of Routine Data Requests by the Fund Company.
(a) As long as Intermediary is complying with the Frequent Trading Monitoring policies and procedures set out herein, the Fund agrees not to make routine requests for data from Intermediary. Intermediary will, however, provide reports and information to the Fund, in accordance with the terms of this Agreement as requested in writing for due diligence or audit purposes.
(b) If the Fund identifies a Contractholder that has been subject to the Purchase Restriction Period more than once because of repeated Frequent Trading, the Fund may provide written direction to Intermediary to implement special restrictions on such Contractholder as the Fund deems necessary. Intermediary will use reasonable efforts to impose such restrictions to the extent they are administratively feasible.
(c) Intermediary will provide the Fund with a quarterly report summarizing the total number of Contractholders who were restricted from purchasing during the previous calendar quarter.
6. Information Reporting Upon Written Request of the Fund.
(a) Upon receipt of a written request by the Fund as set forth herein, Intermediary agrees to provide certain information with respect to Contractholder-Initiated Exchange Purchases and Contractholder-Initiated Exchange Redemptions as such terms are defined herein through a Plan Contractholders account maintained by Intermediary. Such information will include:
· The Contractholders taxpayer identification number (TIN), Individual/International Taxpayer Identification Number (ITIN), or other government-issued identifier (GII), if known
· Intermediarys alpha or numeric company identifier (e.g., NSCC number)
· Fund/Omnibus Account Number Intermediarys trading account number for the Restricted Fund
· Intermediary Fund Identification The individual fund identifier on Intermediarys system(s)
· Indirect Intermediary Identification Intermediarys alpha or numeric identifier for another party (e.g., a third party administrator) that holds the account information
· Intermediarys alpha or numeric identifier for the Plan (e.g., Plan number)
· Trade Date(s)
· Transaction Type (e.g., purchase or redemption)
· Dollar Amount
· Security Identification (e.g., CUSIP)
(b) The Fund acknowledges and agrees that Intermediary will only provide such information
regarding a Contractholder that Intermediary is permitted to provide without Contractholder consent under applicable laws, rules, and regulations. If Intermediary is required by law to obtain Contractholder consent in order to provide certain information to the Fund, Intermediary will use reasonable efforts to obtain such consent.
(c) Written requests for data must set forth the specific period, not to exceed 90 days from the date of the request, for which transaction information is sought. The Fund or its designee may request transaction information older than 90 days from the date of the request, as it deems necessary to investigate compliance with policies established by the Fund for the purpose of eliminating or reducing any dilution of the value of the outstanding shares issued by the Fund.
(d) Intermediary agrees to transmit the requested information that is on its books and records to the Fund or their designee as soon as reasonably practicable, and agrees to use commercially reasonable efforts to transmit the requested information within five business days after receipt of the request. Intermediary has no information housed by an indirect intermediary. The requested information will be communicated in accordance with standards that are mutually agreed upon by the Parties.
(e) The Fund or its designee agree not to use the information received from Intermediary for any purpose other than to comply with SEC Rule 22c-2, and such other applicable laws, rules, and regulations. The Fund shall treat the information as strictly confidential and shall take such steps as are reasonably necessary to protect its confidentiality and prevent the unauthorized disclosure or use of such information.
(f) Intermediary agrees to take reasonable steps to execute written instructions from the Fund to restrict or prohibit further purchases or exchanges of Shares by a Contractholder that has been identified by the Fund as having engaged in transactions involving a Restricted Fund (directly or indirectly through the Intermediarys account) that violate the trading policies established by the Fund for the purpose of eliminating or reducing potentially harmful market timing or frequent trading. Intermediary agrees to provide written confirmation to the Fund or its designee that instructions have been executed. Intermediary agrees to provide confirmation as soon as reasonably practicable and shall use commercially reasonable efforts to provide such confirmation not later than ten business days after the instructions have been executed.
7. Modifications. Intermediary and the Fund reserve the right to modify the Frequent Trading monitoring practices at any time by mutual agreement.
JANUS ASPEN SERIES
FUND PARTICIPATION AGREEMENT
(Institutional Shares)
THIS AGREEMENT is entered into as of the 3rd day of December 2020, between JANUS ASPEN SERIES, an open-end management investment company organized as a Delaware statutory trust (the Trust), and Protective Life Insurance Company, a life insurance company organized under the laws of the State of Tennessee (the Company), on its own behalf and on behalf of each segregated asset account of the Company set forth on Schedule A, as may be amended from time to time (the Accounts).
W I T N E S S E T H:
WHEREAS, the Trust has registered with the Securities and Exchange Commission (SEC) as an open-end management investment company under the Investment Company Act of 1940, as amended (the 1940 Act), and the beneficial interest in the Trust is divided into several series of shares, each series representing an interest in a particular managed portfolio of securities and other assets (the Portfolios); and
WHEREAS, the Trust has registered the offer and sale of a class of shares designated the Institutional (Shares) of each of its Portfolios under the Securities Act of 1933, as amended (the 1933 Act); and
WHEREAS, the Trust desires to act as an investment vehicle for separate accounts established for variable life insurance policies and variable annuity contracts to be offered by insurance companies that have entered into participation agreements with the Trust (the Participating Insurance Companies); and
WHEREAS, the Trust has received an order from the Securities and Exchange Commission granting Participating Insurance Companies and their separate accounts exemptions from the provisions of Sections 9(a), 13(a), 15(a) and 15(b) of the 1940 Act, and Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the Trust to be sold to and held by variable annuity and variable life insurance separate accounts of both affiliated and unaffiliated life insurance companies and certain qualified pension and retirement plans (the Exemptive Order); and
WHEREAS, the Company has registered or will register (unless registration is not required under applicable law) certain variable life insurance policies and/or variable annuity contracts under the 1933 Act (the Contracts); and
WHEREAS, the Company has registered or will register each Account as a unit investment trust under the 1940 Act; and
WHEREAS, the Company desires to utilize the Shares of one or more Portfolios as an investment vehicle of the Accounts;
NOW, THEREFORE, in consideration of their mutual promises, the parties agree as follows:
ARTICLE I
Sale of Trust Shares
1.1 The Trust shall make Shares of its Portfolios listed on Schedule B available to the Accounts at the net asset value next computed after receipt of such purchase order by the Trust (or its agent), as established in accordance with the provisions of the then current prospectus of the Trust. Shares of a particular Portfolio of the Trust shall be ordered in such quantities and at such times as determined by the Company to be necessary to meet the requirements of the Contracts. The Trustees of the Trust (the Trustees) may refuse to sell Shares of any Portfolio to any person, or suspend or terminate the offering of Shares of any Portfolio if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Trustees acting in good faith and in light of their fiduciary duties under federal and any applicable state laws, necessary in the best interests of the shareholders of such Portfolio. With respect to payment of purchase price by the Company and of redemption proceeds by the Trust, the Company and the Trust shall remit gross purchase and sale orders with respect to each Portfolio and shall transmit one net payment per Portfolio in accordance with the provisions of this Article I.
1.2 The Trust will redeem any full or fractional Shares of any Portfolio when requested by the Company on behalf of an Account at the net asset value next computed after receipt by the Trust (or its agent) of the request for redemption, as established in accordance with the provisions of the then current prospectus of the Trust. The Trust shall make payment for such Shares in the manner established from time to time by the Trust, but in no event shall payment be delayed for a greater period than is permitted by the 1940 Act.
1.3 For the purposes of Sections 1.1 and 1.2, the Trust hereby appoints the Company as its agent for the limited purpose of receiving and accepting purchase and redemption orders resulting from investment in and payments under the Contracts. Receipt by the Company shall constitute receipt by the Trust provided that (i) such orders are received by the Company in good order prior to the time the net asset value of each Portfolio is priced in accordance with its prospectus and (ii) the Trust receives notice of such orders by 9:00 a.m. New York time on the next following Business Day. Business Day shall mean any day on which the New York Stock Exchange is open for trading and on which the Trust calculates its net asset value pursuant to the rules of the Securities and Exchange Commission.
1.4 Purchase orders that are transmitted to the Trust in accordance with Section 1.3 shall be paid for no later than 12:00 p.m. New York time on the same Business Day that the Trust receives notice of the order. Payments shall be made in federal funds transmitted by wire.
1.5 Issuance and transfer of the Trusts Shares will be by book entry only. Stock certificates will not be issued to the Company or the Account. Shares ordered from the Trust will
be recorded in the appropriate title for each Account or the appropriate subaccount of each Account.
1.6 The Trust shall furnish prompt notice to the Company of any income dividends or capital gain distributions payable on the Trusts Shares. The Company hereby elects to receive all such income dividends and capital gain distributions as are payable on a Portfolios Shares in additional Shares of that Portfolio. The Trust shall notify the Company of the number of Shares so issued as payment of such dividends and distributions.
1.7 The Trust shall make the net asset value per Share for each Portfolio available to the Company on a daily basis as soon as reasonably practical after the net asset value per Share is calculated. If the Trust provides the Company with materially incorrect share net asset value information, the Trust shall make an adjustment to the number of shares purchased or redeemed for the Accounts to reflect the correct net asset value per share. The Trust shall make the determination as to whether an error in net asset value has occurred and is a material error in accordance with its own internal policies, which are consistent with SEC materiality guidelines. Any material error in the calculation or reporting of net asset value per share, dividend or capital gains information shall be reported promptly upon discovery to the Company.
1.8 The Trust agrees that its Shares will be offered and sold only to (a) Participating Insurance Companies and their separate accounts and (b) certain qualified pension and retirement plans to the extent permitted by the Exemptive Order. The Trust and the Company agree that no Shares of any Portfolio will be sold directly to the general public. The Company further agrees that Trust Shares will be used only for the purposes of funding the Contracts and Accounts listed in Schedule A, as amended from time to time.
1.9 The Trust agrees that all Participating Insurance Companies shall have the obligations and responsibilities regarding pass-through voting and conflicts of interest corresponding to those contained in Section 2.8 and Article IV of this Agreement.
1.10 (a) All orders accepted by the Company shall be subject to the terms of the then current prospectus of each Portfolio, including without limitation, policies regarding excessive trading. The Company shall use its best efforts, and shall reasonably cooperate with, the Trust to enforce stated prospectus policies regarding transactions in Shares, particularly those related to excessive trading and short-term trading. The Company acknowledges that orders accepted by it in violation of the Trusts stated policies may be subsequently revoked or cancelled by the Trust and that the Trust shall not be responsible for any losses incurred by the Company or Contract or Account as a result of such cancellation. The Trust or its agent shall notify the Company of such cancellation prior to 12:00 p.m. New York time on the next Business Day after any such cancellation.
(b) The Company acknowledges and agrees that all orders for Shares are subject to acceptance or rejection by the Trust in its sole discretion and the Trust may, in its discretion and without notice, suspend or withdraw the sale of Shares of any Fund, including the sale of such Shares to the Company for the account of any Contract owner. In addition, the
Company acknowledges that the Trust has the right to refuse any purchase order for any reason, particularly if the Trust determines that a Portfolio would be unable to invest the money effectively in accordance with its investment policies or would otherwise be adversely affected due to the size of the transaction, frequency of trading by the account or other factors.
1.11 The Company certifies that it is following all relevant rules and regulations, as well as internal policies and procedures, regarding forward pricing and the handling of mutual fund orders on a timely basis. As evidence of its compliance, the Company shall:
(a) permit the Trust or its agent to audit its operations, as well as any books and records preserved in connection with its provision of services under this Agreement; or
(b) provide the Trust with the results of a Financial Intermediary Controls and Compliance Assessment (FICCA), a Statement on Standards for Attestation Engagements No. 16 (SSAE-16) review, or similar report of independent auditors upon request; or
(c) provide, upon request, certification to the Trust that it is following all relevant rules, regulations, and internal policies and procedures regarding forward pricing and the handling of mutual fund orders on a timely basis.
ARTICLE II
Obligations of the Parties
2.1 The Trust shall prepare and be responsible for filing with the Securities and Exchange Commission and any state regulators requiring such filing all shareholder reports, notices, proxy materials (or similar materials such as voting instruction solicitation materials), prospectuses and statements of additional information of the Trust. The Trust shall bear the costs of registration and qualification of its shares, preparation and filing of the documents listed in this Section 2.1 and all taxes to which an issuer is subject on the issuance and transfer of its shares.
2.2 At the option of the Company, the Trust shall either (a) provide the Company (at the Companys expense) with as many copies of the Trusts Shares current prospectus, annual report, semi-annual report and other shareholder communications, including any amendments or supplements to any of the foregoing, as the Company shall reasonably request; or (b) provide the Company with a camera ready copy of such documents in a form suitable for printing. The Trust shall provide the Company with a copy of the Shares statement of additional information in a form suitable for duplication by the Company. The Trust (at its expense) shall provide the Company with copies of any Trust-sponsored proxy materials in such quantity as the Company shall reasonably require for distribution to Contract owners.
2.3 (a) If the Company elects to print shareholder communications pursuant to 2.2(b) above, the Company shall bear the costs of printing the Trusts Shares prospectus, shareholder reports and other shareholder communications to owners of and applicants for policies for which Shares of the Trust are serving or are to serve as an investment vehicle, as well as the statement of additional information. The Company shall bear the costs of distributing such
prospectuses, statements of additional information, shareholder reports and other shareholder communications to policy owners and applicants. The Company shall bear the costs of distributing proxy materials (or similar materials such as voting solicitation instructions) to Contract owners. The Company assumes sole responsibility for ensuring that such materials are delivered to Contract owners in accordance with applicable federal and state securities laws.
(b) If the Company elects to include any materials provided by the Trust, specifically prospectuses, statements of additional information, shareholder reports and proxy materials, on its web site or in any other computer or electronic format, the Company assumes sole responsibility for maintaining such materials in the form provided by the Trust and for promptly replacing such materials with all updates provided by the Trust.
2.4 The Company agrees and acknowledges that Janus Henderson Group plc (Janus Henderson) or its affiliate is the sole owner of the name and mark Janus and/or Janus Henderson. All references contained in this Agreement to the name or mark Janus and/or Janus Henderson shall include but not be limited to the Janus Henderson logo, the website www.janushenderson.com and any and all electronic links relating to such website. Neither the Company, nor its affiliates, employees, or agents shall, without prior written consent of Janus Henderson, use the name or mark Janus and/or Janus Henderson, including any derivations thereof, or make representations regarding the Trust, Janus Henderson, or their affiliates, or any products or services sponsored, managed, advised, or administered by the Trust, Janus Henderson, or their affiliates, except those contained in the then-current Prospectus and the then-current printed sales literature for the Shares of the Portfolios. The Company will make no use of the name or mark Janus and/or Janus Henderson, including any derivations thereof, except as expressly provided in this Agreement or expressly authorized by Janus Henderson in writing. All goodwill associated with the name and mark Janus and/or Janus Henderson, including any derivations thereof, shall inure to the benefit of Janus Henderson or its affiliate. Upon termination of this Agreement for any reason, the Company shall immediately cease any and all use of any Janus and/or Janus Henderson mark(s).
2.5 At least annually, the Company shall furnish, or cause to be furnished, to the Trust or its designee, a copy of each Contract prospectus or statement of additional information in which the Trust or its investment adviser is named prior to the filing of such document with the Securities and Exchange Commission. Any references to the Trust, its investment adviser, or the Portfolio(s) within each Contract Prospectus or SAI shall be consistent with the then current prospectus of the Trust or Portfolio(s). Prior to first use, the Company shall furnish, or shall cause to be furnished, to the Trust or its designee, each piece of sales literature or other promotional material (together, the Marketing Material) in which the Trust or its investment adviser is named, at least fifteen (15) Business Days prior to its first use. No such Marketing Material shall be used if the Trust or its designee reasonably objects to such use within fifteen (15) Business Days after receipt of such Marketing Material. For avoidance of doubt, the Company need not provide for approval each additional piece of Marketing Materials that is of substantially the same type. Notwithstanding the foregoing, Company shall provide the Trust, for its review and approval, any Marketing Material that materially deviates from pre-approved Material.
2.6 The Company shall not give any information or make any representations or statements on behalf of the Trust or concerning the Trust or its investment adviser in connection with the sale of the Contracts other than information or representations contained in and accurately derived from the registration statement or prospectus for the Trust Shares (as such registration statement and prospectus may be amended or supplemented from time to time), reports of the Trust, Trust-sponsored proxy statements, or in sales literature or other promotional material approved by the Trust or its designee, except as required by legal process or regulatory authorities or with the written permission of the Trust or its designee.
2.7 The Trust shall not give any information or make any representations or statements on behalf of the Company or concerning the Company, the Accounts or the Contracts other than information or representations contained in and accurately derived from the registration statement or prospectus for the Contracts (as such registration statement and prospectus may be amended or supplemented from time to time), or in materials approved by the Company for distribution including sales literature or other promotional materials, except as required by legal process or regulatory authorities or with the written permission of the Company.
2.8 So long as, and to the extent that the Securities and Exchange Commission interprets the 1940 Act to require pass-through voting privileges for variable policyowners, the Company will provide pass-through voting privileges to owners of policies whose cash values are invested, through the Accounts, in shares of the Trust. The Trust shall require all Participating Insurance Companies to calculate voting privileges in the same manner and the Company shall be responsible for assuring that the Accounts calculate voting privileges in the manner established by the Trust. With respect to each Account, the Company will vote Shares of the Trust held by the Account and for which no timely voting instructions from policyowners are received as well as Shares it owns that are held by that Account, in the same proportion as those Shares for which voting instructions are received. The Company and its agents will in no way recommend or oppose or interfere with the solicitation of proxies for Trust shares held by Contract owners without the prior written consent of the Trust, which consent may be withheld in the Trusts sole discretion.
2.9 The Company has determined that the investment restrictions set forth in the current Trust prospectus are sufficient to comply with all investment restrictions under state insurance laws that are currently applicable to the Portfolios as a result of the Accounts investment therein. The Company shall notify the Trust of any additional applicable state insurance laws that restrict the Portfolios investments, or otherwise affect the operation of the Trust after the date of this Agreement.
ARTICLE III
Representations and Warranties
3.1 The Company represents and warrants that:
(a) it is an insurance company duly organized and in good standing under the laws of the State of Tennessee and that it has legally and validly established each Account as a
segregated asset account under such law on the date set forth in Schedule A;
(b) each Account has been registered or, prior to any issuance or sale of the Contracts, will be registered as a unit investment trust in accordance with the provisions of the 1940 Act;
(c) the Contracts or interests in the Accounts (1) are or, prior to issuance, will be registered as securities under the 1933 Act or, alternatively (2) are not registered because they are properly exempt from registration under the 1933 Act or will be offered exclusively in transactions that are properly exempt from registration under the 1933 Act. The Company further represents and warrants that the Contracts will be issued and sold in compliance in all material respects with all applicable federal and state laws; and the sale of the Contracts shall comply in all material respects with state insurance suitability requirements;
(d) it is, and shall carry out its activities under this Agreement, in compliance with all applicable anti-money laundering laws, rules and regulations including, but not limited to, the U.S.A. PATRIOT Act of 2001, P.L. 107-56 (Oct. 26, 2011). The Company further represents that it has policies and procedures in place to detect money laundering and terrorist financing, including as applicable the verification of identification, performing OFAC (Office of Foreign Assets Control) screening(s), and reporting of suspicious activity for beneficial owners; and
(e) The Company is a financial intermediary as defined by SEC Rule 22c-2 of the 1940 Act (The Rule), and has entered into an appropriate agreement with the Trust or one of its affiliates pursuant to the requirements of The Rule.
3.2 The Trust represents and warrants that:
(a) it is duly organized and validly existing under the laws of the State of Delaware;
(b) the Trust Shares offered and sold pursuant to this Agreement will be registered under the 1933 Act and the Trust shall be registered under the 1940 Act prior to any issuance or sale of such Shares. The Trust shall amend its registration statement under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its Shares. The Trust shall register and qualify its Shares for sale in accordance with the laws of the various states only if and to the extent deemed advisable by the Trust; and
(c) the investments of each Portfolio will comply with the diversification requirements set forth in Section 817(h) of the Internal Revenue Code of 1986, as amended, and the rules and regulations thereunder.
ARTICLE IV
Potential Conflicts
4.1 The parties acknowledge that the Trusts shares may be made available for investment to other Participating Insurance Companies. In such event, the Trustees will monitor the Trust for the existence of any material irreconcilable conflict between the interests of the contract owners of all Participating Insurance Companies. An irreconcilable material conflict may arise for a variety of reasons, including: (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling, no-action or interpretative letter, or any similar action by insurance, tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the investments of any Portfolio are being managed; (e) a difference in voting instructions given by variable annuity contract and variable life insurance contract owners; or (f) a decision by an insurer to disregard the voting instructions of contract owners. The Trustees shall promptly inform the Company if they determine that an irreconcilable material conflict exists and the implications thereof.
4.2 The Company agrees to promptly report any potential or existing conflicts of which it is aware to the Trustees. The Company will assist the Trustees in carrying out their responsibilities under the Exemptive Order by providing the Trustees with all information reasonably necessary for the Trustees to consider any issues raised including, but not limited to, information as to a decision by the Company to disregard Contract owner voting instructions.
4.3 If it is determined by a majority of the Trustees, or a majority of its disinterested Trustees, that a material irreconcilable conflict exists that affects the interests of Contract owners, the Company shall, in cooperation with other Participating Insurance Companies whose contract owners are also affected, at its expense and to the extent reasonably practicable (as determined by the Trustees) take whatever steps are necessary to remedy or eliminate the irreconcilable material conflict, which steps could include: (a) withdrawing the assets allocable to some or all of the Accounts from the Trust or any Portfolio and reinvesting such assets in a different investment medium, including (but not limited to) another Portfolio of the Trust, or submitting the question of whether or not such segregation should be implemented to a vote of all affected Contract owners and, as appropriate, segregating the assets of any appropriate group (i.e., annuity contract owners, life insurance contract owners, or variable contract owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected Contract owners the option of making such a change; and (b) establishing a new registered management investment company or managed separate account.
4.4 If a material irreconcilable conflict arises because of a decision by the Company to disregard Contract owner voting instructions and that decision represents a minority position or would preclude a majority vote, the Company may be required, at the Trusts election, to withdraw the affected Accounts investment in the Trust and terminate this Agreement with respect to such Account; provided, however that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the disinterested Trustees. Any such withdrawal and termination must take place within six (6) months after the Trust gives written notice that this provision is being implemented. Until the end of such six (6) month period, the Trust shall continue to accept and implement orders by the Company for the purchase and redemption of shares of the Trust.
4.5 If a material irreconcilable conflict arises because a particular state insurance
regulators decision applicable to the Company conflicts with the majority of other state regulators, then the Company will withdraw the affected Accounts investment in the Trust and terminate this Agreement with respect to such Account within six (6) months after the Trustees inform the Company in writing that it has determined that such decision has created an irreconcilable material conflict; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the disinterested Trustees. Until the end of such six (6) month period, the Trust shall continue to accept and implement orders by the Company for the purchase and redemption of Shares of the Trust.
4.6 For purposes of Sections 4.3 through 4.6 of this Agreement, a majority of the disinterested Trustees shall determine whether any proposed action adequately remedies any irreconcilable material conflict, but in no event will the Company be required to establish a new funding medium for the Contracts if an offer to do so has been declined by vote of a majority of Contract owners materially adversely affected by the irreconcilable material conflict. In the event that the Trustees determine that any proposed action does not adequately remedy any irreconcilable material conflict, then the Company will withdraw the Accounts investment in the Trust and terminate this Agreement within six (6) months after the Trustees inform the Company in writing of the foregoing determination; provided, however, that such withdrawal and termination shall be limited to the extent required by any such material irreconcilable conflict as determined by a majority of the disinterested Trustees.
4.7 The Company shall at least annually submit to the Trustees such reports, materials or data as the Trustees may reasonably request so that the Trustees may fully carry out the duties imposed upon them by the Exemptive Order, and said reports, materials and data shall be submitted more frequently if deemed appropriate by the Trustees.
4.8 If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Exemptive Order) on terms and conditions materially different from those contained in the Exemptive Order, then the Trust and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with Rules 6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such rules are applicable.
ARTICLE V
Indemnification
5.1 Indemnification By the Company. The Company agrees to indemnify and hold harmless the Trust and each of its Trustees, officers, employees and agents and each person, if any, who controls the Trust within the meaning of Section 15 of the 1933 Act (collectively, the Trust Indemnified Parties for purposes of this Article V) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the indemnified party) or expenses (including the reasonable costs of investigating or defending any alleged loss, claim, damage, liability or expense and reasonable legal counsel fees incurred in connection therewith) (collectively, Losses), to which the Trust Indemnified Parties may
become subject under any statute or regulation, or at common law or otherwise, insofar as such Losses:
(a) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in a registration statement or prospectus for the Contracts or in the Contracts themselves or in sales literature for the Trust generated or approved by the Company on behalf of the Contracts or Accounts (or any amendment or supplement to any of the foregoing) (collectively, the Company Documents for the purposes of this Article V), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this indemnity shall not apply as to any Trust Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and was accurately derived from written information furnished to the Company by or on behalf of the Trust for use in Company Documents or otherwise for use in connection with the sale of the Contracts or the Shares; or
(b) arise out of or result from statements or representations (other than statements or representations contained in and accurately derived from the Trust Documents as defined in Section 5.2(a)) or wrongful conduct of the Company or persons under its control, with respect to the sale or acquisition of the Contracts or the Shares; or
(c) arise out of or result from any untrue statement or alleged untrue statement of a material fact contained in the Trust Documents or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such statement or omission was made in reliance upon and accurately derived from written information furnished to the Trust by or on behalf of the Company; or
(d) arise out of or result from any failure by the Company to provide the services or furnish the materials required under the terms of this Agreement; or
(e) arise out of or result from any material breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Company.
5.2 Indemnification By the Trust. The Trust agrees to indemnify and hold harmless the Company and each of its directors, officers, employees and agents and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the Company Indemnified Parties for purposes of this Article V) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the indemnified party) or expenses (including the reasonable costs of investigating or defending any alleged loss, claim, damage, liability or expense and reasonable legal counsel fees incurred in connection therewith) (collectively, Losses), to which the Company Indemnified Parties may become subject under any statute or regulation, or at common law or otherwise, insofar as such Losses:
(a) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the registration statement or prospectus for the Trust (or any amendment or supplement thereto), (collectively, the Trust Documents for the purposes of this Article V), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this indemnity shall not apply as to any Company Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and was accurately derived from written information furnished to the Trust by or on behalf of the Company for use in the Trust Documents or otherwise for use in connection with the sale of the Contracts or the Shares; or
(b) arise out of or result from statements or representations (other than statements or representations contained in and accurately derived from the Company Documents) or wrongful conduct of the Trust or persons under its control, with respect to the sale or acquisition of the Contracts or the Shares; or
(c) arise out of or result from any untrue statement or alleged untrue statement of a material fact contained in the Company Documents or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such statement or omission was made in reliance upon and accurately derived from written information furnished to the Company by or on behalf of the Trust; or
(d) arise out of or result from any failure by the Trust to provide the services or furnish the materials required under the terms of this Agreement; or
(e) arise out of or result from any material breach of any representation and/or warranty made by the Trust in this Agreement or arise out of or result from any other material breach of this Agreement by the Trust.
5.3 Neither the Company nor the Trust shall be liable under the indemnification provisions of Sections 5.1 or 5.2, as applicable, with respect to any Losses incurred or assessed against an indemnified party that arise from such indemnified partys willful misfeasance, bad faith or negligence in the performance of such indemnified partys duties or by reason of such indemnified partys reckless disregard of obligations or duties under this Agreement.
5.4 Neither the Company nor the Trust shall be liable under the indemnification provisions of Sections 5.1 or 5.2, as applicable, with respect to any claim made against an indemnified party unless such indemnified party shall have notified the other party in writing within a reasonable time after the summons, or other first written notification, giving information of the nature of the claim shall have been served upon or otherwise received by such indemnified party (or after such indemnified party shall have received notice of service upon or other notification to any designated agent), but failure to notify the party against whom indemnification is sought of any such claim shall not relieve that party from any liability which it may have to the indemnified party in the absence of Sections 5.1 and 5.2.
5.5 In case any such action is brought against the indemnified parties, the
indemnifying party shall be entitled to participate, at its own expense, in the defense of such action. The indemnifying party also shall be entitled to assume the defense thereof, with counsel reasonably satisfactory to the party named in the action. After notice from the indemnifying party to the indemnified party of an election to assume such defense, the indemnified party shall bear the fees and expenses of any additional counsel retained by it, and the indemnifying party will not be liable to the indemnified party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.
ARTICLE VI
Termination
6.1 This Agreement may be terminated by either party for any reason by ninety (90) days advance written notice delivered to the other party.
6.2 Notwithstanding any termination of this Agreement, the Trust shall, at the option of the Company, continue to make available additional shares of the Trust (or any Portfolio) pursuant to the terms and conditions of this Agreement for all Contracts in effect on the effective date of termination of this Agreement, provided that the Company continues to pay the costs set forth in Section 2.3.
6.3 The provisions of Article V shall survive the termination of this Agreement, and the provisions of Article IV and Section 2.8 shall survive the termination of this Agreement as long as Shares of the Trust are held on behalf of Contract owners in accordance with Section 6.2.
ARTICLE VII
Notices
Any notice shall be sufficiently given when sent by registered or certified mail to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other party.
If to the Trust:
Janus Aspen Series
151 Detroit Street
Denver, Colorado 80206
Attention: Head of Legal U.S.
If to the Company:
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, Alabama 35223
Attention: Senior Vice President, Chief Product Officer
With a copy to:
Senior Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
ARTICLE VIII
Miscellaneous
8.1 The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
8.2 This Agreement may be executed simultaneously in two or more counterparts, each of which taken together shall constitute one and the same instrument. Counterparts may be executed in either original or electronically transmitted form (e.g., facsimile or emailed portable document format (PDF)), and the parties hereby adopt as original any signatures received via electronically transmitted form. Facsimile or electronic signatures will have the same legal effect as original signatures.
8.3 If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.
8.4 This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of State of Colorado.
8.5 The parties to this Agreement acknowledge and agree that all liabilities of the Trust arising, directly or indirectly, under this Agreement, of any and every nature whatsoever, shall be satisfied solely out of the assets of the Trust and that no Trustee, officer, agent or holder of shares of beneficial interest of the Trust shall be personally liable for any such liabilities.
8.6 Each party shall cooperate with each other party and all appropriate governmental authorities (including without limitation the Securities and Exchange Commission, the Financial Industry Regulatory Authority and state insurance regulators) and shall permit such authorities reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.
8.7 The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.
8.8 The parties to this Agreement acknowledge and agree that this Agreement shall not be exclusive in any respect.
8.9 Neither this Agreement nor any rights or obligations hereunder may be assigned
by either party without the prior written approval of the other party.
8.10 No provisions of this Agreement may be amended or modified in any manner except by a written agreement properly authorized and executed by both parties. Any delay in enforcing a partys rights under this Agreement, including the schedules to this Agreement, or any waiver as to a particular default or other matter shall not constitute a waiver of such partys rights to the future enforcement of its rights under this Agreement, except with respect to an express written and signed waiver relating to a particular matter for a particular period of time.
IN WITNESS WHEREOF, the parties have caused their duly authorized officers to execute this Participation Agreement as of the date and year first above written.
[signature page follows]
|
JANUS ASPEN SERIES |
||
|
|
||
|
By: |
|
|
|
Name: |
Byron Hittle |
|
|
Title: |
Interim Vice President, Secretary |
|
|
|
||
|
PROTECTIVE LIFE INSURANCE COMPANY |
||
|
|
||
|
By: |
|
|
|
Name: |
|
|
|
Title: |
|
|
Schedule A
Separate Accounts and Associated Contracts
Name of Separate Account |
|
Contracts Funded by Separate Account |
Protective COLI VUL Separate Account |
|
Protective® Executive Benefits Registered VUL |
Protective COLI PPVUL Separate Account |
|
Protective® Executive Benefits Private Placement VUL |
EXECUTION COPY
FUND PARTICIPATION AGREEMENT
This Fund Participation Agreement (the Agreement), effective as of December 11, 2020, is made by and among Protective Life Insurance Company_(Company), JPMorgan Insurance Trust (the Trust), and J. P. Morgan Investment Management Inc., the Trusts investment adviser in its role as investment adviser, the Adviser) and administrator (in its role as administrator, the Administrator).
WHEREAS, the Trust engages in business as an open-end management investment company and is available to act as the investment vehicle for separate accounts established by insurance companies for individual and group life insurance policies and annuity contracts with variable accumulation and/or pay-out provisions (hereinafter referred to individually and/or collectively as Variable Insurance Products);
WHEREAS, insurance companies desiring to utilize the Trust as an investment vehicle under their Variable Insurance Products are required to enter into participation agreements with the Trust and the Administrator (the Participating Insurance Companies);
WHEREAS, shares of the Trust are divided into several series of shares, each representing the interest in a particular managed portfolio of securities and other assets, any one or more of which may be made available for Variable Insurance Products of Participating Insurance Companies;
WHEREAS, the Trust intends to offer shares of the series set forth on Schedule B (each such series hereinafter referred to as a Portfolio) as may be amended from time to time by mutual agreement of the parties hereto under this Agreement to the accounts of the Company specified on Schedule A (hereinafter referred to individually as an Account, collectively, the Accounts);
WHEREAS, the Trust has obtained an order from the Securities and Exchange Commission, granting the Trust exemptions from the provisions of Sections 9(a), 13(a), 15(a), and 15(b) of the Investment Company Act of 1940, as amended (hereinafter the 1940 Act) and Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the Trust to be sold to and held by Variable Insurance Product separate accounts of both affiliated and unaffiliated insurance companies (hereinafter the Shared Funding Exemptive Order);
WHEREAS, the Trust is registered as an open-end management investment company under the 1940 Act and its shares are registered under the Securities Act of 1933, as amended (hereinafter the 1933 Act);
WHEREAS, the Adviser is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and any applicable state securities laws;
WHEREAS, the Adviser is the investment adviser of the Portfolios of the Trust;
WHEREAS, the Company has registered certain Variable Insurance Products under the 1933 Act or will not register the Variable Insurance Products in proper reliance upon an exemption from registration under the 1933 Act; and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, each Account intends to purchase shares of the Portfolios to fund certain of the aforesaid Variable Insurance Products and the Trust is authorized to sell such shares to each such Account at net asset value.
NOW, THEREFORE, in consideration of their mutual promises, the Company, the Trust, the Adviser, and the Administrator agree as follows:
Article 1
The Contracts
1. The Company represents that it has established each of the Accounts specified on Schedule A as a separate account under Tennessee law, and has registered each such Account as a unit investment trust under the 1940 Act to serve as an investment vehicle for variable annuity contracts and/ or variable life contracts offered by the Company (the Contracts) or will not register the Account in proper reliance upon an exclusion from registration under the 1940 Act. The Contracts provide for the allocation of net amounts received by the Company to separate divisions of the Accounts for investment in the shares of the Portfolios. Selection of a particular division is made by the Contract owner who may change such selection from time to time in accordance with the terms of the applicable Contract. The Company agrees to make every reasonable effort to market its Contracts. In marketing its Contracts, the Company will comply with all applicable state or Federal laws.
Article 2
Trust Shares
2.1. The Trust agrees to make available for purchase by the Company shares of the Portfolios and shall execute orders placed for each Account on a daily basis at the net asset value next computed after receipt by the Trust or its designee of such order. For purposes of this Section 2.1, the Company shall be the designee of the Trust for receipt of such orders from the Account and receipt by such designee shall constitute receipt by the Trust; provided that the Trusts designated transfer agent receives notice of such order by 10:00 a.m. Eastern Time on the next following Business Day (Trade Date plus 1). Notwithstanding the foregoing, the Company shall use its best efforts to provide the Trusts designated transfer agent with notice of such orders by 9:30 a.m. Eastern Time on Trade Date plus 1. Business Day shall mean any day on which the New York Stock Exchange is open for trading and on which the Trust calculates its net asset value pursuant to the rules of the Securities and Exchange Commission, as set forth in the Trusts prospectus and statement of additional information. Notwithstanding the foregoing, the Board of Trustees of the Trust (hereinafter the Board) may refuse to permit the Trust to sell shares of any Portfolio to any person, or suspend or terminate the offering of shares of any Portfolio if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Board acting in good faith and in light of their fiduciary duties under federal and any applicable state laws, necessary in the best interests of the shareholders of such Portfolio.
2.2. The Trust agrees that shares of the Trust will be sold only to Participating Insurance Companies for their Variable Insurance Products and, in the Trusts discretion, to qualified pension and retirement plans. No shares of any Portfolio will be sold to the general public.
2.3. The Trust agrees to redeem for cash, on the Companys request, any full or fractional shares of the Trust held by an Account, executing such requests on a daily basis at the net asset value next computed after receipt by the Trust or its designee of the request for redemption. For purposes of this Section 2.3, the Company shall be the designee of the Trust for receipt of requests for redemption from each Account and receipt by such designee shall constitute receipt by the Trust; provided that the Trusts designated transfer agent receives notice of such request for redemption on Trade Date plus 1 in accordance with the timing rules described in Section 2.1.
2.4. The Company agrees that purchases and redemptions of Portfolio shares offered by the then current prospectus of the Trust shall be made in accordance with the provisions of such prospectus. The Accounts of the Company, under which amounts may be invested in the Trust are listed on Schedule A attached hereto and incorporated herein by reference, as such Schedule A may be amended from time to time by mutual written agreement of all of the parties hereto.
2.5. The Company will place separate orders to purchase or redeem shares of each Portfolio. Each order shall describe the net amount of shares and dollar amount of each Portfolio to be purchased or redeemed. In the event of net purchases, the Company shall pay for Portfolio shares on Trade Date plus 1. Payment shall be in federal funds transmitted by wire. In the event of net redemptions, the Portfolio shall pay
the redemption proceeds in federal funds transmitted by wire by 2:00 p.m. Eastern Time on Trade Date plus 1. Notwithstanding the foregoing, if the payment of redemption proceeds on the next Business Day would require the Portfolio to dispose of Portfolio securities or otherwise incur substantial additional costs, and if the Portfolio has determined to settle redemption transactions for all shareholders on a delayed basis, proceeds shall be wired to the Company within seven (7) days and the Portfolio shall notify in writing the person designated by the Company as the recipient for such notice of such delay by 3:00 p.m. Eastern Time on Trade Date plus 1.
2.6. Issuance and transfer of the Trusts shares will be by book entry only. Share certificates will not be issued to the Company or any Account. Shares ordered from the Trust will be recorded in an appropriate title for each Account or the appropriate subaccount of each Account.
2.7. On each record date, the Administrator shall use its best efforts to furnish same day notice by 6:30 p.m. Eastern Time (by wire, telephone, electronic media or by fax) to the Company of any dividends or capital gain distributions payable on the Trusts shares. The Company hereby elects to receive all such dividends and capital gain distributions as are payable on the Portfolio shares in additional shares of that Portfolio. The Company reserves the right to revoke this election and to receive all such dividends and capital gain distributions in cash. The Trust shall notify the Company of the number of shares so issued as payment of such dividends and distributions.
2.8. The Administrator shall make the net asset value per share of each Portfolio available to the Company on a daily basis as soon as reasonably practical after the net asset value per share is calculated and shall use its best efforts to make such net asset value per share available by 7:00 p.m. Eastern Time. In the event that the Administrator is unable to meet the 7:00 p.m. time stated immediately above, then the Administrator shall provide the Company with additional time to notify the Administrator of purchase or redemption orders pursuant to Sections 2.1 and 2.3, respectively, above. Such additional time shall be equal to the additional time that the Administrator takes to make the net asset values available to the Company.
2.9. If the Administrator provides materially incorrect share net asset value information through no fault of the Company, the Company shall be entitled to an adjustment with respect to the Trust shares purchased or redeemed to reflect the correct net asset value per share as subsequently determined by the Administrator. The determination of the materiality of any net asset value pricing error shall be based on the Trusts policy for correction of pricing errors (the Pricing Policy). The Company shall correct such error in its records and in the records prepared by it for Contract owners in accordance with information provided by the Administrator. Any material error in the calculation or reporting of net asset value per share, dividend or capital gain information shall be reported promptly upon discovery to the Company.
2.10 The Administrator shall provide information to the Company of the amount of shares traded and the associated cost per share (NAV) total trade amount and the outstanding share balances held by the Account in each Portfolio as of the end of each Business Day. Such information will be furnished (electronically or by fax) by 1:00 p.m. Eastern time on the next Business Day.
2.11 Contract Owner Information
2.11(a) Agreement to Provide Information. Company agrees to provide the Fund, or its designee, upon written request, the taxpayer identification number (TIN), the Individual/International Taxpayer Identification Number (ITIN), or other government-issued identifier (GII), and the Contract owner number or participant account number associated with the Shareholder, if known, of any or all Shareholder(s) of the account, and the amount, date and transaction type (purchase, redemption, transfer, or exchange) of every purchase, redemption, transfer, or exchange of Shares held through an Insurance Company Fund Account maintained by the Company during the period covered by the request. Unless otherwise specifically requested by the Fund, the Intermediary shall only be required to provide information relating to Shareholder-Initiated Transfer Purchases or Shareholder-Initiated Transfer Redemptions.
(i) Period Covered by Request. Requests must set forth a specific period, not to exceed one year from the date of the request, for which transaction information is sought. A request may be ongoing and continuous (e.g., for each trading day throughout the year) or for specified periods of time. A Portfolio may request transaction information older than one year from the date of the request as it deems necessary to investigate compliance with policies established by the Portfolio for the purpose of eliminating or reducing market timing and abusive trading practices.
(ii) Form and Timing of Response. Company agrees to provide, promptly upon request of the Fund or its designee, the requested information specified in 2.11(a). If requested by the Fund, or its designee, Company agrees to use best efforts to determine promptly whether any specific person about whom it has received the identification and transaction information specified in 2.11(a) is itself a financial intermediary (indirect intermediary) and, upon further request of the Fund, or its designee, promptly either (i) provide (or arrange to have provided) the information set forth in 2.11(a) for those shareholders who hold an account with an indirect intermediary or (ii) restrict or prohibit the indirect intermediary from purchasing, in nominee name on behalf of other persons, securities issued by the Fund. Company additionally agrees to inform the Fund whether it plans to perform (i) or (ii). (b) Responses required by this paragraph must be communicated in writing and in a format mutually agreed upon by the Fund or its designee and the Company; and (c) To the extent practicable, the format for any transaction information provided to the Fund should be consistent with the NSCC Standardized Data Reporting Format.
(iii) Limitations on Use of Information. The Fund agrees not to use the information received pursuant to this Amendment for any purpose other than as necessary to comply with the provisions of Rule 22c-2 or to fulfill other regulatory or legal requirements subject to the privacy provisions of Title V of the Gramm-Leach-Bliley Act (Public Law 106-102) and comparable state laws.
2.11(b) Agreement to Restrict Trading. Company agrees to execute written instructions from the Fund to restrict or prohibit further purchases or exchanges of Shares by a Shareholder that has been identified by the Fund as having engaged in transactions of the Funds Shares (directly or indirectly through the Insurance Company Fund Account) that violate policies established by the Fund for the purpose of eliminating or reducing market timing and abusive trading practices. Unless otherwise directed by the Fund, any such restrictions or prohibitions shall only apply to Shareholder-Initiated Transfer Purchases or Shareholder-Initiated Transfer Redemptions that are effected directly or indirectly through Company. Instructions must be received by Company at the following address, or such other address that Company may communicate to the Fund in writing from time to time, including, if applicable, an e-mail and/or facsimile telephone number:
Dianne Samartzis
Dianne.Samartzis@protective.com
priority@protective.com this is the preferred email
1707 North Randall Road, Suite 310
Elgin, IL. 60123
Fax 205-268-4328
(i) Form of Instructions. Instructions to restrict or prohibit trading must include the TIN, ITIN, or GII and the specific individual Contract owner number or participant account number associated with the Shareholder, if known, and the specific restriction(s) to be executed, including how long the restriction(s) is(are) to remain in place. If the TIN, ITIN, GII or the specific individual contract owner number or participant account number associated with the Shareholder is not known, the instructions must include an equivalent identifying number of the Shareholder(s) or account(s) or other agreed upon information to which the instruction relates.
(ii) Timing of Response. Company agrees to execute instructions as soon as reasonably practicable, but not later than five Business Days after receipt of the instructions by the Company.
iii) Confirmation by Intermediary. Company must provide written confirmation to the Fund that instructions have been executed. Company agrees to provide confirmation as soon as reasonably practicable, but not later than ten business days after the instructions have been executed.
2.11 (c) Definitions. For purposes of this Section 2.11:
(i) The term Insurance Company Fund Account means an omnibus account with the Fund maintained by Company.
(ii) The term Fund includes JPMorgan Distribution Services, Inc., which is the Trusts principal underwriter; the Trusts transfer agent and the series of the Trust listed in the Agreement.
(iii) The term Shares means the interests of Shareholders corresponding to the redeemable securities of record issued by the Fund under the Investment Company Act that are held by or through an Insurance Company Fund Account.
(iv) The term Shareholder means the holder of interests in a variable annuity or variable life insurance contract issued by the Company (Contract), or a participant in an employee benefit plan with a beneficial interest in a Contract.
(v) The term Shareholder-Initiated Transfer Purchase means a transaction that is initiated or directed by a Shareholder that results in a transfer of assets within a Contract to a Fund, but does not include transactions that are executed: (a) automatically pursuant to a contractual or systematic program or enrollment such as transfer of assets within a Contract to a Fund as a result of dollar cost averaging programs, insurance company approved asset allocation programs, or automatic rebalancing programs; (b) pursuant to a Contract death benefit; (c) one-time step-up in Contract value pursuant to a Contract death benefit; (d) allocation of assets to a Fund through a Contract as a result of payments such as loan repayments, scheduled contributions, retirement plan salary reduction contributions, or planned premium payments to the Contract; or (e) pre- arranged transfers at the conclusion of a required free look period.
(vi) The term Shareholder-Initiated Transfer Redemption means a transaction that is initiated or directed by a Shareholder that results in a transfer of assets within a Contract out of a Fund, but does not include transactions that are executed: (a) automatically pursuant to a contractual or systematic program or enrollments such as transfers of assets within a Contract out of a Fund as a result of annuity payouts, loans, systematic withdrawal programs, insurance company approved asset allocation programs and automatic rebalancing programs; (b) as a result of any deduction of charges or fees under a Contract; (c) within a Contract out of a Fund as a result of scheduled withdrawals or surrenders from a Contract; or (d) as a result of payment of a death benefit from a Contract.
(vii) The term written and/or in writing within this Section 2.11 or any Section of this Agreement includes electronic writings and facsimile transmissions.
(viii) The term Financial Intermediary shall mean a financial intermediary as defined in 22c-2 of the Investment Company Act.
(ix) The term purchase does not include the automatic reinvestment of dividends.
(x) The term promptly as used in 2.11(a)(ii) shall mean as soon as practicable but in no event later than 10 business days from the Companys receipt of the request for information from the Fund or its designee.
Article 3
Prospectuses, Reports to Shareholders and Proxy Statements, Voting
3.1. The Trust shall provide the Company with as many printed copies of the Trusts current prospectuses as the Company may reasonably request. The Administrator will provide the Company with a copy of the statement of additional information suitable for duplication. If requested by the Company, in lieu of providing printed copies, the Trust shall provide camera-ready film or computer diskettes containing the Trusts prospectuses and statement of additional information in order for the Company once each year (or more frequently if the prospectuses and/or statement of additional information for the Trust is amended during the year) to have the prospectuses for the Contracts and the applicable Trust prospectuses printed together in one document or separately. The Company may elect to print the Trusts prospectuses and/or its statement of additional information in combination with other investment companies prospectuses and statements of additional information.
3.2(a). The Company will deliver or cause to be delivered to each of its Contract owners, at or prior to the time of purchase of any Portfolio shares, a copy of such Portfolios prospectus and, upon request, a copy of its statement of additional information. For prospectuses and statements of additional information provided by the Company to its existing owners of Contracts in order to update disclosure as required by the 1933 Act and/or the 1940 Act, the cost of setting in type, printing and distributing shall be borne by the Trust. If the Company chooses to receive camera-ready film or computer diskettes in lieu of receiving printed copies of the Trusts prospectus and/or statement of additional information, the Trust shall bear the cost of typesetting to provide the Trusts prospectus and/or statement of additional information to the Company in the format in which the Trust is accustomed to formatting prospectuses and statements of additional information, respectively, and the Company shall bear the expense of adjusting or changing the format to conform with any of its prospectuses and/or statements of additional information. In such event, the Trust will reimburse the Company in an amount equal to the product of x and y where x is the number of such prospectuses distributed to owners of the Contracts, and y is the Trusts per unit cost of printing the Trusts prospectuses. The same procedures shall be followed with respect to the Trusts statement of additional information. The Trust shall not pay any costs of typesetting, printing and distributing the Trusts prospectus and/or statement of additional information to prospective Contract owners. Except as otherwise provided in this Section 3.2, all expenses of preparing, setting in type and printing and distributing Trust prospectuses and statements of additional information shall be the expense of the Company.
3.2(b). The Trust, at the Companys expense, shall provide the Company with copies of Annual and Semi-Annual Reports (the Reports) in such quantity as the Company shall reasonably require for distributing to Contract owners. The Trust, at its expense, shall provide the Contract owners designated by the Company with copies of its proxy statements and other communications to shareholders (except for prospectuses and statements of additional information, which are covered in Section 3.2(a) above, and Reports). The Trust shall not pay any costs of distributing Reports and other communications to prospective Contract owners.
3.2(c). The Company agrees to provide the Trust or its designee with such information as may be reasonably requested by the Trust to assure that the Trusts expenses do not include the cost of typesetting, printing or distributing any of the foregoing documents other than those actually distributed to existing Contract owners.
3.2(d). Except as otherwise provided in this Agreement, the Trust shall pay no fee, other compensation or other expenses under this Agreement. The Trust may, however, pay the Company servicing fees under a written servicing agreement for certain Portfolios pursuant to the services plan it has adopted. In addition, the Trust has adopted a plan pursuant to Rule 12b-1 to finance distribution expenses for certain Portfolios, and the Trusts distributor may pay fees under such plan to the Company or to a designated affiliate under a separate written agreement between such parties.
3.2(e). All expenses, including expenses to be borne by the Trust pursuant to Section 3.2 hereof, incident to performance by the Trust under this Agreement shall be paid by the Trust. The Trust shall see to it that all its shares are registered and authorized for issuance in accordance with applicable federal law and, if
and to the extent deemed advisable by the Trust, in accordance with applicable state laws prior to their sale. The Trust shall bear the expenses for the cost of registration and qualification of the Trusts shares.
3.2(f). To the extent the parties hereto desire to make use of summary prospectuses under Rule 498 of the 1933 Act, each agrees to do so in accordance with the terms set forth in Schedule C.
3.3. If and to the extent required by law, the Company shall with respect to proxy material distributed by the Trust to Contract owners designated by the Company to whom voting privileges are required to be extended:
(i) solicit voting instructions from Contract owners;
(ii) vote the Trust shares in accordance with instructions received from Contract owners; and
(iii) vote Trust shares for which no instructions have been received in the same proportion as Trust shares of such Portfolio for which instructions have been received, so long as and to the extent that the Securities and Exchange Commission continues to interpret the 1940 Act to require pass-through voting privileges for variable contract owners.
The Company reserves the right to vote Trust shares held in any segregated asset account in its own right, to the extent permitted by law.
Article 4
Sales Material and Information
4.1. The Company shall furnish, or shall cause to be furnished, to the Trust, the Adviser or their designee, drafts of the separate accounts prospectuses and statements of additional information and each piece of sales literature or other promotional material prepared by the Company or any person contracting with the Company to prepare such material in which the Trust, the Adviser or the Administrator is described, at least ten Business Days prior to its use. No such material shall be used if the Trust, the Adviser, the Administrator or their designee reasonably objects to such use within ten Business Days after receipt of such material.
4.2. Neither the Company nor any person contracting with the Company to prepare sales literature or other promotional material shall give any information or make any representations or statements on behalf of the Trust or concerning the Trust in connection with the sale of the Contracts other than the information or representations contained in the registration statement or Trust prospectus, as such registration statement or Trust prospectus may be amended or supplemented from time to time, or in reports to shareholders or proxy statements for the Trust, or in sales literature or other promotional material approved by the Trust or its designee, except with the permission of the Trust or its designee.
4.3. The Administrator shall furnish, or shall cause to be furnished, to the Company or its designee, each piece of sales literature or other promotional material prepared by the Trust in which the Company or its Accounts, are described at least ten Business Days prior to its use. No such material shall be used if the Company or its designee reasonably objects to such use within ten Business Days after receipt of such material.
4.4. Neither the Trust, the Administrator, nor the Adviser shall give any information or make any representations on behalf of the Company or concerning the Company, each Account, or the Contracts, other than the information or representations contained in a registration statement or prospectus for the Contracts, as such registration statement or prospectus may be amended or supplemented from time to time, or in published reports or solicitations for voting instruction for each Account which are in the public domain or approved by the Company for distribution to Contract owners, or in sales literature or other promotional material approved by the Company or its designee, except with the permission of the Company.
4.5. The Trust will provide to the Company, upon its request, at least one complete copy of all registration statements, prospectuses, statements of additional information, reports, proxy statements, and all amendments to any of the above, that relate to the Trust or its shares, promptly after the filing of such document with the Securities and Exchange Commission or other regulatory authorities.
4.6. The Company will provide to the Trust, upon the Trusts request, at least one complete copy of all registration statements, prospectuses, statements of additional information, reports, solicitations for voting instructions, sales literature and other promotional materials, applications for exemptions, requests for no action letters, and all amendments to any of the above, that relate to the investment in an Account or Contract promptly after the filing of such documents with the Securities and Exchange Commission or other regulatory authorities.
4.7. For purposes of this Article 4, the phrase sales literature or other promotional material includes, but is not limited to, any of the following: advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, internet, telephone or tape recording, videotape, display, signs or billboards, motion pictures, or other public media), sales literature (i.e., any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), and educational or training materials or other communications distributed or made generally available to some or all agents or employees.
4.8. The Company and its agents shall make no representations concerning the Trust except those contained in the then-current prospectus and statement of additional information of the Trust and in current printed sales literature of the Trust.
Article 5
Administrative Services to Contract Owners
5. Administrative services to Contract owners shall be the responsibility of the Company and shall not be the responsibility of the Trust, the Adviser or the Administrator. The Company, the Trust and the Administrator recognize that the Account(s) will be the sole shareholder(s) of Trust shares issued pursuant to the Contracts.
Article 6
Representations and Warranties
6.1. The Trust represents that it believes, in good faith, that each Portfolio is currently qualified as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the Code) and that it will make every effort to maintain such qualification of the Trust and that it will notify the Company immediately upon having a reasonable basis for believing that a Portfolio has ceased to so qualify or that it might not so qualify in the future.
6.2. The Company represents that it believes, in good faith, that the Contracts will at all times be treated as annuity contracts under applicable provisions of the Code, and that it will make every effort to maintain such treatment and that it will notify the Trust immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future.
6.3. The Trust represents that it believes, in good faith, that the Portfolios will at all times comply with the diversification requirements set forth in Section 817(h) of the Code and Section 1.817-5(b) of the regulations under the Code, and that it will make every effort to maintain the Trusts compliance with such diversification requirements, and that it will notify the Company immediately upon having a reasonable basis for believing that a Fund has ceased to so qualify or that a Portfolio might not so qualify in the future. Within 60 days of the end of the preceding calendar quarter, the Trust shall use its best efforts to provide the Company with a certificate of compliance with Section 817(h) during that quarter. Notwithstanding the foregoing, any failure to provide such certification of compliance within the time period described will not constitute a breach of this agreement.
6.4. The Company represents and warrants that the interests of the Contracts are or will be registered unless exempt and that it will maintain such registration under the 1933 Act and the regulations thereunder to the extent required by the 1933 Act and that the Contracts will be issued and sold in compliance with all applicable federal and state laws and regulations. The Company also represents and warrants that the Portfolios will be sold in accordance with such Portfolios current prospectus. The Company further represents and warrants that it is an insurance company duly organized and in good standing under applicable law and that it has legally and validly established each Account prior to any issuance or sale thereof as a segregated asset account under the TennesseeInsurance Code and the regulations thereunder and has registered or, prior to any issuance or sale of the Contracts, will maintain the registration of each Account as a unit investment trust in accordance with and to the extent required by the provisions of the 1940 Act and the regulations thereunder, unless exempt therefrom, to serve as a segregated investment account for the Contracts. The Company shall amend its registration statement for its Contracts under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its Contracts.
6.5. The Company represents that it believes, in good faith, that the Account is a segregated asset account and that interests in the Account are offered exclusively through the purchase of a variable contract, within the meaning of such terms under Section 1.817-5(f)(2) of the regulations under the Code, and that it will make every effort to continue to meet such definitional requirements, and that it will notify the Trust immediately upon having a reasonable basis for believing that such requirements have ceased to be met or that they might not be met in the future.
6.6. The Trust represents and warrants that it is and shall continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Trust in an amount no less than the minimal coverage as required currently by Rule 17g-(1) of the 1940 Act or related provisions as may be promulgated from time to time. Such bond shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company. The Trust will notify the Company immediately upon having a reasonable basis for believing that the Trust no longer has the coverage required by this Section 6.6.
6.7. The Company represents and warrants that all of its directors, officers, employees, investment advisers, and other entities dealing with the money or securities of the Trust are and shall continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Trust, in an amount not less than five million dollars ($5,000,000). Such bond shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company. The Company agrees to make all reasonable efforts to see that this bond or another bond containing these provisions is always in effect and agrees to notify the Trust immediately upon having a reasonable basis for believing that the Company no longer has the coverage required by this Section 6.7.
6.8. The Trust represents that a majority of its disinterest trustees have approved the Trusts distribution plan adopted pursuant to Rule 12b-1 under the 1940 Act.
6.9. The Adviser and the Administrator each represents and warrants that it complies with all applicable federal and state laws and regulations and that it will perform its obligations for the Trust and the Company in compliance with the laws and regulations of its state of domicile and any applicable state and federal laws and regulations.
Article 7
Statements and Reports
7.1. The Administrator or its designee will make available electronically to the Company within five (5) Business Days after the end of each month a monthly statement of account confirming all transactions made during that month in the Account.
7.2. The Trust and Administrator agree to provide the Company no later than March 1 of each year with the investment advisory and other expenses of the Trust incurred during the Trusts most recently completed fiscal year, to permit the Company to fulfill its prospectus disclosure obligations under the SECs variable annuity fee table requirements.
Article 8
Potential Conflicts
8.1. If required under the Shared Funding Exemptive Order, the Board will monitor the Trust for the existence of any material irreconcilable conflict between the interests of the Contract owners of all Accounts investing in the Trust. An irreconcilable material conflict may arise for a variety of reasons, including: (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling, no-action or interpretative letter, or any similar action by insurance, tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the investments of any Portfolio are being managed; (e) a difference in voting instructions given by variable annuity contract owners and variable life insurance Contract owners; or (f) a decision by a Participating Insurance Company to disregard the voting instructions of contract owners. The Board shall promptly inform the Company if it determines that an irreconcilable material conflict exists and the implications thereof.
8.2. If required under the Shared Funding Exemptive Order, the Company will report in writing any potential or existing material irreconcilable conflict of which it is aware to the Administrator. Upon receipt of such report, the Administrator shall report the potential or existing material irreconcilable conflict to the Board. The Administrator shall also report to the Board on a quarterly basis whether the Company has reported any potential or existing material irreconcilable conflicts during the previous calendar quarter. The Company will assist the Board in carrying out its responsibilities under the Shared Funding Exemptive Order, by providing the Board with all information reasonably necessary for the Board to consider any issues raised. This includes, but is not limited to, an obligation by the Company to inform the Board whenever Contract owner voting instructions are disregarded.
8.3. If required under the Shared Funding Exemptive Order, and it is determined by a majority of the Board, or a majority of its disinterested trustees, that a material irreconcilable conflict exists, the Company and other Participating Insurance Companies shall, at their expense and to the extent reasonably practicable (as determined by a majority of the disinterested trustees), take whatever steps are necessary to remedy or eliminate the irreconcilable material conflict, up to and including: (1) withdrawing the assets allocable to some or all of the separate accounts from the Trust or any Portfolio and reinvesting such assets in a different investment medium, including (but not limited to) another Portfolio of the Trust, or submitting the question whether such segregation should be implemented to a vote of all affected Contract owners and, as appropriate, segregating the assets of any appropriate group (i.e., annuity contract owners, life insurance policy owners, or variable contract owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected Contract owners the option of making such a change; and (2) establishing a new registered management investment company or managed separate account. No charge or penalty will be imposed as a result of such withdrawal. The Company agrees that it bears the responsibility to take remedial action in the event of a Board determination of an irreconcilable material conflict and the cost of such remedial action, and these responsibilities will be carried out with a view only to the interests of Contract owners.
8.4. If required under the Shared Funding Exemptive Order, if a material irreconcilable conflict arises because of a decision by the Company to disregard Contract owner voting instructions and that decision represents a minority position or would preclude a majority vote, the Company may be required, at the Trusts election, to withdraw the affected Accounts investment in the Trust and terminate this Agreement with respect to such Account (at the Companys expense); provided, however that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the disinterested members of the Board. No charge or penalty will be imposed as a result of such withdrawal. The Company agrees that it bears the responsibility to take remedial action in the event of a Board
determination of an irreconcilable material conflict and the cost of such remedial action, and these responsibilities will be carried out with a view only to the interests of Contract owners.
8.5. If required under the Shared Funding Exemptive Order, for purposes of Sections 8.3 through 8.4 of this Agreement, a majority of the disinterested members of the Board shall determine whether any proposed action adequately remedies any irreconcilable material conflict, but in no event will the Trust be required to establish a new funding medium for the Contracts. The Company shall not be required by Section 8.3 through 8.4 to establish a new funding medium for the Contracts if an offer to do so has been declined by vote of a majority of Contract owners materially adversely affected by the irreconcilable material conflict.
8.6. If required under the Shared Funding Exemptive Order, and to the extent that Rule 6e-2 and Rule 6e-3(T) under the 1940 Act are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Shared Funding Exemptive Order) on terms and conditions materially different from those contained in the Shared Funding Exemptive Order, then the Trust and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with Rules 6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such rules are applicable.
8.7. If required under the Shared Funding Exemptive Order, each of the Company and the Adviser shall at least annually submit to the Board such reports, materials or data as the Board may reasonably request so that the Board may fully carry out the obligations imposed upon them by the provisions hereof and in the Shared Funding Exemptive Order, and said reports, materials and data shall be submitted more frequently if deemed appropriate by the Board. Without limiting the generality of the foregoing or the Companys obligations under Section 8.2, the Company shall provide to the Administrator a written report to the Board no later than January 15th of each year indicating whether any material irreconcilable conflicts have arisen during the prior fiscal year of the Trust. All reports received by the Board of potential or existing conflicts, and all Board action with regard to determining the existence of a conflict, notifying Participating Insurance Companies of a conflict, and determining whether any proposed action adequately remedies a conflict, shall be properly recorded in the minutes of the Board or other appropriate records, and such minutes or other records shall be made available to the Securities and Exchange Commission upon request.
Article 9
Indemnification
9.1. Indemnification By The Company
9.1 (a). The Company agrees to indemnify and hold harmless the Trust, the Administrator, the Adviser, and each member of their respective Boards and officers and each person, if any, who controls the Trust within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 9.1) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Company) or litigation (including legal and other expenses), to which the Indemnified Parties may become subject under any statute, regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Trusts shares or the Contracts and:
(i) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the registration statement or prospectus for the Contracts or contained in the Contracts or sales literature for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Company by or on behalf of the Trust for use in the registration statement or prospectus for the Contracts or in the Contracts or sales literature (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Trust shares; or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus or sales literature of the Trust not supplied by the Company, or persons under its control and other than statements or representations authorized by the Trust) or unlawful conduct of the Company or persons under its control, with respect to the sale or distribution of the Contracts or Trust shares; or
(iii) arise out of or as a result of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, or sales literature of the Trust or any amendment thereof or supplement thereto or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such a statement or omission was made in reliance upon and in conformity with information furnished to the Trust by or on behalf of the Company; or
(iv) arise as a result of any failure by the Company to provide the services and furnish the materials under the terms of this Agreement; or
(v) arise out of or result from any material breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Company; as limited by and in accordance with the provisions of Section 9.1(b) and 9.1(c) hereof.
9.1(b). The Company shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified Party as such may arise from such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement.
9.1(c). The Company shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Company in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Company of any such claim shall not relieve the Company from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Company shall be entitled to participate, at as own expense, in the defense of such action. The Company also shall be entitled to assume the defense thereof, with counsel satisfactory to the Indemnified Party named in the action. After notice from the Company to such Indemnified Party of the Companys election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Company shall not be liable to such Indemnified Party under this Agreement for any legal or other expenses subsequently incurred by such Indemnified Party independently in connection with the defense thereof other than reasonable costs of investigation.
9.1(d). The Indemnified Parties will promptly notify the Company of the commencement of any litigation or proceedings against them in connection with the issuance or sale of the Trust shares or the Contracts or the operation of the Trust.
9.2. Indemnification by Administrator
9.2(a). The Administrator agrees to indemnify and hold harmless the Company and each of its directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 9.2) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Administrator) or litigation (including legal and other expenses) to which the Indemnified Parties may become subject under any statute, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement or prospectus or sales literature of the Trust (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Trust or the Administrator by or on behalf of the Company, the Adviser, Counsel for the Trust, the independent public accountant to the Trust, or any person or entity that is not acting as agent for or controlled by the Administrator for use in the registration statement or prospectus for the Trust or in sales literature (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Portfolio shares; or
(ii) arise out of or as a result of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, or sales literature covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished to the Company by or on behalf of the Administrator; or
(iii) arise as a result of any failure by the Administrator to provide the services and furnish the materials under the terms of this Agreement; or
(iv) arise out of or result from any material breach of any representation and/or warranty made by the Administrator in this Agreement or arise out of or result from any other material breach of this Agreement by the Administrator; as limited by and in accordance with the provisions of Section 9.2(b) and 9.2(c) hereof.
9.2(b). The Administrator shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified Party as such may arise from such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement.
9.2(c). The Administrator shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Administrator in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Administrator of any such claim shall not relieve the Administrator from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Administrator will be entitled to participate, at its own expense, in the defense thereof. The Administrator also shall be entitled to assume the defense thereof, with counsel satisfactory to the Indemnified Party named in the action. After notice from the Administrator to such Indemnified Party of the Administrators election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Administrator will not be liable to such Indemnified Party under this Agreement for any legal or other expenses subsequently incurred by such Indemnified Party independently in connection with the defense thereof other than reasonable costs of investigation.
9.2(d). The Company agrees promptly to notify the Administrator of the commencement of any litigation or proceedings against it or any of its Indemnified Parties in connection with the issuance or sale of the Contracts or the operation of each Account in which the Portfolios are made available.
9.3. Indemnification by the Adviser
9.3(a). The Adviser agrees to indemnify and hold harmless the Company and its directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (hereinafter collectively, the Indemnified Parties and individually, Indemnified Party, for purposes of this Section 9.3) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Adviser) or litigation (including legal and other expenses) to which the Indemnified Parties may become subject under any statute, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement or prospectus or sales literature of the Trust (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Adviser or the Trust by or on behalf of the Company, the Administrator, Counsel for the Trust, the independent public accountant to the Trust, or any person or entity that is not acting as agent for or controlled by the Adviser for use in the registration statement or prospectus for the Trust or in sales literature (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Portfolio shares; or
(ii) arise out of or as a result of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, or sales literature covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished to the Company by or on behalf of the Adviser; or
(iii) arise as a result of any failure by the Adviser to provide the services and furnish the materials under the terms of this Agreement; or
(iv) arise out of or result from any material breach of any representation and/or warranty made by the Adviser in this Agreement or arise out of or result from any other material breach of this Agreement by the Adviser; as limited by and in accordance with the provisions of Section 9.3(b) and 9.3(c) hereof.
9.3(b). The Adviser shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified Party as may arise from such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement.
9.3(c). The Adviser shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Adviser in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Adviser of any such claim shall not relieve the Adviser from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Adviser will be entitled to participate, at its own expense, in the defense thereof. The Adviser also shall be entitled to assume the defense thereof, with counsel satisfactory to the Indemnified Party named in the action. After notice from the Adviser to such Indemnified Party of the
Advisers election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Adviser will not be liable to such Indemnified Party under this Agreement for any legal or other expenses subsequently incurred by such Indemnified Party independently in connection with the defense thereof other then reasonable costs of investigation.
9.3(d). The Company agrees to promptly notify the Adviser of the commencement of any litigation or proceedings against it or any of Indemnified Parties in connection with this Agreement, the issuance or sale of the Contracts, with respect to the operation of each Account, or the sale or acquisition of shares of the Trust.
9.4. Indemnification by the Trust
9.4(a). The Trust agrees to indemnify and hold harmless the Company and its directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (hereinafter collectively, the Indemnified Parties and individually, Indemnified Party, for purposes of this Section 9.4) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Trust) or litigation (including legal and other expenses) to which the Indemnified Parties may become subject under any statute, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement or prospectus or sales literature of the Trust (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished the Trust by or on behalf of the Adviser, the Company, or the Administrator for use in the registration statement or prospectus for the Trust or in sales literature (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Portfolio shares; or
(ii) arise out of or as a result of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, or sales literature covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished to the Company by or on behalf of the Trust; or
(iii) arise as a result of any failure by the Trust to provide the services and furnish the materials under the terms of this Agreement; or
(iv) arise out of or result from any material breach of any representation and/or warranty made by the Trust in this Agreement or arise out of or result from any other material breach of this Agreement by the Trust; as limited by and in accordance with the provisions of Section 9.4(b) and 9.4(c) hereof.
9.4(b). The Trust shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified Party as may arise from such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement.
9.4(c). The Trust shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Trust in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received
notice of such service on any designated agent), but failure to notify the Trust of any such claim shall not relieve the Trust from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Trust will be entitled to participate, at its own expense, in the defense thereof. The Trust also shall be entitled to assume the defense thereof, with counsel satisfactory to the Indemnified Party named in the action. After notice from the Trust to such Indemnified Party of the Trusts election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Trust will not be liable to such Indemnified Party under this Agreement for any legal or other expenses subsequently incurred by such Indemnified Party independently in connection with the defense thereof other than reasonable costs of investigation.
9.4(d). The Company agrees to promptly notify the Trust of the commencement of any litigation or proceedings against it or any of the Indemnified Parties in connection with this Agreement, the issuance or sale of the Contracts, with respect to the operation of each Account, or the sale or acquisition of shares of the Trust.
Article 10
Applicable Law
10.1. This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of The Commonwealth of Massachusetts.
10.2. This Agreement shall be subject to the provisions of the 1933, 1934 and 1940 Acts, and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the Securities and Exchange Commission may grant (including, but not limited to, the Shared Funding Exemptive Order) and the terms hereof shall be interpreted and construed in accordance therewith.
Article 11
Termination
11.1. This Agreement shall continue in full force and effect until the first to occur of:
(a) termination by any party for any reason upon ninety days advance written notice delivered to the other parties; or
(b) termination by the Company by written notice to the Trust, the Adviser, and the Administrator with respect to any Portfolio based upon the Companys determination that shares of such Portfolio are not reasonably available to meet the requirements of the Contracts. Reasonable advance notice of election to terminate shall be furnished by the Company, said termination to be effective ten (10) days after receipt of notice unless the Trust makes available a sufficient number of shares to reasonably meet the requirements of the Account within said ten (10) day period; or
(c) termination by the Company upon written notice to the Trust, the Adviser, and the Administrator with respect to any Portfolio in the event any of the Portfolios shares are not registered, issued or sold in accordance with applicable state and/or federal law or such law precludes the use of such shares as the underlying investment medium of the Contracts issued or to be issued by the Company. The terminating party shall give prompt notice to the other parties of its decision to terminate; or
(d) termination by the Company upon written notice to the Trust, the Adviser and the Administrator with respect to any Portfolio in the event that such portfolio ceases to qualify as a Regulated Investment Company under Subchapter M of the Code or under any successor or similar provision; or
(e) termination by the Company upon written notice to the Trust, the Adviser, and the Administrator with respect to any Portfolio in the event that such Portfolio fails to meet the diversification requirements specified in Section 6.3 hereof; or
(f) termination by either the Trust, the Adviser, or the Administrator by written notice to the Company, if either one or more of the Trust, the Adviser, or the Administrator, shall determine, in its or their sole judgment exercised in good faith, that the Company and/or their affiliated companies has suffered a material adverse change in its business, operations, financial condition or prospects since the date of this Agreement or is the subject of material adverse publicity, provided that the Trust, the Adviser, or the Administrator will give the Company sixty (60) days advance written notice of such determination of its intent to terminate this Agreement, and provided further that after consideration of the actions taken by the Company and any other changes in circumstances since the giving of such notice, the determination of the Trust, the Adviser, or the Administrator shall continue to apply on the 60th day since giving of such notice, then such 60th day shall be the effective date of termination; or
(g) termination by the Company by written notice to the Trust, the Adviser, or the Administrator, if the Company shall determine, in its sole judgment exercised in good faith, that either the Trust, the Adviser, or the Administrator has suffered a material adverse change in its business, operations, financial condition or prospects since the date of this Agreement or is the subject of material adverse publicity, provided that the Company will give the Trust, the Adviser, and the Administrator sixty (60) days advance written notice of such determination of its intent to terminate this Agreement, and provided further that after consideration of the actions taken by the Trust, the Adviser, or the Administrator and any other changes in circumstances since the giving of such notice, the determination of the Company shall continue to apply on the 60th day since giving of such notice, then such 60th day shall be the effective date of termination; or
(h) termination by any party upon the other partys breach of any representation or any material breach of any provision of this Agreement, which breach has not been cured to the satisfaction of the terminating party within ten (10) days after written notice of such breach is delivered to the Trust or the Company, as the case may be; or
(i) termination by the Trust, the Adviser, or Administrator by written notice to the Company in the event an Account or Contract is not registered (unless exempt from registration) or sold in accordance with applicable federal or state law or regulation, or the Company fails to provide pass-through voting privileges as specified in Section 3.3.
11.2. Effect of Termination. Notwithstanding any termination of this Agreement, the Trust may continue to make available additional shares of the Trust pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as Existing Contracts) unless such further sale of Trust shares is proscribed by law, regulation or applicable regulatory body, or unless the Trust determines that liquidation of the Trust following termination of this Agreement is in the best interests of the Trust and its shareholders. The parties agree that this Section 11.2 shall not apply to any terminations under Article 8 and the effect of such Article 8 terminations shall be governed by Article 8 of this Agreement.
11.3. The Company shall not redeem Trust shares attributable to the Contracts (as distinct from Trust shares attributable to the Companys assets held in the Account) except (i) as necessary to implement Contract owner initiated or approved transactions, or (ii) as required by state and/or federal laws or regulations or judicial or other legal precedent of general application (hereinafter referred to as a Legally Required Redemption) or (iii) as permitted by an order of the SEC pursuant to Section 26(b) of the 1940 Act. Upon request, the Company will promptly furnish to the Trust, the Adviser and the Administrator the opinion of counsel for the Company (which counsel shall be reasonably satisfactory to the Trust and the Adviser) to the effect that any redemption pursuant to clause (ii) above is a Legally Required Redemption. Furthermore,
except in cases where permitted under the terms of the Contracts, the Company shall not prevent Contract owners from allocating payments to a Portfolio that was otherwise available under the Contracts without first giving the Trust or the Adviser 30 days notice of its intention to do so.
Article 12
Notices
Any notice shall be sufficiently given when sent by registered or certified mail to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other party.
If to the Trust:
JPMorgan Insurance Trust
Mail Code OH1-1299
1111 Polaris Parkway
OH1-1299
Columbus, Ohio 43240
Attn: Contract Administrator
If to the Administrator:
JPMorgan Funds Management, Inc.
Mail Code OH1-1299
1111 Polaris Parkway
OH1-1299
Columbus, Ohio 43240
Attention: Contract Administrator
If to the Adviser:
J.P. Morgan Investment Management Inc.
383 Madison Avenue
New York, NY 10179-0001
Attn: Contract Administrator
If to the Company:
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, AL 35223
Attention: Senior Vice President, Chief Product Officer
With a copy to:
Senior Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
Article 13
Miscellaneous
13.1. All persons dealing with the Trust must look solely to the property of the Trust for the enforcement of any claims against the Trust as neither the Board, officers, agents or shareholders assume any personal liability for obligations entered into on behalf of the Trust. Each of the Company, the Adviser, and the Administrator acknowledges and agrees that, as provided by the Trusts Amended and Restated Declaration of Trust, the shareholders, trustees, officers, employees and other agents of the Trust and the Portfolios shall not personally be bound by or liable for matters set forth hereunder, nor shall resort be had to their private property for the satisfaction of any obligation or claim hereunder. The Trusts Amended and Restated Declaration of Trust is on file with the Secretary of State The Commonwealth of Massachusetts.
13.2. The Company will comply with all applicable laws and regulations aimed at preventing, detecting, and reporting money laundering and suspicious transactions. Without limiting the generality of the foregoing, the Company shall take all necessary and appropriate steps, consistent with applicable regulations and generally accepted industry practices, to: (i) obtain, verify, and retain information with regard to Contract owner identification and source of Contract owner funds, and (ii) maintain records of all Contract owner transactions. The Company will (but only to the extent consistent with applicable law) take all steps necessary and appropriate to provide the Trust with any requested information about Contract owners and their accounts in the event that the Trust shall request such information due to an inquiry or investigation by any law enforcement, regulatory, or administrative authority. To the extent permitted by applicable law and regulations, the Company will notify the Trust of any concerns that the Company may have in connection with any Contract owner in the context of relevant anti-money laundering laws or regulations.
13.3. Subject to the requirements of legal process and regulatory authority, each party hereto shall treat as confidential the names and addresses of the owners of the Contracts and all information reasonably identified as confidential in writing by any other party hereto and, except as permitted by this Agreement, shall not disclose, disseminate or utilize such names and addresses and other confidential information until such time as it may come into the public domain without the express written consent of the affected party.
13.4. The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
13.5. This Agreement may be executed simultaneously in two or more counterparts, each of which taken together shall constitute one and the same instrument.
13.6. If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of this Agreement shall not be affected thereby.
13.7. Each party hereto shall cooperate with each other party and all appropriate governmental authorities (including without limitation the Securities and Exchange Commission, the Financial Industry Regulatory Authority and state insurance regulators) and shall permit such authorities (and other parties hereto) reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.
13.8. The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations at law or in equity, which the parties hereto are entitled to under state and federal laws.
13.9. This Agreement or any of the rights and obligations hereunder may not be assigned by any party without the prior written consent of all parties hereto; provided, however, that the Adviser may, with advance written notice to the other parties hereto, assign this Agreement or any rights or obligations hereunder to any affiliate of or company under common control with the Adviser if such assignee is duly licensed and registered to perform the obligations of the Adviser under this Agreement.
13.10. The Company shall furnish, or shall cause to be furnished, to the Trust or its designee upon request, copies of the following reports:
(a) the Companys annual statement (prepared under statutory accounting principles) and annual report (prepared under generally accepted accounting principles (GAAP), if any), as soon as practical and in any event within 90 days after the end of each fiscal year;
(b) the Companys June 30th quarterly statements (statutory), as soon as practical and in any event within 45 days following such period;
(c) any financial statement, proxy statement, notice or report of the Company sent to stockholders and/or policyholders, as soon as practical after the delivery thereof to stockholders;
(d) any registration statement (without exhibits) and financial reports the Company filed with the Securities and Exchange Commission or any state insurance regulator, as soon as practical after the filing thereof; and
(e) any other public report submitted to the Company by independent accountants in connection with any annual, interim or special audit made by them of the books of the Company, as soon as practical after the receipt thereof.
13.11. The names JPMorgan Insurance Trust and Trustees of JPMorgan Insurance Trust refer respectively to the Trust created and the Trustees, as trustees but not individually or personally, acting from time to time under a Declaration of Trust dated June 7, 1993 to which reference is hereby made and a copy of which is on file at the office of the Secretary of The Commonwealth of Massachusetts and elsewhere as required by law, and to any and all amendments thereto so filed or hereafter filed. The obligations of JPMorgan Insurance Trust entered into in the name or on behalf thereof by any of the Trustees, representatives or agents are made not individually, but in such capacities, and are not binding upon any of the Trustees, shareholders or representatives of the Trust personally, but bind only the assets of the Trust, and all persons dealing with any series of shares of the Trust must look solely to the assets of the Trust belonging to such series for the enforcement of any claims against the Trust.
13.12. The Trust and the Administrator agree to consult with the Company concerning whether any Portfolio of the Trust qualifies to provide a foreign tax credit pursuant to Section 853 of the Code.
[SIGNATURE PAGES FOLLOW]
|
PROTECTIVE LIFE INSURANCE COMPANY |
|||
|
|
|||
|
By: |
|
||
|
|
|||
|
Name: |
|
||
|
|
|||
|
Title: |
|
||
|
|
|||
|
JPMORGAN INSURANCE TRUST |
|||
|
|
|||
|
By: |
|
||
|
|
|||
|
Name: |
|
||
|
|
|||
|
Title: |
|
||
|
|
|||
|
J.P. MORGAN INVESTMENT MANAGEMENT INC. |
|||
|
|
|||
|
By: |
|
||
|
|
|||
|
Name: |
|
||
|
|
|||
|
Title: |
|
||
SCHEDULE A
SEPARATE ACCOUNTS AND CONTRACTS
as of December, 11 2020 which Accounts and Contracts may be changed from time to time upon written notification to the Trust by the Company within a reasonable time from such change;
Name of Separate Account and Date Established by Board of
|
|
Policy/Contract
|
Protective COLI VUL Separate Account (02/25/2020) |
|
Protective Executive Benefits Registered VUL |
Protective COLI PPVUL Separate Account (4/14/2020) |
|
Protective Executive Benefits Private Placement VUL |
Schedule B
Portfolios of the Trust
All Class 1 Shares of the Portfolios that fall under the JPMorgan Insurance Trust
Schedule C
Summary Prospectus
This Schedule C shall apply to the parties use of summary prospectuses under Rule 498 (Rule 498) of the 1933 Act and to the extent the terms set forth in this Schedule C conflict with the terms of the Agreement, the terms of this Schedule C shall control with respect to summary prospectuses. In addition to the terms set forth in the Agreement, the parties agree as follows when using summary prospectuses:
1. Definitions. Unless otherwise noted, terms used in this Schedule C shall have the same meaning as in the Agreement. For purposes of this Schedule C:
a. The term Portfolio Documents shall mean those documents prepared by the Trust that, pursuant to Rule 498(e)(1), must be publicly accessible, free of charge, at the Web site address specified on the cover page or at the beginning of the Summary Prospectus. Portfolio Documents include each Portfolios current Summary Prospectus, Statutory Prospectus, Statement of Additional Information, and most recent annual and semi-annual reports to shareholders under Rule 30e-1 of the Investment Company Act of 1940 (the 1940 Act).
b. The term Portfolio Documents Web Site shall mean the Web site maintained by the Trust or its agent where Contract Owners and prospective Contract Owners may access the Portfolio Documents in compliance with Rule 498.
c. The term Statutory Prospectus shall mean a prospectus that satisfies the requirements of section 10(a) of the 1933 Act.
d. The term Summary Prospectus shall have the same meaning as set forth in Rule 498.
e. The term Applicable Law shall mean the Federal Securities Laws as defined in Rule 38a-1(e)(1) under the 1940 Act, any rules promulgated under such Federal Securities Laws, and any applicable guidance received from the Securities and Exchange Commission (SEC) or from the staff of the SEC (the SEC Staff) thereunder. As used herein, the phrase any applicable guidance received from the SEC or from the SEC Staff thereunder shall refer only to published no-action relief, interpretative guidance, exemptive orders or final rulemaking guidance, but shall specifically exclude oral statements, speeches or informal guidance that may be provided by the SEC or the SEC Staff from time to time. The term Applicable Law also includes any state laws, rules and regulations that may apply to this Amendment.
2. Use of Summary Prospectus.
a. Obligations of the Trust. The Trust agrees to the following provisions as of the date hereof and for as long as this Schedule C is in effect and valid:
i. The Trust shall comply with the requirements of Rule 498 and Applicable Law in connection with the offer and sale of Portfolio shares as specified in this Schedule C.
ii. Any Summary Prospectuses provided by the Trust to the Company and the hosting of such Summary Prospectuses will comply in all material respects with all applicable requirements of Rule 498 and Applicable Law.
iii. The Trust shall specify, in the legend on the cover page or at the beginning of a Portfolios Summary Prospectus, as required by Rule 498(b)(1)(v), the specific Web site address for the Portfolio Documents Web Site and toll free number and e-mail address provided by the Trust.
iv. If the Company elects to utilize a Summary Prospectus made available by the Trust, the Trust will provide Company copies of the Summary Prospectuses and any supplements thereto in the same manner as described in the Agreement for the Statutory Prospectuses. Prospectus as used in the
Agreement will include both the Summary Prospectuses and Statutory Prospectuses, as the context requires.
v. If at any point the Trust determines that it no longer wishes to utilize the Summary Prospectus delivery option, the Trust must provide the Company with at least sixty (60) days advance written notice of this intent so that the Company can arrange to deliver a Statutory Prospectus in place of a Summary Prospectus. The Trust shall continue to maintain the Portfolio Documents Web Site for a minimum of 180 days.
vi. If at any point the Trust determines that a Portfolio will be liquidated or merged with another variable insurance products fund, the Trust must either provide the Company with at least sixty (60) days advance written notice or must provide prompt notice once the information about the liquidation or merger is made public if that period is less than sixty (60) days so that the Company can arrange to deliver a Statutory Prospectus in place of a Summary Prospectus. The Trust shall continue to maintain the Portfolio Documents Web Site for a minimum of 180 days.
vii. The Trust will provide that the current versions of the Portfolio Documents remain continuously available from the time the Summary Prospectus is sent or given until at least 90 days after the last date that the Portfolio has reason to believe that the Company delivered a security or communications in reliance upon Rule 498(e)(1).
viii. Any non-public personal information or personally identifiable financial information about any Contract Owner or prospective Contract Owner, obtained in connection with fulfillment of Summary Prospectuses or Statutory Prospectuses will be used by the Trust solely for the purpose of responding to fulfillment requests.
ix. The Trust shall be responsible for compliance with the provisions of Rule 498(f)(i) involving Contract Owner requests for additional Portfolio Documents made directly to the Trust.
b. Obligations of the Company. The Company agrees to the following provisions as of the date hereof and for as long as the Amendment is in effect and valid:
i. The Company shall comply with the requirements of Rule 498 and Applicable Law in connection with the delivery of the Summary Prospectuses for the Portfolios.
ii. Company shall deliver (or arrange for delivery of) a Summary Prospectus for each Portfolio that a prospective Contract Owner identifies on his or her application as an intended investment option under a Contract or to which a Contract Owner currently allocates premium payments or transfers Contract value. To the extent such Summary Prospectus is made available by the Trust, the Company, in its sole discretion, reserves the right to deliver to Contract Owners a Summary Prospectus for each Portfolio that has served as an investment option under a Contract issued by the Company. In addition, the Company, in its sole discretion, reserves the right to deliver the Statutory Prospectus in place of the Summary Prospectus. The Company shall deliver (or arrange for delivery of) such Summary or Statutory Prospectuses at the times required by applicable provisions of the 1933 Act and 1940 Act, the rules or regulations thereunder, and any applicable guidance received from the SEC or from the SEC Staff thereunder.
iii. To the extent that a Summary Prospectus is made available by the Trust, the Company shall provide Trust at least 30 days prior notice of its desire to generally use Summary Prospectuses instead of Statutory Prospectuses for prospectus delivery, provided, however, that nothing herein shall prevent the Company from delivering a Statutory Prospectus in place of a Summary Prospectus in a particular instance.
iv. The Company shall deliver all Summary Prospectuses and all Statutory Prospectuses in compliance with the Greater Prominence requirements of Rule 498(f)(2) and Applicable Law.
v. The Company may, in its sole discretion, bind together the Summary Prospectuses or Statutory Prospectuses for the Funds with Summary Prospectuses and Statutory Prospectuses for other investment options under the Contract and the Contract Prospectus(es) as long as such binding is done in compliance with Rule 498(c)(2) and Applicable Law.
vi. The Company shall be permitted, but not required, in its sole discretion, to post copies of Portfolio Documents on the Companys Web site. The Trust hereby grants to the Company a non-exclusive, worldwide, royalty-free, perpetual license to create a hyperlink from the Companys Web site to the Portfolio Documents Web Site. The Trust may, in its sole and absolute discretion, revoke such license at any time. Notwithstanding the foregoing, the Trust shall remain solely responsible for ensuring that the Portfolio Documents, including the Summary Prospectuses for the Portfolios, comply with Rule 498 and any applicable guidance received from the SEC or from the SEC Staff thereunder.
vii. The Company may not alter any Portfolio Documents without the prior written consent of the Trust.
viii. The Company shall respond to requests for additional Portfolio Documents made by Contract Owners directly to the Company with documents provided by the Trust within three Business Days of the request.
This Schedule C may be removed at any time, without termination of the Agreement or the payment of any penalty, by mutual agreement of the parties in writing.
FOURTH AMENDMENT TO PARTICIPATION AGREEMENT
THIS FOURTH AMENDMENT TO PARTICIPATION AGREEMENT (the Amendment) is made as of the 30th day of November, 2020, by and among PROTECTIVE LIFE INSURANCE COMPANY, a life insurance company organized under the laws of the State of Tennessee (the Company), acting herein for and on behalf of the Company and on behalf of each separate account set forth on attached Schedule A, as the same may be amended from time to time (the Separate Accounts); LEGG MASON PARTNERS VARIABLE EQUITY TRUST and LEGG MASON PARTNERS VARIABLE INCOME TRUST (each a Fund, collectively the Funds), LEGG MASON PARTNERS FUND ADVISOR, LLC, (the Advisor) and LEGG MASON INVESTOR SERVICES, LLC (the Distributor), collectively (the Parties).
RECITALS
WHEREAS, the Parties entered into a Participation Agreement dated November 1, 2009, as amended (the Agreement);
WHEREAS, the Parties desire to amend the Agreement to update the separate accounts and funds listed in Schedule A and restate Schedule B; and
WHEREAS, the Parties now desire to further modify the Agreement as provided herein.
NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants and conditions set forth herein, and for other good and valuable consideration, the Parties agree to amend the Agreement as follows:
1. Schedules A and B. Schedules A and B to the Agreement are hereby deleted in their entirety and replaced with Schedules A and B attached hereto.
2. Ratification and Confirmation of Agreement. In the event of a conflict between the terms of this Amendment and the Agreement, it is the intention of the parties that the terms of this Amendment shall control and the Agreement shall be interpreted on that basis. To the extent the provisions of the Agreement have not been amended by this Amendment, the Parties hereby confirm and ratify the Agreement.
3. Counterparts. This Amendment may be executed in two or more counterparts, each of which shall be an original and all of which together shall constitute one instrument.
4. Full Force and Effect. Except as expressly supplemented, amended or consented to hereby, all of the representations, warranties, terms, covenants and conditions of the Agreement shall remain unamended and shall continue to be in full force and effect.
[Remainder of Page Intentionally Left Blank]
IN WITNESS WHEREOF, the undersigned have executed this Amendment No. 4 as of the date first above written.
|
PROTECTIVE LIFE INSURANCE COMPANY |
|
|
On its behalf and each Separate Account named in |
|
|
Schedule A |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
|
|
|
LEGG MASON PARTNERS VARIABLE EQUITY TRUST |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
|
|
|
LEGG MASON PARTNERS VARIABLE INCOME TRUST |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
|
|
|
LEGG MASON PARTNERS FUND ADVISOR, LLC |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
|
|
|
LEGG MASON INVESTOR SERVICES, LLC |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
Schedule A
Separate Accounts and Associated Products
Separate Account |
|
Product |
Protective Variable Annuity Separate Account |
|
Protective Variable Annuity
|
Protective Variable Life Separate Account |
|
Premiere II
|
Protective COLI VUL Separate Account |
|
Protective Executive Benefits Registered VUL |
Protective COLI PPVUL Separate Account |
|
Protective Executive Benefits Private Placement VUL |
PLICO Variable Annuity Account S |
|
Schwab Genesis Variable Annuity
|
SCHEDULE B
PORTFOLIOS AVAILABLE UNDER THE CONTRACTS
All Funds shall pay 12b-1 fees in the amount as stated in each Funds then current prospectus.
Fund Trust Name |
|
Portfolio Fund Name |
|
Class |
|
CUSIP |
Legg Mason Partners Variable Equity Trust |
|
ClearBridge Variable Mid Cap Portfolio |
|
I |
|
52467X708 |
Legg Mason Partners Variable Equity Trust |
|
ClearBridge Variable Mid Cap Portfolio |
|
II |
|
52467X856 |
Legg Mason Partners Variable Equity Trust |
|
ClearBridge Variable Small Cap Growth Portfolio |
|
I |
|
52467M843 |
Legg Mason Partners Variable Equity Trust |
|
ClearBridge Variable Small Cap Growth Portfolio |
|
II |
|
52467M819 |
Legg Mason Partners Variable Equity Trust |
|
QS Legg Mason Dynamic Multi-Strategy VIT Portfolio |
|
I |
|
52467M793 |
Legg Mason Partners Variable Equity Trust |
|
QS Legg Mason Dynamic Multi-Strategy VIT Portfolio |
|
II |
|
52467M785 |
Legg Mason Partners Variable Income Trust |
|
Western Asset Core Plus VIT Portfolio |
|
I |
|
52467K771 |
AMENDED AND RESTATED
PARTICIPATION AGREEMENT
AMONG
MFS VARIABLE INSURANCE TRUST,
MFS VARIABLE INSURANCE TRUST II,
MFS VARIABLE INSURANCE TRUST III,
PROTECTIVE LIFE INSURANCE COMPANY
AND
MFS FUND DISTRIBUTORS, INC.
THIS AGREEMENT, made and entered into effective as of the 1ST day of May 2012, by and among MFS VARIABLE INSURANCE TRUST, a Massachusetts business trust (the Trust I), MFS VARIABLE INSURANCE TRUST II, a Massachusetts business trust (the Trust II), MFS VARIABLE INSURANCE TRUST III, a Delaware statutory trust (Trust III) (Trust I, Trust II and Trust III each referred to, individually, as the Trust and, collectively, as the Trusts), Protective Life Insurance Company, a Tennessee corporation (the Company), and on behalf of each of the segregated asset accounts of the Company set forth in Schedule A hereto, as may be amended from time to time (the Accounts), and MFS Fund Distributors, Inc., a Delaware corporation (MFD). This Agreement shall amend and supersede the following Participation Agreements:
· Amended and Restated Participation Agreement dated April 14th, 2000, as amended, by and among MFS VARIABLE INSURANCE TRUST, UNITED INVESTORS LIFE INSURANCE COMPANY, and MASSACHUSETTS FINANCIAL SERVICES COMPANY
· Amended and Restated Participation Agreement dated June 1st, 2003, as amended, by and among MFS VARIABLE INSURANCE TRUST, PROTECTIVE LIFE INSURANCE COMPANY, and MASSACHUSETTS FINANCIAL SERVICES COMPANY
WHEREAS, each Trust is registered as an open-end management investment company under the Investment Company Act of 1940, as amended (the 1940 Act), and its shares are registered or will be registered under the Securities Act of 1933, as amended (the 1933 Act);
WHEREAS, shares of beneficial interest of each Trust are divided into several series of shares, each representing the interests in a particular managed pool of securities and other assets;
WHEREAS, certain series of shares of each Trust are divided into two separate share classes, an Initial Class and a Service Class, and each Trust on behalf of the Service Class has adopted a Rule 12b-1 plan under the 1940 Act pursuant to which the Service Class pays a distribution fee;
WHEREAS, the series of shares of each Trust (each, a Portfolio, and, collectively, the Portfolios) and the classes of shares of those Portfolios (the Shares) offered by each Trust to the Company and the Accounts are set forth on Schedule A attached hereto;
WHEREAS, MFD is registered as a broker-dealer with the Securities and Exchange Commission (the SEC) under the Securities Exchange Act of 1934, as amended (hereinafter the 1934 Act), and is a member in good standing of the Financial Industry Regulatory Authority, Inc. (F1NRA);
WHEREAS, the Company will issue certain variable annuity and/or variable life insurance contracts (individually, the Policy or, collectively, the Policies) which, if required by applicable law, will be registered under the 1933 Act;
WHEREAS, the Accounts are duly organized, validly existing segregated asset accounts, established by resolution of the Board of Directors of the Company, to set aside and invest assets attributable to the aforesaid variable annuity and/or variable life insurance contracts that are allocated to the Accounts (the Policies and the Accounts covered by this Agreement, and each corresponding Portfolio covered by this Agreement in which the Accounts invest, is specified in Schedule A attached hereto as may be modified from time to time);
WHEREAS, the Company has registered or will register the Accounts as unit investment trusts under the 1940 Act (unless exempt therefrom);
WHEREAS, MFS is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and any applicable state securities law, and is the Trusts investment adviser;
WHEREAS, Investment Distributors, Inc., the underwriter for the Policies, is registered as a broker-dealer with the SEC under the 1934 Act and is a member in good standing of FINRA; and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company intends to purchase the Shares of the Portfolios as specified in Schedule A attached hereto on behalf of the Accounts to fund the Policies, and the Trusts intend to sell such Shares to the Accounts at net asset value; and
NOW, THEREFORE, in consideration of their mutual promises, each Trust, MFD, and the Company agree as follows:
ARTICLE I. SALE OF TRUST SHARES
1.1. Each Trust agrees to sell to the Company those Shares which the Accounts order (based on orders placed by Policy holders prior to the pricing time set forth in the applicable Portfolios prospectus, e.g., the close of regular trading on the New York Stock Exchange, Inc. (the NYSE) on that Business Day, as defined below) and which arc available for purchase by such Accounts, executing such orders on a daily basis at the net asset value next computed after receipt by such Trust or its designee of the order for the Shares. For purposes of this Section 1.1, the Company shall be the designee of each Trust for receipt of such orders from Policy owners and receipt by such designee shall constitute receipt by each Trust; provided that such Trust receives notice of such orders by 10:00 a.m. New York time on the next following Business Day. Business Day shall mean any day on which the NYSE is open for trading and on which such Trust calculates its net asset value pursuant to the rules of the SEC. The Company will ensure that orders for transactions in Shares by Policy owners comply with each Portfolios prospectus (including statement of additional information) restrictions with respect to purchases, redemptions and exchanges. The Company will not engage in, authorize or facilitate market timing or late trading in Shares and has implemented controls designed to identify and prevent market timing and late trading in Shares by Policy holders.
1.2. Each Trust agrees to make the Shares available indefinitely for purchase at the applicable net asset value per share by the Company and the Accounts on those days on which the Trust calculates its net asset value pursuant to rules of the SEC and each Trust shall calculate such net asset value on each day which the NYSE is open for trading. Notwithstanding the foregoing, the Board of Trustees of the relevant Trust (the Board) may refuse to sell any Shares to the Company and the Accounts, or suspend or terminate the offering of the Shares if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Board acting in good faith and in light of its fiduciary duties under federal and any applicable state laws, necessary in the best interest of the Shareholders of such Portfolio.
1.3. Each Trust and MFD agree that the Shares will be sold only to insurance companies that have entered into participation agreements with the relevant Trust and its affiliate (the Participating Insurance Companies) and their separate accounts, qualified pension and retirement plans, and any other person or plan permitted to hold shares of such Trust pursuant to Treasury Regulation 1.817-5 without impairing the ability of the Company, on behalf of its separate accounts, to consider the Shares as constituting investments of the separate accounts for the purpose of satisfying the diversification requirements of Section 817(h). Each Trust and MFD will not sell such Trust shares to any insurance company or separate account unless an agreement containing provisions substantially the same as Articles II, III, VI and VII of this Agreement is in effect to govern such sales. The Company will not resell the Shares except to such Trust or its agents.
1.4. Each Trust agrees to redeem for cash or, if mutually agreed upon by the parties and to the extent permitted by applicable law, in-kind, on the Companys request, any full or fractional Shares held by the Accounts (based on orders placed by Policy owners prior to the close of regular trading on the NYSE on that Business Day), executing such requests on a daily basis at the net asset value next computed after receipt by such Trust or its designee of the request for redemption. For purposes of this Section 1.4, the Company shall be the designee of such Trust for receipt of requests for redemption from Policy owners and receipt by such designee shall constitute receipt by such Trust; provided that such Trust receives notice of such request for redemption by 10:00 a.m. New York time on the next following Business Day.
1.5. Each purchase, redemption and exchange order placed by the Company shall be placed separately for each Portfolio and shall not be netted with respect to any Portfolio. However, with respect to payment of the purchase price by the Company and of redemption proceeds by the Trusts, the Company and the relevant Trust shall net purchase and redemption orders with respect to each Portfolio and shall transmit one net payment for all of the Portfolios in accordance with Section 1.6 hereof.
1.6. In the event of net purchases, the Company shall pay for the Shares by close of business (5:00 p.m.). New York time on the next Business Day after an order to purchase the Shares is made in accordance with the provisions of Section 1.1 hereof. In the event of net redemptions, each Trust shall pay the redemption proceeds by close of business (5:00 p.m.) New York time on the next Business Day after an order to redeem the shares is made in accordance with the provisions of Section 1.4. hereof. All such payments shall be in federal funds transmitted by wire.
1.7. Issuance and transfer of the Shares will be by book entry only. Stock certificates will not be issued to the Company or the Accounts. The Shares ordered from each Trust will be recorded in an appropriate title for the Accounts or the appropriate subaccounts of the Accounts.
1.8. Each Trust shall furnish same day notice (by wire or telephone followed by written confirmation) to the Company of any dividends or capital gain distributions payable on the Shares. The Company hereby elects to receive all such dividends and distributions as are payable on a Portfolios Shares
in additional Shares of that Portfolio. Each Trust shall notify the Company of the number of Shares so issued as payment of such dividends and distributions.
1.9. Each Trust or its custodian shall make the net asset value per share for each Portfolio available to the Company on each Business Day as soon as reasonably practicable after the net asset value per share is calculated and shall use its best efforts to make such net asset value per share available by 6:30 p.m. New York time. In the event that such Trust is unable to meet the 6:30 p.m. time stated herein, it shall provide additional time for the Company to place orders for the purchase and redemption of Shares. Such additional time shall be equal to the additional time which such Trust takes to make the net asset value available to the Company. If such Trust provides materially incorrect share net asset value information, such Trust shall make an adjustment to the number of shares purchased or redeemed for the Accounts to reflect the correct net asset value per share and such Trust shall bear the cost of adjusting the error. Any material error in the calculation or reporting of net asset value per share, dividend or capital gains information shall be reported promptly upon discovery to the Company.
1.10 Each party or its designee shall maintain and preserve all records as required by law to be maintained and preserved in connection with providing the services hereunder and in making Shares available to the Policy holders. Upon the request of MFD or a Trust, the Company shall provide copies of all the historical records relating to transactions between the relevant Portfolios and the Policy holders, written communications regarding the relevant Portfolios to or from such Policy holders accounts and other materials, in each case to the extent necessary for such Trust or its designee to meet its recordkeeping obligations under applicable law or regulation, including to comply with any request of a governmental body or self-regulatory organization.
ARTICLE II. CERTAIN REPRESENTATIONS, WARRANTIES AND COVENANTS
2.1. The Company represents and warrants that the Policies are or will be registered under the 1933 Act or are exempt from or not subject to registration thereunder, and that the Policies will be issued, sold, and distributed in compliance in all material respects with all applicable state and federal laws, including without limitation the 1933 Act, the Securities Exchange Act of 1934, as amended (the 1934 Act), and the 1940 Act. The Company further represents and warrants that it is an insurance company duly organized and in good standing under applicable law and that it has legally and validly established the Account as a segregated asset account under applicable law and has registered or, prior to any issuance or sale of the Policies, will register the Accounts as unit investment trusts in accordance with the provisions of the 1940 Act (unless exempt therefrom) to serve as segregated investment accounts for the Policies, and that it will maintain such registration for so long as any Policies are outstanding. The Company shall amend the registration statements under the 1933 Act for the Policies and the registration statements under the 1940 Act for the Accounts from time to time as required in order to effect the continuous offering of the Policies or as may otherwise be required by applicable law. The Company shall register and qualify the Policies for sales in accordance with the securities laws of the various states only if and to the extent deemed necessary by the Company.
2.2. The Company represents and warrants that the Policies are currently and at the time of issuance will be treated as life insurance, endowment or annuity contracts under applicable provisions of the Internal Revenue Code of 1986, as amended (the Code), that it will maintain such treatment and that it will notify the Trusts or MFD immediately upon having a reasonable basis for believing that the Policies have ceased to be so treated or that they might not be so treated in the future.
2.3. The Company represents and warrants that the underwriter for the individual variable annuity and the variable life policies is a member in good standing of FINRA and is a registered
broker-dealer with the SEC. The Company represents and warrants that the Company and its underwriter will sell and distribute such policies in accordance in all material respects with all applicable state and federal securities laws, including without limitation the 1933 Act, the 1934 Act, and the 1940 Act.
2.4. Each Trust and MFD represent and warrant that the Shares sold pursuant to this Agreement shall be registered under the 1933 Act, duly authorized for issuance and sold in compliance with the laws of The Commonwealth of Massachusetts and all applicable federal and state securities laws and that such Trust is and shall remain registered under the 1940 Act. Each Trust shall amend the registration statement for its Shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its Shares. Each Trust shall register and qualify the Shares for sale in accordance with the laws of the various states only if and to the extent deemed necessary by such Trust.
2.5. MFD represents and warrants that it is a member in good standing of FINRA and is registered as a broker-dealer with the SEC. Each Trust and MFD severally represent that such Trust and MFD will sell and distribute the Shares in accordance in all material respects with all applicable state and federal securities laws, including without limitation the 1933 Act, the 1934 Act, and the 1940 Act.
2.6. Each Trust represents that it is lawfully organized and validly existing under the laws of The Commonwealth of Massachusetts and that it does and will comply in all material respects with the 1940 Act and any applicable regulations thereunder.
2.7. MFD represents and warrants that it is and shall remain duly registered under all applicable federal securities laws and that it shall perform its obligations for the Trusts in compliance in all material respects with any applicable federal securities laws and with the securities laws of The Commonwealth of Massachusetts. MFD represents and warrants that MFS is not subject to state securities laws other than the securities laws of The Commonwealth of Massachusetts and is exempt from registration as an investment adviser under the securities laws of The Commonwealth of Massachusetts.
2.8. No less frequently than annually, the Company shall submit to each Board such reports, material or data as such Board may reasonably request so that it may carry out fully the obligations imposed upon it by the conditions contained in the exemptive application pursuant to which the SEC has granted exemptive relief to permit mixed and shared funding (the Mixed and Shared Funding Exemptive Order).
2.9. The Company acknowledges that, with respect to Service Class Shares of a Portfolio, it or its affiliate(s) may receive payments under a Trusts Rule 12b-1 plan. The Company, and not the relevant Trust, MFS or MFD, is responsible for providing any disclosures relating to this Agreement and/or payments made to the Company to Policy owners.
ARTICLE III. PROSPECTUS AND PROXY STATEMENTS; VOTING
3.1. At least annually, each Trust or its designee shall provide the Company, free of charge, with as many copies of the current prospectus (describing only the Portfolios listed in Schedule A hereto) for the Shares as the Company may reasonably request for distribution to existing Policy owners whose Policies are funded by such Shares. Each Trust or its designee shall provide the Company, at the Companys expense, with as many copies of the current prospectus for the Shares as the Company may reasonably request for distribution to prospective purchasers of Policies. In the event that the Company utilizes a summary prospectus for any Trust, the term or prospectus shall mean the summary prospectus for the relevant Trust and the term statement of additional information shall mean the statutory prospectus, together with corresponding statement of additional information, for the relevant Trust.
If requested by the Company in lieu thereof, a Trust or its designee shall provide such documentation (including a camera ready copy of the new prospectus as set in type or, at the request of the Company, as a diskette or electronic file in the form sent to the financial printer) and other assistance as is reasonably necessary in order for the parties hereto once each year (or more frequently if the prospectus for the Shares is supplemented or amended) to have the prospectus for the Policies and the prospectus for the Shares printed together in one document; the expenses of such printing to be apportioned between (a) the Company and (b) the relevant Trust(s) or its designee in proportion to the number of pages of the Policy and Shares prospectuses, taking account of other relevant factors affecting the expense of printing, such as covers, columns, graphs and charts; such Trust or its designee to bear the cost of printing the Shares prospectus portion of such document for distribution to owners of existing Policies funded by the Shares and the Company to bear the expenses of printing the portion of such document relating to the Accounts; provided, however, that the Company shall bear all printing expenses of such combined documents where used for distribution to prospective purchasers or to owners of existing Policies not funded by the Shares. In the event that the Company requests that a Trust or its designee provides such Trusts prospectus in a camera ready or electronic file format, such Trust shall be responsible for providing the prospectus in the format in which it or the Underwriter is accustomed to formatting prospectuses and shall bear the expense of providing the prospectus in such format (e.g., typesetting expenses), and the Company shall bear the expense of adjusting or changing the format to conform with any of its prospectuses. In addition, the Trust or its designee will bear the cost of distributing the prospectuses for the Shares to owners of existing Policies funded by the Shares.
3.2. The prospectus for the Shares shall state that the statement of additional information for the Shares is available from the relevant Trust or its designee. Each Trust or its designee, at its expense, shall print and provide such statement of additional information to the Company (or a master of such statement suitable for duplication by the Company) for distribution to any owner of a Policy funded by the Shares. Each Trust or its designee, at the Companys expense, shall print and provide such statement to the Company (or a master of such statement suitable for duplication by the Company) for distribution to a prospective purchaser who requests such statement or to an owner of a Policy not funded by the Shares.
3.3. Each Trust or its designee shall provide the Company free of charge copies, if and to the extent applicable to the Shares, of such Trusts proxy materials, reports to Shareholders and other communications to Shareholders in such quantity as the Company shall reasonably require for distribution to Policy owners.
3.4. Notwithstanding the provisions of Sections 3.1, 3.2, and 3.3 above, or of Article V below, the Company shall pay the expense of printing or providing documents to the extent such cost is considered a distribution expense. Distribution expenses would include by way of illustration, but are not limited to, the printing of the Shares prospectus or prospectuses for distribution to prospective purchasers or to owners of existing Policies not funded by such Shares.
3.5. Each Trust hereby notifies the Company that it may be appropriate to include in the prospectus pursuant to which a Policy is offered disclosure regarding the potential risks of mixed and shared funding.
3.6. If and to the extent required by the 1940 Act or other applicable law, the Company shall;
(a) solicit voting instructions from Policy owners;
(b) vote the Shares in accordance with instructions received from Policy owners; and
(c) vote the Shares for which no instructions have been received in the same proportion as the Shares of such Portfolio for which instructions have been received from Policy owners;
so long as and to the extent that the SEC continues to interpret the 1940 Act to require pass through voting privileges for variable contract owners. The Company will in no way recommend action in connection with or oppose or interfere with the solicitation of proxies for the Shares held for such Policy owners. The Company reserves the right to vote shares held in any segregated asset account in its own right, to the extent permitted by law. Participating Insurance Companies shall be responsible for assuring that each of their separate accounts holding Shares calculates voting privileges in the manner required by the Mixed and Shared Funding Exemptive Order. Each Trust and MFD will notify the Company of any changes of interpretations or amendments to the Mixed and Shared Funding Exemptive Order.
ARTICLE IV. SALES MATERIAL AND INFORMATION
4.1. The Company shall furnish, or shall cause to be furnished, to each Trust or its designee, each piece of sales literature or other promotional material in which such Trust, MFS, any other investment adviser to such Trust, or any, affiliate of MFD is named, at least three (3) Business Days prior to its use. No such material shall be used if such Trust, MFD, or their respective designees reasonably objects to such use within three (3) Business Days after receipt of such material.
4.2. The Company shall not give any information or make any, representations or statement on behalf of any Trust, MFS, or other investment adviser to any Trust, or any affiliate of MFD or concerning such Trust or any other such entity in connection with the sale of the Policies other than the information or representations contained in the registration statement, prospectus or statement of additional information for the Shares, as such registration statement, prospectus and statement of additional information may be amended or supplemented from time to time, or in reports or proxy statements for such Trust, or in sales literature or other promotional material approved by such Trust, MFD or their respective designees, except with the permission of such Trust, MFD or their respective designees. Each Trust, MFD or their respective designees each agrees to respond to any request for approval on a prompt and timely basis. The Company shall adopt and implement procedures reasonably designed to ensure that information concerning a Trust, MFD or any of their affiliates which is intended for use only by brokers or agents selling the Policies (i.e., information that is not intended for distribution to Policy owners or prospective Policy owners) is so used, and neither the Trusts, MFD nor any of their affiliates shall be liable for any losses, damages or expenses relating to the improper use of such broker only materials.
4.3. Each Trust or its designee shall furnish, or shall cause to be furnished, to the Company or its designee, each piece of sales literature or other promotional material in which the Company and/or the Accounts is named, at least three (3) Business Days prior to its use. No such material shall be used if the Company or its designee reasonably objects to such use within three (3) Business Days after receipt of such material.
4.4. The Trusts and MFD shall not give any information or make any representations on behalf of the Company or concerning the Company, the Accounts, or the Policies in connection with the sale of the Policies other than the information or representations contained in a registration statement, prospectus, or statement of additional information for the Policies, as such registration statement, prospectus and statement of additional information may be amended or supplemented from time to time, or in reports for the Accounts, or in sales literature or other promotional material approved by the Company or its designee, except with the permission of the Company. The Company or its designee agrees to respond to any request for approval on a prompt and timely basis. The Trusts and MFD may not alter any material so provided by the Company or its designee (including, without limitation, presenting or delivering such material in a different medium, e.g.,
electronic or internet) without the prior written consent of the Company. The parties hereto agree that this Section 4.4. is neither intended to designate nor otherwise imply that MFD is an underwriter or distributor of the Policies.
4.5. Upon request of the other party, the Company and each Trust (or its designee in lieu of the Company or such Trust, as appropriate) will each provide to the other at least one complete copy of all registration statements, prospectuses, statements of additional information, reports, proxy statements, sales literature and other promotional materials, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to the Policies, or to such Trust or its Shares, prior to or contemporaneously with the filing of such document with the SEC or other regulatory authorities. The Company and a Trust shall also each promptly inform the other of the results of any examination by the SEC (or other regulatory authorities) that relates to the Policies, such Trust or its Shares, and the party that was the subject of the examination shall provide the other party with a copy of relevant portions of any deficiency letter or other correspondence or written report regarding any such examination.
4.6. No party shall use any other partys names, logos, trademarks or service marks, whether registered or unregistered, without the prior written consent of such other party, or after written consent therefor has been revoked, provided that separate consent is not required under this Section 4.6 to the extent that consent to use a partys name, logo, trademark or service mark in connection with a particular piece of advertising or sales literature has previously been given by a party under Sections 4.2 and 4.4 of this Agreement. The Company shall not use in advertising, publicly or otherwise the name of the Trusts, MFD or any of their affiliates nor any trade name, trademark, trade device, servicemark, symbol or any abbreviation, contraction or simulation thereof of the Trusts, MFD, or their affiliates without the prior written consent of the relevant Trust or MFD in each instance. The Trusts and MFD shall not use in advertising, publicly or otherwise the name of the Company or any of its affiliates nor any trade name, trademark, trade device, servicemark, symbol or any abbreviation, contraction or simulation thereof of the Company or its affiliates without the prior written consent of the Company in each instance.
4.7. Each Trust and MFD will provide the Company with as much notice as is reasonably practicable of any proxy solicitation for any Portfolio, and of any material change in such Trusts registration statement, particularly any change resulting in change to the registration statement or summary prospectus, statutory prospectus or statement of additional information for any Account. Each Trust and MFD will cooperate with the Company so as to enable the Company to solicit proxies from Policy owners or to make changes to its summary prospectus, statutory prospectus, statement of additional information or registration statement, in an orderly manner. Each Trust and MFD will make reasonable efforts to attempt to have changes affecting Policy prospectuses become effective simultaneously with the annual updates for such prospectuses.
4.8. For purpose of this Article IV and Article VIII, the phrase sales literature or other promotional material includes but is not limited to advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media), and sales literature (such as brochures, circulars, reprints or excerpts or any other advertisement, sales literature, or published articles), distributed or made generally available to customers or the public, educational or training materials or communications distributed or made generally available to some or all agents or employees.
ARTICLE V. FEES AND EXPENSES
5.1. Each Trust shall pay no fee or other compensation to the Company under this Agreement, and the Company shall pay no fee or other compensation to either Trust, except that, to the extent a Trust or
any Portfolio has adopted and implemented a plan pursuant to Rule 12b-1 under the 1940 Act to finance distribution and for Shareholder servicing expenses, then such Trust may make payments to the Company or to the underwriter for the Policies in accordance with such plan. Each party, however, shall, in accordance with the allocation of expenses specified in Articles III and V hereof, reimburse other parties for expenses initially paid by one party but allocated to another party. In addition, nothing herein shall prevent the parties hereto from otherwise agreeing to perform, and arranging for appropriate compensation for, other services relating to such Trust and/or to the Accounts.
5.2. Each Trust or its designee shall bear the expenses for the cost of registration and qualification of the Shares under all applicable federal and state laws, including preparation and filing of such Trusts registration statement, and payment of filing fees and registration fees; preparation and filing of such Trusts proxy materials and reports to Shareholders; setting in type and printing its prospectus and statement of additional information (to the extent provided by and as determined in accordance with Article III above); setting in type and printing the proxy materials and reports to Shareholders (to the extent provided by and as determined in accordance with Article III above); such preparation of all statements and notices required of such Trust by any federal or state law with respect to its Shares; all taxes on the issuance or transfer of the Shares; and the costs of distributing such Trusts prospectuses and proxy materials to owners of Policies funded by the Shares and any expenses permitted to be paid or assumed by such Trust pursuant to a plan, if any, under Rule 12b-1 under the 1940 Act. Such Trust shall not bear any expenses of marketing the Policies.
5.3. The Company shall bear the expenses of distributing the Shares prospectus or prospectuses in connection with new sales of the Policies and of distributing a Trusts Shareholder reports to Policy owners. The Company shall bear all expenses associated with the registration, qualification, and filing of the Policies under applicable federal securities and state insurance laws; the cost of preparing, printing and distributing the Policy prospectus and statement of additional information; and the cost of preparing, printing and distributing annual individual account statements for Policy owners as required by state insurance laws.
5.4. With respect to the Service Class Shares of a Portfolio, the relevant Trust may make payments quarterly to MFD under a Portfolios Rule 12b-1 plan, and MFD may in turn use these payments to pay or reimburse the Company for expenses incurred or paid (as the case may be) by the Company attributable to Policies offered by the Company, provided that no such payment shall be made with respect to any quarterly period in excess of an amount determined from time to time by such Trusts Board and disclosed in such Trusts prospectus. MFD shall not be required to provide any payment to the Company with respect to any quarterly period pursuant to a Trusts Rule 12b-1 plan unless and until MFD has received the corresponding payment from such Trust pursuant to the Trusts Rule 12b-1 plan. MFD shall not be required to provide any payment to the Company with respect to any quarterly period pursuant to a Trusts Rule 12b-1 plan if (i) such Trusts Rule 12b-1 plan is no longer in effect during such quarterly period; or (ii) regulatory changes result in the rescission of Rule 12b-1 or otherwise prohibit the making of such payments. Each Trusts prospectus or statement of additional information may provide further details about such payments and the provisions and terms of such Trusts Rule 12b-1 plan, and the Company hereby agrees that neither such Trust, nor MFD has made any representations to the Company with respect to such Trusts Rule 12b-1 plan in addition to, or conflicting with, the description set forth in such Trusts prospectus.
5.5. In calculating the payments due under this Agreement, the Company agrees that it will permit MFD or its representatives to have reasonable access to its employees and records for the purposes of monitoring of the quality of the services provided hereunder, verifying the Companys compliance with the terms of this Agreement and verifying the accuracy of any information provided by the Company that forms the basis of the fee calculations. In addition, if requested by MFD, the Company will provide a certification (which may take the form of a control report or set of agreed upon standards) satisfactory to MFD that certifies the performance of the services by the Company and the accuracy of information provided by the Company.
ARTICLE VI. DIVERSIFICATION AND RELATED LIMITATIONS
6.1. Each Trust and MFD represent and warrant that each Portfolio of the Trust will meet the diversification requirements of Section 817 (h) (1) of the Code and Treas. Reg. 1.817-5, relating to the diversification requirements for variable annuity, endowment, or life insurance contracts, as they may be amended from time to time (and any revenue rulings, revenue procedures, notices, and other published announcements of the Internal Revenue Service interpreting these sections), as if those requirements applied directly to each such Portfolio. In the event that any Portfolio is not so diversified at the end of any applicable quarter, such Trust and MFD will make every effort to: (a) adequately diversify the Portfolio so as to achieve compliance within the grace period afforded by Treas. Reg. 1.817.5, and (b) notify the Company.
6.2. Each Trust and MFD represent that each Portfolio will elect to be qualified as a Regulated Investment Company under Subchapter M of the Code and that they will maintain such qualification (under Subchapter M or any successor or similar provision).
ARTICLE VII. POTENTIAL MATERIAL CONFLICTS
7.1. Each Trust agrees that its relevant Board, constituted with a majority of disinterested trustees, will monitor each Portfolio of such Trust for the existence of any material irreconcilable conflict between the interests of the variable annuity contract owners and the variable life insurance policy owners of the Company and/or affiliated companies (contract owners) investing in such Trust. The relevant Board shall have the sole authority to determine if a material irreconcilable conflict exists, and such determination shall be binding on the Company only if approved in the form of a resolution by a majority of the relevant Board, or a majority of the disinterested trustees of the relevant Board. The relevant Board will give prompt notice of any such determination to the Company.
7.2. The Company agrees that it will be responsible for assisting each relevant Trust Board in carrying out its responsibilities under the conditions set forth in the Trusts exemptive application pursuant to which the SEC has granted the Mixed and Shared Funding Exemptive Order by providing each Board, as it may reasonably request, with all information necessary for such Board to consider any issues raised and agrees that it will be responsible for promptly reporting any potential or existing conflicts of which it is aware to such Board including, but not limited to, an obligation by the Company to inform such Board whenever contract owner voting instructions are disregarded. The Company also agrees that, if a material irreconcilable conflict arises, it will at its own cost remedy such conflict up to and including (a) withdrawing the assets allocable to some or all of the Accounts from the relevant Trust(s) or any Portfolio and reinvesting such assets in a different investment medium, including (but not limited to) another Portfolio of a Trust, or submitting to a vote of all affected contract owners whether to withdraw assets from a Trust or any Portfolio and reinvesting such assets in a different investment medium and, as appropriate, segregating the assets attributable to any appropriate group of contract owners that votes in favor of such segregation, or offering to any of the affected contract owners the option of segregating the assets attributable to their contracts or policies, and (b) establishing a new registered management investment company and segregating the assets underlying the Policies, unless a majority of Policy owners materially adversely affected by the conflict have voted to decline the offer to establish a new registered management investment company.
7.3. A majority of the disinterested trustees of the relevant Board shall determine whether any proposed action by the Company adequately remedies any material irreconcilable conflict. In the event that a
Board determines that any proposed action does not adequately remedy any material irreconcilable conflict, the Company will withdraw from investment in the relevant Trust each of the Accounts designated by the disinterested trustees and terminate this Agreement within six (6) months after the relevant Board informs the Company in writing of the foregoing determination; provided, however, that such withdrawal and termination shall be limited to the extent required to remedy any such material irreconcilable conflict as determined by a majority of the disinterested trustees of the relevant Board.
7.4. If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Mixed and Shared Funding Exemptive Order) on terms and conditions materially different from those contained in the Mixed and Shared Funding Exemptive Order, then (a) the Trusts and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with Rule 6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such rules are applicable; and (b) Sections 3.5, 3.6, 7.1, 7.2, 7.3 and 7.4 of this Agreement shall continue in effect only to the extent that terms and conditions substantially identical to such Sections are contained in such Rule(s) as so amended or adopted.
ARTICLE VIII. INDEMNIFICATION
8.1. Indemnification by the Company
The Company agrees to indemnify and hold harmless each Trust, MFD, any affiliates of MFD, and each of their respective directors/trustees, officers and each person, if any, who controls each Trust or MFD within the meaning of Section 15 of the 1933 Act, and any agents or employees of the foregoing (each an Indemnified Party, or collectively, the Indemnified Parties for purposes of this Section 8.1) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Company) or expenses (including reasonable counsel fees) to which any Indemnified Party may become subject under any statute, regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Shares or the Policies and:
(a) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus or statement of additional information for the Policies or contained in the Policies or sales literature or other promotional material for the Policies (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reasonable reliance upon and in conformity with information furnished to the Company or its designee by or on behalf of the relevant Trust or MFD for use in the registration statement, prospectus or statement of additional information for the Policies or in the Policies or sales literature or other promotional material (or any amendment or supplement) or otherwise for use in connection with the sale of the Policies or Shares; or
(b) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, statement of additional information or sales literature or other promotional material of relevant Trust not supplied by the Company or its designee, or persons under its control and on which the Company has reasonably relied) or wrongful conduct of the Company or persons under its control, with respect to the sale or distribution of the Policies or Shares; or
(c) arise out of any untrue statement or alleged untrue statement of a material fact contained in the registration statement, prospectus, statement of additional information, or sales literature or other promotional literature of the relevant Trust, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished to the relevant Trust by or on behalf of the Company; or
(d) arise out of or result from any material breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Company; or
(e) arise as a result of any failure by the Company to provide the services and furnish the materials under the terms of this Agreement;
as limited by and in accordance with the provisions of this Article VIII.
8.2. Indemnification by the Trusts
Each Trust severally agrees to indemnify and hold harmless the Company and each of its directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act, and any agents or employees of the foregoing (each an Indemnified Party, or collectively, the Indemnified Parties for purposes of this Section 8.2) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of such Trust) or expenses (including reasonable counsel fees) to which any Indemnified Party may become subject under any statute, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Shares or the Policies and:
(a) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus, statement of additional information or sales literature or other promotional material of such Trust (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statement therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reasonable reliance upon and in conformity with information furnished to such Trust, MFS, MFD or their respective designees by or on behalf of the Company for use in the registration statement, prospectus or statement of additional information for such Trust or in sales literature or other promotional material for such Trust (or any amendment or supplement) or otherwise for use in connection with the sale of the Policies or Shares; or
(b) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, statement of additional information or sales literature or other promotional material for the Policies not supplied by such Trust, MFS, MFD or any of their respective designees or persons under their respective control and on which any such entity has reasonably relied) or wrongful conduct of such Trust or persons under its control, with respect to the sale or distribution of the Policies or Shares; or
(c) arise out of any untrue statement or alleged untrue statement of a material fact contained in the registration statement, prospectus, statement of additional information, or sales literature or other promotional literature of the Accounts or relating to the Policies, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission
was made in reliance upon information furnished to the Company by or on behalf of such Trust, MFS or MFD; or
(d) arise out of or result from any material breach of any representation and/or warranty made by such Trust in this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification requirements specified in Article VI of this Agreement) or arise out of or result from any other material breach of this Agreement by such Trust; or
(e) arise out of or result from the materially incorrect or untimely calculation or reporting of the daily net asset value per share or dividend or capital gain distribution rate; or
(f) arise as a result of any failure by such Trust to provide the services and furnish the materials under the terms of the Agreement;
as limited by and in accordance with the provisions of this Article VIII.
8.3. In no event shall any Trust be liable under the indemnification provisions contained in this Agreement to any individual or entity, including without limitation, the Company, or any Participating Insurance Company or any Policy holder, with respect to any losses, claims, damages, liabilities or expenses that arise out of or result from (i) a breach of any representation, warranty, and/or covenant made by the Company hereunder or by any Participating Insurance Company under an agreement containing substantially similar representations, warranties and covenants; (ii) the failure by the Company or any Participating Insurance Company to maintain its segregated asset account (which invests in any Portfolio) as a legally and validly established segregated asset account under applicable state law and as a duly registered unit investment trust under the provisions of the 1940 Act (unless exempt therefrom); or (iii) the failure by the Company or any Participating Insurance Company to maintain its variable annuity and/or variable life insurance contracts (with respect to which any Portfolio serves as an underlying funding vehicle) as life insurance, endowment or annuity contracts under applicable provisions of the Code.
8.4. Neither the Company nor any Trust shall be liable under the indemnification provisions contained in this Agreement with respect to any losses, claims, damages, liabilities or expenses to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, willful misconduct, or negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement.
8.5. Promptly after receipt by an Indemnified Party under this Section 8.5 of notice of commencement of any action, such Indemnified Party will, if a claim in respect thereof is to be made against the indemnifying party under this section, notify the indemnifying party of the commencement thereof; but the omission so to notify the indemnifying party will not relieve it from any liability which it may have to any Indemnified Party otherwise than under this section. In case any such action is brought against any Indemnified Party, and it notified the indemnifying party of the commencement thereof, the indemnifying party will be entitled to participate therein and, to the extent that it may wish, assume the defense thereof, with counsel satisfactory to such Indemnified Party. After notice from the indemnifying party of its intention to assume the defense of an action, the Indemnified Party shall bear the expenses of any additional counsel obtained by it, and the indemnifying party shall not be liable to such Indemnified Party under this section for any legal or other expenses subsequently incurred by such Indemnified Party in connection with the defense thereof other than reasonable costs of investigation.
8.6. Each of the parties agrees promptly to notify the other parties of the commencement of any litigation or proceeding against it or any of its respective officers, directors, trustees, employees or 1933 Act
control persons in connection with the Agreement, the issuance or sale of the Policies, the operation of the Accounts, or the sale or acquisition of Shares.
8.7. A successor by law of the parties to this Agreement shall be entitled to the benefits of the indemnification contained in this Article VIII. The indemnification provisions contained in this Article VIII shall survive any termination of this Agreement.
ARTICLE IX. APPLICABLE LAW
9.1. This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of The Commonwealth of Massachusetts.
9.2. This Agreement shall be subject to the provisions of the 1933, 1934 and 1940 Acts, and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the SEC may grant and the terms hereof shall be interpreted and construed in accordance therewith.
ARTICLE X. NOTICE OF FORMAL PROCEEDINGS
Each Trust and MFD agree that each such party shall promptly notify the other parties to this Agreement, in writing, of the institution of any formal proceedings brought against such party or its designees by FINRA, the SEC, or any insurance department or any other regulatory body regarding such partys duties under this Agreement or related to the sale of the Policies, the operation of the Accounts, or the purchase of the Shares.
ARTICLE XI. CONTROLS AND PROCEDURES
11.1. The Company has implemented controls and procedures that are reasonably designed to ensure compliance with applicable laws and regulations, as well as the terms of this Agreement. Without limiting the foregoing, these controls and procedures are reasonably designed to ensure, and MFD or a Trust may request certifications on an annual basis with respect to, each of the following:
(a) Orders for Shares received by the Company for each Portfolio comply with the Portfolios restrictions with respect to purchases, transfers, redemptions and exchanges as set forth in each Portfolios prospectus and statement of additional information;
(b) Orders for Shares received by the Company prior to the Portfolios pricing time set forth in its prospectus (e.g., the close of the New York Stock Exchange normally 4:00 p.m. Eastern time) are segregated from those received by the Company at or after such time, and are properly transmitted to the Portfolios (or their agents) for execution at the current days net asset value (NAV); and orders received by the Company at or after such time are properly transmitted to the Portfolios (or their agents) for execution at the next days NAV;
(c) Late trading in Shares by Policy holders is identified and prevented and market timing is appropriately addressed;
(d) Compliance with applicable state securities laws, including without limitation blue sky laws and related rules and regulations;
(e) Compliance with all applicable federal, state and foreign laws, rules and regulations regarding the detection and prevention of money laundering activity; and
(f) Effective business continuity and disaster recovery systems with respect to the services contemplated by the Agreement.
11.2 The Company shall ensure that any other party to whom the Company assigns or delegates any services hereunder is responsible for, and has controls and procedures that are reasonably designed to ensure, each of the items set forth in Section 11.1 above.
ARTICLE XII. TERMINATION
12.1. This Agreement shall terminate with respect to the Accounts, or one, some, or all Portfolios:
(a) at the option of any party upon six (6) months advance written notice to the other parties; or
(b) at the option of the Company to the extent that the Shares of Portfolios are not reasonably available to meet the requirements of the Policies or are not appropriate funding vehicles for the Policies, as reasonably determined by the Company. Without limiting the generality of the foregoing, the Shares of a Portfolio would not be appropriate funding vehicles if, for example, such Shares did not meet the diversification or other requirements referred to in Article VI hereof; or if the Company would be permitted to disregard Policy owner voting instructions pursuant to Rule 6e-2 or Rule 6e-3(T) under the 1940 Act. Prompt notice of the election to terminate for such cause and an explanation of such cause shall be furnished to the relevant Trust(s) by the Company; or
(c) at the option of a Trust or MFD upon institution of formal proceedings against the Company by FINRA, the SEC, or any insurance department or any other regulatory body that would have a material adverse impact on the Companys duties under this Agreement or related to the sale of the Policies, the operation of the Accounts, or the purchase of the Shares; or
(d) at the option of the Company upon institution of formal proceedings against a Trust by FINRA, the SEC, or any state securities or insurance department or any other regulatory body that would have a material adverse impact on such Trusts or MFDs duties under this Agreement or related to the sale of the Shares; or
(e) at the option of the Company, a Trust or MFD upon receipt of any necessary regulatory approvals and/or the vote of the Policy owners having an interest in the Accounts (or any subaccounts) to substitute the shares of another investment company for the corresponding Portfolio Shares in accordance with the terms of the Policies for which those Portfolio Shares had been selected to serve as the underlying investment media. The Company will give thirty (30) days prior written notice to the relevant Trust(s) of the Date of any proposed vote or other action taken to replace the Shares; or
(f) termination by either a Trust or MFD by written notice to the Company, if either one or both of such Trust or MFD shall determine, in their sole judgment exercised in good faith, that the Company has suffered a material adverse change in its business, operations, financial condition, or prospects since the date of this Agreement or is the subject of material adverse publicity; or
(g) termination by the Company by written notice to a Trust and MFD, if the Company shall determine, in its sole judgment exercised in good faith, that such Trust or MFD has suffered a material adverse change in this business, operations, financial condition or prospects since the date of this Agreement or is the subject of material adverse publicity; or
(h) at the option of any party to this Agreement, upon another partys material breach of any provision of this Agreement; or
(i) upon assignment of this Agreement, unless made with the written consent of the parties hereto.
(j) at the option of the Company if a Trust fails to meet the diversification requirements specified in Article VI (other than any failure caused by the Companys actions or omissions) or the Company has a reasonable expectation that such Trust will fail to meet these diversification requirements in the future.
12.2. The notice shall specify the Portfolio or Portfolios, Policies and, if applicable, the Accounts as to which the Agreement is to be terminated.
12.3. It is understood and agreed that the right of any party hereto to terminate this Agreement pursuant to Section 12.1(a) may be exercised for cause or for no cause.
12.4. Except as necessary to implement Policy owner initiated transactions, or as required by state insurance laws or regulations, the Company shall not redeem the Shares attributable to the Policies (as opposed to the Shares attributable to the Companys assets held in the Accounts), until ten (10) days after the Company shall have notified the relevant Trust of its intention to do so.
12.5. Notwithstanding any termination of this Agreement, each Trust and MFD shall, at the option of the Company, continue to make available additional shares of the Portfolios pursuant to the terms and conditions of this Agreement, for all Policies in effect on the effective date of termination of this Agreement (the Existing Policies), except as otherwise provided under Article VII of this Agreement. Specifically, without limitation, the owners of the Existing Policies shall be permitted to transfer or reallocate investment under the Policies, redeem investments in any Portfolio and/or invest in each Trust upon the making of additional purchase payments under the Existing Policies.
ARTICLE XIII. NOTICES
Any notice shall be sufficiently given when sent by registered or certified mail, overnight courier or facsimile to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other party.
If to Trust I:
MFS Variable Insurance Trust
111 Huntington Avenue
Boston, Massachusetts 02199
email: DLGDSDealerSpt@MFS.com
Facsimile No.: (617) 954-5182
Attn: Susan S. Newton, Assistant Secretary
If to Trust II:
MFS Variable Insurance Trust II
111 Huntington Avenue
Boston, Massachusetts 02199
email: DLGDSDealerSpt@MFS.com
Facsimile No.: (617) 954-5182
Attn: Susan S. Newton, Assistant Secretary
If to Trust III:
MFS Variable Insurance Trust III
111 Huntington Avenue
Boston, Massachusetts 02199
email: DLGDSDealerSpt@MFS.com
Facsimile No.: (617) 954-5182
Attn: Susan S. Newton, Assistant Secretary
If to the Company:
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, AL 35223
email: john.sawyer@protective.com
Attn: Mr. John R. Sawyer
With copies to:
Senior Associate Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
email: max.berueffy@protective.com
If to MFD:
MFS Fund Distributors, Inc.
111 Huntington Avenue
Boston, Massachusetts 02199
email: DLGDSDealerSpt@MFS.com
Attn: General Counsel
ARTICLE XIV. MISCELLANEOUS
14.1. Subject to the requirement of legal process and regulatory authority, each party hereto shall treat as confidential the names and addresses of the owners of the Policies and all information reasonably identified as confidential in writing by any other party hereto and, except as permitted by this Agreement or as otherwise required by applicable law or regulation, shall not disclose, disseminate or utilize such names and
addresses and other confidential information without the express written consent of the affected party until such time as it may come into the public domain.
14.2. The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
14.3. This Agreement may be executed simultaneously in one or more counterparts, each of which taken together shall constitute one and the same instrument.
14.4. If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.
14.5. The Schedule attached hereto, as modified from time to time, is incorporated herein by reference and is part of this Agreement.
14.6. Each party hereto shall cooperate with each other party in connection with inquiries by appropriate governmental authorities (including without limitation the SEC, FINRA, and state insurance regulators) relating to this Agreement or the transactions contemplated hereby.
14.7. The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.
14.8. A copy of Trust Is and Trust IIs Declaration of Trust is on file with the Secretary of State of The Commonwealth of Massachusetts. The Company acknowledges that the obligations of or arising out of this instrument are not binding upon any of each Trusts trustees, officers, employees, agents or shareholders individually, but are binding solely upon the assets and property of the relevant Trust in accordance with its proportionate interest hereunder. The Company further acknowledges that the assets and liabilities of each Portfolio are separate and distinct and that the obligations of or arising out of this instrument are binding solely upon the assets or property of the Portfolio on whose behalf the relevant Trust has executed this instrument. The Company also agrees that the obligations of each Portfolio hereunder shall be several and not joint, in accordance with its proportionate interest hereunder, and the Company agrees not to proceed against any Portfolio for the obligations of another Portfolio.
[Signature Page Follows]
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and on its behalf by its duly authorized representative and its seal to be hereunder affixed hereto as of the date specified above.
|
PROTECTIVE LIFE INSURANCE COMPANY |
|
|
By its authorized officer |
|
|
|
|
|
By: |
/s/ John R. Sawyer |
|
|
John R. Sawyer |
|
|
Senior Vice President and Chief Distribution Officer |
|
|
|
|
MFS VARIABLE INSURANCE TRUST, on behalf of the Portfolios By its authorized officer and not individually, |
|
|
|
|
|
By: |
/s/ Susan S. Newton |
|
|
Susan S. Newton |
|
|
Assistant Secretary |
|
|
|
|
MFS VARIABLE INSURANCE TRUST II, on behalf of the Portfolios By its authorized officer and not individually, |
|
|
|
|
|
By: |
/s/ Susan S. Newton |
|
|
Susan S. Newton |
|
|
Assistant Secretary |
|
|
|
|
MFS VARIABLE INSURANCE TRUST II, on behalf of the Portfolios By its authorized officer and not individually, |
|
|
|
|
|
By: |
/s/ Susan S. Newton |
|
|
Susan S. Newton |
|
Assistant Secretary |
|
|
|
|
|
MFS FUND DISTRIBUTORS, INC. By its authorized officer, |
|
|
|
|
|
By: |
/s/ James A. Jessee |
|
|
James A. Jessee |
|
|
President |
SCHEDULE A
SEPARATE ACCOUNT AND POLICIES SUBJECT TO THE PARTICIPATION AGREEMENT
PROTECTIVE VARIABLE ANNUITY SEPARATE ACCOUNT - ALL POLICIES
PROTECTIVE VARIABLE LIFE SEPARATE ACCOUNT - ALL POLICIES
FIRST VARIABLE ANNUITY FUND E - ALL POLICIES
PORTFOLIOS SUBJECT TO THE PARTICIPATION AGREEMENT
May 1, 2012
All Portfolios or series of shares of the Trusts that are available and open to new investors on or after the effective date of this Agreement.
AMENDMENT NO. 1 TO PARTICIPATION AGREEMENT
THIS AMENDMENT NO. 1 TO THE AMENDED AND RESTATED PARTICIPATION AGREEMENT is made as of this 1st day of October, 2020 by and among MFS VARIABLE INSURANCE TRUST, a Massachusetts business trust (the Trust I), MFS VARIABLE INSURANCE TRUST II, a Massachusetts business trust (the Trust II), MFS VARIABLE INSURANCE TRUST III, a Delaware statutory trust (the Trust III)( (Trust I, Trust II and Trust III each referred to individually, as the Trust and, collectively the Trusts), MFS FUND DISTRIBUTORS, INC., a Delaware corporation (MFD), and PROTECTIVE LIFE INSURANCE COMPANY, a Tennessee corporation (the Company), on its own behalf and on behalf of each segregated asset accounts of the Company as set forth on Schedule A of the Agreement (defined below) (the Accounts). Capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the Agreement (defined below).
RECITALS
WHEREAS, the Trusts, the Company and MFD are parties to a certain Participation Agreement dated May 1, 2012 (the Agreement), in which the series of shares of each Trust (each, a Portfolio, and, collectively, the Portfolios) and the classes of shares of those Portfolios (the Shares) offered by each Trust to the Company and the Accounts are set forth on Schedule A of the Agreement;
WHEREAS, the Company will issue certain variable annuity and/or variable life insurance contracts (individually, the Policy or, collectively, the Policies) which, if required by applicable law, will be registered under the 1933 Act;
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company intends to purchase the Shares of the Portfolios as specified in Schedule A of the Agreement on behalf of the Accounts to fund the Policies, and the Trusts intend to sell such Shares to the Accounts at net asset value; and
WHEREAS, the parties desire to amend the Agreement to add an additional Policy to Schedule A; and
NOW, THEREFORE, in consideration of the mutual promises set forth herein, the parties hereto agree that Schedule A of the Agreement is deleted and replaced with Schedule A attached hereto.
Except as expressly amended hereby, the Agreement shall continue in full force and effect.
[Signature page to follow.]
IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the date first above written.
PROTECTIVE LIFE INSURANCE COMPANY
|
|
MFS VARIABLE INSURANCE TRUST, on behalf of the Portfolios
|
||
|
|
|
||
|
|
By: |
|
|
[Name] |
|
[Name] |
||
[Title] |
|
[Title] |
||
|
|
|
||
MFS FUND DISTRIBUTORS, INC.
|
|
MFS VARIABLE INSURANCE TRUST II, on behalf of the Portfolios
|
||
|
|
|
||
By: |
|
|
By: |
|
[Name] |
|
[Name] |
||
[Title] |
|
[Title] |
||
|
|
|
||
|
|
MFS VARIABLE INSURANCE TRUST III, on behalf of the Portfolios
|
||
|
|
|
||
|
|
By: |
|
|
|
|
[Name] |
||
|
|
[Title] |
||
SCHEDULE A
SEPARATE ACCOUNT AND POLICIES SUBJECT TO THE PARTICIPATION AGREEMENT
PROTECTIVE VARIABLE ANNUITY SEPARATE ACCOUNT ALL POLICIES
PROTECTIVE VARIABLE LIFE SEPARATE ACCOUNT ALL POLICIES
FIRST VARIABLE ANNUITY FUND E ALL POLICIES
PROTECTIVE COLI PPVUL SEPARATE ACCOUNT PROTECTIVE BENEFITS PRIVATE PLACEMENT VUL
PROTECTIVE COLI VUL SEPARATE ACCOUNT PROTECTIVE BENEFITS REGISTERED VUL
PORTFOLIOS SUBJECT TO THE PARTICIPATION AGREEMENT
October 1, 2020
All Portfolios or series of shares of the Trusts that are available and open to new investors on or after the effective date of this Agreement.
FUND PARTICIPATION AGREEMENT
THIS AGREEMENT, made as of the 30th day of November 2020, by and between NEUBERGER BERMAN ADVISERS MANAGEMENT TRUST (TRUST), NEUBERGER BERMAN BD LLC (NB BD), a Delaware limited liability company, and PROTECTIVE LIFE INSURANCE COMPANY (the LIFE COMPANY).
WHEREAS, TRUST is registered with the Securities and Exchange Commission (SEC) under the Investment Company Act of 1940, as amended (40 Act) as an open-end, diversified management investment company; and
WHEREAS, TRUST is organized as a series fund comprised of several portfolios (Portfolios), the currently available of which are listed on Appendix A hereto; and
WHEREAS, TRUST was organized to act as the funding vehicle for certain variable life insurance and/or variable annuity contracts (Variable Contracts) offered by life insurance companies through separate accounts of such life insurance companies (Participating Insurance Companies) and also offers its shares to certain qualified pension and retirement plans; and
WHEREAS, TRUST has received an order from the SEC, dated May 5, 1995 (File No. 812-9164), granting Participating Insurance Companies and their separate accounts exemptions from the provisions of Sections 9(a), 13(a), 15(a) and 15(b) of the 40 Act, and Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the Portfolios of the TRUST to be sold to and held by variable annuity and variable life insurance separate accounts of both affiliated and unaffiliated life insurance companies and certain qualified pension and retirement plans (the Order); and
WHEREAS, LIFE COMPANY has established or will establish one or more separate accounts (Separate Accounts) to offer Variable Contracts and is desirous of having TRUST as one of the underlying funding vehicles for such Variable Contracts; and
WHEREAS, NB BD is registered with the SEC as an investment adviser under the Investment Advisers Act of 1940 and as a broker-dealer under the Securities Exchange Act of 1934, as amended; and
WHEREAS, NB BD is the distributor and principal underwriter, as that term is defined in the 40 Act, of the shares of each Portfolio of TRUST; and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, LIFE COMPANY intends to purchase shares of TRUST to fund the aforementioned Variable Contracts and TRUST is authorized to sell such shares to LIFE COMPANY at net asset value;
NOW, THEREFORE, in consideration of their mutual promises, LIFE COMPANY, TRUST, and NB BD agree as follows:
Article I. SALE OF TRUST SHARES
1.1 TRUST agrees to make available to the Separate Accounts of LIFE COMPANY shares of the selected Portfolios as listed in Appendix A for investment of proceeds from Variable Contracts allocated to the designated Separate Accounts, such shares to be offered as provided in TRUSTs Prospectus.
1.2 TRUST agrees to sell to LIFE COMPANY those shares of the selected Portfolios of TRUST which LIFE COMPANY orders, executing such orders on a daily basis at the net asset value next computed after receipt by TRUST or its designee of the order for the shares of TRUST. For purposes of this Section 1.2, LIFE COMPANY shall be the designee of TRUST for receipt of such orders from LIFE COMPANY and receipt by such designee shall constitute receipt by TRUST; provided that TRUST receives notice of such order by 11:00 a.m. New York Time on the next following Business Day. Business Day shall mean any day on which the New York Stock Exchange is open for trading and on which TRUST calculates its net asset value pursuant to the rules of the SEC.
1.3 TRUST agrees to redeem for cash, on LIFE COMPANYs request, any full or fractional shares of TRUST held by LIFE COMPANY, executing such requests on a daily basis at the net asset value next computed after receipt by TRUST or its designee of the request for redemption. For purposes of this Section 1.3, LIFE COMPANY shall be the designee of TRUST for receipt of requests for redemption from LIFE COMPANY and receipt by such designee shall constitute receipt by TRUST; provided that TRUST receives notice of such request for redemption by 11:00 a.m. New York time on the next following Business Day.
1.4 TRUST shall furnish, on or before the ex-dividend date, notice to LIFE COMPANY of any income dividends or capital gain distributions payable on the shares of any Portfolio of TRUST. LIFE COMPANY hereby elects to receive all such income dividends and capital gain distributions as are payable on a Portfolios shares in additional shares of the Portfolio. TRUST shall notify LIFE COMPANY of the number of shares so issued as payment of such dividends and distributions. LIFE COMPANY reserves the right to revoke this election by written notice to the Trust.
1.5 TRUST shall make the net asset value per share for the selected Portfolio(s) available to LIFE COMPANY on a daily basis as soon as reasonably practicable after the net asset value per share is calculated but shall use its best efforts to make such net asset value available by 6:30 p.m. New York time. If TRUST provides LIFE COMPANY with materially incorrect share net asset value information through no fault of LIFE COMPANY, LIFE COMPANY on behalf of the Separate Accounts, shall be entitled to an adjustment to the number of shares purchased or redeemed to reflect the correct share net asset value and the TRUST shall bear the reasonable and necessary expenses of correcting such errors including correcting statements previously provided to Contract owners in connection with TRUST shares held by Variable Contract owners or in adjusting proceeds paid to Variable Contract owners who have redeemed interests under their Variable Contracts. Any material error (determined in accordance with SEC guidelines) in the calculation of net asset value per share, dividend or capital gain information shall be reported promptly upon discovery to LIFE COMPANY.
1.6 At the end of each Business Day, LIFE COMPANY shall use the information described in Section 1.5 to calculate Separate Account unit values for the day. Using these unit values, LIFE COMPANY shall process each such business days Separate Account transactions based on requests and premiums received by it by the time as of which the TRUST calculates its share price as disclosed in the prospectus for the TRUST to determine the net dollar amount of TRUST shares which shall be purchased or redeemed at that days closing net asset value per share. The net share purchase or redemption orders so determined shall be transmitted to TRUST by LIFE COMPANY by 11:00 a.m. New York Time on the Business Day next following LIFE COMPANYs receipt of such requests and premiums in accordance with the terms of Sections 1.2 and 1.3 hereof.
1.7 If LIFE COMPANYs order requests the net purchase of TRUST shares, LIFE COMPANY shall pay for such purchase by wiring federal funds to TRUST or its designated custodial account on the day the order is actually transmitted by LIFE COMPANY by 4:00 p.m. New York Time. If LIFE COMPANYs order requests a net redemption resulting in a payment of redemption proceeds to LIFE COMPANY, TRUST shall wire the redemption proceeds to LIFE COMPANY on the day the order is actually received by TRUST by 4:00 p.m. New York Time unless doing so would require TRUST to dispose of portfolio securities or otherwise incur additional costs, but in such event, proceeds shall be wired to LIFE COMPANY within seven days and TRUST shall notify the person designated in writing by LIFE COMPANY as the recipient for such notice of such delay by 4:00 p.m. New York Time the same business day that LIFE COMPANY transmits the redemption order to TRUST. If LIFE COMPANYs order requests the application of redemption proceeds from the redemption of shares to the purchase of shares of another fund administered or distributed by NB BD, TRUST shall so apply such proceeds on the same Business Day that LIFE COMPANY transmits such order to TRUST.
1.8 Notwithstanding Section 1.7, TRUST reserves the right to suspend the right of redemption or postpone the date of payment or satisfaction upon redemption consistent with Section 22(e) of the 40 Act and any rules thereunder.
1.9 TRUST agrees that all shares of the Portfolios of TRUST will be sold only to Participating Insurance Companies which have agreed to participate in TRUST to fund their Separate Accounts and/or to certain qualified pension and other retirement plans, all in accordance with the requirements of Section 817(h) of the Internal Revenue Code of 1986, as amended (Code) and Treasury Regulation 1.817-5. Shares of the Portfolios of TRUST will not be sold directly to the general public.
1.10 TRUST may refuse to sell shares of any Portfolio to any person, or suspend or terminate the offering of the shares of any Portfolio if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Board of Trustees of TRUST, acting in good faith and in light of its fiduciary duties under federal and any applicable state laws, deemed necessary and in the best interests of the shareholders of such Portfolios.
1.10 Notwithstanding any other provision to the contrary, to the extent that LIFE COMPANY utilizes the National Securities Clearing Corporations (NSCC) Mutual Fund Settlement, Entry and Registration Verification system (Fund/SERV), then the following provisions shall apply:
a. On each Business Day, LIFE COMPANY shall aggregate purchase orders and redemption orders for each Separate Account received by LIFE COMPANY prior to the Close of Trading on Business Day and shall communicate to the TRUST by National Securities Clearing Corporations (NSCC) Mutual Fund Settlement, Entry and Registration Verification system (Fund/SERV) the aggregate purchase and redemption orders for each Separate Account received by Insurance Company prior to the Close of Trading by no later than the NSCCs Defined Contribution Clearance & Settlement (DCC&S) cycle 8 (generally 7:30 a.m. Eastern time) on the following Business Day.
b. The LIFE COMPANY or its designee certifies that all instructions delivered to the TRUST or its designee on any Business Day shall have been received by the LIFE COMPANY or its designee from the Separate Account based on instructions from Contract owners received by the close of trading (normally 4:00 p.m. New York time) on the New York Stock Exchange (the Close of Trading) on such Business Day and that any instructions received by the LIFE COMPANY or its designee after the Close of Trading on any given Business Day will be transmitted to the TRUST or its designee on the next Business Day. The LIFE COMPANY or its designee further certifies that all such Instructions received by it from the Separate Account based on instructions from Variable Contract owners by the Close of Trading on any Business Day will be delivered to the TRUST or its designee on such Business Day.
c. Trade and, if applicable, broker/dealer information provided by the LIFE COMPANY or its designee to the TRUST or its designee through Fund/SERV shall be accurate, complete and, in the format prescribed by the NSCC. All instructions by the LIFE COMPANY or its designee for each Fund/SERV transaction shall be true and correct and will have been duly authorized. The LIFE COMPANY or its designee shall adopt, implement and maintain procedures reasonably designed to ensure the accuracy of all transmissions through Fund/SERV and to limit the access to, and the inputting of data into, Fund/SERV to persons specifically authorized by the LIFE COMPANY.
d. The LIFE COMPANY or its designee shall perform any and all duties, functions, procedures and responsibilities assigned to it under this Agreement and as otherwise established by the NSCC. The LIFE COMPANY or its designee shall conduct each of the forgoing activities in a competent manner and in compliance with (a) all applicable laws, rules and regulations, including NSCC rules and procedures relating to Fund/SERV, and (b) the then current prospectuses and statements of additional information of the Portfolios.
e. For each Fund/SERV transaction, the LIFE COMPANY or its designee shall provide the TRUST and its designee with all information necessary or appropriate to establish and maintain each Fund/SERV transaction (and any subsequent changes to such information) which the LIFE COMPANY or its designee hereby certifies is and shall remain true and correct. The LIFE COMPANY or its designee shall maintain documents required by the TRUST or by applicable law, rules or regulations to effect Fund/SERV transactions.
f. Processing errors which result from any delay or error caused by the LIFE COMPANY or its designee may be adjusted through Fund/SERV by the LIFE COMPANY or its designee by the necessary transactions on an as-of basis and the cost to the TRUST and its designee of such transactions
shall be borne by the LIFE COMPANY; provided however, prior authorization must be obtained from the TRUST if the transaction is back dated more than one day or to a previous calendar year.
g. Any information provided by the TRUST or its designee to the LIFE COMPANY or its designee electronically through Fund/SERV and pursuant to this Agreement shall satisfy the delivery obligations as outlined by SEC Rule 10b-10 and, as such, the TRUST and its designee have the informed consent of the LIFE COMPANY or its designee to suppress the delivery of this information using paper-media. The LIFE COMPANY or its designee will promptly verify the accuracy of all confirmations of transactions and records received by the LIFE COMPANY or its designee through Fund/SERV.
h. Aggregate purchase and redemption orders accepted by the TRUST, but not transmitted via the DCC&S NSCC Fund/SERV, shall be processed and settled in accordance with the provisions of this Agreement without regard to this Section 1.10.
Article II. REPRESENTATIONS AND WARRANTIES
2.1 LIFE COMPANY represents and warrants that it is an insurance company duly organized and in good standing under applicable law and that it has legally and validly established each Separate Account as a segregated asset account under such laws, and that LIFE COMPANY the principal underwriter for the Variable Contracts, is registered as a broker-dealer under the Securities Exchange Act of 1934.
2.2 LIFE COMPANY represents and warrants that it has registered or, prior to any issuance or sale of the Variable Contracts, will register each Separate Account as a unit investment trust (UIT) in accordance with the provisions of the 40 Act and cause each Separate Account to remain so registered to serve as a segregated asset account for the Variable Contracts, unless an exemption from registration is available.
2.3 LIFE COMPANY represents and warrants that the Variable Contracts will be registered under the Securities Act of 1933 (the `33 Act) unless an exemption from registration is available prior to any issuance or sale of the Variable Contracts and that the Variable Contracts will be issued and sold in compliance in all material respects with all applicable federal and state laws and further that the sale of the Variable Contracts shall comply in all material respects with state insurance law suitability requirements.
2.4 LIFE COMPANY represents and warrants that the Variable Contracts are currently and at the time of issuance will be treated as life insurance, endowment or annuity contracts under applicable provisions of the Code, that it will maintain such treatment and that it will notify TRUST immediately upon having a reasonable basis for believing that the Variable Contracts have ceased to be so treated or that they might not be so treated in the future.
2.5 LIFE COMPANY represents and warrants that it shall deliver such prospectuses, statements of additional information, proxy statements and periodic reports of the TRUST as required to be delivered under applicable federal or state law and interpretations of federal and state securities regulators thereunder in connection with the offer, sale or acquisition of the Variable Contracts.
2.6 TRUST represents and warrants that the Portfolio shares offered and sold pursuant to this Agreement will be registered under the 33 Act and sold in accordance with all applicable federal and state laws, and TRUST shall be registered under the 40 Act prior to and at the time of any issuance or sale of such shares. TRUST shall amend its registration statement under the 33 Act and the 40 Act from time to time as required in order to effect the continuous offering of its shares. TRUST shall register and qualify its shares for sale in accordance with the laws of the various states to the extent necessary to perform its obligations under this Agreement.
2.7 TRUST represents and warrants that each Portfolio currently complies, and will continue to comply with the diversification requirements set forth in Section 817(h) of the Code, and the rules and regulations thereunder, including without limitation Treasury Regulation 1.817-5 (or any successor or similar provisions), and will notify LIFE COMPANY immediately upon having a reasonable basis for believing any Portfolio has ceased to comply or might not so comply and will immediately take all reasonable steps to adequately diversify the Portfolio to achieve compliance within the grace period afforded by Regulation 1.817-5. Upon request, and in any event no later than 60 days following the end of each calendar quarter, TRUST will provide Company with a certificate of compliance with Section 817(h).
2.8 TRUST represents and warrants that each Portfolio invested in by the Separate Account is currently qualified as a regulated investment company under Subchapter M of the Code, that it will maintain such qualification under Subchapter M (or any successor or similar provisions) and will notify LIFE COMPANY immediately upon having a reasonable basis for believing any Portfolio has ceased to so qualify or might not so qualify in the future.
2.9 Subject to review by LIFE COMPANY as provided in section 4.2 of this Agreement, LIFE COMPANY hereby consents to the use by TRUST of the name of LIFE COMPANY and to the reference by TRUST to the relationship between LIFE COMPANY and TRUST as part of an informational page on TRUSTS site on the World Wide Web portion of the Internet. The LIFE COMPANY hereby further consents to TRUSTS establishing a link between TRUSTS site and LIFE COMPANYs site from the same place that LIFE COMPANY is listed on TRUSTS site as described in the preceding sentence.
2.10 The Trust represents that to the extent that it decides to finance distribution expenses pursuant to Rule 12b-1 under the 1940 Act, it will have a board of trustees, a majority of whom are not interested persons of the Trust, to formulate and approve any plan under Rule 12b-1 to finance distribution expenses.
2.11 The Trust represents that the Trusts investment policies, fees and expenses are and shall at all times remain in compliance with the laws of the State of Delaware and the Trust represents that its respective operations are and shall at all times remain in material compliance with the laws of the State of Delaware to the extent required to perform this Agreement.
2.12 The Trust represents that it is lawfully organized and validly existing under the laws of the State of Delaware and that it does and will comply in all material respects with the 1940 Act.
2.13 NB BD represents and warrants that it is a member in good standing of the Financial Industry Regulatory Authority (FINRA) and is registered as a broker-dealer with the SEC. NB BD further represents that it will sell and distribute the Trusts share in accordance with the laws of the State of Delaware and any applicable state and federal securities law.
2.14 The Trust represents and warrants that its directors, officers, employees dealing with the money and/or securities of the Trust are and shall continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Trust in an amount not less than the minimum coverage as required by Rule 17g-(1) under the 1940 Act or related provisions as may be promulgated from time to time. The aforesaid blanket fidelity bond shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company.
2.15 NB BD represents and warrants that it is registered as an investment adviser and shall remain duly registered under all applicable federal and state securities laws and that it shall perform its obligations for the Trust in compliance in all material respects with the laws of the State of Delaware and any applicable state and federal securities laws.
2.16 Each party represents and warrants that the execution and delivery of this Agreement and the consummation of the transactions contemplated herein have been duly authorized by all necessary corporate, partnership or trust action, as applicable, by such party, and, when so executed and delivered, this Agreement will be the valid and binding obligation of such party enforceable in accordance with its terms.
2.17 LIFE COMPANY represents and warrants that all orders for the purchase and sale of TRUST shares submitted to the TRUST (or counted by LIFE COMPANY in submitting a net order under Section 1.6 of the Agreement) for execution at a price based on the net asset value per share (NAV) of the Trusts Portfolios next computed after receipt by LIFE COMPANY on a particular Business day, will have been received in good order by LIFE COMPANY prior to the time as of which the TRUST calculates its NAV on that Business Day, as disclosed in the prospectus for the pertinent Portfolio (the trading deadline), in accordance with Rule 22c-1 under the 1940 Act (subject only to exceptions as permitted under Rule 22c-1(c) under the 1940 Act, respecting initial purchase payments on variable annuity contracts, and to the established administrative procedures of LIFE COMPANY as described under Rule 6e-3(T), paragraph (b)(12)(iii) under the 1940 Act respecting premium processing for variable life insurance contracts).
2.18 In the prospectus for the Portfolios, the TRUST reserves the right to reject an investment or exchange order or to withdrawal the exchange privilege from any investor that NB BD believes is trying to time the market or is otherwise making exchanges that Neuberger Berman Management LLC believes to be excessive (collectively, these practices are referred to herein as excessive short-term trading). The Trust prospectus also discloses, and NB BD and LIFE COMPANY acknowledge, that frequent exchanges can interfere with fund management and affect costs and performance for other
shareholders. Accordingly, LIFE COMPANY agrees that it will cooperate with NB BD and the TRUST, by taking steps acceptable to NB BD and the TRUST to prevent its Variable Contract owners from excessive short-term trading in any Portfolio of the TRUST, which may include any one or more of the following measures: (i) by providing information, upon reasonable request, to NB BD and the TRUST, about cash flows into and out of any of the Portfolios from the separate accounts of LIFE COMPANY; (ii) by providing information, upon reasonable request, to NB BD and the TRUST, about any policies and procedures that LIFE COMPANY employs respecting frequent transfers of contract value among sub-accounts of the Separate Accounts, and about compliance with any such policies and procedures; (iii) by providing information, upon reasonable request, to NB BD and the TRUST respecting Variable Contract owner transactions, holdings and other information pertinent to the prevention of excessive short-term trading (although NB BD and TRUST acknowledge that such information need not include information that would identify owners of the Variable Contracts); (iv) by taking steps necessary, upon reasonable request of NB BD or the TRUST, to eliminate or prevent excessive short-term trading, including, but not limited to, restricting or withdrawing exchange privileges from Variable Contract owners that engage in excessive short-term trading to the extent permitted under applicable law and the terms of the Variable Contracts, and/or restricting and/or withdrawing a Variable Contract owners ability to make exchanges through automated means such as telephone, fax, or internet transmission; and (v) by assessing and collecting any redemption fee that may be adopted by the TRUST with respect to any Portfolio, either to comply with SEC rules or in accordance with any such determination made by the TRUSTs Board of Trustees. LIFE COMPANY represents that it shall abide by its policies and procedures reasonably designed to monitor and prevent market timing or excessive short-term trading by its Variable Contract owners.
2.19 LIFE COMPANY will, upon reasonable request, certify to the TRUST and NB BD that LIFE COMPANY is in compliance with Items 2.17 and/or 2.18 above.
2.20 The TRUST represents and warrants that it has adopted a compliance program in accordance with Rule 38a-1 under the 1940 Act, which includes appointing a Chief Compliance Officer (CCO) for the TRUST. The CCO is responsible for monitoring the operation of the TRUSTs compliance program, and for reviewing the compliance programs of service providers to the TRUST covered under Rule 38a-1 (Covered Service Providers).
2.21 The parties to this Agreement represent and warrant that they shall comply with all the applicable laws and regulations designed to prevent money laundering including without limitation the International Money Laundering Abatement and Anti-Terrorist Financing Act of 2001 (Title III of the USA PATRIOT ACT), and if required by such laws or regulations will share information with each other about individuals, entities, organizations and countries suspected of possible terrorist or money laundering activities in accordance with Section 314(b) of the USA PATRIOT ACT.
Article III. PROSPECTUS AND PROXY STATEMENTS
3.1 TRUST shall prepare and be responsible for filing with the SEC and any state regulators requiring such filing all shareholder reports, notices, proxy materials (or similar materials such as voting instruction solicitation materials), prospectuses and statements of additional information of TRUST. TRUST shall bear the costs of registration and qualification of shares of the Portfolios, preparation and filing of the documents listed in this Section 3.1 and all taxes to which an issuer is subject on the issuance and transfer of its shares.
3.2 TRUST will bear the printing costs (or duplicating costs with respect to the statement of additional information) and mailing costs (including postage) associated with the delivery of the following TRUST (or individual Portfolio) documents, and any supplements thereto, to existing Variable Contract owners of LIFE COMPANY (regardless of whether such documents are printed together with, or separate from, the documents for other trusts in the Variable Contracts):
(i) prospectuses and statements of additional information;
(ii) annual and semi-annual reports; and
(iii) proxy materials (including, but not limited to, the proxy cards, notice and statement, as well as the costs associated with tabulating votes). The TRUST may elect to retain, at its own expense, a proxy solicitation firm to perform some or all of the tasks necessary for the LIFE COMPANY to obtain voting instructions from Variable Contract owners.
LIFE COMPANY will submit any bills for printing, duplicating and/or mailing costs, relating to the TRUST documents described above, to TRUST for reimbursement by TRUST. LIFE COMPANY shall monitor such costs and shall use its best efforts to control these costs. LIFE COMPANY will provide TRUST on a semi-annual basis, or more frequently as reasonably requested by TRUST, with a current tabulation of the number of existing Variable Contract owners of LIFE COMPANY whose Variable Contract values are invested in TRUST. This tabulation will be sent to TRUST in the form of a letter signed by a duly authorized officer of LIFE COMPANY attesting to the accuracy of the information contained in the letter. If requested by LIFE COMPANY, the TRUST shall provide such documentation (including a final copy of the TRUSTs prospectus as set in type, a camera-ready copy or in print ready PDF electronic format ) and other assistance as is reasonably necessary in order for LIFE COMPANY to print the current prospectus for the TRUST. Should LIFE COMPANY wish to print any of these documents in a format different from that provided by TRUST, LIFE COMPANY shall provide Trust with sixty (60) days prior written notice and LIFE COMPANY shall bear the cost associated with any format change.
3.3 TRUST will provide, at its expense, LIFE COMPANY with the following TRUST (or individual Portfolio) documents, and any supplements thereto, with respect to prospective Variable Contract owners of LIFE COMPANY:
(i) camera-ready copy or an electronic copy in print ready PDF format of the current prospectus for printing by the LIFE COMPANY;
(ii) a copy of the statement of additional information suitable for duplication;
(iii) camera-ready copy of proxy material suitable for printing; and
(iv) camera-ready copy of the annual and semi-annual reports for printing by the LIFE COMPANY.
3.4 TRUST will provide LIFE COMPANY, upon request, with at least one complete copy of all prospectuses, statements of additional information, annual and semi-annual reports, proxy statements, exemptive applications and all amendments or supplements to any of the above that relate to the Portfolios promptly after the filing of each such document with the SEC or other regulatory authority. LIFE COMPANY will provide TRUST, upon request, with at least one complete copy of all prospectuses, statements of additional information, annual and semi-annual reports, proxy statements, exemptive applications and all amendments or supplements to any of the above that relate to a Separate Account promptly after the filing of each such document with the SEC or other regulatory authority.
3.5 LIFE COMPANY agrees that it will cooperate with NB BD and the TRUST by providing to NB BD and the TRUST, within thirty (30) days prior to any deadline imposed by applicable laws, rules or regulations, information regarding shares sold and redeemed and whether the Separate Accounts are registered or unregistered under the 40 Act and any other information pertinent to enabling NB BD and the TRUST to pay registration or other fees with respect to the TRUST shares sold during the fiscal year in accordance with Rule 24f-2 or to register and qualify TRUST shares under any applicable laws, rules or regulations in a timely manner.
Article IV. SALES MATERIALS; PRIVACY
4.1 LIFE COMPANY will furnish, or will cause to be furnished, to TRUST and NB BD, each piece of sales literature or other promotional material in which TRUST or NB BD is named, at least five (5) Business Days prior to its intended use. No such material will be used if TRUST or NB BD objects to its use in writing within five (5) Business Days after receipt of such material.
4.2 TRUST and NB BD will furnish, or will cause to be furnished, to LIFE COMPANY, each piece of sales literature or other promotional material in which LIFE COMPANY or its Separate Accounts are named, at least five (5) Business Days prior to its intended use. No such material will be used if LIFE COMPANY objects to its use in writing within five (5) Business Days after receipt of such material.
4.3 TRUST and its affiliates and agents shall not give any information or make any representations on behalf of LIFE COMPANY or concerning LIFE COMPANY, the Separate Accounts, or the Variable Contracts issued by LIFE COMPANY, other than the information or representations contained in a registration statement or prospectus for such Variable Contracts, as such registration statement and
prospectus may be amended or supplemented from time to time, or in reports of the Separate Accounts or reports prepared for distribution to owners of such Variable Contracts, or in sales literature or other promotional material approved by LIFE COMPANY or its designee, except with the written permission of LIFE COMPANY.
4.4 LIFE COMPANY and its affiliates and agents shall not give any information or make any representations on behalf of TRUST or concerning TRUST other than the information or representations contained in a registration statement or prospectus for TRUST, as such registration statement and prospectus may be amended or supplemented from time to time, or in sales literature or other promotional material approved by TRUST or its designee, except with the written permission of TRUST.
4.5 For purposes of this Agreement, the phrase sales literature or other promotional material or words of similar import include, without limitation, advertisements (such as material published, or designed for use, in a newspaper, magazine or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures or other public media), sales literature (such as any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, or reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, registration statements, prospectuses, statements of additional information, shareholder reports and proxy materials, and any other material constituting sales literature or advertising under FINRA rules, the 40 Act or the 33 Act.
4.6 Subject to law and regulatory authority, each party hereto shall treat as confidential all information pertaining to the owners of the Variable Contracts and all information reasonably identified as confidential in writing by any other party hereto and, except as permitted by this Agreement, shall not disclose, disseminate or utilize such names and addresses and other confidential information without the express written consent of the affected party until such time as the confidential information may come into the public domain. Each party hereto shall be solely responsible for the compliance of their officers, directors, employees, agents, independent contractors, and any affiliated and non-affiliated third parties with all applicable privacy-related laws and regulations including but not limited to the Gramm-Leach-Bliley Act and Regulation S-P. The provisions of this Section 4.6 shall survive the termination of this Agreement.
Article V. POTENTIAL CONFLICTS
5.1 The Board of Trustees of TRUST (the Board) will monitor TRUST for the existence of any material irreconcilable conflict between the interests of the Variable Contract owners of Participating Insurance Company Separate Accounts investing in the TRUST. A material irreconcilable conflict may arise for a variety of reasons, including: (a) state insurance regulatory authority action; (b) a change in applicable federal or state insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling, or any similar action by insurance, tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the investments of the TRUST are being managed; (e) a difference in voting instructions given by variable annuity and variable life insurance
contract owners or by contract owners of different Participating Insurance Companies; or (f) a decision by a Participating Insurance Company to disregard voting instructions of Variable Contract owners.
5.2 LIFE COMPANY will report any potential or existing conflicts to the Board. LIFE COMPANY will be responsible for assisting the Board in carrying out its responsibilities under the Conditions set forth in the notice issued by the SEC for the TRUST on April 12, 1995 (the Notice) (Investment Company Act Release No. 21003), by providing the Board with all information reasonably necessary for it to consider any issues raised. This responsibility includes, but is not limited to, an obligation by LIFE COMPANY to inform the Board whenever Variable Contract owner voting instructions are disregarded by LIFE COMPANY. These responsibilities will be carried out with a view only to the interests of the Variable Contract owners.
5.3 If a majority of the Board or a majority of its disinterested trustees determines that a material irreconcilable conflict exists, affecting the LIFE COMPANY, LIFE COMPANY, at its expense and to the extent reasonably practicable (as determined by a majority of disinterested trustees), will take any steps necessary to remedy or eliminate the irreconcilable material conflict, including: (a) withdrawing the assets allocable to some or all of the Separate Accounts from the TRUST or any Portfolio thereof and reinvesting those assets in a different investment medium, which may include another Portfolio of TRUST or another investment company or submitting the question as to whether such segregation should be implemented to a vote of all affected Variable Contract owners and, as appropriate, segregating the assets of any appropriate group (i.e., Variable Contract owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected Variable Contract owners the option of making such a change; and (b) establishing a new registered management investment company or managed separate account. If a material irreconcilable conflict arises because of LIFE COMPANYs decision to disregard Variable Contract owner voting instructions, and that decision represents a minority position or would preclude a majority vote, LIFE COMPANY may be required, at the election of the TRUST, to withdraw its Separate Accounts investment in the TRUST, and no charge or penalty will be imposed as a result of such withdrawal. The responsibility to take such remedial action shall be carried out with a view only to the interests of the Variable Contract owners.
For the purposes of this Section 5.3, a majority of the disinterested members of the Board shall determine whether or not any proposed action adequately remedies any material irreconcilable conflict, but in no event will the TRUST or NB BD (or any other investment adviser of the TRUST) be required to establish a new funding medium for any Variable Contract. Further, LIFE COMPANY shall not be required by this Section 5.3 to establish a new funding medium for any Variable Contract if any offer to do so has been declined by a vote of a majority of Variable Contract owners materially affected by the irreconcilable material conflict.
5.4 The Boards determination of the existence of a material irreconcilable conflict and its implications shall be made known promptly and in writing to LIFE COMPANY.
5.5 No less than annually, LIFE COMPANY shall submit to the Board such reports, materials or data as the Board may reasonably request so that the Board may fully carry out the obligations imposed
upon it by these Conditions. Such reports, materials, and data shall be submitted more frequently if deemed appropriate by the Board.
Article VI. VOTING
6.1 LIFE COMPANY will provide pass-through voting privileges to all Variable Contract owners so long as the SEC continues to interpret the 40 Act as requiring pass-through voting privileges for Variable Contract owners. Accordingly, LIFE COMPANY, where applicable, will vote shares of TRUST held by its Separate Accounts in a manner consistent with voting instructions timely received from its Variable Contract owners. LIFE COMPANY shall vote shares for which it has not received timely voting instructions, as well as shares it owns, in the same proportion as it votes those shares for which it has received voting instructions.
6.2 If and to the extent Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 40 Act or the rules thereunder with respect to mixed and shared funding on terms and conditions materially different from any exemptions granted in the Order, then TRUST and/or LIFE COMPANY, as appropriate, shall take such steps as may be necessary to comply with Rule 6e-2 and Rule 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such Rules are applicable.
Article VII. INDEMNIFICATION
7.1 Indemnification by LIFE COMPANY. LIFE COMPANY agrees to indemnify and hold harmless TRUST and NB BD and each of their Trustees, directors, officers, employees and agents and each person, if any, who controls TRUST or NB BD within the meaning of Section 15 of the 33 Act (collectively, the Indemnified Parties for purposes of this Article VII) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of LIFE COMPANY, which consent shall not be unreasonably withheld) or litigation (including legal and other expenses), to which the Indemnified Parties may become subject under any statute, regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements:
(a) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the Registration Statement, prospectus, or sales literature for the Variable Contracts or contained in the Variable Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to LIFE COMPANY by or on behalf of TRUST for use in the registration statement, prospectus or sales literature for the Variable Contracts or in the Variable
Contracts (or any amendment or supplement) or otherwise for use in connection with the sale of the Variable Contracts or TRUST shares; or
(b) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus or sales literature of TRUST not supplied by LIFE COMPANY, or persons under its control) or wrongful conduct of LIFE COMPANY or any of its directors, officers, employees or agents, with respect to the sale or distribution of the Variable Contracts or TRUST shares; or
(c) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, or sales literature of TRUST or any amendment thereof or supplement thereto or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to TRUST for inclusion therein by or on behalf of LIFE COMPANY; or
(d) arise as a result of any failure by LIFE COMPANY to substantially provide the services and furnish the materials under the terms of this Agreement; or
(e) arise out of or result from any material breach of any representation and/or warranty made by LIFE COMPANY in this Agreement or arise out of or result from any other material breach of this Agreement by LIFE COMPANY.
7.2 LIFE COMPANY shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified Party as such may arise from such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement or to TRUST, whichever is applicable.
7.3 LIFE COMPANY shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified LIFE COMPANY in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify LIFE COMPANY of any such claim shall not relieve LIFE COMPANY from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against an Indemnified Party, LIFE COMPANY shall be entitled to participate at its own expense in the defense of such action. LIFE COMPANY also shall be entitled to assume the defense thereof, with counsel reasonably satisfactory to the party named in the action. After notice from LIFE COMPANY to such party of LIFE COMPANYs
election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and LIFE COMPANY will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.
7.4 Indemnification by NB BD. NB BD agrees to indemnify and hold harmless LIFE COMPANY and each of its directors, officers, employees, and agents and each person, if any, who controls LIFE COMPANY within the meaning of Section 15 of the 33 Act (collectively, the Indemnified Parties for the purposes of this Article VII) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of NB BD which consent shall not be unreasonably withheld) or litigation (including legal and other expenses) to which the Indemnified Parties may become subject under any statute, or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements:
(a) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus or sales literature of TRUST (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to NB BD or TRUST by or on behalf of LIFE COMPANY for use in the registration statement or prospectus for TRUST or in sales literature (or any amendment or supplement) or otherwise for use in connection with the sale of the Variable Contracts or TRUST shares; or
(b) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus or sales literature for the Variable Contracts not supplied by NB BD or persons under its control) or wrongful conduct of TRUST or NB BD or persons under their control, with respect to the sale or distribution of the Variable Contracts or TRUST shares; or
(c) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, or sales literature covering the Variable Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to LIFE COMPANY for inclusion therein by or on behalf of TRUST; or
(d) arise as a result of (i) a failure by TRUST to substantially provide the services and furnish the materials under the terms of this Agreement; or (ii) a failure by a Portfolio(s) invested in by the Separate Account to comply with the diversification requirements of Section 817(h) of the Code; or (iii) a failure by a Portfolio(s) invested in by the Separate Account to qualify as a regulated investment company under Subchapter M of the Code; or
(e) arise out of or result from any material breach of any representation and/or warranty made by NB BD or TRUST in this Agreement or arise out of or result from any other material breach of this Agreement by NB BD or TRUST.
7.5 NB BD shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement or to LIFE COMPANY, whichever is applicable.
7.6 NB BD shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified NB BD in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify NB BD of any such claim shall not relieve NB BD from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, NB BD shall be entitled to participate at its own expense in the defense thereof. NB BD also shall be entitled to assume the defense thereof, with counsel reasonably satisfactory to the party named in the action. After notice from NB BD to such party of NB BDs election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and NB BD will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.
7.7 The provision of this Article VII shall survive the termination of this Agreement.
Article VIII. TERM; TERMINATION
8.1 This Agreement shall be effective as of the date hereof and shall continue in force until terminated in accordance with the provisions herein.
8.2 This Agreement shall terminate in accordance with the following provisions:
(a) At the option of LIFE COMPANY or TRUST at any time from the date hereof upon 180 days notice, unless a shorter time is agreed to by the parties;
(b) At the option of LIFE COMPANY, if TRUST shares are not reasonably available to meet the requirements of the Variable Contracts as determined by LIFE COMPANY. Prompt notice of election to terminate shall be furnished by LIFE COMPANY, said termination to be effective ten days after receipt of notice unless TRUST makes available a sufficient number of shares to reasonably meet the requirements of the Variable Contracts within said ten-day period;
(c) At the option of LIFE COMPANY, upon the institution of formal proceedings against TRUST or NB BD by the SEC, FINRA or any other regulatory body, the expected or anticipated ruling, judgment or outcome of which would, in LIFE COMPANYs reasonable judgment, materially impair TRUSTs or NB BDs ability to meet and perform their respective obligations and duties hereunder. Prompt notice of election to terminate shall be furnished by LIFE COMPANY with said termination to be effective upon receipt of notice;
(d) At the option of TRUST, upon the institution of formal proceedings against LIFE COMPANY by the SEC, FINRA or any other regulatory body, the expected or anticipated ruling, judgment or outcome of which would, in TRUSTs reasonable judgment, materially impair LIFE COMPANYs ability to meet and perform its obligations and duties hereunder. Prompt notice of election to terminate shall be furnished by TRUST with said termination to be effective upon receipt of notice;
(e) At the option of LIFE COMPANY, in the event TRUSTs shares are not registered, issued or sold in accordance with applicable state or federal law, or such law precludes the use of such shares as the underlying investment medium of Variable Contracts issued or to be issued by LIFE COMPANY. Termination shall be effective immediately upon notice to TRUST;
(f) At the option of TRUST if the Variable Contracts cease to qualify as annuity contracts or life insurance contracts, as applicable, under the Code, or if TRUST reasonably believes that the Variable Contracts may fail to so qualify. Termination shall be effective upon receipt of notice by LIFE COMPANY;
(g) At the option of LIFE COMPANY, upon TRUSTs breach of any material provision of this Agreement, which breach has not been cured to the satisfaction of LIFE COMPANY within ten days after written notice of such breach is delivered to TRUST;
(h) At the option of TRUST, upon LIFE COMPANYs breach of any material provision of this Agreement, which breach has not been cured to the satisfaction of TRUST within ten days after written notice of such breach is delivered to LIFE COMPANY;
(i) At the option of TRUST, if the Variable Contracts are not registered, issued or sold in accordance with applicable federal and/or state law. Termination shall be effective immediately upon such occurrence without notice to LIFE COMPANY;
(j) At the option of LIFE COMPANY in the event that any Portfolio ceases to qualify as a Regulated Investment Company under Subchapter M of the Code or under any successor or similar provision, or if LIFE COMPANY reasonably believes that any Portfolio may fail to so qualify. Termination shall be effective immediately upon notice to the TRUST;
(k) At the option of LIFE COMPANY in the event that any Portfolio fails to meet the diversification requirements specified in Article II hereof or if LIFE COMPANY reasonably believes that any Portfolio may fail to meet such diversification requirements. Termination shall be effective immediately upon notice to the TRUST;
(l) In the event this Agreement is assigned without the prior written consent of LIFE COMPANY, TRUST, and NB BD, termination shall be effective immediately upon such occurrence without notice.
8.3 Notwithstanding any termination of this Agreement pursuant to Section 8.2 hereof, TRUST shall, at the option of the LIFE COMPANY, continue to make available additional TRUST shares, as provided below, for so long as LIFE COMPANY desires pursuant to the terms and conditions of this Agreement, for all Variable Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as Existing Contracts). Specifically, without limitation, if LIFE COMPANY so elects to make additional TRUST shares available, the owners of the Existing Contracts or LIFE COMPANY, whichever shall have legal authority to do so, shall be permitted to reallocate investments in TRUST, redeem investments in TRUST and/or invest in TRUST upon the payment of additional premiums under the Existing Contracts. In the event of a termination of this Agreement pursuant to Section 8.2 hereof, LIFE COMPANY, as promptly as is practicable under the circumstances, shall notify TRUST and NB BD whether LIFE COMPANY elects to continue to make TRUST shares available after such termination. If TRUST shares continue to be made available after such termination, the provisions of this Agreement shall remain in effect.
8.4 Except as necessary to implement Variable Contract owner initiated transactions, or as required by state insurance laws or regulations, LIFE COMPANY shall not redeem the shares attributable to the Variable Contracts (as opposed to the shares attributable to LIFE COMPANYs assets held in the Separate Accounts or invested directly), and LIFE COMPANY shall not prevent Variable Contract owners from allocating payments to a Portfolio that was otherwise available under the Variable Contracts, until thirty (30) days after the LIFE COMPANY shall have notified TRUST of its intention to do so.
Article IX. NOTICES
Any notice hereunder shall be given by registered or certified mail return receipt requested to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other party.
If to TRUST or NB BD:
Neuberger Berman BD LLC
1290 Avenue of the Americas
New York, NY 10104
Attention: General Counsel Mutual Funds
If to LIFE COMPANY:
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, AL 35223
Attention: Senior Vice President, Chief Product Officer
With a copy to:
Senior Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
Notice shall be deemed given on the date of receipt by the addressee as evidenced by the return receipt.
Article X. MISCELLANEOUS
10.1 The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
10.2 This Agreement may be executed simultaneously in two or more counterparts, each of which taken together shall constitute one and the same instrument.
10.3 If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.
10.4 This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of the State of New York. It shall also be subject to the provisions of the
federal securities laws and the rules and regulations thereunder and to any orders of the SEC granting exemptive relief therefrom and the conditions of such orders.
10.5 The parties agree that the assets and liabilities of each Portfolio are separate and distinct from the assets and liabilities of each other Portfolio. No Portfolio shall be liable or shall be charged for any debt, obligation or liability of any other Portfolio. No Trustee, officer or agent shall be personally liable for such debt, obligation or liability of any Portfolio.
10.6 Each party shall cooperate with each other party and all appropriate governmental authorities (including without limitation the SEC, FINRA, and state insurance regulators) and shall permit such authorities reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.
10.7 The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.
10.8 No provision of this Agreement may be amended or modified in any manner except by a written agreement properly authorized and executed by TRUST, NB BD and the LIFE COMPANY.
ARTICLE XI. SHAREHOLDER INFORMATION RULE 22C-2
11.1 LIFE COMPANY agrees to provide promptly, to the TRUST, upon Written request, the taxpayer identification number (TIN), the Individual/International Taxpayer Identification Number (ITIN) or other government-issued identifier (GII), if known, of any or all Contractholder(s) who have purchased, redeemed, transferred or exchanged Shares held through a Separate Account with LIFE COMPANY during the period covered by the request and the amount, date, name or other identifier of any investment professional(s) associated with the Contractholder(s) or the Separate Account (if known), and transaction type (purchase, redemption, transfer or exchange) of every purchase, redemption, transfer or exchange of Shares. To the extent practicable, the format for any transaction information provided to the Participating Fund should be consistent with the National Securities Clearing Corporation Standardized Data Reporting Format. Unless otherwise specifically and reasonably requested by the TRUST, the LIFE COMPANY shall only be required to provide information relating to Contractholder Initiated Transfer Purchases or Contractholder Initiated Redemptions.
11.2 Requests must set forth a specific period, not to exceed ninety days from the date of the request, for which transaction information is sought. The TRUST may request transaction data older than ninety days from the date of the request as it deems necessary to investigate compliance with policies
established by the TRUST for the purpose of eliminating or reducing dilution to the value of the outstanding Shares issued by the TRUST.
11.3 LIFE COMPANY agrees to use best efforts to determine, promptly upon request of the TRUST, whether any person that holds Shares through LIFE COMPANY or its Separate Account is an indirect intermediary as defined in Rule 22c-2 under the 1940 Act (an Indirect Intermediary), and upon further request of the TRUST, (i) provide or arrange to have provided the information set forth in Section 11.1 of this Article XI regarding Contractholders who hold an account with an Indirect Intermediary; or (ii) restrict or prohibit the Indirect Intermediary from purchasing Shares on behalf of itself or other persons. LIFE COMPANY agrees to inform the TRUST whether LIFE COMPANY plans to perform (i) or (ii).
11.4 TRUST and NB BD agree not to use the information received under this Article XI for marketing or any other similar purpose without the prior written consent of LIFE COMPANY.11.5 LIFE COMPANY agrees to execute Written instructions from the TRUST to restrict or prohibit further purchases or exchanges of Shares by a Contractholder who has been identified by the TRUST as having engaged in transactions of Shares (directly or indirectly through a Separate Account) that violate the policies established by the TRUST for the purpose of eliminating or reducing any dilution of the value of its Shares. Unless otherwise directed by the TRUST, any such restrictions or prohibitions shall only apply to Contractholder Initiated Transfer Purchased or Contractholder Initiated Transfer Redemptions that are affected directly or indirectly through the LIFE COMPANY.
11.5 Instructions provided to LIFE COMPANY will include the TIN, ITIN or GII, if known, and the specific restriction(s) to be executed. If the TIN, ITIN or GII is not known, the instructions will include an equivalent identifying number of the Contractholder(s) or account(s) or other agreed-upon information to which the instructions relates.
11.6 LIFE COMPANY must provide Written confirmation to the TRUST that instructions have been executed. LIFE COMPANY agrees to provide the confirmation as soon as reasonably practicable, but not later than ten Business Days after the instructions have been executed.
11.7 For purposes of this Article XI only,
a. Written communications include electronic communications and facsimile transmissions;
b. TRUST does not include any excepted funds as defined in Rule 22c-2(b) under the 1940 Act; and
c. Contractholder shall include, as applicable, (i) the beneficial owner of Shares, whether the Shares are held directly by Contractholder or by LIFE COMPANY in nominee name; (ii) a Separate Account unit holder, notwithstanding that the Separate Account may be deemed to be the beneficial owner of Shares; or (iii) the holder of interests in a TRUST underlying a variable annuity or variable life insurance contract.
d. The term Contractholder Initiated Transfer Purchase means a transaction that is initiated or directed by a Contractholder that results in a transfer of assets within a Variable Contract to a TRUST Portfolio, but does not include transactions that are executed: (i) automatically pursuant to a contractual or systematic program or enrollment such as a transfer of assets within a Variable Contract to a TRUST Portfolio as a result of dollar cost averaging programs, LIFE COMPANY approved asset allocation programs, or automatic rebalancing programs; (ii) pursuant to a Contract death benefit; (iii) as a result of a one-time step-up in Variable Contract value pursuant to a Contract death benefit; (iv) as a result of an allocation of assets to a TRUST Portfolio through a Variable Contract as a result of payments such as loan repayments, scheduled contributions, retirement plan salary reduction contributions, or planned premium payments to the Variable Contract; or (v) pre-arranged transfers at the conclusion of a required free look period.
e. The term Contractholder Initiated Transfer Redemption means a transaction that is initiated or directed by a Contractholder that results in a transfer of assets within a Variable Contract out of a TRUST Portfolio, but does not include transactions that are executed: (i) automatically pursuant to a contractual or systematic program or enrollments such as transfers of assets within a Variable Contract out of a TRUST Portfolio as a result of annuity payouts, loans, systematic withdrawal programs, LIFE COMPANY approved asset allocation programs and automatic rebalancing programs; (ii) as a result of any deduction of charges or fees under a Variable Contract; (iii) within a Variable Contract out of a TRUST Portfolio as a result of scheduled withdrawals or surrenders from a Variable Contract; or (iv) as a result of payment of a death benefit from a Variable Contract.
[Remainder of this page intentionally left blank]
IN WITNESS WHEREOF, the parties have caused their duly authorized officers to execute this Fund Participation Agreement as of the date and year first above written.
NEUBERGER BERMAN |
|
NEUBERGER BERMAN BD LLC |
||
ADVISERS MANAGEMENT TRUST |
|
|
|
|
|
|
|
|
|
|
|
|
By: |
|
By: |
|
|
Name: |
|
Name: |
|
|
Title: |
|
Title: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PROTECTIVE LIFE INSURANCE COMPANY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
|
|
|
|
Name: Title: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Attest: |
|
|
|
|
Name: |
|
|
|
|
Appendix A
All classes of shares of the TRUST, whether now existing or hereinafter created, and not closed to new investors.
ADDENDUM A
RULES 30e-3 and 498A AGREEMENT
This Addendum (the Addendum) to the Fund Participation Agreement (the Participation Agreement) is entered into as of November 30, 2020, by and among Protective Life Insurance Company (the Company), on its own behalf and on behalf of each separate account of the Company (individually and collectively the Accounts), Neuberger Berman Advisers Management Trust (the Fund), a Delaware statutory trust, and Neuberger Berman BD LLC (the Underwriter), a Delaware limited liability company (collectively, the Parties).
RECITALS
WHEREAS, pursuant to the Participation Agreement among the Parties, the Company invests in shares of certain of the portfolios of the Fund (the Portfolios) as a funding vehicle for the Accounts that issue variable annuity and/or life insurance contracts (the Variable Contracts) to persons that are registered owners of such Variable Contracts on the books and records of the Company (the Contract Owners);
WHEREAS, the Accounts are registered as unit investment trusts under the Investment Company Act of 1940, as amended (the 1940 Act);
WHEREAS, the Company, on behalf of the Accounts, has certain obligations pursuant to Rule 30e-2 under the 1940 Act to deliver Fund shareholder reports to Contract Owners, which obligations may be satisfied by compliance with Rule 30e-3 under the 1940 Act (Rule 30e-3);
WHEREAS, the Company intends to comply with the requirements, terms and conditions of Rule 30e-3 in order to satisfy its obligation to deliver Fund shareholder reports to Contract Owners, including hosting the website of certain fund materials required by Rule 30e-3;
WHEREAS, Section 5(b)(2) of the Securities Act of 1933, as amended (the 1933 Act) may require that a Statutory Prospectus (as defined in Rule 498A under the 1933 Act; Rule 498A) for the Portfolios be delivered to Contract Owners under certain circumstances;
WHEREAS, the Parties intend to meet any such Portfolio Statutory Prospectus delivery requirement by relying on (and complying with the requirements, terms and conditions of) paragraph (j) of Rule 498A for on-line delivery;
WHEREAS, paragraph (j) of Rule 498A requires, inter alia, that some of the Fund Documents (defined below) be posted and maintained on a website specified on the cover page of the Summary Prospectus for the Variable Contracts, and the Company intends to host (or hire a third party to host on its behalf) said website;
NOW, THEREFORE, in consideration of the mutual covenants herein contained, which consideration is full and complete, the Company, the Fund, and the Underwriter hereby agree as follows:
1. Provision of Fund Documents; Website Posting.
(a). Fund Documents. The Fund (and Underwriter) is (are) responsible for preparing and providing the following Fund Documents, as specified in paragraph (b)(1) of Rule 30e-3 and paragraph (j)(1)(iii) of Rule 498A:
(i) Summary Prospectus for the Portfolios;
(ii) Statutory Prospectus for the Portfolios;
(iii) Statement of Additional Information (SAI) for the Portfolios; and
(iv) Most Recent Annual and Semi-Annual Reports to Shareholders (under Rule 30e-1 under the 1940 Act) for the Portfolios (together, the Shareholder Reports) (referred to in Rule 30e-3 as the Current and Prior Report to Shareholders).
(v) Portfolio Holdings For Most Recent First and Third Fiscal Quarters (together with the complete portfolio holdings specified in (v) above, the Portfolio Holdings).
(b). Deadline for Providing, and Currentness of, Fund Documents.
(i). The Fund and the Underwriter shall provide the Summary Prospectus, Statutory Prospectus, and SAI for the Portfolios to the Company (or its designee) on a timely basis (to facilitate the required website posting) and provide any supplements and/or restated documents, as necessary, in order to facilitate a continuous offering of the Portfolio Companys securities and the Variable Contracts.
(ii). The Fund and the Underwriter shall provide the Shareholder Reports and Portfolio Holdings generally no later than five (5) days before the Shareholder
Reports are required to be posted (to facilitate the required website posting).
(c). Format of Fund Documents. The Fund and the Underwriter shall provide the Fund Documents to the Company (or its designee) in an electronic format that is suitable for website posting, and in a format, or formats, that are convenient for both reading online and printing on paper (in accordance with Rule 30e-3 and Rule 498A).
(d). Website Hosting. The Company shall be responsible for and shall fulfill the website posting and other applicable requirements and obligations of the Accounts specified in Rules 30e-3(b) and 498A(j). The Company shall host and maintain the website specified in paragraph (j)(1)(iii) of Rule 498A, so that the Fund Documents are publicly accessible, free of charge, at that website, in accordance with the conditions set forth in that paragraph.
(e). Paper Notice to Contract Owners. The Company shall provide the paper notice to its Contract Owners in accordance with paragraphs (c) and (d) of Rule 30e-3.
(f). Use of Summary Prospectuses.
(i). The Company shall ensure that an Initial Summary Prospectus is used for each currently offered Variable Contract described under the related registration statement, in accordance with paragraph (j)(1)(i) of Rule 498A.
(ii). The Company shall ensure that the Updating Summary Prospectus is used for each currently offered and previously offered Variable Contract, which is still in registration and for which a Prospectus is issued annually
(iii). The Fund and Underwriter shall ensure that a summary prospectus is used for the Portfolios, in accordance with paragraph (j)(1)(ii) of Rule 498A.
2. Provision of Fund Documents for Paper Delivery. The Fund and the Underwriter shall:
(a). At their expense, as the Company may reasonably request from time to time, provide the Company with sufficient paper copies of the then current Fund Documents, so that the Company may maintain a supply of such current paper documents sufficient in its reasonable judgment to meet anticipated requests from Contract Owners (see paragraphs (e) and (f) of Rule 30e-3 and paragraphs (i)(1) and (j)(3) of Rule 498A). Such Company requests shall be fulfilled reasonably promptly, but in no event more than 7 business days after the request from the Company is received by either the Fund or the Underwriter.
(b). Alternatively, if requested by the Company in lieu thereof, the Fund or its
designee shall provide such electronic or other documentation, and such other assistance as is reasonably necessary to have the then current Fund Documents printed for distribution; the reasonable costs of providing the electronic documentation and of such printing to be borne by the Fund.
(c). The Fund and/or the Underwriter shall reimburse the Company for the reasonable costs of mailing the Fund Documents to Contract Owners.
(d). The Company shall fulfill Contract Owner elections to receive future Fund shareholder reports in paper, in accordance with paragraph (f) of Rule 30e-3.
3. Portfolio Expense and Performance Data. The Fund shall provide such data regarding each Portfolios expense ratios and investment performance as the Company shall reasonably request, to facilitate the registration, sale and preparation of the annually updated registration statement of the Variable Contracts on a timely basis.
4. Construction of this Addendum; Participation Agreement.
(a). This Addendum shall be interpreted to be consistent with, and to facilitate compliance with and reliance on, Rule 30e-3 under the 1940 Act and Rule 498A (including paragraph (j) thereof) under the 1933 Act and any interpretations of those Rules by the Securities and Exchange Commission, its staff, courts, or other appropriate legal authorities.
(b). To the extent the terms of this Addendum conflict with the terms of the Participation Agreement, the terms of this Addendum shall control; otherwise, and except as otherwise specifically set forth in this Addendum, the terms of the Participation Agreement shall continue to apply, and shall apply to the duties, responsibilities, rights and obligations of the Parties under and pursuant to this Addendum.
5. Termination. This Addendum shall terminate upon the earlier of:
(a). termination of the Participation Agreement; or
(b). 60 days written notice from any Party to the other Parties.
6. Indemnification. The Fund and the Underwriter specifically agree to indemnify and hold harmless the Company (and its officers, directors, and employees) from any and all liability, claim, loss, demand, damages, costs and expenses (including reasonable attorneys fees) arising from or in connection with any claim or action of any type
whatsoever brought against the Company (or its officers, directors, and employees) as a result of any failure that constitutes gross negligence, reckless disregard or willful misfeasance by the Fund or Underwriter to provide the Fund Documents in accordance with the terms of this Addendum or to fulfill their other duties and responsibilities under this Addendum or for any other breach of this Addendum. The Company specifically agrees to indemnify and hold harmless the Fund and/or the Underwriter (and their officers, directors, and employees) from any and all liability, claim, loss, demand, damages, costs and expenses (including reasonable attorneys fees) arising from or in connection with any claim or action of any type whatsoever brought against the Fund and/or the Underwriter (or their officers, directors, and employees) as a result of any failure that constitutes gross negligence, reckless disregard or willful misfeasance by the Company to fulfill its duties and responsibilities under this Addendum or for any other breach of this Addendum. These indemnifications shall be in addition to and not in lieu of the indemnification provided for in the Participation Agreement or any other addendums or amendments thereto, but otherwise shall be subject to and in accordance with the terms and conditions of the Participation Agreement.
7. Counterparts and Delivery. This Addendum may be executed in two or more counterparts, each of which shall be an original and all of which together shall constitute one instrument. A signed copy of this Addendum delivered by facsimile or by emailing a copy in .pdf form shall be treated as an original and shall bind all Parties just as would the exchange of originally signed copies.
8. Several Liability. The responsibilities, obligations, duties and liabilities of the Fund are separate and distinct from the responsibilities, obligations, duties and liabilities of the Underwriter. Furthermore, the Parties agree that the assets and liabilities of each Portfolio are separate and distinct from the assets and liabilities of each other Portfolio, and that no Portfolio shall be liable or shall be charged for any debt, obligation or liability of any other Portfolio.
Amendment No. 3 to Participation Agreement
Among
Protective Life Insurance Company
PIMCO Variable Insurance Trust, and
PIMCO Investments LLC
Protective Life Insurance Company (the Company), on its behalf and on behalf of certain Accounts of the Company, PIMCO Variable Insurance Trust (the Fund), and PIMCO Investments LLC (the Underwriter), have previously entered into a Participation Agreement dated November 1, 2009, as amended (the Agreement). The parties now desire to further amend the Agreement by this amendment (the Amendment).
Except as modified hereby, all other terms and conditions of the Agreement shall remain in full force and effect. Unless otherwise indicated, the terms defined in the Agreement, as amended, shall have the same meaning in this Amendment.
A M E N D M E N T
For good and valuable consideration, the receipt of which is hereby acknowledged, the parties agree to amend the Agreement as follows:
1. All references to Advisor Class and Institutional Class shares in the Agreement and its subsequent amendments are hereby deleted and replaced with Administrative Class, Advisor Class and Institutional Class shares.
2. Schedule A of the Agreement is deleted and replaced in its entirety with the Schedule A attached hereto.
3. All other terms and provisions of the Agreement not amended herein shall remain in full force and effect.
Counterparts. This Amendment may be executed in any number of counterparts, each of which shall be deemed to be an original.
[Signature Page Follows]
IN WITNESS WHEREOF, the undersigned has caused the Amendment to be executed and effective as of , 2020.
Schedule A
The term Designated Portfolio of the Fund will include any currently offered class of any Portfolio of the below Funds as well as any Portfolio of the Fund or any share class of any Portfolio created subsequent to the date hereof.
PIMCO Variable Insurance Trust: All Portfolios offering Administrative Class, Advisor Class and/or Institutional Class shares.
The terms Segregated Asset Accounts and Products of the Company include any existing Segregated Asset Accounts and Products (as listed below) as well as any Segregated Asset Accounts and/or Products created subsequent to the date hereof, that offer Designated Portfolios.
Segregated Asset Accounts: |
|
Products: |
Protective Variable Annuity Separate Account |
|
Protective Variable Annuity |
|
|
Protective Values/Access Annuity |
|
|
Protective Advantage Variable Annuity |
|
|
Protective Values/Advantage Annuity |
|
|
ProtectiveAccess XL Variable Annuity |
|
|
Protective Variable Annuity B Series |
|
|
Protective Variable Annuity C Series |
|
|
Protective Variable Annuity L Series |
|
|
Protective Variable Annuity II |
|
|
ProtectiveRewards Elite |
|
|
Protective Dimensions |
|
|
Protective Dimensions II |
|
|
Protective Dimensions III |
|
|
Protective Dimensions IV |
|
|
ProtectiveRewards II Annuity |
|
|
Protective Values Annuity |
|
|
Protective Advantage Variable Annuity |
|
|
Protective Variable Annuity Investors Series |
|
|
Protective Investors Benefit Advisory Variable Annuity |
|
|
|
Protective Variable Life Separate Account |
|
Premiere Executive VUL |
|
|
Premiere I VUL |
|
|
Premiere II VUL |
|
|
Premiere III VUL |
|
|
Premiere Protector VUL |
|
|
Premiere Provider VUL |
FUND PARTICIPATION AGREEMENT
Among
PROTECTIVE LIFE INSURANCE COMPANY
PIONEER VARIABLE CONTRACTS TRUST
AMUNDI PIONEER ASSET MANAGEMENT, INC.
AND
AMUNDI PIONEER DISTRIBUTOR, INC.
THIS FUND PARTICIPATION AGREEMENT (the Agreement) is made and entered into as of this 1st day of November, 2020 (the Effective Date) by and among PROTECTIVE LIFE INSURANCE COMPANY (hereinafter PLICO), on its own behalf and on behalf of its accounts listed on Schedule B (collectively referred to as the Accounts) attached hereto; PIONEER VARIABLE CONTRACTS TRUST (hereinafter the Fund);, a trust organized under the laws of Delaware; AMUNDI PIONEER ASSET MANAGEMENT, INC. (hereinafter the Adviser), a corporation organized under the laws of Delaware; and AMUNDI PIONEER DISTRIBUTOR, INC. (hereinafter the Distributor) a corporation organized under the laws of Massachusetts. Each of PLICO, the Accounts, the Fund, the Adviser, and the Distributor may be referred to herein as a Party or collectively as the Parties).
WHEREAS, the Fund is registered as an open-end management investment company under the Investment Company Act of 1940 (the 1940 Act) and its shares are registered under the Securities Act of 1933, as amended (hereinafter the 1933 Act); and
WHEREAS, the Fund has obtained an order from the Securities and Exchange Commission (the SEC), dated July 9, 1997 (File No. 812-10494) (the Mixed and Shared Funding Exemptive Order) granting Participating Insurance Companies and variable annuity and variable life insurance separate accounts exemptions from the provisions of Sections 9(a), 13(a), 15(a) and 15(b) of the 1940 Act and Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the Fund to be sold to and held by variable annuity and variable life insurance companies that may or may not be affiliated with one another and qualified pension and retirement plans (Qualified Plans);
WHEREAS, the Adviser is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and any applicable state securities laws; and
WHEREAS, the Distributor is duly registered as a broker-dealer under the Securities Exchange Act of 1934, as amended (the 1934 Act) and is a member in good standing of the Financial Industry Regulatory Authority, Inc. (the FINRA); and
WHEREAS, the Insurance Party has certain registered and unregistered variable annuity and variable life contracts supported wholly or partially by the Accounts (the Contracts) to be made available to owners thereof, including any participants or employees of such owners as applicable (Contract Owners); and
WHEREAS, to the extent required by applicable law, the Insurance Party has registered the Account(s) as a unit investment trust under the 1940 Act unless excepted from registration pursuant to
Section 3(c)(7) or Section 3(c)(11) of the 1940 Act, and have registered the securities deemed to be issued by the Account(s) under the 1933 Act unless exempt from registration; and
WHEREAS, the PLICO Account(s) is a duly organized, validly existing segregated asset account, established by resolution of the Board of Directors of PLICO under the insurance laws of the State of Tennesee to set aside and invest assets attributable to the PLICO Contracts, and
WHEREAS, to the extent permitted by applicable laws and regulations, PLICO intends to purchase shares in the Fund(s) listed in Schedule A attached hereto and incorporated herein by reference, as such Schedule may be amended from time to time by mutual written agreement (the Designated Portfolio(s)), on behalf of their respective Accounts to fund the applicable Contracts, and the Fund is authorized to sell such shares to unregistered unit investment trusts such as the Accounts at net asset value; and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Accounts also intend to purchase shares in other open-end investment companies or series thereof not affiliated with the Fund (the Unaffiliated Funds) on behalf of the Accounts to fund the Contracts; and
NOW, THEREFORE, the Parties agree as follows:
ARTICLE I. Sale of Fund Shares
1.1. Distributor and the Company agree to provide pricing information, execute orders and wire payments for purchases and redemptions of Fund shares as set forth in this Article I until such time as they mutually agree to utilize the National Securities Clearing Corporation (NSCC). Upon such mutual agreement, Distributor and the Company agree to provide pricing information, execute orders and wire payments for purchases and redemptions of Fund shares through NSCC and its subsidiary systems.
1.2 Distributor agrees to sell to the Company those Shares which the Accounts order in accordance with the terms of this Agreement (based on orders placed by Contract owners or participants on that Business Day, as defined below) and which are available for purchase by such Accounts. Each such order will be executed on a daily basis at the net asset value next computed after receipt by the Fund or its designee of the order for the Shares. For purposes of this Section 1.2, the Company shall be the designee of the Fund for receipt of such orders from Contract owners or participants and receipt by such designee shall constitute receipt by the Fund; provided that the Fund or its designee receives written (or facsimile) notice of such orders by the time the Fund ordinarily calculates its net asset value as described from time to time in the Funds prospectus (which as of the date of this Agreement is 4:00 p.m. New York time on such Business Day. Business Day shall mean any day on which the New York Stock Exchange, Inc. (the NYSE) is open for trading and on which the Fund calculates its net asset value pursuant to the rules of the SEC.
1.3. Distributor agrees to make the Shares available for purchase at the applicable net asset value per share by the Company and the Accounts on those days on which the Fund calculates its net asset value in accordance with the rules of the SEC. Notwithstanding the foregoing, the Board of Trustees of the Fund (the Board) may refuse to sell any Shares to the Company and the Accounts, or suspend or terminate the offering of the Shares to the Company and the Accounts if such action is required by law or by regulatory authorities having jurisdiction over Adviser, Distributor or the Fund or is, in the sole discretion of the Board acting in good faith and in light of its fiduciary duties under federal and any applicable state laws, in the best interest of the Shareholders of such Designated Portfolio.
1.4. The Fund and Distributor will sell Fund shares only to Participating Insurance Companies and Qualified Plans which have agreed to participate in the Fund to fund their Separate Accounts and/or Qualified Plans all in accordance with the requirement of Section 817(h) of the Internal Revenue Code, as amended (the Code) and the Treasury regulations thereunder. The Company will not resell the Shares
except to the Fund or its agents.
1.5. The Fund agrees, upon the Companys request, to redeem for cash, any full or fractional Shares held by the Accounts (based on orders placed by Contract owners on that Business Day). Each such redemption request shall be executed on a daily basis at the net asset value next computed after receipt by the Fund or its designee of the request for redemption. For purposes of this Section 1.5, the Company shall be the designee of the Fund for receipt of requests for redemption from Contract owners or participants and receipt by such designee shall constitute receipt by the Fund; provided that the Fund or its designee receives written (or facsimile) notice of such request for redemption by the time the Fund ordinarily calculates its net asset value as described from time to time in the Funds prospectus (which as of the date of this Agreement is 4:00 p.m. New York time on such Business Day).
1.6. Each purchase, redemption and exchange order placed by the Company shall be placed separately for each Designated Portfolio and shall not be netted with respect to any Designated Portfolio. However, with respect to payment of the purchase price by the Company and of redemption proceeds by the Fund, the Company and the Fund shall net purchase and redemption orders with respect to each Designated Portfolio and shall transmit one net payment for all of the Designated Portfolios in accordance with Section 1.7 hereof.
1.7. In the event of net purchases, the Company shall pay for the Shares by 11:00 a.m. New York time on the next Business Day after an order to purchase the Shares is made in accordance with the provisions of Section 1.2. hereof. Company shall transmit all such payments in federal funds by wire. If payment in federal funds for any purchase is not received or is received by the Fund after 11:00 a.m. on such Business Day, the Company shall promptly, upon the Funds request, reimburse the Fund for any charges, costs, fees, interest or other expenses incurred by the Fund in connection with any advances to, or borrowings or overdrafts by, the Fund, or any similar expenses (including the cost of and any loss incurred by the Fund in unwinding any purchase of securities by the Fund) incurred by the Fund as a result of portfolio transactions effected by the Fund based upon such purchase request. In the event of net redemptions, the Fund ordinarily shall pay and transmit the proceeds of redemptions of Shares by 11:00 a.m. New York time on the next Business Day after a redemption order is received from the Company in accordance with Section 1.5. hereof, although the Fund reserves the right to postpone the date of payment or satisfaction upon redemption consistent with Section 22(e) of the 1940 Act and any rules pomulgated thereunder. Payments for net redemptions shall be in federal funds transmitted by wire.
1.8. Issuance and transfer of the Shares will be by book entry only. Stock certificates will not be issued to the Company or the Accounts. The Shares ordered from the Fund will be recorded in an appropriate title for the Accounts or the appropriate subaccounts of the Accounts.
1.9. The Fund shall furnish notice (by wire or telephone, followed by written confirmation) no later than 7:00 p.m. New York time on the ex-dividend date to the Company of any dividends or capital gain distributions payable on the Shares. The Company hereby elects to receive all such dividends and distributions as are payable in cash or Shares on a Designated Portfolios Shares in additional Shares of that Designated Portfolio. The Fund shall notify the Company by the end of the next following Business Day of the number of Shares so issued as payment of such dividends and distributions.
1.10. The Fund or its custodian shall make the net asset value per share for each Designated Portfolio available to the Company on each Business Day as soon as reasonably practical after the net asset value per share is calculated and shall use its best efforts to make such net asset value per share available by 6:00 p.m. New York time. In the event of an error in the computation of a Designated Portfolios net asset value per share (NAV) or any dividend or capital gain distribution (each, a pricing error), Adviser or the Fund shall notify the Company as soon as possible after the discovery of the error. Such notification may be verbal, but shall be confirmed promptly in writing in accordance with Article XII of this Agreement.
A pricing error shall be corrected in accordance with the Funds internal policies and procedures. If an adjustment is necessary to correct a material error that occurred through no fault of the Company and such adjustment has caused Contract owners to receive less than the number of Shares or redemption proceeds to which they are entitled, the number of Shares of the applicable Account will be adjusted and the amount of any underpayments will be paid by the Fund or Adviser to the Company for crediting of such amounts to the Contract owners accounts. Upon notification by Adviser of any overpayment due to a material error, the Company shall promptly remit to the Fund or Adviser, as appropriate, any overpayment that has not been paid to Contract owner; however, Adviser acknowledges that the Company does not intend to seek additional payments from any Contract owner who, because of a pricing error, may have underpaid for units of interest credited to his/her account. The costs of correcting such adjustments shall be borne by the Fund or Adviser unless the Company is at fault in which case such costs shall be borne by the Company.
ARTICLE II. Representations and Warranties
2.1. PLICO represents and warrants that it is an insurance company duly organized and in good standing under applicable law and that it has legally and validly established the PLICO Account prior to any issuance or sale of units thereof as a segregated asset account under Tennessee Law.
2.2. PLICO represents and warrants that the Contracts are or will be registered under the 1933 Act or are exempt from or not subject to registration thereunder, and that the Contracts will be issued, sold, and distributed in compliance in all material respects with all applicable state and federal laws, including without limitation the 1933 Act, the 1934 Act, and the 1940 Act. PLICO further represents and warrants that it (i) is an insurance company duly organized and in good standing under applicable law; (ii) has legally and validly established each Account as a segregated asset account under applicable law; (iii) has registered or, prior to any issuance or sale of the Contracts, will register the Accounts as unit investment trusts in accordance with the provisions of the 1940 Act (unless exempt therefrom) to serve as segregated investment accounts for the Contracts, and (iv) will maintain such registration for so long as any Contracts are outstanding. PLICO shall amend the registration statements under the 1933 Act for the Contracts and the registration statements under the 1940 Act for the Accounts from time to time as required in order to effect the continuous offering of the Contracts or as may otherwise be required by applicable law. PLICO shall register and qualify the Contracts for sales in accordance with the securities laws of the various states only if and to the extent deemed necessary by them. At the time PLICO is required to deliver the Funds prospectus or statement of additional information to a purchaser of Shares in accordance with the requirements of federal or state securities laws, PLICO shall distribute to such Contract purchasers the then current Fund prospectus, as supplemented.
2.3. PLICO represents and warrants that the Contracts are currently and at the time of issuance will be treated as life insurance, endowment or annuity contracts under applicable provisions of the Code, that it will maintain such treatment and that it will notify the Fund or the Adviser immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future.
2.4. PLICO represents and warrants that it, as the underwriter for the individual variable annuity contracts and the variable life policies, is a member in good standing of FINRA and is a registered broker-dealer with the SEC. PLICO represents and warrants that it will sell and distribute such contracts and policies in accordance in all material respects with all applicable state and federal securities laws, including without limitation the 1933 Act, the 1934 Act, and the 1940 Act and state insurance law suitability requirements.
2.5. The Fund represents and warrants that Designated Portfolio(s) shares sold pursuant to this Agreement shall be registered under the 1933 Act, duly authorized for issuance and sold in compliance with all applicable federal securities laws including without limitation the 1933 Act, the 1934 Act, and the 1940 Act and that the Fund is and shall remain registered under the 1940 Act. The Fund shall amend the
registration statement for its shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its shares.
2.6. The Fund and Adviser agree to comply with applicable provisions and SEC staff interpretations of the 1940 Act to assure that the investment advisory or management fees paid to the Adviser by the Fund are in accordance with the requirements of the 1940 Act. To the extent that the Fund finances distribution expenses pursuant to Rule 12b-1, the Fund undertakes to have its Board, a majority of whom are not interested persons of the Fund, formulate and approve any plan pursuant to Rule 12b-1 under the 1940 Act to finance distribution expenses.
2.7. The Fund represents and warrants that the investment policies, fees and expenses of the Designated Portfolio(s) are and shall at all times remain in compliance with the Funds Prospectus and any Applicable Law. The Fund and Distributor represent and warrant that they will make every effort to ensure that Designated Portfolio(s) shares will be sold in compliance with all Applicable Law. The Fund and Distributor shall register and qualify the shares for sale in accordance with the laws of the various states if and to the extent required by Applicable Law. PLICO will endeavor to keep the Adviser informed of any change in state insurance laws, regulations or interpretations of the foregoing that affect the Designated Portfolio(s) (a Law Change). In the event of a Law Change, the Fund agrees that it may (in its sole discretion) take any action required by a Law Change.
2.8. The Fund represents and warrants that it is lawfully organized and validly existing under the laws of the State of Delaware and that it does and will comply in all material respects with the 1940 Act.
2.9. The Adviser represents and warrants that it is and shall remain duly registered under all applicable federal and state securities laws and that it shall perform its obligations for the Fund in compliance in all material respects with the laws of the State of Delaware and any applicable state and federal securities laws.
2.10. The Distributor represents and warrants that it is and shall remain duly registered under all applicable federal and state securities laws and that it shall perform its obligations for the Fund in compliance in all material respects with the laws of the Commonwealth of Massachusetts and any applicable state and federal securities laws.
2.11. The Fund and the Adviser represent and warrant that all of their respective officers, employees, investment advisers, and other individuals or entities dealing with the money and/or securities of the Fund are, and shall continue to be at all times, covered by one or more blanket fidelity bonds or similar coverage for the benefit of the Fund in an amount not less than the minimal coverage required by Rule 17g-1 under the 1940 Act or related provisions as may be promulgated from time to time. The aforesaid bonds must include coverage for larceny and embezzlement and must be issued by a reputable bonding company.
2.12. The Fund will provide PLICO with as much advance notice as is reasonably practicable of any material change affecting the Designated Portfolio(s) (including, but not limited to, any material change in the registration statement or prospectus affecting the Designated Portfolio(s)) and any proxy solicitation affecting the Designated Portfolio(s) and consult with PLICO in order to implement any such change in an orderly manner, recognizing the expenses of changes and attempting to minimize such expenses by implementing them in conjunction with regular annual updates of the prospectus for the Contracts.
2.13. No less frequently than annually, PLICO shall submit to the Board of Trustees of the Fund (the Board) such reports, material or data as the Board may reasonably request so that it may carry out fully the obligations imposed upon it by the conditions contained in the Mixed and Shared Funding Exemptive Order pursuant to which the SEC has granted exemptive relief to permit mixed and shared funding.
2.14. PLICO represents and warrants, for purposes other than diversification under Section 817 of the Code, that the Contracts are currently at the time of issuance and, assuming the Fund meets the requirements of Article VI, will be treated as annuity contracts under applicable provisions of the Code, and that it will make every effort to maintain such treatment and that it will notify the Fund, the Adviser, and the Distributor immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future. In addition, PLICO represents and warrants that each Account is a segregated asset account and that interests in the Account are offered exclusively through the purchase of or transfer into a variable contract within the meaning of such terms under Section 817 of the Code and the regulations thereunder. PLICO will use every effort to continue to meet such definitional requirements and will notify the Fund, the Adviser, and the Distributor immediately upon having a reasonable basis for believing that such requirements have ceased to be met or that they might not be met in the future. PLICO represents and warrants represents and warrants that it will not purchase Fund shares with assets derived from tax-qualified retirement plans except, indirectly, through Contracts purchased in connection with such plans.
ARTICLE III. Prospectuses and Proxy Statements; Voting
3.1. If applicable state or federal laws or regulations require that prospectuses for the Fund be distributed to all Contract owners, then at least annually, the Adviser or Distributor shall provide PLICO with as many copies of the Funds current prospectus for the Designated Portfolio(s) as PLICO may reasonably request for marketing purposes (including distribution to Contract owners with respect to new sales of a Contract), with expenses to be borne in accordance with Schedule C. If requested by PLICO in lieu thereof, the Adviser, Distributor or Fund shall provide such documentation (including a camera-ready copy and computer diskette of the current prospectus for the Designated Portfolio(s)) and other assistance as is reasonably necessary in order for PLICO once each year (or more frequently if the prospectuses for the Designated Portfolio(s) are amended) to have the prospectus for the Contracts and the Funds prospectus for the Designated Portfolio(s) printed together in one document. The Fund and Adviser agree that in the future, PLICO may request that the prospectus (and semi-annual and annual reports) for the Designated Portfolio(s) describe only the Designated Portfolio(s) and not name or describe any other portfolios or series that may be in the Fund, unless required by law. Should PLICO determine that they will make the prospectuses available in an electronic format, the Fund, Adviser or Distributor, as applicable agree to assist PLICO in obtaining the required information from EDGAR and the expenses associated with this form of distribution will be borne in accordance with Schedule C.
3.2. If applicable state or federal laws or regulations require that the Statement of Additional Information (SAI) for the Fund be distributed to all Contract owners, then the Fund, Distributor and/or the Adviser shall provide PLICO with copies of the Funds SAI or documentation thereof for the Designated Portfolio(s) in such quantities, with expenses to be borne in accordance with Schedule C, as PLICO may reasonably require to permit timely distribution thereof to Contract owners. The Adviser and/or the Fund shall also provide SAIs to any Contract owner or prospective owner who requests such SAI from the Fund (although it is anticipated that such requests will be made to PLICO).
3.3. The Fund, Distributor and/or Adviser shall provide PLICO with copies of the Funds proxy material, reports to stockholders and other communications to stockholders for the Designated Portfolio(s) in such quantity, with expenses to be borne in accordance with Schedule C, as PLICO may reasonably require to permit timely distribution thereof to Contract owners, as required by law.
3.4. It is understood and agreed that, except with respect to information regarding PLICO provided in writing by PLICO, it is not responsible for the content of the prospectus or SAI for the Designated Portfolio(s).
3.5. The Fund hereby notifies PLICO that it may be appropriate to include in the prospectus pursuant to which a Contract is offered disclosure regarding the potential risks of mixed and shared funding.
3.6. If and to the extent required by law, PLICO shall:
(i) solicit voting instructions from Contract owners;
(ii) vote the Designated Portfolio(s) shares held in the Accounts in accordance with instructions received from Contract owners; and
(iii) vote Designated Portfolio shares held in the Accounts for which no instructions have been received in the same proportion as Designated Portfolio(s) shares for which instructions have been received from Contract owners, so long as and to the extent that the SEC continues to interpret the 1940 Act to require pass-through voting privileges for variable contract owners. PLICO reserves the right to vote Fund shares held in any segregated asset account in its own right, to the extent permitted by law.
3.6. The Fund will comply with all provisions of the 1940 Act requiring voting by shareholders, and in particular the Fund will either provide for annual meetings (except insofar as the SEC may interpret Section 16 of the 1940 Act not to require such meetings) or, as the Fund currently intends, comply with Section 16(c) of the 1940 Act (although the Fund is not one of the trusts described in Section 16(c) of that Act) as well as with Sections 16(a) and, if and when applicable, 16(b). Further, the Fund will act in accordance with the SECs interpretation of the requirements of Section 16(a) with respect to periodic elections of directors or trustees and with whatever rules the Commission may promulgate with respect thereto.
ARTICLE IV. Sales Material and Information
4.1. PLICO shall furnish, or shall cause to be furnished, to the Fund or its designee, a copy of each piece of sales literature or other promotional material that PLICO develops or proposes to use and in which the Fund (or a Portfolio thereof), its Adviser or one of its sub-advisers or the Distributor is named in connection with the Contracts, at least ten (10) Business Days prior to its use. No such material shall be used if the Fund reasonably objects to such use within five (5) Business Days after receipt of such material.
4.2. PLICO shall not give any information or make any representations or statements on behalf of the Fund in connection with the sale of the Contracts other than the information or representations contained in the registration statement, prospectus or SAI for the Fund shares, as the same may be amended or supplemented from time to time, or in sales literature or other promotional material approved by the Fund, Distributor or Adviser, except with the permission of the Fund, Distributor or Adviser. The Fund, the Adviser, and the Distributor or their respective designees each agrees to respond to any request for approval on a prompt and timely basis. PLICO shall adopt and implement procedures reasonably designed to ensure that information concerning the Fund, the Adviser, and the Distributor or any of their affiliates which is intended for use only by brokers or agents selling the Contracts (i.e., information that is not intended for distribution to Contract owners or prospective Contract owners) is so used, and neither the Fund, the Adviser, and the Distributor nor any of their affiliates shall be liable for any losses, damages or expenses relating to the improper use of such broker only materials.
4.3. The Fund, the Distributor or the Adviser shall furnish, or shall cause to be furnished, to PLICO, a copy of each piece of sales literature or other promotional material in which and/or its separate account(s) are named at least ten (10) Business Days prior to its use. No such material shall be used if PLICO reasonably objects to such use within five (5) Business Days after receipt of such material.
4.4. The Fund and the Adviser shall not give any information or make any representations on behalf of PLICO or concerning PLICO, the Accounts, or the Contracts other than the information or representations contained in the Contracts, as the same may be amended or supplemented from time to time, or in sales literature or other promotional material approved by PLICO or itsdesignee, except with the permission of PLICO. PLICO or its respective designees agree to respond to any request for approval on a prompt and timely basis. The parties hereto agree that this Section 4.4. is intended neither to designate nor otherwise imply that the Adviser is an underwriter or distributor of the Contracts.
4.5. The Fund will provide to PLICO at least one complete copy of all registration statements, prospectuses, SAIs, sales literature and other promotional materials, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to the Designated Portfolio(s), contemporaneously with the filing of such document(s) with the SEC or FINRA or other regulatory authorities.
4.6. PLICO will provide to the Fund at least one complete copy of all sales literature and other promotional materials, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to the Contracts or the Accounts, contemporaneously with the filing of such document(s) with the SEC, FINRA, or other regulatory authority.
4.7. For purposes of Articles IV and VII, the phrase sales literature and other promotional material includes, but is not limited to, advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media; e.g., on-line networks such as the Internet or other electronic media), sales literature (i.e., any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, and shareholder reports, and proxy materials (including solicitations for voting instructions) and any other material constituting sales literature or advertising under the FINRA rules, the 1933 Act or the 1940 Act.
4.8. At the request of any Party to this Agreement, each other Party will make available to the other Partys independent auditors and/or representative of the appropriate regulatory agencies, all records, data and access to operating procedures that may be reasonably requested in connection with compliance and regulatory requirements related to this Agreement or any Partys obligations under this Agreement.
4.9 Subject to the terms of Sections 4.1 and 4.2 of this Agreement, the Fund (and its Portfolios), the Adviser and the Distributor hereby each consents in connection with the marketing of the Contracts to PLICO use of their names or other identifying marks, including PIONEER INVESTMENTS® in connection with the marketing of the Contracts. The Fund, the Adviser, and the Distributor or their affiliates may withdraw this authorization as to any particular use of any such name or identifying mark at any time: (i) upon a reasonable determination that such use would have a material adverse effect on its reputation or marketing efforts or its affiliates or (ii) if any of the Portfolios of the Fund cease to be available through PLICO. Except as set forth in the previous sentence, the Company will not cause or permit, without prior written permission, the use, description or reference to a Pioneer partys name, or to the relationship contemplated in this Agreement, in any advertisement, or promotional materials or activities, including
without limitation, any advertisement or promotional materials published, distributed, or made available, or any activity conducted through, the Internet or any other electronic medium.
ARTICLE V. Fees and Expenses
5.1. The Fund and the Adviser will pay certain fees in accordance with Schedule D. In addition, the Parties will bear certain expenses in accordance with Schedule C, as well as Articles III and V of this Agreement.
5.2. All expenses incident to performance by the Fund, Distributor and the Adviser under this Agreement shall be paid by the appropriate Party, as further provided in Schedule C. The Fund shall ensure that all shares of the Designated Portfolio(s) are registered and authorized for issuance in accordance with applicable federal law and, if and to the extent required, in accordance with applicable state laws prior to their sale.
5.3. The Parties shall bear the expenses of routine annual distribution (mailing costs) of the Funds prospectus and distribution (mailing costs) of the Funds proxy materials and reports to owners of Contracts offered by PLICO, which may be required by law, in accordance with Schedule C.
5.4 The Fund, the Distributor and the Adviser acknowledge that a principal feature of the Contracts is the Contract owners ability to choose from a number of unaffiliated mutual funds (and portfolios or series thereof), including the Designated Portfolio(s) and the Unaffiliated Funds, and to transfer the Contracts cash value between funds and portfolios. The Fund and the Adviser agree to cooperate with PLICO in facilitating the operation of the Accounts and the Contracts as described in the prospectus for the Contracts, including but not limited to cooperation in facilitating transfers between Unaffiliated Funds.
5.5. PLICO agrees to provide certain administrative services, specified in Schedule C attached hereto, in connection with the arrangements contemplated by this Agreement. The Parties intend that the services referred to in Section 5.4 be recordkeeping, shareholder communication, and other transaction facilitation and processing, and related administrative services and are not the services of an underwriter or principal underwriter of the Fund, and PLICO are not underwriters of Shares within the meaning of the 1933 Act.
ARTICLE VI. Diversification and Qualification
6.1. The Fund, Distributor and Adviser represent and warrant that the Fund and each Designated Portfolio thereof will at all times invest money from the Contracts in such a manner as to ensure that the Contracts will be treated as variable contracts under the Code and the regulations issued thereunder. Without limiting the scope of the foregoing, the Fund will at all times comply with Section 817(h) of the Code and Treasury Regulation §1.817-5, relating to the diversification requirements for variable annuity, endowment, or life insurance contracts and any amendments or other modifications to such Section or Regulations. In the event of a breach of this Article VII by the Fund, it will take all reasonable steps (a) to notify the Insurance Companies of such breach and (b) to adequately diversify the Fund so as to achieve compliance within the grace period afforded by Regulation §1.817-5.
6.2. The Fund, the Distributor and the Adviser represent and warrant that the Fund and each Designated Portfolio is currently qualified as a Regulated Investment Company under Subchapter M of the Internal Revenue Code of 1986, as amended (hereinafter the Code), and that each Designated Portfolio will maintain such qualification (under Subchapter M or any successor or similar provisions) as long as this
Agreement is in effect.
6.3. The Fund, Distributor or Adviser will notify PLICO promptly upon having a reasonable basis for believing that the Fund or any Designated Portfolio has ceased to comply with the aforesaid Subchapter M qualification requirements or might not so comply in the future.
ARTICLE VII. Indemnification
7.1. Indemnification by PLICO
(a) PLICO agrees to indemnify and hold harmless the Fund, the Distributor and the Adviser and each of their respective officers and directors or trustees and each person, if any, who controls the Fund, Distributor or Adviser within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 7.1) against any and all losses, claims, expenses, damages and liabilities (including amounts paid in settlement with the written consent of PLICO) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, expenses, damages or liabilities (or actions in respect thereof) or settlements are related to the sale or acquisition of the Funds shares or the Contracts and:
(i) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the Contracts or sales literature or other promotional material for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this Agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to PLICO by or on behalf of the Adviser or Fund for use in the Contracts or sales literature or other promotional material (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or Fund shares; or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in sales literature or other promotional material of the Fund not supplied by PLICO or persons under its control) or wrongful conduct of PLICO or persons under its control, with respect to the sale or distribution of the Contracts or Fund Shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in sales literature or other promotional material of the Fund, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, if such a statement or omission was made in reliance upon information furnished in writing to the Fund by or on behalf of PLICO; or
(iv) arise as a result of any failure by PLICO to provide the services and furnish the materials under the terms of this Agreement; or
(v) arise out of or result from any material breach of any representation and/or warranty made by PLICO in this Agreement or arise out of or result from any other material breach of this Agreement by PLICO,
as limited by and in accordance with the provisions of Sections 7.1(b) and 7.1(c) of this Agreement.
(b) PLICO shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.
(c) PLICO shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party has notified PLICO in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim has been served upon such Indemnified Party (or after such Indemnified Party has received notice of such service on any designated agent), but failure to notify PLICO of any such claim shall not relieve PLICO from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent that PLICO has been prejudiced by such failure to give notice. In case any such action is brought against the Indemnified Parties, PLICO shall be entitled to participate, at its own expense, in the defense of such action. PLICO also shall be entitled to assume the defense thereof, with counsel satisfactory to the Party named in the action. After notice from PLICO to such Party of PLICOs election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and PLICO will not be liable to such Party under this Agreement for any legal or other expenses subsequently incurred by such Party independently in connection with the defense thereof other than reasonable costs of investigation.
(d) The Indemnified Parties will promptly notify PLICO of the commencement of any litigation or proceedings against them in connection with the issuance or sale of the Fund Shares or the Contracts or the operation of the Fund.
7.2. Indemnification by the Adviser
(a) The Adviser agrees to indemnify and hold harmless PLICO and its directors and officers and each person, if any, who controls PLICO within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 7.2) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with the written consent of the Adviser) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Funds shares or the Contracts and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement or prospectus or SAI or sales literature or other promotional material of the Fund prepared by the Fund, the Distributor or the Adviser (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this Agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to the Adviser, the Distributor or the Fund by or on behalf of PLICO for use in the registration statement, prospectus or SAI for the Fund or in sales literature or other promotional material (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or the Fund shares; or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in sales literature or other promotional material for the Contracts not supplied by the Adviser or persons under its control) or wrongful conduct of the Fund, the Distributor or the Adviser or persons under their control, with respect to the sale or distribution of the Contracts or Fund shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in sales literature or other promotional material covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished in writing to PLICO by or on behalf of the Adviser, the Distributor or the Fund; or
(iv) arise as a result of any failure by the Fund, the Distributor or the Adviser to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification and other qualification requirements specified in Article VI of this Agreement); or
(v) arise out of or result from any material breach of any representation and/or warranty made by the Fund, the Distributor or the Adviser in this Agreement or arise out of or result from any other material breach of this Agreement by the Adviser, the Distributor or the Fund; or
(vi) arise out of or result from the incorrect or untimely calculation or reporting by the Fund, the Distributor or the Adviser of the daily net asset value per share or dividend or capital gain distribution rate;
as limited by and in accordance with the provisions of Sections 7.2(b) and 7.2(c). This indemnification is in addition to and apart from the responsibilities and obligations of the Adviser specified in Article VI.
(b) The Adviser shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.
(c) The Adviser shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party has notified the Adviser in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim has been served upon such Indemnified Party (or after such Indemnified Party has received notice of such service on any designated agent), but failure to notify the Adviser of any such claim shall not relieve the Adviser from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent that the Adviser has been prejudiced by such failure to give notice. In case any such action is brought against the Indemnified Parties, the Adviser will be entitled to participate, at its own expense, in the defense thereof. The Adviser also shall be entitled to assume the defense thereof, with counsel satisfactory to the Party named in the action. After notice from the Adviser to such Party of the Advisers election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Adviser will not be liable to such Party under this Agreement for any legal or other expenses subsequently incurred by such Party independently in connection with the defense thereof other than reasonable costs of investigation.
(d) PLICO agrees to promptly notify the Adviser of the commencement of any litigation or proceedings against it or any of its officers or directors in connection with the issuance or sale of the Contracts or the operation of the Accounts.
7.3. Indemnification by the Distributor
(a) The Distributor agrees to indemnify and hold harmless PLICO and their directors and officers and each person, if any, who controls PLICO within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 7.3) against any and all losses, claims, expenses, damages and liabilities (including amounts paid in settlement with the written consent of the Distributor) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Funds shares or the Contracts and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement or prospectus or SAI or sales literature or other promotional material of the Fund prepared by the Fund, Adviser or Distributor (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this Agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to the Adviser, the Distributor or Fund by or on behalf of PLICO for use in the registration statement or SAI or prospectus for the Fund or in sales literature or other promotional material (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or Fund shares; or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, SAI, sales literature or other promotional material for the Contracts not supplied by the Distributor or persons under its control) or wrongful conduct of the Fund, the Distributor or Adviser or persons under their control, with respect to the sale or distribution of the Contracts or Fund shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI, sales literature or other promotional material covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished in writing to PLICO by or on behalf of the Adviser, the Distributor or Fund; or
(iv) arise as a result of any failure by the Fund, Adviser or Distributor to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification and other qualification requirements specified in Article VI of this Agreement); or
(v) arise out of or result from any material breach of any representation and/or warranty made by the Fund, Adviser or Distributor in this Agreement or arise out of or result from any other material breach of this Agreement by the Fund, Adviser or Distributor; or
(vi) arise out of or result from the incorrect or untimely calculation or reporting of the daily net asset value per share or dividend or capital gain distribution rate;
as limited by and in accordance with the provisions of Sections 7.3(b) and 7.3(c). This indemnification is in addition to and apart from the responsibilities and obligations of the Distributor specified in Article VI.
(b) The Distributor shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or negligence in the performance or such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.
(c) The Distributor shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party has notified the Distributor in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim has been served upon such Indemnified Party (or after such Indemnified Party has received notice of such service on any designated agent), but failure to notify the Distributor of any such claim shall not relieve the Distributor from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent that the Distributor has been prejudiced by such failure to give notice. In case any such action is brought against the Indemnified Parties, the Distributor will be entitled to participate, at its own expense, in the defense thereof. The Distributor also shall be entitled to assume the defense thereof, with counsel satisfactory to the Party named in the action. After notice from the Distributor to such Party of the Distributors election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Distributor will not be liable to such Party under this Agreement for any legal or other expenses subsequently incurred by such Party independently in connection with the defense thereof other than reasonable costs of investigation.
(d) PLICO agrees to promptly notify the Distributor of the commencement of any litigation or proceedings against it or any of its officers or directors in connection with the issuance or sale of the Contracts or the operation of the Accounts.
ARTICLE VIII. POTENTIAL MATERIAL CONFLICTS
8.1. The Fund agrees that the Board, constituted with a majority of disinterested trustees, will monitor each Portfolio of the Fund for the existence of any material irreconcilable conflict between the interests of the variable annuity contract owners and the variable life insurance policy owners of PLICO and/or affiliated companies (contract owners) investing in the Fund. A material irreconcilable conflict may arise for a variety of reasons, including: (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling, no-action or interpretive letter, or any similar action by insurance, tax or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the investments of any Portfolio are being managed; (e) a difference in voting instructions given by variable annuity contract and variable life insurance contract owners or by contract owners of different Insurance Parties; or (f) a decision by an PLICO to disregard the voting instructions of contract owners. The Board shall have the sole authority to determine if a material irreconcilable conflict exists, and such determination shall be binding on PLICO only if approved in the form of a resolution by a majority of the Board, or a majority of the disinterested trustees of the Board. The Board will give prompt notice of any such determination to PLICO.
8.2. PLICO agrees that it will be responsible for assisting the Board in carrying out its responsibilities under the conditions set forth in the Funds exemptive application pursuant to which the SEC has granted the Mixed and Shared Funding Exemptive Order by providing the Board, as it may reasonably request, with all information necessary for the Board to consider any issues raised and agrees that it will be responsible for promptly reporting any potential or existing conflicts of which it is aware to the Board including, but not limited to, an obligation by PLICO to inform the Board whenever contract owner voting instructions are disregarded. PLICO also agrees that, if a material irreconcilable conflict arises, it will at its own cost remedy such conflict up to and including (a) withdrawing the assets allocable to some or all of the Accounts from the Fund or any Portfolio and reinvesting such assets in a different investment medium, including (but not limited to) another Portfolio of the Fund, or submitting to a vote of all affected contract owners whether to withdraw assets from the Fund or any Portfolio and reinvesting such assets in a different investment medium and, as appropriate, segregating the assets attributable to any appropriate group of contract owners (e.g., annuity contract owners, life insurance owners or variable contract owners of one or more Insurance Parties) that votes in favor of such segregation, or offering to any of the affected contract owners the option of segregating the assets attributable to their contracts or policies, and (b) establishing a new registered management investment company and segregating the assets underlying the Contracts, unless a majority of Contract owners materially adversely affected by the conflict have voted to decline the offer to establish a new registered management investment company.
8.3. A majority of the disinterested trustees of the Board shall determine whether any proposed action by PLICO adequately remedies any material irreconcilable conflict. In the event that the Board determines that any proposed action does not adequately remedy any material irreconcilable conflict, PLICO will withdraw from investment in the Fund each of the Accounts designated by the disinterested trustees and terminate this Agreement within six (6) months after the Board informs PLICO in writing of the foregoing determination; provided, however, that such withdrawal and termination shall be limited to the extent required to remedy any such material irreconcilable conflict as determined by a majority of the disinterested trustees of the Board.
8.4 If a material irreconcilable conflict arises because of a decision by PLICO to disregard Contract owner voting instructions and that decision represents a minority position or would preclude a majority vote, PLICO may be required, at the Funds election, to withdraw the Accounts investment in the Fund and terminate this Agreement; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the Funds independent trustees. Any such withdrawal and termination must take place within six (6) months after the Fund gives written notice that this provision is being implemented, and until the end of that six-month period the Distributor and the Fund shall continue to accept and implement orders by PLICO for the purchase and redemption of shares of the Fund.
8.5. If material irreconcilable conflict arises because of particular state insurance regulators decision applicable to PLICO conflicts with the majority of other state regulators, then PLICO will withdraw the Accounts investment in the Fund and terminate this Agreement within six (6) months after the Funds Board informs PLICO in writing that it has determined that such decision has created a material irreconcilable conflict; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the disinterested members of the Funds Board. Until the end of the foregoing six (6) month period, the Fund and the Distributor shall continue to accept and implement orders by PLICO for the purchase and redemption of shares of the Fund.
8.6 For purposes of Sections 8.3 through 8.6 of this Agreement, a majority of the disinterested members of the Board shall determine whether any proposed action adequately remedies any material irreconcilable conflict, but in no event will the Fund be required to establish a new funding medium for the Contracts. PLICO shall not be required by Section 8.2 to establish a new funding medium for the contracts
if an offer to do so has been declined by vote of a majority of Contract owners affected by the material irreconcilable conflict. In the event that the Board determines that any proposed action does not adequately remedy any material irreconcilable conflict, then PLICO will withdraw the Accounts investment in the Fund and terminate this Agreement within six (6) months after the Board informs PLICO in writing of the foregoing determination; provided, however, that such withdrawal and termination shall be limited to the extent required by any such material irreconcilable conflict as determined by a majority of the independent trustees.
8.7. If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Mixed and Shared Funding Exemptive Order) on terms and conditions materially different from those contained in the Mixed and Shared Funding Exemptive Order, then (a) the Fund and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with Rule 6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such rules are applicable; and (b) Sections 3.5, 3.6, 8.1, 8.2, 8.3 and 8.7 of this Agreement shall continue in effect only to the extent that terms and conditions substantially identical to such Sections are contained in such Rule(s) as so amended or adopted.
ARTICLE IX. Applicable Law
9.1. This Agreement will be construed and interpreted in accordance with the laws of the State of Massachusetts, without regard to the Massachusetts Conflict of Laws provisions.
9.2. This Agreement is subject to the provisions of the 1933, 1934, and 1940 Acts, and the rules and regulations and rulings thereunder, including such exemptions from those statutes (including, but not limited to, the Mixed and Shared Funding Exemptive Order), rules and regulations as the SEC may grant and the terms of this Agreement will be interpreted and construed in accordance therewith.
ARTICLE X. Termination
10.1. This Agreement will terminate:
(a) at the option of any Party, with or without cause, with respect to some or all Portfolios, upon six (6) months advance written notice delivered to the other Parties; provided, however, that such notice shall not be given earlier than six (6) months following the Effective Date of this Agreement; or
(b) at the option of PLICO by written notice to the other Parties with respect to any Portfolio based upon PLICOs determination that shares of such Portfolio are not reasonably available to meet the requirements of the Contracts; or
(c) at the option of PLICO by written notice to the other Parties with respect to any Portfolio in the event any of the Portfolios shares are not registered, issued or sold in accordance with applicable state and/ or federal law or such law precludes the use of such shares as the underlying investment media of the Contracts issued or to be issued by such Insurance Party; or
(d) at the option of the Fund, Distributor or Adviser in the event that formal administrative proceedings are instituted against PLICO by FINRA, the SEC, the Insurance Commissioner or like official of any state or any other regulatory body regarding PLICOs duties under this Agreement or related to the sale of the Contracts, the operation of any Account, or the purchase of the Fund shares, if, in each case, the Fund, Distributor or Adviser, as the case may be, reasonably determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of such Insurance Party to perform its obligations under this Agreement; or
(e) at the option of PLICO in the event that formal administrative proceedings are instituted against the Fund, the Distributor or the Adviser by FINRA, the SEC, or any state securities or insurance department or any other regulatory body, if PLICO reasonably determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Fund, the Distributor or the Adviser to perform their obligations under this Agreement; or
(f) at the option of either the Fund, the Distributor or the Adviser, if (i) the Fund, the Distributor or Adviser, respectively, determines, in its sole judgment reasonably exercised in good faith, that PLICO has suffered a material adverse change in its business or financial condition or is the subject of material adverse publicity and that material adverse change or publicity will have a material adverse impact on PLICOs ability to perform its obligations under this Agreement, (ii) the Fund, the Distributor or Adviser notifies PLICO of that determination and its intent to terminate this Agreement, and (iii) after considering the actions taken by PLICO and any other changes in circumstances since the giving of such a notice, the determination of the Fund, the Distributor or Adviser continues to apply on the sixtieth (60th) day following the giving of that notice, which sixtieth day will be the effective date of termination; or
(g) at the option of PLICO, if (i) it determines, in its sole judgment reasonably exercised in good faith, that the Fund, the Distributor or Adviser has suffered a material adverse change in its business or financial condition or is the subject of material adverse publicity and that material adverse change or publicity will have a material adverse impact on the Funds, Distributors or Advisers ability to perform its obligations under this Agreement, (ii) such Insurance Party notifies the Fund, Distributor or Adviser, as appropriate, of that determination and its intent to terminate this Agreement, and (iii) after considering the actions taken by the Fund, Distributor or Adviser and any other changes in circumstances since the giving of such a notice, the determination of PLICO continues to apply on the sixtieth (60th) day following the giving of that notice, which sixtieth day will be the effective date of termination; or
(h) at the option of any non-defaulting Party in the event of a material breach of this Agreement by any Party (the Defaulting Party) other than as described in 10.1(a)-(g); provided, that the non-defaulting Party gives written notice thereof to the Defaulting Party, with copies of such notice to all other non-defaulting Parties, and if such breach has not been remedied within thirty (30) days after such written notice is given, then the non-defaulting Party giving such written notice may terminate this Agreement by giving thirty (30) days written notice of termination to the Defaulting Party.
10.2. Notice Requirement. No termination of this Agreement will be effective unless the Party terminating this Agreement gives prior written notice to all other Parties of its intent to terminate, which notice must set forth the basis for the termination. Furthermore:
(a) in the event any termination is based upon the provisions of Section 10.1(a), 10.1(f), 10.1(g) or 10.1(h) of this Agreement, the prior written notice must be given in advance of the effective date of termination as required by those provisions unless such notice period is shortened by mutual written agreement of the Parties;
(b) in the event any termination is based upon the provisions of Section 10.1(d) or 10.1(e) of this Agreement, the prior written notice must be given at least sixty (60) days before the effective date of termination; and
(c) in the event any termination is based upon the provisions of Section 10.1(b) or 10.1(c), the prior written notice must be given in advance of the effective date of termination, which date will be determined by the Party sending the notice.
10.3. Effect of Termination. Notwithstanding any termination of this Agreement, the Fund, the Distributor and the Adviser shall, at the option of PLICO, continue to make available additional shares of the Designated Portfolio(s) pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as Existing Contracts). Specifically, without limitation, the owners of the Existing Contracts shall be permitted to reallocate investments in the Designated Portfolio(s), redeem investments in the Designated Portfolio(s) and/or invest in the Designated Portfolio(s) upon the making of additional purchase payments under the Existing Contracts.
109.4. Surviving Provisions. Notwithstanding any termination of this Agreement, each Partys obligations under Article VII, Section 12.1, and Section 12.5 will survive and not be affected by any termination of this Agreement. In addition, with respect to Existing Contracts, all provisions of this Agreement will also survive and not be affected by any termination of this Agreement.
ARTICLE XI. Notices
Any notice will be sufficiently given when sent by registered or certified mail to the other Party at the address of such Party set forth below or at such other address as such Party may from time to time specify in writing to the other Parties.
PROTECTIVE LIFE INSURANCE COMPANY
2801 Highway 280 South
Birmingham AL 35223
Attention: Senior Vice President, Chief Product Officer
With a copy to:
Senior Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
If to the Fund:
Pioneer Variable Contracts Trust
60 State Street
Boston, Massachusetts 02109
Attn: Secretary
If to the Adviser:
Amundi Pioneer Asset Management, Inc.
60 State Street
Boston, Massachusetts 02109
Attn: General Counsel.
If to the Distributor:
Amundi Pioneer Distributor, Inc.
60 State Street
Boston, Massachusetts 02109
Attn: General Counsel
ARTICLE XII. Miscellaneous
12.1. Subject to the requirements of legal process and regulatory authority, each Party shall treat as confidential the names and addresses of the owners of the Contracts and all information reasonably identified as confidential in writing by any other Party and, except as permitted by this Agreement, shall not disclose, disseminate or utilize such names and addresses and other confidential information without the express written consent of the affected Party until such time as such information may come into the public domain. Without limiting the foregoing, no Party shall disclose any information that another Party has designated as proprietary.
12.2. The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
12.3. This Agreement may be executed simultaneously in two or more counterparts, each of which taken together constitutes one and the same instrument. Any signature that is delivered by facsimile transmission or by email delivery of a pdf format data file will create a valid and binding obligation of the Party executing with the same force and effect as if such facsimile or pdf signature were an original thereof.
12.4. If any provision of this Agreement is held or made invalid by a court decision, statute, rule or otherwise, the remainder of this Agreement will not be affected thereby.
12.5. Each Party shall cooperate with each other Party and all appropriate governmental authorities (including without limitation the SEC, the FINRA and state insurance regulators) and shall permit such other Party and authorities reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby. Notwithstanding the generality of the foregoing, each Party further agrees to furnish the [Alabama] Insurance Commissioner with any information or reports in connection with services provided under this Agreement which such Commissioner may reasonably request in order to ascertain whether the variable annuity operations of PLICO are being conducted in a manner consistent with the applicable states applicable laws or regulations.
12.6. The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the Parties are entitled to under state and federal laws.
12.7 This Agreement may not be amended except by a writing signed by each of the Parties. The terms or provisions of this Agreement may be waived only by a writing signed by the Party waiving compliance. No waiver by any Party of any term or provision of this Agreement will be deemed to be a continuing waiver, or deemed to be a waiver of any other term or provision of this Agreement.
12.8. This Agreement or any of the rights and obligations hereunder may not be assigned by any Party without the prior written consent of all Parties.
12.9. PLICO is hereby expressly put on notice of the limitation of liability as set forth in the Declarations of Trust of the Fund and agree that the obligations assumed by the Fund, the Distributor and the Adviser pursuant to this Agreement are limited in any case to the Fund and Adviser and their respective assets and PLICO shall not seek satisfaction of any such obligation from the shareholders of the Fund, officers, employees or agents of the Fund, if an applicable trust.
12.10. The Fund, the Distributor and the Adviser agree that the obligations assumed by each Insurance Party pursuant to this Agreement are limited in any case to PLICO and its assets and neither the
Fund, Distributor nor Adviser shall seek satisfaction of any such obligation from the shareholders of PLICO, its directors, officers, employees or agents, or any of them, except to the extent permitted under this Agreement.
12.11. No provision of this Agreement may be deemed or construed to modify or supersede any contractual rights, duties, or indemnifications, as between the Adviser, the Distributor and the Fund.
12.12. None of the Parties shall be liable to the other for any and all losses, damages, costs, charges, counsel fees, payments, expenses or liability due to any failure, delay or interruption in performing its obligations under this Agreement, and without the fault or negligence of such Party, due to causes or conditions beyond its control including, without limitation, labor disputes, strikes (whether legal or illegal), lock outs (whether legal or illegal), civil commotion, riots, war and war-like operations including acts of terrorism, embargoes, epidemics, invasion, rebellion, hostilities, insurrections, explosions, floods, unusually severe weather conditions, earthquakes, military power, sabotage, governmental regulations or controls, failure of power, fire or other casualty, accidents, national or local emergencies, boycotts, picketing, slow-downs, work stoppages, acts of God or natural disasters, provided that such failure or delay was not capable of mitigation pursuant to a prudent business continuity, disaster recovery or similar program.
12.13. This Agreement sets forth the entire agreement and understanding of the Parties relating to the subject matter hereof, and supersedes all other prior agreements, arrangements, and understandings, whether written or oral, between the Parties.
(The remainder of this page intentionally left blank; signature page to follow)
IN WITNESS WHEREOF, each of the Parties has caused this Agreement to be executed on its behalf by its duly authorized representative, to be effective as of the Effective Date.
PROTECTIVE LIFE INSURANCE COMPANY |
|
|
|
|
|
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
|
|
|
PIONEER VARIABLE CONTRACTS TRUST |
|
|
|
|
|
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
|
|
|
AMUNDI PIONEER ASSET MANAGEMENT, INC. |
|
|
|
|
|
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
|
|
|
AMUNDI PIONEER DISTRIBUTOR, INC. |
|
|
|
|
|
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
SCHEDULE A
DESIGNATED PORTFOLIOS
Pioneer Bond VCT I
Pioneer Real Estate Shares VCT I
Pioneer Equity Income VCT I
Pioneer High Yield VCT I
Any and all other portfolios of the Fund available to new investors on or after the effective date of this Agreement which, pursuant to the terms of the Funds registration statement, may be eligible to serve as underlying funds to the Separate Accounts listed in Schedule B as agreed between the parties.
SCHEDULE B
SEPARATE ACCOUNTS
PROTECTIVE LIFE INSURANCE COMPANY Accounts
PLICO Variable Annuity Account S
Protective COLI VUL Separate Account
Protective COLI PPVUL Separate Account
SCHEDULE C
EXPENSES
The Fund and/or Adviser, and PLICO will coordinate the functions and pay the costs of completing these functions based upon an allocation of costs in the tables below.
Item |
|
Function |
|
Party Responsible
|
|
Party
|
Mutual Fund Prospectus |
|
Printing of combined prospectuses, or compiling of electronic prospectus, if needed in the future |
|
PLICO |
|
Fund or Adviser, as applicable |
|
|
Fund or Adviser shall supply PLICO with such numbers of the Designated Portfolio(s) prospectus(es) as PLICO reasonably requests |
|
PLICO |
|
Fund or Adviser, as applicable |
|
|
Distribution to New and Inforce Clients |
|
PLICO |
|
Fund or Adviser, as applicable |
|
|
Distribution to Prospective Clients |
|
PLICO |
|
PLICO |
Mutual Fund Prospectus Update & Distribution |
|
If Required by Fund or Adviser |
|
Fund or Adviser |
|
Fund or Adviser |
|
|
If Required by PLICO |
|
PLICO |
|
PLICO |
Mutual Fund SAI |
|
Printing |
|
Fund or Adviser |
|
Fund or Adviser |
|
|
Distribution |
|
PLICO |
|
PLICO |
Proxy Material for Mutual Fund: |
|
Printing if proxy required by Law |
|
Fund or Adviser |
|
Fund or Adviser |
|
|
Distribution to Contract owners (including labor, if required) if proxy required by Law |
|
PLICO |
|
Fund or Adviser |
|
|
Printing & distribution if required by PLICO |
|
PLICO |
|
PLICO |
Mutual Fund Annual & Semi-Annual Report |
|
Printing of combined reports |
|
PLICO |
|
Fund or Adviser |
|
|
Distribution |
|
PLICO |
|
PLICO |
Other communication to New and Prospective clients |
|
If Required by the Fund or Adviser |
|
PLICO |
|
Fund or Adviser |
|
|
If Required by PLICO |
|
PLICO |
|
PLICO |
Other communication to Inforce Clients |
|
Distribution (including labor and printing) if required by the Fund or Adviser |
|
PLICO |
|
Fund or Adviser |
|
|
Distribution (including labor and printing) if required by PLICO |
|
PLICO |
|
PLICO |
Errors in Share Price calculation |
|
Cost of error to participants |
|
PLICO |
|
Fund or Adviser |
|
|
Cost of administrative work to correct error |
|
PLICO, Fund, or Adviser |
|
Fund or Adviser or PLICO if PLICO is at fault for the error |
Operations of the Fund |
|
All operations and related expenses, including the cost of registration and qualification of shares, taxes on the issuance or transfer of shares, cost of management of the business affairs of the Fund, and expenses paid or assumed by the fund pursuant to any Rule 12b-1 plan |
|
Fund or Adviser |
|
Fund or Adviser |
SCHEDULE D
ADMINISTRATIVE SERVICES
A. PLICO, or an affiliate, will provide the properly registered and licensed personnel and systems needed for all customer servicing and support for both fund and annuity information and questions including:
responding to Contract owner inquiries;
delivering prospectuses both fund and annuity;
entering initial and subsequent orders;
transferring cash to insurance company and/or funds;
explaining fund objectives and characteristics;
entering transfers between funds;
responding to fund balance and allocation inquiries;
mailing fund prospectus.
B. PLICO, or an affiliate, will communicate all purchase, withdrawal, and exchange orders it receives from its customers to each Designated Portfolio.
Administrative Service Fee
For the services related to Class I shares of any Designated Portfolio, PLICO or its PLICO affiliate shall receive a fee of 0.35% per annum of the average aggregate daily net asset value of shares of the Designated Portfolio(s) held in the Accounts, and for the services related to Class II shares of any Designated Portfolio, PLICO or its affiliate shall receive a fee of 0.25% per annum of the average aggregate daily net asset value of shares of the Designated Portfolio(s) held in the Accounts. In each case, the fee is payable by the Adviser, or its designee, directly to PLICO or its affiliate. Such fee shall be paid in arrears quarterly. Each quarterly fee will be determined based on assets in the Accounts and each quarterly fee will be independent of every other quarterly fee. Such fee shall be due and payable automatically within 20 (twenty) days after the last day of the quarter to which such payment relates.
PLICO will calculate the asset balance on each day on which the fee is to be paid pursuant to this Agreement with respect to each Designated Portfolio held in the Accounts and will invoice the Adviser accordingly.
12b-1 Distribution Related Fees
The Adviser, or its designee, agrees to pay PLICO or its affiliate a fee of 0.25% per annum of the average aggregate daily net asset value of Class II shares of Designated Portfolio(s) held in the Accounts. Such fee shall be paid in arrears, quarterly. Each quarterly fee will be determined based on assets in the Accounts and each quarterly fee will be independent of every other quarterly fee. Such fee shall be due and payable automatically within 20 (twenty) days after the last day of the quarter to which such payment relates.
PARTICIPATION AGREEMENT
Among
PUTNAM VARIABLE TRUST
PUTNAM RETAIL MANAGEMENT LIMITED PARTNERSHIP
And
PROTECTIVE LIFE INSURANCE COMPANY
THIS AGREEMENT, made and entered into as of this 9th day of November 2020, among Protective Life Insurance Company (the Company), [an insurance company organized under Tennessee law], on its own behalf and on behalf of each separate account of the Company set forth on Schedule A hereto, as such Schedule may be amended from time to time (each such account hereinafter referred to as the Account), PUTNAM VARIABLE TRUST (the Trust), a Massachusetts business trust, and PUTNAM RETAIL MANAGEMENT LIMITED PARTNERSHIP (the Underwriter), a Massachusetts limited partnership.
WHEREAS, the Trust is an open-end diversified management investment company and is available to act as the investment vehicle for separate accounts now in existence or to be established at any date hereafter for variable life insurance policies and variable annuity contracts (collectively, the Variable Insurance Products) to be offered by insurance companies which have entered into Participation Agreements with the Trust and the Underwriter (the Participating Insurance Companies); and
WHEREAS, the beneficial interest in the Trust is divided into several series of shares, each designated a Fund and each representing the interest in a particular managed portfolio of securities and other assets; and
WHEREAS, the Trust has obtained an order from the Securities and Exchange Commission, dated December 29, 1993 (File No. 812-8612), granting the variable annuity and variable life insurance separate accounts participating in the Trust exemptions from the provisions of sections 9(a), 13(a), 15(a) and 15(b) of the Investment Company Act of 1940, as amended (the 1940 Act), and Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the Trust to be sold to and held by variable annuity and variable life insurance separate accounts of the Participating Insurance Companies (the Shared Funding Exemptive Order); and
WHEREAS, the Trust is registered as an open-end management investment company under the 1940 Act and the sale of its shares is registered under the Securities Act of 1933, as amended (the 1933 Act); and
WHEREAS, the Company has registered or will register certain variable life and/or variable annuity contracts under the 1933 Act and any applicable state securities and insurance law unless such contracts are exempt from registration under the 1933 Act; and
WHEREAS, each Account is a duly organized, validly existing segregated asset separate account, established by resolution of the Board of Directors of the Company, to set aside and invest assets attributable to one or more variable insurance contracts (the Contracts, the Contract(s) and the Account(s) covered by the Agreement are specified in Schedule A); and
WHEREAS, the Company has registered or will register the Account as a unit investment trust under the 1940 Act, unless such Accounts are exempt from registration under the 1940 Act; and
WHEREAS, the Underwriter is registered as a broker dealer with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended (the 1934 Act), and is a member in good standing of the Financial Industry Regulatory Authority (the FINRA); and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company intends to purchase shares in certain Funds (Authorized Funds, the Authorized Funds covered by the Agreement are specified in Schedule B) on behalf of each Account to fund certain of the Contracts and the Underwriter is authorized to sell such shares to unit investment trusts such as each Account at net asset value;
NOW, THEREFORE, in consideration of the mutual promises herein, the Company, the Trust and the Underwriter agree as follows:
ARTICLE 1. Sale of Trust Shares
1.1 The Underwriter agrees, subject to the Trusts rights under Section 1.2 and otherwise under this Agreement, to sell to the Company those Trust shares representing interests in Authorized Funds which each Account orders, executing such orders on a daily basis at the net asset value next computed after receipt by the Trust or its designee of the order for the shares of the Trust. For purposes of this Section 1.1, the Company shall be the designee of the Trust for receipt of such orders from each Account and receipt by such designee as of 4 p.m. Eastern Standard Time shall constitute receipt by the Trust; provided that the Trust receives notice of such order by 9:30 a.m. Eastern Standard time on the next following Business Day. Business Day shall mean any day on which the New York Stock Exchange is open for trading and on which the Trust calculates its net asset value pursuant to the rules of the Securities and Exchange Commission. The initial Authorized Funds are set forth in Schedule B, as such schedule is amended from time to time.
1.2 The Trust agrees to make its shares available for purchase at the applicable net asset value per share by the Company for its separate Accounts listed on Schedule A, on those
days on which the Trust calculates its net asset value pursuant to rules of the Securities and Exchange Commission and the Trust. Notwithstanding the foregoing, the Trustees of the Trust (the Trustees) may refuse to sell shares of any Fund to the Company or any other person, or suspend or terminate the offering of shares of any Fund if such action is required by law or by regulatory authorities having jurisdiction over the Trust or if the Trustees determine, in the exercise of their fiduciary responsibilities, that to do so would be in the best interests of shareholders.
1.3 The Trust and the Underwriter agree that shares of the Trust will be sold only to Participating Insurance Companies and their separate accounts. No shares of any Fund will be sold to the general public.
1.4 The Trust shall redeem its shares in accordance with the terms of its then current prospectus. For purposes of this Section 1.4, the Company shall be the designee of the Trust for receipt of requests for redemption from each Account and receipt by such designee by the close of trading on the New York Stock Exchange on a day shall constitute receipt by the Trust on that day; provided that the Trust receives written (or facsimile) notice of such request for redemption by 9:30 a.m., Eastern time, on the next following Business Day. In connection with the foregoing and Section 1.1 above, the Company agrees to provide information, at the Underwriters reasonable request, on its late trading controls procedures, and the Company represents that it has controls and procedures in place to prevent the acceptance of orders or requests for redemption of shares of the Trust after the close of trading on the New York Stock Exchange on a day for trades that will be based on the net asset value determined as of the close of trading on the New York Stock Exchange on such day.
1.5 The Company agrees that the Contracts are not intended to serve as vehicles for frequent transfers among the Funds. As such, the Company agrees on its own behalf, and on behalf of any designee of the Company, to review and identify activity that might be construed as market timing and to abide by Putnams practices and policies by restricting activity of any Contract owner identified, either by the Trust, the Underwriter, the Company, or its designee, as a market timer. The parties acknowledge and agree that the transactions contemplated under this Agreement shall be subject to the provisions of the Rule 22c-2 Agreement dated as of this date and entered into by and among Underwriter, Company and Putnam Investor Services, Inc.
1.6 The Company or its designated agent shall purchase and redeem the shares of Authorized Funds offered by the then current prospectus of the Trust in accordance with the provisions of such prospectus.
1.7 The Company shall pay for Trust shares on the next Business Day after an order to purchase Trust shares is made in accordance with the provisions of Section 1.1 hereof. Payment shall be in federal funds transmitted by wire.
1.8 Issuance and transfer of the Trusts shares will be by book entry only. Share certificates will not be issued to the Company or any Account. Shares ordered from the Trust
will be recorded as instructed by the Company to the Underwriter in an appropriate title for each Account or the appropriate sub-account of each Account.
1.9 The Underwriter shall furnish prompt notice (by wire or telephone, followed by written confirmation) to the Company of the declaration of any income, dividends or capital gain distributions payable on the Trusts shares. The Company hereby elects to receive all such income dividends and capital gain distributions as are payable on the Fund shares in additional shares of that Fund. The Company reserves the right to revoke this election and to receive all such income dividends and capital gain distributions in cash. The Underwriter shall notify the Company of the number of shares so issued as payment of such dividends and distributions.
1.10 The Underwriter shall make the net asset value per share for each Fund available to the Company on a daily basis as soon as reasonably practical after the Trust calculates its net asset value per share and each of the Trust and the Underwriter shall use its best efforts to make such net asset value per share available by 7:00 p.m. Eastern time.
ARTICLE II. Representations and Warranties
2.1 The Company represents and warrants that
(a) at all times during the term of this Agreement the Contracts are or will be registered under the 1933 Act, to the extent required, unless exempt from regiastration under the 1933 Act; the Contracts will be issued and sold in compliance in all material respects with all applicable laws and the sale of the Contracts shall comply in all material respects with state insurance suitability requirements. The Company further represents and warrants that it is an insurance company duly organized and in good standing under applicable law and that it has legally and validly established each Account prior to any issuance or sale thereof as a separate account under applicable law and has registered or, prior to any issuance or sale of the Contracts, will register each Account as a unit investment trust in accordance with the provisions of the 1940 Act, unless exempt from registration under the 1940 Act, to serve as a segregated investment account for the Contracts; and
(b) the Contracts are currently treated as endowment, annuity or life insurance contracts, under applicable provisions of the Internal Revenue Code of 1986, as amended (the Code), and that it will make every effort to maintain such treatment and that it will notify the Trust and the Underwriter immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future.
2.2 The Trust represents and warrants that
(a) at all times during the term of this Agreement Trust shares sold pursuant to this Agreement shall be registered under the 1933 Act, duly authorized for issuance and sold by the Trust to the Company in compliance with all applicable laws, subject to the terms of Section 2.4 below, and the Trust is and shall remain registered under the 1940 Act. The Trust shall amend
the Registration Statement for its shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its shares. The Trust shall register and qualify the shares for sale in accordance with the laws of the various states only if and to the extent deemed advisable by the Trust or the Underwriter in connection with their sale by the Trust to the Company and only as required by Section 2.4;
(b) it is currently qualified as a Regulated Investment Company under Subchapter M of the Code, and that it will use its best efforts to maintain such qualification (under Subchapter M or any successor provision), and that it will notify the Company immediately upon having a reasonable basis for believing that it has ceased to so qualify or that it might not so qualify in the future; and
(c) it is lawfully organized and validly existing under the laws of the Commonwealth of Massachusetts and that it does and will comply in all material respects with the 1940 Act.
2.3 The Underwriter represents and warrants that it is a member in good standing of the FINRA and is registered as a broker-dealer with the SEC. The Underwriter further represents that it will sell and distribute the Trust shares in accordance with all applicable securities laws applicable to it, including without limitation the 1933 Act, the 1934 Act, and the 1940 Act.
2.4 Notwithstanding any other provision of this Agreement, the Trust shall be responsible for the registration and qualification of its shares and of the Trust itself under the laws of any jurisdiction only in connection with the sales of shares directly to the Company through the Underwriter. The Trust shall not be responsible, and the Company shall take full responsibility, for determining any jurisdiction in which any qualification or registration of Trust shares or the Trust by the Trust may be required in connection with the sale of the Contracts or the indirect interest of any Contract in any shares of the Trust and advising the Trust thereof at such time and in such manner as is necessary to permit the Trust to comply.
2.5 The Trust makes no representation as to whether any aspect of its operations (including, but not limited to, fees and expenses and investment policies) complies with the insurance laws or regulations of the various states.
ARTICLE III. Prospectuses and Proxy Statements; Voting
3.1 The Trust shall provide such documentation (including a camera-ready copy of its prospectus) and other assistance as is reasonably necessary in order for the Company once each year (or more frequently if the prospectus for the Trust is amended) to have the prospectus for the Contracts and the Trusts prospectus printed together in one or more documents (such printing to be at the Companys expense).
3.2 The Trusts Prospectus shall state that the Statement of Additional
Information (the Statement) for the Trust is available from the Underwriter or its designee (or in the Trusts discretion, the Prospectus shall state that such Statement is available from the Trust), and the Underwriter (or the Trust), at its expense, shall print and provide such Statement free of charge to the Company and to any owner of a Contract or prospective owner who requests such Statement.
3.3 The Trust, at its expense, shall provide the Company with copies of its reports to shareholders, proxy material and other communications to shareholders in such quantity as the Company shall reasonably require for distribution to the Contract owners, such distribution to be at the expense of the Company, except for proxy materials which are at the expense of the Trust.
3.4 The Company shall vote all Trust shares as required by law and the Shared Funding Exemptive Order. The Company reserves the right to vote Trust shares held in any separate account in its own right, to the extent permitted by law and the Shared Funding Exemptive Order. The Company shall be responsible for assuring that each of its separate accounts participating in the Trust calculates voting privileges in a manner consistent with all legal requirements and the Shared Funding Exemptive Order.
3.5 The Trust will comply with all applicable provisions of the 1940 Act requiring voting by shareholders, and in particular the Trust will either provide for annual meetings or comply with Section 16(c) of the 1940 Act (although the Trust is not one of the trusts described in Section 16(c) of that Act) as well as with Sections 16(a) and, if and when applicable, 16(b). Further, the Trust will act in accordance with the Securities and Exchange Commissions interpretation of the requirements of Section 16(a) with respect to periodic elections of trustees and with whatever rules the Commission may promulgate with respect thereto.
ARTICLE IV. Sales Material and Information
4.1 Without limiting the scope or effect of Section 4.2 hereof, the Company shall furnish, or shall cause to be furnished, to the Underwriter each piece of sales literature or other promotional material (as defined hereafter) in which the Trust, its investment adviser or the Underwriter is named at least 15 days prior to its use. No such material shall be used if the Underwriter objects to such use within five Business Days after receipt of such material.
4.2 The Company shall not give any information or make any representations or statements on behalf of the Trust or concerning the Trust in connection with the sale of the Contracts other than the information or representations contained in the registration statement or prospectus for the Trust shares, as such registration statement and prospectus may be amended or supplemented from time to time, or in annual or semi-annual reports or proxy statements for the Trust, or in sales literature or other promotional material approved by the Trust or its designee or by the Underwriter, except with the written permission of the Trust or the Underwriter or the designee of either or as is required by law.
4.3 The Underwriter or its designee shall furnish, or shall cause to be furnished, to the Company or its designee, each piece of sales literature or other promotional material prepared by the Underwriter in which the Company and/or its separate account(s) is named at least 15 days prior to its use. No such material shall be used if the Company or its designee objects to such use within five Business Days after receipt of such material.
4.4 Neither the Trust nor the Underwriter shall give any information or make any representations on behalf of the Company or concerning the Company, each Account, or the Contracts other than the information or representations contained in a registration statement or prospectus for the Contracts, as such registration statement and prospectus may be amended or supplemented from time to time, or in published reports for each Account which are in the public domain or approved by the Company for distribution to Contract owners, or in sales literature or other promotional material approved by the Company or its designee, except with the written permission of the Company or as is required by law.
4.5 For purposes of this Article IV, the phrase sales literature or other promotional material includes, but is not limited to, advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media), sales literature (i.e. any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all registered representatives.
ARTICLE V. Fees and Expenses
5.1 Except as provided in Article VI, the Trust and Underwriter shall pay no fee or other compensation to the Company under this Agreement.
5.2 All expenses incident to performance by each party of its respective duties under this Agreement shall be paid by that party. The Trust shall bear the expenses for the cost of registration and qualification of the Trusts shares, preparation and filing of the Trusts prospectus and registration statement, proxy materials and reports, setting the prospectus and shareholder reports in type, setting in type and printing the proxy materials, and the preparation of all statements and notices required by any federal or state law, in each case as may reasonably be necessary for the performance by it of its obligations under this Agreement.
5.3 The Company shall bear the expenses of (a) printing and distributing the Trusts prospectus in connection with sales of the Contracts and (b) distributing the reports to Trusts Shareholders.
Article VI. Service Fees
6.1 So long as the Company complies with its obligations in this Article VI, the Underwriter shall pay the Company a service fee (the Service Fee) on shares of the Funds held in the Accounts at the annual rates specified in Schedule B (excluding any accounts for the Companys own corporate retirement plans), subject to Section 6.2 hereof.
6.2 The Company understands and agrees that all Service Fee payments are subject to the limitations contained in each Funds Distribution Plan, which may be varied or discontinued at any time and hereby waives the right to receive such Service Fee payments with respect to the Fund if the Fund ceases to pay 12b-1 fees to the Underwriter.
6.3 (a) The Companys failure to provide the services described in Section 6.4 or otherwise comply with the terms of this Agreement will render it ineligible to receive Service Fees; and
(b) the Underwriter may, without the consent of the Company, amend this Article VI to change the terms of the Service Fee payments with prior written notice to the Company.
6.4 The Company will provide the following services to the Contract Owners purchasing Fund shares:
(i) Maintaining regular contact with Contract owners and assisting in answering inquiries concerning the Funds;
(ii) Assisting in printing and distributing shareholder reports, prospectuses and other sale and service literature provided by the Underwriter;
(iii) Assisting the Underwriter and its affiliates in the establishment and maintenance of shareholder accounts and records;
(iv) Assisting Contract owners in effecting administrative changes, such as exchanging shares in or out of the Funds;
(v) Assisting in processing purchase and redemption transactions; and
(vi) Providing any other information or services as the Contract owners or the Underwriter may reasonably request.
The Company will support the Underwriters marketing efforts by granting reasonable requests for visits to the Companys offices by representatives of the Underwriter.
6.5 The Companys compliance with the service requirement set forth in this Agreement will be evaluated from time to time by monitoring redemption levels of Fund shares held in any Account and by such other methods as the Underwriter deems appropriate.
6.6 The provisions of this Article VI shall remain in effect for not more than one year from the date hereof and thereafter for successive annual periods only so long as such continuance is specifically approved at least annually by the Trustees in conformity with Rule 12b-1. This Agreement shall automatically terminate in the event of its assignment (as defined by the 1940 Act). In addition, this Article VI may be terminated at any time, without the payment of any penalty, with respect to any Fund or the Trust as a whole by any party upon written notice delivered or mailed by registered mail, postage prepaid, to the other party, or, as provided in Rule 12b-1 under the 1940 Act by the Trustees or by the vote of the holders of the outstanding voting securities of any Fund.
6.7 The Underwriter shall provide the Trustees of each of the Funds, and such Trustees shall review at least quarterly, a written report of the amounts paid to the Company under this Article VI and the purposes for which such expenditures were made.
ARTICLE VII. Diversification
7.1 The Trust shall use its best efforts to cause each Authorized Fund to maintain a diversified pool of investments that would, if such Fund were a segregated asset account, satisfy the diversification provisions of Treas. Reg. § 1.817-5(b)(1) or (2). The Trust will take all reasonable steps to notify the Company upon having a reasonable basis for believing any Fund has ceased to comply or might not so comply and will immediately take all reasonable steps to adequately diversify the Fund to achieve compliance with the grace period afforded by regulation 1.817-5. The Trust shall provide Company a certification of each Funds compliance with Section 817(h) of the Code and Treasury Regulation 1.817-5 within sixty (60) days of the end of each calendar quarter.
ARTICLE VIII. Potential Conflicts
8.1 The Trustees will monitor the Trust for the existence of any material irreconcilable conflict between the interests of the contract owners of all separate accounts investing in the Trust. A material irreconcilable conflict may arise for a variety of reasons, including: (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance, tax, or securities law or regulations, or a public ruling, private letter ruling, no-action or interpretative letter, or any similar action by insurance, tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the investments of any Fund are being managed; (e) a difference in voting instructions given by variable annuity contract and variable life insurance contract owners; or (f) a decision by an insurer to disregard the voting instructions of contract owners. The Trust shall promptly inform the Company if the Trustees determine that a material irreconcilable conflict exists and the implications thereof.
8.2 The Company will report any potential or existing conflicts of which it is aware to the Trustees. The Company will assist the Trustees in carrying out their responsibilities under the Shared Funding Exemptive Order by providing the Trustees with all information reasonably necessary for the Trustees to consider any issues raised. This includes, but is not limited to, an obligation by the Company to inform the Trustees whenever Contract owner voting instructions are disregarded.
8.3 If it is determined by a majority of the Trustees, or a majority of the disinterested Trustees, that a material irreconcilable conflict exists, the Company shall to the extent reasonably practicable (as determined by a majority of the disinterested Trustees), take, at the Companys expense, whatever steps are necessary to remedy or eliminate the material irreconcilable conflict, up to and including: (1) withdrawing the assets allocable to some or all of the separate accounts from the Trust or any Fund and reinvesting such assets in a different investment medium, including (but not limited to) another Fund of the Trust, or submitting the question whether such segregation should be implemented to a vote of all affected contract owners and, as appropriate, segregating the assets of any appropriate group (i.e., annuity contract owners, life insurance contract owners, or variable contract owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected contract owners the option of making such a change; and (2) establishing a new registered management investment company or managed separate account.
8.4 If a material irreconcilable conflict arises because of a decision by the Company to disregard Contract owner voting instructions and that decision represents a minority position or would preclude a majority vote, the Company may be required, at the Trusts election, to withdraw the affected Accounts investment in one or more portfolios of the Trust and terminate this Agreement with respect to such Account; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the disinterested Trustees. No charge or penalty shall be imposed as a result of such withdrawal. Any such withdrawal and termination must take place within six (6) months after the Trust gives written notice that this provision is being implemented, and until the end of that six month period the Underwriter and Trust shall, to the extent permitted by law and any exemptive relief previously granted to the Trust, continue to accept and implement orders by the Company for the purchase (or redemption) of shares of the Trust.
8.5 If a material irreconcilable conflict arises because of a particular state insurance regulators decision applicable to the Company to disregard Contract owner voting instructions and that decision represents a minority position that would preclude a majority vote, then the Company may be required, at the Trusts direction, to withdraw the affected Accounts investment in one or more Authorized Funds of the Trust; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the disinterested Trustees. Any such withdrawal and termination must take place within six (6) months after the Trust gives written
notice that this provision is being implemented, unless a shorter period is required by law, and until the end of the foregoing six month period (or such shorter period if required by law), the Underwriter and Trust shall, to the extent permitted by law and any exemptive relief previously granted to the Trust, continue to accept and implement orders by the Company for the purchase (and redemption) of shares of the Trust. No charge or penalty will be imposed as a result of such withdrawal.
8.6 For purposes of Sections 8.3 through 8.6 of this Agreement, a majority of the disinterested Trustees shall determine whether any proposed action adequately remedies any material irreconcilable conflict. Neither the Trust nor the Underwriter shall be required to establish a new funding medium for the Contracts, nor shall the Company be required to do so, if an offer to do so has been declined by vote of a majority of Contract owners materially adversely affected by the material irreconcilable conflict. In the event that the Trustees determine that any proposed action does not adequately remedy any material irreconcilable conflict, then the Company will withdraw the Accounts investment in one or more Authorized Funds of the Trust and terminate this Agreement within six (6) months (or such shorter period as may be required by law or any exemptive relief previously granted to the Trust) after the Trustees inform the Company in writing of the foregoing determination; provided, however, that such withdrawal and termination shall be limited to the extent required by any such material irreconcilable conflict as determined by a majority of the disinterested Trustees. No charge or penalty will be imposed as a result of such withdrawal.
8.7 The responsibility to take remedial action in the event of the Trustees determination of a material irreconcilable conflict and to bear the cost of such remedial action shall be the obligation of the Company, and the obligation of the Company set forth in this Article VIII shall be carried out with a view only to the interests of Contract owners.
8.8 If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Shared Funding Exemptive Order) on terms and conditions materially different from those contained in the Shared Funding Exemptive Order, then (a) the Trust and/or the Company, as appropriate, shall take such steps as may be necessary to comply with Rules 6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such rules are applicable; and (b) Sections 3.4, 3.5, 8.1, 8.2, 8.3, 8.4 and 8.5 of this Agreement shall continue in effect only to the extent that terms and conditions substantially identical to such Sections are contained in such Rule(s) as so amended or adopted.
8.9 The Company has reviewed the Shared Funding Exemption Order and hereby assumes all obligations referred to therein which are required, including, without limitation, the obligation to provide reports, material or data as the Trustees may request as conditions to such Order, to be assumed or undertaken by the Company.
ARTICLE IX. Indemnification
9.1 Indemnification by the Company
9.1 (a) The Company shall indemnify and hold harmless the Trust and the Underwriter and each of the Trustees, directors of the Underwriter, officers, employees or agents of the Trust or the Underwriter and each person, if any, who controls the Trust or the Underwriter within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 9.1) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Company which consent may not be unreasonably withheld) or litigation (including reasonable legal and other expenses), to which the Indemnified Parties may become subject under any statute, regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Trusts shares or the Contracts or the performance by the parties of their obligations hereunder and:
(i) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in a Registration Statement, Prospectus or Statement of Additional Information for the Contracts or contained in the Contracts or sales literature for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Company by or on behalf of the Trust for use in the Registration Statement, Prospectus or Statement of Additional Information for the Contracts or in the Contracts or sales literature (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Trust shares; or
(ii) arise out of or as a result of written statements or representations (other than statements or representations contained in the Trusts Registration Statement or Prospectus, or in sales literature for Trust shares not supplied by the Company, or persons under its control) or wrongful conduct of the Company or persons under its control, with respect to the sale or distribution of the Contracts or Trust shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a Registration Statement, Prospectus, or sales literature of the Trust or any amendment thereof or supplement thereto or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such a statement or omission was made in reliance upon information furnished to the Trust or the Underwriter by or on behalf of the Company; or
(iv) arise out of or result from any breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other breach of
this Agreement by the Company, as limited by and in accordance with the provisions of Sections 9.1(b) and 9.1(c) hereof.
9.1 (b) The Company shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified Party to the extent such may arise from such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement or to the Trust, whichever is applicable.
9.1 (c) The Company shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Company in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), on the basis of which the Indemnified Party should reasonably know of the availability of indemnity hereunder in respect of such claim but failure to notify the Company of any such claim shall not relieve the Company from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Company shall be entitled to participate, at its own expense, in the defense of such action. The Company also shall be entitled to assume the defense thereof, with counsel satisfactory to the Indemnified Party named in the action. After notice from the Company to such Indemnified Party of the Companys election to assume the defense thereof the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Company will not be liable to such Indemnified Party under this Agreement for any legal or other expenses subsequently incurred by such Indemnified Party independently in connection with the defense thereof other than reasonable costs of investigation.
9.1 (d) The Underwriter shall promptly notify the Company of the commencement of any litigation or proceedings against the Trust or the Underwriter in connection with the issuance or sale of the Trust Shares or the Contracts or the operation of the Trust.
9. 1 (e) The provisions of this Section 9.1 shall survive any termination of this Agreement.
9.2 Indemnification by the Underwriter
9.2 (a) The Underwriter shall indemnify and hold harmless the Company and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act and any director, officer, employee or agent of the foregoing (collectively, the Indemnified Parties for purposes of this Section 9.2) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Underwriter which consent may not be
unreasonably withheld) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Trusts shares or the Contracts or the performance by the parties of their obligations hereunder and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the sales literature of the Trust prepared by or approved by the Trust or Underwriter (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Underwriter or Trust by or on behalf of the Company for use in sales literature (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Trust shares; or
(ii) arise out of or as a result of written statements or representations (other than statements or representations contained in the Registration Statement, Prospectus, Statement of Additional Information or sales literature for the Contracts not supplied by the Underwriter or persons under its control) of the Underwriter or persons under its control, with respect to the sale or distribution of the Contracts or Trust shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a Registration Statement, Prospectus, Statement of Additional Information or sales literature covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished to the Company by or on behalf of the Underwriter; or
(iv) arise out of or result from any breach of any representation and/or warranty made by the Underwriter in this Agreement or arise out of or result from any other breach of this Agreement by the Underwriter; as limited by and in accordance with the provisions of Sections 9.2(b) and 9.2(c) hereof.
9.2 (b) The Underwriter shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified Party as such may arise from such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement or to each Company or the Account, whichever is applicable.
9.2 (c) The Underwriter shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Underwriter in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent) on the basis of which the Indemnified Party should reasonably know of the availability of indemnity hereunder in respect of such claim, but failure to notify the Underwriter of any such claim shall not relieve the Underwriter from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Underwriter will be entitled to participate, at its own expense, in the defense thereof. The Underwriter also shall be entitled to assume the defense thereof, with counsel satisfactory to the Indemnified Party named in the action. After notice from the Underwriter to such Indemnified Party of the Underwriters election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Underwriter will not be liable to such Indemnified Party under this Agreement for any legal or other expenses subsequently incurred by such Indemnified Party independently in connection with the defense thereof other than reasonable costs of investigation.
9.2 (d) The Company shall promptly notify the Underwriter of the Trust of the commencement of any litigation or proceedings against it or any of its officers or directors, in connection with the issuance or sale of the Contracts or the operation of each Account.
9.2 (e) The provisions of this Section 9.2 shall survive any termination of this Agreement.
9.3 Indemnification by the Trust
9.3 (a) The Trust shall indemnify and hold harmless the Company, and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act and any director, officer, employee or agent of the foregoing (collectively, the Indemnified Parties for purposes of this Section 9.3) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Trust which consent may not be unreasonably withheld) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the operations of the Trust and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in a Registration Statement, Prospectus and Statement of Additional Information of the Trust (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not
apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Underwriter or Trust by or on behalf of the Company for use in the Registration Statement, Prospectus, or Statement of Additional Information for the Trust (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Trust shares; or
(ii) arise out of or result from any material breach of any representation and/or warranty made by the Trust in this Agreement or arise out of or result from any other material breach of this Agreement by the Trust, as limited by and in accordance with the provisions of Sections 9.3(b) and 9.3(c) hereof.
9.3 (b) The Trust shall not be liable under the indemnification provision with respect to any losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified Party as such may arise from such Indemnified Partys willful misfeasance, bad faith, or gross negligence or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement or to the Company, the Trust, the Underwriter or each Account, whichever is applicable.
9.3 (c) The Trust shall not be liable under this indemnification provision with respect to any claim made against any Indemnified Party unless such Indemnified Party shall have notified the Trust in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent) on the basis of which the Indemnified Party should reasonably know of the availability of indemnity hereunder in respect of such claim, but failure to notify the Trust of any such claim shall not relieve the Trust from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Trust will be entitled to participate, at its own expense, in the defense thereof. The Trust also shall be entitled to assume the defense thereof, with counsel reasonably satisfactory to the Indemnified Party named in the action. After notice from the Trust to such Indemnified Party of the Trusts election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Trust will not be liable to such Indemnified Party under this Agreement for any legal or other expenses subsequently incurred by such Indemnified Party independently in connection with the defense thereof other than reasonable costs of investigation.
9.3 (d) The Company agrees promptly to notify the Trust of the commencement of any litigation or proceedings against it or any of its officers or, directors, in connection with this Agreement, the issuance or sale of the Contracts or the sale or acquisition of shares of the Trust.
9.3 (e) The provisions of this Section 9.3 shall survive any termination of this Agreement.
ARTICLE X. Applicable Law
10.1 This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of the Commonwealth of Massachusetts.
10.2 This Agreement shall be subject to the provisions of the 1933, 1934 and 1940 Acts, and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the Securities and Exchange Commission may grant (including, but not limited to, the Shared Funding Exemptive Order) and the terms hereof shall be interpreted and construed in accordance therewith.
ARTICLE XI. Termination
11.1 This Agreement shall terminate:
(a) at the option of any party upon 90 days advance written notice to the other parties; or
(b) at the option of the Trust or the Underwriter in the event that formal administrative proceedings are instituted against the Company by the FINRA, the Securities and Exchange Commission, the Insurance Commissioner of any state or any other regulatory body regarding the Companys duties under this Agreement or related to the sales of the Contracts, with respect to the operation of any Account, or the purchase of the Trust shares, provided, however, that the Trust or the Underwriter determines in its sole judgment, exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Company to perform its obligations under this Agreement; or
(c) at the option of the Company in the event that formal administrative proceedings are instituted against the Trust or Underwriter by the FINRA, the Securities and Exchange Commission, or any state securities or insurance department or any other regulatory body in respect of the sale of shares of the Trust to the Company, provided, however, that the Company determines in its sole judgment, exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Trust or Underwriter to perform its obligations under this Agreement; or
(d) with respect to any Account, upon requisite vote of the Contract owners having an interest in such Account (or any subaccount) to substitute the shares of another investment company for the corresponding Fund shares of the Trust in accordance with the terms of the Contracts for which those Fund shares had been selected to serve as the underlying investment media. The Company will give 30 days prior written notice to the Trust of the date of any proposed vote to replace the Trusts shares; or
(e) with respect to any Authorized Fund, upon 30 days advance written notice from the Underwriter to the Company, upon a decision by the Underwriter to cease offering shares of the Fund for sale.
11.2 It is understood and agreed that the right of any party hereto to terminate this Agreement pursuant to Section 11.1 (a) may be exercised for any reason or for no reason.
11.3 No termination of this Agreement shall be effective unless and until the party terminating this Agreement gives prior written notice to all other parties to this Agreement of its intent to terminate, which notice shall set forth the basis for such termination. Such prior written notice shall be given in advance of the effective date of termination as required by this Article XI.
11.4 Notwithstanding any termination of this Agreement, subject to Section 1.2 of this Agreement, the Trust and the Underwriter shall, at the option of the Company, continue to make available additional shares of the Trust pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as Existing Contracts). Specifically, without limitation, subject to Section 1.2 of this Agreement, the owners of the Existing Contracts shall be permitted to reallocate investments in the Trust, redeem investments in the Trust and/or invest in the Trust upon the making of additional purchase payments under the Existing Contracts. The parties agree that this Section 11.4 shall not apply to any termination under Article VIII and the effect of such Article VIII termination shall be governed by Article VIII of this Agreement.
11.5 The Company shall not redeem Trust shares attributable to the Contracts (as opposed to Trust shares attributable to the Companys assets held in either Account) except (i) as necessary to implement Contract owner initiated transactions, or (ii) as required by state and/or federal laws or regulations or judicial or other legal precedent of general application (hereinafter referred to as a Legally required Redemption). Upon request, the Company will promptly furnish to the Trust and the Underwriter an opinion of counsel for the Company, reasonably satisfactory to the Trust, to the effect that any redemption pursuant to clause (ii) above is a Legally Required Redemption. Furthermore, except in cases where permitted under the terms of the Contracts, subject to Section 1.2 of this Agreement, the Company shall not prevent Contract owners from allocating payments to an Authorized Fund that was otherwise available under the Contracts without first giving the Trust or the Underwriter 90 days notice of its intention to do.
ARTICLE XII. Notices
Any notice shall be sufficiently given when sent by registered or certified mail to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other party.
If to the Trust:
100 Federal Street
Boston, MA 02110
Attention:
If to the Underwriter:
100 Federal Street
Boston, MA 02110
Attention: General Counsel
If to the Company:
Protective Life Insurance Company
2801 Highway 280 South
Birmingham AL 35223
Attention: Senior Vice President, Chief Product Officer
With a copy to:
Senior Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
ARTICLE XIII. Miscellaneous
13.1 A copy of the Agreement and Declaration of Trust of the Trust is on file with the Secretary of State of the Commonwealth of Massachusetts, and notice is hereby given that this instrument is executed on behalf of the Trustees of the Trust as Trustees and not individually and that the obligations of or arising out of this instrument, including without limitation Article VII, are not binding upon any of the Trustees or shareholders individually but binding only upon the assets and property of the Trust.
13.2 The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
13.3 This Agreement may be executed simultaneously in two or more counterparts, each of which taken together shall constitute one and the same instrument.
13.4 If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.
13.5 Each party hereto shall cooperate with each other party and all appropriate governmental authorities (including without limitation the Securities and Exchange Commission, the FINRA and state insurance regulators) and shall permit such authorities reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.
13.6 The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.
13.7 Notwithstanding any other provision of this Agreement, the obligations of the Trust and the Underwriter are several and, without limiting in any way the generality of the foregoing, neither such party shall have any liability for any action or failure to act by the other party, or any person acting on such other partys behalf.
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and on its behalf by its duly authorized representative and its seal to be hereunder affixed hereto as of the date specified below.
|
PROTECTIVE LIFE INSURANCE COMPANY |
|
By its authorized officer, |
|
|
|
|
|
Name: |
|
Title: |
|
|
|
PUTNAM VARIABLE TRUST |
|
By its authorized officer, |
|
|
|
|
|
Name: |
|
Title: |
|
|
|
PUTNAM RETAIL MANAGEMENT LIMITED PARTNERSHIP |
|
By its authorized officer, |
|
|
|
|
|
Name: |
|
Title: |
SCHEDULE A
Separate Accounts
Name of Separate Account |
|
Contracts Funded by Separate Account |
Protective COLI VUL Separate Account |
|
Protective Executive Benefits Registered VUL |
|
|
|
Protective COLI PPVUL Separate Account |
|
Protective Executive Benefits Private Placement VUL |
PARTICIPATION AGREEMENT
Among
T. ROWE PRICE EQUITY SERIES, INC.,
T. ROWE PRICE FIXED INCOME SERIES, INC.,
T. ROWE PRICE INTERNATIONAL SERIES, INC.
T. ROWE PRICE INVESTMENT SERVICES, INC.,
and
PROTECTIVE LIFE INSURANCE COMPANY
THIS AGREEMENT, made and entered into as of this 8th day of December, 2020 by and among Protective Life Insurance Company (hereinafter, the Company), a Tennessee insurance company, on its own behalf and on behalf of each segregated asset account of the Company (each account hereinafter referred to as the Account), and the undersigned funds, each, a corporation organized under the laws of Maryland (each hereinafter referred to as the Fund) and T. Rowe Price Investment Services, Inc. (hereinafter the Underwriter), a Maryland corporation.
WHEREAS, the Fund engages in business as an open-end management investment company and is or will be available to act as the investment vehicle for separate accounts established for variable life insurance and variable annuity contracts (the Variable Insurance Products) to be offered by insurance companies which have entered into participation agreements with the Fund and Underwriter (hereinafter Participating Insurance Companies); and
WHEREAS, the beneficial interest in the Fund is divided into several series of shares, each designated a Portfolio and representing the interest in a particular managed portfolio of securities and other assets; and
WHEREAS, the Fund has obtained an order from the Securities and Exchange Commission (SEC) granting Participating Insurance Companies and variable annuity and variable life insurance separate accounts exemptions from the provisions of sections 9(a), 13(a), 15(a), and 15(b) of the Investment Company Act of 1940, as amended, (hereinafter the 1940 Act) and Rules 6e-2(b)(15) and 6e-3(T) (b)(15) thereunder, to the extent necessary to permit shares of the Fund to be sold to and held by variable annuity and variable life insurance separate accounts of both affiliated and unaffiliated life insurance companies (hereinafter the Shared Funding Exemptive Order); and
WHEREAS, the Fund is registered as an open-end management investment company under the 1940 Act and shares of the Portfolios are registered under the Securities Act of 1933, as amended (hereinafter the 1933 Act); and
WHEREAS, T. Rowe Price Associates, Inc. (the Adviser) is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and any applicable state securities laws; and
WHEREAS, the Company has issued or will issue certain variable life insurance or variable annuity contracts (including any certificates thereunder) supported wholly or partially by the Account (the Contracts), and
WHEREAS, the Account is duly established and maintained as a segregated asset account, established by resolution of the Board of Directors of the Company to set aside and invest assets attributable to the aforesaid Contracts; and
WHEREAS, the Company has registered or will register the Account as a unit investment trust under the 1940 Act or will not register the Account in proper reliance upon an exclusion from registration under the 1940 Act; and
WHEREAS, the Underwriter is registered as a broker dealer with the SEC under the Securities Exchange Act of 1934, as amended (hereinafter the 1934 Act), and is a member in good standing of the Financial Industry Regulatory Authority (hereinafter FINRA); and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company intends to purchase shares in the Portfolios on behalf of the Account to fund the aforesaid Contracts, and the Underwriter is authorized to sell such shares to unit investment trusts such as the Account at net asset value;
NOW, THEREFORE, in consideration of their mutual promises, the Company, the Fund and the Underwriter agree as follows:
ARTICLE I. Sale of Fund Shares
1.1 The Underwriter agrees to sell to the Company those shares of the Portfolios which the Account orders, executing such orders on a daily basis at the net asset value next computed after receipt by the Fund or its designee of the order for the shares of the Portfolios.
1.2 The Fund agrees to make shares of the Portfolios available for purchase at the applicable net asset value per share by the Company and the Account on those days on which the Fund calculates its net asset value pursuant to rules of the SEC, and the Fund shall use its best efforts to calculate such net asset value on each day which the New York Stock Exchange is open for trading. Notwithstanding the foregoing, the Board of Directors of the Fund (hereinafter the Board) may refuse to sell shares of any Portfolio to any person, or suspend or terminate the offering of shares of any Portfolio if such action is required by law or by regulatory authorities having jurisdiction, or is, in the sole discretion of the Board acting in good faith and in light of their fiduciary duties under federal and any applicable state laws, necessary in the best interests of the shareholders of such Portfolio.
1.3 The Fund and the Underwriter agree that shares of the Fund will be sold only to Participating Insurance Companies and their separate accounts. No shares of any Portfolios will be sold to the general public. The Fund and the Underwriter will not sell Fund shares to any insurance
company or separate account unless an agreement containing provisions substantially the same as Articles I, III and VII of this Agreement is in effect to govern such sales.
1.4 The Fund agrees to redeem, on the Companys request, any full or fractional shares of the Portfolios held by the Company, executing such requests on a daily basis at the net asset value next computed after receipt by the Fund or its designee of the request for redemption, except that the Fund reserves the right to suspend the right of redemption or postpone the date of payment or satisfaction upon redemption consistent with Section 22(e) of the 1940 Act and any sales thereunder, and in accordance with the procedures and policies of the Fund as described in the then current prospectus.
1.5 For purposes of Sections 1.1 and 1.4, the Company shall be the designee of the Fund for receipt of purchase and redemption orders from the Account, and receipt by such designee shall constitute receipt by the Fund; provided that the Company receives the order by 4:00 p.m. Eastern time and the Fund receives notice of such order by 8:00 a.m. Eastern time on the next following Business Day. Business Day shall mean any day on which the New York Stock Exchange is open for trading and on which the Fund calculates its net asset value pursuant to the rules of the SEC. In the event that Companys Designee (as defined below) submits purchase, redemption or transfer instructions with the Funds, the agreement between the Underwriter (or its affiliate) and the agent shall govern such orders.
1.6 The Company agrees to purchase and redeem the shares of each Portfolio offered by the then current prospectus of the Fund and in accordance with the provisions of such prospectus.
1.7 The Company, or its Designee, shall pay for Fund shares one Business Day after receipt of an order to purchase Fund shares is made in accordance with the provisions of Section 1.5 hereof. Payment shall be in federal funds transmitted by wire by 4:00 p.m. Eastern time. If payment in Federal Funds for any purchase is not received or is received by the Fund after 4:00 p.m. Eastern time on such Business Day, the Company shall promptly, upon the Funds request, reimburse the Fund for any charges, costs, fees, interest or other expenses incurred by the Fund in connection with any advances to, or borrowings or overdrafts by, the Fund, or any similar expenses incurred by the Fund, as a result of portfolio transactions effected by the Fund based upon such purchase request. For purposes of Section 2.8 and 2.9 hereof, upon receipt by the Fund of the federal funds so wired, such funds shall cease to be the responsibility of the Company and shall become the responsibility of the Fund.
1.8 Issuance and transfer of the Funds shares will be by book entry only. Stock certificates will not be issued to the Company or any Account. Shares ordered from the Fund will be recorded in an appropriate title for each Account or the appropriate subaccount of each Account.
1.9 The Fund shall furnish same day notice (by wire or telephone, followed by written confirmation) to the Company of any income, dividends or capital gain distributions payable on the Portfolios shares. The Company hereby elects to receive all such income, dividends, and capital gain distributions as are payable on Portfolio shares in additional shares of that Portfolio. The Company reserves the right to revoke this election and to receive all such income dividends and capital gain distributions in cash. The Fund shall notify the Company of the number of shares so issued as payment of such dividends and distributions.
1.10 The Fund shall make the net asset value per share for each Portfolio available to the Company on a daily basis as soon as reasonably practical after the net asset value per share is calculated (normally by 6:30 p.m. Eastern time) and shall use its best efforts to make such net asset value per share available by 7 p.m. Eastern time. If the net asset value is materially incorrect through no fault of the Company, the Company on behalf of each Account, shall be entitled to an adjustment to the number of shares purchased or redeemed to reflect the correct net asset value in accordance with Fund procedures. Any material error in the net asset value shall be reported to the Company promptly upon discovery. Any administrative or other costs or losses incurred for correcting underlying Contract owner accounts shall be at Companys expense.
1.11 The Parties hereto acknowledge that the arrangement contemplated by this Agreement is not exclusive; the Funds shares may be sold to other insurance companies (subject to Section 1.3 and Article VI hereof) and the cash value of the Contracts may be invested in other investment companies.
1.12 Company, Funds and Underwriter acknowledge and agree that Company may use agents or a designee (Designee) to perform some or all of its responsibilities listed herein, including Designee, or Designees agent, submitting orders for purchases, transfers, and redemptions of the Funds and that such orders will be made through the National Securities Clearing Corporation (NSCC) pursuant to the terms of the Defined Contribution Clearance & Settlement Fund/SERV Networking Agreement between T. Rowe Price Services, Inc, the transfer agent to the Funds, and the Designee, or its agent (DCC&S Agreement) and that in the event of any conflict between the terms of the Agreement and the DCC&S Agreement related to the purchase and redemption of shares through the NSCC, the terms of the DCC&S Agreement shall govern. To the extent that Company utilizes a Designee, Company shall be liable to the Funds and Underwriter as if Company had acted or failed to act instead of the Designee, or the Designees agent.
Company shall cause Designee to (i) verify new account information and documentation, (ii) forward purchase and redemption orders to the Fund for processing, (ii) maintain share lot history in order to properly account for cost basis and other applicable reporting purposes, (iv) reconcile any differences between Designees records and the Funds records (the Funds records shall be official and as determined by the Fund), (v) assess and remit any applicable redemption fees in accordance with the Funds prospectus by the 10th calendar day of the month for the previous months redemption fee owed, and (vi) repay any duplicative or excessive payment or shares it has received within thirty (30) days after written notice thereof if either (a) such payment are in the Designees custody, possession or control or (b) such payment or shares was due to an error attributable to Designee, or Designees agent.
ARTICLE II. Representations and Warranties
2.1 The Company represents and warrants that the Contracts are or will be registered under the 1933 Act or that the Contracts are not registered because they are properly exempt from registration under the 1933 Act or will be offered exclusively in transactions that are properly exempt from registration under the 1933 Act. The Company further represents and warrants that the Contracts will be issued and sold in compliance in all material respects with all applicable federal and state laws and that the sale of the Contracts shall comply in all material respects with state insurance suitability requirements. The Company further represents and warrants that it is an
insurance company duly organized and in good standing under applicable law and that it has legally and validly established the Account prior to any issuance or sale thereof as a segregated asset account under the Tennessee insurance laws and has registered or, prior to any issuance or sale of the Contracts, will register the Account as a unit investment trust in accordance with the provisions of the 1940 Act to serve as a segregated investment account for the Contracts or that it has not registered the Account in proper reliance upon an exclusion from registration under the 1940 Act.
2.2 The Fund represents and warrants that Fund shares sold pursuant to this Agreement shall be registered under the 1933 Act, duly authorized for issuance and sold in compliance with the laws of each state and all applicable federal and state securities laws and that the Fund is and shall remain registered under the 1940 Act. The Fund shall amend the Registration Statement for its shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its shares. The Fund shall register and qualify the shares for sale in accordance with the laws of the various states only if and to the extent deemed advisable by the Fund or the Underwriter.
2.3 [RESERVED]
2.4 The Fund makes no representations as to whether any aspect of its operations, including but not limited to, investment policies, fees and expenses, complies with the insurance and other applicable laws of the various states, except that the Fund represents that the Funds investment policies, fees and expenses are and shall at all times remain in compliance with the laws of each state to the extent required to perform this Agreement.
2.5 The Fund represents that it is lawfully organized and validly existing under the laws of the State of Maryland and that it does and will comply in all material respects with the 1940 Act.
2.6 The Underwriter represents and warrants that it is a member in good standing of the FINRA and is registered as a broker-dealer with the SEC. The Underwriter further represents that it will sell and distribute the Fund shares in accordance with the any applicable state and federal securities laws.
2.7 The Underwriter represents and warrants that the Adviser is and shall remain duly registered under all applicable federal and state securities laws and that the Adviser shall perform its obligations for the Fund in compliance in all material respects with any applicable state and federal securities laws.
2.8 The Fund and the Underwriter represent and warrant that all of their directors, officers, employees, investment advisers, and other individuals or entities dealing with the money and/or securities of the Fund are and shall continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Fund in an amount not less than the minimum coverage as required currently by Rule 17g-1 of the 1940 Act or related provisions as may be promulgated from time to time. The aforesaid bond shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company.
2.9 The Company represents and warrants that all of its directors, officers, employees, and other individuals/entities employed or controlled by the Company dealing with the money and/or securities of the Fund are covered by a blanket fidelity bond or similar coverage in an amount not
less than $10 million. The aforesaid bond includes coverage for larceny and embezzlement and is issued by a reputable bonding company. The Company agrees to make all reasonable efforts to see that this bond or another bond containing these provisions is always in effect and agrees to notify the Fund and the Underwriter in the event that such coverage no longer applies. The Company agrees to exercise its best efforts to ensure that other individuals/entities not employed or controlled by the Company and dealing with the money and/or securities of the Fund maintain a similar bond or coverage in a reasonable amount.
In addition to the fidelity bond noted above, Company shall, at its own cost and expense, obtain and maintain in full force and effect, with financially sound and reputable insurers or reinsurers having A.M. Best ratings of at least A (VII) or better, the following insurance to cover Companys obligations under this Agreement: (i) $5 million aggregate commercial general and/or umbrella liability insurance; (ii) workers compensation insurance for its own employees that meets the statutory limits of the states in which Company operates and all federal statutes and regulations , as applicable, including Employers Liability of $1 million per accident, employee and injury; (iii) at least $10 million aggregate professional liability insurance covering all acts, errors, mistakes or omissions arising out of the work or services provided under the Agreement and (vi) $5 million per occurrence, $10 million aggregate privacy/cyber liability coverage (first and third party exposure). Prior to the commencement of this agreement and annually upon renewal, Company shall provide to the Underwriter insurance certificates evidencing such coverage. Nothing in this Agreement including any indemnification shall be construed to relieve any insurer of its obligation to pay claims consistent with the provisions of a valid insurance policy. For all claims made coverages noted above, Company shall maintain such coverages for at least one year after the completion of the Agreement.
ARTICLE III. Prospectuses, Statements of Additional Information, and Proxy Statements; Voting
3.1 The Underwriter shall provide the Company (at the Companys expense) with as many copies of the Funds current prospectus (describing only the Portfolios for which Company is currently invested) as the Company may reasonably request. If requested by the Company in lieu thereof, the Fund shall provide such documentation (including a final copy of the new prospectus as set in type, at the Funds expense) and other assistance as is reasonably necessary in order for the Company (at the Companys expense) once each year (or more frequently if the prospectus for the Fund is amended) to have the prospectus (which shall include an offering memorandum, if any) for the Contracts, and the Funds prospectus printed together in one document (such printing to be at the Companys expense).
3.2 The Funds prospectus shall state that the current Statement of Additional Information (SAI) for the Fund is available from the Company (or, in the Funds discretion, from the Fund), and the Underwriter (or the Fund), at its expense, shall print, or otherwise reproduce, and provide sufficient copies of such SAI free of charge to the Company for itself, and for any owner of a Contract who requests such SAI. The Company shall send an SAI to any such Contract owner within 3 business days of the receipt of a request.
3.3 The Fund, at its expense, shall provide the Company with copies of its proxy material, reports to shareholders, and other communications to shareholders in such quantity as the Company shall reasonably require for distributing to Contract owners in the Fund. The Underwriter (at the
Companys expense) shall provide the Company with copies of the Funds annual and semi-annual reports to shareholders in such quantity as the Company shall reasonably request for use in connection with offering the Variable Contracts issued by the Company. If requested by the Company in lieu thereof, the Underwriter shall provide such documentation (which may include a final copy of the Funds annual and semi-annual reports as set in type or on diskette) and other assistance as is reasonably necessary in order for the Company (at the Companys expense) to print such shareholder communications for distribution to Contract owners. The Company shall send a copy of the Funds annual or semi-annual report within 3 business days of the receipt of a request by a Contract owner.
3.4 The Company shall:
(i) solicit voting instructions from Contract owners;
(ii) vote the Fund shares in accordance with instructions received from Contract owners; and
(iii) vote Fund shares for which no instructions have been received in the same proportion as Fund shares of such Portfolio for which instructions have been received,
so long as and to the extent that the SEC continues to interpret the 1940 Act to require pass-through voting privileges for variable contract owners or to the extent otherwise required by law. The Company reserves the right to vote Fund shares held in any segregated asset account in its own right, to the extent permitted by law.
3.5 Participating Insurance Companies shall be responsible for assuring that each of their separate accounts participating in a Portfolio calculates voting privileges as required by the Shared Funding Exemptive Order and consistent with any reasonable standards that the Fund may adopt.
3.6 The Fund will comply with all provisions of the 1940 Act requiring voting by shareholders, and in particular the Fund will either provide for annual meetings or comply with Section 16(c) of the 1940 Act (although the Fund is not one of the trusts described in Section 16(c) of that Act) as well as with Sections 16(a) and, if and when applicable, 16(b). Further, the Fund will act in accordance with the SECs interpretation of the requirements of Section 16(a) with respect to periodic elections of directors or trustees and with whatever rules the SEC may promulgate with respect thereto.
3.7 Summary Prospectus
3.7(a) Definitions. For purposes of this Section 3.7, the terms Summary Prospectus and Statutory Prospectus shall have the same meaning ascribed to them in Rule 498 of the 1933 Act (Rule 498)
3.7(b) Obligations of the Fund.
(i) The Fund shall provide the Company with copies of the Summary Prospectus in the same manner and at the same time as the Agreement requires it to provide the Company with Statutory Prospectuses.
(ii) The Fund shall be responsible for compliance with Rule 498(e).
(iii) The Fund agree that the URL indicated on each Summary Prospectus will lead directly to the web page used for hosting Summary Prospectuses and that such web page will host the current Fund and Portfolio documents required to be posted in compliance with Rule 498.
The Fund shall use its best efforts to promptly notify the Company of the unexpected interruptions in availability of this web page. The Fund agrees that the web page used for hosting Summary Prospectuses will not contain any marketing materials.
(iv) At the Companys request, the Fund will provide the Company with URLs to the current Fund and Portfolio documents for use with Companys electronic delivery of Fund and Portfolio documents, or on the Companys website. The Fund will be responsible for ensuring the integrity of the URLs and for maintaining the Fund and Portfolio documents on the website to which such URLs originally navigate.
(v) The Company shall be permitted, but not required, in its sole discretion to post a copy of each Portfolios Statutory Prospectuses and/or Summary Prospectuses, SAI supplements, annual reports, and semi-annual reports on the Companys website. Notwithstanding the foregoing, the Fund shall be and remain solely responsible for ensuring that the Fund complies with the requirement for hosting these documents under Rule 498.
(vi) If the Fund determines that it will end its use of the Summary Prospectus delivery option, the Fund will use its best efforts to provide the Company with reasonable advance notice of its intent.
3.7(c) Representation and Warranties of the Fund.
(i) The Fund represents and warrants that the Summary Prospectuses will comply in all material respects with the requirements of Rule 498 applicable to the Fund and its Portfolios.
(ii) The Funds represents and warrants that the web site hosting of the Summary Prospectuses will comply in all material respects with the requirements of Rule 498 applicable to the Fund and its Portfolios. The Fund further represents and warrants that it has appropriate policies and procedures in place to ensure that such web site continuously complies with Rule 498.
(iii) The Fund represents and warrants that it will be responsible for compliance with the provisions of Rule 498(f)(1) involving requests for additional Fund documents made directly to the Fund or one of its affiliates. The Fund further represents and warrants that any information obtained about Contract owners pursuant to this provision will be used solely for the purposes of responding to requests for additional Fund documents.
(iv) The Fund represents and warrants that it will use commercially reasonable efforts to employ procedures consistent with industry practices designed to reduce exposure to viruses.
3.7(d) Representations and Warranties of the Company.
(i) The Company represents and warrants that it will be responsible for compliance with the provision of 498(f)(1) involving requests for additional Fund documents made by Contract owners directly to the Company or one of its affiliates.
(ii) The Company represents and warrants that any binding together of Summary Prospectuses and/or Statutory Prospectuses will be done in compliance with Rule 498.
(iii) The Company represents and warrants that all of its activities involving the Contracts and their corresponding investments in the Funds shall comply with all applicable Federal and state laws, rules, and regulations.
3.7(e) The parties agree that the Company is not required to distribute Summary Prospectuses to Contract owners, but rather that the use of Summary Prospectuses will be at the Companys discretion. The Company agrees that it will give the Fund reasonable advance notice of its intended use of Summary Prospectuses or Statutory Prospectus.
ARTICLE IV. Sales Material and Information
4.1 The Company shall furnish, or shall cause to be furnished, to the Fund or its designee, each piece of sales literature or other promotional material that the Company develops or uses and in which the Fund (or a Portfolio thereof) or the Adviser or the Underwriter is named, at least ten calendar days prior to its use. No such material shall be used if the Fund or its designee reasonably object to such use within ten calendar days after receipt of such material. The Fund or its designee
reserves the right to reasonably object to the continued use of such material, and no such material shall be used if the Fund or its designee so object.
4.2 The Company shall not give any information or make any representations or statements on behalf of the Fund or concerning the Fund in connection with the sale of the Contracts other than the information or representations contained in the registration statement or prospectus or SAI for the Fund shares, as such registration statement and prospectus or SAI may be amended or supplemented from time to time, or in reports or proxy statements for the Fund, or in sales literature or other promotional material approved by the Fund or its designee or by the Underwriter, except with the permission of the Fund or the Underwriter or the designee of either.
4.3 The Fund, Underwriter, or its designee shall furnish, or shall cause to be furnished, to the Company, each piece of sales literature or other promotional material in which the Company, and/or its Account, is named at least ten calendar days prior to its use. No such material shall be used if the Company reasonably objects to such use within ten calendar days after receipt of such material. The Company reserves the right to reasonably object to the continued use of such material and no such material shall be used if the Company so objects.
4.4. The Fund and the Underwriter shall not give any information or make any representations on behalf of the Company or concerning the Company, the Account, or the Contracts other than the information or representations contained in a registration statement, prospectus, or SAI for the Contracts, as such registration statement, prospectus or SAI may be amended or supplemented from time to time, or in published reports for the Account which are in the public domain or approved by the Company for distribution to Contract owners, or in sales literature or other promotional material approved by the Company or its designee, except with the permission of the Company.
4.5 The Fund will provide to the Company at least one complete copy of all registration statements, prospectuses, SAIs, reports, proxy statements, sales literature and other promotional materials, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to the Fund or its shares, within a reasonable time after the filing of such document(s) with the SEC or other regulatory authorities.
4.6 The Company will provide to the Fund at least one complete copy of all registration statements, prospectuses, SAIs, reports, solicitations for voting instructions, sales literature and other promotional materials, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to the Contracts or the Account, within a reasonable time after the filing of such document(s) with the SEC or other regulatory authorities.
4.7 For purposes of this Article IV, the phrase sales literature and other promotional materials includes, but is not limited to, any of the following that refer to the Fund or any affiliate of the Fund: advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media), sales literature (i.e., any written communication distributed or made generally available to customers or the public, including brochures, circulars, reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, and
registration statements, prospectuses, SAIs, shareholder reports, proxy materials, and any other communications distributed or made generally available with regard to the Funds.
ARTICLE V. Fees and Expenses
5.1 The Fund and the Underwriter shall pay no fee or other compensation to the Company under this Agreement, except that if the Fund or any Portfolio adopts and implements a plan pursuant to Rule 12b-1 to finance distribution expenses, then the Underwriter may make payments to the Company or to the underwriter for the Contracts if and in amounts agreed to by the Underwriter in writing, and such payments will be made out of existing fees otherwise payable to the Underwriter, past profits of the Underwriter, or other resources available to the Underwriter. No such payments shall be made directly by the Fund.
5.2 All expenses incident to performance by the Fund under this Agreement shall be paid by the Fund, except as otherwise provided herein. The Fund shall see to it that all its shares are registered and authorized for issuance in accordance with applicable federal law and, if and to the extent deemed advisable by the Fund, in accordance with applicable state laws prior to their sale. The Fund shall bear the expenses for the cost of registration and qualification of the Funds shares, preparation and filing of the Funds prospectus and registration statement, proxy materials and reports, setting the prospectus in type, setting in type and printing the proxy materials and reports to shareholders (including the costs of printing a prospectus that constitutes an annual report), the preparation of all statements and notices required by any federal or state law, and all taxes on the issuance or transfer of the Funds shares.
5.3 The Company shall bear the expenses of printing the Funds prospectus (in accordance with 3.1) and of distributing the Funds prospectus, proxy materials, and reports to Contract owners and prospective Contract owners.
ARTICLE VI. Diversification and Qualification
6.1 The Fund will invest the assets of each Portfolio in such a manner as to ensure that the Contracts will be treated as annuity, endowment, or life insurance contracts, whichever is appropriate, under the Internal Revenue Code of 1986, as amended (the Code) and the regulations issued thereunder (or any successor provisions). Without limiting the scope of the foregoing, each Portfolio of the Fund will comply with Section 817(h) of the Code and Treasury Regulation 1.817-5, and any Treasury interpretations thereof, relating to the diversification requirements for variable annuity, endowment, or life insurance contracts, and any amendments or other modifications or successor provisions to such Section or Regulations. In the event of a breach of this Article VI by the Fund, it will take all reasonable steps (a) to notify the Company of such breach and (b) to adequately diversify the Fund so as to achieve compliance within the grace period afforded by Regulation 817.5. Upon request, the Fund shall provide Company a certification of each Funds compliance with Section 817(h) of the Code and Treasury Regulation 1.817-5 for the preceding calendar quarter.
6.2 The Fund represents that each Portfolio is or will be qualified as a Regulated Investment Company under Subchapter M of the Code, and that it will make every effort to maintain such qualification (under Subchapter M or any successor or similar provisions) and that it will notify
the Company immediately upon having a reasonable basis for believing that it has ceased to so qualify or that it might not so qualify in the future.
6.3 The Company represents that the Contracts are currently, and at the time of issuance shall be, treated as life insurance, endowment contracts, or annuity insurance contracts, under applicable provisions of the Code, and that it will make every effort to maintain such treatment, and that it will notify the Fund and the Underwriter immediately upon having a reasonable basis for believing the Contracts have ceased to be so treated or that they might not be so treated in the future. The Company agrees that any prospectus offering a contract that is a modified endowment contract as that term is defined in Section 7702A of the Code (or any successor or similar provision), shall identify such contract as a modified endowment contract.
ARTICLE VII. Potential Conflicts.
7.1 The Board will monitor the Fund for the existence of any material irreconcilable conflict between the interests of the contract owners of all separate accounts investing in the Fund. An irreconcilable material conflict may arise for a variety of reasons, including: (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling, no-action or interpretative letter, or any similar action by insurance, tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the investments of any Portfolio are being managed; (e) a difference in voting instructions given by variable annuity contract and variable life insurance contract owners; or (f) a decision by an insurer to disregard the voting instructions of contract owners. The Board shall promptly inform the Company if it determines that an irreconcilable material conflict exists and the implications thereof.
7.2. The Company will report any potential or existing conflicts of which it is aware to the Board. The Company will assist the Board in carrying out its responsibilities under the Shared Funding Exemptive Order, by providing the Board with all information reasonably necessary for the Board to consider any issues raised. This includes, but is not limited to, an obligation by the Company to inform the Board whenever Contract owner voting instructions are disregarded.
7.3 If it is determined by a majority of the Board, or a majority of its disinterested members, that a material irreconcilable conflict exists, the Company and other Participating Insurance Companies shall, at their expense and to the extent reasonably practicable (as determined by a majority of the disinterested Board members), take whatever steps are necessary to remedy or eliminate the irreconcilable material conflict, up to and including: (1), withdrawing the assets allocable to some or all of the separate accounts from the Fund or any Portfolio and reinvesting such assets in a different investment medium, including (but not limited to) another Portfolio of the Fund, or submitting the question whether such segregation should be implemented to a vote of all affected contract owners and, as appropriate, segregating the assets of any appropriate group (i.e., annuity contract owners, life insurance contract owners, or variable contract owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected contract owners the option of making such a change; and (2), establishing a new registered management investment company or managed separate account.
7.4 If a material irreconcilable conflict arises because of a decision by the Company to disregard contract owner voting instructions and that decision represents a minority position or
would preclude a majority vote, the Company may be required, at the Funds election, to withdraw the affected Accounts investment in the Fund and terminate this Agreement with respect to such Account provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the disinterested members of the Board. Any such withdrawal and termination must take place within six (6) months after the Fund gives written notice that this provision is being implemented, and until the end of that six month period the Fund shall continue to accept and implement orders by the Company for the purchase (and redemption) of shares of the Fund.
7.5 If a material irreconcilable conflict arises because a particular state insurance regulators decision applicable to the Company conflicts with the majority of other state regulators, then the Company will withdraw the affected Accounts investment in the Fund and terminate this Agreement with respect to such Account within six months after the Board informs the Company in writing that it has determined that such decision has created an irreconcilable material conflict; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the disinterested members of the Board. Until the end of the foregoing six month period, the Fund shall continue to accept and implement orders by the company for the purchase (and redemption) of shares of the Fund.
7.6 For purposes of Section 7.3 through 7.6 of this Agreement, a majority of the disinterested members of the Board shall determine whether any proposed action adequately remedies any irreconcilable material conflict, but in no event will the Fund be required to establish a new funding medium for the Contracts. The Company shall not be required by Section 7.3 to establish a new funding medium for the Contract if an offer to do so has been declined by vote of a majority of Contract owners materially adversely affected by the irreconcilable material conflict. In the event that the Board determines that any proposed action does not adequately remedy any irreconcilable material conflict, then the Company will withdraw the Accounts investment in the Fund and terminate this Agreement within six (6) months after the Board informs the Company in writing of the foregoing determination; provided, however, that such withdrawal and termination shall be limited to the extent required by any such material irreconcilable conflict as determined by a majority of the disinterested members of the Board.
7.7 If and to the extent Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Shared Funding Exemptive Order) on terms and conditions materially different from those contained in the Shared Funding Exemptive Order, then (a) the Fund and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with Rules 6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such rules are applicable; and (b) Sections 3.4, 3.5, 3.6, 7.1., 7.2, 7.3, 7.4, and 7.5 of this Agreement shall continue in effect only to the extent that terms and conditions substantially identical to such Sections are contained in such Rule(s) as so amended or adopted.
ARTICLE VIII. Indemnification
8.1 Indemnification By the Company
8.1(a). The Company agrees to indemnify and hold harmless the Fund and the Underwriter and each of their officers and directors and each person, if any, who controls the Fund or the Underwriter within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 8.1) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Company) or litigation (including legal and other expenses), to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Funds shares or the Contracts and:
(i) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the Registration Statement, prospectus (which shall include an offering memorandum, if any), or statement of additional information (SAI) for the Contracts or contained in the Contracts or sales literature or other promotional material for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Company by or on behalf of the Fund for use in the Registration Statement, prospectus or SAI for the Contracts or in the Contracts or sales literature or other promotional material (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Fund shares; or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the Registration Statement, prospectus or sales literature or other promotional material of the Fund not supplied by the Company or persons under its control) or wrongful conduct of the Company or persons under its authorization or control, with respect to the sale or distribution of the Contracts or Fund Shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a Registration Statement, prospectus, SAI, or sales literature or other promotional material of the Fund or any amendment thereof or supplement thereto or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such a statement or omission was made in reliance upon information furnished to the Fund by or on behalf of the Company; or
(iv) arise as a result of any material failure by the Company to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the qualification requirements specified in Article VI of this Agreement); or
(v) arise out of or result from any material breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Company, as limited by and in accordance with the provisions of Sections 8.1(b) and 8.1(c) hereof.
8.1(b). The Company shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of its obligations or duties under this Agreement.
8.1(c). The Company shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Company in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Company of any such claim shall not relieve the Company from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against an Indemnified Party, the Company shall be entitled to participate, at its own expense, in the defense of such action. The Company also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action and to settle the claim at its own expense; provided, however, that no such settlement shall, without the Indemnified Parties written consent, include any factual stipulation referring to the Indemnified Parties or their conduct. After notice from the Company to such party of the Companys election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Company will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.
8.1(d). The Indemnified Parties will promptly notify the Company of the commencement of any litigation or proceedings against them in connection with the issuance or sale of the Fund Shares or the Contracts or the operation of the Fund relating to the Agreement.
8.2 Indemnification by the Underwriter
8.2(a). The Underwriter agrees to indemnify and hold harmless the Company and each of it directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 8.2) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Underwriter) or litigation (including legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Funds shares or the Contracts; and
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the Registration Statement
or prospectus or SAI or sales literature or other promotional material of the Fund (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Underwriter or Fund by or on behalf of the Company for use in the Registration Statement or prospectus for the Fund or in sales literature or other promotional material (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Fund shares; or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the Registration Statement, prospectus or sales literature or other promotional material for the Contracts not supplied by the Underwriter or persons under its control) or wrongful conduct of the Fund or Underwriter or persons under their control, with respect to the sale or distribution of the Contracts or Fund shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a Registration Statement, prospectus, SAI, or sales literature or other promotional material of the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished to the Company by or on behalf of the Fund; or
(iv) arise as a result of any material failure by the Fund to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification and other qualification requirements specified in Article VI of this Agreement); or
(v) arise out of or result from any material breach of any representation and/or warranty made by the Underwriter in this Agreement or arise out of or result from any other material breach of this Agreement by the Underwriter; as limited by and in accordance with the provisions of Sections 8.2(b) and 8.2(c) hereof.
8.2(b). The Underwriter shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or negligence in the performance or such Indemnified Partys duties or by reason of such Indemnified
Partys reckless disregard of obligations and duties under this Agreement or to the Company or the Account, whichever is applicable.
8.2(c). The Underwriter shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Underwriter in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Underwriter of any such claim shall not relieve the Underwriter from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Party, the Underwriter will be entitled to participate, at its own expense, in the defense thereof. The Underwriter also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action and to settle the claim at its own expense; provided, however, that no such settlement shall, without the Indemnified Parties written consent, include any factual stipulation referring to the Indemnified Parties or their conduct. After notice from the Underwriter to such party of the Underwriters election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Underwriter will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.
8.2(d). The Company agrees promptly to notify the Underwriter of the commencement of any litigation or proceedings against it or any of its officers or directors in connection with the issuance or sale of the Contracts or the operation of the Account.
8.3 Indemnification By the Fund
8.3(a). The Fund agrees to indemnify and hold harmless the Company and each of its directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 8.3) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with the written consent of the Fund) or litigation (including legal and other expenses) to which the Indemnified Parties may be required to pay or may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, expenses, damages, liabilities or expenses (or actions in respect thereof) or settlements, are related to the operations of the Fund and:
(i) arise as a result of any material failure by the Fund to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification and other qualification requirements specified in Article VI of this Agreement); or
(ii) arise out of or result from any material breach of any representation and/or warranty made by the Fund in this Agreement or arise out of or result from any other material breach of this Agreement by the Fund;
as limited by and in accordance with the provisions of Sections 8.3(b) and 8.3(c) hereof.
8.3(b). The Fund shall not be liable under this indemnification provision with respect to any losses, claims, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement or to the Company, the Fund, the Underwriter or the Account, whichever is applicable.
8.3(c). The Fund shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Fund in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Fund of any such claim shall not relieve the Fund from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Fund will be entitled to participate, at its own expense, in the defense thereof. The Fund also shall be entitled to assume the expense thereof, with counsel satisfactory to the party named in the action and to settle the claim at its own expense; provided, however, that no such settlement shall, without the Indemnified Parties written consent, include any factual stipulation referring to the Indemnified Parties or their conduct. After notice from the Fund to such party of the Funds election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Fund will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.
8.3(d). The Company and the Underwriter agree promptly to notify the Fund of the commencement of any litigation or proceeding against it or any of its respective officers or directors in connection with the Agreement, the issuance or sale of the Contracts, the operation of the Account, or the sale or acquisition of shares of the Fund.
ARTICLE IX. Applicable Law
9.1 This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of the State of Maryland.
9.2 This Agreement shall be subject to the provisions of the 1933, 1934 and 1940 Acts, and the rules and regulations and rulings thereunder, including such exemptions from those statutes,
rules and regulations as the SEC may grant (including, but not limited to, any Shared Funding Exemptive Order) and the terms hereof shall be interpreted and construed in accordance therewith.
ARTICLE X. Termination
10.1 This Agreement shall continue in full force and effect until the first to occur of:
(a) termination by any party, for any reason with respect to some or all Portfolios, by six (6) months advance written notice delivered to the other parties; or
(b) termination by the Company by written notice to the Fund and the Underwriter with respect to any Portfolio based upon the Companys determination that shares of the Fund are not reasonably available to meet the requirements of the Contracts; provided that such termination shall apply only to the Portfolio not reasonably available; or
(c) termination by the Company by written notice to the Fund and the Underwriter in the event any of the Portfolios shares are not registered, issued or sold in accordance with applicable state and/or federal law or such law precludes the use of such shares as the underlying investment media of the Contracts issued or to be issued by the Company; or
(d) termination by the Fund or Underwriter in the event that formal administrative proceedings are instituted against the Company by the FINRA, the SEC, the Insurance Commissioner or like official of any state or any other regulatory body regarding the Companys duties under this Agreement or related to the sale of the Contracts, the operation of any Account, or the purchase of the Fund shares; provided, however, that the Fund or Underwriter determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Company to perform its obligations under this Agreement; or
(e) termination by the Company in the event that formal administrative proceedings are instituted against the Fund or Underwriter by the FINRA, the SEC, or any state securities or insurance department or any other regulatory body; provided, however, that the Company determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Fund or Underwriter to perform its obligations under this Agreement; or
(f) termination by the Company by written notice to the Fund and the Underwriter with respect to any Portfolio in the event that such Portfolio ceases to qualify as a Regulated Investment Company under Subchapter M or fails to comply with the Section 817(h) diversification requirements specified in Article VI hereof, or if the Company reasonably believes that such Portfolio may fail to so qualify or comply; or
(g) termination by the Fund or Underwriter by written notice to the Company in the event that the Contracts fail to meet the qualifications specified in Section 6.3 hereof; or if the Fund or Underwriter reasonably believes that such Contracts may fail to so qualify; or
(h) termination by either the Fund or the Underwriter by written notice to the Company, if either one or both of the Fund or the Underwriter respectively,
shall determine, in their sole judgment exercised in good faith, that the Company has suffered a material adverse change in its business, operations, financial condition, or prospects since the date of this Agreement or is the subject of material adverse publicity; or
(i) termination by the Company by written notice to the Fund and the Underwriter, if the Company shall determine, in its sole judgment exercised in good faith, that the Fund or the Underwriter has suffered a material adverse change in its business, operations, financial condition or prospects since the date of this Agreement or is the subject of material adverse publicity.
10.2 Effect of Termination. Notwithstanding any termination of this Agreement, the Fund and the Underwriter shall, at the option of the Company, continue to make available additional shares of the Fund pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as Existing Contracts). Specifically, the owners of the Existing Contracts may be permitted to reallocate investments in the Fund, redeem investments in the Fund and/or invest in the Fund upon the making of additional purchase payments under the Existing Contracts. The parties agree that this Section 10.2 shall not apply to any termination under Article VII and the effect of such Article VII termination shall be governed by Article VII of this Agreement. The parties further agree that this Section 10.2 shall not apply to any termination under Section 10.1(g) of this Agreement.
10.3 The Company shall not redeem Fund shares attributable to the Contracts (as opposed to Fund shares attributable to the Companys assets held in the Account) except (i) as necessary to implement Contract owner initiated or approved transactions, (ii) as required by state and/or federal laws or regulations or judicial or other legal precedent of general application (hereinafter referred to as a Legally Required Redemption), or (iii) pursuant to the terms of a substitution order issued by the SEC pursuant to Section 26(b) of the 1940 Act. Upon request, the Company will promptly furnish to the Fund and the Underwriter the opinion of counsel for the Company (which counsel shall be reasonably satisfactory to the Fund and the Underwriter) to the effect that any redemption pursuant to clause (ii) above is a Legally Required Redemption. Furthermore, except in cases where permitted under the terms of the Contracts, the Company shall not prevent Contract owners from allocating payments to a Portfolio that was otherwise available under the Contracts without first giving the Fund or the Underwriter 90 days notice of its intention to do so.
10.4 Notwithstanding any termination of this Agreement, each partys obligation under Article VIII to indemnify the other parties shall survive.
ARTICLE XI. Notices
Any notice shall be sufficiently given when sent by registered or certified mail to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other party.
If to the Fund:
T. Rowe Price Associates, Inc.
4515 Painters Mill Road
Owings Mills, Maryland 21117
Attention: Legal Department
If to Underwriter:
T. Rowe Price Investment Services, Inc.
4515 Painters Mill Road
Owings Mills, Maryland 21117
Attention: Legal Department
If to the Company:
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, AL 35223
Attention: Senior Vice President, Chief Product Officer
With a copy to:
Senior Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
ARTICLE XII. Miscellaneous
12.1 All references herein to the Fund are to each of the undersigned Funds as if this agreement were between such individual Fund and the Underwriter and the Company. All references herein to the Adviser relate solely to the Adviser of such individual Fund, as appropriate. All persons dealing with a Fund must look solely to the property of such Fund, and in the case of a series company, the respective Portfolio as though such Portfolio had separately contracted with the Company and the Underwriter for the enforcement of any claims against the Fund. The parties agree that neither the Board, officers, agents or shareholders assume any personal liability or responsibility for obligations entered into by or on behalf of the Fund.
12.2 Subject to the requirements of legal process and regulatory authority, each party hereto shall treat as confidential the names and addresses of the owners of the Contracts and all information reasonably identified as confidential in writing by any other party hereto and, except as permitted by this Agreement, shall not disclose, disseminate or utilize such names and addresses and other confidential information without the express written consent of the affected party until such time as such information may come into the public domain.
12.3 The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
12.4 This Agreement may be signed in any number of counterparts, including facsimile copies thereof or electronic scan copies thereof delivered by electronic mail, each of which shall be deemed an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.
12.5 If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.
12.6 Each party hereto shall cooperate with each other party and all appropriate governmental authorities (including without limitation the SEC, the FINRA, and state insurance regulators) and shall permit such authorities reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby. Notwithstanding the generality of the foregoing, each party hereto further agrees to furnish to any State Insurance Commissioner with any information or reports in connection with services provided under this Agreement which such Commissioner may request in order to ascertain whether the variable annuity operations of the Company are being conducted in a manner consistent with states variable annuity laws and regulations and any other applicable law or regulations.
12.7 The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies, and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.
12.8 This Agreement or any of the rights and obligations hereunder may not be assigned by any party without the prior written consent of all parties hereto.
12.9 Upon request, the Company shall furnish or cause to be furnished, to the Fund or its designee copies of the following reports:
(a) the Companys annual statement (prepared under statutory accounting principles) and annual report (prepared under generally accepted accounting principles (GAAP), if any), as soon as practical and in any event within 90 days after the end of each fiscal year.
(b) the Companys quarterly statements (statutory) (and GAAP, if any), as soon as practical and in any event within 45 days after the end of each quarterly period.
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and on its behalf by its duly authorized representative and its seal to be hereunder affixed hereto as of the date specified below.
COMPANY: |
PROTECTIVE LIFE INSURANCE COMPANY |
|
|
|
By its authorized officer |
|
|
|
By: |
|
Title: |
|
|
|
|
|
Date: |
|
|
|
|
FUND: |
T. ROWE PRICE EQUITY SERIES, INC. |
|
|
|
|
|
By its authorized officer |
|
|
|
|
|
By: |
|
|
|
|
|
Title: |
Vice President |
|
|
|
|
Date: |
|
|
|
|
FUND: |
T. ROWE PRICE FIXED INCOME SERIES, INC. |
|
|
|
|
|
By its authorized officer |
|
|
|
|
|
By: |
|
|
|
|
|
Title: |
Vice President |
|
|
|
|
Date: |
|
|
|
|
|
Signature page continues |
|
|
|
|
FUND: |
T. ROWE PRICE INTERNATIONAL SERIES, INC. |
|
|
|
|
|
By its authorized officer |
|
|
|
|
|
By: |
|
|
|
|
|
Title: |
Vice President |
|
|
|
|
Date: |
Among
VAN ECK WORLDWIDE INSURANCE TRUST
VAN ECK SECURITIES CORPORATION
VAN ECK ASSOCIATES CORPORATION
and
PROTECTIVE LIFE INSURANCE COMPANY
THIS AGREEMENT, made and entered into to be effective on September 30, 1998, by and among Protective Life Insurance Company, (hereinafter the Company), a Tennessee corporation, on its own behalf and on behalf of each segregated asset account of the Company set forth on Schedule A hereto and incorporated herein by this reference, as such Schedule A may from time to time be amended by mutual written agreement of the parties hereto (each such account hereinafter referred to as the Account), and VAN ECK WORLDWIDE INSURANCE TRUST, an unincorporated business trust organized under the laws of the Commonwealth of Massachusetts (hereinafter the Fund), VAN ECK SECURITIES CORPORATION (hereinafter the Underwriter), a Delaware corporation and VAN ECK ASSOCIATES CORPORATION (hereinafter the Adviser), a Delaware corporation.
WHEREAS, the Fund engages in business as an open-end management investment company and is available to act as the investment vehicle for separate accounts established for variable life insurance policies and variable annuity contracts (hereafter referred to collectively as the Variable Insurance Products) to be offered by insurance companies which have entered into participation agreements with the Fund and the Underwriter (hereinafter the Participating Insurance Companies); and
WHEREAS, the beneficial interest in the Fund is divided into several series of shares, each representing the interest in a particular managed portfolio of securities and other assets (each such series hereinafter referred to as a Portfolio); and
WHEREAS, the Fund has obtained an order from the Securities and Exchange Commission (hereinafter the SEC) (File No. 811-5083), granting Participating Insurance Companies and variable annuity and variable life insurance separate accounts exemptions from the provisions of Sections 9(a), 13(a), 15(a), and 15(b) of the Investment Company Act of 1940, as amended, (hereinafter the 1940 Act) and Rules 6e-2(b) (15) and 6e-3(T) (b) (15) thereunder, to the extent necessary to permit shares of the Fund to be sold to and held by variable annuity and variable life insurance separate accounts of both affiliated and unaffiliated life insurance companies (hereinafter the Shared Funding Order); and
WHEREAS, the Fund is registered as an open-end management investment company under the 1940 Act and its shares are registered under the Securities Act of 1933, as amended (hereinafter the 1933 Act); and
WHEREAS, the Company has registered or will register certain variable life insurance and variable annuity contracts (the Contracts) under the 1933 Act, unless such contracts are exempt from registration thereunder; and
WHEREAS, each Account is a duly organized, validly existing segregated asset account, established by resolution of the Board of Directors of the Company, on the date shown for such Account on Schedule A hereto, to set aside and invest assets attributable to the aforesaid variable life insurance and variable annuity contracts; and
WHEREAS, the Company has registered or will register each Account as a unit investment trust under the 1940 Act, unless such Account is exempt from registration thereunder; and
WHEREAS, the Underwriter is registered as a broker-dealer with the SEC under the Securities Exchange Act of 1934, as amended (hereinafter the 1934 Act), and is a member in good standing of the National Association of Securities Dealers, Inc. (hereinafter the NASD); and
WHEREAS, the Adviser is duly registered as an investment adviser under the Investment Advisers Act of 1940 and any applicable state securities law; and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company intends to purchase shares in the Portfolios on behalf of each Account to fund certain of the aforesaid variable life and variable annuity contracts and the Underwriter is authorized to sell such shares to unit investment trusts such as each Account at net asset value;
NOW, THEREFORE, in consideration of their mutual promises, the Company, the Fund, the Underwriter and the Adviser agree as follows:
ARTICLE I
Sale of Fund Shares
1.1. The Underwriter agrees to sell to the Company those shares of the Portfolios (which are listed on Schedule B attached hereto and incorporated herein by this reference, as such Schedule B may from time to time be amended by mutual written agreement of the parties hereto) which each Account orders, executing such orders on a daily basis at the net asset value per share next computed after receipt by the Fund or its designee of the order for the shares of the Portfolios subject to the terms and conditions of this Agreement. For purposes of this Section 1.1, the Company shall be the designee of the Fund for receipt of such orders from each Account and receipt by such designee shall constitute receipt by the Fund; provided that the Fund receives notice of such order by 10:00 a.m., Eastern time, on the next following Business Day; however,
the company undertakes to use its best efforts to provide such notice to the Fund by no later than 9:30 a.m., Eastern time. Business Day shall mean any day on which the New York Stock Exchange is open for business and on which the Fund calculates the Portfolios net asset values pursuant to the rules of the SEC.
1.2. The Fund agrees to make Portfolio shares available for purchase at the applicable net asset value per share by the Company and its Accounts on those days on which the Fund calculates net asset values pursuant to the rules of the SEC and the Fund shall use reasonable efforts to calculate such net asset values on each day on which the New York Stock Exchange is open for trading. Notwithstanding the foregoing, the Board of Trustees of the Fund (hereinafter the Board) may refuse to sell shares of any Portfolio to any person, or suspend or terminate the offering of shares of any Portfolio, if such action is required by law or by regulatory authorities having jurisdiction, or if it is, in the sole discretion of the Board, acting in good faith and in light of its fiduciary duties under Federal and any applicable state laws, in the best interests of the shareholders of such Portfolio.
1.3. The Fund and the Underwriter agree that shares of the Fund will be sold only to Participating Insurance Companies and their separate accounts or other accounts (e.g., qualified retirement plans) as may be permitted so that the Variable Insurance Products continue to qualify as a life insurance, annuity or variable contract under Section 817(h) of the Internal Revenue Code of 1986, as amended (hereinafter the Code). No shares of any Portfolio will be sold to the general public.
1.4. The Fund and the Underwriter will not sell Fund shares to any insurance company, separate account or other account unless an agreement containing provisions substantially the same as Article I, Section 2.5 of Article II, Sections 3.4 and 3.5 of Article III, Article V and Article VII of this Agreement is in effect to govern such sales.
1.5. Subject to its rights under Section 18(f) of the 1940 Act, the Fund agrees to redeem for cash, on the Companys request, any full or fractional shares of a Portfolio held by the Company, executing such requests on a daily basis at the net asset value per share next computed after receipt by the Fund or its designee of the request for redemption. For purposes of this Section 1.5, the Company shall be the designee of the Fund for receipt of requests for redemption from each Account and receipt by such designee shall constitute receipt by the Fund; provided that the Fund receives notice of such request for redemption by 10:00 a.m., Eastern Time, on the next following Business Day; however, the Company undertakes to use its best efforts to provide such notice to the Fund by no later than 9:30 a.m., Eastern time. Payment of redemption proceeds for any whole or fractional shares shall be made within seven days of actual receipt of the redemption request by the Fund, or within such greater or lesser period as may be permitted by law or rule, regulation, interpretive position or order of the SEC; provided that if the Fund does not pay for the Fund shares that are redeemed on the next Business Day after a request to redeem shares is made, then the Fund shall apply any such delay in redemptions uniformly to all holders of shares of that Portfolio. Payment shall be in federal funds transmitted by wire pursuant to the instructions of the Company or by a credit toward any shares purchased on the Business Day on which the redemption payment is made.
1.6. The Company agrees that purchases and redemptions of Portfolio shares offered by the then-current prospectus of the Fund shall be made in accordance with the provisions of such prospectus. The Company agrees that all net amounts available in the Accounts which are listed in Schedule A attached hereto and incorporated herein by this reference, as such Schedule A may from time to time be amended by mutual written agreement of the parties hereto, shall be invested in the Portfolios and in such other funds advised by the Adviser as are listed in Schedule B, or in the Companys general account; provided that such amounts may also be invested in an investment company other than the Fund if (a) such other investment company, or series thereof, has investment objectives or policies that are substantially different from the investment objectives and policies of the Portfolios of the Fund listed on Schedule B to this Agreement; or (b) the Company gives the Fund and the Underwriter 45 days written notice of its intention to make such other investment company available as a funding vehicle for the Contracts; or (c) such other investment company was available as a funding vehicle for the Contracts prior to the date of this Agreement and the Company so informs the Fund and Underwriter prior to their signing this Agreement (a list of such funds appearing on Schedule C to this Agreement); or (d) the Fund or Underwriter consents in writing to the use of such other investment company.
1.7. The Company shall pay for Portfolio shares on the next Business Day after an order to purchase such shares is made in accordance with the provisions of this Article I. Payment shall be in federal funds transmitted by wire or by a credit for any shares redeemed. For purposes of Sections 2.10 and 2.11, upon receipt by the Fund of the federal funds so wired, such funds shall cease to be the responsibility of the Company and shall become the responsibility of the Fund.
1.8. Issuance and transfer of the Funds shares will be by book entry only. Stock certificates will not be issued to the Company or any Account. Shares ordered from the Fund will be recorded in an appropriate title for each Account or the appropriate subaccount of each Account.
1.9. The Fund shall furnish same day notice (by wire or telephone, followed by written confirmation) to the Company of any income dividends or capital gain distributions payable on the Portfolios shares. The Company hereby elects to receive all such income dividends and capital gain distributions as are payable on the Portfolio shares in additional shares of that Portfolio. The Company reserves the right to revoke this election and to receive all such income dividends and capital gain distributions in cash. The Fund shall notify the Company of the number of shares so issued as payment of such dividends and distributions.
1.10. The Fund shall make the net asset value per share for each Portfolio available to the Company on a daily basis as soon as reasonably practical after the net asset value per share is calculated, and shall use its best efforts to make such net asset value per share available by 6:30 p.m., Eastern Time. If the Fund provides materially incorrect share net asset value information, the Fund shall make an adjustment to the number of shares purchased or redeemed for the Accounts to reflect the correct net asset value per share. Any material error in the calculation or reporting of net asset value per share, dividend or capital gains information shall be reported promptly upon discovery to the Company.
ARTICLE II
Representations and Warranties
2.1. The Company represents and warrants that the Contracts are or will be registered under the 1933 Act or exempt therefrom; that the Contracts will be issued and sold in compliance in all material respects with all applicable federal and state laws and that the sale of the Contracts shall comply in all material respects with state insurance suitability requirements. The Company further represents and warrants that it is an insurance company duly organized and in good standing under applicable law and that it has legally and validly established each Account prior to any issuance or sale thereof as a segregated asset account under the Insurance Code and Regulations of the State of Tennessee, and has registered or, prior to any issuance or sale of the Contracts, will, unless exempt from registration, register each Account as a unit investment trust in accordance with the provisions of the 1940 Act to serve as a segregated investment account for the Contracts.
2.2. Subject to Article IV hereof, the Company represents that it believes that the Contracts are currently and at the time of issuance will be eligible for treatment as life insurance or annuity contracts under applicable provisions of the Code and that it will make every effort to maintain such treatment and that it will notify the Fund and the Underwriter promptly upon having a reasonable basis for believing that the Contracts may have ceased to be so treated or that they might not be so treated in the future.
2.3. The Company represents and warrants that all of its directors/trustees, employees, investment advisers and other individuals/entities dealing with money and/or securities of the Fund are and shall continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Fund, in an amount not less than $5 million. The aforesaid bond shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company. The Company shall notify the Fund, the Underwriter and the Adviser in the event that such coverage no longer applies.
2.4. The Fund represents and warrants that Fund shares sold pursuant to this Agreement are registered under the 1933 Act, duly authorized for issuance and sale in compliance in all material respects with the terms of this Agreement and all applicable federal and state securities laws, and that, while shares of the Portfolios are being offered for sale, the Fund is and shall remain registered under the 1940 Act. The Fund shall amend its Registration Statement under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of Portfolio shares. The Fund shall register or otherwise qualify the shares for sale in accordance with the laws of the various, states only if and to the extent deemed advisable by the Fund or the Underwriter.
2.5. The Fund represents that each Portfolio is qualified as a Regulated Investment Company under Subchapter M of the Code and that it will make every effort to maintain such qualification (under Subchapter M or any successor or similar provision) and that it will notify the Company promptly upon having determined that any Portfolio may have ceased to so qualify or that it might not so qualify in the future.
2.6. The Fund currently does not intend to make any payments to finance distribution expenses pursuant to Rule 12b-1 under the 1940 Act or otherwise, although it may make such payments in the future. To the extent that it decides to finance distribution expenses pursuant to Rule 12b-1, the Fund undertakes to have a board of trustees, a majority of whom are not interested persons of the Fund, formulate and approve any plan under Rule 12b-1 to finance distribution expenses.
2.7. The Fund makes no representation as to whether any aspect of its operations (including, but not limited to, fees, expenses and investment policies) complies with the insurance laws or regulations of the various states except that the Fund represents that the Fund has disclosed or made available, in writing, all information requested by Company and represents and warrants that such written information is true and accurate in all material respects as of the effective date of this Agreement. Without prior written notice to the Company, the Fund will not make any changes in fundamental investment policies or advisory fees, and shall at all times remain in compliance with federal securities law as it applies to insurance products. The Company will use its best efforts to provide the Fund with copies of amendments to provisions of state insurance laws and regulations related to separate accounts and variable products, which may affect Fund operations.
2.8. The Fund represents that it is lawfully organized and validly existing under the laws of the Commonwealth of Massachusetts and that it does and will comply in all material respects with the 1940 Act.
2.9. The Underwriter represents and warrants that it is a member in good standing of the NASD and is registered as a broker-dealer with the SEC. The Underwriter further represents that it will sell and distribute Portfolio shares to the Company in accordance with all applicable state and federal securities laws, including, without limitation, the 1933 Act, the 1934 Act and the 1940 Act.
2.10. The Adviser represents and warrants that it is and shall remain duly registered in all material respects under all applicable federal and state securities laws and that it shall perform its obligations for the Fund in compliance in all material respects with any applicable state and federal securities laws.
2.11. The Fund, the Underwriter and the Adviser represent and warrant that all of their directors/trustees, officers, employees, investment advisers and other individuals/entities dealing with money and/or securities of the Fund are and shall continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Fund, in an amount not less than the minimum coverage as required by Rule 17g-1 of the 1940 Act or related provisions as may from time to time be promulgated. The aforesaid bond shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company. The Fund shall notify the Company in the event such coverage no longer applies.
ARTICLE III
Prospectuses and Proxy Statements; Voting
3.1. The Underwriter shall provide the Company (at the Underwriters expense) with as many copies of the Funds current prospectus as the Company may reasonably request. If requested by the Company in lieu thereof, the Fund shall provide such documentation (including a final copy of the new prospectus as set in type at the Funds expense) and other assistance as is reasonably necessary in order for the Company once each year (or more frequently if the prospectus for the Fund is amended) to have the prospectus (or private offering memorandum, if a Contract and its associated Account are exempt from registration) for the Contracts and the Funds prospectus printed together in one document (such printing to be at the Companys expense unless otherwise agreed upon in writing by the Company and the Underwriter or the Company and the Adviser).
3.2. The Funds prospectus shall state that the Statement of Additional Information for the Fund is available from the Underwriter (or in the Funds discretion, from the Fund), and the Underwriter (or the Fund), at its expense, shall provide such Statement of Additional Information free of charge to the Company and to any owner of a Contract or prospective owner who requests such Statement.
3.3. The Fund, at its expense, shall provide the Company with copies of its proxy statements, reports to shareholders, and other communications to shareholders in such quantity as the Company shall reasonably require for distributing to Contract owners.
3.4. If and to the extent required by law, the Company shall:
(i) solicit voting instructions from Contract owners;
(ii) vote Portfolio shares in accordance with instructions received from Contract owners; and
(iii) vote Portfolio shares for which no instructions have been received in the same proportion as shares of such Portfolio for which instructions have been received,
so long as and to the extent that the SEC continues to interpret the 1940 Act to require pass-through voting privileges for variable contract owners. The Company reserves the right to vote Fund shares held in any account in its own right, to the extent permitted by law. The Company shall be responsible for assuring that each of its separate accounts participating in the Fund calculates voting privileges in a manner consistent with the standards set forth in the Shared Funding Order and rules and regulations of the SEC, which standards will also be provided to other Participating Insurance Companies.
3.5. The Fund will comply with all provisions of the 1940 Act requiring voting by shareholders, and in particular, the Fund will either provide for annual meetings or comply with Section 16(c) of the 1940 Act (although the Fund is not one of the trusts described in Section 16(c) of that Act) as well as with Sections 16(a) and, if and when applicable, 16(b). Further, the Fund will act in accordance with the SECs interpretation of the requirements of Section 16(a) with respect to periodic elections of trustees and with whatever rules the SEC may promulgate with respect thereto.
ARTICLE IV
Sales Material and Information
4.1. The Company shall furnish, or shall cause to be furnished, to the Fund or its designee, each piece of sales literature or other promotional material in which the Fund, the Underwriter or the Adviser is named, at least fifteen Business Days prior to its use. No such material shall be used if the Fund or its designee reasonably objects in writing to such use within fifteen business days after receipt of such material.
4.2. The Company shall not give any information or make any representations or statements on behalf of the Fund or concerning the Fund in connection with the sale of the Contracts other than the information or representations contained in the registration statement or prospectus for the Fund, as such registration statement and prospectus may from time to time be amended or supplemented, or in reports or proxy statements for the Fund, or in sales literature or other promotional material provided to the Company by the Fund or its designee or by the Underwriter, except with the permission of the Fund or its designee. The Fund agrees to respond to any request for approval on a prompt and timely basis.
4.3. The Fund, the Underwriter or their designee shall furnish, or shall cause to be furnished, to the Company or its designee, each piece of sales literature or other promotional material in which the Company and/or its separate account(s), is named at least fifteen Business Days prior to its use. No such material shall be used if the Company reasonably objects in writing to such use within fifteen business days after receipt of such material.
4.4. The Fund and the Underwriter shall not give any information or make any representations on behalf of the Company or concerning the Company, each Account, or the Contracts other than the information or representations contained in a registration statement or prospectus for the Contracts, as such registration statement and prospectus may from time to time be amended or supplemented, or in published reports which are in the public domain or approved by the Company for distribution to Contract owners, or in sales literature or other promotional material approved by the Company or its designee, except with the permission of the Company.
4.5. The Fund will provide to the Company at least one complete copy of all registration statements, prospectuses, Statements of Additional Information, reports, proxy statements, sales literature and other promotional materials, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to any of the Portfolios
or their shares, promptly following the filing of such document with the SEC or other regulatory authorities.
4.6. The Company will provide to the Fund at least one complete copy of all registration statements, prospectuses, Statements of Additional Information, reports, solicitations for voting instructions, sales literature and other promotional materials, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to the Contracts or each Account, promptly following the filing of such document with the SEC or other regulatory authorities; and, if a Contract and its associated Account are exempt from registration, the equivalents to the above.
4.7. For purposes of this Agreement, the phrase sales literature or other promotional material includes, but is not limited to, any of the following that refer to the Fund or any affiliate of the Fund: advertisements (such as material published or designed for use in a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape or electronic display, signs or billboards, motion pictures, or other public media), sales literature (i.e., any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees.
ARTICLE V
Fees and Expenses
5.1. The Fund and the Underwriter shall pay no fee or other compensation to the Company under this Agreement, except as provided herein or in any other written agreement.
5.2. Except as otherwise expressly provided in the Agreement, all expenses incident to performance by the Fund under this Agreement shall be paid by the Fund. The Fund shall see to it that all Portfolio shares are registered and authorized for issuance in accordance with applicable federal law and, if and to the extent deemed advisable by the Fund, in accordance with applicable state laws prior to their sale. The Fund shall bear the expenses for the cost of registration and qualification of the Portfolios shares, preparation and filing of the Funds prospectus and registration statement, proxy materials and reports, setting the prospectus in type, setting in type and printing the proxy materials and reports to shareholders (including the costs of printing a prospectus that constitutes an annual report), the preparation of all statements and notices required by any federal or state law and all taxes on the issuance or transfer of the Portfolios shares.
5.3. The Company shall bear the expenses of distributing the Funds prospectus to owners of Contracts issued by the Company and of distributing the Funds proxy materials and reports to such Contract owners.
ARTICLE VI
Diversification
6.1. The Fund will at all times invest money from the Contracts in such a manner as to ensure that the Contracts will be treated as variable contracts under the Code and the regulations issued thereunder. Without limiting the scope of the foregoing, the Fund will at all times comply with Section 817(h) of the Code and Treasury Regulation 1.817-5, relating to the diversification requirements for variable annuity, endowment or life insurance contracts and any amendments or other modifications to such Section or Regulation. In the event of a breach of this Article VI by the Fund, it will take all reasonable steps (a) to notify Company of such breach and (b) to adequately diversify the Fund so as to achieve compliance with the grace period afforded by Regulation 1.817-5.
ARTICLE VII
Potential Conflicts
7.1. The Board will monitor the Fund for the existence of any material irreconcilable conflict between the interests of the contract owners of all separate accounts investing in the Fund. A material irreconcilable conflict may arise for a variety of reasons, including: (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance, tax or securities laws or regulations, or a public ruling, private letter ruling, no-action or interpretive letter or any similar action by insurance, tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the investments of a Portfolio are being managed; (e) a difference in voting instructions given by variable annuity contract and variable life insurance contract owners; or (f) a decision by a Participating Insurance Company to disregard the voting instructions of contract owners. The Board shall promptly inform the Company if it determines that a material irreconcilable conflict exists and the implications thereof.
7.2. The Company will report any potential or existing conflicts to the Board. The Company will assist the Board in carrying out its responsibilities under the Shared Funding Order, by providing the Board with all information reasonably necessary for the Board to consider any issues raised. This includes, but is not limited to, an obligation by the Company to inform the Board whenever any of the events in Section 7.1, as they pertain to the Company, occur (e.g., a decision to disregard contract owner voting instructions).
7.3. If it is determined by a majority of the Board, or a majority of its disinterested trustees, that a material irreconcilable conflict exists, the Company and other Participating Insurance Companies shall, at their expense and to the extent reasonably practicable (as determined by a majority of the disinterested trustees), take whatever steps are necessary to remedy or eliminate the material irreconcilable conflict, up to and including: (1) withdrawing the assets allocable to some or all of the separate accounts from the Fund or any Portfolio and reinvesting such assets in a different investment medium, including (but not limited to) another Portfolio of the Fund, or submitting the question whether such segregation should be
implemented to a vote of all affected Contract owners and, as appropriate, segregating the assets of any appropriate group (i.e., annuity contract owners, life insurance contract owners or variable contract owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected contract owners the option of making such a change, and (2) establishing a new registered management investment company or managed separate account.
7.4. If a material irreconcilable conflict arises because of a decision by the Company to disregard contract owner voting instructions and that decision represents a minority position or would preclude a majority vote, the Company may be required, at the Funds election, to withdraw the affected Accounts investment in the Fund and terminate this Agreement with respect to such Account; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the disinterested trustees of the Board. Any such withdrawal and termination must take place within six months after the Fund gives written notice that this provision is being implemented, and until the end of that six month period the Fund and the Underwriter shall continue to accept and implement orders by the Company for the purchase (and redemption) of shares of the Fund.
7.5. If a material irreconcilable conflict arises because a particular state insurance regulators decision applicable to the Company conflicts with that of other state regulators, then the Company will withdraw the affected Accounts investment in the Fund and terminate this Agreement with respect to such Account within six months after the Board informs the Company in writing that it has determined that such decision has created a material irreconcilable conflict; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the disinterested trustees of the Board. Until the end of that six month period, the Fund and the Underwriter shall continue to accept and implement orders by the Company for the purchase (and redemption) of shares of the Fund.
7.6. For purposes of Sections 7.3 through 7.6 of this Agreement, a majority of the disinterested trustees of the Board shall determine whether any proposed action adequately remedies a material irreconcilable conflict, but in no event will the Fund be required to establish a new funding medium for the Contracts. The Company shall not be required by Section 7.3 to establish a new funding medium for the Contracts if an offer to do so has been declined by vote of a majority of Contract owners materially adversely affected by the material irreconcilable conflict. In the event that the Board determines that any proposed action does not adequately remedy a material irreconcilable conflict, then the Company will withdraw the Accounts investment in the Fund and terminate this Agreement within six months after the Board informs the Company in writing of the foregoing determination; provided, however, that such withdrawal and termination shall be limited to the extent required by any such material irreconcilable conflict as determined by a majority of the disinterested trustees of the Board.
7.7. If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Shared Funding Order) on
terms and conditions materially different from those contained in the Shared Funding Order, then (a) the Fund and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with Rules 6e-2 and 6e-3(T), as amended, and Rule 6e-3 as adopted, to the extent such rules are applicable; and (b) Sections 3.4, 3.5, 7.1, 7.2, 7.3, 7.4 and 7.5 of this Agreement shall continue in effect only to the extent that terms and conditions substantially identical to such Sections are contained in such Rule(s) as so amended or adopted.
ARTICLE VIII
Indemnification
8.1. Indemnification By The Company
8.1(a). The Company agrees to indemnify and hold harmless the Fund, the Underwriter and the Adviser and each trustee/director and officer thereof and each person, if any, who controls the Fund, the Underwriter, or the Adviser within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 8.1) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Company), expenses or litigation (including legal and other expenses) (hereinafter referred to collectively as a Loss), to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as a Loss is related to the sale or acquisition of the Funds shares or the Contracts and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus or private offering memorandum for the Contracts or contained in the Contracts or sales literature or other promotional materials for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statement therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with written information furnished to the Company by or on behalf of the Indemnified Party for use in the registration statement or prospectus for the Contracts or in the Contracts or in sales literature or any other promotional materials or activities (or any amendment or supplement to any of the foregoing); or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus or sales literature or other promotional materials of the Fund not supplied by the Company, or persons under its control) or wrongful conduct of the Company or persons under its control, with respect to the sale or distribution of the Contracts or Fund shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus or sales literature or other promotional materials of the Fund (or any amendment or supplement to any of the foregoing) or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading if such statement or omission was made in reliance upon or in conformity with written information furnished to the Fund, the Underwriter or the Adviser by or on behalf of the Company; or
(iv) arise as a result of any failure by the Company to provide the services and furnish the materials under the terms of this Agreement; or
(v) arise out of or result from any material breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Company, as limited by and in accordance with the provisions of Sections 8.1 (b) and 8.1(c) hereof.
8.1(b). The Company shall not be liable under this indemnification provision with respect to any Loss incurred or assessed against an Indemnified Party as such may arise from such Indemnified Partys willful misfeasance, bad faith or gross negligence in the performance of such Indemnified Partys duties, or by reason of such Indemnified Partys reckless disregard of obligations or duties under this Agreement or to the Fund, the Underwriter or the Adviser, whichever is applicable.
8.1(c). The Company shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Company in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Company of any such claim shall not relieve the Company from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Company shall be entitled to participate, at its own expense, in the defense thereof. The Company also shall be entitled to assume the defense thereof, with counsel satisfactory to the Indemnified Party named in the action. After notice from the Company to such Indemnified Party of the Companys election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Company will not be liable to such Indemnified Party under this Agreement for any legal or other expenses subsequently incurred by such Indemnified Party independently in connection with the defense thereof other than reasonable costs of investigation.
8.1(d). The Indemnified Parties will promptly notify the Company of the commencement of any litigation or proceedings against them in connection with this Agreement, the issuance or sale of Portfolio shares or the Contracts or the operation of the Fund.
8.2. Indemnification By The Fund
8.2(a). The Fund agrees to indemnify and hold harmless the Company, and each of its directors/trustees and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 8.2) against any Loss to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as a Loss is related to the sale or acquisition of the Funds shares or the Contracts and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus, statement of additional information, sales literature or other promotional materials of the Fund (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with written information furnished to the Fund, the Underwriter or the Adviser by or on behalf of the Indemnified Party for use in the registration statement, prospectus, statement of additional information, sales literature or other promotional materials or activities for the Fund or the Contracts (or any amendment or supplement to any of the foregoing); or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, statement of additional information, sales literature or other promotional materials for the Contracts not supplied by the Fund, the Underwriter, the Adviser, or persons under their control) or wrongful conduct of the Fund, the Underwriter, the Adviser, or persons under their control, with respect to the sale or distribution of the Contracts or Fund shares; or
(iii) arise out of the untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, statement of additional information or private offering memorandum for the Contracts, or contained in the Contracts or sales literature or other promotional materials for the Contracts (or any amendment or supplement to any of the foregoing) or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon or in conformity with written information furnished to the Company by or on behalf of the Fund, the Underwriter or the Adviser, or persons under their control; or
(iv) arise as a result of any failure by the Fund to provide the services and furnish the materials under the terms of this Agreement (including a failure to comply with the diversification requirements specified in Article VI of this Agreement);or
(v) arise out of or result from any material breach of any representation and/or warranty made by the Fund in this Agreement or arise out of or result from any other material breach of this Agreement by the Fund, as limited by and in accordance with the provisions of Sections 8.2(b) and 8.2(c) hereof; or
(vi) arise out of or result from the material incorrect or untimely calculation or reporting of the daily net asset value per share or dividend or capital gain distribution rate.
8.2(b). The Fund shall not be liable under this indemnification provision with respect to any Loss incurred or assessed against an Indemnified Party as such may arise from such Indemnified Partys willful misfeasance, bad faith or gross negligence in the performance of such Indemnified Partys duties, or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement or to the Company, an Account, the Fund, the Underwriter or the Adviser, whichever is applicable.
8.2(c). The Fund shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Fund in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Fund of any such claim shall not relieve the Fund from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Fund shall be entitled to participate, at its own expense, in the defense thereof. The Fund also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action. After notice from the Fund to such party of the Funds election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Fund will not be liable to such Indemnified Party under this Agreement for any legal or other expenses subsequently incurred by such Indemnified Party independently in connection with the defense thereof other than reasonable costs of investigation.
8.2(d). The Company will promptly notify the Fund of the commencement of any litigation or proceedings against the Indemnified Parties in connection with this Agreement, the issuance or sale of Portfolio shares or the Contracts, the operation of each Account or the acquisition of shares of the Fund.
8.3. Indemnification By The Underwriter
8.3(a) The Underwriter agrees to indemnify and hold harmless the Company and each of its directors/trustees and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 8.3) against any Loss to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as a Loss is related to the sale or acquisition of the Funds shares or the Contracts and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus, statement of additional information, sales literature or other promotional materials of the Fund (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with written information furnished to the Fund, the Underwriter or the Adviser by or on behalf of the Indemnified Party for use in the registration statement, prospectus, statement of additional information, sales literature or other promotional materials or activities for the Fund or the Contracts (or any amendment or supplement to any of the foregoing); or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, statement of additional information, sales literature or other promotional materials for the Contracts not supplied by the Fund, the Underwriter, the Adviser, or persons under their control) or wrongful conduct of the Fund, the Underwriter, the Adviser, or persons under their control, with respect to the sale or distribution of the Contracts or Fund shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, statement of additional information or private offering memorandum for the Contracts, or contained in the Contracts or sales literature or other promotional materials for the Contracts (or any amendment or supplement to any of the foregoing) or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon or in conformity with written information furnished to the Company by or on behalf of the Fund, the Underwriter, the Adviser, or persons under their control; or
(iv) arise as a result of any failure by the Underwriter to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification requirements specified in Article VI of this Agreement);
(v) arise out of or result from any material breach of any representation and/or warranty made by the Underwriter in this Agreement or arise out of or result from any other material breach of this Agreement by the Underwriter, as limited by and in accordance with the provisions of Sections 8.3(b) and 8.3(c) hereof; or
(vi) arise out of or result from the materially incorrect or untimely calculation or reporting of the daily net asset value per share or dividend or capital gain distribution rate.
8.3(b). The Underwriter shall not be liable under this indemnification provision with respect to any Loss incurred or assessed against an Indemnified Party as such may arise from such Indemnified Partys willful misfeasance, bad faith or gross negligence in the performance of such Indemnified Partys duties, or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement or to the Company or an Account, whichever is applicable.
8.3(c). The Underwriter shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Underwriter in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Underwriter of any such claim shall not relieve the Underwriter from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Underwriter shall be entitled to participate, at its own expense, in the defense thereof. The Underwriter also shall be entitled to assume the defense thereof, with counsel satisfactory to the Indemnified Party named in the action. After notice from the Underwriter to such Party of the Underwriters election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Underwriter will not be liable to such Party under this Agreement for any legal or other expenses subsequently incurred by such Party independently in connection with the defense thereof other than reasonable costs of investigation.
8.3(d). The Company will promptly notify the Underwriter of the commencement of any litigation or proceedings against the Indemnified Parties in connection with this Agreement, the issuance or sale of Portfolio shares or the Contracts or the operation of each Account.
8.4. Indemnification By The Adviser
8.4(a) The Adviser agrees to indemnify and hold harmless the Company and each of its directors/trustees and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the Indemnified Parties for purposes of this Section 8.4) against any Loss to which the Indemnified Parties may become subject under any -statute or regulation, at common law or otherwise, insofar as a Loss is related to the sale or acquisition of the Funds shares or the Contracts and:
(i) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus, statement of additional information, sales literature or other promotional materials of the Fund (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with written information furnished to the Fund, the Underwriter or the Adviser by or on behalf of the Indemnified Party for use in the registration statement, prospectus, statement of additional information, sales literature or other promotional materials or activities for the Fund or the Contracts (or any amendment or supplement to any of the foregoing); or
(ii) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, statement of additional information, sales literature or other promotional materials for the Contracts not supplied by the Fund, the Underwriter, the Adviser, or persons under their control) or wrongful conduct of the Fund, the Underwriter, the Adviser or persons under their control, with respect to the sale or distribution of the Contracts or Fund shares; or
(iii) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, statement of additional information or private offering memorandum for the Contracts, or contained in the Contracts, or sales literature or other promotional materials for the Contracts (or any amendment or supplement to any of the foregoing) or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon or in conformity with written information furnished to the Company by or on behalf of the Fund, the Underwriter, the Adviser, or persons under their control; or
(iv) arise as a result of any failure by the Adviser to provide the services and furnish the materials under the terms of this Agreement (including a failure by the Fund, whether unintentional or in good faith or otherwise, to comply with the diversification requirements specified in Article VI of this Agreement); or
(v) arise out of or result from any material breach of any representation and/or warranty made by the Adviser in this Agreement or arise out of or result from any other material breach of this Agreement by the Adviser, as limited by and in accordance with the provisions of Sections 8.4(b) and 8.4(c) hereof; or
(vi) arise out of or result from the materially incorrect or untimely calculation or reporting of the daily net asset value per share or dividend or capital gain distribution rate.
8.4(b). The Adviser shall not be liable under this indemnification provision with respect to any Loss incurred or assessed against an Indemnified Party as such may arise from such Indemnified Partys willful misfeasance, bad faith or gross negligence in the performance of such Indemnified Partys duties, or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement or to the Company or an Account, whichever is applicable.
8.4(c). The Adviser shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Adviser in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Adviser of any such claim shall not relieve the Adviser from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision. In case any such action is brought against the Indemnified Parties, the Adviser shall be entitled to participate, at its own expense, in the defense thereof. The Adviser also shall be entitled to assume the defense thereof, with counsel satisfactory to the Indemnified Party named in the action. After notice from the Adviser to such party of the Advisers election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Adviser will not be liable to such Indemnified Party under this Agreement for any legal or other expenses subsequently incurred by such Indemnified Party independently in connection with the defense thereof other than reasonable costs of investigation.
8.4(d). The Company will promptly notify the Adviser of the commencement of any litigation or proceedings against the Indemnified Parties in connection with this Agreement, the issuance or sale of Portfolio shares or the Contracts or the operation of each Account.
8.5. Except as otherwise expressly provided in the Agreement, no party shall be liable to any other party for special, consequential, punitive or exemplary damages, or damages of a like kind or nature.
ARTICLE IX
Applicable Law
9.1. This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of the State of New York.
9.2. This Agreement shall be subject to the provisions of the 1933 Act, the 1934 Act and the 1940 Act and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the SEC may grant (including, but not limited to, the Shared Funding Order) and the terms of this Agreement shall be interpreted and construed in accordance therewith.
ARTICLE X
Termination
10.1. This Agreement shall continue in full force and effect until the first to occur of:
(a) termination by any party for any reason by six (6) months advance written notice delivered to the other parties; or
(b) termination by the Company by written notice to the Fund and the Underwriter with respect to any Portfolio based upon the Companys determination that shares of such Portfolio are not reasonably available to meet the requirements of the Contracts; or
(c) termination by the Company by written notice to the Fund and the Underwriter with respect to any Portfolio in the event any of the Portfolios shares are not registered, issued or sold in accordance with applicable state and/or federal law or such law precludes the use of such shares as the underlying investment media of the Contracts issued or to be issued by the Company; or
(d) termination by the Company by written notice to the Fund, the Underwriter and the Adviser with respect to any Portfolio in the event that such Portfolio ceases to qualify as a regulated investment company under Subchapter M of the Code or under any successor or similar provision, or if the Company reasonably believes that the Fund will fail to so qualify; or
(e) termination by the Company by written notice to the Fund, the Underwriter and the Adviser with respect to any Portfolio in the event that such Portfolio fails to meet the diversification requirements specified in Article VI hereof; or
(f) termination by either the Fund or the Underwriter by written notice to the Company, if either one or both of the Fund or the Underwriter shall determine, in their sole judgment exercised in good faith, that the Company and/or its affiliated companies has suffered a material adverse change in its business, operations, financial condition or prospects since the date of this Agreement or is the subject of material adverse publicity which is likely to have a material adverse impact upon the business and operations of the Company; or
(g) termination by the Company by written notice to the Fund and the Underwriter, if the Company shall determine, in its sole judgment exercised in good faith, that the Fund, the Adviser or the Underwriter has suffered a material adverse change in its business, operations, financial condition or prospects since the date of this Agreement or is the subject of material adverse publicity which is likely to have a material adverse impact upon the business and operations of the Fund, the Adviser, or the Underwriter; or
(h) termination by the Fund or the Underwriter by written notice to the Company, if the Company gives the Fund and the Underwriter the written notice specified in Section 1.6(b) hereof and at the time such notice was given there was no notice of termination outstanding under any other provision of this Agreement and the investment company that is the subject of Section 1.6(b) notice has investment objectives or policies that are not substantially different from the investment objectives and policies of the Portfolios of the Fund listed on Schedule B to this Agreement; provided, however, that any termination under this Section 10.1(h) shall be effective ninety days after the notice specified in Section 1.6(b) was given; or
(i) termination by the Company by written notice to the Fund and the Underwriter or by the Fund or the Underwriter by written notice to the Company, in the event that an irreconcilable material conflict exists among the interests of (1) all Contract owners of variable insurance products or all separate accounts or (2) the interest of the Participating Insurance Companies investing in the Fund as delineated in Article VII of this Agreement; or
(j) termination by the Company by written notice to the Fund and the Underwriter or by the Fund or the Underwriter by written notice to the Company, in the event of the non-terminating partys material breach of any provision of this Agreement; or
(k) termination by the Company by written notice to the Fund and the Underwriter, or by the Fund or the Underwriter by written notice to the Company, upon receipt of any necessary regulatory approvals or the vote of the Contract owners having an interest in the Account (or any subaccount) to substitute the shares of another investment company for the corresponding Portfolio shares of the Fund in accordance with the terms of the Contracts for which those Portfolio shares had been selected to serve as the underlying investment media. The Company will give forty-five (45) days prior written notice to the Fund and the Underwriter of the date of any proposed vote or other action taken to replace the Funds shares.
10.2. Effect of Termination. Notwithstanding termination of this Agreement, the Fund and the Underwriter shall continue to make available additional shares of the Fund pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as Existing Contracts). Specifically, without limitation, the owners of the Existing Contracts shall be permitted to retain investments in the Fund, reinvest dividends and redeem investments in the Fund. If shares of the Fund continue to be made available after termination of this Agreement pursuant to this Section 10.2, the provisions of this Agreement shall remain in effect except for Section 10.1 and thereafter the Fund, the Underwriter or the Company may terminate the Agreement, as so continued pursuant to this Section 10.2, upon written notice to the other party, such notice to be for a period that is reasonable under the circumstances but need not be for more than ninety days (90). The parties agree that this Section 10.2 shall not apply to any terminations under Section 1.2 of Article I or under Article VII, and the effect of such Article VII terminations shall be governed by Article VII of this Agreement.
10.3 The Company shall not redeem Fund shares attributable to the Contracts (as opposed to Fund shares attributable to the Companys assets held in the Account) except (i) as necessary to implement Contract Owner initiated or approved transactions; or (ii) as required by state and/or federal laws or regulations or judicial or other legal precedent of general application (hereinafter referred to as a Legally Required Redemption); or (iii) as a result of action by the Funds Board, acting in good faith, upon ninety (90) days advance written notice to the Company and Contract Owners; or upon ninety (90) days advance written notice to the Fund of the Companys intention to do so. Upon request, the Company will promptly furnish to the Fund and the Underwriter the opinion of counsel for the Company (which counsel shall be reasonably satisfactory to the Fund and the Underwriter) to the effect that any redemption pursuant to clause (ii) above is a Legally Required Redemption, or is as permitted by an order of the SEC pursuant to Section 26(b) of the 1940 Act. In the event that the Company is to redeem shares pursuant to clause (iii) above, the Fund will promptly furnish to the Company the opinion of counsel for the Fund (which counsel shall be reasonably satisfactory to the Company) to the effect that any such redemption is not in violation of the 1940 Act or any rule or regulation thereunder, or is as permitted by an order of the SEC. Furthermore, except in cases where permitted under the terms of the Contracts, the Company shall not prevent Contract Owners from allocating payments to a Portfolio that was otherwise available under the Contracts without first giving the Fund or the Underwriter ninety (90) days advance written notice of its intention to do so.
ARTICLE XI
Notices
Any notice shall be sufficiently given when sent by registered or certified mail or next-day delivery to the other parties at the address of such parties set forth below or at such other address as any party may from time to time specify in writing to the other parties.
If to the Company:
2801 Highway 280 South
Birmingham, Alabama 35223
Attention: Steve M. Callaway, Senior Associate Counsel,
with a copy to Carolyn King, Senior Vice President
If to the Fund:
99 Park Avenue
New York, New York 10016
Attention: President, with a copy to the General Counsel
If to the Underwriter:
99 Park Avenue
New York, New York 10016
Attention: President, with a copy to the General Counsel
If to the Adviser:
99 Park Avenue
New York, New York 10016
Attention: President, with a copy to the General Counsel
ARTICLE XII
Miscellaneous
12.1. The Company, the Adviser and the Underwriter each understand and agree that the obligations of the Fund under this Agreement are not binding upon the Board, any shareholder, officer or agent personally, but bind only the Fund and the Funds property.
12.2. Subject to the requirements of legal process and regulatory authority, each party hereto shall treat as confidential the names and addresses of the owners of the Contracts and all information reasonably identified as confidential in writing by any other party hereto and, except as permitted by this Agreement, shall not disclose, disseminate or utilize such names and addresses and other confidential information without the express written consent of the affected party, until such time as it may come into the public domain.
12.3. The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
12.4. This Agreement may be executed simultaneously in two or more counterparts, each of which taken together shall constitute one and the same instrument.
12.5. If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.
12.6. Each party hereto shall cooperate with each other party and all appropriate governmental authorities (including, without limitation, the SEC, the NASD and state insurance regulators) and shall permit such authorities reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.
12.7. The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.
12.8. This Agreement or any of the rights and obligations hereunder may not be assigned by any party without the prior written consent of all parties hereunder; provided, however, that the Underwriter may assign this Agreement or any rights or obligations hereunder to any affiliate of or company under common control with the Underwriter, if such assignee is duly licensed and registered to perform the obligations of the Underwriter under this Agreement.
12.9. Upon request, the Company shall furnish, or shall cause to be furnished, to the Fund or its designee, copies of the following reports:
(a) the Companys most recent annual statement (prepared under statutory accounting principles) and annual report (prepared under generally accepted accounting principles (GAAP), if any;
(b) the Companys most recent quarterly statements (statutory) (and GAAP, if any);
(c) any financial statement, proxy statement, notice or report of the Company sent to stockholders and/or policyholders;
(d) any registration statement (without exhibits) and financial reports of the Company filed with the SEC or any state insurance regulator.
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and on its behalf by its duly authorized representative and its seal to be hereunder affixed hereto as of the date specified below.
PROTECTIVE LIFE INSURANCE COMPANY |
|
Attest: |
||
|
|
|
|
|
By: |
/s/ Carolyn King |
|
By: |
/s/ Steve M. Callaway |
|
|
|
|
|
Name: |
Carolyn King |
|
Name: |
Steve M. Callaway |
|
|
|
|
|
Title: |
Senior Vice President |
|
Title: |
Senior Associate Counsel |
|
|
|
||
VAN ECK WORLDWIDE INSURANCE TRUST |
|
Attest: |
||
|
|
|
|
|
By: |
/s/ Thomas Elwood |
|
By: |
/s/ Bruce J. Smith |
|
|
|
|
|
Name: |
Thomas Elwood |
|
Name: |
Bruce J. Smith |
|
|
|
|
|
Title: |
VP & Secretary |
|
Title: |
VP & Treasurer |
|
|
|
||
VAN ECK SECURITIES CORPORATION |
|
Attest: |
||
|
|
|
|
|
By: |
/s/ Thomas Elwood |
|
By: |
/s/ Bruce J. Smith |
|
|
|
|
|
Name: |
Thomas Elwood |
|
Name: |
Bruce J. Smith |
|
|
|
|
|
Title: |
VP & Secretary |
|
Title: |
Senior Vice President |
|
|
|
||
VAN ECK ASSOCIATES CORPORATION |
|
Attest: |
||
|
|
|
|
|
By: |
/s/ Thomas Elwood |
|
By: |
/s/ Bruce J. Smith |
|
|
|
|
|
Name: |
Thomas Elwood |
|
Name: |
Bruce J. Smith |
|
|
|
|
|
Title: |
VP & Secretary |
|
Title: |
Senior Vice President |
SCHEDULE A
ACCOUNTS
Name of Account |
|
Date Established by the Companys
|
|
|
|
Protective Variable Annuity Separate Account |
|
12/23/93 |
|
|
|
Protective Variable Life Separate Account |
|
2/22/95 |
SCHEDULE B
PORTFOLIOS AND OTHER FUNDS
ADVISED BY ADVISER
I. Portfolios
Worldwide Hard Assets Fund
Worldwide Real Estate Fund
II. Other Funds Advised by the Adviser
SCHEDULE C
OTHER INVESTMENT COMPANIES AVAILABLE
AS FUNDING VEHICLE FOR THE CONTRACTS
Protective Investment Company
Oppenheimer Variable Account Funds
MFS®Variable Insurance Trust
Calvert Variable Series, Inc.
Van Eck Securities Corporation
99 Park Avenue - 8th Floor
New York, NY 10016
212-687-5200 Toll Free (800) 221-2220
SUPPLEMENTAL AGREEMENT TO PARTICIPATION AGREEMENT
Related to Van Eck Worldwide Insurance Trust
Protective Life
Attn: Steve M. Callaway
2801 Highway 280 South
Birmingham, AL 35223
We are providing Protective Life (you) with this SUPPLEMENTAL AGREEMENT dated October 22, 2004 (Supplemental Agreement) to the Participation Agreement among Van Eck Worldwide Insurance Trust (Fund), Van Eck Securities Corporation (Underwriter), Van Eck Associates Corporation (Adviser) and you (Participation Agreement).
WHEREAS, in consideration for your continued ability to purchase shares of portfolios of Van Eck Worldwide Insurance Trust (collectively, Portfolios) as an investment vehicle for your segregated asset accounts established for variable life insurance policies and variable annuity contracts as provided for by the Participation Agreement, as it may be amended from time to time, you agree to the following supplemental terms.
Supplemental Agreements
1. In addition to the representations and warranties made by you in the Participation Agreement, you agree to: (a) comply with all applicable compensation disclosure requirements imposed on you by law, regulation or rule of a self-regulatory organization, including revenue sharing disclosure, (b) comply with all suitability requirements applicable under state or federal law, regulation or rule of a self-regulatory organization (c) not permit any orders for purchase, sale or redemption of Portfolio shares to be received by you after the time of computation as stated in the applicable Portfolios prospectus and Statement of Additional Information (Offering Documents) (currently, the close of regular trading on the New York Stock Exchange, which is normally 4:00 p.m. (Eastern Time) on a business day of the Portfolio), (d) cooperate with the Fund in identifying and restricting any abusive short-term or frequent trading in Portfolio shares, (e) implement measures reasonably designed to protect the privacy and safeguard the personal information of all beneficial owners of Portfolio shares, including compliance with all applicable law, rule and regulation applicable to the privacy and safeguarding of information of Fund shareholders and their accounts.
3. You agree to comply, voluntarily or by operation of law or regulation, with the provisions of the Bank Secrecy Act, as amended, other relevant anti-money laundering law and any regulations, rules or interpretations thereunder, including without limitation those applicable
to customer identification programs, the filing of suspicious activity reports and the adoption and maintenance of an anti-money laundering program. In addition, you will comply with all requirements to verify whether your customers may not purchase Fund shares by reason of being a person, country or other entity forbidden to do so by the Office of Foreign Assets Control of the U.S. Department of Treasury or any similar list maintained by the United States government or its agencies or instrumentalities or any applicable self-regulatory organization. Upon request of one of the other parties to this Participation Agreement, you will provide a certification of your compliance with this paragraph that is satisfactory to the requesting party.
4. The indemnification provisions of the Participation Agreement are fully incorporated into this Supplemental Agreement and fully apply to the provisions of this Supplemental Agreement. Such indemnification provisions shall survive any termination of this Supplemental Agreement.
5. To the extent that any term(s) of this Supplemental Agreement is inconsistent with the Offering Documents, the Offering Documents shall be controlling. To the extent that any term(s) of this Supplemental Agreement is inconsistent with any term(s) of the Participation Agreement, this Supplemental Agreement shall be controlling, except to the extent this Supplemental Agreement expressly provides otherwise.
IN WITNESS WHEREOF, this Supplemental Agreement has been acknowledged and executed as of the date set forth below by a duly authorized officer of the entity named below.
|
|
Protective Life |
|
|
|
|
|
|
|
|
By: |
/s/ R. Stephen Briggs |
|
|
|
|
Name of Authorized Signatory: R. Stephen Briggs |
|
|
|
|
|
|
|
|
|
Executive Vice President |
|
|
|
|
Title: |
|
|
|
|
|
|
|
|
|
Dated: |
December 7, 2004 |
|
FIRST AMENDMENT TO
PARTICIPATION AGREEMENT
This First Amendment is, dated and effective as of December , 2020, to the Participation Agreement (the Agreement), effective September 30, 1998,, between VAN ECK WORLWIDE INSURANCE TRUST (THE FUND), VAN ECK SECURITIES CORPRATION (The Underwriter), VAN ECK ASSOCIATES CORPORATION (the Adviser) and PROTECTIVE LIFE INSURANCE COMPANY (the Company).
WHEREAS, the parties wish to amend the Agreement to update the separate accounts listed in Schedule A and the Portfolios of the Fund listed in Schedule B;
NOW THEREFORE, the parties hereby agree to amend the Agreement as follows:
1. Van Eck VIP Trust. All references to Van Eck Worldwide Insurance Trust shall be replaced with VanEck VIP Trust.
2. Schedules A and B. Schedules A and B to the Agreement are hereby deleted in their entirety and replaced with Schedules A and B attached hereto.
3. Ratification and Confirmation of Agreement. In the event of a conflict between the terms of this Amendment and the Agreement, it is the intention of the parties that the terms of this Amendment shall control and the Agreement shall be interpreted on that basis. To the extent the provisions of the Agreement have not been amended by this Amendment, the Parties hereby confirm and ratify the Agreement.
4. Counterparts. This Amendment may be executed in two or more counterparts, each of which shall be an original and all of which together shall constitute one instrument.
5. Full Force and Effect. Except as expressly supplemented, amended or consented to hereby, all of the terms, representations, warranties, terms, covenants and conditions of the Agreement shall remain unamended and shall continue to be in full force and effect.
IN WITNESS WHEREOF, the parties have each caused this Agreement to be executed in its name and on its behalf by its duly authorized representative as of the date and year first above written.
VAN ECK VIP TRUST |
VAN ECK ASSOCIATES CORPORATION |
|||
|
|
|||
By: |
|
|
By: |
|
Name: |
|
|
Name: |
|
Title: |
|
|
Title: |
|
|
|
|||
VAN ECK SECURITIES CORPORATION |
PROTECTIVE LIFE INSURANCE |
|||
|
|
|
|
|
By: |
|
|
By: |
|
Name: |
|
|
Name: |
|
Title: |
|
|
Title: |
|
SCHEDULE A
SEPARATE ACCOUNTS OF PROTECTIVE LIFE INSURANCE COMPANY
Separate Accounts |
|
Date Established by the Board of Directors |
Protective Variable Annuity Separate Account |
|
12/23/1993 |
Protective Life Variable Account |
|
2/22/1995 |
Protective COLI VUL Separate Account |
|
02/25/2020 |
Protective COLI PPVUL Separate Account |
|
4/14/2020 |
SCHEDULE B
PORTFOLIOS OF THE VAN ECK WORLWIDE INSURANCE TRUST
Van Eck Worldwide Real Estate Fund
VanEck VIP Global Hard Assets Fund
Van Eck VIP Emerging Markets Fund
PARTICIPATION AGREEMENT
AMONG
VICTORY VARIABLE INSURANCE
FUNDS,
VICTORY CAPITAL MANAGEMENT INC.,
VICTORY CAPITAL SERVICES, INC.,
AND
PROTECTIVE LIFE INSURANCE COMPANY
THIS PARTICIPATION AGREEMENT is made and entered into this 1st day of December 2020, by and among Victory Variable Insurance Funds, a Delaware statutory trust (the Trust); Victory Capital Management Inc., a New York Corporation (the Adviser); for purposes of Sections 2.4, 2.9 and 5.1 and Article VIII only, Victory Capital Services, Inc. (VCS); and Protective Life Insurance Company, a Tennessee insurance company (the Company) on its own behalf and on behalf of each of the segregated asset accounts of the Company set forth on Schedule A hereto, as may be amended from time to time (the Accounts).
WHEREAS, the Trust is registered as an open-end management investment company under the Investment Company Act of 1940, as amended (the 1940 Act), and its shares are registered or will be registered under the Securities Act of 1933, as amended (the 1933 Act);
WHEREAS, the series of shares of the Trust (each, a Portfolio, and, collectively, the Portfolios) and the classes of shares of those Portfolios (the Shares) offered by the Trust to the Company and the Accounts are set forth on Schedule B attached hereto;
WHEREAS, the Adviser is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and any applicable state securities law, and is the Trusts investment adviser;
WHEREAS, the Company will issue certain variable annuity and/or variable life insurance contracts (individually, the Policy or, collectively, the Policies) which, if required by applicable law, will be registered under the 1933 Act;
WHEREAS, the Accounts are duly organized, validly existing segregated asset accounts, established by resolution of the Board of Directors of the Company, to set aside and invest assets attributable to the aforesaid variable annuity and/or variable life insurance contracts that are allocated to the Accounts (the Policies and the Accounts covered by this Agreement, and each corresponding Portfolio covered by this Agreement in which the Accounts invest, are specified on the Schedules attached hereto as may be modified from time to time);
WHEREAS, the Company has registered or will register the Accounts as unit investment trusts under the 1940 Act (unless exempt therefrom);
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company intends to purchase the Shares of the Portfolios as specified on Schedule B attached hereto (the Shares) on behalf of the Accounts to fund the Policies, and the Trust intends to sell such Shares to the Accounts at net asset value (NAV);
NOW, THEREFORE, in consideration of their mutual promises, the Trust, the Adviser, VCS and the Company agree as follows:
ARTICLE I. SALE OF TRUST SHARES
1.1 The Trust (through VCS) agrees to sell to the Company those Shares which the Accounts order (based on orders placed by Policy holders on that Business Day, as defined below) and which are available for purchase by such Accounts, executing such orders on a daily basis at the NAV next computed after receipt and acceptance by the Trust or its designee of the order for the Shares. For purposes of this Section 1.1, the Company shall be the designee of the Trust for receipt of such orders from Policy owners and receipt and acceptance by such designee shall constitute receipt and acceptance by the Trust; provided that the Trust receives notice of such orders by 8:30 a.m. New York time on the next following Business Day. Business Day shall mean any day on which the New York Stock Exchange (the NYSE) is open for trading and on which the Trust calculates NAV pursuant to the rules of the Securities and Exchange Commission (SEC) and the Portfolios then-current prospectus.
The Company and the Trust intend to clear trades through, and make use of, the NSCCs Defined Contribution Clearing and Settlement (DCC&S) Fund/SERV system, the terms of which are set forth in Section 1.2 below shall apply. If the use of Fund/Serv is not operationally feasible, or the parties otherwise agree, the terms set forth in Section 1.3 shall apply.
1.2 Orders for the purchase or redemption of Shares of the Portfolios on behalf of the Accounts (Instructions) will be placed directly by the Company or its designee with the Trust. Instructions in good order received by the Company prior to the close of trading on the New York Stock Exchange on any given Business Day (the Trade Date) and transmitted to the Trust by no later than 8:30 a.m. New York time on the next following Trade Date (Trade Date +1), will be executed at the NAV determined as of the close of trading on the Trade Date.
As set forth below, upon the timely receipt by the Trust of the Instructions, the Trust will execute the purchase or redemption transactions (as the case may be) at the price for each Portfolio computed as of the close of trading on the Trade Date.
(a) Except as otherwise provided herein, all purchase and redemption transactions will settle T+1. Settlements will be through Federal Wire transfers to an account designated by a Portfolio and will be initiated by 6:00 p.m. New York time or the Federal Reserve deadline.
(b) On any Business Day when the Federal Reserve Wire Transfer System is closed, all communication and processing rules will be suspended for settlement of Instructions. Instructions will be settled on the next Business Day on which the Federal Wire Transfer System is open. The original T+1 settlement date will not apply. Rather for
purposes of the paragraph (b) only, the settlement date will be the date on which the Instruction settles.
(c) The Company shall, upon receipt of any confirmation or statement concerning the Accounts, verify the accuracy of the information contained therein against the information contained in the Companys internal record-keeping system and shall promptly advise the Trust in writing of any discrepancies between such information. The Trust and the Company shall cooperate to resolve any such discrepancies as soon as reasonably practicable.
1.3 (a) For each Business Day, the Company or its designee shall transmit to the Trust Instructions received by the close of trading on the New York Stock Exchange and shall transmit such Instructions without modification to the Trust or its designee, except for netting and/or aggregation, via the DCC&S Fund/SERV system no later than 5:00 A.M. New York time on the next Business Day. Notwithstanding the foregoing, to the extent Instructions are not transmitted to the Trust via the DCC&S Fund/SERV system, the Company shall notify the Trust, and such Instructions shall be either (i) transmitted via facsimile or (ii) resubmitted via the DCC&S Fund/SERV system by no later than 8:30 a.m. New York time on T + 1. On each Business Day, the Trust shall accept, and effect changes in its records upon receipt of purchase, redemption and registration, Instructions from the Company electronically through DCC&S.
(b) The Trust or its designee shall perform any and all duties, functions, procedures and responsibilities assigned to it under this Agreement and as otherwise established by the NSCC. The Trust or its designee shall conduct each of the foregoing activities in a competent manner and in compliance with (a) all applicable laws, rules and regulations, including NSCC Fund/SERV-DCCS rules and procedures relating to Fund/SERV; (b) the then-current Prospectus of a Portfolio; and (c) any provision relating to Fund/SERV in any other agreement of the Trust or its designee that would affect its duties and obligations pursuant to this Agreement.
(c) Confirmed trades and any other information provided by Trust to Company or its designee through Fund/SERV and pursuant to this Agreement shall be accurate, complete, and in the format prescribed by the NSCC.
(d) Trade information provided by Company or its designee to Trust through Fund/SERV and pursuant to this Agreement shall be accurate, complete and, in the format prescribed by the NSCC. All Instructions by Company or its designee regarding each Fund/SERV Account shall be true and correct and will have been duly authorized by the registered holder.
1.4 Subject to the terms set forth in the Trusts registration statement (including the Trusts right to refuse to sell Shares to any person), the Trust, so long as this Agreement is in effect, agrees to make the Shares available for purchase at the applicable NAV per share by the Company on behalf of the Accounts on those days on which the Trust calculates its NAV pursuant to rules of the SEC and the Portfolios then-current prospectus. Notwithstanding the foregoing, the Board of Trustees of the Trust (the Board) may refuse to permit the Trust to sell any Shares to the
Company and the Accounts, or suspend or terminate the offering of the Shares if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Board acting in good faith and in light of its fiduciary duties under federal and any applicable state laws, necessary in the best interest of the shareholders of such Portfolio (Shareholders). The Trust reserves the right to take all actions, including but not limited to, dissolution, reorganization, liquidation, merger or sale of all assets of the Trust or any Portfolio upon the sole authorization of the Board, acting in good faith, and shall notify the Company promptly, in writing, of any such determination by the Board.
1.5 The parties hereto acknowledge that the arrangement contemplated by this Agreement is not exclusive; the Trusts shares may be sold to other insurance companies and the cash value of the Policies may be invested in other investment companies.
1.6 The Trust agrees to redeem for cash, on the Companys request, any full or fractional Shares held by the Accounts (based on orders placed by Policy owners on that Business Day), executing such requests on a daily basis at the NAV next computed after receipt by the Trust or its designee of the request for redemption in proper form, except that (i) the Company shall not redeem Shares attributable to Policy owners except in the circumstances permitted in Section 11.4 and (ii) the Trust reserves the right to suspend the right of redemption or postpone the date of payment or satisfaction upon redemption to the extent permitted by the 1940 Act, and any rules thereunder, and in accordance with the procedures and policies of the Trust as described in the Portfolios then-current prospectus. For purposes of this Section 1.6, the Company shall be the designee of the Trust for receipt of requests for redemption from each Account and receipt by such designee of a request in proper form prior to the close of regular trading on the NYSE shall constitute receipt by the Trust; provided that the Trust receives notice of such request for redemption by 8:30 a.m. New York time on the next following Business Day.
1.7 Each purchase, redemption and exchange order placed by the Company shall be placed separately for each Portfolio and shall not be netted with respect to any other Portfolio. However, with respect to payment of the purchase price by the Company to the Trust or redemption proceeds by the Trust to the Company, the Company and the Trust shall net purchase and redemption payments actually to be made with respect to each Portfolio on the same day and shall transmit one net payment for all of the Portfolios in accordance with Section 1.7 hereof.
1.8 The Company agrees to purchase and redeem the Shares of each Portfolio in accordance with the provisions of the Portfolios then-current prospectus.
1.9 In the event of net purchases, the Company shall pay for the Shares by the Federal Funds deadline on the next Business Day after an order to purchase the Shares is made in accordance with the provisions of Section 1.1. hereof. Subject to Section 1.4 of this Agreement, in the event of net redemptions, the Trust shall pay the redemption proceeds by the Federal Funds deadline on the next Business Day after an order to redeem the Shares is made in accordance with the provisions of Section 1.6. hereof. All such payments shall be in federal funds transmitted by wire.
1.10 Issuance and transfer of the Shares will be by book entry only. Stock certificates will not be issued to the Company or the Accounts. The Shares ordered from the Trust will be recorded in an appropriate title for the Accounts or the appropriate subaccounts of the Accounts.
1.11 The Trust shall furnish same day notice (by wire or telephone followed by written confirmation) to the Company of any dividends or capital gain distributions payable on the Shares. The Company on behalf of the Accounts hereby elects to receive all such dividends and distributions as are payable on a Portfolios Shares in additional Shares of that Portfolio. The Trust shall notify the Company of the number of Shares so issued as payment of such dividends and distributions.
1.12 The Trust or its custodian shall make the NAV per share for each Portfolio available to the Company on each Business Day as soon as reasonably practicable after the NAV per share is calculated and shall use its best efforts to make such NAV per share available by 7:00 p.m. New York time. In the event that the Trust is unable to meet the 7:00 p.m. time stated herein, it shall provide additional time for the Company to place orders for the purchase and redemption of Shares received by the Company prior to the close of regular trading on the NYSE on that day. Such additional time shall be equal to the additional time which the Trust takes to make the NAV available to the Company. If the Trust provides materially incorrect share NAV information, the Trust shall make an adjustment to the number of Shares purchased or redeemed for the Accounts to reflect the correct NAV per Share. Any material error in the calculation or reporting of NAV per Share, dividend, or capital gains information shall be reported promptly upon discovery to the Company.
ARTICLE II. CERTAIN REPRESENTATIONS, WARRANTIES AND COVENANTS
2.1 The Company represents and warrants that the Policies are or will be registered under the 1933 Act or are exempt from or not subject to registration thereunder, and that the Policies will be issued, sold, and distributed in compliance in all material respects with all applicable state and federal laws, including without limitation the 1933 Act, the Securities Exchange Act of 1934, as amended (the 1934 Act), and the 1940 Act. The Company further represents and warrants that it is an insurance company duly organized and in good standing under applicable law and that it has legally and validly established the Account as a segregated asset account under applicable law and has registered or, prior to any issuance or sale of the Policies, will register the Accounts as unit investment trusts in accordance with the provisions of the 1940 Act (unless exempt therefrom) to serve as segregated investment accounts for the Policies, and that it will maintain such registration for so long as any Policies are outstanding. The Company shall amend the registration statements under the 1933 Act for the Policies and the registration statements under the 1940 Act for the Accounts from time to time as required in order to effect the continuous offering of the Policies or as may otherwise be required by applicable law. The Company shall register and qualify the Policies for sale in accordance with the securities laws of the various states only if and to the extent deemed necessary by the Company.
2.2 The Company represents and warrants that the Policies are currently and at the time of issuance will be treated as life insurance, endowment or annuity contracts under applicable provisions of the Internal Revenue Code of 1986, as amended (the Code), that it will maintain such treatment and that it will notify the Trust or the Adviser immediately upon having a
reasonable basis for believing that the Policies have ceased to be so treated or that they might not be so treated in the future. The Company represents and warrants that the Agreement has been duly authorized, executed, and delivered by the Company and that the Agreement is the valid and binding obligation of the Company enforceable against the Company in accordance with its terms.
2.3 The Company represents that it has and will continue to have the necessary facilities, equipment, and personnel to perform its duties and obligations under the Agreement.
2.4 VCSA represents and warrants that it is a member in good standing of the Financial Industry Regulatory Authority, Inc. (FINRA) and is a registered broker-dealer with the SEC under the 1934 Act.
2.5 The Company represents and warrants that the Policies will be sold and distributed in accordance in all material respects with all applicable state and federal securities laws, including without limitation the 1933 Act, the 1934 Act, and the 1940 Act.
2.6 The Trust represents and warrants that the Shares sold pursuant to this Agreement shall be registered under the 1933 Act, duly authorized for issuance and sold in compliance with applicable federal and state securities laws and that the Trust is and shall remain registered under the 1940 Act. The Trust shall amend the registration statement for its Shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of the Shares. The Trust shall register and qualify the Shares for sale in accordance with the laws of all fifty (50) states, the District of Columbia, the U.S. Virgin Islands, the Commonwealth of Puerto Rico, and the U.S. Territory of Guam, to the extent necessary under applicable state law.
2.7 The Trust represents and warrants that the Agreement has been duly authorized, executed, and delivered by the Trust and that the Agreement is the valid and binding obligation of the Trust enforceable against the Trust in accordance with its terms.
2.8 The Trust represents that it will sell and distribute the Shares in accordance in all material respects with all applicable state and federal securities laws, including without limitation the 1933 Act, the 1934 Act, and the 1940 Act.
2.9 Each of the Adviser and VCS represents and warrants that the Agreement has been duly authorized, executed, and delivered by each of the Adviser and VCS and that the Agreement is the valid and binding obligation of each of the Adviser and VCS enforceable against each of the Adviser and VCS in accordance with its terms.
2.10 The parties agree to comply with the applicable privacy and notice provisions of Regulation S-P, as they may be amended from time to time.
2.11 The Company agrees to comply with applicable U.S. Department of Treasury and/or Office of Foreign Assets Control laws, regulations, requirements, and guidance (OFAC Requirements) by adopting compliance policies and procedures with respect to Policy owners investments in the Accounts. The Company agrees to comply with applicable money laundering and current transactions reporting laws, regulations, and government or regulatory guidance, including the use of a customer identification program, suspicious activity reporting, and recordkeeping requirements (collectively with the OFAC Requirements, the AML
Requirements), and with any anti-money laundering guidelines as may be agreed to by the parties. The Company will ensure the ability of federal examiners to obtain information and records relating to AML Requirements. Upon the reasonable request of the Trust or its agent, and in accordance with AML Requirements, the Company with provide sufficient documentation regarding the Companys compliance with AML Requirements.
2.12 The Trust makes no representations as to whether any aspect of its operations (including, but not limited to investment policies and fees and expenses) complies with the insurance and other applicable laws of the various states.
2.13 No less frequently than annually, the Company shall submit to the Board such reports, material or data as the Board may reasonably request so that it may carry out fully the obligations imposed upon it by the conditions contained in the exemptive application pursuant to which the SEC has granted exemptive relief to permit mixed and shared funding (the Mixed and Shared Funding Exemptive Order).
2.14 The Company, on its own behalf and on behalf of its affiliates and agents, represents and warrants that it has internal controls over the processing and transmission of orders suitably designed to prevent or detect on a timely basis orders received after the close of the NYSE (Market Close) from being aggregated with orders received before Market Close and to avoid errors that could result in late transmissions of orders.
ARTICLE III. PROSPECTUSES, SHAREHOLDER REPORTS, AND PROXY STATEMENTS; VOTING
3.1 The Trust shall provide the Company, at the Trusts expense, with as many copies of each Portfolios current prospectus, reports to Shareholders, other communications to Shareholders, and any supplements to the foregoing as the Company may reasonably request for distribution to existing Policy owners whose Policies are funded by such Shares. The Trust shall provide the Company, at the Companys expense, with as many copies of each Portfolios current prospectus, reports to Shareholders, other communications to Shareholders, and any supplements to the foregoing as the Company may reasonably request for distribution to prospective purchasers of Policies or to owners of existing Policies not funded by the Shares. If requested by the Company in lieu thereof, the Trust shall provide the Company with each Portfolios current prospectus in camera ready format or other electronic format acceptable to the Companys financial printer and other assistance as is reasonably necessary in order for the Company once each year (or more frequently if a prospectus for the Portfolio is revised) to have the prospectus for the Policies and the Portfolios prospectuses printed together in one document. The expense of such printing shall be (i) apportioned between (a) the Company and (b) the Trust in proportion to the number of pages of the Policies and Portfolios prospectuses, taking account other relevant factors affecting the expense of printing, such as covers, columns, graphs, and charts, with respect to the prospectuses for existing Policy owners whose Policies are funded by the Shares or (ii) borne by the Company with respect to prospectuses for prospective purchasers of Policies or to owners of existing Policies not funded by the Shares.
3.2 The prospectus for each Portfolio shall state that the statement of additional information for the Portfolio is available upon request. The Trust shall print and provide a master
of such statement of additional information suitable for duplication by the Company for distribution to any owner of a Policy who requests such statement.
3.3 The Trust or its designee, at the Trusts expense, shall provide the Company copies, if and to the extent applicable to the Shares, of the Trusts proxy materials in such quantity as the Company shall reasonably require for distribution to any owner of a Policy funded by the Shares.
3.4 Notwithstanding the provisions of Sections 3.1, 3.2, and 3.3 above, or of Article V below, the Company shall pay the expense of printing or providing documents to the extent such cost is considered a distribution expense. Distribution expenses include by way of illustration, but are not limited to, the printing of the Shares prospectus or prospectuses for distribution to prospective purchasers or to owners of existing Policies not funded by such Shares.
3.5 The Company shall be responsible for maintaining procedures regarding any delivery required by applicable law, including without limitation, the 1933 Act, to Policy owners whose Policies are funded by a Portfolios Shares of (i) Portfolio prospectuses and statements of additional information, including any annual revised copies of the prospectus and statements of additional information and other revisions or supplements or (ii) semi-annual and annual shareholder reports. The Trust shall be responsible for the timely delivery to the Company of these documents so that the Company may follow its procedures.
3.6 The Trust hereby notifies the Company that it may be appropriate to include in the prospectus pursuant to which a Policy is offered disclosure regarding the potential risks of mixed and shared funding.
3.7 If and to the extent required by law, the Company shall:
(a) Solicit voting instructions from Policy owners;
(b) Vote the Shares in accordance with instructions received from Policy owners; and
(c) Vote the Shares for which no instructions have been received in the same proportion as the Shares of such Portfolio for which instructions have been received from Policy owners; so long as and to the extent that the SEC continues to interpret the 1940 Act to require pass through voting privileges for variable contract owners. The Company will in no way recommend action in connection with or oppose or interfere with the solicitation of proxies for the Shares held for such Policy owners. The Company reserves the right to vote shares held in any segregated asset account in its own right, to the extent permitted by law. Insurance companies that have entered into participation agreements with the Trust (Participating Insurance Companies) shall be responsible for assuring that each of their separate accounts holding Shares calculates voting privileges in the manner required by the Mixed and Shared Funding Exemptive Order. The Trust will promptly notify the Company of any changes of interpretations or amendments to the Mixed and Shared Funding Exemptive Order.
ARTICLE IV. SALES MATERIAL AND INFORMATION
4.1 The Company shall furnish, or shall cause to be furnished, to the Trust or its designee, each piece of sales literature or other promotional material in which the Trust, the Adviser, any other investment adviser to the Trust, or any affiliate of the Adviser are named, at least five (5) Business Days prior to its use. No such material shall be used if the Trust, the Adviser, VCS, or their respective designees, reasonably objects to such use within five (5) Business Days after receipt of such material.
4.2 The Company shall not give any information or make any representations or statement on behalf of the Trust, the Adviser, any other investment adviser to the Trust, or any affiliate of the Adviser or concerning the Trust or any other such entity in connection with the sale of the Policies other than the information or representations contained in the registration statement, prospectus or statement of additional information for the Shares, as such registration statement, prospectus and statement of additional information may be amended or supplemented from time to time, or in reports or proxy statements for the Trust, or in sales literature or other promotional material approved by the Trust, the Adviser or their respective designees, except with the permission of the Trust, the Adviser or their respective designees. The Trust, the Adviser or their respective designees each agrees to respond to any request for approval on a prompt and timely basis. The Company shall adopt and implement policies and procedures reasonably designed to ensure that information concerning the Trust, the Adviser or any of their affiliates which is intended for use only by brokers or agents selling the Policies (i.e., information that is not intended for distribution to Policy owners or prospective Policy owners) is so used, and neither the Trust, the Adviser nor any of their affiliates shall be liable for any losses, damages or expenses relating to the improper use of such broker only materials.
4.3 The Trust or its designee shall furnish, or shall cause to be furnished, to the Company or its designee, each piece of sales literature or other promotional material in which the Company and/or the Accounts are named, at least five (5) Business Days prior to its use. No such material shall be used if the Company or its designee reasonably objects to such use within five (5) Business Days after receipt of such material.
4.4 The Trust and the Adviser shall not give any information or make any representations on behalf of the Company or concerning the Company, the Accounts, or the Policies in connection with the sale of the Policies other than the information or representations contained in a registration statement, prospectus, or statement of additional information for the Policies, as such registration statement, prospectus and statement of additional information may be amended or supplemented from time to time, or in reports for the Accounts, or in sales literature or other promotional material approved by the Company or its designee, except with the permission of the Company. The Company or its designee agrees to respond to any request for approval on a prompt and timely basis.
4.5 The Company and the Trust (or its designee in lieu of the Company or the Trust, as appropriate) will each provide to the other at least one complete copy of all registration statements, prospectuses, statements of additional information, reports, proxy statements, sales literature and other promotional materials, applications for exemptions, requests for no-action letters, and all
amendments to any of the above, that relate to the Policies, or to the Trust or its Shares, promptly after the filing of such document with the SEC or other regulatory authorities.
4.6 The Trust or the Adviser will provide the Company with reasonable advance notice of any proxy solicitation for any Portfolio, and of any material change in the Trusts registration statement, particularly any change resulting in change to the registration statement or prospectus or statement of additional information for any Account. The Trust and the Adviser will cooperate with the Company so as to enable the Company to solicit proxies from Policy owners or to make changes to its prospectus, statement of additional information or registration statement in an orderly manner. The Trust and the Adviser will make reasonable efforts to attempt to have changes affecting Policy prospectuses become effective simultaneously with the annual updates for the prospectuses.
For purpose of this Article IV and Article VIII, the phrase sales literature or other promotional material includes but is not limited to advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media), and sales literature (such as brochures, circulars, reprints or excerpts or any other advertisement, sales literature, or published articles), distributed or made generally available to customers or the public, educational or training materials or communications distributed or made generally available to some or all agents or employees.
ARTICLE V. FEES AND EXPENSES
5.1 For the administrative services provided by the Company as described on Schedule C (the Administrative Services), VCS agrees to pay or cause to be paid the fees as described on Schedule C.
5.2 To the extent the Trust or any Portfolio or any series of Shares has adopted and implemented a plan pursuant to Rule 12b-1 under the 1940 Act to finance distribution and for Shareholder servicing expenses, then the Trust, such Portfolio, or such series, as the case may be, shall pay the Rule 12b-1 fee to VCA, in its capacity as the underwriter for the Shares, and VCA shall make payments to the Company or to the underwriter for the Policies in accordance with such plan from the amounts of Rule 12b-l fees received by it as may be agreed to by VCA and the Company from time to time; each party, however, shall, in accordance with the allocation of expenses specified in Article III and this Article V, reimburse other parties for expenses initially paid by one party but allocated to another party. In addition, nothing herein shall prevent the parties hereto from otherwise agreeing to perform, and arranging for appropriate compensation for, other services relating to the Trust and/or to the Accounts.
The Trust shall bear the expenses for the cost of registration and qualification of the Shares under all applicable federal and state laws, including preparation and filing of the Trusts registration statement, and payment of filing fees and registration fees; preparation and filing of the Trusts proxy materials and reports to Shareholders; setting in type and printing is prospectus and statement of additional information (to the extent provided by and as determined in accordance with Article III above); setting in type and printing the proxy materials, reports to Shareholders, and other communications to Shareholders (to the extent provided by and as determined in
accordance with Article III above); the preparation of all statements and notices required of the Trust by any federal or state law with respect to its Shares; all taxes on the issuance or transfer of the Shares; and the costs of distributing the Trusts proxy materials to owners of Policies funded by the Shares. The costs of distributing the Portfolios prospectuses, statements of additional information, shareholder reports, and other Shareholder communications to owners of Policies funded by Shares of the Portfolios shall be borne by the relevant Portfolio. The Trust shall not bear any expenses of marketing the Policies.
5.3 The Company shall bear the expenses of distributing the Portfolios prospectuses, statement of additional information, shareholder reports, and any other communications to Policy owners, except for distributing such materials to owners of policies funded by Shares of the Portfolios, as provided for in Section 5.2 above. The Company shall bear all expenses associated with the registration, qualification, and filing of the Policies under applicable federal securities and state insurance laws; the cost of preparing, printing, and distributing the Policy prospectus and statement of additional information and the cost of preparing, printing, and distributing annual individual account statements for Policy owners as required by state insurance laws.
5.4 All expenses incident to performance by the Trust under this Agreement shall be paid by the Trust. All expenses incident to performance by the Company under this Agreement shall be paid by the Company.
ARTICLE VI. DIVERSIFICATION AND RELATED LIMITATIONS
6.1 The Trust and the Adviser represent that each Portfolio of the Trust shall meet the diversification requirements of Section 817(h)(l) of the Code and Treas. Reg. 1.817-5, relating to the diversification requirements for variable annuity, endowment, or life insurance contracts, as they may be amended from time to time (and any revenue rulings, revenue procedures, notices, and other published announcements of the Internal Revenue Service interpreting these sections), as if those requirements applied directly to each such Portfolio. The Trust will notify the Company immediately upon having a reasonable basis for believing that such requirements have ceased to be met or that they might not be met in the future. Upon request of the Company, and within 60 days of the end of the preceding calendar quarter, the Trust or the Adviser will provide Company with a certificate of compliance with Section 817(h) during that quarter. Notwithstanding the foregoing, any failure to provide such certification of compliance within the time period described will not constitute a breach of this agreement.
6.2 The Trust represents that each Portfolio will elect to be qualified as a Regulated Investment Company under Subchapter M of the Code and that they will use reasonable best efforts to maintain such qualification (under Subchapter M or any successor or similar provision). The Trust will notify the Company immediately upon having a reasonable basis for believing that such requirements have ceased to be met or that they might not be met in the future.
6.3 The Company represents that the Policies are currently, and at the time of issuance shall be, treated as life insurance or annuity contracts under applicable provisions of the Code, and that it will make every effort to maintain such treatment, and that it will notify the Fund and the Adviser immediately upon having a reasonable basis for believing the Policies have ceased to be so treated or that they might not be so treated in the future. The Company agrees that any
prospectus offering a contract that is a modified endowment contract as that term is defined in Section 7702A of the Code (or any successor or similar provision), shall identify such contract as a modified endowment contract. In addition, the Company represents that each of its Accounts is a segregated asset account and that interests in the Accounts are offered exclusively through the purchase of or transfer into a variable contract within the meaning of such terms under Section 817 of the Code and the regulations thereunder. The Company will use every effort to continue to meet such definitional requirements, and it will notify the Trust and the Adviser immediately upon having a reasonable basis for believing that such requirements have ceased to be met or that they might not be met in the future.
ARTICLE VII. POTENTIAL MATERIAL CONFLICTS
7.1 The Trust agrees that it will monitor each Portfolio of the Trust for the existence of any material irreconcilable conflict between the interests of the variable annuity contract owners and the variable life insurance policy owners of the Company and/or affiliated companies (contract owners) investing in the Trust. The Board shall have the sole authority to determine if a material irreconcilable conflict exists, and such determination shall be binding on the Company only if approved in the form of a resolution by a majority of the Board, or a majority of the disinterested trustees of the Board. The Trust will give prompt notice of any such determination to the Company.
7.2 The Company will promptly report any potential or existing conflicts of which it is aware to the Board. The Company also agrees that it will be responsible for assisting the Board in carrying out its responsibilities under the conditions set forth in the Mixed and Shared Funding Exemptive Order by providing the Board, as it may reasonably request, with all information necessary for the Board to consider any issues raised and agrees that it will be responsible for promptly reporting any potential or existing conflicts of which it is aware to the Board including, but not limited to, an obligation by the Company to inform the Board whenever contract owner voting instructions are disregarded. The Company also agrees that, if a material irreconcilable conflict arises, it will at its own cost remedy such conflict up to and including (a) withdrawing the assets allocable to some or all of the Accounts from the Trust or any Portfolio and reinvesting such assets in a different investment medium, including (but not limited to) another Portfolio of the Trust, or submitting to a vote of all affected contract owners whether to withdraw assets from the Trust or any Portfolio and reinvesting such assets in a different investment medium and, as appropriate, segregating the assets attributable to any appropriate group of contract owners that votes in favor of such segregation, or offering to any of the affected contract owners the option of segregating the assets attributable to their contracts or policies, and (b) establishing a new registered management investment company and segregating the assets underlying the Policies, unless a majority of Policy owners materially adversely affected by the conflict have voted to decline the offer to establish a new registered management investment company.
7.3 A majority of the disinterested trustees of the Board shall determine whether any proposed action by the Company adequately remedies any material irreconcilable conflict. In the event that the Board determines that any proposed action does not adequately remedy any material irreconcilable conflict, the Company will withdraw from investment in the Trust each of the Accounts designated by the disinterested trustees and terminate this Agreement within six (6) months after the Board informs the Company in writing of the foregoing determination; provided,
however, that such withdrawal and termination shall be limited to the extent required to remedy any such material irreconcilable conflict as determined by a majority of the disinterested trustees of the Board.
7.4 If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Mixed and Shared Funding Exemptive Order) on terms and conditions materially different from those contained in the Mixed and Shared Funding Exemptive Order, then (a) the Trust and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with Rule 6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such rules are applicable; and (b) Sections 3.6, 3.7, 7.1, 7.2, 7.3 and 7.4 of this Agreement shall continue in effect only to the extent that terms and conditions substantially identical to such Sections are contained in such Rule(s) as so amended or adopted.
ARTICLE VIII. INDEMNIFICATION
8.1 Indemnification by the Company
The Company agrees to indemnify and hold harmless the Trust, each Portfolio, the Adviser, VCS, and each of their respective directors/trustees, officers, employees and agents (each an Indemnified Party, or collectively, the Indemnified Parties for purposes of this Section 8.1) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Company) or expenses (including reasonable counsel fees) to which any Indemnified Party may become subject under any statute, regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Shares or the Policies and:
(a) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus or statement of additional information for the Policies or contained in the Policies or sales literature or other promotional material for the Policies (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances, not misleading provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reasonable reliance upon and in conformity with information furnished to the Company or its designee by or on behalf of the Trust, a Portfolio, the Adviser, or VCS for use in the registration statement, prospectus or statement of additional information for the Policies or in the Policies or sales literature or other promotional material (or any amendment or supplement) or otherwise for use in connection with the sale of the Policies or Shares; or
(b) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, statement of additional information or sales literature or other promotional material of the Trust not supplied by the Company or its designee, or persons under its control and on which the
Company has reasonably relied) or wrongful conduct of the Company or persons under its control, with respect to the sale or distribution of the Policies or Shares; or
(c) arise out of any untrue statement or alleged untrue statement of a material fact contained in the registration statement, prospectus, statement of additional information, or sales literature or other promotional literature of the Trust, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished to the Trust by or on behalf of the Company; or
(d) arise out of or result from any material breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Company; or
(e) arise as a result of any failure by the Company to provide the services and furnish the materials under the terms of this Agreement; or
(f) arise as a result of the provision by the Company to the Fund of insufficient or incorrect information regarding the purchase or redemption of shares, or the failure of the Company to provide such information or payment for shares in accordance with the deadlines stated in Article I; as limited by and in accordance with the provisions of this Article VIII.
8.2 Indemnification by the Trust
The Trust agrees to indemnify and hold harmless the Company and its directors/trustees, officers, employees and agents (each an Indemnified Party, or collectively, the Indemnified Parties for purposes of this Section 8.2) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Trust) or expenses (including reasonable counsel fees) to which any Indemnified Party may become subject under any statute, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Shares or the Policies and:
(a) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus; statement of additional information or sales literature or other promotional material of the Trust (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statement therein, in light of the circumstances, not misleading, provided that this agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reasonable reliance upon and in conformity with information furnished to the Trust, a Portfolio, the Adviser, VCS, or their respective designees by or on behalf of the Company for use in the registration statement, prospectus or statement of additional information for the Trust or in sales literature or other promotional material for the Trust (or any
amendment or supplement) or otherwise for use in connection with the sale of the Policies or Shares; or
(b) arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, statement of additional information or sales literature or other promotional material for the Policies not supplied by the Trust, the Adviser, VCS, or any of their respective designees or persons under their respective control and on which any such entity has reasonably relied) or wrongful conduct of the Trust or persons under its control, with respect to the sale or distribution of the Policies or Shares; or
(c) arise out of any untrue statement or alleged untrue statement of a material fact contained in the registration statement, prospectus, statement of additional information, or sales literature or other promotional literature of the Accounts or relating to the Policies, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished to the Company by or on behalf of the Trust; or
(d) arise out of or result from any material breach of any representation and/or warranty made by the Trust in this Agreement or arise out of or result from any other material breach of this Agreement by the Trust; or
(e) arise as a result of any failure by the Trust to provide the services and furnish the materials under the terms of the Agreement; or
(f) arise as a result of the provision by the Trust to the Company of insufficient or incorrect information regarding the purchase or redemption of shares, or the failure of the Trust to provide such information or payment for shares in accordance with the deadlines stated in Article I; or
(g) arise out of or result from the materially incorrect or untimely calculation or reporting of the daily NAV per share or dividend or capital gain distribution rate, as limited by and in accordance with the provisions of this Article VIII.
8.3 Indemnification by the Adviser
The Adviser agrees to indemnify and hold harmless the Company and its directors/trustees, officers, employees and agents (each an Indemnified Party, or collectively, the Indemnified Parties for purposes of this Section 8.3) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of the Adviser) or expenses (including reasonable counsel fees) to which any Indemnified Party may become subject under any statute, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Shares or the Policies and:
(a) arise out of any untrue statement or alleged untrue statement of a material fact contained in the registration statement, prospectus, statement of additional
information, or sales literature or other promotional literature of the Accounts or relating to the Policies, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished to the Company by the Adviser; or
(b) arise out of or result from any material breach of any representation and/or warranty made by the Adviser in this Agreement or arise out of or result from any other material breach of this Agreement by the Adviser; or
(c) arise as a result of any failure by the Adviser to provide the services and furnish the materials under the terms of the Agreement, as limited by and in accordance with the provisions of this Article VIII.
8.4 Indemnification by VCS
VCS agrees to indemnify and hold harmless the Company, the Trust, and each Portfolio and each of their respective trustees, officers, employees and agents (each an Indemnified Party, or collectively, the Indemnified Parties for purposes of this Section 8.4) against any and all losses, claims, damages, liabilities (including amounts paid in settlement with the written consent of VCS) or expenses (including reasonable counsel fees) to which any Indemnified Party may become subject under any statute, regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Shares and arise out of or result from any material breach of any representation and/or warranty made by VCS in this Agreement or arise out of or result from any other material breach of this Agreement by VCS, as limited by and in accordance with the provisions of this Article VIII.
8.5 Limitation of Liability
(a) In no event shall the Trust be liable under the indemnification provisions contained in this Agreement to any Indemnified Party, as defined in Section 8.2, with respect to any losses, claims, damages, liabilities or expenses that arise out of or result from (i) a breach of any representation, warranty, and/or covenant made by the Company hereunder or by any participating insurance company under an agreement containing substantially similar representations, warranties and covenants; (ii) the failure by the Company or any participating insurance company to maintain its segregated asset account (which invests in any Portfolio) as a legally and validly established segregated asset account under applicable state law and as a duly registered unit investment trust under the provisions of the 1940 Act (unless exempt therefrom); or (iii) the failure by the Company or any Participating Insurance Company to maintain its variable annuity and/or variable life insurance contracts (with respect to which any Portfolio serves as an underlying funding vehicle) as life insurance, endowment or annuity contracts under applicable provisions of the Code.
(b) In no event shall the Company be liable under the indemnification provisions contained in this Agreement to any Indemnified Party, as defined in Section 8.1, with respect to any losses, claims, damages, liabilities or expenses that arise out of or result from (i) a
breach of any representation, warranty, and/or covenant made by the Trust, the Adviser, or VCS hereunder; (ii) the failure by any Portfolio to meet the diversification requirements of Section 817(h)(l) of the Code and Treasury Regulation 1.817-5 relating to diversification requirements for variable annuity, endowment, or life insurance contracts, as if those requirements applied directly to any such Portfolio, unless caused, in whole or in part, by a breach by the Company of any representation, warranty and/or covenant made by the Company hereunder; or (iii) the failure by any Portfolio to be qualified as a Regulated Investment Company under Subchapter M of the Code.
8.6 Neither the Company, the Trust, the Adviser nor VCS shall be liable under the indemnification provisions contained in this Agreement with respect to any losses, claims, damages, liabilities or expenses to which an Indemnified Party would otherwise be subject by reason of such Indemnified Partys willful misfeasance, willful misconduct, or negligence in the performance of such Indemnified Partys duties or by reason of such Indemnified Partys reckless disregard of obligations and duties under this Agreement.
8.7 Promptly after receipt by an Indemnified Party under this Section 8.7 of notice of commencement of any action, such Indemnified Party will, if a claim in respect thereof is to be made against the indemnifying party under this section, notify the indemnifying party of the commencement thereof; but the omission so to notify the indemnifying party will not relieve it from any liability which it may have to any Indemnified Party otherwise than under this section. In case any such action is brought against any Indemnified Party, and it notified the indemnifying party of the commencement thereof, the indemnifying party will be entitled to participate therein and, to the extent that it may wish, assume the defense thereof, with counsel satisfactory to such Indemnified Party; provided, however, that the indemnifying party shall not consent to a settlement or any other disposition not involving a final adjudication that includes a factual stipulation referring to the Indemnified Party or its conduct, without the written consent of the Indemnified Party, which shall not be unreasonably withheld. After notice from the indemnifying party of its intention to assume the defense of an action with counsel satisfactory to such Indemnified Party, the Indemnified Party shall bear the expenses of any additional counsel obtained by it, and the indemnifying party shall not be liable to such Indemnified Party under this section for any legal or other expenses subsequently incurred by such Indemnified Party in connection with the defense thereof other than reasonable costs of investigation.
8.8 Each of the parties agrees promptly to notify the other parties of the commencement of any litigation or proceeding against it or any of its respective officers, directors, trustees, employees or 1933 Act control persons in connection with the Agreement, the issuance or sale of the Policies, the operation of the Accounts, or the sale or acquisition of Shares.
8.9 A successor by law of the parties to this Agreement shall be entitled to the benefits of the indemnification contained in this Article VIII. The indemnification provisions contained in this Article VIII shall survive any termination of this Agreement.
ARTICLE IX. APPLICABLE LAW
9.1 This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of the State of New York.
9.2 This Agreement shall be subject to the provisions of the 1933, 1934 and 1940 Acts, and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the SEC may grant (including, but not limited to, the Mixed and Shared Funding Exemptive Order) and the terms hereof shall be interpreted and construed in accordance therewith.
ARTICLE X. NOTICE OF FORMAL PROCEEDINGS
The Trust, the Adviser, and the Company agree that each such party shall promptly notify the other parties to this Agreement, in writing, of the institution of any formal proceedings brought against such party or its designees by FINRA, the SEC, or any insurance department or any other regulatory body regarding such partys duties under this Agreement or related to the sale of the Policies, the operation of the Accounts, or the purchase of the Shares.
ARTICLE XI. TERMINATION
11.1 This Agreement shall terminate with respect to the Accounts, or one, some, or all Portfolios, as the case may be:
(a) at the option of any party upon three (3) months advance written notice to the other parties; or
(b) at the option of the Company to the extent that the Shares of Portfolios are not reasonably available to meet the requirements of the Policies or are not appropriate funding vehicles for the Policies, as reasonably determined by the Company. Without limiting the generality of the foregoing, the Shares of a Portfolio would not be appropriate fund vehicles if, for example, such Shares did not meet the diversification or other requirements referred to in Article VI hereof; or if the Company would be permitted to disregard Policy owner voting instructions pursuant to Rule 6e-2 or 6e-3(T) under the 1940 Act. Prompt notice of the election to terminate for such cause and an explanation of such cause shall be furnished to the Trust and the Adviser by the Company; or
(c) at the option of the Trust or the Adviser in the event that the Policies fail to meet the qualifications specified in sections 2.1 and 2.2 hereof. Prompt notice of the election to terminate for such cause and an explanation of such cause shall be furnished to the Company by the Trust or the Adviser; or
(d) at the option of the Trust or the Adviser upon institution of formal proceedings against the Company by FINRA, the SEC, or any insurance department or any other regulatory body regarding the Companys duties under this Agreement or related to the sale of the Policies, or the operation of the Accounts; or
(e) at the option of the Company upon institution of formal proceedings against the Trust or the Adviser by FINRA, the SEC, or any state securities or insurance department or any other regulatory body regarding the Trusts or Advisers duties under this Agreement or related to the sale of the Shares; or
(f) at the option of the Company, the Trust or the Adviser upon receipt of any necessary regulatory approvals and/or the vote of the Policy owners having an interest in the Accounts (or any subaccounts) to substitute the shares of another investment company for the corresponding Portfolio Shares in accordance with the terms of the Policies for which those Portfolio Shares had been selected to serve as the underlying investment media. The Company will give thirty (30) days prior written notice to the Trust and the Adviser of the date of any proposed vote or other action taken to replace the Shares; or
(g) at the option of either the Trust or the Adviser by written notice to the Company, if either one, or both, of the Trust or the Adviser, respectively, shall determine, in its or their sole judgment exercised in good faith, that the Company has suffered a material adverse change in its business, operations, financial condition, or prospects since the date of this Agreement or is the subject of material adverse publicity; or
(h) at the option of the Company by written notice to the Trust and the Adviser, if the Company shall determine, in its sole judgment exercised in good faith, that the Trust or the Adviser has suffered a material adverse change in its business, operations, financial condition or prospects since the date of this Agreement or is the subject of material adverse publicity; or
(i) at the option of either the Adviser or the Trust if the Board has decided to (i) refuse to sell shares of any Portfolio to the Company and/or any of its Accounts; (ii) suspend or terminate the offering of shares of any Portfolio; or (iii) dissolve, reorganize, liquidate, merge or sell all assets of the Trust or any Portfolio, subject to the provisions of Section 1.2 hereof; or
(j) at the option of any party to this Agreement, upon another partys material breach of any provision of this Agreement; or
(k) upon assignment of this Agreement, unless made with the written consent of the parties hereto; or
(l) at the option of the Company, upon termination of any investment advisory agreement between the Trust, on behalf of any Portfolio, and the Adviser.
11.2 The notice shall specify the Portfolio or Portfolios, Policies and, if applicable, the Accounts as to which the Agreement is to be terminated.
11.3 It is understood and agreed that the right of any party hereto to terminate this Agreement pursuant to Section 11.1(a) may be exercised for cause or for no cause.
11.4 The Company shall not redeem Shares attributable to the Policies (as opposed to Shares attributable to the Companys assets held in the Account) except (i) as necessary to implement Policy owner initiated or approved transactions, (ii) as required by state and/or federal laws or regulations or judicial or other legal precedent of general application (hereinafter referred to as a Legally Required Redemption), (iii) upon 45 days prior written notice to the Trust and the Adviser, as permitted by an order of the SEC pursuant to Section 26(c) of the 1940 Act, but only if a substitution of other securities for the shares of the Portfolios is consistent with the terms
of the Policies, or (iv) as permitted under the terms of the Policy. Upon request, the Company will promptly furnish to the Trust and the Adviser reasonable assurance that any redemption pursuant to clause (ii) above is a Legally Required Redemption. Furthermore, except in cases where permitted under the terms of the Policies or in accordance with the Companys frequent trading policy, the Company shall not prevent Policy owners from allocating payments to a Portfolio that was otherwise available under the Policies without first giving the Fund and the Adviser 45 days notice of its intention to do so.
11.5 (a) Notwithstanding any termination of this Agreement, and except as provided in Section l l.5(b) hereof, the Trust shall, at the option of the Company, continue, until six months after the date of termination, and from six-month period to six-month period thereafter if mutually agreed to by the Trust, the Adviser, and the Company, to make available additional Shares pursuant to the terms and conditions of this Agreement, for all Policies in effect on the effective date of termination of this Agreement (hereinafter referred to as Existing Policies) and the Company will continue to provide services as provided herein with respect to Shares invested through Existing Policies of Policy owners.
Specifically, based on instructions from the owners of the Existing Policies, the Accounts shall be permitted to reallocate and redeem investments in the Portfolios, and shall be permitted to invest in the Portfolios in the event that owners of the Existing Policies make additional premium payments under the Existing Policies.
(b) The parties agree that this Section 11.5 shall not apply to any terminations under Article VII and the effect of such Article VII terminations shall be governed by Article VII of this Agreement. The parties further agree that, to the extent that all or a portion of the assets of the Accounts continue to be invested in any Portfolio, Articles I, II, VI, VII, VIII, and IX, and section 13.1 will remain in effect after termination.
ARTICLE XII. NOTICES
Any notice shall be sufficiently given when sent by registered or certified mail, overnight courier or facsimile to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other party.
If to the Trust:
Victory Variable Insurance Funds
4900 Tiedeman Road 4th Floor
Brooklyn, Ohio 44144
Attn: General Counsel
If to the Adviser and VCS:
Victory Capital Services, Inc. and/or Victory Capital Management Inc.
4900 Tiedeman Road 4th Floor
Brooklyn, Ohio 44144
Attn: General Counsel
If to the Company:
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, AL 35223
Attention: Senior Vice President, Chief Product Officer
With a copy to:
Senior Counsel Variable Products
Protective Life Corporation
2801 Highway 280 South
Birmingham, AL 35223
ARTICLE XIII. MISCELLANEOUS
13.1 Subject to the requirement of legal process and regulatory authority, each party hereto shall treat as confidential the names and addresses of the owners of the Policies and all information reasonably identified as confidential in writing by any other party hereto and, except as permitted by this Agreement or as otherwise required by applicable law or regulation, shall not disclose, disseminate or utilize such names and addresses and other confidential information without the express written consent of the affected party until such time as it may come into the public domain.
13.2 This Agreement may not be assigned by any party hereto except with the prior written consent of each of the other parties hereto.
13.3 The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
13.4 This Agreement may be executed simultaneously in one or more counterparts, each of which taken together shall constitute one and the same instrument.
13.5 If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.
13.6 The Schedules attached hereto, as modified from time to time, is incorporated herein by reference and are part of this Agreement.
13.7 Each party hereto shall cooperate with each other party in connection with inquiries by appropriate governmental authorities (including without limitation the SEC, FINRA, and state insurance regulators) relating to this Agreement or the transactions contemplated hereby.
13.8 The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.
13.9 Notice is hereby given that the Trusts Trust Instrument, as may be amended from time to time, has been executed on behalf of the Trust by such persons as trustees of the Trust and not individually and that the obligations of this instrument are not binding upon any of the Trustees, officers, or Shareholders individually but are binding only upon the assets and property of the Portfolios. The Company further acknowledges that the assets and liabilities of each Portfolio are separate and distinct and that the obligations of or arising out of this instrument are binding solely upon the assets or property of the Portfolio on whose behalf the Trust has executed this instrument. The Company also agrees that the obligations of each Portfolio hereunder shall be separate and not joint, and the Company agrees to look solely to the assets and property of the respective Portfolios listed on Schedule B hereto as though each such Portfolio had separately contracted with the Company for the enforcement of any claims against the Trust.
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and on its behalf by its duly authorized representative as of the date first specified above.
|
VICTORY VARIABLE INSURANCE FUNDS, on behalf of the series Portfolios, individually and not jointly |
||
|
By its authorized officer, |
||
|
|
||
|
By: |
|
|
|
|
Christopher Dyer, President |
|
|
|
||
|
VICTORY CAPITAL MANAGEMENT INC. |
||
|
By its authorized officer, |
||
|
|
|
|
|
By: |
|
|
|
|
Michael Policarpo, President, CFO and COO |
|
|
|
||
|
VICTORY CAPITAL SERVICES, INC. |
||
|
By its authorized officer, |
||
|
|
|
|
|
By: |
|
|
|
|
Christopher Dyer, COO |
|
|
|
||
|
PROTECTIVE LIFE INSURANCE COMPANY |
||
|
By its authorized officer, |
||
|
|
|
|
|
By: |
|
|
SCHEDULE A
SEPARATE ACCOUNT AND CONTRACTS
Name of Separate Account and Date Established |
|
Contract Form Number |
|
|
|
Protective COLI VUL Separate Account |
|
Protective Executive Benefits Registered VUL |
|
|
|
Protective COLI PPVUL Separate Account |
|
Protective Executive Benefits Private Placement VUL |
SCHEDULE B
PARTICIPATING PORTFOLIOS
Any portfolios or series of the Trust that are available, or which become available to new investors on or after the Effective Date of this Agreement.
SCHEDULE C
ADMINISTRATIVE SERVICES AND FEES
ADMINISTRATIVE SERVICES
The Company agrees to perform the following Administrative Services:
Maintenance of Books and Records
· Assist, as reasonably requested by the Trust, Adviser or VCS, in maintaining book entry records on behalf of a Portfolio regarding issuance to, transfer within (via net purchase orders) and redemption by an Account of Portfolio Shares.
· Maintain general ledgers regarding each Accounts holdings of Portfolio Shares, coordinate and reconcile information, and coordinate maintenance of ledgers by financial institutions and other contract owner service, providers.
Communication with the Portfolio
· Serve as the designee of the Portfolio for receipt of purchase and redemption Share orders from each Account and to transmit such orders, and payment therefor, to the Portfolio.
· Coordinate with the Portfolios agents in respect of daily valuation of the Portfolios Shares and an Accounts units.
Purchase Orders
· Determine net amount available from the Company, on behalf of each Account, for investment in the Portfolio.
· Deposit receipts from the Company, on behalf of each Account, at the Portfolios custodian (generally by wire transfer).
· Notify the Portfolios custodian of the estimated amount required to pay any dividend or distribution to the Accounts or the Company.
· Purchase Shares of the Portfolio on behalf of each Account at the applicable price computed in accordance with the Participation Agreement.
Redemption Orders
· Determine net amount of redemptions of Portfolio Shares by the Company, on behalf of each Account.
· Notify the Portfolios custodian and Portfolio of cash required to meet redemption payments to the Company, on behalf of each Account.
· Redeem Shares of the Portfolio on behalf of each Account, at the applicable price computed in accordance with the Participation Agreement.
· Participate in any action plan as may be mutually agreed upon in writing from time to time by the parties to address market timing transactions in the Portfolios Shares.
Processing Distributions from the Portfolio
· Process ordinary dividends and capital gains received on behalf of each Account.
· Reinvest the Portfolios distributions on behalf of each Account, to the extent the Company continues to desire reinvestment.
Reports
· Periodic information reporting to the Portfolio, including, but not limited to, furnishing registration statements, prospectuses, statements of additional information, reports, solicitations for voting instructions, sales or promotional materials and any other SEC filings with respect to the Accounts invested in the Portfolio.
Portfolio-related Policy Holder Services
· Provide general information with respect to Portfolio inquiries (not including information about performance or related to sales).
· Provide information regarding performance of the Portfolio and the related subaccount(s) of the Accounts.
· Respond to inquiries from Policy holders relating to Portfolio proxy statements.
Other Administrative Support
· Provide other administrative and legal compliance support for the Portfolio as mutually agreed upon in writing by the parties, to the extent permitted or required under applicable statutes.
FEES
For the Administrative Services, VCS shall pay, or cause to be paid, to the Company a fee of 0.10% per annum of the average aggregate daily NAV of Shares of the Portfolios held in the Accounts. Such fee shall be paid in arrears quarterly. Each quarterly fee shall be determined based on the assets in the Accounts, and each quarterly fee will be independent of every other quarterly fee. Such fee shall be due and payable automatically within 30 days of the receipt of the invoice from Company.
For the avoidance of doubt, the parties acknowledge that the fees described herein are not for the purpose of distribution of Portfolio Shares.
CONSENT OF COUNSEL
We hereby consent to the use of our name and to the references to our Firm under the caption Legal Matters in the Statement of Additional Information included in Pre-Effective Amendment No. 1 to the Registration Statement on Form N-6 under the Securities Act of 1933, as amended (the 1933 Act), of Protective Executive Benefits Registered VUL (File No. 333-248236). In giving such consent, however, we do not admit that we are within the category of persons whose consent is required under Section 7 of the 1933 Act or the rules and regulations of the Securities and Exchange Commission thereunder.
|
/s/ Faegre Drinker Biddle & Reath LLP |
|
Faegre Drinker Biddle & Reath LLP |
Washington, D.C.
December 16, 2020
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Pre-Effective Amendment No. 1 to the registration statement on Form N-6 (Registration Statement) of Protective COLI VUL of our report dated March 25, 2019, relating to the consolidated financial statements and financial statement schedules of Protective Life Insurance Company and subsidiaries as of December 31, 2018 and for each of the two years in the period ended December 31, 2018, which appears in this Registration Statement. We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ PricewaterhouseCoopers LLP |
|
Birmingham, Alabama |
December 15, 2020 |
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Protective Life Insurance Company:
We consent to the use of our report dated March 25, 2020, with respect to the consolidated financial statements of Protective Life Insurance Company and subsidiaries as of December 31, 2019 and for the year then ended included in the Statement of Additional Information which is part of this registration statement on Form N-6 and to the reference to our firm under the heading Experts in the Statement of Additional Information.
/s/ KPMG LLP |
|
Birmingham, Alabama |
December 16, 2020 |
PROTECTIVE LIFE INSURANCE COMPANY
DESCRIPTION OF ISSUANCE, TRANSFER, AND REDEMPTION PROCEDURES FOR
PROTECTIVE EXECUTIVE BENEFITS REGISTERED VUL POLICIES
ISSUED THROUGH PROTECTIVE COLI VUL SEPARATE ACCOUNT
Pursuant to Rule 6e-3(T)(b)(12)(iii)
This document sets forth the administrative procedures that will be followed by Protective Life Insurance Company (Protective Life or the Company) in connection with the issuance of Protective Executive Benefits Registered VUL, an individual flexible premium variable universal life insurance policy (the Policy), the transfer of assets held thereunder, and the redemption by Owners of their interests in such Policy. The defined terms used in this memorandum are the same as the defined terms in the Policy or prospectus, unless otherwise defined herein.
I. PROCEDURES RELATING TO ISSUANCE AND PURCHASE OF POLICIES
A. Application and Underwriting
Upon receipt of a completed application, the Company will follow underwriting (e.g., evaluation of risks) procedures designed to determine whether the applicant is insurable. The underwriting policies of the Company are established by management. The Company uses information from the application and, in some cases, inspection reports, attending physician statements, or medical examinations to determine whether a Policy should be issued as applied for, rated, or rejected. Medical examinations of applicants may be required. Medical examinations are requested of any applicant, regardless of age and amount of requested coverage, if an examination is deemed necessary to underwrite the risk. Substandard risks may be referred to reinsurers for full or partial reinsurance of the substandard risk. The Company will not issue a Policy until the underwriting procedures have been completed.
Insurance coverage under a Policy will begin as of the Policy Effective Date, which is generally the Issue Date. If, an initial minimum premium is received with an application, the Policy Effective Date will be the later of the date that the application is signed or any required medical examination is completed.
In order to obtain a more favorable Issue Age, the Company may permit Owners to backdate a Policy by electing a Policy Effective Date which is up to six months prior to the date of the original application; state restrictions may apply. Charges will be deducted, as of the new Policy Effective Date, for the backdated period for Monthly Deductions.
B. Initial Premium Processing and Premium Payments
Premiums for the Policies will not be the same for all Owners. The minimum initial premium depends on a number of factors, including age, sex and Premium class of the proposed Insured, the initial Face Amount requested by the applicant, any supplemental riders and endorsements requested by the applicant and the planned periodic premiums that the applicant selects.
For Policies issued in states where, upon cancellation during the Cancellation Period, the Company is required to return at least the Owners premium payments, the Company reserves the right to allocate the initial net premium payment (and any subsequent net premium payments made during the Cancellation Period) to the Money Market Sub-Account until the expiration of the number of days in the Cancellation Period. Upon expiration of this period, the Policy Value in the Money Market Sub-Account and all net premium payments will be allocated according to the Owners allocation instructions then in effect. In all other states, the Company will allocate the initial net premium payment (and any subsequent net premium payments made during the Cancellation Period) in accordance with the Owners instructions.
The Company may recommend a periodic premium amount. The actual amount of premium needed may change, depending on the number of premium payments made, changes in coverage, investment experience, monthly risk rate, and partial withdrawals and Policy loans made.
An Owner may make unscheduled premium payments as described below prior to reaching Attained Age 121. Additional premium payments may be limited to amounts that will not cause the Policy to become a modified endowment contract under Section 7702A of the Internal Revenue Code. The minimum additional premium payment that will be accepted at one time is set forth in the Policy Schedule. The Company reserves the right to restrict or refuse additional premium payments that exceed the initial periodic premium amount shown on the Policy Schedule. No premium will be refused if it is necessary to continue coverage of the Policy.
The cost of insurance rate for a Policy is based on and varies with the Issue Age, sex and Premium class of the Insured and on the number of years that a Policy has been in force. Protective Life places Insureds in the following Premium classes, based on underwriting: fully underwritten (ages 20-75) and guaranteed underwriting (ages 20-70). Protective Life guarantees that the cost of insurance rates used to calculate the monthly cost of insurance charge will not exceed the maximum cost of insurance rates set forth in the Policies. The guaranteed rates for standard classes are based on the 2017 Commissioners Standard Ordinary Mortality Tables, Male or Female, Smoker or Nonsmoker Mortality Rates (2017 CSO Tables). The guaranteed rates for substandard classes are based on multiples of, or additions to, the 2017 CSO Tables. Currently, the guaranteed minimum rate is$0.01 per $1000 and the guaranteed maximum rate is $83.33 per $1000.
Protective Lifes current cost of insurance rates may be less than the guaranteed rates that are set forth in the Policy. Current cost of insurance rates will be determined based on Protective Lifes expectations as to future mortality, investment earnings, expenses, taxes, and persistency experience. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience.
Protective Life will also determine a separate cost of insurance rate for each increment of Face Amount based on the Policy duration and the Issue Age, sex and Premium class of the Insured at the time of the request for an increase. The following rules will apply for purposes of determining the Net Amount at Risk for each Premium class.
Protective Life places the Insured in a Premium class when the Policy is issued, based on Protective Lifes underwriting of the application. This original Premium class applies to the Initial Face Amount. When an increase in Face Amount is requested, Protective Life conducts underwriting before approving the increase (except as noted below) to determine whether a different Premium class will apply to the increase. If the Premium class for the increase has lower cost of insurance rates than the original Premium class (or the Premium class of a previous increase), the Premium class for the increase also will be applied to the Initial Face Amount and any previous increases in Face Amount beginning as of the effective date of the current increase. If the Premium class for the increase has a higher cost of insurance rate than the original Premium class (or the Premium class of a previous increase), the Premium class for the increase will apply only to the increase in Face Amount.
C. Lapse and Reinstatement Procedures
Failure to pay planned periodic premiums will not necessarily cause a Policy to Lapse (terminate without value). Paying all planned periodic premiums will not necessarily prevent a Policy from lapsing. A Policy will Lapse if its Policy Value less the Policy Debt is insufficient to cover the Monthly Deduction on the Monthly Anniversary Day. If the Cash Surrender Value on any Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. This could happen if investment experience has been sufficiently unfavorable that it has resulted in a decrease in Cash Surrender Value or the Cash Surrender Value has decreased because an Owner has not paid sufficient Net Premiums to offset prior Monthly Deductions.
There is a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past due Monthly Deductions. Protective Life will send the Owner, at the Owners last known address and the last known address of any assignee of record, notice of the premium required to prevent Lapse. A Policy will remain in effect during the grace period. If the Insured should die during the grace period, the Death Benefit Proceeds payable
to the Beneficiary will reflect a reduction for the Monthly Deductions due on or before the date of the Insureds death as well as any unpaid Policy Debt or liens (including accrued interest). Unless the premium stated in the notice is paid before the grace period ends, the Policy will Lapse.
A Policy may be reinstated within 3 years after the coverage ceased, unless it has been surrendered. For a Policy to be reinstated, the Company must receive:
1. A Request from the Owner;
2. Evidence of insurability for the Insured and any other person covered by any rider or endorsement, at the Owners expense;
3. Payment of the cost of insurance for the grace period;
4. Payment of an amount equal to 4 months cost of insurance and other expense charges. Such payment less the expense charges will be credited to the Policy Value as of the date of reinstatement; and
5. Payment or reinstatement of any Policy Debt which was outstanding as of the date the coverage ceased, including interest thereon. Interest will be the maximum loan interest rate per year and will be compounded annually to the date of the Policy reinstatement.
Reinstatement will become effective on the date the application for reinstatement is approved by the Company. In some circumstances, the reinstated Policy may be a modified endowment contract under Section 7702A of the Code, even if the Policy was not a modified endowment contract prior to lapse.
II. REDEMPTION PROCEDURES: SURRENDER AND RELATED TRANSACTIONS
The principal policy provisions and administrative procedures regarding redemption transactions are summarized below. Due to the insurance nature of the Policies, the procedures that will be followed may be different from the redemption procedures for mutual funds and contractual plans.
A. Surrenders and Withdrawals
At any time while the Policy is still in force and while the Insured is still living, the Owner may surrender the Policy for its Cash Surrender Value. Cash Surrender Value is determined as of the end of the Valuation Period during which the Written Notice in Good Order requesting the surrender, the Policy and any other required documents are received by Protective Life at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 P.M. Central Time. Protective Life will process any surrender request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Date. The Cash Surrender Value is paid in a lump sum unless the Owner requests payment under a settlement option that the Company is then offering. Payment is generally made within 7 calendar days but may be subject to postponement. A Policy which terminates upon surrender cannot later be reinstated.
There is no surrender charge associated with the Policy.
An Owner may request, by Written Notice in Good Order received at the Home Office, a partial withdrawal of Policy Value at any time while the Policy is in force. The amount of any partial withdrawal must be at least $500 and may not exceed 90% of Policy Value less outstanding Policy Debt. The Company will charge an administrative fee not greater than $25 per withdrawal on partial withdrawals after the first in a Policy Year. The partial withdrawal fee will be deducted proportionally from all Sub-Accounts and Fixed Account. There are limits to taking partial withdrawals from the Fixed Account.
The Total Face Amount (if Death Benefit Option 1 applies) and Policy Value will be reduced by the amount of any withdrawals. Protective Life will withdraw the amount requested, plus a withdrawal charge from unloaned Policy Value as of the end of the Valuation Period during which the Written Notice in Good Order is received at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 P.M. Central Time.
Protective Life will process any withdrawal request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Date. The amount of a withdrawal will be withdrawn from the
Sub-Accounts and the Fixed Account in proportion to the amounts in the Sub-Accounts and the Fixed Account bearing on your Policy Value. An Owner cannot repay amounts taken as a partial withdrawal. Any subsequent payments received by the Company will be treated as additional premium payments and will be subject to the Companys limitations on premiums.
B. Changes in Face Amount
The Owner may request a change in the Face Amount of the Policy at any time within certain limits. The request must be received in writing in Good Order at the Home Office.
Any increase in the Face Amount must be at least $25,000 and an application must be submitted in Good Order. Protective Life will require satisfactory Evidence of Insurability. In addition, the Insureds current Attained Age must be less than the maximum Issue Age for the Policies, as determined by Protective Life from time to time. he increase in Face Amount will become effective as of the Monthly Anniversary Day following the date that Protective Life approves the request for the increase, and the Policy Value will be adjusted to the extent necessary to reflect a Monthly Deduction as of the effective date based on the increase in Face Amount.
Each increase to the Face Amount is considered to be a new segment to the Policy. When an increase is approved, Net Premium is allocated against the original Policy segment up to the seven-pay Premium limit established on the Issue Date. Any excess Net Premium is then allocated toward the new segment. Each segment will have a separate target Premium associated with it. The expense charge applied to Net Premium is higher up to target and lower for Net Premium in excess of the target as described in detail in the CHARGES AND DEDUCTIONS section of the Prospectus. The expense charge formula will apply to each segment based on the target Net Premium for that segment. In addition, each segment will have a new incontestability period and suicide exclusion period as described in the DEATH BENEFIT PROCEEDS Limits on Policy Rights section of the Prospectus.
Increasing the Face Amount of the Policy may increase the Death Benefit and may have the effect of increasing monthly cost of insurance charges.
The minimum decrease in the Face Amount is $25,000 and a request must be submitted in Good Order. The decrease in Face Amount will become effective on the Monthly Anniversary Day following the date that Protective Life approves the request for the decrease. If the decrease would cause the Death Benefit to be based on the applicable factor in the Table of Death Benefit Factors shown in the Policy Schedule, Protective Life reserves the right to decline or limit the amount of such decrease. Although Protective Life will attempt to notify an Owner if a decrease in the Face Amount will cause a Policy to be considered a modified endowment contract under Section 7702A of the Code, we will not automatically return premium.
The Face Amount after any decrease must be at least $100,000. If the Initial Face Amount of the Policy has been increased prior to the requested decrease, then the decrease will first be applied against any previous increases in Face Amount in the reverse order in which they occurred.
Decreasing the Face Amount of the Policy may reduce the Death Benefit and may have the effect of decreasing monthly cost of insurance charges.
C. Change in Death Benefit Option
The Owner must indicate a Death Benefit Option in the application for the Policy. On or after the first Policy Anniversary, but not more than once each Policy Year, the Owner may change the Death Benefit Option on the Policy subject to the following rules. The request must be received in writing in Good Order at the Home Office. After any change, the Face Amount must be at least $100,000. The effective date of the change will be the Monthly Anniversary Day that coincides with or next follows the day that Protective Life approves the request. Protective Life may require satisfactory Evidence of Insurability. All changes must be approved by Protective Life at the Home Office before they will be effective. Any change will be effective on the Monthly Anniversary following the date the Company approves the Request. Protective Life reserves the right to decline to change the Death Benefit Option if
after the change the Death Benefit would not be based on the applicable factor in the Table of Death Benefit Factors shown in the Policy Schedule.
When a change from Option 1 to Option 2 is made, the Face Amount after the change is effected will be equal to the Face Amount before the change less the Policy Value on the effective date of the change. When a change from Option 2 to Option 1 is made, the Face Amount after the change will be equal to the Face Amount before the change is effected plus the Policy Value on the effective date of the change.
There is a maximum fee of $100 for change of death benefits as stated in the Policy Schedule.
D. Death Benefit Claims
While the Policy remains in force, the Company will pay a death benefit to the named beneficiary in accordance with the death benefit option elected by the Owner. The Company will pay the death benefit within seven calendar days after receipt in its home office of all necessary proof of death of the Insured. Payment of a death benefit may be postponed under certain circumstances, such as the New York Stock Exchange being closed for reasons other than customary weekend and holiday closings. Death Benefit Proceeds are paid in a lump sum or under a settlement option that the Company is then offering.
The Death Benefit Proceeds are equal to the Death Benefit calculated as of the date of the Insureds death, less (1) any Policy Debt on that date and any liens for payments made under an accelerated death benefit rider or endorsement (including any accrued interest), and less (2) any past due Monthly Deductions.
The calculation of the Death Benefit depends on the Death Benefit Option elected.
The Policy has two Death Benefit Options:
Option 1. The Level Death Option. Under this option, the death benefit is the greater of
· the Policys Total Face Amount shown on the Policy Schedule, less any partial withdrawals; or
· the Cash Value on the Insureds date of death multiplied by the applicable factor in the Table of Death Benefit Factors shown in the Policy Schedule for the Insureds age at date of death.
Option 2. The Coverage Plus Option. Under this option, the death benefit is the greater of
· The Total Face Amount shown on the Policy Schedule, plus the Policy Value on the Insureds date of death; or,
· the Cash Value on the Insureds date of death multiplied by the applicable factor in the Table of Death Benefit Factors shown in the Policy Schedule for the Insureds age at date of death.
E. Policy Loans
The Owner may request a loan under a Policy. Loans allow the Owner to access Policy Value without incurring taxes and charges associated with withdrawals. Policy loans must be requested by Written Notice in Good Order received at the Home Office. Generally the minimum loan amount is $500 and the maximum loan amount is 90% of the Policy Value. This maximum is reduced by (i) any Policy Debt or any lien outstanding (including accrued interest) on the Valuation Date your loan request is received and (ii) the current Monthly Deductions remaining for the balance of the Policy Year. Outstanding Policy Debt, any lien, and the Monthly Deductions therefore reduces the amount available for new Policy loans. Loan proceeds generally are mailed within seven calendar days of the loan being approved.
When a Policy loan is made, an amount equal to the loan is transferred out of the Sub-Accounts and/or the Fixed Account and into a Loan Account established for the Policy. Like the Fixed Account, a Policys Loan Account is part of Protective Lifes General Account and amounts therein earn interest as credited by Protective Life from time to time. Because Loan Account values are part of Policy Value, a loan will have no immediate effect on the Policy Value. In contrast, Cash Surrender Value (including, as applicable, Variable Account Value and Fixed Account Value) under a Policy is reduced immediately by the amount transferred to the Loan Account. The Owner can specify the Sub-Accounts and/or the Fixed Account from which collateral is transferred to the Loan Account. If
no allocation is specified, collateral is transferred from each Sub-Account and from the Fixed Account in the same proportion that the value in each Sub-Account and the Fixed Account bears to the total unloaned Policy Value on the date that the loan is made.
On each Policy Anniversary, an amount of Policy Value equal to any due and unpaid loan interest (explained below), is also transferred to the Loan Account. Such interest is transferred from each Sub-Account and the Fixed Account in the same proportion that each Sub-Account Value and the Fixed Account Value bears to the total unloaned Policy Value.
The Owner may repay all or part of Policy Debt (the amount borrowed plus accrued interest) at any time while the Insured is living and the Policy is in force. Loan repayments in Good Order must be sent to the Home Office and are credited as of the Valuation Date received. The Owner may specify by Written Notice that any unscheduled premiums paid while a loan is outstanding be applied as loan repayments. (Loan repayments, unlike unscheduled premium payments, are not subject to the premium expense charge.) When a loan repayment is made, Policy Value in the Loan Account in an amount equal to the repayment is transferred from the Loan Account to the Sub-Accounts and the Fixed Account. Thus, a loan repayment will have no immediate effect on the Policy Value, but the Cash Surrender Value (including, as applicable, Variable Account Value and Fixed Account Value) under a Policy is increased immediately by the amount transferred from the Loan Account. Unless specified otherwise by the Owner(s), amounts are transferred to the Sub-Accounts and the Fixed Account in the same proportion that Net Premiums are allocated. Protective Lifes ability to credit interest on Policy Value in the Loan Account is subject to the Companys financial strength and claims paying ability.
Loan Interest Rates
The interest rate on the Policy loan will be determined annually, using a simple interest formula, at the beginning of each Policy Year. Specific loan interest rate information can be obtained by calling 888-353-2654. That interest rate will be guaranteed for that Policy Year and will apply to all Policy loans outstanding during that Policy Year. Interest is due and payable on each Policy Anniversary. Interest not paid when due will be added to the principal amount of the loan and will bear interest at the loan interest rate.
Presently, the maximum interest rate for Policy loans is the Moodys Corporate Bond Yield Average Monthly Average Corporates, which is published by Moodys Investor Service, Inc. If the Moodys Corporate Bond Yield Average ceases to be published, the maximum interest rate for Policy loans will be derived from a substantially similar average adopted by your states Insurance Commissioner.
We must reduce our Policy loan interest rate if the maximum loan interest rate is lower than the loan interest rate for the previous Policy Year by one-half of one percent or more.
We may increase the Policy loan interest rate but such increase must be at least one-half of one percent. No increase may be made if the Policy loan interest rate would exceed the maximum loan interest rate.
We will send you advance notice of any increase in the Policy loan rate.
III. TRANSFERS
You may transfer the Fixed Account Value or any Policy Value in a Sub-Account to other Sub-Accounts or the Fixed Account, subject to certain restrictions described below.
Upon receipt of Written Notice in Good Order to Protective Life at the Home Office you may transfer the Fixed Account Value to the Variable Account or the Variable Account Value to the Fixed Account subject to certain restrictions described below. Transfer requests received at the Home Office before 3:00 P.M. Central Time are processed as of the Valuation Date the request is received. Requests received in Good Order at or after 3:00 P.M. Central Time are processed as of the next Valuation Date.
Fixed Account Transfers
Transfers into the Fixed Account are limited to once every 60 days and to a maximum amount of $20 million, which can be increased with prior Home Office approval. Your transfer will be rejected if it would cause the value of the Fixed Account to exceed such maximum dollar amount. The limits on the frequency and amount of Transfers into the Fixed Account may be changed or waived by the Company.
Transfers from the Fixed Account may only be made once every 365 days. The maximum to be transferred out will be the greater of 25% of your balance in the Fixed Account or the amount of the transfer in the previous 365-day period. Due to these limitations, if you want to transfer all of your Policy Value from the Fixed Account to the Variable Account, it may take several years to do so. Loans and partial withdrawals are treated as Transfers out of the Fixed Account.
Sub-Account Transfers
An Owner may at any time (in some circumstances only after the Cancellation Period) transfer to another Sub-Account, all or a portion of the Variable Account Value allocated to a Sub-Account.
A fee of $10 per transfer will apply for all non-electronic transfers in excess of 12 made in a Policy Year. We may change the amount of the transfer fee; however, it is guaranteed to never exceed $10 per transfer. All transfers requested on the same Business Day will count as only one transfer toward the 12 free transfers. Likewise, any transfers under dollar cost averaging or periodic rebalancing of your Sub-Account Value under the rebalancing option do not count toward the 12 free transfers (a one-time rebalancing, however, will be counted as one transfer). Currently, electronic transfers do not count towards the 12 free transfers; however, we reserve the right, at any time, to charge for electronic transfers in excess of the free transfers allowed.
Upon receipt of Written Notice in Good Order, or where transfers are allowed to be made electronically or in such manner as Protective Life authorizes from time to time, to Protective Life at the Home Office, you may transfer the Variable Account Value between Sub-Accounts, subject to certain restrictions described below. Transfers may be requested by indicating the transfer of either a specified dollar amount or a specified percentage of the Sub-Account Value from which the transfer will be made. Transfer requests received at the Home Office before 3:00 P.M. Central Time are processed as of the Valuation Date the request is received. Requests received in Good Order at or after 3:00 P.M. Central Time are processed as of the next Valuation Date.
Transfer privileges are subject to the Companys consent. We reserve the right to impose limitations on transfers, including, but not limited to: (1) the minimum amount that may be transferred to a Sub-Account; and (2) the minimum Sub-Account Value that must remain following a transfer from that Sub-Account. In addition, we may enforce the restriction on transfers set forth in your Policy and in cases of identified market timing unless the Sub-Account has additional restrictions that are noted in the respective Funds prospectus. Protective Life may, however defer transfers under the same conditions that payment of Death Benefit Proceeds, withdrawals and surrenders may be delayed. The minimum amount that may be transferred is the lesser of $100 or the entire amount in any Sub-Account from which the transfer is made. If, after the transfer, the amount remaining in a Sub-Account(s) would be less than $1000, Protective Life reserves the right to transfer the entire amount instead of the requested amount.
The Company will give written notice thirty (30) days before we limit the number of transfers. The transfer fee, if any, is deducted from the amount being transferred. Protective Life reserves the right to terminate, suspend or modify transfer privileges at any time.
Dollar Cost Averaging
If the Owner elects at the time of application or at any time thereafter by Written Notice in Good Order to Protective Life at the Home Office, the Owner may systematically and automatically allocate a predetermined dollar amount, subject to the Companys minimum, at regular intervals from a Sub-Account (Source Sub-Account) to one or more other specified Sub-Accounts, subject to the following restriction: no transfers may be made into or out of the Fixed Account. This is known as the Dollar-Cost Averaging method of investment. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one particular time, Owner may be less
susceptible to the impact of market fluctuations in Sub-Account unit values. Protective Life, however, makes no guarantee that the Dollar-Cost Averaging method will result in a profit or protect against loss.
The unit value will be determined on the dates of the transfers. You must specify the dollar amount to be transferred into each designated Sub-Account. Transfers may be set up on any one of the following frequency periods: monthly, quarterly, semiannually, or annually. The transfer will be initiated on the next frequency period following the date of your request. We will provide a list of Sub-Accounts eligible for Dollar-Cost Averaging that may be modified from time to time. Amounts transferred through Dollar-Cost Averaging are not counted against the 12 free transfers allowed in a Policy Year. You may not participate in Dollar-Cost Averaging and Portfolio Rebalancing (described below) at the same time. Participation in Dollar-Cost Averaging does not assure a greater profit, or any profit, nor will it prevent or necessarily alleviate losses in a declining market.
Automatic transfers for Dollar-Cost Averaging are subject to all transfer restrictions and limits on frequent transfer activity. Dollar-Cost Averaging transfers may commence on any day of the month that you request. If no day is selected, transfers will occur on the Monthly Anniversary Day. We have the right to restrict these transfers until 6 days after the end of the Cancellation Period.
Once elected, Protective Life will continue to process Dollar-Cost Averaging transfers until the earlier of the following:(1) the number of designated transfers has been completed, (2) the Policy Value in the appropriate source Sub-Account is depleted, (3) the Owner, by Written Notice received by Protective Life at the Home Office, instructs Protective Life to cease the automatic transfers, (4) a grace period begins under the Policy, or (5) the maximum amount of Policy Value has been transferred under the Dollar-Cost Averaging program.
Automatic transfers made to facilitate Dollar-Cost Averaging will not count toward the 12 transfers permitted each Policy Year. Protective Life reserves the right to modify, suspend, or terminate dollar cost averaging at any time.
Portfolio Rebalancing
At the time of application or at any time thereafter by Written Notice in Good Order to Protective Life, Owner may instruct Protective Life to automatically transfer, on a periodic basis, Owner Variable Account Value among specified Sub-Accounts to achieve a particular percentage allocation of Variable Account Value among such Sub-Accounts. Such percentage allocations must be in whole numbers and must allocate amounts only among the Sub-Accounts. Portfolio Rebalancing does not include transfers into or out of the Fixed Account. There is no charge for this service. A minimum Variable Account Value of $100 is required for Portfolio Rebalancing.
Participation in portfolio rebalancing does not assure a greater profit, or any profit, nor will it prevent or necessarily alleviate losses in a declining market.
Unless Owner instruct otherwise when electing rebalancing, the percentage allocation of Owner Variable Account Value for Portfolio Rebalancing will be based on Owner premium allocation instructions in effect at the time of rebalancing. Owner can change Owner premium allocation instructions by submitting Written Notice in Good Order to the Home Office. Portfolio Rebalancing may commence on any day of the month that Owner request except the 29th, 30th or 31st. If no day is selected, rebalancing will occur on each applicable Monthly Anniversary Day. We have the right to restrict Portfolio Rebalancing until six days after the end of the Cancellation Period.
Owner may request that rebalancing occur one time only. If Protective Life receives Written Notice at the Home Office before 3:00 P.M. Central Time, the transfer will take place that same day. If Protective Life receives Written Notice at the Home Office at or after 3:00 P.M. Central Time, Protective Life will process the transfer as of the next Business Day. This transfer will count as one transfer towards the 12 free transfers allowed in a Policy Year.
Owner may also choose to rebalance Owner Variable Account Value on a quarterly, semiannual, or annual basis, in which case the first transfer will be initiated on the next frequency period following the date of Owner request. On that date, Owner Variable Account Value will be automatically reallocated to the selected Sub-Accounts. Thereafter, Owner Variable Account Value will be rebalanced once each frequency period. In order to
participate in the Portfolio Rebalancing option, Owner entire Variable Account Value must be included. Transfers made with these frequencies will not count against the 12 free transfers allowed in a Policy Year.
Owner may change or terminate Portfolio Rebalancing by Written Notice in Good Order received by Protective Life at the Home Office. Portfolio Rebalancing transfers will not count as one of the 12 free transfers available during any Policy Year.
Protective Life reserves the right to modify, suspend, or terminate portfolio rebalancing at any time.
IV. REFUNDS
The right to examine and cancel the Policy is as defined in the Policy. The Owner may cancel a Policy for a refund during the Cancellation Period by returning it to the Companys home office or to the sales representative who sold it along with a written request. The Cancellation Period is determined by the law of the state in which the application is signed and is shown in the Policy. In most states, it expires at the latest of: (1) 10 days after the Owner receives the Policy; (2) 45 days after the Owner signs the application; or (3) 10 days after the Company mails or delivers a Notice of Right of Withdrawal. Return of the Policy by mail is effective when it is received at the home office.
Within seven calendar days after receiving the returned Policy, the Company will refund (i) the difference between premiums paid and amounts allocated to the fixed account or the variable account (after deduction of any policy fees and/or other charges), plus (ii) fixed account value determined as of the date the returned Policy is received, plus (iii) variable account value determined as of the date the returned Policy is received. This amount may be more or less than the aggregate Premium Payments. In states where required, the Company will refund Premium Payments to the Owner of the Policy.
An increase in Face Amount may also be cancelled by the Owner in accordance with the Policys cancellation period provisions. The amount refunded will be calculated in accordance with the provisions described above. If no additional Premium Payments are required in connection with the Face Amount increase, the amount refunded is limited to that portion of the first monthly deduction following the increase and will be reallocated to the Sub-Account(s) and the Fixed Account in the same proportion that each sub-account value and the fixed account value bears to the total unloaned Policy Value as of the effective date of the cancellation. The effective date of this cancellation will be equal to the effective date of the face increase.
V. GENERAL PROVISIONS
A. Suicide
If the Insured dies by suicide, while sane or insane, within two years after the Policy Effective Date, the Death Benefit will be limited to the premium payments made before death, less any Policy Debt, liens (including accrued interest) and any withdrawals. If the Face Amount is increased and if the Insured commits suicide, while sane or insane, within 2 years from the effective date of any increase, the Company will pay the cost of insurance paid for the amount of increase. The Face Amount of the Policy will be reduced to the Face Amount that was in effect prior to the increase. The Company will not pay any portion of the increased Face Amount, other than the Death Benefit (and only if it is greater than the Face Amount prior to the increase).
The Company reserves the right to request and obtain evidence as to the manner and/or cause of the Insureds death.
B. Representations and Contestability
Unless fraud is involved, Protective Life will not contest the Policy, or any supplemental rider or endorsement, after the Policy, rider, or endorsement has been in force during the Insureds lifetime for two years from the Policy Effective Date or the effective date of the rider or endorsement. Likewise, unless fraud is involved, Protective Life will not contest an increase in the Face Amount with respect to statements made in the Evidence of Insurability for
that increase after the increase has been in force during the life of the Insured for two years after the effective date of the increase.
C. Misstatement of Age or Sex
If the Insureds age or sex (in non-unisex states) has been misstated in the application for the Policy or in any application for supplemental riders or endorsements, the Death Benefit under the Policy or such supplemental riders or endorsements is the amount which would have been provided by the most recent cost of insurance charge, and the cost of such supplemental riders or endorsements, at the correct age and sex. The applicable factor used in determining the Death Benefit shall be the factor required by Section 7702 of the Code reflecting the Insureds correct age and/or sex.
If the age is misstated in such a way that the Insured was not eligible for coverage under the Policy, a mortality charge and benefit will be extrapolated.
Dated: December 14, 2020
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each of the undersigned Directors and the Chief Financial Officer of Protective Life Insurance Company, a Tennessee corporation (the Company), by his execution hereof or upon an identical counterpart hereof, does hereby constitute and appoint Richard J. Bielen, Alyson Saad or Steven G. Walker, and each or any of them, his true and lawful attorney-in-fact and agent, for him and in his name, place and stead, to execute and sign the following Registration Statements on Form N-6 filed by the Company, with the Securities and Exchange Commission, pursuant to the provisions of the Securities Act of 1933, as amended (the 1933 Act) and the Investment Company Act of 1940, as amended (the 1940 Act):
Protective Executive Benefits Registered VUL File No. 333-248236
Protective COLI VUL File No. 811-23604
Further, each of the undersigned authorizes said attorney-in-fact, and each of them, to execute and sign any and all pre-effective and post-effective amendments to such Registration Statements, and to file same, with all exhibits and schedules thereto and all other documents in connection therewith, with the Securities and Exchange Commission pursuant to the provisions of the 1933 Act and the 1940 Act, and with such state securities authorities as may be appropriate, granting unto said attorney-in-fact and agent, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes of the undersigned might or could do in person, hereby ratifying and confirming all the acts of said attorney-in-fact and agent or any of them which they may lawfully do in the premises or cause to be done by virtue hereof.
IN WITNESS WHEREOF, each of the undersigned has hereunto set his hand and sealed this 16 day of December, 2020.
/s/ Richard J. Bielen |
|
/s/ Steven G. Walker |
Richard J. Bielen |
|
Steven G. Walker |
|
|
|
/s/ Michael G. Temple |
|
|
Michael G. Temple |
|
|
|
|
|
WITNESS TO ALL SIGNATURES: |
|
|
|
|
|
/s/ Alyson Saad |
|
|
Alyson Saad |
|
|